Citrus Sinensis ID: 005298
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 703 | 2.2.26 [Sep-21-2011] | |||||||
| O61122 | 478 | Serine/threonine-protein | yes | no | 0.378 | 0.556 | 0.634 | 1e-104 | |
| B0LT89 | 431 | Serine/threonine-protein | yes | no | 0.375 | 0.612 | 0.659 | 1e-96 | |
| Q99KH8 | 431 | Serine/threonine-protein | yes | no | 0.375 | 0.612 | 0.655 | 2e-96 | |
| Q9Y6E0 | 443 | Serine/threonine-protein | yes | no | 0.375 | 0.595 | 0.651 | 9e-96 | |
| Q9P289 | 416 | Serine/threonine-protein | no | no | 0.375 | 0.634 | 0.632 | 2e-93 | |
| Q9Z2W1 | 426 | Serine/threonine-protein | no | no | 0.382 | 0.631 | 0.642 | 2e-93 | |
| Q99JT2 | 416 | Serine/threonine-protein | no | no | 0.375 | 0.634 | 0.632 | 4e-93 | |
| Q3SWY6 | 426 | Serine/threonine-protein | no | no | 0.382 | 0.631 | 0.638 | 2e-92 | |
| O00506 | 426 | Serine/threonine-protein | no | no | 0.382 | 0.631 | 0.634 | 8e-92 | |
| Q86IX1 | 737 | Serine/threonine-protein | no | no | 0.375 | 0.358 | 0.539 | 5e-79 |
| >sp|O61122|SVKA_DICDI Serine/threonine-protein kinase svkA OS=Dictyostelium discoideum GN=svkA PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 380 bits (975), Expect = e-104, Method: Compositional matrix adjust.
Identities = 170/268 (63%), Positives = 222/268 (82%), Gaps = 2/268 (0%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
E IG+GSFG+V+K +K+ N+ +AIK IDLE++EDEIEDIQ+EI+VLSQC SP++T+Y+G
Sbjct: 16 EKIGKGSFGEVFKGINKKTNETIAIKTIDLEDAEDEIEDIQQEINVLSQCESPFVTKYFG 75
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
S+L +KLWIIMEY+AGGSV DL++ GP DE IA ILR+LL +EYLH+EGKIHRDIK
Sbjct: 76 SFLKGSKLWIIMEYLAGGSVLDLMKPGP-FDEGYIAIILRELLKGLEYLHSEGKIHRDIK 134
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
AAN+LL+ +GDVK+ADFGVS QLT +++R TFVGTPFWMAPEVI+ + GY+ KADIWS+
Sbjct: 135 AANVLLSASGDVKLADFGVSGQLTDQMTKRNTFVGTPFWMAPEVIKQT-GYDSKADIWSM 193
Query: 199 GITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258
GIT +EMAKGEPP ADLHPMR LF+IP++ PP L+ +FS+ KEF +LCL K P +RP+A
Sbjct: 194 GITALEMAKGEPPRADLHPMRALFLIPKDPPPTLEGNFSKGFKEFCALCLNKDPNQRPTA 253
Query: 259 KELLRHRFIRNARKSPRLLERIRERPKY 286
K+LL+H+FI+ A+K+ L + I R K+
Sbjct: 254 KDLLKHKFIKAAKKTSSLTDLIERRQKW 281
|
Involved in regulation of actin cytoskeleton organization during cell motility; F-actin fragmenting and capping protein allowing dynamic rearrangements of the actin cytoskeleton. Also part of a regulatory pathway from the centrosome to the midzone, thus regulating the completion of cell division. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|B0LT89|STK24_RAT Serine/threonine-protein kinase 24 OS=Rattus norvegicus GN=Stk24 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 354 bits (908), Expect = 1e-96, Method: Compositional matrix adjust.
Identities = 176/267 (65%), Positives = 219/267 (82%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPY+T
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ G PLDE+ IA ILR++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDEIQIATILREILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPM+VLF+IP+ NPP L+ +SR +KEFV CL K P+
Sbjct: 202 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGSYSRPLKEFVEACLNKEPSF 261
Query: 255 RPSAKELLRHRF-IRNARKSPRLLERI 280
RP+AKELL+H+F IRNA+K+ L E I
Sbjct: 262 RPTAKELLKHKFIIRNAKKTSYLTELI 288
|
Serine/threonine-protein kinase that acts on both serine and threonine residues and promotes apoptosis in response to stress stimuli and caspase activation. Mediates oxidative-stress-induced cell death by modulating phosphorylation of JNK1-JNK2 (MAPK8 and MAPK9), p38 (MAPK11, MAPK12, MAPK13 and MAPK14) during oxidative stress. Plays a role in a staurosporine-induced caspase-independent apoptotic pathway by regulating the nuclear translocation of AIFM1 and ENDOG and the DNase activity associated with ENDOG. Phosphorylates STK38L on 'Thr-442' and stimulates its kinase activity. Regulates cellular migration with alteration of PTPN12 activity and PXN phosphorylation: phosphorylates PTPN12 and inhibits its activity and may regulate PXN phosphorylation through PTPN12 (By similarity). Acts as a key regulator of axon regeneration in the adult optic nerve and radial nerve. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q99KH8|STK24_MOUSE Serine/threonine-protein kinase 24 OS=Mus musculus GN=Stk24 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 353 bits (907), Expect = 2e-96, Method: Compositional matrix adjust.
Identities = 175/267 (65%), Positives = 220/267 (82%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPY+T
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ G PLDE+ IA ILR++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDEIQIATILREILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPM+VLF+IP+ NPP L+ ++S+ +KEFV CL K P+
Sbjct: 202 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 261
Query: 255 RPSAKELLRHRF-IRNARKSPRLLERI 280
RP+AKELL+H+F IRNA+K+ L E I
Sbjct: 262 RPTAKELLKHKFIIRNAKKTSYLTELI 288
|
Serine/threonine-protein kinase that acts on both serine and threonine residues and promotes apoptosis in response to stress stimuli and caspase activation. Mediates oxidative-stress-induced cell death by modulating phosphorylation of JNK1-JNK2 (MAPK8 and MAPK9), p38 (MAPK11, MAPK12, MAPK13 and MAPK14) during oxidative stress. Plays a role in a staurosporine-induced caspase-independent apoptotic pathway by regulating the nuclear translocation of AIFM1 and ENDOG and the DNase activity associated with ENDOG. Phosphorylates STK38L on 'Thr-442' and stimulates its kinase activity. Regulates cellular migration with alteration of PTPN12 activity and PXN phosphorylation: phosphorylates PTPN12 and inhibits its activity and may regulate PXN phosphorylation through PTPN12. Acts as a key regulator of axon regeneration in the optic nerve and radial nerve. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y6E0|STK24_HUMAN Serine/threonine-protein kinase 24 OS=Homo sapiens GN=STK24 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 351 bits (901), Expect = 9e-96, Method: Compositional matrix adjust.
Identities = 174/267 (65%), Positives = 219/267 (82%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPY+T
Sbjct: 36 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 95
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ G PLDE IA ILR++L ++YLH+E KIH
Sbjct: 96 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIH 154
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 155 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 213
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+A+GEPP ++LHPM+VLF+IP+ NPP L+ ++S+ +KEFV CL K P+
Sbjct: 214 IWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 273
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERI 280
RP+AKELL+H+FI RNA+K+ L E I
Sbjct: 274 RPTAKELLKHKFILRNAKKTSYLTELI 300
|
Serine/threonine-protein kinase that acts on both serine and threonine residues and promotes apoptosis in response to stress stimuli and caspase activation. Mediates oxidative-stress-induced cell death by modulating phosphorylation of JNK1-JNK2 (MAPK8 and MAPK9), p38 (MAPK11, MAPK12, MAPK13 and MAPK14) during oxidative stress. Plays a role in a staurosporine-induced caspase-independent apoptotic pathway by regulating the nuclear translocation of AIFM1 and ENDOG and the DNase activity associated with ENDOG. Phosphorylates STK38L on 'Thr-442' and stimulates its kinase activity. Regulates cellular migration with alteration of PTPN12 activity and PXN phosphorylation: phosphorylates PTPN12 and inhibits its activity and may regulate PXN phosphorylation through PTPN12. May act as a key regulator of axon regeneration in the optic nerve and radial nerve. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9P289|MST4_HUMAN Serine/threonine-protein kinase MST4 OS=Homo sapiens GN=MST4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 344 bits (882), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 169/267 (63%), Positives = 214/267 (80%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC S Y+T
Sbjct: 24 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL +KLWIIMEY+ GGS DL+++G P DE IA +L+++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKGSKLWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVIQ S Y+ KAD
Sbjct: 143 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +D+HPMRVLF+IP+ NPP L F++ KEF+ CL K P+
Sbjct: 202 IWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSF 261
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERI 280
RP+AKELL+H+FI +N++K+ L E I
Sbjct: 262 RPTAKELLKHKFIVKNSKKTSYLTELI 288
|
Mediator of cell growth. Modulates apoptosis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Z2W1|STK25_MOUSE Serine/threonine-protein kinase 25 OS=Mus musculus GN=Stk25 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 343 bits (881), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 174/271 (64%), Positives = 211/271 (77%), Gaps = 2/271 (0%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ L+ IG+GSFG+VYK D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPYIT
Sbjct: 20 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 79
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
Y+GSYL TKLWIIMEY+ GGS DL++ G PL+E IA ILR++L ++YLH+E KIH
Sbjct: 80 RYFGSYLKSTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSERKIH 138
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 139 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKAD 197
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +DLHPMRVLF+IP+ NPP L+ H S+ KEFV CL K P
Sbjct: 198 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNNPPTLEGHHSKPFKEFVEACLNKDPRF 257
Query: 255 RPSAKELLRHRFIRNARKSPRLLERIRERPK 285
RP+AKELL+H+FI K L + +R K
Sbjct: 258 RPTAKELLKHKFITRYTKKTSFLTELIDRYK 288
|
Oxidant stress-activated serine/threonine kinase that may play a role in the response to environmental stress. Targets to the Golgi apparatus where it appears to regulate protein transport events, cell adhesion, and polarity complexes important for cell migration. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q99JT2|MST4_MOUSE Serine/threonine-protein kinase MST4 OS=Mus musculus GN=Mst4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (878), Expect = 4e-93, Method: Compositional matrix adjust.
Identities = 169/267 (63%), Positives = 214/267 (80%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC S Y+T
Sbjct: 24 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL +KLWIIMEY+ GGS DL+++G P DE IA +L+++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKGSKLWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVIQ S Y+ KAD
Sbjct: 143 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +D+HPMRVLF+IP+ NPP L F++ KEF+ CL K P+
Sbjct: 202 IWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLIGDFTKSFKEFIDACLNKDPSF 261
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERI 280
RP+AKELL+H+FI +N++K+ L E I
Sbjct: 262 RPTAKELLKHKFIVKNSKKTSYLTELI 288
|
Mediator of cell growth. Modulates apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3SWY6|STK25_BOVIN Serine/threonine-protein kinase 25 OS=Bos taurus GN=STK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (873), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 173/271 (63%), Positives = 211/271 (77%), Gaps = 2/271 (0%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ L+ IG+GSFG+VYK D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPYIT
Sbjct: 20 FTKLDRIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 79
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
Y+GSYL TKLWIIMEY+ GGS DL++ G PL+E IA ILR++L ++YLH+E KIH
Sbjct: 80 RYFGSYLKSTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSERKIH 138
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 139 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKAD 197
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +DLHPMRVLF+IP+ +PP L+ H S+ KEFV CL K P
Sbjct: 198 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGHHSKPFKEFVEACLNKDPRF 257
Query: 255 RPSAKELLRHRFIRNARKSPRLLERIRERPK 285
RP+AKELL+H+FI K L + +R K
Sbjct: 258 RPTAKELLKHKFITRYTKKTSFLTELIDRYK 288
|
Oxidant stress-activated serine/threonine kinase that may play a role in the response to environmental stress. Targets to the Golgi apparatus where it appears to regulate protein transport events, cell adhesion, and polarity complexes important for cell migration. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O00506|STK25_HUMAN Serine/threonine-protein kinase 25 OS=Homo sapiens GN=STK25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (867), Expect = 8e-92, Method: Compositional matrix adjust.
Identities = 172/271 (63%), Positives = 210/271 (77%), Gaps = 2/271 (0%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ L+ IG+GSFG+VYK D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPYIT
Sbjct: 20 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 79
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
Y+GSYL TKLWIIMEY+ GGS DL++ G PL+E IA ILR++L ++YLH+E KIH
Sbjct: 80 RYFGSYLKSTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSERKIH 138
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 139 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKAD 197
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +DLHPMRVLF+IP+ +PP L+ S+ KEFV CL K P
Sbjct: 198 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRF 257
Query: 255 RPSAKELLRHRFIRNARKSPRLLERIRERPK 285
RP+AKELL+H+FI K L + +R K
Sbjct: 258 RPTAKELLKHKFITRYTKKTSFLTELIDRYK 288
|
Oxidant stress-activated serine/threonine kinase that may play a role in the response to environmental stress. Targets to the Golgi apparatus where it appears to regulate protein transport events, cell adhesion, and polarity complexes important for cell migration. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q86IX1|DST1_DICDI Serine/threonine-protein kinase dst1 OS=Dictyostelium discoideum GN=dst1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (757), Expect = 5e-79, Method: Compositional matrix adjust.
Identities = 145/269 (53%), Positives = 191/269 (71%), Gaps = 5/269 (1%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
E +G+GSFG V+KA K VAIK+I L++ E I+D++KEIS+L++C P I +Y+G
Sbjct: 33 ERLGKGSFGQVFKAVHFANGKVVAIKIISLDDQE-AIKDVRKEISILAECNYPNIVQYFG 91
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
SY +LWI+MEY GGSV+DL+Q + E IA I R+ L + YLH KIHRDIK
Sbjct: 92 SYFKDHQLWIVMEYCGGGSVSDLLQVIDTISEDEIALICREALKGLNYLHEFKKIHRDIK 151
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
NILL + G+VK+ADFGVSAQL T S+R TFVGTP+WMAPEVIQ ++ Y+ KAD+WSL
Sbjct: 152 GGNILLNDRGEVKLADFGVSAQLFNTFSKRNTFVGTPYWMAPEVIQENK-YDGKADVWSL 210
Query: 199 GITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH--FSRLMKEFVSLCLKKVPAERP 256
GIT IEMA+G PP +++HPMRV+F+IPRE P L + +S ++F+S CL K PAERP
Sbjct: 211 GITAIEMAEGLPPNSNVHPMRVIFMIPREESPALTDKSIWSDKFQDFISKCLTKDPAERP 270
Query: 257 SAKELLRHRFIRNARKSPRLLERIRERPK 285
+AKELL H FI+ +K +L + E K
Sbjct: 271 TAKELLNHEFIQ-TKKPLSILSDLVENCK 298
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 703 | ||||||
| 225461512 | 706 | PREDICTED: uncharacterized protein LOC10 | 0.995 | 0.991 | 0.759 | 0.0 | |
| 255584401 | 697 | ATP binding protein, putative [Ricinus c | 0.978 | 0.987 | 0.765 | 0.0 | |
| 356549701 | 695 | PREDICTED: uncharacterized protein LOC10 | 0.988 | 1.0 | 0.725 | 0.0 | |
| 224128268 | 703 | predicted protein [Populus trichocarpa] | 0.972 | 0.972 | 0.747 | 0.0 | |
| 356543342 | 700 | PREDICTED: uncharacterized protein LOC10 | 0.992 | 0.997 | 0.728 | 0.0 | |
| 356517110 | 700 | PREDICTED: uncharacterized protein LOC10 | 0.990 | 0.994 | 0.729 | 0.0 | |
| 356543344 | 709 | PREDICTED: uncharacterized protein LOC10 | 0.992 | 0.984 | 0.717 | 0.0 | |
| 449456635 | 713 | PREDICTED: uncharacterized protein LOC10 | 0.988 | 0.974 | 0.698 | 0.0 | |
| 15232528 | 690 | putative protein kinase [Arabidopsis tha | 0.980 | 0.998 | 0.683 | 0.0 | |
| 356542296 | 679 | PREDICTED: uncharacterized protein LOC10 | 0.943 | 0.976 | 0.713 | 0.0 |
| >gi|225461512|ref|XP_002285125.1| PREDICTED: uncharacterized protein LOC100258981 isoform 1 [Vitis vinifera] gi|302142973|emb|CBI20268.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1038 bits (2684), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 537/707 (75%), Positives = 606/707 (85%), Gaps = 7/707 (0%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
MA+ A + +A GSRFSSLELIGRGSFGDVYK FDKELNKDVAIKVIDLEE+EDEIEDIQK
Sbjct: 1 MAEAAAIMDATGSRFSSLELIGRGSFGDVYKGFDKELNKDVAIKVIDLEEAEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG PLDEMSIACILRDL
Sbjct: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGQPLDEMSIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR M
Sbjct: 181 EVIQNSEGYNEKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRPM 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKELL+HRFIRNARKSPRLLERIRERPKY I+++ +TP NG +
Sbjct: 241 KEFVSLCLKKVPAERPSAKELLKHRFIRNARKSPRLLERIRERPKYQIKDDAETPRNGPK 300
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
+GE S TVKV RD R EETV+ SSQG+T+RNAGW+FSLS S TGT+R+ ++PPQ RE+
Sbjct: 301 GIGEGSDTVKVTRDSRGEETVRASSQGKTLRNAGWDFSLSGSQSTGTVRSVIRPPQARER 360
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDDTS 420
KPE SY Q ++TA+ +NH SASGS +ES + + ARD+Y+D+ QD+ +EDD+ S
Sbjct: 361 KPEVSY-QAPSRKTADSNNHLLSASGSGRYESSEIFLGKEARDAYYDE-QDNSHEDDELS 418
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPR 480
S SGTVV+RSPRG +SS F D+S++SS+TY S EDASTSGTVV R HDDSDS RTP+
Sbjct: 419 VSGSGTVVVRSPRGYQSSIPFSDQSSLSSNTYASLEDASTSGTVVIRSHHDDSDSPRTPK 478
Query: 481 SRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNND-GEYRRREQIT 539
SRLGIQER+S+A EDSA+NLAEAKAA+Q GLRKGNARER LGK+N D E R+ EQIT
Sbjct: 479 SRLGIQERTSTAPPEDSAINLAEAKAAMQGGLRKGNARERSVLGKVNKDEQEKRKTEQIT 538
Query: 540 SSSDSSRDSRDYLDAQRGFSRPRQGSDEEESAKIA--SSSGALSVLLIPSIKEAVADDSE 597
SSSDSSR SR+Y DA + F+R RQ SD++ESA+ A SSS ALS+L IPS+KEA DDS+
Sbjct: 539 SSSDSSRHSREYYDAPKAFARSRQSSDDDESARAAVLSSSKALSILFIPSLKEAGLDDSK 598
Query: 598 GPVVRQVVSSLAYMERIKPGSCEVFVRRLLQQLASSKESSVKELQELSSRIFTKGKTA-- 655
G + V ++L MER KPGSCEV V +LLQ LASSKESS+K+LQEL++R+FTKGKTA
Sbjct: 599 GAIGHAVANALINMERTKPGSCEVLVSKLLQHLASSKESSLKDLQELATRVFTKGKTAPE 658
Query: 656 EAAQNANAEDNKKKQPNKDVNSNANLSPLARFLLSRWQGQASRDLNP 702
EA DN+K+Q NK++NSN NLSPLARFLLSRWQGQ SRDL+P
Sbjct: 659 EAENANAEADNRKRQQNKELNSNPNLSPLARFLLSRWQGQVSRDLSP 705
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584401|ref|XP_002532933.1| ATP binding protein, putative [Ricinus communis] gi|223527297|gb|EEF29449.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1009 bits (2609), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/694 (76%), Positives = 598/694 (86%), Gaps = 6/694 (0%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
M D AGL EAAGSRFSSLELIG+GSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK
Sbjct: 1 MGDAAGLMEAAGSRFSSLELIGKGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCR PYITEYYGSYL+QTKLWIIMEYMAGGSVADL+QSG PLDE+SIACILRDL
Sbjct: 61 EISVLSQCRCPYITEYYGSYLNQTKLWIIMEYMAGGSVADLLQSGHPLDEISIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHAIEYLHNEGKIHRDIKAANILL+ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAIEYLHNEGKIHRDIKAANILLSENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR M
Sbjct: 181 EVIQNSEGYNEKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRPM 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKELL+HRFI+NARKSPRLLERIRERPKY I++ +TP NG +
Sbjct: 241 KEFVSLCLKKVPAERPSAKELLKHRFIKNARKSPRLLERIRERPKYQIRDA-ETPRNGPK 299
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
+GEAS TVKV RD R + TV+ S+QG+ ++NAGW+FS+ S +GT+++ ++PPQVREK
Sbjct: 300 PMGEASDTVKVSRDVRDDGTVRASAQGKPLKNAGWDFSIGGSLSSGTVKSVLRPPQVREK 359
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDDTS 420
K E SYN+ T +RT+E N S SG+ L SPD + ARD D+ D+ ++ DD S
Sbjct: 360 KTENSYNKVT-QRTSESGNFLLSPSGNALQGSPDLLFGKDARDLRPDEHLDNSHDYDDLS 418
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPR 480
S SGTVVIR+PRGS+SS LFRD+S+ SSST S EDASTSGTV++RGQHDD DS +TP+
Sbjct: 419 ISGSGTVVIRTPRGSQSSTLFRDQSSPSSSTVASFEDASTSGTVIFRGQHDDYDSPQTPK 478
Query: 481 SRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDG-EYRRREQIT 539
SRLGI+ER+SSASLEDSAVNLAEAKA I++GLRKGNARER AL K+NNDG E RRREQ+T
Sbjct: 479 SRLGIKERTSSASLEDSAVNLAEAKAVIEAGLRKGNARERSALHKINNDGHENRRREQMT 538
Query: 540 SSSDSSRDSRDYLDAQRGFSRPRQGSDEEESAKIASSSGALSVLLIPSIKEAVADDSEGP 599
+SS S SRDY DAQR F R RQ SD+EESA+IA SS LSVLL+PS+KE ADD EG
Sbjct: 539 NSS-DSSSSRDYFDAQRMFPRSRQVSDDEESARIALSSAPLSVLLMPSLKETYADDPEGS 597
Query: 600 VVRQVVSSLAYMERIKPGSCEVFVRRLLQQLASSKESSVKELQELSSRIFTKGK-TAEAA 658
VVR V +SL +MER+KPGS +V VR LLQ+LASSKESS+K+LQEL++ +F+KGK T E
Sbjct: 598 VVRSVTNSLIHMERMKPGSTDVLVRSLLQRLASSKESSMKDLQELAACLFSKGKATPEET 657
Query: 659 QNANAE-DNKKKQPNKDVNSNANLSPLARFLLSR 691
QNA+ E +NKKKQ NKD NSNANLSPLARFLLSR
Sbjct: 658 QNASTEAENKKKQQNKDFNSNANLSPLARFLLSR 691
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549701|ref|XP_003543230.1| PREDICTED: uncharacterized protein LOC100814188 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 983 bits (2542), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 510/703 (72%), Positives = 593/703 (84%), Gaps = 8/703 (1%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
MAD+AGL EA+GSRFSSLELIG+GSFGDVYKAFD+ELNK VAIKVIDLEESEDEI+DIQK
Sbjct: 1 MADVAGLVEASGSRFSSLELIGQGSFGDVYKAFDRELNKLVAIKVIDLEESEDEIDDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCR PYITEYYGSYL+QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL
Sbjct: 61 EISVLSQCRCPYITEYYGSYLNQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHA++YLH+EGKIHRDIKAANILL+ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAVDYLHSEGKIHRDIKAANILLSENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQN++GYNEKADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLD+HFSR +
Sbjct: 181 EVIQNTDGYNEKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDDHFSRPL 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKELL+ RFIRNARKS +L ERIRERPKY I+E+ +TP NG
Sbjct: 241 KEFVSLCLKKVPAERPSAKELLKDRFIRNARKSSKLSERIRERPKYQIKEDEETPRNGPS 300
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
+GEASGTVKV RD R EE + S QG+T+++AGW+FS+ S GTGT R +PPQ R+K
Sbjct: 301 GMGEASGTVKVARDSRGEENNRPSDQGKTLKSAGWDFSIGGSQGTGTFRNVSRPPQFRDK 360
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDDTS 420
K E S+NQ T ++ ER G S + S L+ES ++S R R + D+ D++ EDD+ S
Sbjct: 361 KTEVSHNQLTQRKAPERGYQGVSVNRSALNESLESSFGRDLRVPHHDEHLDNHLEDDELS 420
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPR 480
+ SGTVVIRSP+GSRSS FRD+S++SSS+Y S EDAS+SGTVV RGQHD+SDS +TPR
Sbjct: 421 GNGSGTVVIRSPKGSRSSA-FRDQSSLSSSSYASFEDASSSGTVVLRGQHDESDSPQTPR 479
Query: 481 SRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDGEYRRREQITS 540
SRLG+ +R+S+AS+EDSA NLAEAKAAI LRK NARERLA GK+NND + +R+Q S
Sbjct: 480 SRLGLNDRNSNASMEDSAANLAEAKAAI---LRKSNARERLARGKINNDRQESKRDQKAS 536
Query: 541 SSDSSRDSRDYLDAQRGFSRPRQGSDEEESAKIASSSGALSVLLIPSIKEAVADDSEGPV 600
SSDSSR +Y DA + R SD EESAKI SSS LSVLLIPS+KEA+ADD E +
Sbjct: 537 SSDSSRPHGEY-DAHKSMLRSHHASDGEESAKIMSSSVPLSVLLIPSLKEAIADDPE--L 593
Query: 601 VRQVVSSLAYMERIKPGSCEVFVRRLLQQLASSKESSVKELQELSSRIFTKGKTAEAAQN 660
+R V++SL ME KP SC+VFV++LLQ+LASSKE S+K++Q L+ ++F+K K+AE QN
Sbjct: 594 MRAVINSLINMEGTKPKSCDVFVKKLLQRLASSKEDSLKDMQGLAGQLFSKNKSAEETQN 653
Query: 661 ANAEDNKKKQPNKDVNSNANLSPLARFLLSRWQGQASRDLNPT 703
A A DN+KKQ NK+ NSN+NLSPLARFLLSRWQGQ SRDLNP+
Sbjct: 654 AEA-DNRKKQQNKEHNSNSNLSPLARFLLSRWQGQTSRDLNPS 695
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128268|ref|XP_002329122.1| predicted protein [Populus trichocarpa] gi|222869791|gb|EEF06922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 982 bits (2539), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/694 (74%), Positives = 587/694 (84%), Gaps = 10/694 (1%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
MAD AGL EAAG+RFSSLELIGRGSFGDVYKAFDKEL+K+VAIKVIDLEESEDEIEDIQK
Sbjct: 1 MADAAGLMEAAGARFSSLELIGRGSFGDVYKAFDKELDKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVL QCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL+QSGPPLDEMSIACILRDL
Sbjct: 61 EISVLRQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLLQSGPPLDEMSIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHAIEYLHNEGKIHRDIKAANILL+ENGDVKVADFGVSAQLT T+SRRKTFVGTPFWMAP
Sbjct: 121 LHAIEYLHNEGKIHRDIKAANILLSENGDVKVADFGVSAQLTGTVSRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYN KADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR M
Sbjct: 181 EVIQNSEGYNVKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRPM 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVS CLKK RP+AKELLRHRFIRNARKSPRLLERIRERP Y I+ + +TP NG
Sbjct: 241 KEFVSFCLKK----RPTAKELLRHRFIRNARKSPRLLERIRERPMYQIK-DAETPRNGPI 295
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
+GE TVKVVRD R++ TV+ S QG+ +NAGW+FS+ S TGTIR+A +PPQVREK
Sbjct: 296 GIGEGFDTVKVVRDLRADGTVRASGQGKPFKNAGWDFSIGGSQTTGTIRSAARPPQVREK 355
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDDTS 420
K + SYN+ T +R +E NH SASG+ L ES + S + ARD Y DD QD+ Y+DDD S
Sbjct: 356 KTDISYNKDTQRRASESGNHLLSASGNALQESLELSYGKDARDPYHDDHQDNSYDDDDLS 415
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPR 480
S SGTVVIR+P+G +SS LFRD++ SSST TS EDASTSGTVV+RGQHD+SDS RT +
Sbjct: 416 VSGSGTVVIRTPKGYQSSALFRDQNNASSSTSTSFEDASTSGTVVFRGQHDESDSPRTHK 475
Query: 481 SRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDG-EYRRREQIT 539
SRLG+QER+SS+SLEDSA+NLAEA+AA+Q GLRK NARER N G E RRREQ+T
Sbjct: 476 SRLGMQERTSSSSLEDSALNLAEARAALQGGLRKVNARERFVPSNNNRYGLENRRREQLT 535
Query: 540 SSSDSSRDSRDYLDAQRGFSRPRQGSDEEESAKIASSSGALSVLLIPSIKEAVADDSEGP 599
+SSDSSR SR+Y DA + F R +Q S+ EESA+IAS+S LSVLLIPS+KEAVADDSE
Sbjct: 536 NSSDSSRSSREYFDAPKAFPRSQQASNVEESARIASAS--LSVLLIPSLKEAVADDSERA 593
Query: 600 VVRQVVSSLAYMERIKPGSCEVFVRRLLQQLASSKESSVKELQELSSRIFTKGKTA-EAA 658
+ V +SL MER+KPGSC++FVR LLQQLASSKESS+++LQEL++ + +KGKT E
Sbjct: 594 LFHAVTNSLVNMERVKPGSCDIFVRSLLQQLASSKESSLRDLQELAAHLLSKGKTTPEET 653
Query: 659 QNANAE-DNKKKQPNKDVNSNANLSPLARFLLSR 691
QN N + D++KKQP K+ NSNANLSPLARFLLSR
Sbjct: 654 QNGNTDVDSRKKQPTKEFNSNANLSPLARFLLSR 687
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543342|ref|XP_003540120.1| PREDICTED: uncharacterized protein LOC100786501 isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 980 bits (2534), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/703 (72%), Positives = 592/703 (84%), Gaps = 5/703 (0%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
MAD+AGL EAAG+RFSSLELIG+GSFGDVYK FDKELNK+VAIKVIDLEESEDEIEDIQK
Sbjct: 1 MADIAGLAEAAGARFSSLELIGQGSFGDVYKGFDKELNKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCRSPYITEYYGS+L+QTKLWIIMEYMAGGSVADL+QSGPPLDEMSIACILRDL
Sbjct: 61 EISVLSQCRSPYITEYYGSFLNQTKLWIIMEYMAGGSVADLLQSGPPLDEMSIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHAI+YLHNEGKIHRDIKAANILLT+NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAIDYLHNEGKIHRDIKAANILLTDNGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR M
Sbjct: 181 EVIQNSEGYNEKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRYM 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP+LLERIRERPKY I+E+ TP N R
Sbjct: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPKLLERIRERPKYQIKEDQTTPRNAPR 300
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
+GEAS T+KV +D R +ET Q S QG+T+R++GW+FS+ S GTGT R+ +PPQ R+K
Sbjct: 301 GMGEASDTIKVAKDLRGDETNQPSGQGKTLRSSGWDFSIGGSQGTGTFRSVSRPPQFRDK 360
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDDTS 420
K E S +Q ++ E G S + S L+E + S + Y D+ D++ E+D+ S
Sbjct: 361 KTEVSDHQLNQRKIPESGYQGESGNKSALNELLETSFGKDLGVPYHDEHPDNHLENDEFS 420
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGT-VVYRGQHDDSDSARTP 479
+ SGTVVIRSP+G + S +FRD+S+ SSS+Y S ED STSGT VV QHDDSDS +TP
Sbjct: 421 GNGSGTVVIRSPKGPQPS-MFRDQSSQSSSSYASFEDVSTSGTVVVLHSQHDDSDSPQTP 479
Query: 480 RSRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDGEYRRREQIT 539
RSRLG+ R+S+ASLEDSA NL EAKAAIQ GLRK N RER ALGK+NND + +R+Q++
Sbjct: 480 RSRLGLNSRNSNASLEDSATNLVEAKAAIQGGLRKVNVRERFALGKLNNDVQDSKRDQMS 539
Query: 540 SSSDSSRDSRDYLDAQRGFSRPRQGSDEEESAKIASSSGALSVLLIPSIKEAVADDSEGP 599
SSSDSSR SR+Y DA + FSR D+EESAKI SSS LSVLLIPS+KEA+ADD +G
Sbjct: 540 SSSDSSRPSREYFDAPKAFSRSHYSIDDEESAKIISSSVPLSVLLIPSLKEAIADDPDGS 599
Query: 600 VVRQVVSSLAYMERIKPGSCEVFVRRLLQQLASSKESSVKELQELSSRIFTKGKTAEAAQ 659
+V+ V+++L ME KP SC+VFV++LLQQLASSKESS K+LQEL+ +IF+K K++E +
Sbjct: 600 IVQIVINALVNMESTKPQSCDVFVKKLLQQLASSKESSFKDLQELAGQIFSKTKSSEETR 659
Query: 660 NANAEDNKKKQPNKDVNSNANLSPLARFLLSRWQGQASRDLNP 702
NA + DNKK+ NK+V+SN+NLSPLARFLLSRWQGQ SRDLNP
Sbjct: 660 NAES-DNKKQ--NKEVHSNSNLSPLARFLLSRWQGQTSRDLNP 699
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517110|ref|XP_003527233.1| PREDICTED: uncharacterized protein LOC100788857 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 980 bits (2533), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/705 (72%), Positives = 595/705 (84%), Gaps = 9/705 (1%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
MAD+AGL EAAG+RFSSLELIG+GSFGDVYK FD+ELNK+VAIKVIDLEESEDEIEDIQK
Sbjct: 1 MADIAGLAEAAGARFSSLELIGQGSFGDVYKGFDRELNKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCRSPYITEYYGS+L+QTKLWIIMEYMAGGSVADL+QSGPPLDEMSIACILRDL
Sbjct: 61 EISVLSQCRSPYITEYYGSFLNQTKLWIIMEYMAGGSVADLLQSGPPLDEMSIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHAI+YLHNEGKIHRDIKAANILLT+NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAIDYLHNEGKIHRDIKAANILLTDNGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYN KADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR M
Sbjct: 181 EVIQNSEGYNVKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRYM 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP+LLERIRERPKY I+E+ TP N R
Sbjct: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPKLLERIRERPKYQIKEDQMTPRNAPR 300
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
+GEAS T+KV +D R +ET Q S QG+++R++GW+FS+ S GTGT R+ +PPQ R+K
Sbjct: 301 GMGEASDTIKVAKDLRGDETNQPSGQGKSLRSSGWDFSIGGSQGTGTFRSVSRPPQFRDK 360
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARD---SYFDDRQDDYYEDD 417
K E S +Q +++ E S + S +ES + T + +D +Y D+ D++ EDD
Sbjct: 361 KIELSNHQLNQRKSPESGYQVGSDNKSAHNESLE---TYFGKDLGVAYHDEHPDNHLEDD 417
Query: 418 DTSASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSAR 477
+ S + SGTVVIRSP+G + S LFRD+S+ SSS+Y S ED STSGTVV R Q++DSDS +
Sbjct: 418 EFSGNGSGTVVIRSPKGPQPS-LFRDQSSRSSSSYASFEDVSTSGTVVLRSQYNDSDSPQ 476
Query: 478 TPRSRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDGEYRRREQ 537
TPRSRLG+ R+S+ASLEDSA NLAEAK AIQ GLRK N RER ALGK+NND + RR Q
Sbjct: 477 TPRSRLGLNSRNSNASLEDSATNLAEAKVAIQGGLRKVNIRERFALGKLNNDVQDSRRGQ 536
Query: 538 ITSSSDSSRDSRDYLDAQRGFSRPRQGSDEEESAKIASSSGALSVLLIPSIKEAVADDSE 597
I+SSSDSSR SR+Y DAQ+GFSR D+EESAKI SSS LSVLLIPS+KEA+ADD +
Sbjct: 537 ISSSSDSSRPSREYFDAQKGFSRSHYAIDDEESAKIISSSAPLSVLLIPSLKEAIADDPD 596
Query: 598 GPVVRQVVSSLAYMERIKPGSCEVFVRRLLQQLASSKESSVKELQELSSRIFTKGKTAEA 657
G +V+ V+ +L ME KP SC+V V++LLQQLASSKESS+K+LQEL+ +IF+K K+AE
Sbjct: 597 GSIVQIVIDALVNMESTKPQSCDVLVKKLLQQLASSKESSLKDLQELAGQIFSKTKSAE- 655
Query: 658 AQNANAEDNKKKQPNKDVNSNANLSPLARFLLSRWQGQASRDLNP 702
+N NAE + KK+ NK+V+SN+NLSPLARFLLSRWQGQ SRDLNP
Sbjct: 656 -ENRNAESDNKKKQNKEVHSNSNLSPLARFLLSRWQGQTSRDLNP 699
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543344|ref|XP_003540121.1| PREDICTED: uncharacterized protein LOC100786501 isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 973 bits (2516), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/712 (71%), Positives = 592/712 (83%), Gaps = 14/712 (1%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
MAD+AGL EAAG+RFSSLELIG+GSFGDVYK FDKELNK+VAIKVIDLEESEDEIEDIQK
Sbjct: 1 MADIAGLAEAAGARFSSLELIGQGSFGDVYKGFDKELNKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCRSPYITEYYGS+L+QTKLWIIMEYMAGGSVADL+QSGPPLDEMSIACILRDL
Sbjct: 61 EISVLSQCRSPYITEYYGSFLNQTKLWIIMEYMAGGSVADLLQSGPPLDEMSIACILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHAI+YLHNEGKIHRDIKAANILLT+NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAIDYLHNEGKIHRDIKAANILLTDNGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR M
Sbjct: 181 EVIQNSEGYNEKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRYM 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP+LLERIRERPKY I+E+ TP N R
Sbjct: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPKLLERIRERPKYQIKEDQTTPRNAPR 300
Query: 301 AVGEASGTVKVVRDKRSEET---------VQVSSQGQTVRNAGWNFSLSESHGTGTIRTA 351
+GEAS T+KV +D R +ET + S QG+T+R++GW+FS+ S GTGT R+
Sbjct: 301 GMGEASDTIKVAKDLRGDETNHEFSDGQFLNCSGQGKTLRSSGWDFSIGGSQGTGTFRSV 360
Query: 352 VKPPQVREKKPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQD 411
+PPQ R+KK E S +Q ++ E G S + S L+E + S + Y D+ D
Sbjct: 361 SRPPQFRDKKTEVSDHQLNQRKIPESGYQGESGNKSALNELLETSFGKDLGVPYHDEHPD 420
Query: 412 DYYEDDDTSASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGT-VVYRGQH 470
++ E+D+ S + SGTVVIRSP+G + S +FRD+S+ SSS+Y S ED STSGT VV QH
Sbjct: 421 NHLENDEFSGNGSGTVVIRSPKGPQPS-MFRDQSSQSSSSYASFEDVSTSGTVVVLHSQH 479
Query: 471 DDSDSARTPRSRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDG 530
DDSDS +TPRSRLG+ R+S+ASLEDSA NL EAKAAIQ GLRK N RER ALGK+NND
Sbjct: 480 DDSDSPQTPRSRLGLNSRNSNASLEDSATNLVEAKAAIQGGLRKVNVRERFALGKLNNDV 539
Query: 531 EYRRREQITSSSDSSRDSRDYLDAQRGFSRPRQGSDEEESAKIASSSGALSVLLIPSIKE 590
+ +R+Q++SSSDSSR SR+Y DA + FSR D+EESAKI SSS LSVLLIPS+KE
Sbjct: 540 QDSKRDQMSSSSDSSRPSREYFDAPKAFSRSHYSIDDEESAKIISSSVPLSVLLIPSLKE 599
Query: 591 AVADDSEGPVVRQVVSSLAYMERIKPGSCEVFVRRLLQQLASSKESSVKELQELSSRIFT 650
A+ADD +G +V+ V+++L ME KP SC+VFV++LLQQLASSKESS K+LQEL+ +IF+
Sbjct: 600 AIADDPDGSIVQIVINALVNMESTKPQSCDVFVKKLLQQLASSKESSFKDLQELAGQIFS 659
Query: 651 KGKTAEAAQNANAEDNKKKQPNKDVNSNANLSPLARFLLSRWQGQASRDLNP 702
K K++E +NA + DNKK+ NK+V+SN+NLSPLARFLLSRWQGQ SRDLNP
Sbjct: 660 KTKSSEETRNAES-DNKKQ--NKEVHSNSNLSPLARFLLSRWQGQTSRDLNP 708
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449456635|ref|XP_004146054.1| PREDICTED: uncharacterized protein LOC101214412 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2452), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/719 (69%), Positives = 573/719 (79%), Gaps = 24/719 (3%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
M+D+A + EA +RFSSLELIGRGSFGDVYK FDKELNK+VAIKVIDLEESEDEIEDIQK
Sbjct: 1 MSDVASIAEAVAARFSSLELIGRGSFGDVYKGFDKELNKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL+QSGPPLDEMSI+CILRDL
Sbjct: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLLQSGPPLDEMSISCILRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHAI+YLH EGKIHRDIKAANILL+ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAIDYLHTEGKIHRDIKAANILLSENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGIT IEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSR M
Sbjct: 181 EVIQNSEGYNEKADIWSLGITAIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRPM 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEE-PDTPINGV 299
KE VSLCLKK+PAERPSAKELL+HRFI+NARKSPRLLERIRERPKY I+EE +TP NG
Sbjct: 241 KELVSLCLKKIPAERPSAKELLKHRFIKNARKSPRLLERIRERPKYQIKEEDAETPTNGS 300
Query: 300 RAVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVRE 359
RA+GE + TVKV R+ R EETV+ S+Q + +NAGW+FS+ H TGT+R+ VKPPQ+RE
Sbjct: 301 RAIGETTDTVKVSRNVR-EETVRASNQNKAPKNAGWDFSIGGPHSTGTVRSVVKPPQIRE 359
Query: 360 KKPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSY-FDDRQDD------ 412
+KPE Y Q P R E N + SG + S D S RDSY D +D
Sbjct: 360 RKPEIPYGQGAPSRVPESGNW-LAVSG---YASRDTSEN--TRDSYSMGDASEDVNFPHF 413
Query: 413 --------YYEDDDTSASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTV 464
+ ++ S S SGTVVIRSPRGS++S F + S+ S S ED S SGTV
Sbjct: 414 ISLSYNYFFRSHEELSVSGSGTVVIRSPRGSQASTQFHNESSPSESAQGYFEDTSFSGTV 473
Query: 465 VYRGQHDDSDSARTPRSRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALG 524
V RGQ DDS S +TP+SR+GIQER+SS S EDSA NLAEAKAAIQ+GL+K NAR+R A+
Sbjct: 474 VMRGQRDDSGSPQTPKSRMGIQERTSSFSPEDSASNLAEAKAAIQAGLKKANARDRSAIN 533
Query: 525 KMNNDGEYRRREQITSSSDSSRDSRDYLDAQRGFSRPRQGSDEEESAKIASSSGALSVLL 584
K+N+ E RR EQ SSSDSSR SR++ DA R +P DEEESAKIA SS LSVL
Sbjct: 534 KLNDRKENRRTEQTVSSSDSSRHSREFFDAPRALVKPSLSLDEEESAKIALSSAPLSVLF 593
Query: 585 IPSIKEAVADDSEGPVVRQVVSSLAYMERIKPGSCEVFVRRLLQQLASSKESSVKELQEL 644
+ S+KE VADDSEG R V+++L ME +KPGSCEV +LLQ+LASSKESS+K+LQ+L
Sbjct: 594 MSSLKEVVADDSEGSPSRTVINALINMEHLKPGSCEVLATKLLQKLASSKESSLKDLQDL 653
Query: 645 SSRIFTKGKTA-EAAQNANAEDNKKKQPNKDVNSNANLSPLARFLLSRWQGQASRDLNP 702
++R+F+K KT E QN DN KK PN++++SN+NLS LARFLLSRWQGQ SRDL+P
Sbjct: 654 ATRLFSKAKTVPEDTQNVTDSDNSKKLPNRELHSNSNLSSLARFLLSRWQGQVSRDLSP 712
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15232528|ref|NP_188140.1| putative protein kinase [Arabidopsis thaliana] gi|9294249|dbj|BAB02151.1| MAP kinase [Arabidopsis thaliana] gi|22316560|emb|CAD44272.1| map 4 kinase alpha2 [Arabidopsis thaliana] gi|24030319|gb|AAN41328.1| putative MAP kinase [Arabidopsis thaliana] gi|332642112|gb|AEE75633.1| putative protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 929 bits (2401), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/701 (68%), Positives = 561/701 (80%), Gaps = 12/701 (1%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
M D+AGLQEAAG+RFS +ELIGRGSFGDVYKAFDK+LNK+VAIKVIDLEESEDEIEDIQK
Sbjct: 1 MDDVAGLQEAAGARFSQIELIGRGSFGDVYKAFDKDLNKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
EISVLSQCR PYITEYYGSYLHQTKLWIIMEYMAGGSVADL+QS PLDE SIACI RDL
Sbjct: 61 EISVLSQCRCPYITEYYGSYLHQTKLWIIMEYMAGGSVADLLQSNNPLDETSIACITRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHA+EYLHNEGKIHRDIKAANILL+ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAVEYLHNEGKIHRDIKAANILLSENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE PPQLDEHFSR +
Sbjct: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRETPPQLDEHFSRQV 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKK PAERPSAKEL++HRFI+NARKSP+LLERIRERPKY ++E+ +TP NG +
Sbjct: 241 KEFVSLCLKKAPAERPSAKELIKHRFIKNARKSPKLLERIRERPKYQVKEDEETPRNGAK 300
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
A E+SGTV++ RD+RS+ S QG TV+NAGW+F++ S GT+R A+KPPQ RE+
Sbjct: 301 APVESSGTVRIARDERSQGAPGYSFQGNTVKNAGWDFTVGGSQSIGTVR-ALKPPQARER 359
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYYEDDDTS 420
+ E S N+ + + T N SA+GST+ E+ + R R + +D +D ++E+DD+S
Sbjct: 360 RQEVSPNRISQRTTRPSGNQWSSATGSTISEASEGGFVR--RHPFQNDHEDGFHEEDDSS 417
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPR 480
S SGTVVIR+PR S+SS +FR+ S+ SS Y + +DAS SGTVV RGQ+DDS S RTP+
Sbjct: 418 LSGSGTVVIRTPRSSQSSSVFREPSSGSSGRYAAFDDASASGTVVVRGQYDDSGSPRTPK 477
Query: 481 SRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDGEY-RRREQIT 539
SRLGIQER+SSAS EDS NLAEAKAA+ +G R+G ARERL +G NNDG+ RRREQ+
Sbjct: 478 SRLGIQERTSSAS-EDSNANLAEAKAALDAGFRRGKARERLGMGNNNNDGKVNRRREQMA 536
Query: 540 SSSDSSRDSRDYLDAQRGFSRPRQGSDEEESAKIASSSGALSVLLIPSIKEAVADDSEGP 599
SD SR+S D Q+ R Q SDEE+ + S +LSVLLIPS+KEA+ DDS+
Sbjct: 537 DDSDYSRNSGDKSSKQKVVPRSEQVSDEEDDSIWESLPASLSVLLIPSLKEALGDDSKES 596
Query: 600 VVRQVVSSLAYMERIKPGSCEVFVRRLLQQLASSKESSVKELQELSSRIFTKGKTAEAAQ 659
VR V SL MER KPGSCE FV +L++ L SSKE+SVKEL +++ +F K A
Sbjct: 597 TVRTVSRSLVMMEREKPGSCEAFVAKLIELLGSSKEASVKELHDMAVCVFAKTTPDNA-- 654
Query: 660 NANAEDNKKKQPNKDVNSNANLSPLARFLLSRWQGQASRDL 700
+NK KQ NK+ +SN N+SPL RFLLSRW GQ+SRDL
Sbjct: 655 -----ENKMKQANKEFSSNTNVSPLGRFLLSRWLGQSSRDL 690
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542296|ref|XP_003539605.1| PREDICTED: uncharacterized protein LOC100815042 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 922 bits (2384), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/671 (71%), Positives = 560/671 (83%), Gaps = 8/671 (1%)
Query: 33 FDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92
FD+ELNK VAIKVIDLEESEDEI+DIQKEISVLSQCR PYITEYYGSYL+QTKLWIIMEY
Sbjct: 17 FDRELNKLVAIKVIDLEESEDEIDDIQKEISVLSQCRCPYITEYYGSYLNQTKLWIIMEY 76
Query: 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV 152
MAGGSVADLIQSGPPLDEMSIACILRDLLHA++YLH+EGKIHRDIKAANILL+ENGDVKV
Sbjct: 77 MAGGSVADLIQSGPPLDEMSIACILRDLLHAVDYLHSEGKIHRDIKAANILLSENGDVKV 136
Query: 153 ADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPL 212
ADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN++GYNEKADIWSLGIT IEMAKGEPPL
Sbjct: 137 ADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNTDGYNEKADIWSLGITAIEMAKGEPPL 196
Query: 213 ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272
ADLHPMRVLFIIPRENPPQLD+HFSR +KEFVSLCLKKVPAERPSAKELL+ RFIRNARK
Sbjct: 197 ADLHPMRVLFIIPRENPPQLDDHFSRPLKEFVSLCLKKVPAERPSAKELLKDRFIRNARK 256
Query: 273 SPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVKVVRDKRSEETVQVSSQGQTVRN 332
S +L ERIRERPKY I+E+ +TP NG +GEASGTVKV RD R EE + S QG+T+++
Sbjct: 257 SSKLSERIRERPKYQIKEDEETPRNGPSGMGEASGTVKVARDLRGEENNRPSDQGKTLKS 316
Query: 333 AGWNFSLSESHGTGTIRTAVKPPQVREKKPEFSYNQYTPKRTAERSNHGFSASGSTLHES 392
AGW+FS+ S GTGT R +PPQ R+K E S+NQ T ++ + G S + S L+ES
Sbjct: 317 AGWDFSIGGSQGTGTFRNVSRPPQFRDKITEVSHNQLTQRKAPQSGYQGGSVNRSALNES 376
Query: 393 PDASPTRYARDSYFDDRQDDYYEDDDTSASASGTVVIRSPRGSRSSGLFRDRSAVSSSTY 452
++S R R + D+ D++ EDD+ S + SGTVVIRSP+GSRSS FRD+S+ SSS+Y
Sbjct: 377 LESSFGRDLRVPHHDEHLDNHLEDDELSGNGSGTVVIRSPKGSRSSA-FRDQSSQSSSSY 435
Query: 453 TSAEDASTSGTVVYRGQHDDSDSARTPRSRLGIQERSSSASLEDSAVNLAEAKAAIQSGL 512
S EDAS+SGTVV RGQHD+SDS +TPRSRLG+ +R+S+AS+EDSA NLAEAKAAI L
Sbjct: 436 ASFEDASSSGTVVLRGQHDESDSPQTPRSRLGLNDRNSNASMEDSAANLAEAKAAI---L 492
Query: 513 RKGNARERLALGKMNNDGEYRRREQITSSSDSSRDSRDYLDAQRGFSRPRQGSDEEESAK 572
RK NARE+LA GK+NND + +R+Q SSSDSSR +Y DA +G R SD EESAK
Sbjct: 493 RKSNAREKLARGKINNDRQESKRDQKASSSDSSRPHGEY-DAHKGMLRSHHASDGEESAK 551
Query: 573 IASSSGALSVLLIPSIKEAVADDSEGPVVRQVVSSLAYMERIKPGSCEVFVRRLLQQLAS 632
I SSS LSVLLIPS+KEA+ADD E +VR V++SL ME KP SC+VFV++LLQ+LAS
Sbjct: 552 IMSSSVPLSVLLIPSLKEAIADDPE--LVRAVINSLINMEGTKPKSCDVFVKKLLQRLAS 609
Query: 633 SKESSVKELQELSSRIFTKGKTAEAAQNANAEDNKKKQPNKDVNSNANLSPLARFLLSRW 692
SKE S+K+LQ L+ ++F+K K+A+ +NA A DN+KKQ NK+ NSN+NLSPLARFLLSRW
Sbjct: 610 SKEDSLKDLQGLADQLFSKTKSAQETRNAEA-DNRKKQQNKEHNSNSNLSPLARFLLSRW 668
Query: 693 QGQASRDLNPT 703
QGQ SRDLNP+
Sbjct: 669 QGQTSRDLNPS 679
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 703 | ||||||
| TAIR|locus:2087130 | 690 | AT3G15220 [Arabidopsis thalian | 0.980 | 0.998 | 0.636 | 1.1e-224 | |
| WB|WBGene00001526 | 653 | gck-1 [Caenorhabditis elegans | 0.388 | 0.418 | 0.554 | 5.7e-86 | |
| FB|FBgn0086736 | 642 | GckIII "Germinal centre kinase | 0.395 | 0.433 | 0.546 | 5.9e-86 | |
| DICTYBASE|DDB_G0286359 | 478 | svkA "severin kinase" [Dictyos | 0.485 | 0.713 | 0.490 | 7.2e-86 | |
| RGD|1563568 | 415 | Mst4 "serine/threonine protein | 0.449 | 0.761 | 0.504 | 5e-85 | |
| ZFIN|ZDB-GENE-080516-5 | 412 | mst4 "serine/threonine protein | 0.394 | 0.672 | 0.553 | 6.6e-85 | |
| MGI|MGI:1917665 | 416 | 2610018G03Rik "RIKEN cDNA 2610 | 0.449 | 0.759 | 0.504 | 8.2e-85 | |
| UNIPROTKB|Q9P289 | 416 | MST4 "Serine/threonine-protein | 0.449 | 0.759 | 0.504 | 1.7e-84 | |
| MGI|MGI:2385007 | 431 | Stk24 "serine/threonine kinase | 0.413 | 0.675 | 0.558 | 2.7e-84 | |
| ZFIN|ZDB-GENE-040426-2841 | 420 | stk24b "serine/threonine kinas | 0.413 | 0.692 | 0.545 | 4.5e-84 |
| TAIR|locus:2087130 AT3G15220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2169 (768.6 bits), Expect = 1.1e-224, P = 1.1e-224
Identities = 446/701 (63%), Positives = 520/701 (74%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXX 60
M D+AGLQEAAG+RFS +ELIGRGSFGDVYKAFDK+LNK+VAIKV
Sbjct: 1 MDDVAGLQEAAGARFSQIELIGRGSFGDVYKAFDKDLNKEVAIKVIDLEESEDEIEDIQK 60
Query: 61 XXSVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
SVLSQCR PYITEYYGSYLHQTKLWIIMEYMAGGSVADL+QS PLDE SIACI RDL
Sbjct: 61 EISVLSQCRCPYITEYYGSYLHQTKLWIIMEYMAGGSVADLLQSNNPLDETSIACITRDL 120
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
LHA+EYLHNEGKIHRDIKAANILL+ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP
Sbjct: 121 LHAVEYLHNEGKIHRDIKAANILLSENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAP 180
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE PPQLDEHFSR +
Sbjct: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRETPPQLDEHFSRQV 240
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
KEFVSLCLKK PAERPSAKEL++HRFI+NARKSP+LLERIRERPKY ++E+ +TP NG +
Sbjct: 241 KEFVSLCLKKAPAERPSAKELIKHRFIKNARKSPKLLERIRERPKYQVKEDEETPRNGAK 300
Query: 301 AVGEASGTVKVVRDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREK 360
A E+SGTV++ RD+RS+ S QG TV+NAGW+F++ S GT+R A+KPPQ RE+
Sbjct: 301 APVESSGTVRIARDERSQGAPGYSFQGNTVKNAGWDFTVGGSQSIGTVR-ALKPPQARER 359
Query: 361 KPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARDSXXXXXXXXXXXXXXTS 420
+ E S N+ + + T N SA+GST+ E+ + R R +S
Sbjct: 360 RQEVSPNRISQRTTRPSGNQWSSATGSTISEASEGGFVR--RHPFQNDHEDGFHEEDDSS 417
Query: 421 ASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSARTPR 480
S SGTVVIR+PR S+SS +FR+ S+ SS Y + +DAS SGTVV RGQ+DDS S RTP+
Sbjct: 418 LSGSGTVVIRTPRSSQSSSVFREPSSGSSGRYAAFDDASASGTVVVRGQYDDSGSPRTPK 477
Query: 481 SRLGIQERSSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDGEY-RRREQIT 539
SRLGIQER+SSAS EDS NLAEAKAA+ +G R+G ARERL +G NNDG+ RRREQ+
Sbjct: 478 SRLGIQERTSSAS-EDSNANLAEAKAALDAGFRRGKARERLGMGNNNNDGKVNRRREQMA 536
Query: 540 XXXXXXXXXXXYLDAQRGFSRPRQGSDEEESAKIASSSGALSVLLIPSIKEAVADDSEGP 599
Q+ R Q SDEE+ + S +LSVLLIPS+KEA+ DDS+
Sbjct: 537 DDSDYSRNSGDKSSKQKVVPRSEQVSDEEDDSIWESLPASLSVLLIPSLKEALGDDSKES 596
Query: 600 VVRQVVSSLAYMERIKPGSCEVFVRRLLQQLASSKESSVKELQELSSRIFTKGKTXXXXX 659
VR V SL MER KPGSCE FV +L++ L SSKE+SVKEL +++ +F K
Sbjct: 597 TVRTVSRSLVMMEREKPGSCEAFVAKLIELLGSSKEASVKELHDMAVCVFAK-------T 649
Query: 660 XXXXXXXXXXXPNKDVNSNANLSPLARFLLSRWQGQASRDL 700
NK+ +SN N+SPL RFLLSRW GQ+SRDL
Sbjct: 650 TPDNAENKMKQANKEFSSNTNVSPLGRFLLSRWLGQSSRDL 690
|
|
| WB|WBGene00001526 gck-1 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 780 (279.6 bits), Expect = 5.7e-86, Sum P(2) = 5.7e-86
Identities = 153/276 (55%), Positives = 196/276 (71%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ E IGRGSFG+VYK D + VAIK+ VLSQC S Y+T
Sbjct: 34 FTKQERIGRGSFGEVYKGIDNRTGRVVAIKIIDLEQAEDEIEDIQQEIQVLSQCDSQYVT 93
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+Y+GS+L +KLWIIMEY+ GGS DL +SG LDE IA ILR++L +EYLH+E KIH
Sbjct: 94 KYFGSFLKGSKLWIIMEYLGGGSALDLTKSGK-LDESHIAVILREILKGLEYLHSERKIH 152
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+L++E+GDVKVADFGV+ QLT T+ +R TFVG+PFWMAPE+I+ S Y+ KAD
Sbjct: 153 RDIKAANVLVSEHGDVKVADFGVAGQLTETVKKRITFVGSPFWMAPELIKQSS-YDYKAD 211
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD-EHFSRLMKEFVSLCLKKVPA 253
IWSLGIT IE+A GEPP +DLHPMRVLF+IP+ PP L +S+ KEFV +CL K P
Sbjct: 212 IWSLGITAIELANGEPPHSDLHPMRVLFLIPKNPPPVLQGSQWSKPFKEFVEMCLNKDPE 271
Query: 254 ERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQ 289
RPSA LL+H+FI+ A+K+ L++ I +Y ++
Sbjct: 272 NRPSASTLLKHQFIKRAKKNSILVDLIERAAEYRLR 307
|
|
| FB|FBgn0086736 GckIII "Germinal centre kinase III" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 5.9e-86, Sum P(3) = 5.9e-86
Identities = 154/282 (54%), Positives = 203/282 (71%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ E IG+GSFG+V+K D + VAIK+ VLSQC SPY+T
Sbjct: 13 FTKQERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIDDIQQEIMVLSQCDSPYVT 72
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGS+L TKLWIIMEY+ GGS DL+++G +EM I ILR++L ++YLH+E K+H
Sbjct: 73 KYYGSFLKGTKLWIIMEYLGGGSALDLMKAGS-FEEMHIGIILREVLKGLDYLHSERKLH 131
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T S+R TFVGTPFWMAPEVI+ S+ Y+ KAD
Sbjct: 132 RDIKAANVLLSEQGDVKLADFGVAGQLTNTTSKRNTFVGTPFWMAPEVIKQSQ-YDAKAD 190
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPMRVLF+IP+ NPPQL +++ K+FV CL K P
Sbjct: 191 IWSLGITAIELAKGEPPNSELHPMRVLFLIPKNNPPQLTGSYTKSFKDFVEACLNKDPEN 250
Query: 255 RPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQ--EEPDT 294
RP+AKELL++ FI+ A+K+ L++ I K+ + +E +T
Sbjct: 251 RPTAKELLKYPFIKKAKKNAYLIDLIDRFKKWKVSKGDESET 292
|
|
| DICTYBASE|DDB_G0286359 svkA "severin kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 831 (297.6 bits), Expect = 7.2e-86, Sum P(2) = 7.2e-86
Identities = 176/359 (49%), Positives = 241/359 (67%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYITEYYG 78
E IG+GSFG+V+K +K+ N+ +AIK +VLSQC SP++T+Y+G
Sbjct: 16 EKIGKGSFGEVFKGINKKTNETIAIKTIDLEDAEDEIEDIQQEINVLSQCESPFVTKYFG 75
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
S+L +KLWIIMEY+AGGSV DL++ GP DE IA ILR+LL +EYLH+EGKIHRDIK
Sbjct: 76 SFLKGSKLWIIMEYLAGGSVLDLMKPGP-FDEGYIAIILRELLKGLEYLHSEGKIHRDIK 134
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
AAN+LL+ +GDVK+ADFGVS QLT +++R TFVGTPFWMAPEVI+ + GY+ KADIWS+
Sbjct: 135 AANVLLSASGDVKLADFGVSGQLTDQMTKRNTFVGTPFWMAPEVIKQT-GYDSKADIWSM 193
Query: 199 GITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258
GIT +EMAKGEPP ADLHPMR LF+IP++ PP L+ +FS+ KEF +LCL K P +RP+A
Sbjct: 194 GITALEMAKGEPPRADLHPMRALFLIPKDPPPTLEGNFSKGFKEFCALCLNKDPNQRPTA 253
Query: 259 KELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVKVVRDKRSE 318
K+LL+H+FI+ A+K+ L + I R K+ +Q +NG A E + RD +S
Sbjct: 254 KDLLKHKFIKAAKKTSSLTDLIERRQKW-LQ------LNGNNADDENDD---LDRDAKSN 303
Query: 319 ETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREKKPEFSYNQYTPKRTAER 377
E + T++ ++ E T T V P ++E++ + Q TP T ++
Sbjct: 304 EE-DFGWEFPTIKQKS-PVAVQEQQQTPQKPTVVSTP-IKEQQQQ---QQPTPVTTPQQ 356
|
|
| RGD|1563568 Mst4 "serine/threonine protein kinase MST4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 806 (288.8 bits), Expect = 5.0e-85, Sum P(2) = 5.0e-85
Identities = 161/319 (50%), Positives = 215/319 (67%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D + VAIK+ +VLSQC S Y+T
Sbjct: 23 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 82
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL +KLWIIMEY+ GGS DL+++GP DE IA +L+++L ++YLH+E KIH
Sbjct: 83 KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIH 141
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVIQ S Y+ KAD
Sbjct: 142 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKAD 200
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +D+HPMRVLF+IP+ NPP L F++ KEF+ CL K P+
Sbjct: 201 IWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSF 260
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVKVVR 313
RP+AKELL+H+FI +N++K+ L E I ++ + D + + E+S
Sbjct: 261 RPTAKELLKHKFIVKNSKKTSYLTELIDRFKRWKAEGHSDEESDSEGSDSESSSRESNTH 320
Query: 314 DKRSEETVQVSSQGQTVRN 332
+ S TV+ + ++N
Sbjct: 321 PEWSFTTVRKKPDPKKLQN 339
|
|
| ZFIN|ZDB-GENE-080516-5 mst4 "serine/threonine protein kinase MST4" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 797 (285.6 bits), Expect = 6.6e-85, Sum P(3) = 6.6e-85
Identities = 155/280 (55%), Positives = 203/280 (72%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ L+ IG+GSFG+V+K D++ VAIK +VLSQC SP++T
Sbjct: 24 FTKLDRIGKGSFGEVFKGIDRQTQNVVAIKTIDLEEAEDEIEDIQQEITVLSQCDSPHVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL +KLWIIMEY+ GGS DL+++GP DE IA +L+++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP-FDEYQIATMLKEILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R+TFVGTPFWMAPEVIQ S Y+ KAD
Sbjct: 143 RDIKAANVLLSESGEVKLADFGVAGQLTDTQIKRETFVGTPFWMAPEVIQQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +D+HPMRVLF IP+ PP L+ FS++ KEFV CL K PA
Sbjct: 202 IWSLGITAIELAKGEPPNSDMHPMRVLFHIPKNTPPTLNGDFSKIFKEFVDSCLNKDPAF 261
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQEEPD 293
RP+AKELL+H+FI + A+K+ L E I ++ + D
Sbjct: 262 RPTAKELLKHKFIVKYAKKTSYLTELIDRLKRWKAEGHSD 301
|
|
| MGI|MGI:1917665 2610018G03Rik "RIKEN cDNA 2610018G03 gene" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 804 (288.1 bits), Expect = 8.2e-85, Sum P(2) = 8.2e-85
Identities = 161/319 (50%), Positives = 215/319 (67%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D + VAIK+ +VLSQC S Y+T
Sbjct: 24 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL +KLWIIMEY+ GGS DL+++GP DE IA +L+++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVIQ S Y+ KAD
Sbjct: 143 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +D+HPMRVLF+IP+ NPP L F++ KEF+ CL K P+
Sbjct: 202 IWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLIGDFTKSFKEFIDACLNKDPSF 261
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVKVVR 313
RP+AKELL+H+FI +N++K+ L E I ++ + D + + E+S
Sbjct: 262 RPTAKELLKHKFIVKNSKKTSYLTELIDRFKRWKAEGHSDEESDSEGSDSESSSRESNPH 321
Query: 314 DKRSEETVQVSSQGQTVRN 332
+ S TV+ + ++N
Sbjct: 322 PEWSFTTVRKKPDPKKLQN 340
|
|
| UNIPROTKB|Q9P289 MST4 "Serine/threonine-protein kinase MST4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 806 (288.8 bits), Expect = 1.7e-84, Sum P(2) = 1.7e-84
Identities = 161/319 (50%), Positives = 215/319 (67%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D + VAIK+ +VLSQC S Y+T
Sbjct: 24 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL +KLWIIMEY+ GGS DL+++GP DE IA +L+++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVIQ S Y+ KAD
Sbjct: 143 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +D+HPMRVLF+IP+ NPP L F++ KEF+ CL K P+
Sbjct: 202 IWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSF 261
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVKVVR 313
RP+AKELL+H+FI +N++K+ L E I ++ + D + + E++
Sbjct: 262 RPTAKELLKHKFIVKNSKKTSYLTELIDRFKRWKAEGHSDDESDSEGSDSESTSRENNTH 321
Query: 314 DKRSEETVQVSSQGQTVRN 332
+ S TV+ + V+N
Sbjct: 322 PEWSFTTVRKKPDPKKVQN 340
|
|
| MGI|MGI:2385007 Stk24 "serine/threonine kinase 24" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 844 (302.2 bits), Expect = 2.7e-84, P = 2.7e-84
Identities = 166/297 (55%), Positives = 216/297 (72%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+ +VLSQC SPY+T
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ GP LDE+ IA ILR++L ++YLH+E KIH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-LDEIQIATILREILKGLDYLHSEKKIH 142
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 201
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPM+VLF+IP+ NPP L+ ++S+ +KEFV CL K P+
Sbjct: 202 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 261
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQ---EEPDTPINGVRAVGEASG 307
RP+AKELL+H+FI RNA+K+ L E I ++ + E+ + + V G+ASG
Sbjct: 262 RPTAKELLKHKFIIRNAKKTSYLTELIDRYKRWKAEQSHEDSSSEDSDVETDGQASG 318
|
|
| ZFIN|ZDB-GENE-040426-2841 stk24b "serine/threonine kinase 24b (STE20 homolog, yeast)" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 810 (290.2 bits), Expect = 4.5e-84, Sum P(2) = 4.5e-84
Identities = 162/297 (54%), Positives = 210/297 (70%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVXXXXXXXXXXXXXXXXXSVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+ +VLSQC SP++T
Sbjct: 12 FTKLERIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPFVT 71
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ G LDE IA ILR++L +EYLH+E KIH
Sbjct: 72 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGS-LDETQIATILREILKGLEYLHSEKKIH 130
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 131 RDIKAANVLLSEQGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 189
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +DLHPM+VLF+IP+ NPP L+ ++ + +KEFV CL K P+
Sbjct: 190 IWSLGITAIELAKGEPPHSDLHPMKVLFLIPKNNPPTLEGNYCKPLKEFVEACLNKEPSF 249
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQE---EPDTPINGVRAVGEASG 307
RP+AKELL+H+ I R A+K+ L E I + ++ ++ E + + G+ASG
Sbjct: 250 RPTAKELLKHKLIVRFAKKTSYLTELIDKYKRWKAEQSRAESSSDESDSEPDGQASG 306
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 703 | |||
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 0.0 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-129 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-127 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-125 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-120 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-120 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-119 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-113 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-109 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-107 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-107 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-105 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-97 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-97 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-97 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-89 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-86 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-85 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-82 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-82 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-81 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-80 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-79 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-78 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-75 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-75 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-73 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-72 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-71 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-71 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-70 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-69 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-69 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-67 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-66 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-64 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-64 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-63 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-63 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-62 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-60 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-59 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-58 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-57 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-56 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-55 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-55 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-54 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-54 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-54 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-54 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-52 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-50 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-49 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-49 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-49 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-49 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-49 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-49 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-48 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-48 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-48 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-48 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-48 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-48 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-47 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-47 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-46 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-44 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-44 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-43 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-42 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-42 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-41 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-41 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-40 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-39 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-39 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-39 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-38 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-38 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-38 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-38 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-38 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-37 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-37 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-35 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-35 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-35 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-34 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-34 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-34 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-34 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-34 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-33 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-33 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-33 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-33 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-32 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-31 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-31 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-31 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-30 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-30 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-30 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-30 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-30 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-29 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-29 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-29 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-29 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-29 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-29 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-29 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-29 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-29 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-29 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-28 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-28 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-28 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-28 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-28 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-28 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-28 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-28 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-27 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-27 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-27 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-27 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-27 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-26 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-26 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-26 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-26 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-26 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-26 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-25 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-25 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-25 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-24 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-24 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-24 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-24 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-24 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-24 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-23 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-23 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-23 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-23 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-23 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-23 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-23 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-23 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-22 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-22 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-22 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-21 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-21 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-21 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-21 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-21 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-21 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-21 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-20 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-20 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-20 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-20 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-20 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-19 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-19 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-19 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-18 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-18 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-18 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-17 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-16 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-16 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-15 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-11 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-10 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-04 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 526 bits (1358), Expect = 0.0
Identities = 190/275 (69%), Positives = 224/275 (81%), Gaps = 3/275 (1%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
F+ LE IG+GSFG+VYKA DK N+ VAIKVIDLEE+EDEIEDIQ+EI LSQCRSPY
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
IT+YYGS+L +KLWIIMEY GGS DL++ G LDE IA ILR++L +EYLH EGK
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGK 119
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIKAANILL+E GDVK+ADFGVS QLT T+S+R TFVGTPFWMAPEVI+ S GY+EK
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS-GYDEK 178
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH-FSRLMKEFVSLCLKKV 251
ADIWSLGIT IE+AKGEPPL+DLHPMRVLF+IP+ NPP L+ + FS+ K+FVSLCL K
Sbjct: 179 ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKD 238
Query: 252 PAERPSAKELLRHRFIRNARKSPRLLERIRERPKY 286
P ERPSAKELL+H+FI+ A+K+ L I K+
Sbjct: 239 PKERPSAKELLKHKFIKKAKKTSYLTLLIERIKKW 273
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 381 bits (982), Expect = e-129
Identities = 146/256 (57%), Positives = 180/256 (70%), Gaps = 7/256 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F LE +G GS+G VYKA KE + VAIKV+ E+++++I KEIS+L QC SPYI
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+YYGSY T LWI+MEY GSV+D+++ L E IA IL L +EYLH+ KI
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIKA NILL E G K+ADFGVS QLT T+++R T +GTPFWMAPEVIQ GYN KA
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNNKA 180
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGIT IEMA+G+PP +D+HPMR +F+IP + PP L E +S +FV CL K
Sbjct: 181 DIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKD 240
Query: 252 PAERPSAKELLRHRFI 267
P ERPSA +LL+H FI
Sbjct: 241 PEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 378 bits (973), Expect = e-127
Identities = 137/255 (53%), Positives = 182/255 (71%), Gaps = 6/255 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F LE IG+G FG+VYKA K K+VAIKVI LE E + E I EI +L +C+ P I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK-EKIINEIQILKKCKHPNIV 60
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+YYGSYL + +LWI+ME+ +GGS+ DL++S L E IA + ++LL +EYLH+ G I
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGII 120
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIKAANILLT +G+VK+ DFG+SAQL+ T + R T VGTP+WMAPEVI + Y+ KA
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVING-KPYDYKA 178
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGIT IE+A+G+PP ++L PM+ LF I PP L E +S K+F+ CL+K
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKN 238
Query: 252 PAERPSAKELLRHRF 266
P +RP+A++LL+H F
Sbjct: 239 PEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 371 bits (954), Expect = e-125
Identities = 142/261 (54%), Positives = 185/261 (70%), Gaps = 8/261 (3%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ ++ IG G++GDVYKA D + VAIKVI LE D+ E IQ+EIS+L +CR P
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPN 61
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEG 131
I Y+GSYL + KLWI+MEY GGS+ D+ Q PL E+ IA + R+ L + YLH G
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSE--GY 189
KIHRDIK ANILLTE+GDVK+ADFGVSAQLT TI++RK+F+GTP+WMAPEV GY
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY 181
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLD--EHFSRLMKEFVS 245
+ K DIW+LGIT IE+A+ +PP+ DLHPMR LF+I + N PP+L E +S + +F+
Sbjct: 182 DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIK 241
Query: 246 LCLKKVPAERPSAKELLRHRF 266
CL K P +RP+A +LL+H F
Sbjct: 242 KCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 360 bits (926), Expect = e-120
Identities = 173/267 (64%), Positives = 215/267 (80%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPY+T
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL+++G P DE IA +L+++L ++YLH+E KIH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEKKIH 124
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVIQ S Y+ KAD
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKAD 183
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +D+HPMRVLF+IP+ NPP L FS+ KEF+ CL K P+
Sbjct: 184 IWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSF 243
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERI 280
RP+AKELL+H+FI +NA+K+ L E I
Sbjct: 244 RPTAKELLKHKFIVKNAKKTSYLTELI 270
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 359 bits (921), Expect = e-120
Identities = 174/267 (65%), Positives = 218/267 (81%), Gaps = 3/267 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+V+K D K VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPY+T
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYGSYL TKLWIIMEY+ GGS DL++ G PLDE IA ILR++L ++YLH+E KIH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIH 124
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKAD 183
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP ++LHPM+VLF+IP+ NPP L+ ++S+ +KEFV CL K P+
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSF 243
Query: 255 RPSAKELLRHRFI-RNARKSPRLLERI 280
RP+AKELL+H+FI R A+K+ L E I
Sbjct: 244 RPTAKELLKHKFIVRFAKKTSYLTELI 270
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 357 bits (916), Expect = e-119
Identities = 174/271 (64%), Positives = 211/271 (77%), Gaps = 2/271 (0%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F+ LE IG+GSFG+VYK D + VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPYIT
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
YYGSYL TKLWIIMEY+ GGS DL++ G PL+E IA ILR++L ++YLH+E KIH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSERKIH 124
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIKAAN+LL+E GDVK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ KAD
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKAD 183
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254
IWSLGIT IE+AKGEPP +DLHPMRVLF+IP+ +PP L+ +S+ KEFV CL K P
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRF 243
Query: 255 RPSAKELLRHRFIRNARKSPRLLERIRERPK 285
RP+AKELL+H+FI K L + +R K
Sbjct: 244 RPTAKELLKHKFITRYTKKTSFLTELIDRYK 274
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 342 bits (880), Expect = e-113
Identities = 136/267 (50%), Positives = 193/267 (72%), Gaps = 5/267 (1%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR--- 69
S + LELIGRG++G VY+ + VA+K+I+L+ +D++ DIQ+E+++LSQ R
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
P IT+YYGSYL +LWIIMEY GGSV L+++GP + E I+ I+R++L A++Y+H
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVLVALKYIHK 119
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
G IHRDIKAANIL+T G+VK+ DFGV+A L + S+R TFVGTP+WMAPEVI + Y
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-DEHFSRLMKEFVSLCL 248
+ KADIWSLGIT+ EMA G PP +D+ R + +IP+ PP+L D +S+L++EFV+ CL
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACL 239
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPR 275
+ P ER SA+ELL+ ++I+ K+P
Sbjct: 240 DEEPKERLSAEELLKSKWIKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 331 bits (851), Expect = e-109
Identities = 124/262 (47%), Positives = 181/262 (69%), Gaps = 12/262 (4%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
+E+IG G+ VY A N+ VAIK IDLE+ + +++++KE+ +SQC P + +YY
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPP---LDEMSIACILRDLLHAIEYLHNEGKIH 134
S++ +LW++M Y++GGS+ D+++S P LDE IA +L+++L +EYLH+ G+IH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIH 125
Query: 135 RDIKAANILLTENGDVKVADFGVSAQL----TRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
RDIKA NILL E+G VK+ADFGVSA L RT RKTFVGTP WMAPEV++ GY+
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH-----FSRLMKEFVS 245
KADIWS GIT IE+A G P + PM+VL + + +PP L+ +S+ ++ +S
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMIS 245
Query: 246 LCLKKVPAERPSAKELLRHRFI 267
LCL+K P++RP+A+ELL+H+F
Sbjct: 246 LCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 326 bits (839), Expect = e-107
Identities = 126/265 (47%), Positives = 177/265 (66%), Gaps = 6/265 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ +LE IG G+ G+VYKA D+ K+VAIK + L + E I EI ++ C+ P I
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIINEILIMKDCKHPNIV 78
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+YY SYL +LW++MEYM GGS+ D+I Q+ ++E IA + R++L +EYLH++ I
Sbjct: 79 DYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK+ NILL+++G VK+ADFG +AQLT+ S+R + VGTP+WMAPEVI+ + Y K
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD-YGPKV 197
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGI IEMA+GEPP P+R LF+I + P L E +S K+F++ CL K
Sbjct: 198 DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKD 257
Query: 252 PAERPSAKELLRHRFIRNARKSPRL 276
P +RPSA+ELL+H F++ A
Sbjct: 258 PEKRPSAEELLQHPFLKKACPKEEF 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 325 bits (836), Expect = e-107
Identities = 130/274 (47%), Positives = 177/274 (64%), Gaps = 19/274 (6%)
Query: 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CR 69
F +E+IG G++G VYKA K+ + VAIK++D+ E DE E+I++E ++L +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSN 61
Query: 70 SPYITEYYGSYL------HQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRD 119
P I +YG+++ + +LW++ME GGSV DL++ G L E IA ILR+
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 120 LLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMA 179
L + YLH IHRDIK NILLT+N +VK+ DFGVSAQL T+ RR TF+GTP+WMA
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181
Query: 180 PEVI----QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--D 233
PEVI Q Y+ ++D+WSLGIT IE+A G+PPL D+HPMR LF IPR PP L
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241
Query: 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
E++S+ +F+S CL K +RP +ELL H FI
Sbjct: 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 319 bits (821), Expect = e-105
Identities = 102/256 (39%), Positives = 148/256 (57%), Gaps = 5/256 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ LE +G GSFG VY A DK+ K VAIKVI ++ + + E I +EI +L + + P I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
Y + + KL+++MEY GG + DL++ L E LR +L A+EYLH++G +H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K NILL E+G VK+ADFG++ QL + TFVGTP +MAPEV+ +GY + D
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVLL-GKGYGKAVD 178
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH---FSRLMKEFVSLCLKKV 251
IWSLG+ + E+ G+PP + LF + P S K+ + L K
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKD 238
Query: 252 PAERPSAKELLRHRFI 267
P +R +A+E L+H F
Sbjct: 239 PEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 300 bits (770), Expect = 3e-97
Identities = 117/256 (45%), Positives = 164/256 (64%), Gaps = 8/256 (3%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
EL+GRGSFG VY A DK+ + +A+K ++L SE+E+E +++EI +LS + P I YY
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 78 GSYLHQTK--LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
GS + K L I +EY++GGS++ L++ L E I R +L + YLH+ G +HR
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 136 DIKAANILLTENGDVKVADFGVSAQL--TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
DIK ANIL+ +G VK+ADFG + +L T + GTP+WMAPEVI E Y A
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI-RGEEYGRAA 184
Query: 194 DIWSLGITVIEMAKGEPPLADLH-PMRVLF-IIPRENPPQLDEHFSRLMKEFVSLCLKKV 251
DIWSLG TVIEMA G+PP ++L PM L+ I PP++ EH S K+F+ CL++
Sbjct: 185 DIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRD 244
Query: 252 PAERPSAKELLRHRFI 267
P +RP+A ELL+H F+
Sbjct: 245 PKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 299 bits (768), Expect = 4e-97
Identities = 115/250 (46%), Positives = 159/250 (63%), Gaps = 2/250 (0%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
+LIGRG+FG VYK + E VAIK I LE+ E+ ++ I +EI +L + P I +Y
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
GS L+II+EY GS+ +I+ P E +A + +L + YLH +G IHRDI
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDI 125
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWS 197
KAANIL T++G VK+ADFGV+ +L + VGTP+WMAPEVI+ S G + +DIWS
Sbjct: 126 KAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS-GASTASDIWS 184
Query: 198 LGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPS 257
LG TVIE+ G PP DL+PM LF I +++ P L E S +K+F+ C +K P RP+
Sbjct: 185 LGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPT 244
Query: 258 AKELLRHRFI 267
AK+LL+H +I
Sbjct: 245 AKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 299 bits (768), Expect = 8e-97
Identities = 121/269 (44%), Positives = 175/269 (65%), Gaps = 8/269 (2%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G+FG VYKA KE A K+I +E SE+E+ED EI +LS+C+ P I Y +Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 81 LHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKA 139
++ KLWI++E+ GG++ ++ + L E I + R +L A+ +LH+ IHRD+KA
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKA 131
Query: 140 ANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ----NSEGYNEKADI 195
NILLT +GDVK+ADFGVSA+ T+ +R TF+GTP+WMAPEV+ Y+ KADI
Sbjct: 132 GNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADI 191
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE--HFSRLMKEFVSLCLKKVPA 253
WSLGIT+IE+A+ EPP +L+PMRVL I + PP LD+ +S +F+ CL K P
Sbjct: 192 WSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPD 251
Query: 254 ERPSAKELLRHRFIRNARKSPRLLERIRE 282
+RP+A ELL+H F+ + + + + + E
Sbjct: 252 DRPTAAELLKHPFVSDQSDNKAIKDLLAE 280
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 279 bits (715), Expect = 3e-89
Identities = 101/261 (38%), Positives = 149/261 (57%), Gaps = 9/261 (3%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK--EISVLSQCRSPY 72
+ L +G GSFG VYKA K K VA+K++ SE +D EI +L + P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKR-SEKSKKDQTARREIRILRRLSHPN 59
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I ++ + L+++MEY GG + D + G PL E I +L +EYLH+ G
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRD+K NILL ENG VK+ADFG++ +L ++ S TFVGTP++MAPEV+ GY K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF------SRLMKEFVSL 246
D+WSLG+ + E+ G+PP + + + L +I R P L+ S K+ +
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239
Query: 247 CLKKVPAERPSAKELLRHRFI 267
CL K P++RP+A+E+L+H +
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 271 bits (694), Expect = 4e-86
Identities = 128/258 (49%), Positives = 179/258 (69%), Gaps = 7/258 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F ++ IG G++GDVYKA + + AIKVI LE ED +Q+EI ++ C+ I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMMKDCKHSNIV 69
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
Y+GSYL + KLWI ME+ GGS+ D+ PL E IA + R+ L + YLH++GK+H
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMH 129
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV--IQNSEGYNEK 192
RDIK ANILLT+NG VK+ADFGVSAQ+T TI++RK+F+GTP+WMAPEV ++ GYN+
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDE--HFSRLMKEFVSLCL 248
DIW++GIT IE+A+ +PP+ DLHPMR LF++ + N PP+L + +S FV + L
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMAL 249
Query: 249 KKVPAERPSAKELLRHRF 266
K P +RP+A++LL+H F
Sbjct: 250 TKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 270 bits (691), Expect = 1e-85
Identities = 124/258 (48%), Positives = 181/258 (70%), Gaps = 7/258 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ ++ +G G++GDVYKA + + A+K+I LE +D IQ+EI ++ +C+ I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD-FSLIQQEIFMVKECKHCNIV 69
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
Y+GSYL + KLWI MEY GGS+ D+ PL E+ IA + R+ L + YLH++GK+H
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV--IQNSEGYNEK 192
RDIK ANILLT+NGDVK+ADFGV+A++T TI++RK+F+GTP+WMAPEV ++ + GYN+
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQL 189
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDE--HFSRLMKEFVSLCL 248
DIW++GIT IE+A+ +PP+ DLHPMR LF++ + N PP+L + +S FV + L
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISL 249
Query: 249 KKVPAERPSAKELLRHRF 266
K P +RP+A+ LL H F
Sbjct: 250 TKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 261 bits (670), Expect = 2e-82
Identities = 108/263 (41%), Positives = 160/263 (60%), Gaps = 9/263 (3%)
Query: 16 SSLEL---IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
S LE +G+GS G VYK K K A+K I ++ E+ + + +E+ L C SPY
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + YG++ + ++ I++EYM GGS+ADL++ + E +A I R +L ++YLH +
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120
Query: 133 -IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
IHRDIK +N+L+ G+VK+ADFG+S L T+ + TFVGT +M+PE IQ E Y+
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ-GESYSY 179
Query: 192 KADIWSLGITVIEMAKGEPPLADLH---PMRVLFIIPRENPPQL-DEHFSRLMKEFVSLC 247
ADIWSLG+T++E A G+ P ++ I PP L E FS ++F+S C
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239
Query: 248 LKKVPAERPSAKELLRHRFIRNA 270
L+K P +RPSA ELL+H FI+ A
Sbjct: 240 LQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 262 bits (670), Expect = 6e-82
Identities = 127/283 (44%), Positives = 177/283 (62%), Gaps = 12/283 (4%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL--EESEDEIEDIQKEISVLSQCRSP 71
F+ L IG GSFG VY A D N+ VAIK + ++S ++ +DI KE+ L Q R P
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNE 130
EY G YL + W++MEY G S +D+++ PL E+ IA I L + YLH+
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-QNSEG- 188
+IHRDIKA NILLTE G VK+ADFG SA L +S +FVGTP+WMAPEVI EG
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFG-SASL---VSPANSFVGTPYWMAPEVILAMDEGQ 190
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE-HFSRLMKEFVSLC 247
Y+ K D+WSLGIT IE+A+ +PPL +++ M L+ I + + P L +S + FV C
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC 250
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQE 290
L+K+P +RPS++ELL+HRF+ R +++ I +R K ++E
Sbjct: 251 LQKIPQDRPSSEELLKHRFVLRERPPTVIIDLI-QRTKDAVRE 292
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 257 bits (659), Expect = 1e-81
Identities = 99/246 (40%), Positives = 138/246 (56%), Gaps = 34/246 (13%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G FG VY A DK+ K VAIK+I E+S +E++ +EI +L + P I + YG +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 81 LHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKA 139
+ L+++MEY GGS+ DL++ L E I IL +L +EYLH+ G IHRD+K
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 140 ANILLTE-NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
NILL NG VK+ADFG+S LT S KT VGTP +MAPEV+ Y+EK+DIWSL
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180
Query: 199 GITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258
G+ + E+ + +K+ + L+K P +RPSA
Sbjct: 181 GVILYELPE--------------------------------LKDLIRKMLQKDPEKRPSA 208
Query: 259 KELLRH 264
KE+L H
Sbjct: 209 KEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 1e-80
Identities = 132/279 (47%), Positives = 185/279 (66%), Gaps = 17/279 (6%)
Query: 3 DLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEI 62
DL+ L++ AG F +E++G G++G VYK + + AIKV+D+ +EDE E+I+ EI
Sbjct: 7 DLSALRDPAGI-FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV--TEDEEEEIKLEI 63
Query: 63 SVLSQ-CRSPYITEYYGSYL------HQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSI 113
++L + I YYG+++ H +LW++ME+ GSV DL+++ G L E I
Sbjct: 64 NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI 123
Query: 114 ACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
A I R++L + +LH IHRDIK N+LLTEN +VK+ DFGVSAQL RT+ RR TF+G
Sbjct: 124 AYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG 183
Query: 174 TPFWMAPEVIQNSEG----YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP 229
TP+WMAPEVI E Y+ ++DIWSLGIT IEMA+G PPL D+HPMR LF+IPR P
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243
Query: 230 PQL-DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
P+L + +S+ +F+ CL K RPS ++LL+H FI
Sbjct: 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 253 bits (649), Expect = 2e-79
Identities = 99/255 (38%), Positives = 143/255 (56%), Gaps = 6/255 (2%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEY 76
++ IG+GSFG VY K K +K IDL SE E ED E+ +L + P I +Y
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGK 132
Y S+ + KL I+MEY GG ++ I+ G P E I L A++YLH+
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKI 124
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
+HRDIK NI LT NG VK+ DFG+S L+ T+ KT VGTP++++PE+ QN + YN K
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN-KPYNYK 183
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
+DIWSLG + E+ + P + + + I + P + +S ++ VS L+K P
Sbjct: 184 SDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDP 243
Query: 253 AERPSAKELLRHRFI 267
ERPS ++L+ FI
Sbjct: 244 EERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 1e-78
Identities = 103/254 (40%), Positives = 156/254 (61%), Gaps = 6/254 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDL----EESEDEIEDIQKEISVLSQCRSPYIT 74
EL+G GSFG VY+ + + A+K + L + ++ ++ +++EI++LS+ + P I
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+Y G+ + L+I +E + GGS+A L++ E I R +L +EYLH+ +H
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIK ANIL+ NG VK+ADFG++ Q+ S K+F G+P+WMAPEVI GY AD
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQGGYGLAAD 184
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP-PQLDEHFSRLMKEFVSLCLKKVPA 253
IWSLG TV+EMA G+PP + L + +F I R P + +H S K+F+ CL++ P+
Sbjct: 185 IWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPS 244
Query: 254 ERPSAKELLRHRFI 267
RP+A ELL H F+
Sbjct: 245 LRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 245 bits (626), Expect = 1e-75
Identities = 123/269 (45%), Positives = 174/269 (64%), Gaps = 8/269 (2%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G+FG VYKA +KE A KVI+ +SE+E+ED EI +L+ C PYI + G++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 81 LHQTKLWIIMEYMAGGSV-ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKA 139
KLWI++E+ GG+V A +++ L E I I R +L A++YLH+ IHRD+KA
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138
Query: 140 ANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI----QNSEGYNEKADI 195
N+LLT +GD+K+ADFGVSA+ +T+ RR +F+GTP+WMAPEV+ Y+ KADI
Sbjct: 139 GNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 198
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE--HFSRLMKEFVSLCLKKVPA 253
WSLGIT+IEMA+ EPP +L+PMRVL I + PP L + +S ++F+ L K P
Sbjct: 199 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPE 258
Query: 254 ERPSAKELLRHRFIRNARKSPRLLERIRE 282
RPSA +LL H F+ + + L E + E
Sbjct: 259 TRPSAAQLLEHPFVSSVTSNRPLRELVAE 287
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 243 bits (621), Expect = 3e-75
Identities = 127/275 (46%), Positives = 183/275 (66%), Gaps = 17/275 (6%)
Query: 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLS 66
L++ AG F +EL+G G++G VYK + + AIKV+D+ + DE E+I++EI++L
Sbjct: 1 LRDPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV--TGDEEEEIKQEINMLK 57
Query: 67 Q-CRSPYITEYYGSYLHQT------KLWIIMEYMAGGSVADLIQS--GPPLDEMSIACIL 117
+ I YYG+++ + +LW++ME+ GSV DLI++ G L E IA I
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFW 177
R++L + +LH IHRDIK N+LLTEN +VK+ DFGVSAQL RT+ RR TF+GTP+W
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 177
Query: 178 MAPEVIQNSEG----YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL- 232
MAPEVI E Y+ K+D+WSLGIT IEMA+G PPL D+HPMR LF+IPR P+L
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
+ +S+ + F+ CL K ++RP+ ++L++H FI
Sbjct: 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 5e-73
Identities = 105/263 (39%), Positives = 157/263 (59%), Gaps = 5/263 (1%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
S + IG GS G V A DK + VA+K +DL + + E + E+ ++ + P
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR-ELLFNEVVIMRDYQHPN 77
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I E Y SYL +LW++ME++ GG++ D++ ++E IA + +L A+ +LH +G
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLHAQGV 136
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIK+ +ILLT +G VK++DFG AQ+++ + RRK+ VGTP+WMAPEVI + Y +
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPYGTE 195
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH--FSRLMKEFVSLCLKK 250
DIWSLGI VIEM GEPP + P++ + I PP+L S ++ F+ L +
Sbjct: 196 VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR 255
Query: 251 VPAERPSAKELLRHRFIRNARKS 273
PA+R +A ELL H F+ A
Sbjct: 256 DPAQRATAAELLNHPFLAKAGPP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 235 bits (600), Expect = 4e-72
Identities = 119/266 (44%), Positives = 163/266 (61%), Gaps = 18/266 (6%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEY 76
+E IG+G++G V+K +K+ A+K++D DE +I+ E ++L P + ++
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE--EIEAEYNILKALSDHPNVVKF 80
Query: 77 YGSYLHQT-----KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYL 127
YG Y + +LW+++E GGSV DL++ G ++E IA IL + L +++L
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI---- 183
H IHRD+K NILLT G VK+ DFGVSAQLT T RR T VGTPFWMAPEVI
Sbjct: 141 HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 200
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMK 241
Q Y+ + D+WSLGIT IE+ G+PPLADLHPMR LF IPR PP L E +S
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFN 260
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFI 267
+F+ CL K +RP+ +LL+H FI
Sbjct: 261 DFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 233 bits (595), Expect = 2e-71
Identities = 119/261 (45%), Positives = 167/261 (63%), Gaps = 8/261 (3%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G+FG VYKA +KE A KVID +SE+E+ED EI +L+ C P I + ++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVID-TKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 81 LHQTKLWIIMEYMAGGSV-ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKA 139
++ LWI++E+ AGG+V A +++ PL E I + + L A+ YLH IHRD+KA
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKA 131
Query: 140 ANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI----QNSEGYNEKADI 195
NIL T +GD+K+ADFGVSA+ TRTI RR +F+GTP+WMAPEV+ Y+ KAD+
Sbjct: 132 GNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADV 191
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE--HFSRLMKEFVSLCLKKVPA 253
WSLGIT+IEMA+ EPP +L+PMRVL I + PP L + +S K+F+ CL+K
Sbjct: 192 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVD 251
Query: 254 ERPSAKELLRHRFIRNARKSP 274
R + +LL+H F+ P
Sbjct: 252 ARWTTTQLLQHPFVTVNSNKP 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 231 bits (592), Expect = 5e-71
Identities = 105/255 (41%), Positives = 150/255 (58%), Gaps = 11/255 (4%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G+ G V K + K +A+K I LE +E + I +E+ +L +C SPYI +YG++
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKI-HRDIK 138
+ + I MEYM GGS+ +++ + E + I +L + YLH + KI HRD+K
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVK 128
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
+NIL+ G +K+ DFGVS QL +++ KTFVGT +MAPE IQ Y+ K+DIWSL
Sbjct: 129 PSNILVNSRGQIKLCDFGVSGQLVNSLA--KTFVGTSSYMAPERIQ-GNDYSVKSDIWSL 185
Query: 199 GITVIEMAKGEPPLA-----DLHPMRVLFIIPRENPPQLDEH-FSRLMKEFVSLCLKKVP 252
G+++IE+A G P +L I E PP+L FS ++FV+LCL K P
Sbjct: 186 GLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDP 245
Query: 253 AERPSAKELLRHRFI 267
ERPS KELL H FI
Sbjct: 246 RERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 1e-70
Identities = 102/258 (39%), Positives = 151/258 (58%), Gaps = 11/258 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE----ESEDEIEDIQKEISVLSQCRSPYIT 74
+L+G+G+FG VY +D + +++A+K + + E++ E+ ++ EI +L + I
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+YYG L I MEYM GGSV D +++ L E R +L +EYLH+ +H
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTI----SRRKTFVGTPFWMAPEVIQNSEGYN 190
RDIK ANIL G+VK+ DFG S +L +TI + K+ GTP+WM+PEVI + EGY
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMKSVTGTPYWMSPEVI-SGEGYG 185
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP-PQLDEHFSRLMKEFVSLCLK 249
KAD+WS+G TV+EM +PP A+ M +F I + PQL H S + F+
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFV 245
Query: 250 KVPAERPSAKELLRHRFI 267
+ +RPSA+ELLRH F+
Sbjct: 246 ENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 5e-69
Identities = 120/267 (44%), Positives = 160/267 (59%), Gaps = 18/267 (6%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVL-SQCRSPYITEY 76
+E IG+G++G VYK +K+ A+K++D DE +I+ E ++L S P + ++
Sbjct: 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE--EIEAEYNILQSLPNHPNVVKF 84
Query: 77 YGSYLHQTK-----LWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYL 127
YG + K LW+++E GGSV +L++ G LDE I+ IL L +++L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI---- 183
HN IHRD+K NILLT G VK+ DFGVSAQLT T RR T VGTPFWMAPEVI
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMK 241
Q Y+ + D+WSLGIT IE+ G+PPL D+HP++ LF IPR PP L E + R
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFN 264
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIR 268
F+S CL K RPS LL H FI+
Sbjct: 265 HFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 6e-69
Identities = 114/260 (43%), Positives = 168/260 (64%), Gaps = 5/260 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+++ E IG+G+ G VY A D ++VAIK ++L++ + E I EI V+ + + P I
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK-ELIINEILVMRENKHPNI 78
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
Y SYL +LW++MEY+AGGS+ D++ + +DE IA + R+ L A+E+LH+ I
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVI 137
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK+ NILL +G VK+ DFG AQ+T S+R T VGTP+WMAPEV+ Y K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKV 196
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGI IEM +GEPP + +P+R L++I P+L E S + ++F++ CL+
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 256
Query: 252 PAERPSAKELLRHRFIRNAR 271
+R SAKELL+H F++ A+
Sbjct: 257 VEKRGSAKELLQHPFLKIAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 5e-67
Identities = 122/282 (43%), Positives = 173/282 (61%), Gaps = 12/282 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL--EESEDEIEDIQKEISVLSQCRSPY 72
F L IG GSFG VY A + N+ VA+K + +++ ++ +DI KE+ L Q + P
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEG 131
EY G YL + W++MEY G S +DL++ PL E+ IA I L + YLH+
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-QNSEG-Y 189
IHRDIKA NILLTE G VK+ADFG ++ S +FVGTP+WMAPEVI EG Y
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSAS----KSSPANSFVGTPYWMAPEVILAMDEGQY 197
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH-FSRLMKEFVSLCL 248
+ K D+WSLGIT IE+A+ +PPL +++ M L+ I + + P L + ++ + FV CL
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCL 257
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQE 290
+K+P ERP++ ELLRH F+R R R+L + +R K ++E
Sbjct: 258 QKIPQERPASAELLRHDFVRRDR-PARVLIDLIQRTKDAVRE 298
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 217 bits (556), Expect = 6e-66
Identities = 98/264 (37%), Positives = 158/264 (59%), Gaps = 10/264 (3%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE-IEDIQKEISVLSQCRSPY 72
R+ IG G+FG VY A + + + +A+K I +++++ + I++I E+ VL + P
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ +YYG +H+ K++I MEY +GG++ +L++ G LDE I LL + YLH+ G
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQL----TRTISRRKTFVGTPFWMAPEVI--QNS 186
+HRDIK ANI L NG +K+ DFG + +L T ++ GTP +MAPEVI
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPRENPPQLDEH--FSRLMKEF 243
+G+ ADIWSLG V+EMA G+ P ++L + +++F + + P + + S K+F
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF 240
Query: 244 VSLCLKKVPAERPSAKELLRHRFI 267
+ CL+ P +RP+A ELL+H F+
Sbjct: 241 LDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 214 bits (547), Expect = 3e-64
Identities = 113/260 (43%), Positives = 169/260 (65%), Gaps = 5/260 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+++ E IG+G+ G VY A D ++VAIK ++L++ + E I EI V+ + ++P I
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK-ELIINEILVMRENKNPNI 78
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
Y SYL +LW++MEY+AGGS+ D++ + +DE IA + R+ L A+++LH+ I
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALDFLHSNQVI 137
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK+ NILL +G VK+ DFG AQ+T S+R T VGTP+WMAPEV+ + Y K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYGPKV 196
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGI IEM +GEPP + +P+R L++I P+L E S + ++F++ CL+
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMD 256
Query: 252 PAERPSAKELLRHRFIRNAR 271
R SAKELL+H F++ A+
Sbjct: 257 VDRRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 214 bits (545), Expect = 6e-64
Identities = 113/260 (43%), Positives = 170/260 (65%), Gaps = 5/260 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+++ E IG+G+ G VY A D ++VAI+ ++L++ + E I EI V+ + ++P I
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-ELIINEILVMRENKNPNI 79
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
Y SYL +LW++MEY+AGGS+ D++ + +DE IA + R+ L A+E+LH+ I
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK+ NILL +G VK+ DFG AQ+T S+R T VGTP+WMAPEV+ + Y K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYGPKV 197
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGI IEM +GEPP + +P+R L++I P+L E S + ++F++ CL
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 252 PAERPSAKELLRHRFIRNAR 271
+R SAKELL+H+F++ A+
Sbjct: 258 VEKRGSAKELLQHQFLKIAK 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 2e-63
Identities = 117/282 (41%), Positives = 172/282 (60%), Gaps = 12/282 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL--EESEDEIEDIQKEISVLSQCRSPY 72
FS L IG GSFG VY A D ++ VAIK + ++S ++ +DI KE+ L + R P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEG 131
+Y G YL + W++MEY G S +DL++ PL E+ IA + L + YLH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-QNSEG-Y 189
IHRD+KA NILL+E G VK+ DFG ++ ++ FVGTP+WMAPEVI EG Y
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSAS----IMAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE-HFSRLMKEFVSLCL 248
+ K D+WSLGIT IE+A+ +PPL +++ M L+ I + P L H+S + FV CL
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQE 290
+K+P +RP+++ LL+HRF+ R +++ I +R K ++E
Sbjct: 252 QKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI-QRTKDAVRE 292
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 212 bits (540), Expect = 3e-63
Identities = 110/260 (42%), Positives = 169/260 (65%), Gaps = 5/260 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+++ E IG+G+ G V+ A D ++VAIK I+L++ + E I EI V+ + ++P I
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK-ELIINEILVMKELKNPNI 78
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ S+L +L+++MEY+AGGS+ D++ + +DE IA + R+ L A+E+LH I
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVV-TETCMDEAQIAAVCRECLQALEFLHANQVI 137
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK+ N+LL +G VK+ DFG AQ+T S+R T VGTP+WMAPEV+ + Y K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYGPKV 196
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGI IEM +GEPP + +P+R L++I P+L E S + ++F++ CL+
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMD 256
Query: 252 PAERPSAKELLRHRFIRNAR 271
+R SAKELL+H F++ A+
Sbjct: 257 VEKRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 6e-62
Identities = 122/282 (43%), Positives = 172/282 (60%), Gaps = 12/282 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL--EESEDEIEDIQKEISVLSQCRSPY 72
F+ L IG GSFG VY A D N+ VAIK + ++S ++ +DI KE+ L + + P
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEG 131
EY G YL + W++MEY G S +DL++ PL E+ IA I L + YLH+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-QNSEG-Y 189
IHRDIKA NILLTE G VK+ADFG ++ S +FVGTP+WMAPEVI EG Y
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSAS----IASPANSFVGTPYWMAPEVILAMDEGQY 201
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE-HFSRLMKEFVSLCL 248
+ K D+WSLGIT IE+A+ +PPL +++ M L+ I + P L +S + FV CL
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL 261
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQE 290
+K+P +RP+++ELL+H F+ R L++ I +R K ++E
Sbjct: 262 QKIPQDRPTSEELLKHMFVLRERPETVLIDLI-QRTKDAVRE 302
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 202 bits (517), Expect = 3e-60
Identities = 94/267 (35%), Positives = 134/267 (50%), Gaps = 23/267 (8%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEY 76
LE IG+GSFG V K K K + K ID +E E + + E+++L + + P I Y
Sbjct: 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 77 YGSYL--HQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNE 130
Y + L+I+MEY GG +A LIQ ++E I IL LL A+ HN
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 131 GK-----IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
+HRD+K ANI L N +VK+ DFG++ L S KT+VGTP++M+PE + N
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL-N 183
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPL-----ADLHPMRVLFIIPRENPPQLDEHFSRLM 240
Y+EK+DIWSLG + E+ PP L I ++ +S +
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK-----IKEGKFRRIPYRYSSEL 238
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267
E + L P +RPS +ELL+ I
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 3e-59
Identities = 100/263 (38%), Positives = 151/263 (57%), Gaps = 17/263 (6%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-----EDEIEDIQKEISVLSQCRSPYI 73
E++G+G++G VY + + +A+K ++L+ S E E E +Q+E+ +L + I
Sbjct: 6 EVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+Y G+ L + I ME++ GGS++ ++ PL E + +L + YLHN +
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 134 HRDIKAANILLTENGDVKVADFG-------VSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
HRDIK N++L NG +K+ DFG V T + + K+ GTP+WMAPEVI N
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS-NMLKSMHGTPYWMAPEVI-NE 182
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP--RENPPQLDEHFSRLMKEFV 244
GY K+DIWS+G TV EMA G+PPLA + + +F I R P+L + FS +FV
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242
Query: 245 SLCLKKVPAERPSAKELLRHRFI 267
+ CL + ERPSA +LLRH F+
Sbjct: 243 TSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (502), Expect = 4e-58
Identities = 81/253 (32%), Positives = 138/253 (54%), Gaps = 11/253 (4%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVID--LEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G+GSFG V K+ K A+KV+ E+E E ++LS+ P+I + +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
++ + KL++++EY GG + + E +++ A+EYLH+ G I+RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
NILL +G +K+ DFG++ +L+ SR TF GTP ++APEV+ +GY + D WSL
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSL 179
Query: 199 GITVIEMAKGEPPLADLHPMRVLF--IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER- 255
G+ + EM G+PP + ++ I+ ++P + E S ++ +S L+K P +R
Sbjct: 180 GVLLYEMLTGKPPFYA-EDRKEIYEKIL--KDPLRFPEFLSPEARDLISGLLQKDPTKRL 236
Query: 256 --PSAKELLRHRF 266
A+E+ H F
Sbjct: 237 GSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 1e-57
Identities = 102/285 (35%), Positives = 151/285 (52%), Gaps = 26/285 (9%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
L +G G+ G V K K A+K I + + D + I +E+ + C+SPYI
Sbjct: 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62
Query: 75 EYYGSYL--HQTKLWIIMEYMAGGSV----ADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
+YYG++L + + I MEY GGS+ + + G + E + I +L + YLH
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
+ IHRDIK +NILLT G VK+ DFGVS +L S TF GT F+MAPE IQ
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN--SLAGTFTGTSFYMAPERIQGKP- 179
Query: 189 YNEKADIWSLGITVIEMA--------KGEPPLADLHPMRVLFIIPRENPPQL-DE----- 234
Y+ +D+WSLG+T++E+A +GEPPL P+ +L I P+L DE
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG---PIELLSYIVNMPNPELKDEPGNGI 236
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLER 279
+S K+F+ CL+K P RP+ ++L H +I+ K + +
Sbjct: 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAK 281
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 7e-56
Identities = 105/269 (39%), Positives = 165/269 (61%), Gaps = 10/269 (3%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
IG GS G V A +K + VA+K++DL + + E + E+ ++ + + E Y SY
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR-ELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAA 140
L +LW++ME++ GG++ D++ S L+E IA + +L A+ YLH++G IHRDIK+
Sbjct: 88 LVGEELWVLMEFLQGGALTDIV-SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSD 146
Query: 141 NILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGI 200
+ILLT +G VK++DFG AQ+++ + +RK+ VGTP+WMAPEVI + Y + DIWSLGI
Sbjct: 147 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGI 205
Query: 201 TVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKVPAERPSA 258
VIEM GEPP P++ + + PP+L S ++++F+ L + P ER +A
Sbjct: 206 MVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATA 265
Query: 259 KELLRHRFIRNARKSPR----LLERIRER 283
+ELL H F+ P L+++ R+R
Sbjct: 266 QELLDHPFLLQT-GLPECLVPLIQQYRKR 293
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 1e-55
Identities = 100/252 (39%), Positives = 160/252 (63%), Gaps = 5/252 (1%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
IG GS G V A +K K VA+K +DL + + E + E+ ++ + + Y SY
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR-ELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAA 140
L +LW++ME++ GG++ D++ + ++E IA + +L A+ YLHN+G IHRDIK+
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 147
Query: 141 NILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGI 200
+ILLT +G +K++DFG AQ+++ + +RK+ VGTP+WMAPEVI Y + DIWSLGI
Sbjct: 148 SILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGI 206
Query: 201 TVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE--HFSRLMKEFVSLCLKKVPAERPSA 258
VIEM GEPP + P++ + I PP++ + S +++ F+ L L + P++R +A
Sbjct: 207 MVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATA 266
Query: 259 KELLRHRFIRNA 270
+ELL+H F++ A
Sbjct: 267 QELLQHPFLKLA 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 1e-55
Identities = 78/263 (29%), Positives = 126/263 (47%), Gaps = 25/263 (9%)
Query: 18 LELIGRGSFGDVYKA---FDKELNK-DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G G+FG+VYK D E + VA+K + SE+E E+ +E S++ + P I
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
G L+I+ EYM GG + D L + G L + + + +EYL ++
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNF 123
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV---GTPF---WMAPEVIQNS 186
+HRD+ A N L+TEN VK++DFG L+R I + G WMAPE +++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFG----LSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 187 EGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRLMK 241
+ + K+D+WS G+ + E+ GE P + VL ++ P + LM
Sbjct: 180 K-FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELML 238
Query: 242 EFVSLCLKKVPAERPSAKELLRH 264
+ C P +RP+ EL+
Sbjct: 239 Q----CWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 189 bits (480), Expect = 1e-54
Identities = 102/252 (40%), Positives = 154/252 (61%), Gaps = 5/252 (1%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
IG GS G V A K K VA+K +DL + + E + E+ ++ + + E Y SY
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR-ELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAA 140
L +LW++ME++ GG++ D++ + ++E IA + +L A+ LH +G IHRDIK+
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSD 145
Query: 141 NILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGI 200
+ILLT +G VK++DFG AQ+++ + RRK+ VGTP+WMAPE+I Y + DIWSLGI
Sbjct: 146 SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGI 204
Query: 201 TVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKVPAERPSA 258
VIEM GEPP + P++ + +I PP+L S +K F+ L + PA+R +A
Sbjct: 205 MVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATA 264
Query: 259 KELLRHRFIRNA 270
ELL+H F+ A
Sbjct: 265 AELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 1e-54
Identities = 96/262 (36%), Positives = 148/262 (56%), Gaps = 15/262 (5%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDL----EESEDE----IEDIQKEISVLSQCRSP 71
LIG GSFG VY + + +A+K ++L S+D ++ + +EI++L + +
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I +Y GS L L I +EY+ GGSVA L+ + +E + +R +L + YLHN G
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQL------TRTISRRKTFVGTPFWMAPEVIQN 185
IHRDIK ANIL+ G +K++DFG+S +L T+T R + G+ FWMAPEV++
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245
+ Y KADIWSLG V+EM G+ P D ++ +F I P++ + S +F+
Sbjct: 187 TS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLE 245
Query: 246 LCLKKVPAERPSAKELLRHRFI 267
+ +RP+A ELL+H F+
Sbjct: 246 KTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 4e-54
Identities = 98/278 (35%), Positives = 153/278 (55%), Gaps = 20/278 (7%)
Query: 14 RFSSLELI---GRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
R LE I G G+ G V K +A KV+ + + I +E+ ++ +CRS
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS 62
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
PYI +YG++L++ + + ME+M GS+ + + G P+ + I ++ + YL+N
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122
Query: 131 GKI-HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+I HRDIK +NIL+ G +K+ DFGVS +L +I+ TFVGT +M+PE IQ Y
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA--DTFVGTSTYMSPERIQ-GGKY 179
Query: 190 NEKADIWSLGITVIEMAKGEPPLAD--------LHPMRVLFIIPR---ENPPQL-DEHFS 237
K+D+WSLGI++IE+A G+ P A PM +L ++ + E PP+L F
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239
Query: 238 RLMKEFVSLCLKKVPAERPSAKELLRHR-FIRNARKSP 274
+++FV CL K P ERP+ ++L FI+ R S
Sbjct: 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 9e-54
Identities = 90/263 (34%), Positives = 146/263 (55%), Gaps = 16/263 (6%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
L+ +G+G++G VYK + +A+K I LE E + I E+ +L + SPYI ++Y
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPP---LDEMSIACILRDLLHAIEYLHNEGK-I 133
G++ + +++ MEYM GS+ L G + E + I ++ +++L E I
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG----- 188
HRD+K N+L+ NG VK+ DFGVS L +++ KT +G +MAPE I+ S G
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--KTNIGCQSYMAPERIK-SGGPNQNP 182
Query: 189 -YNEKADIWSLGITVIEMAKGE---PPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244
Y ++D+WSLG++++EMA G PP + L I +PP L +S ++FV
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFV 242
Query: 245 SLCLKKVPAERPSAKELLRHRFI 267
+ CL K+P RP+ +LL H ++
Sbjct: 243 AKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 3e-52
Identities = 99/305 (32%), Positives = 162/305 (53%), Gaps = 46/305 (15%)
Query: 16 SSLELIGRGSFGD--VYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
L LIG+ V+ A K N VA+K I+L+ S+++++ +Q+EI Q + P
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLHNE 130
I Y S++ ++L+++ MA GS DL+++ P L E++IA IL+D+L+A++Y+H++
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP-------FWMAPEVI 183
G IHR +KA++ILL+ +G V ++ S + + R++ P W++PEV+
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 184 -QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL---------- 232
QN +GYNEK+DI+S+GIT E+A G P D+ ++L R P L
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240
Query: 233 ---------DEH--------------FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269
+EH FS +FV LCL++ P RPSA +LL H F +
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300
Query: 270 ARKSP 274
++
Sbjct: 301 CKRRN 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 4e-52
Identities = 78/263 (29%), Positives = 131/263 (49%), Gaps = 20/263 (7%)
Query: 19 ELIGRGSFGDVYKA-FDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+ +G G+FG+VYK + K +VA+K + + SE+E +D KE V+ + P +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI-LRDLLH-------AIEY 126
G + L++++EYM GG + D L +S P + + L+DLL +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVI 183
L ++ +HRD+ A N L+ E+ VK++DFG+S + RK G WMAPE +
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK-TGGKLPIRWMAPESL 179
Query: 184 QNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVL-FIIPRENPPQLDEHFSRLMK 241
++ + K+D+WS G+ + E G P L VL ++ P+ E+ +
Sbjct: 180 KDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK-PEYCPDELY 237
Query: 242 EFVSLCLKKVPAERPSAKELLRH 264
E + C + P +RP+ EL+
Sbjct: 238 ELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-50
Identities = 95/259 (36%), Positives = 151/259 (58%), Gaps = 15/259 (5%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
E++G G+ G VYKA+ + +A+KVI L+ + + + I E+ +L +C SPYI +Y
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
G++ + ++ I E+M GGS+ D+ + P E + I ++ + YL + +HRD+
Sbjct: 66 GAFFVENRISICTEFMDGGSL-DVYRKIP---EHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWS 197
K +N+L+ G VK+ DFGVS QL +I+ KT+VGT +MAPE I + E Y +D+WS
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVSTQLVNSIA--KTYVGTNAYMAPERI-SGEQYGIHSDVWS 178
Query: 198 LGITVIEMAKGEPPL-------ADLHPMRVLFIIPRENPPQLDEH-FSRLMKEFVSLCLK 249
LGI+ +E+A G P L P+++L I E+PP L FS F++ C++
Sbjct: 179 LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMR 238
Query: 250 KVPAERPSAKELLRHRFIR 268
K P ERP+ + L+ H FI
Sbjct: 239 KQPKERPAPENLMDHPFIV 257
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 8e-50
Identities = 84/252 (33%), Positives = 135/252 (53%), Gaps = 4/252 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
+ + ++G+G+FG+ E + V K ++L SE E D EI +LS + P
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNE 130
I YY ++ L I MEY GG++ D I Q G +E + L ++ A+ Y+H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
G +HRDIK NI LT+ G +K+ DFG+S L S +T VGTP++M+PE+ Q + YN
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK-YN 179
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
K+DIW+LG + E+ + +P+ ++ I + N + +S + V L++
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239
Query: 251 VPAERPSAKELL 262
P +RP+A E+L
Sbjct: 240 DPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 1e-49
Identities = 78/268 (29%), Positives = 126/268 (47%), Gaps = 38/268 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G G+FG+VYK K +VA+K + + SE +IE+ +E ++ + P +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLH-------AIE 125
+ G + L+I+MEYM GG + L ++ P L L DLL +E
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLS-------LSDLLSFALQIARGME 116
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP-----FWMAP 180
YL ++ IHRD+ A N L+ EN VK++DFG L+R + + WMAP
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFG----LSRDLYDDDYYRKRGGKLPIRWMAP 172
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPREN----PPQLDEH 235
E ++ + + K+D+WS G+ + E+ GE P + VL + PP
Sbjct: 173 ESLKEGK-FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPE 231
Query: 236 FSRLMKEFVSLCLKKVPAERPSAKELLR 263
LM + C + P +RP+ EL+
Sbjct: 232 LYDLMLQ----CWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 174 bits (441), Expect = 2e-49
Identities = 103/263 (39%), Positives = 150/263 (57%), Gaps = 20/263 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE----ESEDEIEDIQKEISVLSQCRSPYIT 74
+L+G+G+FG VY +D + +++A+K + + E+ E+ ++ EI +L I
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 75 EYYGSYL--HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+YYG + L I ME+M GGS+ D ++S L E R +L + YLH+
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTI----SRRKTFVGTPFWMAPEVIQNSEG 188
+HRDIK ANIL G+VK+ DFG S +L +TI + K+ GTP+WM+PEVI + EG
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYWMSPEVI-SGEG 185
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-IIPRENPPQLDEHFSRLMKEFVSLC 247
Y KADIWS+G TV+EM +PP A+ M +F I + P L H S ++F
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF---- 241
Query: 248 LKKVPAE---RPSAKELLRHRFI 267
LK++ E RPSA ELLRH F+
Sbjct: 242 LKRIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 5e-49
Identities = 100/263 (38%), Positives = 152/263 (57%), Gaps = 20/263 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI----DLEESEDEIEDIQKEISVLSQCRSPYIT 74
+L+GRG+FG+VY +D + +++A+K + D +E+ E+ ++ EI +L R I
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 75 EYYGSYL--HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+YYG + KL I +EYM GGS+ D +++ L E R +L + YLH+
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR----KTFVGTPFWMAPEVIQNSEG 188
+HRDIK ANIL G+VK+ DFG S ++ +TI K+ GTP+WM+PEVI + EG
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPEVI-SGEG 185
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-IIPRENPPQLDEHFSRLMKEFVSLC 247
Y KAD+WS+ TV+EM +PP A+ M +F I + P L + S ++F
Sbjct: 186 YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF---- 241
Query: 248 LKKVPAE---RPSAKELLRHRFI 267
LK++ E RP+A+ LLRH F+
Sbjct: 242 LKQIFVEEKRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 6e-49
Identities = 84/264 (31%), Positives = 140/264 (53%), Gaps = 15/264 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI-----DLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G G+F Y+A D + +A+K + E E+ +E ++KEI ++++ P+I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
G+ + + +E+MAGGSV+ L+ E I LL + YLH I
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 134 HRDIKAANILLTENG-DVKVADFGVSAQLTRTISR----RKTFVGTPFWMAPEVIQNSEG 188
HRD+K AN+L+ G +++ADFG +A+L + + +GT +MAPEV++ E
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR-GEQ 184
Query: 189 YNEKADIWSLGITVIEMAKGEPPL-ADLHP--MRVLFIIPREN-PPQLDEHFSRLMKEFV 244
Y D+WS+G +IEMA +PP A+ H + ++F I P + EH S +++
Sbjct: 185 YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVT 244
Query: 245 SLCLKKVPAERPSAKELLRHRFIR 268
CL+ P +RP ++ELL+H R
Sbjct: 245 LRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 6e-49
Identities = 102/259 (39%), Positives = 150/259 (57%), Gaps = 14/259 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE----ESEDEIEDIQKEISVLSQCRSPYIT 74
+L+G+G+FG VY +D + +++A K + + E+ E+ ++ EI +L + I
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 75 EYYGSYLHQTK--LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+YYG + + L I MEYM GGSV D +++ L E R +L + YLH+
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTI----SRRKTFVGTPFWMAPEVIQNSEG 188
+HRDIK ANIL G+VK+ DFG S +L +TI + ++ GTP+WM+PEVI + EG
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWMSPEVI-SGEG 185
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-IIPRENPPQLDEHFSRLMKEFVSLC 247
Y KAD+WSLG TV+EM +PP A+ M +F I + PQL H S ++F+ C
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLG-C 244
Query: 248 LKKVPAERPSAKELLRHRF 266
+ RPSA+ELLRH F
Sbjct: 245 IFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 7e-49
Identities = 79/267 (29%), Positives = 128/267 (47%), Gaps = 35/267 (13%)
Query: 18 LELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G G+FG+VYK +VA+K + + SE +IE+ +E ++ + P I
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLH-------AIEY 126
+ G + L I+MEYM GG + D ++ P E+S L DLL +EY
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELS----LSDLLSFALQIARGMEY 118
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP-----FWMAPE 181
L ++ IHRD+ A N L+ EN VK++DFG L+R + + WMAPE
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFG----LSRDLYDDDYYKVKGGKLPIRWMAPE 174
Query: 182 VIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPREN----PPQLDEHF 236
++ + + K+D+WS G+ + E+ GE P + VL + + PP
Sbjct: 175 SLKEGK-FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPEL 233
Query: 237 SRLMKEFVSLCLKKVPAERPSAKELLR 263
+LM + C + P +RP+ EL+
Sbjct: 234 YKLMLQ----CWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 8e-49
Identities = 90/253 (35%), Positives = 142/253 (56%), Gaps = 6/253 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYI 73
F L IG+GSFG V+K K + A+K IDL + + E E+ E VL++ S YI
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEG 131
YY S+L + KL I+MEY G + L+ Q G PL E + +L + +LH++
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
+HRDIK+ N+ L +VK+ D GV+ L+ + T VGTP++++PE+ ++ YNE
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP-YNE 180
Query: 192 KADIWSLGITVIEMAKGEPPL-ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
K+D+W+LG+ + E G+ P A+ +L II PP + + +S+ + + + CL K
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQMYSQQLAQLIDQCLTK 239
Query: 251 VPAERPSAKELLR 263
+RP +LLR
Sbjct: 240 DYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 101/297 (34%), Positives = 151/297 (50%), Gaps = 41/297 (13%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F L +G G+ G V K + +A K+I LE I +E+ VL +C SPYI
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI- 133
+YG++ ++ I ME+M GGS+ +++ + E + I +L + YL + KI
Sbjct: 63 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIM 122
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRD+K +NIL+ G++K+ DFGVS QL +++ +FVGT +M+PE +Q + Y ++
Sbjct: 123 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTH-YTVQS 179
Query: 194 DIWSLGITVIEMAKGE---PP-----LADLH-------------------------PMRV 220
DIWSLG++++EMA G PP L + PM +
Sbjct: 180 DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239
Query: 221 ---LFIIPRENPPQL-DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273
L I E PP+L FS ++FV CLKK P ER KEL +H FI+ A
Sbjct: 240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 3e-48
Identities = 87/267 (32%), Positives = 146/267 (54%), Gaps = 19/267 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE---------DEIEDIQKEISVLSQCR 69
ELIG+G++G VY A + + +A+K ++L + D ++ ++ EI L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
I +Y G + L I +EY+ GGS+ +++ +E + +L + YLH+
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI---SRRKTFVGTPFWMAPEVIQN- 185
+G +HRD+KA N+L+ +G K++DFG+S + + I + + G+ FWMAPEVI +
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-----PPQLDEHFSRLM 240
S+GY+ K DIWSLG V+EM G P +D + +F + + PP + + S +
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVA 245
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267
+F++ C P RP+A+ELL+H FI
Sbjct: 246 LDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 4e-48
Identities = 94/255 (36%), Positives = 145/255 (56%), Gaps = 8/255 (3%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGS 79
++G+G++G VY A D +AIK I +S ++ + +EI++ S + I +Y GS
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGS 73
Query: 80 YLHQTKLWIIMEYMAGGSVADLIQS--GPPLD-EMSIACILRDLLHAIEYLHNEGKIHRD 136
I ME + GGS++ L++S GP D E +I + +L ++YLH+ +HRD
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133
Query: 137 IKAANILL-TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-QNSEGYNEKAD 194
IK N+L+ T +G VK++DFG S +L +TF GT +MAPEVI + GY AD
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPAD 193
Query: 195 IWSLGITVIEMAKGEPPLADL-HPMRVLFIIPR-ENPPQLDEHFSRLMKEFVSLCLKKVP 252
IWSLG T++EMA G+PP +L P +F + + P++ E S K F+ C + P
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDP 253
Query: 253 AERPSAKELLRHRFI 267
+R SA +LL+ F+
Sbjct: 254 DKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 4e-48
Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 31/280 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSP 71
F ++IG GSF V A +KE NK+ AIK++D + E +++ ++ E VL++ P
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I + Y ++ + L+ ++EY G + I+ LDE ++L A+EYLH++G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--------------------RRKTF 171
IHRD+K NILL ++ +K+ DFG + L S R +F
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FIIPRENPP 230
VGT +++PE++ + +D+W+LG + +M G+PP + I+ E
Sbjct: 183 VGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE--Y 239
Query: 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAK----ELLRHRF 266
+F K+ + L P +R EL H F
Sbjct: 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 4e-48
Identities = 87/268 (32%), Positives = 135/268 (50%), Gaps = 36/268 (13%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI------EDIQKEISVLSQCRSPYIT 74
+G G FG V K N+ A+K + + I E I E +L +C P+I
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV----KKRHIVETGQQEHIFSEKEILEECNHPFIV 56
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDE----MSIACILRDLLHAIEYLHNE 130
+ Y ++ + ++++MEY GG + +++ DE IAC++ A EYLHN
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVL----AFEYLHNR 112
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
G I+RD+K N+LL NG VK+ DFG + +L + TF GTP ++APE+I N +GY+
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG-QKTWTFCGTPEYVAPEIILN-KGYD 170
Query: 191 EKADIWSLGITVIEMAKGEPPLA--DLHPMRVLFIIPREN-----PPQLDEHFSRLMKEF 243
D WSLGI + E+ G PP D PM + I + N P +D+ L+K
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIK-- 228
Query: 244 VSLCLKKVPAER-----PSAKELLRHRF 266
L ++ P ER K++ +H++
Sbjct: 229 -QLL-RRNPEERLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 9e-48
Identities = 91/269 (33%), Positives = 147/269 (54%), Gaps = 9/269 (3%)
Query: 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ 67
A + +L IG G+ G VYK K+ +A+K + +++E + I ++ V+ +
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 68 CR-SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY 126
PYI + YG ++ + ++I ME M+ L + P+ E + + ++ A+ Y
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHY 129
Query: 127 L-HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-- 183
L G IHRD+K +NILL +G+VK+ DFG+S +L + ++ ++ G +MAPE I
Sbjct: 130 LKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYMAPERIDP 188
Query: 184 QNSEG-YNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQLD--EHFSRL 239
+ Y+ +AD+WSLGI+++E+A G+ P + VL I +E PP L E FS
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248
Query: 240 MKEFVSLCLKKVPAERPSAKELLRHRFIR 268
FV LCL K +RP +ELL+H FIR
Sbjct: 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 1e-47
Identities = 91/261 (34%), Positives = 136/261 (52%), Gaps = 18/261 (6%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
F L+ +G+GS+G VYK N+ A+K +DL S+ E ED EI +L+ P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP----PLDEMSIACILRDLLHAIEYLH 128
I Y ++L KL I+MEY G ++ I + E I I LL ++ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
+ +HRD+K+ANILL N VK+ D G+S L + ++ KT +GTP +MAPEV +
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA--KTQIGTPHYMAPEVWKGRP- 177
Query: 189 YNEKADIWSLGITVIEMAKGEPP-----LADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243
Y+ K+DIWSLG + EMA PP + DL +V R P + +S+ ++ F
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-YKVQ----RGKYPPIPPIYSQDLQNF 232
Query: 244 VSLCLKKVPAERPSAKELLRH 264
+ L+ P RP+ ++L
Sbjct: 233 IRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 6e-47
Identities = 87/265 (32%), Positives = 139/265 (52%), Gaps = 19/265 (7%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
I +G++G V+ A K AIKVI D+ +++++ + E +LSQ +SPY+ + Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI-RKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
S+ + L+++MEY+ GG +A L+++ LDE + +++ A+EYLH+ G IHRD+
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 138 KAANILLTENGDVKVADFGVSAQ--------LTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
K NIL+ NG +K+ DFG+S L K VGTP ++APEVI +G+
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI-LGQGH 178
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--IIPRENPPQLDEHFSRLMKEFVSLC 247
++ D WSLG + E G PP P + F I+ + D S + +S
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEI-FQNILNGKIEWPEDVEVSDEAIDLISKL 237
Query: 248 LKKVPAERP---SAKELLRHRFIRN 269
L P +R S +E+ H F +
Sbjct: 238 LVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 7e-47
Identities = 89/292 (30%), Positives = 136/292 (46%), Gaps = 49/292 (16%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI--EDIQKEISVLSQCRSPY 72
+ LE +G G++G VYKA DK+ + VA+K I L+ E+ I + +EIS+L + + P
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL-REISLLKELKHPN 59
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQS-GPPLDEMSIACILRDLLHAIEYLH 128
I + + KL+++ EY DL + PL I I+ LL + Y H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---RRKTF-VGTPFWMAPEVIQ 184
+ +HRD+K NIL+ +G +K+ADFG L R R T V T ++ APE++
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFG----LARAFGIPLRTYTHEVVTLWYRAPEILL 171
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLA------------------------DLHPMRV 220
S+ Y+ DIWS+G EM G+P + +
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231
Query: 221 -LFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHRFI 267
P+ P L++ RL E + L L K+ PA+R SAKE L+H +
Sbjct: 232 YKPTFPKFPPKDLEKVLPRLDPEGIDL-LSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 169 bits (428), Expect = 2e-46
Identities = 97/294 (32%), Positives = 139/294 (47%), Gaps = 30/294 (10%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSP- 71
+ L +G GSFG+VY A D K VA+KV+ LE E+E +EI +L+ P
Sbjct: 2 YRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLH 128
I + Y + + L+++MEY+ GGS+ DL++ PL E IL +L A+EYLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 129 NEGKIHRDIKAANILLTENGD-VKVADFGVSAQLTRTISRR------KTFVGTPFWMAPE 181
++G IHRDIK NILL +G VK+ DFG++ L S T VGTP +MAPE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 182 VI--QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------PRE 227
V+ + + +DIWSLGIT+ E+ G PP
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIR 281
P E S+ + + L K P R S+ L H + + + L +
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
|
Length = 384 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 85/258 (32%), Positives = 142/258 (55%), Gaps = 5/258 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPY 72
R+ ++ IG GSFG +Y A K ++ IK IDL + E E +KE+ +L++ + P
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNE 130
I ++ S+ +L+I+MEY GG + I Q G E I + ++++H+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 131 GKIHRDIKAANILLTENGDV-KVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRDIK+ NI L++NG V K+ DFG++ QL ++ T VGTP++++PE+ QN Y
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP-Y 179
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249
N K DIWSLG + E+ + P + +++ I + + +FSR ++ +S K
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239
Query: 250 KVPAERPSAKELLRHRFI 267
P +RPS +L+ F+
Sbjct: 240 VSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 96/268 (35%), Positives = 146/268 (54%), Gaps = 22/268 (8%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVL---SQCRSPYIT 74
L IGRG+FG V K K +A+K I E E + + ++ V+ S C PYI
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC--PYIV 66
Query: 75 EYYGSYLHQTKLWIIMEYMAGG------SVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
++YG+ + WI ME M V ++++S + E + I + A+ YL
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKS--VIPEEILGKIAVATVKALNYLK 124
Query: 129 NEGKI-HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS- 186
E KI HRD+K +NILL NG++K+ DFG+S QL +I++ + G +MAPE I S
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSA 183
Query: 187 -EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV-LFIIPRENPPQL----DEHFSRLM 240
+GY+ ++D+WSLGIT+ E+A G+ P + + L + + +PP L + FS
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF 243
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIR 268
F++LCL K ++RP KELL H FI+
Sbjct: 244 VNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 95/269 (35%), Positives = 141/269 (52%), Gaps = 17/269 (6%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSPYITE 75
+E +GRG++G V K +A+K I + E + + +IS+ S PY
Sbjct: 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD-CPYTVT 64
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADL----IQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+YG+ + +WI ME M S+ G + E + I ++ A+EYLH++
Sbjct: 65 FYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123
Query: 132 K-IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF-VGTPFWMAPEVI---QNS 186
IHRD+K +N+L+ NG VK+ DFG+S L +++ KT G +MAPE I N
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAPERINPELNQ 181
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQL-DEHFSRLMKEFV 244
+GY+ K+D+WSLGIT+IE+A G P P + L + E PQL E FS ++FV
Sbjct: 182 KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFV 241
Query: 245 SLCLKKVPAERPSAKELLRHRFIRNARKS 273
+ CLKK ERP+ ELL+H F
Sbjct: 242 NKCLKKNYKERPNYPELLQHPFFELHLSK 270
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 82/251 (32%), Positives = 131/251 (52%), Gaps = 10/251 (3%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI--EDIQKEISVLSQCRSPYITEYYG 78
IG+G F VYKA + VA+K + + E D +D KEI +L Q P + +Y
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
S++ +L I++E G ++ +I+ + E +I L A+E++H++ +H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMH 129
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIK AN+ +T G VK+ D G+ + + + VGTP++M+PE I GYN K+D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-ENGYNFKSD 188
Query: 195 IWSLGITVIEMAKGEPPL-ADLHPMRVLF--IIPRENPPQLDEHFSRLMKEFVSLCLKKV 251
IWSLG + EMA + P D + L I + PP +H+S +++ VS C+
Sbjct: 189 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPD 248
Query: 252 PAERPSAKELL 262
P +RP +L
Sbjct: 249 PEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 6e-42
Identities = 85/257 (33%), Positives = 141/257 (54%), Gaps = 4/257 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
++ ++ IG GSFG KE K IK I++ + S E E+ +KE++VLS + P
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNE 130
I +Y S+ L+I+M+Y GG + I Q G E I + A++++H+
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
+HRDIK+ NI LT++G +K+ DFG++ L T+ +T +GTP++++PE+ +N YN
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP-YN 179
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
K+DIW+LG + EM + + ++ I R + P + H+S ++ VS K+
Sbjct: 180 NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR 239
Query: 251 VPAERPSAKELLRHRFI 267
P +RPS +L FI
Sbjct: 240 NPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 84/286 (29%), Positives = 141/286 (49%), Gaps = 35/286 (12%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIED-IQKEISVLSQCRSPY 72
R+ L IG G+ G V+KA D+E + VA+K + L E I + +EI L C+ PY
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEG 131
+ + + H + ++MEYM ++++++ PL E + +R LL + Y+H G
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF-VGTPFWMAPEVIQNSEGYN 190
+HRD+K AN+L++ +G +K+ADFG++ + R + V T ++ APE++ + Y+
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 191 EKADIWSLGITVIEMAKGEP--------------------PLADLHP-MRVL----FIIP 225
D+W++G E+ G P P + P + L I
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239
Query: 226 RENPPQ-LDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHRF 266
E+ P L+E F E + L LK + P++R SA E LRH +
Sbjct: 240 PESKPIPLEEIFPDASPEALDL-LKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 87/257 (33%), Positives = 145/257 (56%), Gaps = 10/257 (3%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
++ + ++GRG+FG V+ K K V IK I +E+ ++DE Q E VL P
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
I EYY ++L L I+MEY GG++A+ IQ LDE +I +L A+ ++H +
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 131 GKIHRDIKAANILLTENGDV-KVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRD+K NILL ++ V K+ DFG+S L+ + S+ T VGTP +++PE+ + + Y
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPELCE-GKPY 178
Query: 190 NEKADIWSLGITVIEMAKGEPPL--ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247
N+K+DIW+LG + E+A + A+L P VL I+ P + + +S +++ +
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAANL-PALVLKIMSGTFAP-ISDRYSPDLRQLILSM 236
Query: 248 LKKVPAERPSAKELLRH 264
L P++RP +++
Sbjct: 237 LNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 69/215 (32%), Positives = 116/215 (53%), Gaps = 20/215 (9%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F ++ +G GSFG V K K A+K++ + ++E + E +L R P+
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIAC------ILRDLLHAIEY 126
+ YGS+ + L+++MEY+ GG + ++ E +A +L A+EY
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE-PVARFYAAQVVL-----ALEY 116
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-TRTISRRKTFVGTPFWMAPEVIQN 185
LH+ ++RD+K N+LL +G +K+ DFG + ++ RT T GTP ++APE+I
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT----YTLCGTPEYLAPEIIL- 171
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV 220
S+GY + D W+LGI + EM G PP D +P+++
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 83/261 (31%), Positives = 136/261 (52%), Gaps = 14/261 (5%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVL-SQCRSPYIT 74
L+ I +G+FG VY A + AIKV+ + +++++ +++ E +++ Q SPY+
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+ Y S+ + L+++MEY+ GG A LI++ L E + +++ +E LH G IH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIK N+L+ + G +K+ DFG L+R K FVGTP ++APE I G ++ +D
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFG----LSRNGLENKKFVGTPDYLAPETI-LGVGDDKMSD 175
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKV 251
WSLG + E G PP P V I P ++ E S + ++ L
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 252 PAERPSAK---ELLRHRFIRN 269
PA+R A E+ H F ++
Sbjct: 236 PAKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 80/287 (27%), Positives = 135/287 (47%), Gaps = 35/287 (12%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRSPY 72
++ L ++G G++G V K +K + VAIK + E+ ED + +E+ VL Q R
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHNEG 131
I ++ + +L+++ EY ++ +L+++ P L ++ + LL AI Y H+
Sbjct: 62 IVNLKEAFRRKGRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLT-RTISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRDIK NIL++E+G +K+ DFG + L R S +V T ++ APE++ Y
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180
Query: 191 EKADIWSLGITVIEMAKGEP-------------------PLADLHPMRVL-------FII 224
+ D+W++G + E+ GEP PL H
Sbjct: 181 KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240
Query: 225 PRENPPQLDEH-----FSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
P + P+ E S +F+ CL+ P ER + ELL+H +
Sbjct: 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 4e-39
Identities = 79/251 (31%), Positives = 133/251 (52%), Gaps = 3/251 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+++ L ++G GSFG ++ A+K I L +S +ED +KE +L++ + P I
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ S+ L+I+MEY GG + I Q G E +I + ++++H +
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
+HRDIK+ NI LT+NG VK+ DFG + LT + T+VGTP+++ PE+ +N YN
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP-YNN 179
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251
K+DIWSLG + E+ + P ++ + + + L H+S ++ + K+
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRN 239
Query: 252 PAERPSAKELL 262
P RPSA +L
Sbjct: 240 PRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 87/262 (33%), Positives = 136/262 (51%), Gaps = 10/262 (3%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL----EESEDEIEDIQKEISVLSQCR 69
R+ + +G+GSFG VY DK+ + +KV+ E + +E +E +LS+
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIE 125
P I +++ S+L + II EY G + ++ +G L E + LL +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
Y+H +HRD+KA NI L N +K+ DFGVS L + TF GTP++M+PE +++
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245
+GY+ K+DIWSLG + EM + + V+ I P L E +SR + +
Sbjct: 180 -QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238
Query: 246 LCLKKVPAERPSAKELLRHRFI 267
L K P+ RPSA E+LR+ FI
Sbjct: 239 SMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 92/275 (33%), Positives = 142/275 (51%), Gaps = 18/275 (6%)
Query: 5 AGLQEAAGSRFSSLE---LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKE 61
+G +A S LE IG G+ G VYK + + A+KVI + I +E
Sbjct: 63 SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122
Query: 62 ISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLL 121
I +L P + + + + H ++ +++E+M GGS ++ DE +A + R +L
Sbjct: 123 IEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS----LEGTHIADEQFLADVARQIL 178
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPE 181
I YLH +HRDIK +N+L+ +VK+ADFGVS L +T+ + VGT +M+PE
Sbjct: 179 SGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPE 238
Query: 182 VIQ---NSEGYNEKA-DIWSLGITVIEMAKGEPPLA-----DLHPMRVLFIIPRENPPQL 232
I N Y+ A DIWSLG++++E G P D + + I PP+
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL--MCAICMSQPPEA 296
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
SR + F+S CL++ PA+R SA +LL+H FI
Sbjct: 297 PATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 78/284 (27%), Positives = 135/284 (47%), Gaps = 49/284 (17%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQCR 69
F +++IGRG+FG+V+ DK+ + A+KV+ D+ + +I ++ E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN-QIAHVRAERDILADAD 59
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
SP+I + Y S+ + L+++MEYM GG + +L+ E + + +L+ A++ +H
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQL---------------------------- 161
G IHRDIK NIL+ +G +K+ADFG+ ++
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 162 -TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV 220
+ R + VGTP ++APEV++ Y + D WSLG+ + EM G PP
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLR-GTPYGLECDWWSLGVILYEMLYGFPPFYS------ 232
Query: 221 LFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
L E +++++ SL P P A +L+
Sbjct: 233 ---------DTLQETYNKIINWKESLRFPPDPPVSPEAIDLICR 267
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 81/246 (32%), Positives = 131/246 (53%), Gaps = 12/246 (4%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI--EDIQKEISVLSQCRSPYITEYYG 78
IGRG F +VY+A K VA+K + + E D +D KEI +L Q P + +Y
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 79 SYLHQTKLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
S++ +L I++E G ++ +I + + E ++ L A+E++H+ +H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH 129
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RDIK AN+ +T G VK+ D G+ + + + VGTP++M+PE I + GYN K+D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSD 188
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLKK 250
IWSLG + EMA + P M + + + + PP EH+S ++E VS+C+
Sbjct: 189 IWSLGCLLYEMAALQSPFYG-DKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYP 247
Query: 251 VPAERP 256
P +RP
Sbjct: 248 DPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 80/299 (26%), Positives = 138/299 (46%), Gaps = 58/299 (19%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQCRSPY 72
+ + IG G++G VYKA +K+ + VA+K I +E ++ I +EI +L + R P
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGF-PITAIREIKLLQKLRHPN 59
Query: 73 ITEYYGSYLHQTK--LWIIMEYM----AGGSVADLIQSGP-PLDEMSIACILRDLLHAIE 125
I + K ++++ EYM G L+ S E I C ++ LL ++
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLLEGLQ 114
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF-----VGTPFWMAP 180
YLH+ G +HRDIK +NIL+ +G +K+ADFG L R ++R + V T ++ P
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGVLKLADFG----LARPYTKRNSADYTNRVITLWYRPP 170
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLA---DLHPMRVLFII------------- 224
E++ + Y + D+WS+G + E+ G+P +L + +F +
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230
Query: 225 --PRENPPQLDEHFSRLMKEFVS--------------LCLKKVPAERPSAKELLRHRFI 267
P + + + R ++EF L L P +R SA + L+H +
Sbjct: 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLD--PKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 79/285 (27%), Positives = 129/285 (45%), Gaps = 34/285 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPYI 73
+ L IG G++G VYKA DK + VAIK I L + I +EI +L + P I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + H+ L+++ E+M + LI+ L E I L LL + + H+ G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQNSEGYNE 191
+HRD+K N+L+ G +K+ADFG A+ + R T +V T ++ APE++ +GY+
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFG-LARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178
Query: 192 KADIWSLGITVIEMAKGEPPL---ADL----HPMRVL-------------------FIIP 225
DIWS+G E+ P +++ R L F P
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238
Query: 226 RENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFI 267
++ L + F + + L L P +R +A++ L H +
Sbjct: 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 6e-37
Identities = 92/302 (30%), Positives = 153/302 (50%), Gaps = 49/302 (16%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F + +G G+ G V+K K +A K+I LE I +E+ VL +C SPYI
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI- 133
+YG++ ++ I ME+M GGS+ +++ + E + + ++ + YL + KI
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 126
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRD+K +NIL+ G++K+ DFGVS QL +++ +FVGT +M+PE +Q + Y+ ++
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTH-YSVQS 183
Query: 194 DIWSLGITVIEMA----------------------KGEPPLADLHP-------------- 217
DIWS+G++++EMA +G+P ++ P
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGP 243
Query: 218 --------MRVLFIIPRENPPQLDE-HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268
+L I E PP+L F ++FV+ CL K PAER K+L+ H FI+
Sbjct: 244 DSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK 303
Query: 269 NA 270
+
Sbjct: 304 RS 305
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 66/207 (31%), Positives = 113/207 (54%), Gaps = 6/207 (2%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS 70
++ +G G+FG V+ D+ A+KV+ + E + + + E VL +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P+I + + Q L+++MEY+ GG + +++ + +++ A+EYLH++
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
++RD+K NILL + G +K+ DFG + +L R T GTP ++APEVIQ S+G+N
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWTLCGTPEYLAPEVIQ-SKGHN 176
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHP 217
+ D W+LGI + EM G PP D +P
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 77/259 (29%), Positives = 130/259 (50%), Gaps = 19/259 (7%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKD-VAIKVI---------DLEESEDEIEDIQKEISV 64
++ LE +G G+FG VYK K ++ +A+K I D E + I DI E+++
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 65 L-SQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRD 119
+ Q R P I YY ++L +L+I+M+ + G + + S E I I
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 120 LLHAIEYLHNEGKI-HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178
++ A+ YLH E +I HRD+ NI+L E+ V + DFG++ Q S+ + VGT +
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVVGTILYS 180
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-IIPRENPPQLDEHFS 237
PE+++N E Y EKAD+W+ G + +M +PP + + + I+ P + +S
Sbjct: 181 CPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239
Query: 238 RLMKEFVSLCLKKVPAERP 256
+ + ++ CL RP
Sbjct: 240 EDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 62/204 (30%), Positives = 111/204 (54%), Gaps = 14/204 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L +IG+G+FG V ++ K A+K ++ ++ + + ++ E +L + P+
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAIEYLHN 129
+ + S+ + ++++++ + GG DL + E + + +++ A+EYLH+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGG---DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTPFWMAPEVIQNSE 187
+G IHRDIK NILL E G V + DF ++ ++T T GTP +MAPEV+ +
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTTSTSGTPGYMAPEVLC-RQ 174
Query: 188 GYNEKADIWSLGITVIEMAKGEPP 211
GY+ D WSLG+T E +G+ P
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 87/284 (30%), Positives = 140/284 (49%), Gaps = 31/284 (10%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPY 72
++ +L L+G GS+G V K KE + VAIK E + ++ I +EI +L Q R
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + + +L+++ E++ + DL + LDE + L +L IE+ H+
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNI 121
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIK NIL++++G VK+ DFG + L +V T ++ APE++ Y
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 193 ADIWSLGITVIEMAKGEPPL---ADL----HPMRVL-FIIPR------ENP-------PQ 231
DIW++G V EM GEP +D+ H ++ L +IPR +NP P+
Sbjct: 182 VDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE 241
Query: 232 LDE---------HFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
+ E S L+ + CL+ P +RPS+ +LL H F
Sbjct: 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 2e-34
Identities = 93/304 (30%), Positives = 150/304 (49%), Gaps = 51/304 (16%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F + +G G+ G V K K +A K+I LE I +E+ VL +C SPYI
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI- 133
+YG++ ++ I ME+M GGS+ +++ + E + + +L + YL + +I
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIM 126
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRD+K +NIL+ G++K+ DFGVS QL +++ +FVGT +M+PE +Q + Y+ ++
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTH-YSVQS 183
Query: 194 DIWSLGITVIEMAKGEPPLA---------------------------------------- 213
DIWS+G++++E+A G P+
Sbjct: 184 DIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGH 243
Query: 214 --DLHPMRVLF----IIPRENPPQLDEH-FSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
D P +F I E PP+L F+ +EFV+ CL K PAER K L+ H F
Sbjct: 244 GMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303
Query: 267 IRNA 270
I+ +
Sbjct: 304 IKRS 307
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 70/219 (31%), Positives = 117/219 (53%), Gaps = 13/219 (5%)
Query: 9 EAAGSRFSSLEL---IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEIS 63
+ + + S E+ +G GSFG V A K + AIK + E +++ + +E S
Sbjct: 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKS 70
Query: 64 VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV-ADLIQSGP-PLDEMSIACILRDLL 121
+L + P+I S+ + +++ ++E++ GG + L ++G P D +L+
Sbjct: 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA--ELV 128
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPE 181
A EYLH++ I+RD+K N+LL G VKV DFG + ++ R T GTP ++APE
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---DRTFTLCGTPEYLAPE 185
Query: 182 VIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV 220
VIQ S+G+ + D W++G+ + E G PP D P R+
Sbjct: 186 VIQ-SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223
|
Length = 329 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 76/247 (30%), Positives = 131/247 (53%), Gaps = 14/247 (5%)
Query: 21 IGRGSFGDVYKA---FDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
IGRG F +VY+A D +++ DL +++ D KEI +L Q P + +YY
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEIDLLKQLNHPNVIKYY 68
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPP----LDEMSIACILRDLLHAIEYLHNEGKI 133
S++ +L I++E G ++ +I+ + E ++ L A+E++H+ +
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVM 128
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK AN+ +T G VK+ D G+ + + + VGTP++M+PE I + GYN K+
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKS 187
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLK 249
DIWSLG + EMA + P M + + + + PP +H+S +++ V++C+
Sbjct: 188 DIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCIN 246
Query: 250 KVPAERP 256
P +RP
Sbjct: 247 PDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 80/296 (27%), Positives = 133/296 (44%), Gaps = 47/296 (15%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ----KEISVLSQCR 69
R+ + +G G++ VYKA DKE + VAIK I L E ++ + I +EI +L + +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSG-PPLDEMSIACILRDLLHAIE 125
P I + H++ + ++ E+M DL I+ L I + L +E
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET----DLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI---SRRKTF-VGTPFWMAPE 181
YLH+ +HRD+K N+L+ +G +K+ADFG L R+ +R+ T V T ++ APE
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFG----LARSFGSPNRKMTHQVVTRWYRAPE 172
Query: 182 VIQNSEGYNEKADIWSLGITVIEMAKGEPPLA---DLHPMRVLFII---PREN------- 228
++ + Y D+WS+G E+ P L D+ + +F P E
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 229 -----------PPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRNA 270
P L + F + + L L P +R +A++ L H + N
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 76/261 (29%), Positives = 129/261 (49%), Gaps = 16/261 (6%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQC-RSPYITEY 76
++G+GSFG V A K ++ A+KV+ D+ +D++E E VL+ + P++T+
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
+ + + +L+ +MEY+ GG + IQ DE +++ +++LH G I+RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N+LL G +K+ADFG+ + TF GTP ++APE++ Y D W
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP-YGPAVDWW 180
Query: 197 SLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC---LKKVPA 253
+LG+ + EM G+ P + LF E+ + S KE S+ L K P
Sbjct: 181 ALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLS---KEAKSILKSFLTKNPE 236
Query: 254 ER-----PSAKELLRHRFIRN 269
+R +++ H F R
Sbjct: 237 KRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-33
Identities = 85/326 (26%), Positives = 138/326 (42%), Gaps = 64/326 (19%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI-DLEESEDEIEDIQKEISVLSQCRSPY 72
R+ L+ IG G++G V A DK + VAIK I ++ + + + I +EI +L R
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 73 ITE-----YYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAI 124
I S ++I+ E M DL I+S PL + I L +L +
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELME----TDLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI------SRRKT-FVGTPFW 177
+YLH+ IHRD+K +NIL+ N D+K+ DFG L R + T +V T ++
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFG----LARGVDPDEDEKGFLTEYVVTRWY 172
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP--PLAD-LHPMRVLF------------ 222
APE++ +S Y + DIWS+G E+ +P P D + + ++
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232
Query: 223 IIPREN--------PPQLDEHFSRLMKE-------FVSLCLKKVPAERPSAKELLRHRFI 267
I E P + + S+L + L P +R +A E L H +
Sbjct: 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY- 291
Query: 268 RNARKSPRLLERIRERPKYPIQEEPD 293
L ++ + P+ + P
Sbjct: 292 ---------LAQLHDPEDEPVAKPPF 308
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 77/254 (30%), Positives = 130/254 (51%), Gaps = 5/254 (1%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEY 76
+ ++G+GS+G+V + K IK ++L S E + ++E +LSQ + P I Y
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 77 YGSYLHQT-KLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
S+ + L+I+M + GG + + Q G L E + + A++YLH + +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRD+K N+ LT +KV D G++ L T +GTP++M+PE+ N YN K+
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP-YNYKS 183
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPA 253
D+W+LG V EMA + +++ I P + + +S + E ++ L K P
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPE 243
Query: 254 ERPSAKELLRHRFI 267
+RPS K +LR +I
Sbjct: 244 KRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 81/291 (27%), Positives = 129/291 (44%), Gaps = 60/291 (20%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVI-----DLEE--SEDEIEDIQKEISVLSQCRSPYI 73
+G G+FG VY A +KE + VAIK + EE + E++ ++K L+ P I
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRK----LN--EHPNI 60
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + +L+ + EYM G ++ L++ G P E I I+ +L + ++H G
Sbjct: 61 VKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF---VGTPFWMAPEVIQNSEG 188
HRD+K N+L++ VK+ADFG L R I R + V T ++ APE++ S
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFG----LAREIRSRPPYTDYVSTRWYRAPEILLRSTS 175
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHP-----------MRVL---------------- 221
Y+ DIW+LG + E+ P L P VL
Sbjct: 176 YSSPVDIWALGCIMAELYTLRP----LFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231
Query: 222 ---FIIPRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRF 266
F P+ P L + E + L L+ P +RP+A + L+H +
Sbjct: 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 6/201 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVID--LEESEDEIEDIQKEISVLSQCRSPY 72
F L +G+G +G V+ A K+ + VA+K + L +E+ + E +L+ +S +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + ++ L++ MEY+ GG L+ + L E + ++ A++ LH G
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRD+K N L+ +G +K+ DFG+S ++ + VG+P +MAPEV++ +GY+
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKG---IVTYANSVVGSPDYMAPEVLR-GKGYDFT 178
Query: 193 ADIWSLGITVIEMAKGEPPLA 213
D WSLG + E G PP +
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 7e-32
Identities = 89/316 (28%), Positives = 147/316 (46%), Gaps = 60/316 (18%)
Query: 18 LELIGRGSFGD---VYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYI 73
L +IGRG F D V A K + V ++ I+LE + + + +Q E+ V P I
Sbjct: 3 LTVIGRG-FEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNI 61
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
Y +++ +LW++ +MA GS DLI + + E++IA IL+ +L A++Y+H+ G
Sbjct: 62 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-------WMAPEVI- 183
+HR +KA++IL++ +G V ++ + + R + P W++PEV+
Sbjct: 122 YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQ 181
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--------------IIP---- 225
QN +GY+ K+DI+S+GIT E+A G P D+ ++L IP
Sbjct: 182 QNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241
Query: 226 ----------------------RENPPQLDEH-----FSRLMKEFVSLCLKKVPAERPSA 258
R + + H FS FV CL++ P RPSA
Sbjct: 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA 301
Query: 259 KELLRHRFIRNARKSP 274
LL H F + ++
Sbjct: 302 STLLNHSFFKQIKRRA 317
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 87/279 (31%), Positives = 141/279 (50%), Gaps = 7/279 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQC-RSPYITE 75
+++G+GSFG V+ A K N+ AIK + D+ +D++E E VLS P++T
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
Y ++ + L+ +MEY+ GG + IQS D +++ +++LH++G ++R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K NILL +G +K+ADFG+ + ++ TF GTP ++APE++ + YN D
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTSVDW 179
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255
WS G+ + EM G+ P H LF R + P +R K+ + + P R
Sbjct: 180 WSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERR 238
Query: 256 PSAKELLR-HRFIRNARKSPRLLERIRERPKYPIQEEPD 293
K +R H F R S L ER E P P + +
Sbjct: 239 LGVKGDIRQHPFFREIDWS-ALEEREIEPPFKPKVKSAN 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 81/288 (28%), Positives = 128/288 (44%), Gaps = 44/288 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI-EDIQKEISVLSQCRS---PYI 73
L IG G++G VYKA D + VA+K + + SE+ I +EI++L Q S P I
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 74 TEYY----GSYL-HQTKLWIIMEYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEY 126
G + KL ++ E++ +A + P L +I ++R LL +++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
LH+ +HRD+K NIL+T +G VK+ADFG++ + + V T ++ APEV+ S
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-MALTSVVVTLWYRAPEVLLQS 181
Query: 187 EGYNEKADIWSLGITVIEMAKGEP--------------------PLADLHPMRVLFIIPR 226
Y D+WS+G E+ + P P + P V PR
Sbjct: 182 S-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL--PR 238
Query: 227 EN-PPQLDEHFSRLMKE-------FVSLCLKKVPAERPSAKELLRHRF 266
+ P F + E + L P +R SA E L+H +
Sbjct: 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 66/205 (32%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIE-DIQKEISVLSQCRSP 71
+ F L IG G++G VY+A D + VA+K + ++ D I +EI++L R P
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 72 YITEYY----GSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEY 126
I E G +L ++++MEY +A L+ + P P E + C++ LL ++Y
Sbjct: 67 NIVELKEVVVGKHL--DSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQN 185
LH IHRD+K +N+LLT+ G +K+ADFG+ A+ ++ T V T ++ APE++
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGCLKIADFGL-ARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 186 SEGYNEKADIWSLGITVIEMAKGEP 210
Y D+W++G + E+ +P
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 80/257 (31%), Positives = 133/257 (51%), Gaps = 14/257 (5%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLS-QCRSPYITEY 76
++G+GSFG V A K N+ AIK + D+ +D++E E VL+ P++T
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
+ ++ + L+ +MEY+ GG + IQS DE +++ +++LH +G I+RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N+LL ++G +K+ADFG+ + + TF GTP ++APE+++ + YNE D W
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK-GQKYNESVDWW 180
Query: 197 SLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----P 252
S G+ + EM G+ P + I + P HF R + + CL K+ P
Sbjct: 181 SFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP-----HFPRWISKEAKDCLSKLFERDP 235
Query: 253 AERPSAKELLR-HRFIR 268
+R +R H F R
Sbjct: 236 TKRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 85/325 (26%), Positives = 139/325 (42%), Gaps = 60/325 (18%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F S+++IGRG+FG+V K+ A+K + E ++++ ++ E +L++ +P+
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + Y S+ + L++IMEY+ GG + L+ E + + + AI+ +H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISR------------------RKTF--- 171
IHRDIK N+LL G +K++DFG+ L ++ K
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 172 -----------------VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD 214
VGTP ++APEV + GYN++ D WSLG+ + EM G PP
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 215 LHPM---------RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHR 265
+P + P E P L L+K C + E+ H
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVP--LSPEAKDLIKRL--CCEAERRLGNNGVNEIKSHP 297
Query: 266 FIRNARKSPRLLERIRERPK-YPIQ 289
F + E IRERP +
Sbjct: 298 FFKGVD-----WEHIRERPAPIIPE 317
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 9/209 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L+GRG FG+V +K A+KV+ +++ + ++E +LS SP+
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I + ++ + L+++MEY GG + L+ + DE L +L+ AI +H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPFWMAPEVIQNSEGYN 190
+HRDIK N+L+ G +K+ADFG +A+LT + K VGTP ++APEV+ G
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 191 EKA-----DIWSLGITVIEMAKGEPPLAD 214
+ D WSLG+ EM G P +
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 77/280 (27%), Positives = 125/280 (44%), Gaps = 19/280 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVL---SQCR 69
F L ++GRG FG V A K+ + AIK + + + DE+E + E + + R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS---GPPLDEMSIACILRDLLHAIEY 126
P++ + + + + +MEY AGG + I + P AC++ ++Y
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL----GLQY 116
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
LH ++RD+K N+LL G VK+ADFG+ + R TF GTP ++APEV+ +
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
Y D W LG+ + EM GE P V I + SR +
Sbjct: 177 S-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR-YPRFLSREAISIMRR 234
Query: 247 CLKKVPAER-----PSAKELLRHRFIRNARKSPRLLERIR 281
L++ P R A+++ + F R+ L +I+
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIK 274
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 16/265 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLS-QCRSP 71
F+ L ++G+GSFG V A K ++ AIK++ D+ +D++E E VL+ + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++T+ + + +L+ +MEY+ GG + IQ E ++ + +LH++G
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
I+RD+K N++L G +K+ADFG+ + +TF GTP ++APE+I + Y +
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY-QPYGK 180
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC---L 248
D W+ G+ + EM G+PP D LF E+ + S+ E VS+C L
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLSK---EAVSICKGLL 236
Query: 249 KKVPAER----PSAKELLR-HRFIR 268
K PA+R P+ + +R H F R
Sbjct: 237 TKHPAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-30
Identities = 86/311 (27%), Positives = 136/311 (43%), Gaps = 59/311 (18%)
Query: 21 IGRG--SFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
IGRG + VY A V +++ DLE +E+ ++ +Q E+ + R P I +
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ + LW+I +MA GS L+++ P + E I IL L + YLH G IHR
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHR 125
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-------WMAPEVI-QNSE 187
+IKA++IL++ +G V ++ L R + K P W++PE++ Q+
Sbjct: 126 NIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY 185
Query: 188 GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--------------IIPRENPPQLD 233
GYN K+DI+S+GIT E+A G P D+ ++L P E +
Sbjct: 186 GYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKN 245
Query: 234 EH--------------------------------FSRLMKEFVSLCLKKVPAERPSAKEL 261
FS + V LCL++ P +RPSA L
Sbjct: 246 SQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL 305
Query: 262 LRHRFIRNARK 272
L H F + ++
Sbjct: 306 LSHAFFKQVKE 316
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 1e-29
Identities = 90/307 (29%), Positives = 148/307 (48%), Gaps = 34/307 (11%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRS-PYITE 75
++G+GSFG V A KE + A+KV+ D+ +D++E E +LS R+ P++T+
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
Y + +L+ +ME++ GG + IQ DE ++ A+ +LH++G I+R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K N+LL G K+ADFG+ + TF GTP ++APE++Q Y D
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ-EMLYGPSVDW 179
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVP 252
W++G+ + EM G P + + I + P L + ++K F + K P
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF----MTKNP 235
Query: 253 AERPSA------KELLRHRFIR-------NARK-SPRLLERIRER-------PKYPIQEE 291
R + + +LRH F + N R+ P RI+ R P + I+E+
Sbjct: 236 TMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDF-IKED 294
Query: 292 PD-TPIN 297
P TPI
Sbjct: 295 PVLTPIE 301
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 84/277 (30%), Positives = 142/277 (51%), Gaps = 29/277 (10%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F +++LI G++G VY KE + A+K I+ + ++I+ + E +L+ +P+
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLD-EMSIACILRDLLHAIEYLHNEG 131
+ + S+ + L ++MEY+ GG A L+++ L +M+ +L A+EYLHN G
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLHNYG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVS----------------AQLTRTISRRKTFVGTP 175
+HRD+K N+L+T G +K+ DFG+S + TR ++ GTP
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTP 180
Query: 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--IIPRE-NPPQL 232
++APEVI +GY + D W++GI + E G P P LF +I + P+
Sbjct: 181 EYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIEWPEG 238
Query: 233 DEHFSRLMKEFVSLCLKKVPAER---PSAKELLRHRF 266
DE ++ +S L++ P ER A E+ +HRF
Sbjct: 239 DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 66/196 (33%), Positives = 107/196 (54%), Gaps = 4/196 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRS-PYITE 75
+++G+GSFG V A K ++ AIKV+ D+ +D+++ E +L+ P++T
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ + + +L+ +MEY+ GG + IQ DE ++ A+ +LH G I+R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K NILL G K+ADFG+ + TF GTP ++APE++Q E Y D
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE-YGPSVDW 179
Query: 196 WSLGITVIEMAKGEPP 211
W+LG+ + EM G+PP
Sbjct: 180 WALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 78/271 (28%), Positives = 122/271 (45%), Gaps = 41/271 (15%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+G+GSFG VY+ K + K VAIK ++ S E + E SV+ + ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDE----MSIACILRDLLHAIE------ 125
G ++ME MA G + ++S P E + + + + A E
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFVGT-PF-WMA 179
YL + +HRD+ A N ++ E+ VK+ DFG +TR I RK G P WMA
Sbjct: 134 YLAAKKFVHRDLAARNCMVAEDLTVKIGDFG----MTRDIYETDYYRKGGKGLLPVRWMA 189
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL-FIIPR------ENPPQ 231
PE +++ + K+D+WS G+ + EMA E P L VL F+I EN P
Sbjct: 190 PESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPD 248
Query: 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
+ E + +C + P RP+ E++
Sbjct: 249 -------KLLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 80/286 (27%), Positives = 139/286 (48%), Gaps = 15/286 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEY 76
+L+G+G+FG V +K K A+K++ E ++DE+ E VL R P++T
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
S+ +L +MEY GG + + E +++ A+ YLH+ ++RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N++L ++G +K+ DFG+ + + KTF GTP ++APEV+++++ Y D W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWW 179
Query: 197 SLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVPA 253
LG+ + EM G P + ++ +I E P L K ++ LKK P
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE----AKSLLAGLLKKDPK 235
Query: 254 ER-----PSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDT 294
+R AKE++ HRF + + +++ K + E DT
Sbjct: 236 QRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDT 281
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 83/287 (28%), Positives = 132/287 (45%), Gaps = 37/287 (12%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE--IEDIQ-KEISVLSQCRS 70
++ L IG GS+G V+K ++E + VAIK ESED+ I+ I +EI +L Q +
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P + + + KL ++ EY + +L ++ + E I I+ L A+ + H
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRD+K NIL+T+ G +K+ DFG + LT +V T ++ APE++ Y
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179
Query: 191 EKADIWSLGITVIEMAKGEP----------------PLADLHPM-RVLF----------- 222
D+W++G E+ G+P L DL P + +F
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239
Query: 223 IIPRENPPQLDEHFSRLMK---EFVSLCLKKVPAERPSAKELLRHRF 266
P P L+ F + F+ CL+ P ER S +ELL H +
Sbjct: 240 PEPETREP-LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 79/305 (25%), Positives = 132/305 (43%), Gaps = 59/305 (19%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQK------------EISVLSQ 67
+G G++G V KA+D K VAIK + + E S D +D Q E+ ++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 68 CRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
+ I Y+ + ++M+ MA + ++ L E + CIL +L+ + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQ-----LTRTISRRKTF---------VG 173
H +HRD+ ANI + G K+ADFG++ + + T+S+ +T V
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV 195
Query: 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP----------------------- 210
T ++ APE++ +E Y+ D+WS+G E+ G+P
Sbjct: 196 TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNE 255
Query: 211 ---PLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVSLCLKKVPAERPSAKELLRH 264
P A P+ F P L F S + + LK P ER SAKE L+H
Sbjct: 256 DNWPQAKKLPLYTEF--TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313
Query: 265 RFIRN 269
+ ++
Sbjct: 314 EYFKS 318
|
Length = 335 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 74/293 (25%), Positives = 137/293 (46%), Gaps = 52/293 (17%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE---IEDIQKEISVLSQCRSP 71
+ L I G++G VY+A DK+ + VA+K + +E+ E E I + +EI++L + + P
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSL-REINILLKLQHP 64
Query: 72 YITEY----YGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEY 126
I GS + K++++MEY+ + L+++ P + + C++ LL + +
Sbjct: 65 NIVTVKEVVVGS--NLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
LH+ +HRD+K +N+LL G +K+ DFG++ + + V T ++ APE++ +
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------PREN------------ 228
+ Y+ D+WS+G E+ +P + L I P E
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241
Query: 229 ------PP--QLDEHFSR---------LMKEFVSLCLKKVPAERPSAKELLRH 264
P QL + F L+ ++ PA+R SA++ L+H
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYD----PAKRISAEDALKH 290
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 79/282 (28%), Positives = 131/282 (46%), Gaps = 33/282 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPYI 73
++ +E IG G++G VYK +K+ + VA+K I LE E+ + +EIS+L + + P I
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 74 TEYYGSYLHQTKLWIIMEY--MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ +++L++I E+ M D + G +D + L +L I + H+
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
+HRD+K N+L+ G +K+ADFG++ + V T ++ APEV+ S Y+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYST 181
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------------------------PR 226
DIWS+G EMA +P + LF I P+
Sbjct: 182 PVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPK 241
Query: 227 ENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRH 264
L L ++ + L L+K+ PA+R SAK+ L H
Sbjct: 242 WKKGSLRSAVKNLDEDGLDL-LEKMLIYDPAKRISAKKALNH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 80/261 (30%), Positives = 127/261 (48%), Gaps = 15/261 (5%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVL---SQCRSPYITE 75
IG+G+FG VY+ K+ + A+KV+ +E ++ E+ E ++L SP+I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
S+ + L+++ +YM+GG + +Q E + +L+ A+E+LH ++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 136 DIKAANILLTENGDVKVADFGVS-AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
D+K NILL G + + DFG+S A LT TF GT ++APEV+ + +GY + D
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVD 179
Query: 195 IWSLGITVIEMAKGEPPL--ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
WSLG+ V EM G P D M + P+ S ++FV L + P
Sbjct: 180 FWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK--NVLSDEGRQFVKGLLNRNP 237
Query: 253 AER----PSAKELLRHRFIRN 269
R A EL H F +
Sbjct: 238 QHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 88/295 (29%), Positives = 148/295 (50%), Gaps = 27/295 (9%)
Query: 18 LELIGRGSFGDVY---KAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQCRSP 71
L+++G+G +G V+ K + K A+KV+ + ++ + + E ++L + P
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 72 YITEYYGSYLHQT--KLWIIMEYMAGGSV-ADLIQSGPPLDEMSIACI-LRDLLHAIEYL 127
+I + Y QT KL++I+EY++GG + L + G +++ AC L ++ A+E+L
Sbjct: 61 FIVDLI--YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT--ACFYLSEISLALEHL 116
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSE 187
H +G I+RD+K NILL G VK+ DFG+ + + TF GT +MAPE++ S
Sbjct: 117 HQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS- 175
Query: 188 GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFV 244
G+ + D WSLG + +M G PP + + + I + PP L L+K+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKL- 234
Query: 245 SLCLKKVPAER----PS-AKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDT 294
LK+ P+ R P A E+ H F R+ L ++ K +Q E D
Sbjct: 235 ---LKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDV 286
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 78/268 (29%), Positives = 129/268 (48%), Gaps = 17/268 (6%)
Query: 15 FSSLELIGRGSFGDVY---KAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQC 68
F L ++G G++G V+ K + K A+KV+ + + E + E VL
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 69 R-SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
R P++ + ++ TKL +I++Y+ GG + + E + + +++ A+++L
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQ-LTRTISRRKTFVGTPFWMAPEVIQN- 185
H G I+RDIK NILL G V + DFG+S + L R +F GT +MAPEVI+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPL----ADLHPMRVLFIIPRENPPQLDEHFSRLMK 241
S G+++ D WSLG+ E+ G P + I + PP + S +
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP-FPKTMSAEAR 240
Query: 242 EFVSLCLKKVPAER---PSAKELLRHRF 266
+F+ L+K P +R A E+ H F
Sbjct: 241 DFIQKLLEKDPKKRLGANGADEIKNHPF 268
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 80/267 (29%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNK-DVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
S + L+ +G G FG V+ K K DVAIK+I E + E +D +E V+ + P
Sbjct: 4 SELTFLKELGSGQFGVVHLG--KWRGKIDVAIKMIR-EGAMSE-DDFIEEAKVMMKLSHP 59
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSI---ACILRDLLHAIEYLH 128
+ + YG Q ++I+ EYMA G + + ++ C D+ A+EYL
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS--DVCEAMEYLE 117
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRRKTFVGTPF---WMAPEVI 183
+ G IHRD+ A N L+ E+ VKV+DFG L R + + + GT F W PEV
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFG----LARYVLDDQYTSSQGTKFPVKWAPPEVF 173
Query: 184 QNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVL------FIIPRENPPQLDEHF 236
S ++ K+D+WS G+ + E+ ++G+ P V+ + + R P
Sbjct: 174 DYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR--PKLAPTEV 230
Query: 237 SRLMKEFVSLCLKKVPAERPSAKELLR 263
+M C + P +RP+ K+LL
Sbjct: 231 YTIMY----SCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-28
Identities = 75/255 (29%), Positives = 132/255 (51%), Gaps = 9/255 (3%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEY 76
+L+G+G+FG V +K K A+K++ E ++DE+ E VL R P++T
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
S+ + +L +MEY+ GG + + E +++ A++YLH+ ++RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N++L ++G +K+ DFG+ + + KTF GTP ++APEV+++++ Y D W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND-YGRAVDWW 179
Query: 197 SLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER- 255
LG+ + EM G P + ++ +I E+ + S K +S L K P +R
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMED-IKFPRTLSADAKSLLSGLLIKDPNKRL 238
Query: 256 ----PSAKELLRHRF 266
AKE++RH F
Sbjct: 239 GGGPDDAKEIMRHSF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 86/312 (27%), Positives = 128/312 (41%), Gaps = 67/312 (21%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDI--QKEISVLSQCRS 70
+ L +G G+FG+VYKA + + VA+K I L +E + I +EI +L + +
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKH 66
Query: 71 PYIT-------EYYGSYLHQTK-LWIIMEYMAGGSVADL--IQSGPP--LDEMSIACILR 118
P + E + ++++ YM DL + P L E I C +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYM----DHDLSGLLENPSVKLTESQIKCYML 122
Query: 119 DLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR-------------TI 165
LL I YLH +HRDIKAANIL+ G +K+ADFG L R
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG----LARPYDGPPPNPKGGGGG 178
Query: 166 SRRK--TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLA---DLHPMRV 220
RK V T ++ PE++ Y DIW +G EM P L D+ + +
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238
Query: 221 LFII---PREN--------------------PPQLDEHFSRLMKEFVSLC---LKKVPAE 254
+F + P E P L+E F +L E + L L P +
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298
Query: 255 RPSAKELLRHRF 266
R +A + L H +
Sbjct: 299 RLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 70/232 (30%), Positives = 115/232 (49%), Gaps = 34/232 (14%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS 70
F ++L+G+G G V+ K K A+KV+D +E ++++ + E +L+
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLH 128
P++ Y S+ +T L ++M+Y GG + L+Q P L E ++L A+EYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 129 NEGKIHRDIKAANILLTENGDVKVADF------------------------GVSAQLTRT 164
G ++RD+K NILL E+G + ++DF V++ + T
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 165 IS-----RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPP 211
S R +FVGT ++APEVI + +G+ D W+LGI + EM G P
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVI-SGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 8e-28
Identities = 76/259 (29%), Positives = 135/259 (52%), Gaps = 30/259 (11%)
Query: 18 LELIGRGSFGDVY---KAFDKELNKDVAIKVIDLEESEDEIED---IQKEISVLSQCRSP 71
L+++G+GSFG V+ K + + A+KV L+++ ++ D + E +L++ P
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKV--LKKATLKVRDRVRTKMERDILAEVNHP 58
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+I + + ++ + KL++I++++ GG + + E + L +L A+++LH+ G
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
I+RD+K NILL E G +K+ DFG+S + + +F GT +MAPEV+ N G+ +
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQ 177
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL-MKEFVSLCLKK 250
AD WS G+ + EM G P + +I + ++L M +F+S
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK----------AKLGMPQFLS----- 222
Query: 251 VPAERPSAKELLRHRFIRN 269
P A+ LLR F RN
Sbjct: 223 -----PEAQSLLRALFKRN 236
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 8e-28
Identities = 76/260 (29%), Positives = 135/260 (51%), Gaps = 18/260 (6%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEY 76
+L+G+G+FG V +K + A+K++ E ++DE+ E VL R P++T
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI-HR 135
S+ +L +MEY GG + + E +++ A++YLH+E + +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K N++L ++G +K+ DFG+ + + + KTF GTP ++APEV+++++ Y D
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDW 179
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM----KEFVSLCLKKV 251
W LG+ + EM G P + ++ +I E + F R + K +S LKK
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----EIRFPRTLSPEAKSLLSGLLKKD 234
Query: 252 PAER-----PSAKELLRHRF 266
P +R AKE+++H+F
Sbjct: 235 PKQRLGGGPDDAKEIMQHKF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 9e-28
Identities = 83/286 (29%), Positives = 142/286 (49%), Gaps = 15/286 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEY 76
+L+G+G+FG V +K + A+K++ E ++DE+ E VL R P++T
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
++ +L +MEY GG + + E +++ A+EYLH+ ++RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
IK N++L ++G +K+ DFG+ + + KTF GTP ++APEV+++++ Y D W
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWW 179
Query: 197 SLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVPA 253
LG+ + EM G P + R+ +I E P L K ++ LKK P
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE----AKSLLAGLLKKDPK 235
Query: 254 ER----PS-AKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDT 294
+R PS AKE++ HRF + + +++ K + E DT
Sbjct: 236 QRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDT 281
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 84/277 (30%), Positives = 123/277 (44%), Gaps = 50/277 (18%)
Query: 16 SSLEL---IGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
SL+L +G G FG+V+ N VA+K L+ E +E ++ + R
Sbjct: 6 ESLKLERKLGAGQFGEVWMGT---WNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRH 60
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMS--IACILRDLL 121
+ + Y + ++I+ EYM+ GS+ D ++SG P L +M+ IA
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA------- 113
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK--TFVGTPF--- 176
+ YL + IHRD+ A NIL+ EN K+ADFG L R I + G F
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFG----LARLIEDDEYTAREGAKFPIK 169
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVL------FIIPRENP 229
W APE N + K+D+WS GI + E + G P + VL + +PR P
Sbjct: 170 WTAPEAA-NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR--P 226
Query: 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
P E LM + C K P ERP+ E L+
Sbjct: 227 PNCPEELYDLMLQ----CWDKDPEERPTF-EYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 82/285 (28%), Positives = 140/285 (49%), Gaps = 29/285 (10%)
Query: 15 FSSLELIGRGSFGDVY---KAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQC 68
F L+++G G++G V+ K + K A+KV+ L + +E + E +VL
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 69 R-SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
R SP++ + ++ + KL +I++Y++GG + + E + +++ A+E+L
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQ-LTRTISRRKTFVGTPFWMAPEVIQNS 186
H G ++RDIK NILL G V + DFG+S + L+ R +F GT +MAPE+I+
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
G+ + D WSLGI + E+ G P F + E Q E R++K
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASP----------FTLEGERNTQ-SEVSRRILK----- 225
Query: 247 CLKKVPAE-RPSAKELLRHRFIRNARK----SPRLLERIRERPKY 286
C P+ P A++LL ++ +K P+ I+E P +
Sbjct: 226 CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 92/317 (29%), Positives = 144/317 (45%), Gaps = 58/317 (18%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQCRSP 71
F SL++IGRG+FG+V K+ A+K++ D+ E E ++ I+ E +L + S
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE-QVGHIRAERDILVEADSL 61
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++ + + S+ + L++IME++ GG + L+ L E + + + AI+ +H G
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRT----------------------ISRRK 169
IHRDIK N+LL G VK++DFG+ L + S+RK
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 170 -------------TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH 216
+ VGTP ++APEV + GYN+ D WSLG+ + EM G PP
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 217 PM---------RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
P + I P E P + E L+ F ++ A P +E+ + F
Sbjct: 241 PQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCCEWEHRIGA--PGVEEIKTNPFF 296
Query: 268 RNARKSPRLLERIRERP 284
E IRERP
Sbjct: 297 EGVD-----WEHIRERP 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 76/251 (30%), Positives = 122/251 (48%), Gaps = 7/251 (2%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYG 78
IG+GSFG V + ++ + A+K I S E+ E +VL+Q P+I
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
S+ KL++++ ++ GG + +Q D +LL A+E LH I+RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSL 198
NILL G + + DFG+ + + TF GTP ++APE++ GY + D W+L
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL-GHGYTKAVDWWTL 179
Query: 199 GITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER--- 255
G+ + EM G PP D + + I +E P + + F R K+ + L + P R
Sbjct: 180 GVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLLIGLLSRDPTRRLGY 238
Query: 256 PSAKELLRHRF 266
A+E+ H F
Sbjct: 239 NGAQEIKNHPF 249
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 82/265 (30%), Positives = 136/265 (51%), Gaps = 16/265 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLS-QCRSP 71
F+ L ++G+GSFG V A K ++ AIK++ D+ +D++E E VL+ Q + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++T+ + + +L+ +MEY+ GG + IQ E ++ + +LH G
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
I+RD+K N++L G +K+ADFG+ + +TF GTP ++APE+I + Y +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA-YQPYGK 180
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC---L 248
D W+ G+ + EM G+PP D LF E+ + S KE VS+C +
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLS---KEAVSICKGLM 236
Query: 249 KKVPAER----PSAKELLR-HRFIR 268
K P++R P + +R H F R
Sbjct: 237 TKHPSKRLGCGPEGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 88/317 (27%), Positives = 143/317 (45%), Gaps = 58/317 (18%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQCRSP 71
F SL++IGRG+FG+V K+ A+K++ D+ E E ++ I+ E +L +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE-QVAHIRAERDILVEADGA 61
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++ + + S+ + L++IME++ GG + L+ L E + + + + AI+ +H G
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRT----------------------ISRRK 169
IHRDIK N+LL G VK++DFG+ L + S+RK
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 170 -------------TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH 216
+ VGTP ++APEV + GYN+ D WSLG+ + EM G PP
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 217 PM---------RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
P + + P E P + E L+ F + ++ + +E+ H F
Sbjct: 241 PQETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSN--GVEEIKSHPFF 296
Query: 268 RNARKSPRLLERIRERP 284
IRERP
Sbjct: 297 EGVD-----WGHIRERP 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 72/264 (27%), Positives = 124/264 (46%), Gaps = 20/264 (7%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVID---LEESEDE-IEDIQKEISVLSQCRSPYITEY 76
+G+G FG+V K K A K +D L++ + E + +K+I L + S +I
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58
Query: 77 YGSYLHQTKLWIIMEYMAGGSVA-DLIQSGPP-LDEMSIACILRDLLHAIEYLHNEGKIH 134
++ + L ++M M GG + + G P E ++ +E+LH ++
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K N+LL ++G+V+++D G++ +L + K GTP +MAPEV+Q Y+ D
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPGYMAPEVLQGEV-YDFSVD 176
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRV----LFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
++LG T+ EM G P +V L E + + FS K+ L+K
Sbjct: 177 WFALGCTLYEMIAGRSPFRQ-RKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK 235
Query: 251 VPAER-----PSAKELLRHRFIRN 269
P +R SA E+ H ++
Sbjct: 236 DPEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 46/278 (16%)
Query: 21 IGRGSFGDVYKA-FDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEY 76
+G G FG V +D + VA+K ++ E D ++EI +L I +Y
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 77 YG-SY-LHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYLHNEG 131
G L +IMEY+ GS+ D +Q D++++ +L + ++YL ++
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FWMAPEVIQ 184
IHRD+ A NIL+ VK++DFG L + + K + V P FW APE ++
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFG----LAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 185 NSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMR--VLFIIPRENPPQLDEHFSRLMK 241
S+ ++ +D+WS G+T+ E+ G+P P + I + + L+K
Sbjct: 186 TSK-FSSASDVWSFGVTLYELFTYGDP---SQSPPAEFLRMIGIAQGQMIV-TRLLELLK 240
Query: 242 EFVSL----------------CLKKVPAERPSAKELLR 263
E L C + P +RPS +L+
Sbjct: 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 75/268 (27%), Positives = 138/268 (51%), Gaps = 16/268 (5%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F +++IGRG+FG+V K + A+K++ E + +E +++ S +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I + + ++ L+++MEYM GG + +L+ S + E +++ A++ +H+ G
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDAIHSMGF 163
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPFWMAPEVIQNSEG--- 188
IHRD+K N+LL ++G +K+ADFG ++ + R T VGTP +++PEV+++ G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 189 YNEKADIWSLGITVIEMAKGEPP-LADLHPMRVLFIIPREN----PPQLD--EHFSRLMK 241
Y + D WS+G+ + EM G+ P AD I+ +N P ++ + L+
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLIC 283
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRN 269
F L ++V R E+ H F +N
Sbjct: 284 AF--LTDREVRLGRNGVDEIKSHPFFKN 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 78/255 (30%), Positives = 119/255 (46%), Gaps = 20/255 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
E IG+G+FGDVYK K N +VA+K D +E +L Q P I + G
Sbjct: 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 79 SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ + ++I+ME + GGS+ L + L + + D +EYL ++ IHRD+
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 138 KAANILLTENGDVKVADFGVSAQ-----LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
A N L+ EN +K++DFG+S + T + ++ + W APE + N Y +
Sbjct: 120 AARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK---WTAPEAL-NYGRYTSE 175
Query: 193 ADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIP---RENPPQL-DEHFSRLMKEFVSLC 247
+D+WS GI + E + G+ P + + I R PQL E RLM C
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLML----QC 231
Query: 248 LKKVPAERPSAKELL 262
P RPS E+
Sbjct: 232 WAYDPENRPSFSEIY 246
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 79/289 (27%), Positives = 139/289 (48%), Gaps = 18/289 (6%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRS-PYITEY 76
+IGRGS+ V K+ ++ A+KV+ +L +++I+ +Q E V Q S P++
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
+ + ++L++++EY+ GG + +Q L E ++ A+ +LH G I+RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N+LL +G +K+ D+G+ + TF GTP ++APE+++ E Y D W
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWW 180
Query: 197 SLGITVIEMAKGEPPL------ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
+LG+ + EM G P D++ LF + E P ++ S + L K
Sbjct: 181 ALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK 240
Query: 251 VPAERPSAK------ELLRHRFIRNARKSPRLLERIRERPKYPIQEEPD 293
P ER + ++ H F R+ LLE+ + P + Q D
Sbjct: 241 DPKERLGCQPQTGFSDIKSHTFFRSIDWD--LLEKKQVTPPFKPQITDD 287
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 61/197 (30%), Positives = 110/197 (55%), Gaps = 4/197 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLS-QCRSPYITE 75
+++G+GSFG V A K + A+K + D+ +D++E E VL+ +P++T
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
Y ++ + L+ +ME++ GG + IQ D +++ +++LH++G I+R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K N++L +G +K+ADFG+ + +R TF GTP ++APE++Q + Y D
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK-YTFSVDW 179
Query: 196 WSLGITVIEMAKGEPPL 212
WS G+ + EM G+ P
Sbjct: 180 WSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 90/295 (30%), Positives = 129/295 (43%), Gaps = 56/295 (18%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE------IEDIQKEISVLSQC 68
+ +E IG G++G VYKA DK + VA+K I LE +EDE I +EIS+L +
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLE-TEDEGVPSTAI----REISLLKEL 55
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGP--PLDEMSIACILRDLLHA 123
P I + KL+++ E++ DL + S P LD I L LL
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---RRKTF-VGTPFWMA 179
I Y H+ +HRD+K N+L+ G +K+ADFG L R R T V T ++ A
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFG----LARAFGVPVRTYTHEVVTLWYRA 167
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII--------------- 224
PE++ S Y+ DIWS+G EM P + LF I
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227
Query: 225 ----------PRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRF 266
P+ L + L ++ + L L PA+R SAK L+H +
Sbjct: 228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 61/186 (32%), Positives = 86/186 (46%), Gaps = 24/186 (12%)
Query: 96 GSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154
S+AD+++ G PL+E I + L A+ LH R K+ NILLT +G +K+
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELH------RQAKSGNILLTWDGLLKL-- 52
Query: 155 FGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD 214
G A T SR P++MAPEVIQ + Y EKADI+SLGIT+ E E P +
Sbjct: 53 DGSVAFKTPEQSR-----PDPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNE 106
Query: 215 LHPMRVLFIIPRENPPQLDEHFS---------RLMKEFVSLCLKKVPAERPSAKELLRHR 265
+ + I P D R ++F+ LC ++P R +A L H
Sbjct: 107 ERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166
Query: 266 FIRNAR 271
A
Sbjct: 167 RALFAE 172
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 77/276 (27%), Positives = 132/276 (47%), Gaps = 38/276 (13%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLS-QCRSP 71
F+ L ++G+GSFG V A K ++ AIK++ D+ +D++E E VL+ + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++T+ + + +L+ +MEY+ GG + IQ E ++ + +LH++G
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
I+RD+K N++L G +K+ADFG+ + KTF GTP ++APE+I + Y +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIA-YQPYGK 180
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM----------- 240
D W+ G+ + EM G+ P DE F +M
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPF---------------EGEDEDELFQSIMEHNVAYPKSMS 225
Query: 241 KEFVSLC---LKKVPAER-----PSAKELLRHRFIR 268
KE V++C + K P +R +++ H F R
Sbjct: 226 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 30/280 (10%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F LE +G G++ VYK ++ + VA+K I L+ E +EIS++ + + I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 75 EYYGSYLHQTKLWIIMEYMAGG--SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + KL ++ EYM D LD ++ LL I + H
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
+HRD+K N+L+ + G++K+ADFG++ ++ V T ++ AP+V+ S Y+
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTS 181
Query: 193 ADIWSLGITVIEMAKGEP--------------------PLADLHPMRVLF--------II 224
DIWS+G + EM G P P P
Sbjct: 182 IDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRY 241
Query: 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P ++ QL H L + + L+ P R SA + L+H
Sbjct: 242 PPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 83/278 (29%), Positives = 140/278 (50%), Gaps = 29/278 (10%)
Query: 15 FSSLELIGRGSFGDVY---KAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQC 68
F L+++G G++G V+ K + K A+KV+ + + E + E VL
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 69 R-SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
R SP++ + ++ TKL +I++Y+ GG + + E + +++ A+E+L
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQ-LTRTISRRKTFVGTPFWMAPEVIQNS 186
H G I+RDIK NILL NG V + DFG+S + + R +F GT +MAP++++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 187 EGYNEKA-DIWSLGITVIEMAKGEPPL---------ADLHPMRVLFIIPRENPPQLDEHF 236
+G ++KA D WS+G+ + E+ G P A++ R+L + PP E
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-SRRIL----KSEPPYPQE-M 235
Query: 237 SRLMKEFVSLCLKKVPAER----PS-AKELLRHRFIRN 269
S L K+ + L K P +R PS A E+ +H F +
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPYI 73
F +E IG G++G VYKA +K + VA+K I L+ E+E +EIS+L + P I
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADL--IQSGPPLDEMSIACI---LRDLLHAIEYLH 128
+ + KL+++ E++ DL PL + + I L LL + + H
Sbjct: 62 VKLLDVIHTENKLYLVFEFLH----QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
+ +HRD+K N+L+ G +K+ADFG++ + V T ++ APE++ +
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 189 YNEKADIWSLGITVIEM 205
Y+ DIWSLG EM
Sbjct: 178 YSTAVDIWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 83/295 (28%), Positives = 128/295 (43%), Gaps = 47/295 (15%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVL-SQCRSPY 72
+ LE IG G++G VYKA DK K VA+K LE E+ I +EIS+L S Y
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 73 IT-----EYYGSYLHQTKLWIIMEYMAGG--SVADLIQSGP--PLDEMSIACILRDLLHA 123
I E+ + L+++ EY+ D GP PL +I + LL
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDV-KVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
+ + H G +HRD+K N+L+ + + K+AD G+ + + + T ++ APEV
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV 182
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLAD-------LHPMRVL-------------- 221
+ S Y+ DIWS+G EM++ +P LH ++L
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242
Query: 222 ---FIIPRENP-------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
P+ P P L L+++ L+ PA+R SAK L H +
Sbjct: 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKM----LRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 82/293 (27%), Positives = 145/293 (49%), Gaps = 32/293 (10%)
Query: 3 DLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQK 60
+ LQ A + +++IGRG+FG+V K K A+K++ E + +
Sbjct: 34 KIRKLQMKA-EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 61 EISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDL 120
E +++ SP++ + + ++ L+++MEYM GG + +L+ S + E ++
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEV 151
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPFWMA 179
+ A++ +H+ G IHRD+K N+LL ++G +K+ADFG ++ T + R T VGTP +++
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYIS 211
Query: 180 PEVIQNSEG---YNEKADIWSLGITVIEMAKGEPPL-ADLHPMRVLFIIPRENPPQLDEH 235
PEV+++ G Y + D WS+G+ + EM G+ P AD L
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD----------------SLVGT 255
Query: 236 FSRLMKEFVSLCLKKVPAERPSAKEL----LRHRFIRNARKSPRLLERIRERP 284
+S++M SL + AK L L R +R R +E I++ P
Sbjct: 256 YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNG---VEEIKQHP 305
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 78/261 (29%), Positives = 130/261 (49%), Gaps = 37/261 (14%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK---EISVLSQCRSPYITE 75
IG+G FGDV + + VA+K + +D+ Q E SV++ R P + +
Sbjct: 12 ATIGKGEFGDVMLGDYR--GQKVAVKCL-----KDDSTAAQAFLAEASVMTTLRHPNLVQ 64
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACIL---RDLLHAIEYLHNEG 131
G L L+I+ EYMA GS+ D ++S G + +++A L D+ +EYL +
Sbjct: 65 LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGMEYLEEKN 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVS--AQLTRTISRRKTFVGTPF-WMAPEVIQNSEG 188
+HRD+ A N+L++E+ KV+DFG++ A + + P W APE ++ +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK------LPVKWTAPEALREKK- 175
Query: 189 YNEKADIWSLGITVIEM-AKGEPP-----LADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
++ K+D+WS GI + E+ + G P L D+ P V E P ++MK+
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-HVEKGYRMEAPEGCPPEVYKVMKD 234
Query: 243 FVSLCLKKVPAERPSAKELLR 263
C + PA+RP+ K+L
Sbjct: 235 ----CWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 82/288 (28%), Positives = 137/288 (47%), Gaps = 39/288 (13%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI-EDIQKEISVLSQCRSP 71
+R+ L+ +G G+FG V A D+ ++VAIK I S + + +E+ +L R
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 72 YITEYYGSYLH-QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
I ++ ++ + E + G + L+ S P L++ I L +L ++Y+H+
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYVHSA 127
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQNSEGY 189
G +HRD+K +NIL+ EN D+K+ DFG L R + T +V T ++ APE++ + Y
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFG----LARIQDPQMTGYVSTRYYRAPEIMLTWQKY 183
Query: 190 NEKADIWSLGITVIEMAKGEP--P----------LADL---HPMRVL----------FI- 223
+ + DIWS G EM +G+P P + DL P V+ F+
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 224 -IPRENPPQLDEHFSRLMKEFVSLCLKKV---PAERPSAKELLRHRFI 267
+P+ P E F + L K + P +R SA E L H ++
Sbjct: 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 78/260 (30%), Positives = 130/260 (50%), Gaps = 20/260 (7%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPYITEYYG 78
++G G+ G V A + A+KV+D+E SE + Q E+ L C I + +
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 79 SYLHQTK--------LWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEY 126
+ + + ++++Y G + I+S E + +L A+ +
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHH 158
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGTPFWMAPEVIQ 184
+H++ IHRDIK+ANILL NG VK+ DFG S T+S +TF GTP+++APE I
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE-IW 217
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPL--ADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
+ Y++KAD++SLG+ + E+ + P ++ + + R +P L S M+E
Sbjct: 218 RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP--LPPSISPEMQE 275
Query: 243 FVSLCLKKVPAERPSAKELL 262
V+ L P RPS+ +LL
Sbjct: 276 IVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 76/281 (27%), Positives = 137/281 (48%), Gaps = 38/281 (13%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ 67
R + + +G G+FG V KA L+ VA+K++ + +E ++ D+ E+ ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 68 C-RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACI-------L 117
+ I G + L++++EY A G++ D +++ P
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 118 RDLL-------HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170
+DL+ +E+L ++ IHRD+ A N+L+TE+ +K+ADFG++ + RKT
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 171 FVG-TPF-WMAPEVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRE 227
G P WMAPE + Y ++D+WS G+ + E G P + P+ LF + +E
Sbjct: 192 TNGRLPVKWMAPEAL-FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKE 249
Query: 228 ----NPPQL--DEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
PQ E + LM++ C +VP++RP+ K+L+
Sbjct: 250 GYRMEKPQNCTQELY-HLMRD----CWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 76/271 (28%), Positives = 130/271 (47%), Gaps = 26/271 (9%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRS-PYITEY 76
+IGRGS+ V K+ + A+KVI +L +++I+ +Q E V + P++
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
+ + +++L+ ++E+++GG + +Q L E ++ A+ +LH G I+RD
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRD 121
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N+LL G +K+ D+G+ + R TF GTP ++APE+++ E Y D W
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR-GEDYGFSVDWW 180
Query: 197 SLGITVIEMAKGEPPL--------ADLHPMRVLFIIPREN----PPQLDEHFSRLMKEFV 244
+LG+ + EM G P D + LF + E P L S ++K F
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF- 239
Query: 245 SLCLKKVPAER------PSAKELLRHRFIRN 269
L K P ER +++ H F RN
Sbjct: 240 ---LNKDPKERLGCHPQTGFRDIKSHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 69/256 (26%), Positives = 117/256 (45%), Gaps = 58/256 (22%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE----DEIEDIQKEISVLSQC 68
S F ++ IG G+FG+V + N A+K L +++ ++ ++ E +L++
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKT--LRKADVLMRNQAAHVKAERDILAEA 58
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL-IQSG---PPLDEMSIACILRDLLHAI 124
+ ++ + Y S+ + L+ +M+Y+ GG + L I+ G L IA +L AI
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA----ELTCAI 114
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFG---------------------------- 156
E +H G IHRDIK NIL+ +G +K+ DFG
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174
Query: 157 -----VSAQLTRTISRRK----------TFVGTPFWMAPEVIQNSEGYNEKADIWSLGIT 201
+ + + RR+ + VGTP ++APEV+ + GY + D WS+G+
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVI 233
Query: 202 VIEMAKGEPPLADLHP 217
+ EM G+PP P
Sbjct: 234 LYEMLVGQPPFLADTP 249
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 73/252 (28%), Positives = 125/252 (49%), Gaps = 21/252 (8%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G +G+VY+ K+ + VA+K L+E E+E+ KE +V+ + + P + + G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
+ +II E+M G++ D ++ ++ + + + + A+EYL + IHRD+
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLA 131
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGYNE---KAD 194
A N L+ EN VKVADFG+S +T P W APE S YN+ K+D
Sbjct: 132 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE----SLAYNKFSIKSD 187
Query: 195 IWSLGITVIEMAK-GEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLK 249
+W+ G+ + E+A G P + +V ++ + E P LM+ C +
Sbjct: 188 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA----CWQ 243
Query: 250 KVPAERPSAKEL 261
P++RPS E+
Sbjct: 244 WNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 7/216 (3%)
Query: 59 QKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIA 114
+ E+ L+ C I +++ + KL +IMEY +GG + I+ P E +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 115 CILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--KTFV 172
+ ++ A++ +H+ +HRD+K+ANI L G +K+ DFG S Q + ++S +F
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL 232
GTP+++APE+ + Y++KAD+WSLG+ + E+ P ++ +
Sbjct: 233 GTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268
S MK + L K PA RP+ ++LL F++
Sbjct: 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 36/276 (13%)
Query: 17 SLELI---GRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQC 68
S+ L+ G G+FG+VY+ + + D VA+K + SE + D E ++S+
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLH------ 122
I G + +I++E MAGG + ++ P E + ++DLL
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 123 -AIEYLHNEGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTISRRKTFVGTPF-- 176
+YL IHRDI A N LLT G K+ADFG++ + R RK G
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG--GRAMLP 184
Query: 177 --WMAPEVIQNSEG-YNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----EN 228
WM PE +G + K D+WS G+ + E + G P V+ + +
Sbjct: 185 IKWMPPEAFL--DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP 242
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P R+M + C + P +RP+ +L
Sbjct: 243 PKGCPGPVYRIMTD----CWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 78/261 (29%), Positives = 121/261 (46%), Gaps = 24/261 (9%)
Query: 19 ELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
++IG G FG+V + K K DVAIK + S+ + D E S++ Q P I
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 76 YYGSYLHQTKLWIIMEYMAGGSV-ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
G + II EYM GS+ L ++ + +LR + ++YL +H
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVH 129
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-TPF-WMAPEVIQNSEGYNEK 192
RD+ A NIL+ N KV+DFG+S +L + + T G P W APE I + +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-FTSA 188
Query: 193 ADIWSLGITVIE-MAKGEPPLADLHPMRVLFII--------PRENPPQLDEHFSRLMKEF 243
+D+WS GI + E M+ GE P D+ V+ + P + P L +LM +
Sbjct: 189 SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSAL----YQLMLD- 243
Query: 244 VSLCLKKVPAERPSAKELLRH 264
C +K ERP+ +++
Sbjct: 244 ---CWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-24
Identities = 76/266 (28%), Positives = 140/266 (52%), Gaps = 12/266 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
+ +++IGRG+FG+V K K A+K++ E + +E +++ SP+
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + + ++ L+++MEYM GG + +L+ S + E +++ A++ +H+ G
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGF 163
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPFWMAPEVIQNSEG--- 188
IHRD+K N+LL ++G +K+ADFG ++ + + R T VGTP +++PEV+++ G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 189 YNEKADIWSLGITVIEMAKGEPPL-ADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFVS 245
Y + D WS+G+ + EM G+ P AD I+ +N D S+ K +
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 283
Query: 246 LCL--KKVPAERPSAKELLRHRFIRN 269
L ++V R +E+ RH F +N
Sbjct: 284 AFLTDREVRLGRNGVEEIKRHLFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 63/194 (32%), Positives = 98/194 (50%), Gaps = 4/194 (2%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQ-CRSPYITEYY 77
IG+GSFG V A K K A+KV+ + + E + I E +VL + + P++ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
S+ KL+ +++Y+ GG + +Q E ++ A+ YLH+ I+RD+
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWS 197
K NILL G V + DFG+ + TF GTP ++APEV++ Y+ D W
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWC 181
Query: 198 LGITVIEMAKGEPP 211
LG + EM G PP
Sbjct: 182 LGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-23
Identities = 75/267 (28%), Positives = 127/267 (47%), Gaps = 18/267 (6%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRS-PYITEY 76
+IGRGS+ V K+ + A+KV+ +L +++I+ +Q E V Q + P++
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
+ + +++L+ ++EY+ GG + +Q L E ++ A+ YLH G I+RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIW 196
+K N+LL G +K+ D+G+ + R TF GTP ++APE+++ E Y D W
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR-GEDYGFSVDWW 180
Query: 197 SLGITVIEMAKGEPPL--------ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
+LG+ + EM G P D + LF + E ++ S + L
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 240
Query: 249 KKVPAER----PSA--KELLRHRFIRN 269
K P ER P ++ H F RN
Sbjct: 241 NKDPKERLGCHPQTGFADIQGHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 20/265 (7%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVID---LEESEDEIEDIQKEI--SVLSQCRSPYIT 74
+IGRG FG+VY + K A+K +D ++ + E + + I S++S P+I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 EYYGSYLHQT--KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
SY T KL I++ M GG + + E + +++ +E++HN
Sbjct: 61 CM--SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
++RD+K ANILL E+G V+++D G++ ++ + VGT +MAPEV+Q Y+
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSS 176
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLK 249
AD +SLG + ++ +G P H + I R +L + FS ++ + L+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235
Query: 250 KVPAER-----PSAKELLRHRFIRN 269
+ R A+E+ H F R+
Sbjct: 236 RDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 69/262 (26%), Positives = 114/262 (43%), Gaps = 30/262 (11%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+ +G GSFG V + VA+K + ++ D ++D KE +++ +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYLHNEGK 132
YG L L ++ E GS+ D ++ L I+ + + + + YL ++
Sbjct: 61 LYGVVL-THPLMMVTELAPLGSLLDRLRK-DALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLT------RTISRRKTFVGTPF-WMAPEVIQN 185
IHRD+ A NILL + VK+ DFG+ L K PF W APE +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK----VPFAWCAPESL-R 173
Query: 186 SEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPR-----ENPPQLDEHFSRL 239
+ ++ +D+W G+T+ EM GE P A L ++L I + E P + +
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV 233
Query: 240 MKEFVSLCLKKVPAERPSAKEL 261
M + C PA+RP+ L
Sbjct: 234 MLQ----CWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 66/205 (32%), Positives = 110/205 (53%), Gaps = 8/205 (3%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L++IGRG+FG+V K + A+K+++ E E ++E VL +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEG 131
IT + ++ + L+++M+Y GG + L+ L E L +++ AI+ +H G
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF-VGTPFWMAPEVIQNSEG-- 188
+HRDIK N+LL +NG +++ADFG +L + + VGTP +++PE++Q E
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 189 --YNEKADIWSLGITVIEMAKGEPP 211
Y + D WSLG+ + EM GE P
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 73/245 (29%), Positives = 126/245 (51%), Gaps = 16/245 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSP 71
F+ + +G GSFG V A K + VAIK + + + +++ + E +L+ P
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILR-DLLHAIEYLH 128
+ YGS+ ++ L++++E++ GG ++ P D + C ++ EYL
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND---VGCFYAAQIVLIFEYLQ 148
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
+ ++RD+K N+LL ++G +K+ DFG A++ T R T GTP ++APE++ N G
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGF-AKVVDT--RTYTLCGTPEYIAPEILLNV-G 204
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---ENPPQLDEHFSRLMKEFVS 245
+ + AD W+LGI + E+ G PP P+ + I P LD + LMK+ +S
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLS 264
Query: 246 LCLKK 250
L K
Sbjct: 265 HDLTK 269
|
Length = 340 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 72/264 (27%), Positives = 130/264 (49%), Gaps = 20/264 (7%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQCRSPYIT 74
+IGRG FG+VY + K A+K +D +++ E + + +S++S P+I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
++ KL I++ M GG + + E + +++ +E++HN ++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K ANILL E+G V+++D G++ ++ + VGT +MAPEV+Q Y+ AD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTAYDSSAD 178
Query: 195 IWSLGITVIEMAKGEPPL-----ADLHPM-RVLFIIPRENP----PQLDEHFSRLMKEFV 244
+SLG + ++ +G P D H + R+ + E P P+L L++ V
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV 238
Query: 245 SLCLKKVPAERPSAKELLRHRFIR 268
S K++ A+E+ H F +
Sbjct: 239 S---KRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 66/206 (32%), Positives = 111/206 (53%), Gaps = 8/206 (3%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L++IGRG+FG+V K +K A+K+++ E E ++E VL + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHNEG 131
IT + ++ + L+++M+Y GG + L+ L E L +++ AI+ +H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF-VGTPFWMAPEVIQNSEG-- 188
+HRDIK NIL+ NG +++ADFG +L + + + VGTP +++PE++Q E
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 189 --YNEKADIWSLGITVIEMAKGEPPL 212
Y + D WSLG+ + EM GE P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 5e-23
Identities = 81/289 (28%), Positives = 129/289 (44%), Gaps = 52/289 (17%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQCRSPY 72
F + IG G++G VYKA DK+ + VA+K + L+ +E E I +EI +L Q
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD-NEKEGFPITAIREIKILRQLNHRN 67
Query: 73 ITEYYGSYLHQT---------------KLWIIMEYMAGGSVADLIQSG-PPLDEMSIACI 116
I L + +++ EYM + L++SG E I
Sbjct: 68 IVN-----LKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSF 121
Query: 117 LRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGT 174
++ LL + Y H + +HRDIK +NILL G +K+ADFG+ A+L + R V T
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL-ARLYNSEESRPYTNKVIT 180
Query: 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE 234
++ PE++ E Y D+WS G L +L + +F Q ++
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCI----------LGELFTKKPIF--------QANQ 222
Query: 235 HFSRLMKEFVS-LCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRE 282
++L E +S LC PA P +L ++ ++ R R+RE
Sbjct: 223 ELAQL--ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRR---RLRE 266
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 66/283 (23%), Positives = 127/283 (44%), Gaps = 30/283 (10%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI-EDIQKEISVLSQCRSPY 72
++ LE IG G++G V+KA ++E ++ VA+K + L++ ++ + +EI +L + +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I Y KL ++ EY +D + + LL + + H+
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
+HRD+K N+L+ +NG++K+ADFG++ + V T ++ P+V+ ++ Y+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 180
Query: 193 ADIWSLGITVIEMAKGEPPL---ADLHP-----MRVLFIIPRENPPQLDE--------HF 236
D+WS G E+A PL D+ R+L E+ P + + +
Sbjct: 181 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY 240
Query: 237 SRLM-------------KEFVSLCLKKVPAERPSAKELLRHRF 266
++ + L P +R SA+E L+H +
Sbjct: 241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 6e-23
Identities = 72/277 (25%), Positives = 119/277 (42%), Gaps = 19/277 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAF---DKELNK-DVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ ++++G G+FG VYK + E K VAIKV+ E S ++I E V++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYL 127
P++ G L + +I + M G + D + + + + + YL
Sbjct: 67 DHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-TPF-WMAPEVIQN 185
+ +HRD+ A N+L+ VK+ DFG++ L G P WMA E I +
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 186 SEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLM 240
Y K+D+WS G+TV E M G P + + + ++ + PP ++
Sbjct: 186 RI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVL 244
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLL 277
+ C RP+ KEL+ F + AR R L
Sbjct: 245 VK----CWMIDAESRPTFKELIN-EFSKMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 8e-23
Identities = 77/253 (30%), Positives = 128/253 (50%), Gaps = 21/253 (8%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
IG G FG V+ + E K VAIK I E ED +E V+ + P + + YG
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTI--REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKA 139
++ + ++ E+M G ++D +++ + ++ + D+ + YL + IHRD+ A
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAA 128
Query: 140 ANILLTENGDVKVADFGVSAQLTRTI--SRRKTFVGTPF---WMAPEVIQNSEGYNEKAD 194
N L+ EN VKV+DFG +TR + + + GT F W +PEV S+ Y+ K+D
Sbjct: 129 RNCLVGENQVVKVSDFG----MTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK-YSSKSD 183
Query: 195 IWSLGITVIEM-AKGEPPLADLHPMRVLFIIP---RENPPQLDEHFSRLMKEFVSLCLKK 250
+WS G+ + E+ ++G+ P + V+ I R P+L S+ + E + C K+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLA---SQSVYELMQHCWKE 240
Query: 251 VPAERPSAKELLR 263
P +RPS LL
Sbjct: 241 RPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 8/206 (3%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F +++IGRG+FG+V K + A+K+++ E E ++E +VL +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEG 131
IT + ++ + L+++M+Y GG + L+ L E + +++ AI +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF-VGTPFWMAPEVIQNSEG-- 188
+HRDIK N+LL NG +++ADFG ++ + + + + VGTP +++PE++Q E
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 189 --YNEKADIWSLGITVIEMAKGEPPL 212
Y + D WSLG+ + EM GE P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R+ +L +G G++G V AFD + + VAIK + +S + +E+ +L
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 73 ITEYYGSYLHQTKL------WIIMEYMAGGSVADL--IQSGPPLDEMSIACILRDLLHAI 124
+ + + L +++ M ADL I L + I ++ +L +
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMG----ADLNNIVKCQKLSDDHIQFLVYQILRGL 131
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
+Y+H+ G IHRD+K +NI + E+ ++K+ DFG++ T +V T ++ APE++
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH---TDDEMTGYVATRWYRAPEIML 188
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEP 210
N YN+ DIWS+G + E+ G+
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 72/259 (27%), Positives = 120/259 (46%), Gaps = 20/259 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
F+ +G G FG+V++ K + VAIK++ + + +D QKE+ L + R +
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILK-SDDLLKQQDFQKEVQALKRLRHKH 63
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ + ++II E M GS+ ++S G L S+ + + + YL +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI---SRRKTFVGTPFWMAPEVIQNSE 187
IHRD+ A NIL+ E+ KVADFG++ + + S +K W APE +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK---WTAPEAA-SHG 179
Query: 188 GYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKE 242
++ K+D+WS GI + EM G+ P ++ V I P + + ++M E
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE 239
Query: 243 FVSLCLKKVPAERPSAKEL 261
C P +RPS K L
Sbjct: 240 ----CWAAEPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 75/265 (28%), Positives = 126/265 (47%), Gaps = 34/265 (12%)
Query: 20 LIGRGSFGDVYKAFDKELNKD------VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+G G+FG+VY+ ++ VA+K + ++ E ++ KE ++S P I
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSV------ADLIQSGPP---LDEMSIACILRDLLHAI 124
+ G L +IIME M GG + A + + GPP L E+ C+ D+
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL--DVAKGC 119
Query: 125 EYLHNEGKIHRDIKAANILLTENGD-----VKVADFGVSAQLTRTISRRKTFVGT-PF-W 177
YL IHRD+ A N L++E G VK+ DFG++ + ++ RK G P W
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQL 232
MAPE + + + + ++D+WS G+ + E + G+ P L+ VL + + P
Sbjct: 180 MAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC 238
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPS 257
+ +LM + C + P+ERP+
Sbjct: 239 PDKIYQLM----TNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 9e-22
Identities = 68/236 (28%), Positives = 118/236 (50%), Gaps = 19/236 (8%)
Query: 21 IGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G G+FG V K K K DVAIKV+ E + +++ +E ++ Q +PYI G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAI----EYLHNEGKIH 134
L ++ME +GG + + DE++++ ++ +L+H + +YL + +H
Sbjct: 63 -VCEAEALMLVMEMASGGPLNKFLSGKK--DEITVSNVV-ELMHQVSMGMKYLEGKNFVH 118
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPF-WMAPEVIQNSEGYNE 191
RD+ A N+LL K++DFG+S L S + ++ P W APE I N ++
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI-NFRKFSS 177
Query: 192 KADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKE 242
++D+WS GIT+ E + G+ P + V+ I + + P + LMK+
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKD 233
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 9e-22
Identities = 88/335 (26%), Positives = 150/335 (44%), Gaps = 70/335 (20%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI-DLEESEDEIEDIQK---EISVLSQC 68
++ L+ +G+G++G V+KA D+ + VA+K I D + D Q+ EI L +
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA---TDAQRTFREIMFLQEL 63
Query: 69 RS-PYITEYYGSY--LHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLH 122
P I + + ++++ EYM DL I++ L+++ I+ LL
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYME----TDLHAVIRANI-LEDVHKRYIMYQLLK 118
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT---------FVG 173
A++Y+H+ IHRD+K +NILL + VK+ADFG L R++S + +V
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG----LARSLSELEENPENPVLTDYVA 174
Query: 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG---------------------EPPL 212
T ++ APE++ S Y + D+WS+G + EM G P
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234
Query: 213 ADLHPMR------VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELL 262
D+ ++ +L +P LDE + + + L LKK+ P +R +A+E L
Sbjct: 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDL-LKKLLVFNPNKRLTAEEAL 293
Query: 263 RHRFI---RNARKSPRLLERIR----ERPKYPIQE 290
H ++ N P L I + K + E
Sbjct: 294 EHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSVAE 328
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 64/197 (32%), Positives = 98/197 (49%), Gaps = 4/197 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVL-SQCRSPYITE 75
++IG+GSFG V A K A+KV+ + + E I E +VL + P++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ S+ KL+ +++Y+ GG + +Q E ++ AI YLH+ I+R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K NILL G V + DFG+ + TF GTP ++APEV++ E Y+ D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTVDW 179
Query: 196 WSLGITVIEMAKGEPPL 212
W LG + EM G PP
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 75/283 (26%), Positives = 125/283 (44%), Gaps = 45/283 (15%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRS-PYITEYYG 78
IG G+F +V KA ++ K AIK + +S +++ ++ +EI L + P I
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65
Query: 79 SYLHQT--KLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ +L ++ E M ++ +LI+ PL E + + LL +++++H G HR
Sbjct: 66 VLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHR 124
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF---VGTPFWMAPEVIQNSEGYNEK 192
DIK NIL+ ++ +K+ADFG S R I + + + T ++ APE + Y K
Sbjct: 125 DIKPENILIKDD-ILKLADFG-SC---RGIYSKPPYTEYISTRWYRAPECLLTDGYYGPK 179
Query: 193 ADIWSLGITVIEMAK---------------------GEPP---LADLHPMRVL-FIIPRE 227
DIW++G E+ G P L R + + P +
Sbjct: 180 MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSK 239
Query: 228 NPPQLDEHFSRLMKEFVSLCLKK----VPAERPSAKELLRHRF 266
L + E + L LKK P ER +AK+ LRH +
Sbjct: 240 KGTGLRKLLPNASAEGLDL-LKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 70/265 (26%), Positives = 120/265 (45%), Gaps = 37/265 (13%)
Query: 17 SLELI---GRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
S++L+ G G FG+V++ N + V L+ + +D E ++ + R P +
Sbjct: 7 SIQLLRKLGAGQFGEVWEGL---WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKL 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMS--IACILRDLLHAI 124
+ Y + ++I+ E M GS+ + +Q G P L +M+ +A +
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS-------GM 116
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPE 181
YL + IHRD+ A N+L+ EN KVADFG++ + I + G F W APE
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE--GAKFPIKWTAPE 174
Query: 182 VIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHF 236
++ K+D+WS GI + E + G P + VL + + PP +
Sbjct: 175 AA-LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKEL 233
Query: 237 SRLMKEFVSLCLKKVPAERPSAKEL 261
+M + C K+ P +RP+ + L
Sbjct: 234 YDIMLD----CWKEDPDDRPTFETL 254
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 81/289 (28%), Positives = 121/289 (41%), Gaps = 48/289 (16%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
L+ +G GS+ VYK K + VA+K I LE E +E S+L + I +
Sbjct: 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLH 69
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ L ++ EY+ DL Q G L ++ L LL + Y H +
Sbjct: 70 DIIHTKKTLTLVFEYL----DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKTF---VGTPFWMAPEVIQNSEGY 189
HRD+K N+L++E G++K+ADFG L R S KT+ V T ++ P+V+ S Y
Sbjct: 126 HRDLKPQNLLISERGELKLADFG----LARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 190 NEKADIWSLGITVIEMAKGEP-------PLADLHPMRVLFIIPRE--------------- 227
+ D+W +G EMA G P LH + + P E
Sbjct: 182 STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241
Query: 228 -----NPPQLDEHFSRLMK-----EFVSLCLKKVPAERPSAKELLRHRF 266
P L H RL + E L+ P +R SA E ++H +
Sbjct: 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 81/261 (31%), Positives = 128/261 (49%), Gaps = 21/261 (8%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
S + ++ +G G FG V+ + K VAIK I+ E + E ED +E V+ + P
Sbjct: 4 SELTFMKELGSGQFGVVHLGKWRAQIK-VAIKAIN-EGAMSE-EDFIEEAKVMMKLSHPK 60
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + YG Q L+I+ E+M G + + L Q L + + + +D+ +EYL
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRRKTFVGTPF---WMAPEVIQNS 186
IHRD+ A N L++ G VKV+DFG +TR + + G F W PEV S
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFG----MTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 187 EGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKE 242
+ Y+ K+D+WS G+ + E+ +G+ P V+ +I R P+L S + E
Sbjct: 177 K-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLA---SMTVYE 232
Query: 243 FVSLCLKKVPAERPSAKELLR 263
+ C + P RP+ ELLR
Sbjct: 233 VMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 6/205 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID--LEESEDEIEDIQKEISVL-SQCRSPYITE 75
++IG+GSFG V A K K A+KV+ + + E + I E +VL + P++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ S+ KL+ +++++ GG + +Q E ++ A+ YLH+ ++R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K NILL G V + DFG+ + TF GTP ++APEVI+ + Y+ D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPYDNTVDW 179
Query: 196 WSLGITVIEMAKGEPPL--ADLHPM 218
W LG + EM G PP D+ M
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 72/288 (25%), Positives = 126/288 (43%), Gaps = 32/288 (11%)
Query: 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
A + + +LE +G GS+ VYK + + VA+KVI ++ E +E S+L +
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
I + + L + EYM +IQ L ++ + LL + Y+H +
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ 122
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
+HRD+K N+L++ G++K+ADFG++ + + V T ++ P+V+ + Y+
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182
Query: 191 EKADIWSLGITVIEMAKGEPPLA-------DLHPMRVLFIIPREN--------------- 228
DIW G IEM +G+P L + + +P E+
Sbjct: 183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242
Query: 229 -----PPQLDEHFSRLMK-----EFVSLCLKKVPAERPSAKELLRHRF 266
P QL + RL + + S L P +R SA++ L H +
Sbjct: 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-21
Identities = 71/251 (28%), Positives = 115/251 (45%), Gaps = 60/251 (23%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F ++++IG+G+FG+V K+ K A+K + E +D++ ++ E VL++ SP+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDE----MSIA-CILRDLLHAIEYL 127
+ Y S+ L++IME++ GG + ++ E +A C+L AIE +
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVL-----AIEAV 117
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSA---------------------------- 159
H G IHRDIK NIL+ G +K++DFG+S
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 160 -----QLTRTISRRKTF--------------VGTPFWMAPEVIQNSEGYNEKADIWSLGI 200
+ T+S + VGTP ++APE I +GY ++ D WSLG
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLGA 236
Query: 201 TVIEMAKGEPP 211
+ E G PP
Sbjct: 237 IMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 68/237 (28%), Positives = 122/237 (51%), Gaps = 11/237 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI-DLEESEDEIEDIQKEISVLSQCRSP 71
++F L ++G G++G V K KE + VAIK D EE+E+ E +E+ +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADL--IQSGPPLDEMSIACILRDLLHAIEYLHN 129
I E ++ + KL+++ EY+ + L + +G P ++ + + L+ AI + H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK--VRSYIYQLIKAIHWCHK 118
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQNSEG 188
+HRDIK N+L++ N +K+ DFG + L+ + T +V T ++ +PE++ +
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP- 177
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245
Y + D+WS+G + E++ G+P + LF I + P E MK F S
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ----MKLFYS 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 3e-21
Identities = 73/255 (28%), Positives = 122/255 (47%), Gaps = 9/255 (3%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVL-SQCRSPYITE 75
++IG+GSFG V A K K A+KV+ + + E + I E +VL + P++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ S+ KL+ +++Y+ GG + +Q E ++ A+ YLH+ ++R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
D+K NILL G + + DFG+ + TF GTP ++APEV+ + + Y+ D
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL-HKQPYDRTVDW 179
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255
W LG + EM G PP + + I + P QL + + + + L+K +R
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPNITNSARHLLEGLLQKDRTKR 238
Query: 256 PSAK----ELLRHRF 266
AK E+ H F
Sbjct: 239 LGAKDDFMEIKNHIF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 4e-21
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 16/210 (7%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
G R+ +L IG G++G V A K VAIK I E + + +EI +L + +
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 72 YITEYY-----GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHA 123
I S+ ++I+ E M DL I++ L I L +L
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELME----TDLYKLIKT-QHLSNDHIQYFLYQILRG 118
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGV--SAQLTRTISRRKT-FVGTPFWMAP 180
++Y+H+ +HRD+K +N+LL N D+K+ DFG+ A + T +V T ++ AP
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEP 210
E++ NS+GY + DIWS+G + EM P
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 67/249 (26%), Positives = 108/249 (43%), Gaps = 8/249 (3%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
IG G FGDVY+ + VA+K S E +E ++ Q P+I +
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIH 134
G + + +WI+ME G + +Q LD S+ L A+ YL ++ +H
Sbjct: 72 LIG-VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVH 130
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGYNEKA 193
RDI A N+L++ VK+ DFG+S L + + P WMAPE I N + +
Sbjct: 131 RDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI-NFRRFTSAS 189
Query: 194 DIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
D+W G+ + E + G P + V+ I + + + ++ C P
Sbjct: 190 DVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 249
Query: 253 AERPSAKEL 261
++RP EL
Sbjct: 250 SKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 79/298 (26%), Positives = 133/298 (44%), Gaps = 44/298 (14%)
Query: 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK---EISVLSQ 67
GSR+ +E IG G++G V A D K VAIK I + D ++ E+ +L
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI--PHAFDVPTLAKRTLRELKILRH 60
Query: 68 CRSPYI----TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHA 123
+ I ++++M+ M + +I S PL E I L LL
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF----VGTPFWMA 179
++Y+H+ IHRD+K +N+L+ E+ ++++ DFG++ L+ + + K F V T ++ A
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEM---------------------AKGEPPLADLHPM 218
PE++ + Y D+WS+G EM G P L+ +
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239
Query: 219 ---RVLFII---PRENPPQLDEHF---SRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
RV I PR+ P + F S + +S L+ P ER + ++ L+H F+
Sbjct: 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-21
Identities = 73/255 (28%), Positives = 126/255 (49%), Gaps = 21/255 (8%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
L+ +G G FG V K DVAIK+I E S E E I+ E V+ + + + Y
Sbjct: 9 LKELGTGQFG-VVKYGKWRGQYDVAIKMIK-EGSMSEDEFIE-EAKVMMKLSHEKLVQLY 65
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMS-IACILRDLLHAIEYLHNEGKIHRD 136
G Q ++I+ EYM+ G + + ++ + S + + +D+ + YL ++ IHRD
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRD 125
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTI--SRRKTFVGTPF---WMAPEVIQNSEGYNE 191
+ A N L+ + G VKV+DFG L+R + + VG+ F W PEV+ S+ ++
Sbjct: 126 LAARNCLVDDQGCVKVSDFG----LSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK-FSS 180
Query: 192 KADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIP---RENPPQLDEHFSRLMKEFVSLC 247
K+D+W+ G+ + E+ + G+ P + + + R P L S + + C
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA---SEKVYAIMYSC 237
Query: 248 LKKVPAERPSAKELL 262
+ ERP+ ++LL
Sbjct: 238 WHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 69/251 (27%), Positives = 129/251 (51%), Gaps = 23/251 (9%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
E+IG G FG V + + + VA+K I + + + E +V+++ + G
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLG 66
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILR---DLLHAIEYLHNEGKIH 134
LH L+I+ME M+ G++ + +++ G L +S+ +L+ D+ +EYL ++ +H
Sbjct: 67 VILHN-GLYIVMELMSKGNLVNFLRTRGRAL--VSVIQLLQFSLDVAEGMEYLESKKLVH 123
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+ A NIL++E+G KV+DFG++ + + K V W APE +++ + ++ K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK---WTAPEALKHKK-FSSKSD 179
Query: 195 IWSLGITVIEM-AKGEPPLADLHPMRVLFIIP---RENPPQLDEHFSRLMKEFVSLCLKK 250
+WS G+ + E+ + G P + V + R PP E + ++ C +
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP---EGCPADVYVLMTSCWET 236
Query: 251 VPAERPSAKEL 261
P +RPS +L
Sbjct: 237 EPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-21
Identities = 71/247 (28%), Positives = 116/247 (46%), Gaps = 13/247 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
E IGRG+FG+V+ + N VA+K D +E +L Q P I G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ ++I+ME + GG +++ GP L + ++ + +EYL ++ IHRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTI-SRRKTFVGTPF-WMAPEVIQNSEGYNEKADI 195
A N L+TE +K++DFG+S + + + P W APE + N Y+ ++D+
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL-NYGRYSSESDV 179
Query: 196 WSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLKK 250
WS GI + E + G P A+L + I + P + RLM+ C +
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMER----CWEY 235
Query: 251 VPAERPS 257
P +RPS
Sbjct: 236 DPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQ--- 67
S++ L IG+G+FG+V+KA K+ + VA+K + L E+E E I +EI +L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPITALREIKILQLLKH 70
Query: 68 ---------CRSPYITE--YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACI 116
CR+ Y GS+ +++ E+ L I +
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSF------YLVFEFCEHDLAGLLSNKNVKFTLSEIKKV 124
Query: 117 LRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK------- 169
++ LL+ + Y+H +HRD+KAANIL+T++G +K+ADFG L R S K
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG----LARAFSLSKNSKPNRY 180
Query: 170 -TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM 205
V T ++ PE++ Y D+W G + EM
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-20
Identities = 79/271 (29%), Positives = 127/271 (46%), Gaps = 36/271 (13%)
Query: 19 ELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYI 73
++IG G+FG V KA K+ L D AIK + S+D+ D E+ VL C+ P I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL--CKLGHHPNI 70
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----------------SGPPLDEMSIACIL 117
G+ H+ L++ +EY G++ D ++ + L +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF- 176
D+ ++YL + IHRD+ A NIL+ EN K+ADFG+S + + +KT P
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 188
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPR----ENPPQ 231
WMA E + N Y +D+WS G+ + E+ G P + + +P+ E P
Sbjct: 189 WMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 247
Query: 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
D+ LM++ C ++ P ERPS ++L
Sbjct: 248 CDDEVYDLMRQ----CWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 67/249 (26%), Positives = 118/249 (47%), Gaps = 20/249 (8%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G+G FG+V + K A K ++ + + E E +L++ S +I
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 79 SYLHQTKLWIIMEYMAGGS----VADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
++ +T L ++M M GG + ++ + P E ++ +E+LH I+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K N+LL +G+V+++D G++ +L S+ K + GTP +MAPE++Q E Y+ D
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE-YDFSVD 179
Query: 195 IWSLGITVIEM--------AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
++LG+T+ EM A+GE R+L + + FS K F
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-----NDSVTYPDKFSPASKSFCEA 234
Query: 247 CLKKVPAER 255
L K P +R
Sbjct: 235 LLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 78/263 (29%), Positives = 125/263 (47%), Gaps = 32/263 (12%)
Query: 19 ELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITE 75
++IG G+FG V KA K+ L D AIK + S+D+ D E+ VL + P I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDE-------------MSIACILR---D 119
G+ H+ L++ +EY G++ D ++ L+ +S +L D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 120 LLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WM 178
+ ++YL + IHRD+ A NIL+ EN K+ADFG+S + + +KT P WM
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWM 178
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPR----ENPPQLD 233
A E + N Y +D+WS G+ + E+ G P + + +P+ E P D
Sbjct: 179 AIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237
Query: 234 EHFSRLMKEFVSLCLKKVPAERP 256
+ LM++ C ++ P ERP
Sbjct: 238 DEVYDLMRQ----CWREKPYERP 256
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R++SL+ +G G++G V A DK + VAIK + +SE + +E+++L +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 73 ITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIE 125
+ + +++M YM DL + G PL E + ++ +L ++
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQ 184
Y+H+ G IHRD+K N+ + E+ ++K+ DFG L R T +V T ++ APEVI
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTRWYRAPEVIL 187
Query: 185 NSEGYNEKADIWSLGITVIEMAKGE 209
N YN+ DIWS+G + EM G+
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 72/275 (26%), Positives = 137/275 (49%), Gaps = 40/275 (14%)
Query: 21 IGRGSFGDVYKA----FDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQC-RSPY 72
+G G FG V A DK+ K+ VA+K++ + +E ++ D+ E+ ++ +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPL-------------DEMS----IAC 115
I G+ L++I+EY + G++ + +++ P ++M+ ++C
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT- 174
+ + +EYL ++ IHRD+ A N+L+TEN +K+ADFG++ + +KT G
Sbjct: 143 TYQ-VARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL 201
Query: 175 PF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRE----- 227
P WMAPE + + Y ++D+WS G+ + E+ G P + P+ LF + +E
Sbjct: 202 PVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMD 259
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
P +M++ C +P+ RP+ K+L+
Sbjct: 260 KPANCTNELYMMMRD----CWHAIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 80/281 (28%), Positives = 133/281 (47%), Gaps = 33/281 (11%)
Query: 19 ELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITE 75
++IG G+FG V +A K+ L + AIK++ SE++ D E+ VL + P I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLD-------EMSIACILR---------D 119
G+ ++ L+I +EY G++ D ++ L+ E A L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 120 LLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WM 178
+ ++YL + IHRD+ A N+L+ EN K+ADFG+S + +KT P WM
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPVRWM 185
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPR----ENPPQLD 233
A E + N Y K+D+WS G+ + E+ G P + + +P+ E P D
Sbjct: 186 AIESL-NYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCD 244
Query: 234 EHFSRLMKEFVSLCLKKVPAERPSAKEL-LRHRFIRNARKS 273
+ LM++ C + P ERP ++ ++ + ARK+
Sbjct: 245 DEVYELMRQ----CWRDRPYERPPFAQISVQLSRMLEARKA 281
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 73/284 (25%), Positives = 123/284 (43%), Gaps = 29/284 (10%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ LE +G G++ V+K K VA+K I LE E +E+S+L + I
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+ L ++ EY+ + G + ++ L +L + Y H +H
Sbjct: 68 TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH 127
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K N+L+ E G++K+ADFG++ + V T ++ P+V+ S Y+ + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQID 187
Query: 195 IWSLGITVIEMAKGEPPLA------DLHPM-RVL-------------------FIIPREN 228
+W +G EMA G P +LH + R+L + P+
Sbjct: 188 MWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYK 247
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAE---RPSAKELLRHRFIRN 269
P L H RL E + L K + E R SA+E ++H + R+
Sbjct: 248 PQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 44/278 (15%)
Query: 18 LELIGRGSFGDV----YKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
++ +G+G+FG V Y + VA+K + + + + D ++EI +L + I
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-HSTAEHLRDFEREIEILKSLQHDNI 67
Query: 74 TEYYG-SY-LHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
+Y G Y + L ++MEY+ GS+ D L + LD + + +EYL ++
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FWMAPEVI 183
+HRD+ NIL+ VK+ DFG LT+ + + K + V P FW APE +
Sbjct: 128 RYVHRDLATRNILVESENRVKIGDFG----LTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 184 QNSEGYNEKADIWSLGITVIEM-----AKGEPPLADLH--------PMRVLFIIP--REN 228
S+ ++ +D+WS G+ + E+ PP + M V +I + N
Sbjct: 184 TESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242
Query: 229 -----PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
PP +MKE C P++RPS EL
Sbjct: 243 GRLPAPPGCPAEIYAIMKE----CWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 68/257 (26%), Positives = 125/257 (48%), Gaps = 14/257 (5%)
Query: 21 IGRGSFGDVYKAF--DKELNKDVAIKVIDLEESEDEIED-IQKEISVLSQCRSPYITEYY 77
+G G+FG V K K+ K VA+K++ + ++ ++D + +E +V+ Q +PYI
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 78 GSYLHQTKLWIIMEYMAG-GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
G + + + W+++ +A G + +Q + E +I ++ + ++YL +HRD
Sbjct: 63 G--ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 137 IKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPF-WMAPEVIQNSEGYNEKA 193
+ A N+LL K++DFG+S L + KT P W APE + N ++ K+
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-NYYKFSSKS 179
Query: 194 DIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
D+WS G+ + E + G+ P + V +I + + M + + LC
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239
Query: 253 AERP--SAKEL-LRHRF 266
ERP + EL LR+ +
Sbjct: 240 DERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 35/299 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ L+ +G G++ VYK K + VA+K I LE E +E+S+L + I
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+ + L ++ EY+ L G ++ ++ L LL + Y H +H
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLH 127
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K N+L+ E G++K+ADFG++ + V T ++ P+++ S Y+ + D
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQID 187
Query: 195 IWSLGITVIEMAKGEPPLA------DLHPM-RVL-------------------FIIPREN 228
+W +G EM+ G P LH + R+L + P+
Sbjct: 188 MWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYR 247
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAE---RPSAKELLRHRFIRNARKSPRLLERIRERP 284
L H RL + L K + E R SA+E ++H + L ERI + P
Sbjct: 248 ADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC------LGERIHKLP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 21/261 (8%)
Query: 21 IGRGSFGDVYKAFDKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
+G G+FG V K + +VA+K + E ++ +E SV++Q P I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
G + L ++ME G + ++ + + + + + YL ++ +HRD+
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTIS---RRKTFVGTPF-WMAPEVIQNSEGYNEKA 193
A N+LL K++DFG+S L S R T P W APE I N ++ K+
Sbjct: 122 AARNVLLVNRHQAKISDFGMSRAL-GAGSDYYRATTAGRWPLKWYAPECI-NYGKFSSKS 179
Query: 194 DIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCL 248
D+WS G+T+ E + G P ++ V+ ++ P + + +M C
Sbjct: 180 DVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIM----LSCW 235
Query: 249 KKVPAERPSAKELLRHRFIRN 269
K P +RP+ EL R
Sbjct: 236 KYRPEDRPTFSEL--ESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-20
Identities = 80/260 (30%), Positives = 133/260 (51%), Gaps = 37/260 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
L+ IG+G FGDV D NK VA+K I +++ + E SV++Q R + +
Sbjct: 11 LQTIGKGEFGDVMLG-DYRGNK-VAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 78 GSYLHQ-TKLWIIMEYMAGGSVADLIQS-------GPPLDEMSIACILRDLLHAIEYLHN 129
G + + L+I+ EYMA GS+ D ++S G L + S+ D+ A+EYL
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-----DVCEAMEYLEA 120
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRD+ A N+L++E+ KV+DFG++ + + T K V W APE ++ + +
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---WTAPEALREKK-F 176
Query: 190 NEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPR-ENPPQLD------EHFSRLMK 241
+ K+D+WS GI + E+ + G P + P++ ++PR E ++D +MK
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRI-PLKD--VVPRVEKGYKMDAPDGCPPVVYDVMK 233
Query: 242 EFVSLCLKKVPAERPSAKEL 261
+ C A RPS +L
Sbjct: 234 Q----CWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-19
Identities = 71/274 (25%), Positives = 126/274 (45%), Gaps = 55/274 (20%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS 70
S F ++ +G G+FG+V A + + A+K + ++ + +++ ++ E +L++ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
++ + Y S+ + L+ +M+Y+ GG + L+ E+ + +L AIE +H
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLT---------------------------- 162
G IHRDIK NIL+ +G +K+ DFG+
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 163 ---------RTISRRKT----------FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVI 203
+T+ +R T VGTP ++APEV+ +GY + D WS+G+ +
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILF 239
Query: 204 EMAKGEPPLADLHPMRV-LFIIPREN----PPQL 232
EM G+PP P L +I EN PPQ+
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQV 273
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 80/306 (26%), Positives = 133/306 (43%), Gaps = 63/306 (20%)
Query: 13 SRFSSLELIGRGSFGDVY------------KAFDKELNKD----VAIKVIDLEESEDEIE 56
+ +E +G G FG+V+ KAF + N D VA+KV+ + S++ E
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 57 DIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDE------ 110
D KE+ +LS+ P I G L +IMEYM G + +Q
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 111 --MSIACILRDLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161
+S + LL+ + YL + +HRD+ N L+ +N +K+ADFG+S L
Sbjct: 125 KSLSFST----LLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
Query: 162 -TRTISRRKTFVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM---AKGEPPLADLH 216
+ R + P WMA E + + + K+D+W+ G+T+ E+ + E P L
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCR-EQPYEHLT 238
Query: 217 PMRVL-------------FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
+V+ +PR PP + LM E C ++ +RP+ +E+
Sbjct: 239 DQQVIENAGHFFRDDGRQIYLPR--PPNCPKDIYELMLE----CWRRDEEDRPTFREI-- 290
Query: 264 HRFIRN 269
H F++
Sbjct: 291 HLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 70/274 (25%), Positives = 135/274 (49%), Gaps = 38/274 (13%)
Query: 21 IGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVLSQC-RSPY 72
+G G FG V A L+K+ VA+K++ + +E ++ D+ E+ ++ +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-------------SGPPLDEMSIACILR- 118
I G+ L++I+EY + G++ + ++ + P +++S ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 119 --DLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT-P 175
+ +EYL ++ IHRD+ A N+L+TE+ +K+ADFG++ + +KT G P
Sbjct: 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 176 F-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRE-----N 228
WMAPE + + Y ++D+WS G+ + E+ G P + P+ LF + +E
Sbjct: 206 VKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDK 263
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
P +M++ C VP++RP+ K+L+
Sbjct: 264 PSNCTNELYMMMRD----CWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 70/228 (30%), Positives = 108/228 (47%), Gaps = 15/228 (6%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
E+IG G FG+V + K K VAIK + +E + D E S++ Q P I
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
G + II E+M G++ + Q+ + + +LR + ++YL +H
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT-----PF-WMAPEVIQNSEG 188
RD+ A NIL+ N KV+DFG+S L S T+ + P W APE I +
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTS-DPTYTSSLGGKIPIRWTAPEAIAYRK- 187
Query: 189 YNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPREN--PPQLD 233
+ +D+WS GI + E M+ GE P D+ V+ I ++ PP +D
Sbjct: 188 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMD 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 75/259 (28%), Positives = 125/259 (48%), Gaps = 34/259 (13%)
Query: 17 SLELI---GRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+L+L+ G G FG+V+ + + VAIK L++ E E +++ Q + P +
Sbjct: 7 TLKLVKKLGAGQFGEVWMGYYNG-HTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRL 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
Y + + Q ++II EYM GS+ D +++ G L + + + + ++ +
Sbjct: 64 VRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV--GTPF---WMAPEVIQNS 186
IHRD++AANIL++E K+ADFG L R I + G F W APE I N
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFG----LARLIEDNEYTAREGAKFPIKWTAPEAI-NY 177
Query: 187 EGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL------FIIPR-ENPPQLDEHFSR 238
+ K+D+WS GI + E+ G P + V+ + +PR +N P+ E +
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPE--ELYEL 235
Query: 239 LMKEFVSLCLKKVPAERPS 257
+ C K+ P ERP+
Sbjct: 236 MRL-----CWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-19
Identities = 76/316 (24%), Positives = 135/316 (42%), Gaps = 65/316 (20%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRS 70
S F ++ +G G+FG+V A + A+K + ++ +++ ++ E +L++ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
++ Y S+ + L+ +M+Y+ GG + L+ E + +L A+E +H
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSA------------------------------- 159
G IHRDIK NIL+ +G +K+ DFG+
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 160 ----------QLTRTISRR------KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVI 203
L R +R+ + VGTP ++APEV+ + GY + D WS+G+ +
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILY 239
Query: 204 EMAKGEPPLADLHPMRVLFIIPREN-----PPQLDEHFSRLMKEFVSLCLK--KVPAER- 255
EM G+PP P+ + PPQ ++L E L +K + P +R
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ-----AKLSPEASDLIIKLCRGPEDRL 294
Query: 256 --PSAKELLRHRFIRN 269
A E+ H F +
Sbjct: 295 GKNGADEIKAHPFFKT 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 21 IGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQ----KEISVLSQCRSPYIT 74
IGRG++G VYKA K K+ AIK + +++ I +EI++L + + +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF--KGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 75 EYYGSYLHQT--KLWIIMEYMAGGSVADLIQ--------SGPPLDEMSIACILRDLLHAI 124
+L ++++ +Y + DL Q + + +L +L+ +
Sbjct: 66 SLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 125 EYLHNEGKIHRDIKAANILLT----ENGDVKVADFGVSAQLTRTI-SRRKTF------VG 173
YLH+ +HRD+K ANIL+ E G VK+ D G L R + K V
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG----LARLFNAPLKPLADLDPVVV 177
Query: 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPP 211
T ++ APE++ + Y + DIW++G E+ EP
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPY 72
++ +E IG G++G VYKA D+ N+ +A+K I LE+ ++ + +EIS+L + +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADL-----IQSGPPL--DEMSIACILRDLLHAIE 125
I + +L+++ EY+ DL + S P + I L +L I
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 126 YLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQL---TRTISRRKTFVGTPFWMAPE 181
Y H+ +HRD+K N+L+ +K+ADFG++ RT + V T ++ APE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE---VVTLWYRAPE 173
Query: 182 VIQNSEGYNEKADIWSLGITVIEMAKGEP 210
++ S Y+ DIWS+G EM +P
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 74/274 (27%), Positives = 132/274 (48%), Gaps = 40/274 (14%)
Query: 21 IGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVLSQC-RSPY 72
+G G FG V +A ++K VA+K++ ++ ++ D+ E+ ++ +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-PPLDEMS----------------IAC 115
I G + L++I+EY A G++ + +++ PP + + ++C
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-T 174
+ + +EYL + IHRD+ A N+L+TE+ +K+ADFG++ + +KT G
Sbjct: 140 AYQ-VARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198
Query: 175 PF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPREN---- 228
P WMAPE + + Y ++D+WS GI + E+ G P + P+ LF + RE
Sbjct: 199 PVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELFKLLREGHRMD 256
Query: 229 -PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
P LM+E C VP +RP+ K+L
Sbjct: 257 KPSNCTHELYMLMRE----CWHAVPTQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 72/268 (26%), Positives = 122/268 (45%), Gaps = 16/268 (5%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQCRSP 71
F ++G+G FG+V + K A K ++ +++ + E + E +L + S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQ 60
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHN 129
++ +Y + L +++ M GG + I P +E ++L +E LH
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
E ++RD+K NILL + G ++++D G++ ++ S R VGT +MAPEV+ N + Y
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR-VGTVGYMAPEVLNN-QRY 178
Query: 190 NEKADIWSLGITVIEMAKGEPPL-ADLHPMRVLFIIPR--ENPPQLDEHFSRLMKEFVSL 246
D W LG + EM +G+ P ++ + R E FS K +
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238
Query: 247 CLKKVPAER-----PSAKELLRHRFIRN 269
L K P +R A E+ RH F RN
Sbjct: 239 LLTKDPKQRLGCQEEGAGEVKRHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 32/222 (14%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSP 71
R+ +L+ IG G+ G V A+D ++VAIK + ++ + +E+ ++
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 72 YITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
I + Q L +++ME M ++ +IQ LD ++ +L +L I+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQM--DLDHERMSYLLYQMLCGIK 132
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP-----FWMAP 180
+LH+ G IHRD+K +NI++ + +K+ DFG L RT +F+ TP ++ AP
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAG--TSFMMTPYVVTRYYRAP 186
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF 222
EVI GY E DIWS+G + EM +G VLF
Sbjct: 187 EVILGM-GYKENVDIWSVGCIMGEMIRG----------TVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 5e-19
Identities = 48/146 (32%), Positives = 81/146 (55%), Gaps = 2/146 (1%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F ++ I RG+FG VY K +K A+KV+ + +++ + +Q E L+ +SP+
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I Y S ++++MEY+ GG V L+ DE + ++ A++YLH G
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125
Query: 133 IHRDIKAANILLTENGDVKVADFGVS 158
IHRD+K N+L++ G +K+ DFG+S
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 6e-19
Identities = 75/286 (26%), Positives = 142/286 (49%), Gaps = 38/286 (13%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKE 61
E + +R + + +G G FG V A ++KD VA+K++ + ++ ++ D+ E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 62 ISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACIL- 117
+ ++ + I G+ L++++EY + G++ + +++ P +D C L
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127
Query: 118 ------RDLL-------HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164
+DL+ +EYL ++ IHRD+ A N+L+TE+ +K+ADFG++ +
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187
Query: 165 ISRRKTFVGT-PF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVL 221
+KT G P WMAPE + + Y ++D+WS G+ + E+ G P + P+ L
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEEL 245
Query: 222 FIIPRE-----NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
F + +E P +M+E C VP++RP+ K+L+
Sbjct: 246 FKLLKEGHRMDKPANCTHELYMIMRE----CWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 78/284 (27%), Positives = 125/284 (44%), Gaps = 46/284 (16%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK---------EISVL 65
F ++G+G FG+V + K A K + E + I+K E +L
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL-------EKKRIKKRKGEAMALNEKQIL 54
Query: 66 SQCRSPYITEYYGSYLHQTK--LWIIMEYMAGGSVA-DLIQSGPP-LDEMSIACILRDLL 121
+ S ++ +Y ++TK L +++ M GG + + G P DE ++
Sbjct: 55 EKVNSRFVVSL--AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEIT 112
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMA 179
+E LH E ++RD+K NILL + G ++++D G++ ++ TI R VGT +MA
Sbjct: 113 CGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGTVGYMA 169
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP--------MRVLFIIPRENPPQ 231
PEV++N E Y D W LG + EM +G+ P RV +E+ +
Sbjct: 170 PEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV-----KEDQEE 223
Query: 232 LDEHFSRLMKEFVSLCLKKVPAER-----PSAKELLRHRFIRNA 270
E FS + L K P R A+E+ H F R A
Sbjct: 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 72/296 (24%), Positives = 127/296 (42%), Gaps = 34/296 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ LE +G GS+ VYK K K VA+KVI L+E E +E S+L + I
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+ + L ++ EY+ + + L ++ L LL + Y+H +H
Sbjct: 67 LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILH 126
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K N+L+++ G++K+ADFG++ + V T ++ P+V+ S Y+ D
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLD 186
Query: 195 IWSLGITVIEMAKGE---PPLADLHPM--RVLFI--------------IPRENPPQLDEH 235
+W +G +EM +G P + D+ R+ + +P P + +
Sbjct: 187 MWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLY 246
Query: 236 FSRLMKE-------------FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
+ +++ S L+ P R SA+ L H + + PRL E
Sbjct: 247 SPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL--PPRLWE 300
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 67/231 (29%), Positives = 116/231 (50%), Gaps = 21/231 (9%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED------EI--------ED 57
GSR+ L +G GS G V+ A D + +K VA+K I L + + EI ++
Sbjct: 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 58 IQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACIL 117
I K VL S +TE GS ++I+ EYM +A++++ G PL E +
Sbjct: 64 IVKVYEVLGPSGSD-LTEDVGSLTELNSVYIVQEYME-TDLANVLEQG-PLSEEHARLFM 120
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTF---VG 173
LL ++Y+H+ +HRD+K AN+ + TE+ +K+ DFG++ + S + +
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII 224
T ++ +P ++ + Y + D+W+ G EM G+P A H + + +I
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 70/273 (25%), Positives = 122/273 (44%), Gaps = 33/273 (12%)
Query: 21 IGRGSFGDVYKAFDKELN-----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+G G FG V KA L VA+K++ S E+ D+ E ++L Q P++ +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQ-----------SGPPLDEMSI------ACILR 118
YG+ L +I+EY GS+ ++ S + + A +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 119 DLL-------HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171
DL+ ++YL +HRD+ A N+L+ E +K++DFG+S + S K
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 172 VG-TPF-WMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228
G P WMA E + + Y ++D+WS G+ + E+ G P + P R+ ++
Sbjct: 188 KGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY 246
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
+ E+ S M + C K+ P +RP+ ++
Sbjct: 247 RMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 73/281 (25%), Positives = 122/281 (43%), Gaps = 47/281 (16%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
IG+G+FG V++A L VA+K++ E S D D Q+E +++++ P I +
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLI----------------------QSGPPLDEMSI 113
G + ++ EYMA G + + + + PL
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 114 ACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
CI + + + YL +HRD+ N L+ EN VK+ADFG L+R I +
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG----LSRNIYSADYYKA 188
Query: 174 T-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPR 226
+ P WM PE I + Y ++D+W+ G+ + E+ + G P + V++ +
Sbjct: 189 SENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD 247
Query: 227 EN----PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
N P LM+ LC K+P++RPS + R
Sbjct: 248 GNVLSCPDNCPLELYNLMR----LCWSKLPSDRPSFASINR 284
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 77/262 (29%), Positives = 118/262 (45%), Gaps = 17/262 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCR 69
S ++IG G FG+V K K VAIK + +E + D E S++ Q
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSV-ADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
P I G + I+ EYM GS+ A L + + + +LR + ++YL
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQN 185
+ G +HRD+ A NIL+ N KV+DFG+S L T G W APE I
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 186 SEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR--ENPPQLD--EHFSRLM 240
+ + +D+WS GI + E M+ GE P ++ V+ I P +D +LM
Sbjct: 184 RK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLM 242
Query: 241 KEFVSLCLKKVPAERPSAKELL 262
+ C +K ERP ++++
Sbjct: 243 LD----CWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 51/281 (18%)
Query: 18 LELIGRGSFGDVYKAF--------DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR 69
+G G+FG V+ DKEL VA+K + S D +D ++E +L+ +
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKEL---VAVKTLKETASNDARKDFEREAELLTNFQ 66
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP----LDEMSIAC---ILRDLLH 122
I ++YG ++ EYM G + ++S P L L LL
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 123 -------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-- 173
+ YL ++ +HRD+ N L+ + VK+ DFG+S + T R VG
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR---VGGH 183
Query: 174 --TPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFII----- 224
P WM PE I + + ++D+WS G+ + E+ G+ P L V+ I
Sbjct: 184 TMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242
Query: 225 ---PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
PR P ++ +M C K+ P +R + K++
Sbjct: 243 LQRPRTCPSEV----YDIMLG----CWKRDPQQRINIKDIH 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 70/274 (25%), Positives = 124/274 (45%), Gaps = 23/274 (8%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEIS 63
E A + + +G+GSFG VY+ K + KD VAIK ++ S E + E S
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 64 VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLI------------QSGPPLDEM 111
V+ + ++ G +IME M G + + Q+ P L +M
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 112 SIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171
+ ++ + YL+ +HRD+ A N ++ E+ VK+ DFG++ + T RK
Sbjct: 122 --IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 172 VG-TPF-WMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228
G P WM+PE +++ + +D+WS G+ + E+A E P + +VL +
Sbjct: 180 KGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
++ ++ E + +C + P RPS E++
Sbjct: 239 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 78/291 (26%), Positives = 142/291 (48%), Gaps = 39/291 (13%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLE----ESEDEIEDIQKEISVLSQCRSPYITEY 76
+G+G FG+V K K A K +D + +S +++ ++KEI L + SP+I
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLI----QSGPPLDEM-----SIACILRDLLHAIEYL 127
++ +T L ++M M GG + I + G ++ + I C I +L
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITC-------GILHL 111
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMAPEVIQN 185
H+ ++RD+K N+LL + G+ +++D G++ +L +TI++R GT +MAPE+++
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGTNGYMAPEILK- 167
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV----LFIIPRENPPQLD-EHFSRLM 240
E Y+ D +++G ++ EM G P D H +V L E+ + + ++F+
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTPFKD-HKEKVAKEELKRRTLEDEVKFEHQNFTEES 226
Query: 241 KEFVSLCLKKVPAERPSAKEL----LRHRFIRNARKSPRLLERIRERPKYP 287
K+ L L K P +R ++E +H F + PRL + P P
Sbjct: 227 KDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI-NFPRLEAGLIPPPFVP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 39/269 (14%)
Query: 19 ELIGRGSFGDVYKA--FDKELNK-DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+IG+G FG VY D + K A+K ++ +E+E KE ++ P +
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 76 YYGSYLHQTKL-WIIMEYMAGGSVADLIQS---GPPLDEMSIACILRDLL-------HAI 124
G L +++ YM G + + I+S P ++DL+ +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP---------TVKDLIGFGLQVAKGM 111
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-------SRRKTFVGTPF- 176
EYL ++ +HRD+ A N +L E+ VKVADFG L R I T P
Sbjct: 112 EYLASKKFVHRDLAARNCMLDESFTVKVADFG----LARDIYDKEYYSVHNHTGAKLPVK 167
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRV-LFIIPRENPPQLDE 234
WMA E +Q ++ + K+D+WS G+ + E M +G PP D+ + ++++ Q E
Sbjct: 168 WMALESLQ-TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ-PE 225
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLR 263
+ + E + C P RP+ EL+
Sbjct: 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 9/211 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
++IG G FG+V++ K + VAIK + +E + +D E S++ Q I
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIH 134
G II EYM G++ ++ + +LR + ++YL + +H
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGYNE 191
RD+ A NIL+ N + KV+DFG+S L T G W APE I + +
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-FTS 189
Query: 192 KADIWSLGITVIE-MAKGEPPLADLHPMRVL 221
+D+WS GI + E M+ GE P D+ V+
Sbjct: 190 ASDVWSFGIVMWEVMSFGERPYWDMSNHEVM 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 49/283 (17%)
Query: 14 RFSSLELIGRGSFGDVYKA-----FDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
RF LE +G G+FG VYK ++ VAIK + ++ ++E ++S
Sbjct: 8 RF--LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---------D 119
+ P I G + ++ EY+A G + + + P ++ D
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 120 LLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV-----SAQLTRTISR 167
LH +EYL + +HRD+ A N L+ E VK++DFG+ SA R S+
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFII-- 224
V WM PE I + + ++DIWS G+ + E+ + G P V+ +I
Sbjct: 186 SLLPVR---WMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241
Query: 225 ------PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
P + P ++ LM E C ++PA RP K++
Sbjct: 242 RQLLPCPEDCPARV----YALMIE----CWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-18
Identities = 83/298 (27%), Positives = 142/298 (47%), Gaps = 43/298 (14%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQ 67
E+ + + ++ IG G FG+V+ K + K I E E + E++V+ +
Sbjct: 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68
Query: 68 CRSPYITEYYGSYLHQT--KLWIIMEYMAGGSVADLIQSG----PPLDEMSIACILRDLL 121
+ I Y +L++ KL+I+ME+ G ++ IQ ++E +I I R LL
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 122 HAIEYLHN-------EGKIHRDIKAANILLTE---------------NGD--VKVADFGV 157
HA+ Y HN E +HRD+K NI L+ NG K+ DFG+
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 158 SAQLTRTISRRKTFVGTPFWMAPEVI-QNSEGYNEKADIWSLGITVIEMAKGEPPLADLH 216
S + S + VGTP++ +PE++ ++ Y++K+D+W+LG + E+ G+ P +
Sbjct: 189 SKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247
Query: 217 PMRVLFIIPRENPPQL-----DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269
L I + P L + + L+K ++L K ERPSA + L ++ I+N
Sbjct: 248 NFSQL-ISELKRGPDLPIKGKSKELNILIKNLLNLSAK----ERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 67/254 (26%), Positives = 116/254 (45%), Gaps = 17/254 (6%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
EL+G+G+FG+V+K K+ VA+K + ++ E +L Q P I + G
Sbjct: 1 ELLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYLHNEGKIHR 135
+ ++I+ME + GG ++ DE+ +++ D + YL ++ IHR
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGYNEKAD 194
D+ A N L+ EN +K++DFG+S Q I P W APE + N Y+ ++D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEAL-NYGRYSSESD 176
Query: 195 IWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLK 249
+WS GI + E + G P + + + + P + + ++M+ C
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQR----CWD 232
Query: 250 KVPAERPSAKELLR 263
P RP EL +
Sbjct: 233 YKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 80/283 (28%), Positives = 116/283 (40%), Gaps = 31/283 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ L+L+G G FG V+K + VAIK I ++I + +
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYL 127
YI G L ++ + GS+ D + Q LD + + + YL
Sbjct: 67 DHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL 125
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTPF-WMAPEVIQ 184
+HR++ A NILL + V++ADFGV A L ++ + TP WMA E I
Sbjct: 126 EEHRMVHRNLAARNILLKSDSIVQIADFGV-ADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 185 NSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243
Y ++D+WS G+TV E M+ G P A + P V P L E RL +
Sbjct: 185 FGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---------PDLLEKGERLAQPQ 234
Query: 244 VSL---------CLKKVPAERPSAKELLRHRFIRNARKSPRLL 277
+ C RP+ KE L + F R AR PR L
Sbjct: 235 ICTIDVYMVMVKCWMIDENVRPTFKE-LANEFTRMARDPPRYL 276
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 66/250 (26%), Positives = 114/250 (45%), Gaps = 26/250 (10%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G FG+V+ + N + V L+ ++ +E +++ + + Y
Sbjct: 14 LGAGQFGEVWMGY---YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ ++II EYMA GS+ D ++S P L + S + + Y+ + I
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEGMAYIERKNYI 125
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV--GTPF---WMAPEVIQNSEG 188
HRD++AAN+L++E+ K+ADFG L R I + G F W APE I N
Sbjct: 126 HRDLRAANVLVSESLMCKIADFG----LARVIEDNEYTAREGAKFPIKWTAPEAI-NFGS 180
Query: 189 YNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247
+ K+D+WS GI + E+ G+ P + V+ + R E+ + + + C
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTC 240
Query: 248 LKKVPAERPS 257
K+ ERP+
Sbjct: 241 WKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 68/249 (27%), Positives = 115/249 (46%), Gaps = 17/249 (6%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G+G FG+V+ N + + L+ E +E V+ + R + + Y +
Sbjct: 14 LGQGCFGEVWMG---TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY-AV 69
Query: 81 LHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
+ + ++I+ EYM+ GS+ D + + G L + + + + Y+ +HRD++
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 129
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGYNEKADIWS 197
AANIL+ EN KVADFG++ + + P W APE + K+D+WS
Sbjct: 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWS 188
Query: 198 LGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLKKVP 252
GI + E+ KG P + VL + R PP+ E LM + C +K P
Sbjct: 189 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ----CWRKEP 244
Query: 253 AERPSAKEL 261
ERP+ + L
Sbjct: 245 EERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 35/210 (16%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIK--------VIDLEESEDEIE-----DIQKEISVLSQ 67
IGRG++G V A + E N+ VAIK ID + + EI+ D + I++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 68 CRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAI 124
P+ + Y I+ E M DL I+S L + L LL +
Sbjct: 73 MPPPHREAFNDVY-------IVYELMD----TDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF----VGTPFWMAP 180
+Y+H+ +HRD+K +N+LL N D+K+ DFG L RT S + F V T ++ AP
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFG----LARTTSEKGDFMTEYVVTRWYRAP 177
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEP 210
E++ N Y D+WS+G E+ +P
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-18
Identities = 74/266 (27%), Positives = 130/266 (48%), Gaps = 30/266 (11%)
Query: 20 LIGRGSFGDVYKAFDKELN---KDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSPYIT 74
++G+G FG V +A K + + VA+K++ D+ S D IE+ +E + + + P +
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVI 64
Query: 75 EYYGSYLH---QTKL---WIIMEYMAGGSV-ADLIQS--GPPLDEMSIACILR---DLLH 122
+ G L + +L +I+ +M G + L+ S G + + ++R D+
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-TRTISRRKTFVGTPF-WMAP 180
+EYL ++ IHRD+ A N +L EN V VADFG+S ++ + R+ P W+A
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184
Query: 181 EVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVL-FIIPRE---NPPQLDEH 235
E + ++ Y +D+W+ G+T+ E M +G+ P A + + ++I PP E
Sbjct: 185 ESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLED 243
Query: 236 FSRLMKEFVSLCLKKVPAERPSAKEL 261
LM + C P RPS + L
Sbjct: 244 VYELMCQ----CWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 9e-18
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 12/202 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R+ +L+ IG G+ G V A+D L ++VAIK + +++ + +E+ ++
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 73 ITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY 126
I + Q L +I+ME M ++ +IQ LD ++ +L +L I++
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKH 141
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
LH+ G IHRD+K +NI++ + +K+ DFG+ A+ T +V T ++ APEVI
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 187 EGYNEKADIWSLGITVIEMAKG 208
GY E DIWS+G + EM KG
Sbjct: 201 -GYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 70/263 (26%), Positives = 116/263 (44%), Gaps = 33/263 (12%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-IT 74
+G G+FG V +A L+K VA+K++ E E + E+ ++S + I
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLH-------AIEYL 127
G+ + +I EY G + + ++ + L DLL + +L
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRR-----KRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV--GTPF----WMAPE 181
++ IHRD+ A N+LLT VK+ DFG L R I +V G WMAPE
Sbjct: 158 ASKNCIHRDLAARNVLLTHGKIVKICDFG----LARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 182 VIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSR 238
I N Y ++D+WS GI + E+ + G P + P+ F + ++ EH
Sbjct: 214 SIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGM-PVDSKFYKLIKEGYRMAQPEHAPA 271
Query: 239 LMKEFVSLCLKKVPAERPSAKEL 261
+ + + C P +RP+ K++
Sbjct: 272 EIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSP 71
R+ L+ +G G++G V A D+ VAIK + +SE + +E+ +L +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 72 YITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
+ + L +++M +M G+ + L E I ++ +L ++
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
Y+H G IHRD+K N+ + E+ ++K+ DFG++ Q T S +V T ++ APEVI N
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ---TDSEMTGYVVTRWYRAPEVILN 189
Query: 186 SEGYNEKADIWSLGITVIEMAKGEP 210
Y + DIWS+G + EM G+P
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 40/278 (14%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDE--IEDIQKEISVLSQ 67
S + +GRG FG+V+ A K + + + V L++++DE + ++E+ + +
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 68 CRSPYITEYYGSYLHQTKLWIIMEYMAGG---------SVADLIQSGPPLDEMSIACILR 118
+ G ++I+EY G D PPL +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 119 DLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF----VGT 174
+ +++L N +HRD+ A N L++ +VKV+ L++ + + +
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS----LSKDVYNSEYYKLRNALI 180
Query: 175 PF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFII-------- 224
P W+APE +Q + ++ K+D+WS G+ + E+ +GE P L VL +
Sbjct: 181 PLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239
Query: 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
E P SRL K C P +RPS EL+
Sbjct: 240 VPEGCP------SRLYKLMTR-CWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 53/196 (27%), Positives = 92/196 (46%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ L+ +G G++ V+K K VA+K I LE E +E+S+L + I
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+ + L ++ EY+ L G + ++ + LL + Y H +H
Sbjct: 67 TLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126
Query: 135 RDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
RD+K N+L+ E G++K+ADFG++ + V T ++ P+V+ S Y+ D
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPID 186
Query: 195 IWSLGITVIEMAKGEP 210
+W +G + EMA G P
Sbjct: 187 MWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 71/256 (27%), Positives = 117/256 (45%), Gaps = 25/256 (9%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQCRSP 71
F ++G+G FG+V + K A K ++ +++ + E + E +L + S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKRILEKVNSR 60
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHN 129
++ +Y + L +++ M GG + I + P DE +L +E L
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMAPEVIQNSE 187
E ++RD+K NILL + G ++++D G++ Q+ T+ R VGT +MAPEVI N E
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR---VGTVGYMAPEVINN-E 176
Query: 188 GYNEKADIWSLGITVIEMAKGEPPLA--------DLHPMRVLFIIPRENPPQLDEHFSRL 239
Y D W LG + EM +G+ P + RV +E+ + E FS
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-----KEDQEEYSEKFSED 231
Query: 240 MKEFVSLCLKKVPAER 255
K + L K P ER
Sbjct: 232 AKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 68/246 (27%), Positives = 113/246 (45%), Gaps = 19/246 (7%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G+G FG+V+ K VAIK L+ E +E ++ + R + Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKT--LKPGTMMPEAFLQEAQIMKKLRHDKLVPLY-AV 69
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ + ++I+ E+M GS+ D ++ G P L +M+ + + Y+ I
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA-----AQIADGMAYIERMNYI 124
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGYNEK 192
HRD++AANIL+ +N K+ADFG++ + + P W APE + K
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIK 183
Query: 193 ADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251
+D+WS GI + E+ KG P + VL + R + + E + LC KK
Sbjct: 184 SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKD 243
Query: 252 PAERPS 257
P ERP+
Sbjct: 244 PDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 1e-17
Identities = 61/201 (30%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R+ +L+ IG G+ G V A+D L+++VAIK + +++ + +E+ ++
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 73 ITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY 126
I + Q L +++ME M ++ +IQ LD ++ +L +L I++
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIKH 134
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
LH+ G IHRD+K +NI++ + +K+ DFG+ A+ T +V T ++ APEVI
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 187 EGYNEKADIWSLGITVIEMAK 207
GY E DIWS+G + EM +
Sbjct: 194 -GYKENVDIWSVGCIMGEMVR 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 53/220 (24%), Positives = 107/220 (48%), Gaps = 35/220 (15%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKD--VAIK--------VIDLEESEDEIEDIQ---- 59
R+ ++ +G+G++G V A + E +++ VAIK I + + E++ ++
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 60 -KEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR 118
K I+ L + + YL++ +ME + +I+SG PL + +
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEE----LMEA----DLHQIIRSGQPLTDAHFQSFIY 112
Query: 119 DLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--------KT 170
+L ++Y+H+ +HRD+K N+L+ + ++K+ DFG L R S
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFG----LARGFSENPGENAGFMTE 168
Query: 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP 210
+V T ++ APE++ + + Y + D+WS+G + E+ +P
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 70/273 (25%), Positives = 127/273 (46%), Gaps = 26/273 (9%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQCRSP 71
F ++G+G FG+V + K A K ++ +++ + E + E +L + S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSR 60
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEYL 127
++ +Y + L +++ M GG + I ++G +E ++ +E L
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDL 118
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMAPEVIQN 185
H E ++RD+K NILL ++G ++++D G++ + +TI R VGT +MAPEV++N
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKN 175
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLAD----LHPMRVLFIIPRENPPQLDEHFSRLMK 241
E Y D W+LG + EM G+ P + V ++ +E + E FS +
Sbjct: 176 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDAR 233
Query: 242 EFVSLCLKKVPAER-----PSAKELLRHRFIRN 269
+ L K P ER A+E+ H +
Sbjct: 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 74/280 (26%), Positives = 133/280 (47%), Gaps = 26/280 (9%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+G G+FG V+ A L + VA+K + + S++ +D +E +L+ + +I +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVK 71
Query: 76 YYGSYLHQTKLWIIMEYM----------AGGSVADLIQSGPPLDEMSIACIL---RDLLH 122
+YG + L ++ EYM A G A L+ G E++ + +L + +
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPF-WMAP 180
+ YL ++ +HRD+ N L+ EN VK+ DFG+S + T R P WM P
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 191
Query: 181 EVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL 239
E I + + ++D+WSLG+ + E+ G+ P L V+ I + Q +
Sbjct: 192 ESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKE 250
Query: 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRN-ARKSPRLLE 278
+ + + C ++ P R + KE+ H ++N A+ SP L+
Sbjct: 251 VYDLMLGCWQREPHMRLNIKEI--HSLLQNLAKASPVYLD 288
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI-DLEESEDEIEDIQKEISVLSQCRSPY 72
R+ E+IG+GS+G V A D + VAIK I D+ E + I +EI +L R P
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 73 ITEYYGSYLHQTK-----LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
I E L ++ ++++ E M + +I++ L L LL A++Y+
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFG---VSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
H HRD+K NIL + +K+ DFG V+ T T +V T ++ APE+
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 185 NSEG-YNEKADIWSLGITVIEMAKGEP 210
+ Y DIWS+G E+ G+P
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 20/211 (9%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIE-DIQKEISVLSQCRS-- 70
++ + IG G++G VYKA D VA+K + ++ +ED + +E+++L + +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 71 -PYITEYYGSYL-----HQTKLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHA 123
P I +TK+ ++ E++ L + PP L +I ++R L
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGV----SAQLTRTISRRKTFVGTPFWMA 179
+++LH +HRD+K NIL+T G VK+ADFG+ S Q+ T V T ++ A
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT-----PVVVTLWYRA 175
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEMAKGEP 210
PEV+ S Y D+WS+G EM + +P
Sbjct: 176 PEVLLQST-YATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 75/283 (26%), Positives = 132/283 (46%), Gaps = 39/283 (13%)
Query: 21 IGRGSFGDVYKAFD-KELNKDVAIKVIDLEESEDEIE-DIQKEISVLSQCRS---PYITE 75
IG G++G V+KA D K + VA+K + ++ E+ + +E++VL + P +
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 76 YY-----GSYLHQTKLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHN 129
+ +TKL ++ E++ L + P + +I ++ LL +++LH+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRD+K NIL+T +G +K+ADFG+ A++ + V T ++ APEV+ S Y
Sbjct: 129 HRVVHRDLKPQNILVTSSGQIKLADFGL-ARIYSFQMALTSVVVTLWYRAPEVLLQSS-Y 186
Query: 190 NEKADIWSLGITVIEMAKGEPPL---ADLHPMRVLFII---------PRE---------- 227
D+WS+G EM + +P +D+ + + + PR+
Sbjct: 187 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 246
Query: 228 NPPQLDEHF----SRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
Q E F L K+ + CL PA+R SA L H +
Sbjct: 247 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 9e-17
Identities = 76/269 (28%), Positives = 123/269 (45%), Gaps = 46/269 (17%)
Query: 17 SLELI---GRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
SL+LI G G FG+V+ N + + V L+ E +E ++ + R +
Sbjct: 7 SLQLIKKLGNGQFGEVWMG---TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEY 126
+ Y + + + ++I+ EYM+ GS+ D ++ G P L +M+ + + Y
Sbjct: 64 VQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA-----QVAAGMAY 117
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV--GTPF---WMAPE 181
+ IHRD+++ANIL+ + K+ADFG L R I + G F W APE
Sbjct: 118 IERMNYIHRDLRSANILVGDGLVCKIADFG----LARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 182 VIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFII--------PRENPPQL 232
+ K+D+WS GI + E+ KG P ++ VL + P++ P L
Sbjct: 174 AALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISL 232
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
E LM + C KK P ERP+ + L
Sbjct: 233 HE----LMLQ----CWKKDPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R+ L+ IG G+ G V AFD L +VA+K + +++ + +E+ +L
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 73 ITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIE 125
I + Q L +++ME M A+L Q LD ++ +L +L I+
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIK 137
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
+LH+ G IHRD+K +NI++ + +K+ DFG+ A+ T +V T ++ APEVI
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTACTNFMMTPYVVTRYYRAPEVILG 196
Query: 186 SEGYNEKADIWSLGITVIEMAKG 208
GY E DIWS+G + E+ KG
Sbjct: 197 M-GYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 52/203 (25%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R+ +L +G G++G V A+D L + VA+K + +S +E+ +L +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 73 ITEYYGSYLHQTKL------WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY 126
+ + T + +++ M G + ++++ DE + ++ LL ++Y
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDE-HVQFLIYQLLRGLKY 133
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
+H+ G IHRD+K +N+ + E+ ++++ DFG++ Q ++ +V T ++ APE++ N
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT---GYVATRWYRAPEIMLNW 190
Query: 187 EGYNEKADIWSLGITVIEMAKGE 209
YN+ DIWS+G + E+ KG+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 25/201 (12%)
Query: 21 IGRGSFGDV----YKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEY 76
+G G FG V Y + + VA+K + E + +KEI++L I +Y
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 77 YGSYLHQTK--LWIIMEYMAGGSVADLIQSGPPLDEMSIACIL---RDLLHAIEYLHNEG 131
G Q L +IMEY+ GS+ D + P ++++A +L + + + YLH++
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS------RRKTFVGTP-FWMAPEVIQ 184
IHRD+ A N+LL + VK+ DFG L + + R + +P FW A E ++
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFG----LAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 185 NSEGYNEKADIWSLGITVIEM 205
++ ++ +D+WS G+T+ E+
Sbjct: 184 ENK-FSYASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 69/276 (25%), Positives = 126/276 (45%), Gaps = 41/276 (14%)
Query: 18 LELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+E +G +FG +YK + + VAIK + + + + Q+E S++++ P I
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLD-------EMSIACILR--DLLH- 122
G + + ++ EY+ G + + LI P D + ++ L D LH
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 123 ------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-TRTISRRKTFVGTP 175
+EYL + +H+D+ A NIL+ E VK++D G+S ++ + R + P
Sbjct: 130 AIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 176 F-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPP--------LADLHPMRVLFIIP 225
WM PE I + ++ +DIWS G+ + E+ + G P + ++ R L
Sbjct: 190 IRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCS 248
Query: 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
+ PP++ LM E C ++ P+ RP K++
Sbjct: 249 EDCPPRM----YSLMTE----CWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 59/263 (22%), Positives = 118/263 (44%), Gaps = 29/263 (11%)
Query: 21 IGRGSFGDVYKAF-----DKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G+G+F ++YK D ++ ++V++ + L + + S++SQ +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACIL---RDLLHAIEYLHN 129
+ + YG + + ++ EY+ G + + + +S+ L + L A+ YL +
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLED 119
Query: 130 EGKIHRDIKAANILLTENG-------DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
+ +H ++ NIL+ G +K++D G+ T+ R+ V W+APE
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP----ITVLSREERVERIPWIAPEC 175
Query: 183 IQN-SEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240
I+N AD WS G T++E+ + GE PL+ L ++ +L +
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH--RLPMPDCAEL 233
Query: 241 KEFVSLCLKKVPAERPSAKELLR 263
++ C P +RPS + +LR
Sbjct: 234 ANLINQCWTYDPTKRPSFRAILR 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-16
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 21 IGRGSFGDV----YKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEY 76
+G G FG V Y + VA+K + E + I D++KEI +L I +Y
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 77 YGSYLHQ--TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYLHNEG 131
G + +IME++ GS+ + + +++++ L+ + ++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF------VGTP-FWMAPEVIQ 184
+HRD+ A N+L+ VK+ DFG LT+ I K + + +P FW APE +
Sbjct: 130 YVHRDLAARNVLVESEHQVKIGDFG----LTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 185 NSEGYNEKADIWSLGITVIEM 205
S+ Y +D+WS G+T+ E+
Sbjct: 186 QSKFY-IASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 73/279 (26%), Positives = 127/279 (45%), Gaps = 33/279 (11%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEIS 63
E + + + L +G+GSFG VY+ +++ K VA+K ++ S E + E S
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 64 VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS------------GPPLDEM 111
V+ ++ G ++ME MA G + ++S P L EM
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 112 -SIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170
+A + D + YL+ + +HRD+ A N ++ + VK+ DFG++ + T RK
Sbjct: 122 IQMAAEIAD---GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 171 FVG-TPF-WMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL-FIIP- 225
G P WMAPE +++ + +D+WS G+ + E+ E P L +VL F++
Sbjct: 179 GKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237
Query: 226 --RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
+ P E + LM +C + P RP+ E++
Sbjct: 238 GYLDQPDNCPERVTDLM----RMCWQFNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 63/288 (21%), Positives = 112/288 (38%), Gaps = 61/288 (21%)
Query: 13 SRFSSLELIGRGSFGDVYKA------FDKELNKDVAIKVIDLEESEDEIEDIQKEISVLS 66
R + +L+ G+FG ++ KE ++V +K + SE ++ + +E +L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKE--EEVFVKTVKDHASEIQVTLLLQESCLLY 63
Query: 67 QCRSPYI-------TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMS-IACILR 118
I E +++ YM G++ +Q + + A +
Sbjct: 64 GLSHQNILPILHVCIEDGE------PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 119 DLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL---------- 161
L+H + YLH G IH+DI A N ++ E VK+ D +S L
Sbjct: 118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 162 --TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPM 218
R + WMA E + N E Y+ +D+WS G+ + E+ G+ P ++ P
Sbjct: 178 NENRPVK----------WMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPF 226
Query: 219 RVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
+ + P + +M + C P ERPS +L+
Sbjct: 227 EMAAYLKDGYRLAQPINCPDELFAVM----ACCWALDPEERPSFSQLV 270
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 13/190 (6%)
Query: 24 GSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH 82
G FG V K K K+I + + E + L + +I YY
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPM-----VHQLMKDNPNFIKLYYSVTTL 81
Query: 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANI 142
+ + I M+Y+ G + DL++ L E + I+R L+ A+ LH IH DIK N+
Sbjct: 82 KGHVLI-MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV 140
Query: 143 LLTENGD-VKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGIT 201
L D + + D+G L + I + GT + +PE I Y+ D W++G+
Sbjct: 141 LYDRAKDRIYLCDYG----LCKIIGTPSCYDGTLDYFSPEKI-KGHNYDVSFDWWAVGVL 195
Query: 202 VIEMAKGEPP 211
E+ G+ P
Sbjct: 196 TYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-15
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 32/223 (14%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSP 71
R+ + LIG+G G+VY A+D ++ VA+K I DL E+ + +E + + P
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-------GPPLDE-MSIACILR---DL 120
I Y ++ M Y+ G ++ L++S L E S+ L +
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFG--------------VSAQLTRTIS 166
IEY+H++G +HRD+K NILL G+V + D+G +
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 167 RRKT----FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM 205
T VGTP +MAPE + +E DI++LG+ + +M
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQM 224
|
Length = 932 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-15
Identities = 47/183 (25%), Positives = 89/183 (48%), Gaps = 14/183 (7%)
Query: 41 VAIKV--IDLEESEDEIEDIQKEISVLSQCRSPYITEYYGS-YLHQTKLWIIMEYMAGGS 97
VAIK+ D E E + ++E ++ ++ P I S L+ + EY+ G +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 98 VADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD---VKVAD 154
+ +++ + L ++ +L A+ HN+G +HRD+K NI++++ G KV D
Sbjct: 66 LREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLD 125
Query: 155 FGVSAQLT-------RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK 207
FG+ L T++R +GTP + APE ++ E +D+++ G+ +E
Sbjct: 126 FGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG-EPVTPNSDLYAWGLIFLECLT 184
Query: 208 GEP 210
G+
Sbjct: 185 GQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 53/211 (25%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIK--------VIDLEESEDEI--------ED 57
R+ +L +G G++G V AFD + VA+K +I + + E+ E+
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 58 IQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACIL 117
+ + V + RS + E+ YL + ++ G + ++++ D+ + ++
Sbjct: 78 VIGLLDVFTPARS--LEEFNDVYL--------VTHLMGADLNNIVKCQKLTDD-HVQFLI 126
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFW 177
+L ++Y+H+ IHRD+K +N+ + E+ ++K+ DFG++ T +V T ++
Sbjct: 127 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVATRWY 183
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEMAKG 208
APE++ N YN+ DIWS+G + E+ G
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-15
Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 31/236 (13%)
Query: 36 ELNKDVAIKVIDLEESEDEIE--DIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93
+++KD + + +++ + ++ DI+ S Y + Y YL
Sbjct: 180 DMSKDESADYVPMQDMKGTVKYADIES---------SNYESPY-DQYLPSAP-------- 221
Query: 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153
LI P L M + + + +E+L ++ +HRD+ A N+L+ E VK+
Sbjct: 222 ERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKIC 281
Query: 154 DFGVSAQLTRT---ISRRKTFVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKG 208
DFG++ + R IS+ TF+ P WMAPE I N+ Y +D+WS GI + E+ G
Sbjct: 282 DFGLARDIMRDSNYISKGSTFL--PLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLG 338
Query: 209 EPPLADLHPMRVLFIIPRENPPQLDE--HFSRLMKEFVSLCLKKVPAERPSAKELL 262
P +L PM F + ++ + H S + E + C ++ RP +L+
Sbjct: 339 GTPYPEL-PMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 21 IGRGSFGDVYKAF--DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+GRG++G VYKA D + ++D A+K I E +EI++L + + P +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI---EGTGISMSACREIALLRELKHPNVISLQK 65
Query: 79 SYLHQT--KLWIIMEYMAGGSVADLIQ-------SGPP--LDEMSIACILRDLLHAIEYL 127
+L K+W++ +Y A + +I+ + P L + +L +L I YL
Sbjct: 66 VFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 128 HNEGKIHRDIKAANILLT----ENGDVKVADFGVSAQLT---RTISRRKTFVGTPFWMAP 180
H +HRD+K ANIL+ E G VK+AD G + + ++ V T ++ AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEP 210
E++ + Y + DIW++G E+ EP
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 69/275 (25%), Positives = 128/275 (46%), Gaps = 40/275 (14%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD------VAIKVIDLE-ESEDEIEDIQKEISVLSQCRSP 71
+++G G FG V + +L++D VA+K + L+ + EIE+ E + + P
Sbjct: 5 KILGEGEFGSVMEG---QLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 72 YITEYYGSYLHQTKL------WIIMEYMAGGSV-----ADLIQSGPPLDEMSIACILR-- 118
+ + G + L +I+ +M G + + P +++ + +L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP--EKLPLQTLLKFM 119
Query: 119 -DLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT-PF 176
D+ +EYL N IHRD+ A N +L E+ V VADFG+S ++ R+ + P
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 177 -WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRV---LFIIPRENPPQ 231
W+A E + + Y K+D+W+ G+T+ E+A +G+ P + + L R P+
Sbjct: 180 KWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238
Query: 232 --LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
LDE + + + C + P +RP+ +L
Sbjct: 239 DCLDELY-----DLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 71/268 (26%), Positives = 119/268 (44%), Gaps = 33/268 (12%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYIT 74
+G G FG V + +LN+D VA+K + + + E+ED E + + P +
Sbjct: 7 LGEGEFGSV---MEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 75 EYYGSYLHQTKLW------IIMEYMAGGSV------ADLIQSGPPLDEMSIACILRDLLH 122
G L + +I+ +M G + + L L + + D+
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR-TISRRKTFVGTPF-WMAP 180
+EYL ++ IHRD+ A N +L EN +V VADFG+S ++ R+ P W+A
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPREN----PPQLDEH 235
E + + Y K+D+WS G+T+ E+A +G+ P + + + + N PP +
Sbjct: 184 ESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDG 242
Query: 236 FSRLMKEFVSLCLKKVPAERPSAKELLR 263
LM S C P +RPS + L
Sbjct: 243 LYSLM----SSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 76/303 (25%), Positives = 129/303 (42%), Gaps = 67/303 (22%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCR---------- 69
IG G+FG V+ D K VA+K + ++ ++ + + +E+ +L +
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 70 --SPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAI 124
P+I + +++++ E M +DL I S PL + L +L +
Sbjct: 68 LQPPHIDPF-------EEIYVVTELMQ----SDLHKIIVSPQPLSSDHVKVFLYQILRGL 116
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF-VGTPFWMAPEVI 183
+YLH+ G +HRDIK N+L+ N +K+ DFG++ S+ T V T ++ APE++
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 184 QNSEGYNEKADIWSLG------------------ITVIEMAK---GEPPLADL------- 215
S Y DIWS+G I +++ G P L +
Sbjct: 177 MGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA 236
Query: 216 --HPMRVLFIIPRENP--PQLDEHFSRLMKEFVSLCLKKV---PAERPSAKELLRHRFIR 268
H +R P + P P L S+ E V L + + P +R SA + L H ++
Sbjct: 237 RAHILRG----PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292
Query: 269 NAR 271
R
Sbjct: 293 EGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 78/286 (27%), Positives = 121/286 (42%), Gaps = 37/286 (12%)
Query: 13 SRFSSLELIGRGSFGDVYKAF---DKE-LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ ++++G G+FG VYK D E + VAIKV+ S ++I E V++
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIE 125
SPY+ G L T + ++ + M G + D ++ D + +L + +
Sbjct: 67 GSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMS 123
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-TPF-WMAPEVI 183
YL +HRD+ A N+L+ VK+ DFG++ L + G P WMA E I
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 184 QNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
+ + ++D+WS G+TV E M G P IP P L E RL +
Sbjct: 184 LHRR-FTHQSDVWSYGVTVWELMTFGAKPYDG---------IPAREIPDLLEKGERLPQP 233
Query: 243 FVSLCLKKV-----------PAERPSAKELLRHRFIRNARKSPRLL 277
+C V RP +EL+ F R AR R +
Sbjct: 234 --PICTIDVYMIMVKCWMIDSECRPRFRELV-DEFSRMARDPSRFV 276
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 21 IGRGSFGDVYKAF--DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+GRG++G VYKA D + K+ A+K I E +EI++L + + P +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI---EGTGISMSACREIALLRELKHPNVIALQK 65
Query: 79 SYLHQT--KLWIIMEYMAGGSVADLIQ-------SGPP--LDEMSIACILRDLLHAIEYL 127
+L + K+W++ +Y A + +I+ + P L + +L +L I YL
Sbjct: 66 VFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 128 HNEGKIHRDIKAANILLT----ENGDVKVADFGVSAQLT---RTISRRKTFVGTPFWMAP 180
H +HRD+K ANIL+ E G VK+AD G + + ++ V T ++ AP
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEP 210
E++ + Y + DIW++G E+ EP
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 71/274 (25%), Positives = 119/274 (43%), Gaps = 45/274 (16%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+G G+FG V+ A L + VA+K + E SE +D Q+E +L+ + +I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHIVR 71
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP----LDEMSIACI----LRDLLH----- 122
+YG L ++ EYM G + ++S P L L +L
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 123 --AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR---KTFVGTPF- 176
+ YL + +HRD+ N L+ + VK+ DFG+S + T R +T + P
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML--PIR 189
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFII--------PRE 227
WM PE I + + ++DIWS G+ + E+ G+ P L + I PR
Sbjct: 190 WMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRT 248
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
PP++ +M+ C ++ P +R K++
Sbjct: 249 CPPEVYA----IMQG----CWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 62/253 (24%), Positives = 105/253 (41%), Gaps = 25/253 (9%)
Query: 20 LIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEY 76
++G G FG++ + K +K VAI + S+ + E L Q I
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHR 135
G + I+ EYM+ G++ ++ L + +L L ++YL G +H+
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHK 131
Query: 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP--FWMAPEVIQNSEGYNEKA 193
+ A +L+ + K++ F Q ++ + T G W APE IQ ++ +
Sbjct: 132 GLAAHKVLVNSDLVCKISGFR-RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH-FSSAS 189
Query: 194 DIWSLGITVIE-MAKGEPPLADLHPMRVLFII--------PRENPPQLDEHFSRLMKEFV 244
D+WS GI + E M+ GE P D+ V+ + PR P +LM +
Sbjct: 190 DVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPN----LLHQLMLD-- 243
Query: 245 SLCLKKVPAERPS 257
C +K ERP
Sbjct: 244 --CWQKERGERPR 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISV 64
AG+++A FS LE G+ G + D + + V IK + E +
Sbjct: 87 AGIEKAG---FSILETFTPGAEGFAFACIDNKTCEHVVIKA-------GQRGGTATEAHI 136
Query: 65 LSQCRSPYITEYYGSYLHQTKLWIIME--------YMAGGSVADLIQSGPPLDEMSIACI 116
L P I + G++ + +I+ Y+A ++ D ++I
Sbjct: 137 LRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAK------RNIAICDILAIE-- 188
Query: 117 LRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA-QLTRTISRRKTFVGTP 175
R +L AI+YLH IHRDIKA NI + GDV + DFG + + ++ + GT
Sbjct: 189 -RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247
Query: 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPL 212
APE++ + Y DIWS GI + EMA L
Sbjct: 248 ATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 67/250 (26%), Positives = 114/250 (45%), Gaps = 27/250 (10%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
+G G FG+V+ A NK + V ++ +E E +V+ + + + + +
Sbjct: 14 LGAGQFGEVWMA---TYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH-AV 69
Query: 81 LHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ + ++II E+MA GS+ D ++S P L + S + + ++ I
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-----QIAEGMAFIEQRNYI 124
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV--GTPF---WMAPEVIQNSEG 188
HRD++AANIL++ + K+ADFG L R I + G F W APE I N
Sbjct: 125 HRDLRAANILVSASLVCKIADFG----LARVIEDNEYTAREGAKFPIKWTAPEAI-NFGS 179
Query: 189 YNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247
+ K+D+WS GI ++E+ G P + V+ + R E+ + + C
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRC 239
Query: 248 LKKVPAERPS 257
K P ERP+
Sbjct: 240 WKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 56/209 (26%), Positives = 80/209 (38%), Gaps = 51/209 (24%)
Query: 107 PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166
PL I + +L + YLH + IHRD+K NI + + V + D G +AQ
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAP 211
Query: 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM------------AKGEPPLAD 214
GT APEV+ + YN KADIWS GI + EM + E +
Sbjct: 212 AFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKS 270
Query: 215 LHP-----MRVLFIIPRENPPQLDEHFSRLMKEFVSL------------CLKKV------ 251
H + L + P E P SRL++ F+ C ++V
Sbjct: 271 CHSHLLKIISTLKVHPEEFPRDPG---SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDG 327
Query: 252 -----------PAERPSAKELLRHRFIRN 269
A RPSA+E+L +
Sbjct: 328 EFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356
|
Length = 357 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 62/262 (23%), Positives = 123/262 (46%), Gaps = 24/262 (9%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
E +G+G+F ++K +E+ V +KV+D + + E + S++SQ
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD-KSHRNYSESFFEAASMMSQLSHK 59
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
++ YG + + ++ EY+ GS+ L ++ ++ + + L A+ +L ++
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 131 GKIHRDIKAANILLTENGD--------VKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
G H ++ A N+LL D +K++D G+S T+ ++ + W+ PE
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPWVPPEC 175
Query: 183 IQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241
I+N + + AD WS G T+ E+ + G+ PL+ L + L E+ QL +
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--EDRHQLPAPKWTELA 233
Query: 242 EFVSLCLKKVPAERPSAKELLR 263
++ C+ P RPS + ++R
Sbjct: 234 NLINQCMDYEPDFRPSFRAIIR 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 40/106 (37%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 104 SGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162
SGP PL++ I R LL A+ YLH G IHRD+K NI L E + + DFG + +L
Sbjct: 179 SGPLPLEQAIT--IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 163 RTISRRKTF--VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA 206
+ + GT +PE++ + Y K DIWS G+ + EM+
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLA-LDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 72/279 (25%), Positives = 120/279 (43%), Gaps = 23/279 (8%)
Query: 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ F ++++G G+FG VYK +++ VAIK + S ++I E V++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIE 125
+P++ G L T + +I + M G + D ++ D + +L + +
Sbjct: 67 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMN 123
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-TPF-WMAPEVI 183
YL +HRD+ A N+L+ VK+ DFG++ L G P WMA E I
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 184 QNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSR 238
+ Y ++D+WS G+TV E M G P + + I+ + PP
Sbjct: 184 LHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 242
Query: 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLL 277
+M + C RP +EL+ F + AR R L
Sbjct: 243 IMVK----CWMIDADSRPKFRELII-EFSKMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 68/270 (25%), Positives = 125/270 (46%), Gaps = 32/270 (11%)
Query: 21 IGRGSFGDVYKA--FDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+G G+FG V+ A ++ KD VA+K + + + +D Q+E +L+ + +I +
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 76 YYGSYLHQTKLWIIMEYM----------AGGSVADLIQSGPPLD---EMSIACILR---D 119
+YG L ++ EYM A G A ++ G P E+ ++ +L
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 120 LLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG----TP 175
+ + YL ++ +HRD+ N L+ N VK+ DFG+S + T R VG P
Sbjct: 132 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR---VGGHTMLP 188
Query: 176 F-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLD 233
WM PE I + + ++D+WS G+ + E+ G+ P L V+ I + +
Sbjct: 189 IRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 247
Query: 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
+ + + + C ++ P +R + KE+ +
Sbjct: 248 RVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 40/276 (14%)
Query: 21 IGRGSFGDVYKAFDKELNK-----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
IG G FG K E ++ V +K + + DE +E+ + P + +
Sbjct: 3 IGNGWFG---KVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQS--------GPPLDEMSIACILRDLLHAIEYL 127
G + +++E+ G + + ++S +AC ++ + +L
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMAC---EVASGLLWL 116
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT---ISRRKTFVGTPF-WMAPEVI 183
H IH D+ N LT + VK+ D+G++ + I++ V P W+APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV--PLRWLAPELV 174
Query: 184 QN------SEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN-----PPQ 231
+ + +K++IWSLG+T+ E+ + P DL +VL + RE PQ
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234
Query: 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
LD +S E + C P RP+A+E+ H +
Sbjct: 235 LDLKYSDRWYEVMQFCWLD-PETRPTAEEV--HELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 38/102 (37%), Positives = 54/102 (52%), Gaps = 3/102 (2%)
Query: 107 PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS--AQLTRT 164
PL + + R LL AI+Y+H EG IHRDIK N+L+ D+ + DFG + A+ + +
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315
Query: 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA 206
GT APEV+ + Y DIWS G+ + E A
Sbjct: 316 TPFHYGIAGTVDTNAPEVLA-GDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 57/295 (19%)
Query: 14 RFSSLELIGRGSFGDVY--------KAFDKELNKD--------VAIKVIDLEESEDEIED 57
R + E +G G FG+V+ K DK+ + D VA+K++ + +++ D
Sbjct: 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 58 IQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSI 113
KEI ++S+ + P I + L +I EYM G + + +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 114 ACILRDLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR--- 163
L+ ++YL + +HRD+ N L+ +N +K+ADFG+S L
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 164 -TISRRKTFVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPLADLHPMR 219
I R P WM+ E I + + +D+W+ G+T+ E+ E P + L +
Sbjct: 186 YRIQGRAVL---PIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241
Query: 220 VL-------------FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
V+ +P+ P + +LM C ++ ERPS +E+
Sbjct: 242 VIENTGEFFRDQGRQVYLPK--PALCPDSLYKLMLS----CWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 75/304 (24%), Positives = 121/304 (39%), Gaps = 67/304 (22%)
Query: 19 ELIGRGSFGDVY----------KAFDKELNKD------VAIKVIDLEESEDEIEDIQKEI 62
E +G G FG+V+ N VA+K++ + +++ D KE+
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 63 SVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS------------GPPLDE 110
+LS+ + P I G + + L +I EYM G + + S P
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 111 MSIACILRDLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-T 162
A LLH ++YL + +HRD+ N L+ EN +K+ADFG+S L
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 163 RTISRRKTFVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPLADLHPMR 219
R + P WMA E I + + +D+W+ G+T+ E+ E P +L +
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249
Query: 220 VLFIIPREN----------------PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
V+ EN PP + LM + C + ERPS ++
Sbjct: 250 VI-----ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQ----CWSRDCRERPSFSDI-- 298
Query: 264 HRFI 267
H F+
Sbjct: 299 HAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 71/273 (26%), Positives = 122/273 (44%), Gaps = 44/273 (16%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY 80
IG G FG K E+N + ++E +Q+++ L + + PY + + +
Sbjct: 3 IGNGWFG---KVILGEVNSGYTPAQVVVKELRVS-ASVQEQMKFLEEAQ-PYRSLQHSNL 57
Query: 81 LH-------QTKLWIIMEYMAGGSVADLIQSGPPLDEMS--------IAC-ILRDLLHAI 124
L T ++ME+ G + ++S + M+ +AC I LLH
Sbjct: 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH-- 115
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT---ISRRKTFVGTPF-WMAP 180
LH IH D+ N LLT + VK+ D+G+S + ++ + +V P W+AP
Sbjct: 116 --LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAP 171
Query: 181 EVIQNSEG------YNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN----- 228
E++ G +++++WSLG+T+ E+ + G P L +VL RE
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP 231
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
P+L S E + C + P +RPSA+E+
Sbjct: 232 KPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 9e-12
Identities = 74/308 (24%), Positives = 132/308 (42%), Gaps = 52/308 (16%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
+IG GSFG VY+A + ++ VAIK + D + E+ ++ L+ ++ +YY
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKN----LNHINIIFLKDYY 128
Query: 78 GSYLHQTK-------LWIIMEYM---AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
Y K L ++ME++ + ++ L + L A+ Y+
Sbjct: 129 --YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 128 HNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
H++ HRD+K N+L+ N +K+ DFG SA+ R +++ + F+ APE++ +
Sbjct: 187 HSKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 187 EGYNEKADIWSLGITVIEMAKGEP------------------------PLADLHPMRVLF 222
Y D+WSLG + EM G P L +++P
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305
Query: 223 IIPRENPPQLDEHFSRLMKE----FVSLCLKKVPAERPSAKELLRHRFIRNAR----KSP 274
P P L + F + + F+S LK P +R + E L F + R K P
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365
Query: 275 RLLERIRE 282
+ ++++ +
Sbjct: 366 KYIDKLPD 373
|
Length = 440 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 19 ELIGRGSFGDVY---------------KAFDKELNKDVAIKVIDLEESEDEIEDIQKEIS 63
E +G G FG+V+ FD + VA+K++ + ++ D KEI
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVL-VAVKMLRADVTKTARNDFLKEIK 69
Query: 64 VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIA----CILR- 118
++S+ ++P I G + L +I EYM G + + + A +
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 119 DLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-TRTISRRKT 170
+LL+ ++YL + +HRD+ N L+ + +K+ADFG+S L + R +
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 171 FVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM 205
P WMA E I + + +D+W+ G+T+ EM
Sbjct: 190 RAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 51/164 (31%), Positives = 74/164 (45%), Gaps = 43/164 (26%)
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-----RKTFVGTPF-W 177
+E+L + IHRD+ A NILL+EN VK+ DFG L R I + RK P W
Sbjct: 186 MEFLASRKCIHRDLAARNILLSENNVVKICDFG----LARDIYKDPDYVRKGDARLPLKW 241
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHF 236
MAPE I + + Y ++D+WS G+ + E+ + G P + Q+DE F
Sbjct: 242 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGV---------------QIDEEF 285
Query: 237 SRLMKEFVSL----------------CLKKVPAERPSAKELLRH 264
R +KE + C P +RP+ EL+
Sbjct: 286 CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 53/181 (29%), Positives = 78/181 (43%), Gaps = 43/181 (23%)
Query: 107 PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166
L + C + +E+L + IHRD+ A NILL+EN VK+ DFG L R I
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG----LARDIY 230
Query: 167 R-----RKTFVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMR 219
+ RK P WMAPE I + Y ++D+WS G+ + E+ + G P +
Sbjct: 231 KDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--- 286
Query: 220 VLFIIPRENPPQLDEHFSRLMKEFVSL----------------CLKKVPAERPSAKELLR 263
+DE F R +KE + C P++RP+ EL+
Sbjct: 287 ------------IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 334
Query: 264 H 264
H
Sbjct: 335 H 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 14/156 (8%)
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-------DVKVADFGVSAQLTRTISRR 168
+ + L A+ YL ++ +H ++ A NILL G +K++D GVS +SR
Sbjct: 122 VAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFT---ALSRE 178
Query: 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRE 227
+ P W+APE + + AD WS G T++E+ GE PL + P ++
Sbjct: 179 ERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKK 237
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
+ +L E + + +S CL P +RPS + +LR
Sbjct: 238 H--RLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 70/285 (24%), Positives = 114/285 (40%), Gaps = 35/285 (12%)
Query: 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ ++++G G+FG VYK + + VAIK+++ + E +++
Sbjct: 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIE 125
P++ G L T + ++ + M G + D + D + +L + +
Sbjct: 67 DHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMM 123
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEV 182
YL +HRD+ A N+L+ VK+ DFG+ A+L + G WMA E
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGL-ARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 183 IQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241
I + + ++D+WS G+T+ E M G P IP P L E RL +
Sbjct: 183 IHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDG---------IPTREIPDLLEKGERLPQ 232
Query: 242 EFVSL---------CLKKVPAERPSAKELLRHRFIRNARKSPRLL 277
+ C RP KEL F R AR R L
Sbjct: 233 PPICTIDVYMVMVKCWMIDADSRPKFKELAA-EFSRMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 45/188 (23%)
Query: 98 VADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157
DL +S PL + C + +E+L + IHRD+ A NILL+EN VK+ DFG
Sbjct: 163 TDDLWKS--PLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG- 219
Query: 158 SAQLTRTISR-----RKTFVGTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEP 210
L R I + RK P WMAPE I + + Y ++D+WS G+ + E+ + G
Sbjct: 220 ---LARDIYKDPDYVRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGAS 275
Query: 211 PLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL----------------CLKKVPAE 254
P + Q++E F + +K+ + C + P E
Sbjct: 276 PYPGV---------------QINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE 320
Query: 255 RPSAKELL 262
RP+ L+
Sbjct: 321 RPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-10
Identities = 34/95 (35%), Positives = 56/95 (58%), Gaps = 2/95 (2%)
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGT 174
I++ LL A+EY+H++ IHRDIK NI L +G + + DFG + + + +VGT
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331
Query: 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGE 209
+PE++ +GY E DIWS G+ +++M +
Sbjct: 332 VATNSPEILAG-DGYCEITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 43/190 (22%), Positives = 81/190 (42%), Gaps = 9/190 (4%)
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P + + + + +++++++ GG + I + E + +++ A++ LH E
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
G + RD+ NILL + G +++ F +++ + + APEV SE
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV---ENMYCAPEVGGISE-ET 160
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
E D WSLG + E+ G+ L + HP I + E S + + L+
Sbjct: 161 EACDWWSLGAILFELLTGK-TLVECHPSG----INTHTTLNIPEWVSEEARSLLQQLLQF 215
Query: 251 VPAERPSAKE 260
P ER A
Sbjct: 216 NPTERLGAGV 225
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 53/194 (27%), Positives = 84/194 (43%), Gaps = 39/194 (20%)
Query: 21 IGRGSFGDVYKA--FDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+G G+FG VYKA +K+ K+ V K + E I V C + +
Sbjct: 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNERVRRACPN-SCAD 193
Query: 76 YYGSYLHQTK------LWIIMEYMAGGSVADLIQS--------------------GPPLD 109
+ +L W++ Y ++ADL+QS G +
Sbjct: 194 FVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERE 253
Query: 110 EMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRR 168
I I+R +L A++ LH+ G +HRD+K NI+ +E +G K+ D G +A L I+
Sbjct: 254 NKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI 313
Query: 169 -KTFVGTPFWMAPE 181
K F+ P + APE
Sbjct: 314 PKEFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 53/184 (28%), Positives = 82/184 (44%), Gaps = 20/184 (10%)
Query: 95 GGSVADLIQSGPPLDEMSIACILRDLL-------HAIEYLHNEGKIHRDIKAANILLTEN 147
GS D + L+E +A DLL + +L ++ IHRD+ A NILLT
Sbjct: 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG 250
Query: 148 GDVKVADFGVSAQLTRTISRRKTFV-----GTPF-WMAPEVIQNSEGYNEKADIWSLGIT 201
K+ DFG L R I +V P WMAPE I N Y ++D+WS GI
Sbjct: 251 RITKICDFG----LARDIRNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIL 305
Query: 202 VIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL-MKEFVSLCLKKVPAERPSAK 259
+ E+ + G P + + + +E L + M + + C P +RP+ K
Sbjct: 306 LWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFK 365
Query: 260 ELLR 263
++++
Sbjct: 366 QIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 35/107 (32%), Positives = 58/107 (54%), Gaps = 12/107 (11%)
Query: 109 DEMSIACILRDLL-------HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161
D+ S DLL +E+L ++ +HRD+ A N+LL + VK+ DFG++ +
Sbjct: 228 DDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI 287
Query: 162 ---TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM 205
+ +S+ TF+ WMAPE I ++ Y +D+WS GI + E+
Sbjct: 288 MHDSNYVSKGSTFLPVK-WMAPESIFDNL-YTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 17/158 (10%)
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT--ISRRKTFVGTPFWMAPE 181
+ ++H +H D+ N LT + VKV D+G+ + I W+APE
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 182 VIQNSEG------YNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPREN-----P 229
++ G + +++W+LG+T+ E+ P + L VL + ++
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFK 231
Query: 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
PQL+ +S E + C P +R +A+E+ HR +
Sbjct: 232 PQLELPYSERWYEVLQFCWLS-PEKRATAEEV--HRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 61/274 (22%), Positives = 113/274 (41%), Gaps = 37/274 (13%)
Query: 18 LELIGRGSFGDVYKAF-----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+E +G FG VYK E + VAIK + + E+ + E + S+ + P
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI-------QSGPPLDEMSIACILR--DLLHA 123
I G + L +I Y + + + + G D+ ++ L D +H
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 124 I-------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176
+ E+L + +H+D+ N+L+ + +VK++D G+ ++ + +G
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK--LMGNSL 187
Query: 177 ----WMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPREN--- 228
WM+PE I + ++ +DIWS G+ + E+ + G P V+ +I
Sbjct: 188 LPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP 246
Query: 229 -PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
P LM E C + P+ RP K++
Sbjct: 247 CPDDCPAWVYTLMLE----CWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 39/112 (34%), Positives = 55/112 (49%), Gaps = 25/112 (22%)
Query: 107 PLDEMSIACILRDLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159
PLD L DLL +++L ++ IHRD+ A N+LLT+ K+ DFG
Sbjct: 208 PLD-------LDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFG--- 257
Query: 160 QLTRTISRRKTFV-----GTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEM 205
L R I +V P WMAPE I + Y ++D+WS GI + E+
Sbjct: 258 -LARDIMNDSNYVVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 36/234 (15%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEIS 63
+ + RF L L+G G+FG V +A+D++ + A+K++ +++ EI+ ++K
Sbjct: 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQ 184
Query: 64 VLSQCRSPY--ITEYYGSYLHQTKLWIIM-EYMAGGSVADLIQSGPPLDEMSIACILRDL 120
R P I Y+ + + I+M +Y G + D I P +A I+
Sbjct: 185 ADPADRFPLMKIQRYFQN--ETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQT 240
Query: 121 LHAIEYLHNEGKI-HRDIKAANILLTENGD-----------------VKVADFGVSAQLT 162
A++Y H E + H D+K NIL+ E D V++ D G
Sbjct: 241 GVALDYFHTELHLMHTDLKPENILM-ETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER 299
Query: 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH 216
+ R V T + +PEV+ G+ D+WS+G + E+ G+ L D H
Sbjct: 300 HS---RTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYELYTGK-LLYDTH 348
|
Length = 467 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 3/97 (3%)
Query: 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FIIPRENP- 229
+GTP ++APE++ + + D W+LG+ + E G PP D P +V I+ R+ P
Sbjct: 541 LGTPDYLAPELLL-GKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPW 599
Query: 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
P+ +E S + + + L P +R KEL +H
Sbjct: 600 PEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPL 636
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 53/239 (22%), Positives = 107/239 (44%), Gaps = 22/239 (9%)
Query: 38 NKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----KLWIIME 91
NK+V I+ + + I+ + EI L + S I + YG + +L +I+E
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDV 150
Y G + +++ L + + D + L+ K ++++ + + L+TEN +
Sbjct: 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKL 162
Query: 151 KVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKG 208
K+ G+ L+ + F+ + + +++ + SE Y K DI+SLG+ + E+ G
Sbjct: 163 KIICHGLEKILSSPPFKNVNFMV---YFSYKMLNDIFSE-YTIKDDIYSLGVVLWEIFTG 218
Query: 209 EPPL-----ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
+ P +++ + II + N +L +K V C +RP+ KE+L
Sbjct: 219 KIPFENLTTKEIYDL----IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 12/107 (11%)
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD-------VKVADFGVSAQLTRTISRR 168
+ + L A+ YL ++ +H ++ NILL G +K++D G+ + +SR+
Sbjct: 110 VAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV---LSRQ 166
Query: 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLAD 214
+ P W+APE +++S+ + AD WS G T+ E+ GE PL D
Sbjct: 167 ECVERIP-WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 43/173 (24%), Positives = 79/173 (45%), Gaps = 24/173 (13%)
Query: 7 LQEAAGSRFSSLELIGRGSFGDVYK---AFDKELNKDVAIKVIDLEE----SEDEIEDIQ 59
L + G + +LIG G FG VY+ A D +N K+ +LE E + +
Sbjct: 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNI 65
Query: 60 KEISVLSQCRSPY------ITEYYG-SYLHQTKLW---IIME--YMAGGSVADLIQSGP- 106
+I ++ ++ + I +YYG + +++ I++E + I+
Sbjct: 66 YDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNK 125
Query: 107 PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159
L I I++D+L +EY+H G H DIK NI++ N + D+G+++
Sbjct: 126 KL----IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174
|
Length = 294 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 7/77 (9%)
Query: 93 MAGGSVADLIQSGPPLDEMSIACI---LRDLLHAIEYLHNEGKIHRDIKAANILLTENGD 149
MAG + D P D+ I I +R +L + LH G +HRDIK N+L+T +G
Sbjct: 292 MAGKKIPD----NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ 347
Query: 150 VKVADFGVSAQLTRTIS 166
VK+ DFG + + I+
Sbjct: 348 VKIIDFGAAVDMCTGIN 364
|
Length = 507 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 22/71 (30%), Positives = 40/71 (56%), Gaps = 5/71 (7%)
Query: 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147
I+MEY+ G + DLI S + + R++ + LH+ G IH D+ +N++L+
Sbjct: 76 IVMEYIEGEPLKDLINSNGMEELE----LSREIGRLVGKLHSAGIIHGDLTTSNMILS-G 130
Query: 148 GDVKVADFGVS 158
G + + DFG++
Sbjct: 131 GKIYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 5/68 (7%)
Query: 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147
++MEY+ G + L LD + IL +L + + G +H D+ NIL+TE+
Sbjct: 184 VVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED 238
Query: 148 GDVKVADF 155
GD+ V D+
Sbjct: 239 GDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 28/143 (19%), Positives = 60/143 (41%), Gaps = 11/143 (7%)
Query: 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLS--QCRSPYI 73
SS++L+ G VY ++D +K+ E D ++E+++L + +
Sbjct: 1 SSIKLLKGGLTNRVYLL--GTKDEDYVLKINPSREKG---ADREREVAILQLLARKGLPV 55
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ S +++ME++ G + + ++ IA L +LL + L
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGET----LDEVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 134 HRDIKAANILLTENGDVKVADFG 156
H D+ NIL+ + + + D+
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 703 | |||
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.52 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.85 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.74 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.72 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.5 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.47 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.44 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.38 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.26 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.21 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.17 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.03 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.93 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.93 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.91 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.89 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.75 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.67 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.61 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.57 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.5 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.5 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.41 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.36 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.32 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.17 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.9 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.81 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.79 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.66 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.53 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.46 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.38 | |
| PLN02236 | 344 | choline kinase | 96.35 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.34 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.09 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.6 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.58 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.52 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.5 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.19 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.98 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.76 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.66 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 93.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 92.49 |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-60 Score=504.30 Aligned_cols=451 Identities=50% Similarity=0.752 Sum_probs=361.0
Q ss_pred cchhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 6 ~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
.+.......|..++.||+|+||.||+|++..+++.||||++++....+.++.+++|+.+|.+++++||.++|+.|..+..
T Consensus 6 ~~~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 6 VLKIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred hhcCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 34455667899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
+||+||||.||++.++++.+..+++..+..++++++.||.|||.++.+|||||+.|||+..+|.|||+|||.+.++....
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999988877
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
....+++|||.|||||++.. ..|+.++||||||++.|||++|.+||.+.+++.+++.|.+..||.+...+++.+++||.
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVE 244 (467)
T ss_pred hccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHH
Confidence 77789999999999999985 46999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhccccChhHHHHhhcCCCCCCCC--CCCCCCCcccccccCCCceeeeccCCcchhhhh
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQE--EPDTPINGVRAVGEASGTVKVVRDKRSEETVQV 323 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~e~i~~~~~~~~~~--~~~~~~~~~~~~ge~s~~v~~~r~~r~~et~q~ 323 (703)
.||.++|+.||+|.++|+|+|++...+...+.+.+.+...|.... .+..... .+ +.+ +...
T Consensus 245 ~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r~~~~~~~~~~~~~~~~s---------~p-----~~~---~~~~ 307 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLKHKFIKRAKKTSELKELIDRYKRWRVKKLELPEEISS---------EP-----DSD---LSLE 307 (467)
T ss_pred HHhhcCcccCcCHHHHhhhHHHHhcCCchHHHHHHHHHHHHhhcccCCcccCCC---------cc-----ccc---cccc
Confidence 999999999999999999999999888888888887776665432 1111000 00 000 1111
Q ss_pred ccCCccccccccccccccccCCcccccccCCCcccccCCCcccCCCCCCccccccCCcccCCCCcccCCCCCCCcccccC
Q 005298 324 SSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREKKPEFSYNQYTPKRTAERSNHGFSASGSTLHESPDASPTRYARD 403 (703)
Q Consensus 324 ~~~g~s~~n~~~~fsls~~~~~~~l~em~k~~qi~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~ 403 (703)
...| +.+++.|.|.. +. ....+.+.+......+..... ++. ++++..+.++.+. .+++++.
T Consensus 308 ~~~g-~~~~~~W~f~~-------tv-R~~~~~~~~~~~~~~~s~~~~--------~~~-~~~~~~~~ss~~~-~s~~~~~ 368 (467)
T KOG0201|consen 308 SDNG-VRGEPKWDFGS-------TV-RASRPPVLRESSQSKSSDSPS--------QRT-SSPSGSQPSSGTT-ASGSGFN 368 (467)
T ss_pred ccCC-CCCCccccccc-------cc-cCCCChhhccccccCCccccc--------ccc-cCCCCcccccCCC-CCccccc
Confidence 1112 45677898861 11 111222222222221111100 011 2222222222222 2222222
Q ss_pred CCccccccccCC------CCCCCccccceEEEecCCCCCCcccccccCCCCCCCccccccccccceEEEeccCCCCCCCC
Q 005298 404 SYFDDRQDDYYE------DDDTSASASGTVVIRSPRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVYRGQHDDSDSAR 477 (703)
Q Consensus 404 ~~~~~~~d~~~~------~~~~~~s~~gt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 477 (703)
+...++. -+++-.+..+++ +..++..++++++++.+++...+|.+.++++.++++++.|+.++-.+.+
T Consensus 369 -----~~~s~q~~s~~~~~~s~~~~~~~~~-v~~~~~~~~~~~~~~~s~~~~~~~~~l~~~~~~~~~~~pg~~~~~~~~l 442 (467)
T KOG0201|consen 369 -----KSTSLQNESEYAQPDSACPSPIPSP-VFGLLNCKLSSTIRDPSAGSSGALDSLRNAFSSAENSCPGICDDLISEL 442 (467)
T ss_pred -----CCCccccccccCCCccccccCCCCc-ccccccccccccccccCCccccchHhhhhhHhhhhhcCCCccchhhhHH
Confidence 2222222 233344666888 9999999999999999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCcchhhhcH
Q 005298 478 TPRSRLGIQERSSSASLEDSAVNL 501 (703)
Q Consensus 478 ~~~~~~~~~~~~~~~~~~~~~~~~ 501 (703)
.+ ++++.++.++... +++--++
T Consensus 443 ~~-~~v~~~s~s~~~~-~~~~~~~ 464 (467)
T KOG0201|consen 443 ML-SRVPQFSQSRSLE-EISRNTL 464 (467)
T ss_pred HH-HHhhhhccccccc-chhhhcc
Confidence 99 9999999997776 5554444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-55 Score=462.55 Aligned_cols=268 Identities=31% Similarity=0.559 Sum_probs=247.2
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
...|+++++||+|+||+||+++.++|++.||+|++++.. ......++..|..||.+++||+||+++..|++.+++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 458999999999999999999999999999999997665 234578899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
+||+.||.|+.+|++.+.|+|..++.|+.+|+.||.|||++|||||||||+|||||.+|+++|+|||||+..........
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~ 183 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATR 183 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987666666777
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
++|||+.|||||++.+. .|+..+||||||++|||||+|.+||...+...++.+|.+...+..+..++..+++||+++|.
T Consensus 184 tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~ 262 (357)
T KOG0598|consen 184 TFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLK 262 (357)
T ss_pred cccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhc
Confidence 89999999999999886 69999999999999999999999999999999999998877667777899999999999999
Q ss_pred cCCCCCC----CHHHHHhchhhhccccChhHHHHh
Q 005298 250 KVPAERP----SAKELLRHRFIRNARKSPRLLERI 280 (703)
Q Consensus 250 ~dP~~RP----Ta~eLL~Hpff~~~~~~~~l~e~i 280 (703)
++|.+|. ++.+|-+||||....+...+...+
T Consensus 263 rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l 297 (357)
T KOG0598|consen 263 RDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKL 297 (357)
T ss_pred cCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCC
Confidence 9999996 689999999999887655444433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=450.61 Aligned_cols=256 Identities=41% Similarity=0.705 Sum_probs=238.8
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-EEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-KLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~-~lyLV~Ey 92 (703)
+.+.+.+||+|..|+||+|+++.|++.+|+|++..........++.+|++|++.++|||||.+|++|..+. .++|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 67888999999999999999999999999999977767777889999999999999999999999999999 49999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
|+||+|..+++..++++|..+..|+.++++||.|||. ++||||||||+||||+..|.|||||||.+..+... ..+++
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tf 237 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANTF 237 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hcccc
Confidence 9999999999998999999999999999999999995 99999999999999999999999999999988765 55789
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCC-----CccceeeccCCCCCCCcchh-hhHHHHHHHH
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL-----HPMRVLFIIPRENPPQLDEH-FSRLMKEFVS 245 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~-----~~~~~l~~I~~~~~~~l~~~-is~~L~dLI~ 245 (703)
+||..|||||.+.+. .|+.++||||||++++||.+|+.||... ...+.+..|..+.+|.++.. +++++++||.
T Consensus 238 vGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~ 316 (364)
T KOG0581|consen 238 VGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVS 316 (364)
T ss_pred cccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 999999999999886 5999999999999999999999999874 55677788888889999986 9999999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
.||++||.+||++.|++.|||+++...
T Consensus 317 ~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 317 CCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 999999999999999999999986643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-54 Score=458.62 Aligned_cols=260 Identities=32% Similarity=0.504 Sum_probs=230.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH------HHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED------EIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~------~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~ 84 (703)
....|.+.+.||.|+||.|.+|+++.||+.||||++.+..... ....+.+|++||++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4457899999999999999999999999999999997665322 2345689999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC---CCeeEeccccchhh
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQL 161 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~---g~VKL~DFGlA~~~ 161 (703)
..||||||++||+|.+.+-.++.+.+...+.+++||+.||.|||++||+||||||+|||+..+ -.+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999876 67999999999877
Q ss_pred hhcccccccccCCCCCCchhhhccc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccc-eeeccCCCCC---CCcchh
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLFIIPRENP---PQLDEH 235 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~~--~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~-~l~~I~~~~~---~~l~~~ 235 (703)
. ......++||||.|.|||++... ..+..++||||||||||-+|+|.+||.+..... ...+|.++.. +.....
T Consensus 330 g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~ 408 (475)
T KOG0615|consen 330 G-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDR 408 (475)
T ss_pred c-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhh
Confidence 6 44667889999999999999754 234557899999999999999999998776544 5666666543 345578
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
++.+..+||.+||..||++|||+.++|+||||+...
T Consensus 409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 999999999999999999999999999999998764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-53 Score=466.00 Aligned_cols=256 Identities=32% Similarity=0.579 Sum_probs=238.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|+..++||+|||+.||.+++..+|+.||+|++.+.. .....+.+.+||+|.++|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 68999999999999999999999999999999997643 4456788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|+|..++|.+++++.++++|.+++.|++||+.||.|||+++|||||||..||||+.+.+|||+|||||+.+..+.....+
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999888788889
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.||||.|.|||++.. .+++..+||||+|||||-||.|++||...+-.+.+..|..... .+|..++.++++||..||.+
T Consensus 178 lCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-~~P~~ls~~A~dLI~~lL~~ 255 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-SMPSHLSAEAKDLIRKLLRP 255 (592)
T ss_pred ecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-ccccccCHHHHHHHHHHhcC
Confidence 999999999999975 5699999999999999999999999998887788887766543 55669999999999999999
Q ss_pred CCCCCCCHHHHHhchhhhcc
Q 005298 251 VPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpff~~~ 270 (703)
+|.+|||+++||.|+||...
T Consensus 256 ~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 256 NPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred CcccCCCHHHHhcCHhhhCC
Confidence 99999999999999999544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-52 Score=426.55 Aligned_cols=257 Identities=29% Similarity=0.489 Sum_probs=228.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|+.+..+|+|+||.||+|+++.||+.||||.+..... +...+-..+||.+|++|+|||+|.++++|.....++||||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 479999999999999999999999999999999865544 3334556799999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
||+..-|.++-.....++.+.+..|++|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+..+...++.+
T Consensus 82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDY 161 (396)
T KOG0593|consen 82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDY 161 (396)
T ss_pred ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhh
Confidence 99887777776666789999999999999999999999999999999999999999999999999999888777777889
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-----------------------
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----------------------- 228 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~----------------------- 228 (703)
+.|.||+|||++.+...|+..+|||++||++.||++|.+.|++..+.+.++.|.+..
T Consensus 162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP 241 (396)
T KOG0593|consen 162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP 241 (396)
T ss_pred hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence 999999999999998889999999999999999999999999998888777664210
Q ss_pred ----CCCcc---hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 229 ----PPQLD---EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 229 ----~~~l~---~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
+.++. ..++..+.+|++.||..||.+|++++|+|.|+||..
T Consensus 242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 01111 234567899999999999999999999999999943
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-51 Score=419.61 Aligned_cols=257 Identities=30% Similarity=0.559 Sum_probs=236.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||.|+||.|.+++.+.+|..||+|++++... -.+.+++.+|..||+.+.||+++++++.|.+.+++|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 489999999999999999999999999999999987652 345678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||++||.|+.++++.++|++..+++|+.||+.||+|||+++|++|||||+|||||++|++||+|||+|+.... ..-+
T Consensus 124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---rT~T 200 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---RTWT 200 (355)
T ss_pred eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---cEEE
Confidence 9999999999999999999999999999999999999999999999999999999999999999999987643 2457
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.||||.|+|||+++.. +|+.++|+|+|||++|||+.|.+||...++..++.+|..... .+|..++..+++||..+|+.
T Consensus 201 lCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v-~fP~~fs~~~kdLl~~LL~v 278 (355)
T KOG0616|consen 201 LCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV-KFPSYFSSDAKDLLKKLLQV 278 (355)
T ss_pred ecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-cCCcccCHHHHHHHHHHHhh
Confidence 8999999999999875 699999999999999999999999999999999999887654 66788999999999999999
Q ss_pred CCCCCC-----CHHHHHhchhhhccccCh
Q 005298 251 VPAERP-----SAKELLRHRFIRNARKSP 274 (703)
Q Consensus 251 dP~~RP-----Ta~eLL~Hpff~~~~~~~ 274 (703)
|-.+|. ...+|..||||+...+.+
T Consensus 279 D~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 279 DLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred hhHhhhcCcCCCccccccCcccccccHHH
Confidence 999994 578999999999775544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=439.78 Aligned_cols=259 Identities=32% Similarity=0.495 Sum_probs=233.8
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC----hHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCC
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES----EDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQT 84 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~----~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~ 84 (703)
...++|++.+.||+|+||+|+.|.+..++..||||+++.... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345699999999999999999999999999999998766421 134567889999999999 999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC-CCeeEeccccchhhhh
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTR 163 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~-g~VKL~DFGlA~~~~~ 163 (703)
.+|||||||.||+|.+++...+++.|..++.+|+||+.||+|||++||+||||||+|||++.+ +++||+|||++.....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999999999999999999999999999999999999999999999999999999999 9999999999987743
Q ss_pred cccccccccCCCCCCchhhhcccc-CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhh-hHHHH
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF-SRLMK 241 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~~-~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~i-s~~L~ 241 (703)
......+.|||+.|+|||++.+.. +-+.++|||||||+||.|++|..||.+.+...+...|.... ..++..+ +..++
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~-~~~p~~~~S~~~~ 252 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE-FKIPSYLLSPEAR 252 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC-ccCCCCcCCHHHH
Confidence 445667899999999999999876 55689999999999999999999999988777777766543 3555666 99999
Q ss_pred HHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 242 EFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
.||.+||..+|.+|+|+.+|+.||||+.
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 9999999999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=430.59 Aligned_cols=258 Identities=32% Similarity=0.559 Sum_probs=233.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
.-++|.+.+.||+|+||+||+|+++.++..||||.+.+.. .....+.+..|+.||+.|+|||||.+++++..++.+|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4568999999999999999999999999999999998776 566778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC------CCeeEeccccchhhhh
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN------GDVKVADFGVSAQLTR 163 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~------g~VKL~DFGlA~~~~~ 163 (703)
||||+||+|.+||++.+.+++..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+..
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999999999999999999999999999999999999999999999999999875 3589999999987753
Q ss_pred cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCcchhhhHHHH
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSRLMK 241 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~--~~~l~~~is~~L~ 241 (703)
.....+.||+|.|||||++... .|+.|+|+||+|+|||+|++|++||...++.+....+.++. .+.++..++..+.
T Consensus 168 -~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~ 245 (429)
T KOG0595|consen 168 -GSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLR 245 (429)
T ss_pred -hhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchh
Confidence 3445678999999999999764 59999999999999999999999999998888776665543 5566677788888
Q ss_pred HHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 242 EFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+++...|.++|..|.+..+.+.|+|+...
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 99999999999999999999999998754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=449.79 Aligned_cols=317 Identities=27% Similarity=0.434 Sum_probs=267.3
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyL 88 (703)
-.+|.++++||+|.||+|+++..+.+++.||||++++.. ..++++.+..|..|+.... ||+++.++.+|++.+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 358999999999999999999999999999999998776 4567889999999999885 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||||+.||+|..+ +..+.|++..++.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+|+.........
T Consensus 447 vmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~T 525 (694)
T KOG0694|consen 447 VMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRT 525 (694)
T ss_pred EEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCcc
Confidence 9999999995544 445789999999999999999999999999999999999999999999999999998776556677
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
.++||||.|||||++.+. .|+..+|||+|||+|||||.|..||.+.+..++...|..+.+ .+|..++.++.+|++++|
T Consensus 526 sTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~-~yP~~ls~ea~~il~~ll 603 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSKEAIAIMRRLL 603 (694)
T ss_pred ccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCcccHHHHHHHHHHh
Confidence 899999999999999886 499999999999999999999999999999888888887655 677889999999999999
Q ss_pred ccCCCCCCC-----HHHHHhchhhhccccChhHHHHhhcCCCCCCCCCCCCCCCcccccccCCCceeeeccCCcchhhhh
Q 005298 249 KKVPAERPS-----AKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVKVVRDKRSEETVQV 323 (703)
Q Consensus 249 ~~dP~~RPT-----a~eLL~Hpff~~~~~~~~l~e~i~~~~~~~~~~~~~~~~~~~~~~ge~s~~v~~~r~~r~~et~q~ 323 (703)
.++|++|.. +.+|.+||||+.+.+ ..+..+-.++|..|....+.+..+.+................-.....|.
T Consensus 604 ~k~p~kRLG~~e~d~~~i~~hpFFr~i~w-~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~~~~~~l~~~~q~ 682 (694)
T KOG0694|consen 604 RKNPEKRLGSGERDAEDIKKHPFFRSIDW-DDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTPSDPRPLTEEEQE 682 (694)
T ss_pred ccCcccccCCCCCCchhhhhCCccccCCH-HHHhhccCCCCCCcccCChhhhcccchhhhcCCCccCCCCccccchhhHH
Confidence 999999985 588999999999864 44555555555556555566666666555554444443222223345566
Q ss_pred ccCCccccc
Q 005298 324 SSQGQTVRN 332 (703)
Q Consensus 324 ~~~g~s~~n 332 (703)
.+.|+++.+
T Consensus 683 ~F~~Fs~~~ 691 (694)
T KOG0694|consen 683 AFRDFSFVA 691 (694)
T ss_pred HhcCccccC
Confidence 666665544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=438.46 Aligned_cols=260 Identities=31% Similarity=0.541 Sum_probs=231.9
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
-.+|+++++||+|+||.||+|+.+.||..||||++++.. ..+++..++.|..||...++|+||+||..|++.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 458999999999999999999999999999999998665 456688999999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh------
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR------ 163 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~------ 163 (703)
|||++||++..+|.+.+.|++..+++|+.+++.|++-||.+|+|||||||+|+|||..|++||+|||||+.+..
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999854321
Q ss_pred ---------c--------cc----c--------------------cccccCCCCCCchhhhccccCCccccchhhHHHHH
Q 005298 164 ---------T--------IS----R--------------------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITV 202 (703)
Q Consensus 164 ---------~--------~~----~--------------------~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvIL 202 (703)
. .. . ....+|||.|||||++.+. +|+..+|+|||||||
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k-gY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK-GYGKECDWWSLGCIM 378 (550)
T ss_pred hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC-CCCccccHHHHHHHH
Confidence 0 00 0 0124799999999999986 599999999999999
Q ss_pred HHHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHHHHHHHhccCCCCCCC---HHHHHhchhhhccccC
Q 005298 203 IEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVPAERPS---AKELLRHRFIRNARKS 273 (703)
Q Consensus 203 yELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~dLI~~cL~~dP~~RPT---a~eLL~Hpff~~~~~~ 273 (703)
||||.|.+||...++..++.+|..+. ..+....+++++++||.+||+ ||++|.. ++||.+||||+.+.+.
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 99999999999999999988887553 222334678999999999999 9999975 9999999999988543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-50 Score=437.84 Aligned_cols=261 Identities=29% Similarity=0.530 Sum_probs=234.4
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyL 88 (703)
..+|.+.+.||.|+|++||+|.++.+++.||||++.+... +.....+..|..+|.+| .||.||+||..|+++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 3589999999999999999999999999999999876542 23356678899999999 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc-
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~- 167 (703)
|+||+++|+|.++|++.+.|++.-+++|+.||+.||+|||++|||||||||+|||||.+|++||+|||.|+.+......
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999876432211
Q ss_pred ------------cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchh
Q 005298 168 ------------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH 235 (703)
Q Consensus 168 ------------~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~ 235 (703)
..+++||..|++||+|... ..++.+|||+||||||.|+.|.+||.+.+..-...+|..-.. .++.+
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y-~fp~~ 309 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY-EFPEG 309 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc-cCCCC
Confidence 1458999999999999775 589999999999999999999999999998887777765443 56788
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccCh
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~ 274 (703)
+++.+++||+++|..||.+|+|++||.+||||..+.+..
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 999999999999999999999999999999999886544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=443.46 Aligned_cols=261 Identities=25% Similarity=0.443 Sum_probs=239.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
.-+-|++.+.||+|+.|.|.+|.+..||+.+|||++.+.. .......+.+||-||+.|.||||+++|++|.+..++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 3457999999999999999999999999999999997652 34446789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|+||++||.|++++-++++|++.++..+|+||+.||.|||..+|+||||||+|+||+..++|||+|||+|.... +....
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~gklL 168 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-PGKLL 168 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc-CCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987543 34556
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
.+.||+|.|.|||++.+..+.+.++||||||||||.||+|++||.+.|....+.++.++.. .++..++.++++||.+||
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-~MPs~Is~eaQdLLr~ml 247 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-EMPSNISSEAQDLLRRML 247 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-cCCCcCCHHHHHHHHHHh
Confidence 6889999999999999998888999999999999999999999999888888888877654 677899999999999999
Q ss_pred ccCCCCCCCHHHHHhchhhhccccC
Q 005298 249 KKVPAERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~~~~ 273 (703)
..||.+|+|.+||++|||+......
T Consensus 248 ~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 248 DVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred ccCccccccHHHHhhCchhhcCCCC
Confidence 9999999999999999999866443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=410.50 Aligned_cols=245 Identities=36% Similarity=0.592 Sum_probs=224.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEE-EEEeCCE-EEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYG-SYLHQTK-LWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~-~~~~~~~-lyLV 89 (703)
.+|++++.||+|+||+||++.+..+|..||.|.+.... .....+.+..|+.+|++|+|||||++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 37999999999999999999999999999999987444 4456788899999999999999999999 5655555 8999
Q ss_pred EeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh--cC--ceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 90 MEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHN--EG--KIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs--~g--IVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
||||.+|+|..+|+. +..++|..++.++.|||.||.+||+ .. |+||||||.||+|+.+|.|||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999964 5679999999999999999999998 44 899999999999999999999999999998
Q ss_pred hhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcc-hhhhHHH
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD-EHFSRLM 240 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~-~~is~~L 240 (703)
........+++|||.||+||.+... +|+.++||||+||++|||+.-.+||.+.+-.....+|.....++++ ..++..+
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l 257 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDL 257 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHH
Confidence 8777777889999999999999876 5999999999999999999999999999888888889888887777 7899999
Q ss_pred HHHHHHHhccCCCCCCCH
Q 005298 241 KEFVSLCLKKVPAERPSA 258 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa 258 (703)
..||..|+..||..||+.
T Consensus 258 ~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 258 RELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHccCCcccCCCc
Confidence 999999999999999986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=413.12 Aligned_cols=269 Identities=45% Similarity=0.805 Sum_probs=239.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
....|++.++||.|..++||+|+...++..||||+++.++.....+.+.+|+..|+.++||||++++.+|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34689999999999999999999999999999999999987777899999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc-
Q 005298 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~- 167 (703)
.||.+|++.++++.. ..|+|..|..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+......
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999999999863 35999999999999999999999999999999999999999999999999987665443322
Q ss_pred ---cccccCCCCCCchhh-hccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc---------ch
Q 005298 168 ---RKTFVGTPFWMAPEV-IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL---------DE 234 (703)
Q Consensus 168 ---~~~~iGTp~Y~APEv-l~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l---------~~ 234 (703)
.++++|||+|||||+ .+...+|+.|+||||||++..||.+|..||....+++++.....+.|+.+ ..
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k 263 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDK 263 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhh
Confidence 266799999999999 66667899999999999999999999999999999998877666666522 23
Q ss_pred hhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccChhHHHH
Q 005298 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLER 279 (703)
Q Consensus 235 ~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~e~ 279 (703)
.++..++.+|..||.+||.+|||+.++|+|+||+..+....+...
T Consensus 264 ~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~~~ 308 (516)
T KOG0582|consen 264 KFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLVKK 308 (516)
T ss_pred hhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcchh
Confidence 567789999999999999999999999999999988655544443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=427.76 Aligned_cols=262 Identities=27% Similarity=0.435 Sum_probs=228.0
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCC-EEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQT-KLW 87 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~-~ly 87 (703)
..-.+|.+++.||.|+||.||+|+.+.+|..||||.++.....-+.-.-.+|+..|++|+ |||||+|++++.+.+ .+|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 345689999999999999999999999999999999875543333334568999999999 999999999999988 999
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
|||||| ..+|.++++. +..|++..++.|++||++||+|+|.+|++|||+|||||||.....|||+|||+|+.+.. ..
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S-kp 164 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS-KP 164 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc-CC
Confidence 999999 5799999975 45799999999999999999999999999999999999999888999999999987643 45
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC--CC---------------
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--NP--------------- 229 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~--~~--------------- 229 (703)
.++.++.|.||+|||+++....|+.++|||++||||+|+++-++.|.+.+..+.+++|... .|
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m 244 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM 244 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence 6678999999999999999889999999999999999999999999999888777666321 00
Q ss_pred ----CC--------cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccC
Q 005298 230 ----PQ--------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 230 ----~~--------l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~ 273 (703)
++ +-..++.++.++|.+||.+||.+||||.|+|+||||+.....
T Consensus 245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 01 112367889999999999999999999999999999876543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=428.44 Aligned_cols=264 Identities=43% Similarity=0.768 Sum_probs=241.0
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
....|.....||+|+.|.||.+....+++.||||.+++..- ...+.+.+|+.+|+.++|+|||.+++.|..++.+|+||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 34589999999999999999999999999999999977642 23467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||++||+|.+.+.. ..|+|.+|..|++++++||.|||.+||||||||.+|||++.+|.+||+|||||.++......+.+
T Consensus 350 Eym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred eecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 99999999999876 55999999999999999999999999999999999999999999999999999999888778889
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--chhhhHHHHHHHHHHh
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFVSLCL 248 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l--~~~is~~L~dLI~~cL 248 (703)
.+|||+|||||++... .|+.++||||||++++||+-|++||-..++...++.|.....+.+ +..++..+++|+.+||
T Consensus 429 mVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL 507 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCL 507 (550)
T ss_pred ccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHh
Confidence 9999999999999765 599999999999999999999999999999999998887666554 5689999999999999
Q ss_pred ccCCCCCCCHHHHHhchhhhccccChhHH
Q 005298 249 KKVPAERPSAKELLRHRFIRNARKSPRLL 277 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~~~~~~l~ 277 (703)
+.|+.+|++|.+||+||||+.......+.
T Consensus 508 ~~dv~~RasA~eLL~HpFl~~a~p~ssL~ 536 (550)
T KOG0578|consen 508 VVDVEQRASAKELLEHPFLKMAKPESSLN 536 (550)
T ss_pred hcchhcCCCHHHHhcChhhhhcCCHHHhH
Confidence 99999999999999999997665444433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=411.88 Aligned_cols=259 Identities=42% Similarity=0.717 Sum_probs=223.0
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC--EEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--KLWII 89 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~--~lyLV 89 (703)
..++...+.||+|+||.||++.+..+|..+|||.+....... .+.+.+|+.+|++|+|||||++++...... .++|+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 356888999999999999999999999999999987764333 677999999999999999999999855544 69999
Q ss_pred EeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC-CCCeeEeccccchhhhh---c
Q 005298 90 MEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTR---T 164 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~-~g~VKL~DFGlA~~~~~---~ 164 (703)
|||+++|+|.+++.+.+ +|++..++.+.+||++||.|||++|||||||||+||||+. +|.+||+|||++..... .
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999999999876 8999999999999999999999999999999999999999 69999999999876652 1
Q ss_pred ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCC-CCccceeeccCCC-CCCCcchhhhHHHHH
Q 005298 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD-LHPMRVLFIIPRE-NPPQLDEHFSRLMKE 242 (703)
Q Consensus 165 ~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~-~~~~~~l~~I~~~-~~~~l~~~is~~L~d 242 (703)
......+.||+.|||||++........++|||||||++.||+||.+||.. ......+..+... ..|.++..++.++++
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~ 254 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKD 254 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHH
Confidence 12233578999999999998532233589999999999999999999987 4444444444433 345788899999999
Q ss_pred HHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 243 FVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
||.+||.++|++||||.++|.|||.....
T Consensus 255 Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 255 FLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 99999999999999999999999997643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=404.54 Aligned_cols=252 Identities=30% Similarity=0.507 Sum_probs=220.1
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gG 96 (703)
++||+|+||.||+|.+..+|+.||||++.... .......+.+|+.++++++||||+++++++...+.+||||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999987543 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCCC
Q 005298 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (703)
Q Consensus 97 sL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~ 176 (703)
+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 99999988889999999999999999999999999999999999999999999999999998754333333445789999
Q ss_pred CCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCC
Q 005298 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERP 256 (703)
Q Consensus 177 Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RP 256 (703)
|+|||++.+. .++.++|||||||+||+|++|..||...+.......+... ...++..++..+.+||.+||.+||.+||
T Consensus 161 y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05571 161 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred ccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 9999999765 5899999999999999999999999877655544444333 2345567899999999999999999999
Q ss_pred -----CHHHHHhchhhhcccc
Q 005298 257 -----SAKELLRHRFIRNARK 272 (703)
Q Consensus 257 -----Ta~eLL~Hpff~~~~~ 272 (703)
++.++++||||....+
T Consensus 239 ~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 239 GGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred CCCCCCHHHHHcCCCcCCCCH
Confidence 8999999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=418.34 Aligned_cols=255 Identities=32% Similarity=0.577 Sum_probs=234.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
++|.+.+.||+|+||.||||+.+.|.+.||||.+.+.. .+.++..+.+|++|++.|+|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 47889999999999999999999999999999997665 56678999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
||.| +|+.++...+.++|+.++.|+.+++.||.|||+++|+|||+||.|||+...|++|+||||+|+.+.....-....
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi 160 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI 160 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence 9976 999999999999999999999999999999999999999999999999999999999999998876654445567
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccC
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~d 251 (703)
.|||.|||||++.+. .|+..+|+||||||+|||++|++||...........|.++.. ..+..++..+.+|+..+|.+|
T Consensus 161 kGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v-~~p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 161 KGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV-KPPSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred cCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC-CCcccccHHHHHHHHHHhhcC
Confidence 899999999999864 699999999999999999999999998887777777777654 444589999999999999999
Q ss_pred CCCCCCHHHHHhchhhhcc
Q 005298 252 PAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 252 P~~RPTa~eLL~Hpff~~~ 270 (703)
|.+|.|..+++.|||.+..
T Consensus 239 P~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 239 PAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hhhcccHHHHhcChHHhhh
Confidence 9999999999999998653
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=399.18 Aligned_cols=248 Identities=31% Similarity=0.519 Sum_probs=218.1
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCH
Q 005298 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (703)
Q Consensus 21 LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL 98 (703)
||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||++++++|...+.+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999986432 234456788999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCCCCC
Q 005298 99 ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178 (703)
Q Consensus 99 ~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~ 178 (703)
.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 99998888999999999999999999999999999999999999999999999999999875433333334568999999
Q ss_pred chhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCC--
Q 005298 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERP-- 256 (703)
Q Consensus 179 APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RP-- 256 (703)
|||++.+. .++.++|||||||++|+|++|..||...+.......+... +..++..++..+.+||.+||.++|.+||
T Consensus 161 aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R~~~ 238 (312)
T cd05585 161 APELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLLIGLLSRDPTRRLGY 238 (312)
T ss_pred CHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHcCCCHHHcCCC
Confidence 99999775 5899999999999999999999999877665555444433 3455677899999999999999999997
Q ss_pred -CHHHHHhchhhhcc
Q 005298 257 -SAKELLRHRFIRNA 270 (703)
Q Consensus 257 -Ta~eLL~Hpff~~~ 270 (703)
++.+++.||||...
T Consensus 239 ~~~~e~l~hp~~~~~ 253 (312)
T cd05585 239 NGAQEIKNHPFFSQL 253 (312)
T ss_pred CCHHHHHcCCCcCCC
Confidence 58999999999876
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=423.25 Aligned_cols=350 Identities=28% Similarity=0.483 Sum_probs=266.3
Q ss_pred hhhCCCc-eEEEEEeecCceEEEEEEEcCCCcEEE---EEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005298 9 EAAGSRF-SSLELIGRGSFGDVYKAFDKELNKDVA---IKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (703)
Q Consensus 9 ~~~~~~Y-~il~~LG~GsfG~Vyka~d~~tg~~VA---IKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~ 84 (703)
....++| +...+||+|+|-+||+|+|..+|..|| ||+-+........+++..|+.+|+.|+|||||++|.+|.+..
T Consensus 35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 3445566 455789999999999999999999999 666666667788899999999999999999999999999865
Q ss_pred E--EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeeeeccceEEecCC-CCeeEeccccch
Q 005298 85 K--LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTEN-GDVKVADFGVSA 159 (703)
Q Consensus 85 ~--lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~g--IVHRDIKPeNILLd~~-g~VKL~DFGlA~ 159 (703)
+ +.+|+|.+..|+|..|+++.+.++...++.|++||++||.|||++. |||||||++||||+.+ |.|||+|+|||+
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT 194 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHH
Confidence 5 8899999999999999999999999999999999999999999984 9999999999999965 999999999998
Q ss_pred hhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-eeeccCCCCCC-Ccchhhh
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLFIIPRENPP-QLDEHFS 237 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~-~l~~I~~~~~~-~l~~~is 237 (703)
....... ...+|||.|||||++. +.|+..+||||||++|.||+|+.+||....... .+.++..+..| .+..--.
T Consensus 195 l~r~s~a--ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~d 270 (632)
T KOG0584|consen 195 LLRKSHA--KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKD 270 (632)
T ss_pred Hhhcccc--ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCC
Confidence 8765433 3479999999999997 469999999999999999999999998876554 44445444433 3444446
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccC-----------hhHH-----HHhhcCCCCCCC-CCCCCCCCc--
Q 005298 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS-----------PRLL-----ERIRERPKYPIQ-EEPDTPING-- 298 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~-----------~~l~-----e~i~~~~~~~~~-~~~~~~~~~-- 298 (703)
+++++||.+||.. ...|+|+.|||+||||....-- +.+. +.......+... ....-..+.
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g~~~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~ 349 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGGIVELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDE 349 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhChhhccccccccccchhhcccccccccccccchhhcCCcccccccceeecCCCc
Confidence 8899999999999 8999999999999999764110 0000 000000000000 000000000
Q ss_pred -------ccccccCCC------------ceeeeccC------CcchhhhhccCCccccccccccccccccCCcccccccC
Q 005298 299 -------VRAVGEASG------------TVKVVRDK------RSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVK 353 (703)
Q Consensus 299 -------~~~~ge~s~------------~v~~~r~~------r~~et~q~~~~g~s~~n~~~~fsls~~~~~~~l~em~k 353 (703)
+...+.... .+-..+.+ ..+..+++...++..++..|+|.+..+++.+++.+||+
T Consensus 350 ~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~eMv~ 429 (632)
T KOG0584|consen 350 SEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAHEMVE 429 (632)
T ss_pred hhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHHHHHh
Confidence 000000000 11111111 22234555566788899999999999999999999999
Q ss_pred CCcccccCCC
Q 005298 354 PPQVREKKPE 363 (703)
Q Consensus 354 ~~qi~~~~p~ 363 (703)
+++++++.+.
T Consensus 430 el~~~dq~v~ 439 (632)
T KOG0584|consen 430 ELEITDQPVV 439 (632)
T ss_pred hcCCcccchh
Confidence 9999997776
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=401.55 Aligned_cols=254 Identities=28% Similarity=0.498 Sum_probs=224.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.++++++||||+++++++..++.+|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999986543 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ...
T Consensus 98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~ 174 (329)
T PTZ00263 98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---TFT 174 (329)
T ss_pred cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---cce
Confidence 99999999999998889999999999999999999999999999999999999999999999999998755322 234
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+.... ..++..++..+++||.+||.+
T Consensus 175 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~ 252 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR-LKFPNWFDGRARDLVKGLLQT 252 (329)
T ss_pred ecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-cCCCCCCCHHHHHHHHHHhhc
Confidence 6899999999999775 58899999999999999999999998877666555554433 345566888999999999999
Q ss_pred CCCCCCC-----HHHHHhchhhhccc
Q 005298 251 VPAERPS-----AKELLRHRFIRNAR 271 (703)
Q Consensus 251 dP~~RPT-----a~eLL~Hpff~~~~ 271 (703)
||.+||+ +++|+.||||....
T Consensus 253 dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 253 DHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred CHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 9999997 79999999998754
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=395.26 Aligned_cols=254 Identities=29% Similarity=0.516 Sum_probs=223.5
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999986543 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---~~~~ 157 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---RTWT 157 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC---Cccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999876532 2234
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+.... ..++..++..+++||.+||..
T Consensus 158 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 235 (291)
T cd05612 158 LCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIKKLLVV 235 (291)
T ss_pred ccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHHHHcCC
Confidence 6899999999999765 58899999999999999999999998877655555544332 345566788999999999999
Q ss_pred CCCCCCC-----HHHHHhchhhhccc
Q 005298 251 VPAERPS-----AKELLRHRFIRNAR 271 (703)
Q Consensus 251 dP~~RPT-----a~eLL~Hpff~~~~ 271 (703)
||.+||+ +++++.||||....
T Consensus 236 dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 236 DRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred CHHHccCCccCCHHHHhcCccccCCC
Confidence 9999995 99999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=405.25 Aligned_cols=260 Identities=29% Similarity=0.476 Sum_probs=221.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-------------hHHHHHHHHHHHHHHhCCCCCeeeeEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------------EDEIEDIQKEISVLSQCRSPYITEYYGS 79 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-------------~~~~~~l~~Ei~ILk~L~HPnIV~L~~~ 79 (703)
+.|++++.||+|.||.|.+|++..+++.||||++.+... ...++.+++||.||++|.|||||+|+++
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 589999999999999999999999999999999865431 1124689999999999999999999999
Q ss_pred EEe--CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecccc
Q 005298 80 YLH--QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (703)
Q Consensus 80 ~~~--~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGl 157 (703)
..+ .+.+|||+|||..|.+.+.-.....|.+.+++.|++.++.||+|||.+|||||||||+|+||+.+|+|||+|||.
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGV 256 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGV 256 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccce
Confidence 987 468999999999998876543333399999999999999999999999999999999999999999999999999
Q ss_pred chhhhhc-----ccccccccCCCCCCchhhhccc---cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC
Q 005298 158 SAQLTRT-----ISRRKTFVGTPFWMAPEVIQNS---EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP 229 (703)
Q Consensus 158 A~~~~~~-----~~~~~~~iGTp~Y~APEvl~~~---~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~ 229 (703)
+..+... .......+|||.|||||.+.+. .+.+.+.||||+||+||.|+.|+.||.+....++..+|....
T Consensus 257 s~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p- 335 (576)
T KOG0585|consen 257 SNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP- 335 (576)
T ss_pred eeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc-
Confidence 8765211 1112236899999999998763 234678899999999999999999999998888888887543
Q ss_pred CCcc--hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccC
Q 005298 230 PQLD--EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 230 ~~l~--~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~ 273 (703)
..++ ..+...+++||++||++||.+|++..+|..|||.....+.
T Consensus 336 L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 336 LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 2333 3578899999999999999999999999999999765433
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=390.59 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=212.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++++.||.|+||.||+|.+..++..||||+++..........+.+|+.++++++||||+++++++..++..|+||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 47999999999999999999999999999999987654333445678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 93 MAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 93 v~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~ 163 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE 163 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCc
Confidence 974 899888654 458999999999999999999999999999999999999999999999999986554333333446
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC----------------------CC
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----------------------NP 229 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~----------------------~~ 229 (703)
.|++.|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+... .+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd07871 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP 243 (288)
T ss_pred eecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccC
Confidence 78999999999876556899999999999999999999999765543322111100 00
Q ss_pred C-------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 230 P-------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 230 ~-------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
. .....++..+.+||.+||.+||.+|||++|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0 0112456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=397.83 Aligned_cols=251 Identities=30% Similarity=0.525 Sum_probs=218.5
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gG 96 (703)
+.||+|+||.||++.+..+|..||||++.... .......+.+|+.+++.++||||++++++|...+.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999986542 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCCC
Q 005298 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (703)
Q Consensus 97 sL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~ 176 (703)
+|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||+.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 99999988889999999999999999999999999999999999999999999999999998654333233345689999
Q ss_pred CCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCC
Q 005298 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERP 256 (703)
Q Consensus 177 Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RP 256 (703)
|+|||++.+. .++.++|||||||+||+|++|..||...+.......+.... ..++..+++.+.+||.+||.++|.+|+
T Consensus 161 y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 161 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred cCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCCHHHhC
Confidence 9999999765 58999999999999999999999998776555444443322 234567889999999999999999998
Q ss_pred -----CHHHHHhchhhhccc
Q 005298 257 -----SAKELLRHRFIRNAR 271 (703)
Q Consensus 257 -----Ta~eLL~Hpff~~~~ 271 (703)
++.++++||||....
T Consensus 239 ~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 239 GGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CCCCCCHHHHHcCCCcCCCC
Confidence 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=393.46 Aligned_cols=257 Identities=28% Similarity=0.482 Sum_probs=222.4
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCC-CCeeeeEEEEEeCCEEEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~H-PnIV~L~~~~~~~~~lyLV~ 90 (703)
+|++++.||+|+||.||+|.+..+++.||||++.... .....+.+..|+.++..+.| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999986542 23345678889999999976 46889999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||+++|+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++............
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 99999999999988889999999999999999999999999999999999999999999999999998643322233345
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|+|||++.+. .++.++|||||||+||+|++|+.||...+.......+.... ..++..++..+.+||.+||.+
T Consensus 161 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 238 (324)
T cd05587 161 FCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLLTK 238 (324)
T ss_pred ecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence 6899999999999775 48899999999999999999999998877665555554433 345567889999999999999
Q ss_pred CCCCCCCH-----HHHHhchhhhcccc
Q 005298 251 VPAERPSA-----KELLRHRFIRNARK 272 (703)
Q Consensus 251 dP~~RPTa-----~eLL~Hpff~~~~~ 272 (703)
+|.+|++. +++++||||....+
T Consensus 239 ~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 239 HPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999976 89999999987643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=411.88 Aligned_cols=255 Identities=30% Similarity=0.502 Sum_probs=222.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~lyLV 89 (703)
..|+.++.||+|+||.||+|++..||+.||+|.+.... .+.......+||.||++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 47999999999999999999999999999999998776 334456778999999999999999999999886 689999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-c
Q 005298 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~ 167 (703)
||||+ -+|.-++.. .-.|++.+|+.||.||+.||+|||++||+|||||.+|||||.+|++||+|||||+.+..... .
T Consensus 197 FeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 197 FEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred Eeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence 99995 588888866 45899999999999999999999999999999999999999999999999999987654433 3
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-------------C-----
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-------------P----- 229 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~-------------~----- 229 (703)
.+..+-|.||+|||+|++...|+..+|+||+||||.||++|++.|.+.+..+.+..|.+.. |
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~ 355 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF 355 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence 4556889999999999999999999999999999999999999999887776665552210 0
Q ss_pred ---CCc-------chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 230 ---PQL-------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 230 ---~~l-------~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
..+ ...++....+|+..||..||.+|.||.++|+++||.
T Consensus 356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 000 124567788999999999999999999999999994
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=390.76 Aligned_cols=259 Identities=26% Similarity=0.436 Sum_probs=212.8
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||.|+||.||+|.+..+++.||||++...........+.+|+.++++++||||+++++++.++...|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46899999999999999999999999999999998765433334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 92 yv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 995 677777654 467999999999999999999999999999999999999999999999999998654333333345
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-eeecc------------------CCC----
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLFII------------------PRE---- 227 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~-~l~~I------------------~~~---- 227 (703)
.+||+.|+|||++.+...++.++|||||||+||+|++|..||....... .+..+ ...
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 6789999999998766668899999999999999999999998654321 11000 000
Q ss_pred ----CCCCcc-----hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 228 ----NPPQLD-----EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 228 ----~~~~l~-----~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+..+. ..++..+.+||.+||++||.+|||+.|+++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 000000 12346789999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=393.88 Aligned_cols=254 Identities=29% Similarity=0.504 Sum_probs=218.6
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHH---HhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVL---SQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~IL---k~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
|++++.||+|+||.||+|.+..+++.||||+++... .....+.+..|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999987543 223345677776665 567899999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|||+++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...........
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 999999999998865 5799999999999999999999999999999999999999999999999999865433333344
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
..+|++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+....+ .++..++..+.+||.+||.
T Consensus 160 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 160 TFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV-RYPRFLSREAISIMRRLLR 237 (324)
T ss_pred ccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHhh
Confidence 67899999999999765 588999999999999999999999988766555555544332 3456788999999999999
Q ss_pred cCCCCCC-----CHHHHHhchhhhccc
Q 005298 250 KVPAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 250 ~dP~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
++|.+|| ++.++++||||.+..
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 9999999 799999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=392.52 Aligned_cols=251 Identities=30% Similarity=0.548 Sum_probs=215.5
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHh-CCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQ-CRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~-L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
++||+|+||.||+|.+..+++.||||+++... .....+.+..|..++.. ++||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999986542 22334555667777765 4899999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
|+|..++.....+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999875433333344578999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+... .+.++..++..+.+||.+||..+|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ll~~~l~~~P~~R 238 (316)
T cd05592 161 DYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRWISKEAKDCLSKLFERDPTKR 238 (316)
T ss_pred cccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999775 4899999999999999999999999887766555555433 335566788999999999999999999
Q ss_pred CCH-HHHHhchhhhccc
Q 005298 256 PSA-KELLRHRFIRNAR 271 (703)
Q Consensus 256 PTa-~eLL~Hpff~~~~ 271 (703)
|++ .+++.||||....
T Consensus 239 ~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 239 LGVDGDIRQHPFFRGID 255 (316)
T ss_pred CCChHHHHcCcccCCCC
Confidence 986 5888999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=400.02 Aligned_cols=259 Identities=27% Similarity=0.497 Sum_probs=217.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
..|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++++++|||||++++++.+.+.+||||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999997543 2344667899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-----
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~----- 165 (703)
|||+||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999875321000
Q ss_pred ------------------------------------------cccccccCCCCCCchhhhccccCCccccchhhHHHHHH
Q 005298 166 ------------------------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVI 203 (703)
Q Consensus 166 ------------------------------------------~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILy 203 (703)
......+||+.|+|||++.+. .++.++||||||||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCccceeehhhHHH
Confidence 001245899999999999764 5899999999999999
Q ss_pred HHHhCCCCCCCCCccceeeccCC-CCCC--CcchhhhHHHHHHHHHHhc--cCCCCCCCHHHHHhchhhhcccc
Q 005298 204 EMAKGEPPLADLHPMRVLFIIPR-ENPP--QLDEHFSRLMKEFVSLCLK--KVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 204 ELLtG~~PF~~~~~~~~l~~I~~-~~~~--~l~~~is~~L~dLI~~cL~--~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
||++|..||...+.......+.. .... +....+++.+.+||.+||. .+|..|+++.+|+.||||....+
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 99999999987665443333322 1111 2223578999999999654 45556999999999999987644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=393.91 Aligned_cols=251 Identities=29% Similarity=0.502 Sum_probs=217.9
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
++||+|+||+||+|.++.+++.||||++.... .......+..|+.++..+ +||||+++++++...+.+||||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999986432 223456677888888876 699999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
|+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 99999998888999999999999999999999999999999999999999999999999999865433323334568999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... ..++..++..+.+||.+||.+||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R 238 (320)
T cd05590 161 DYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLSQDAVDILKAFMTKNPTMR 238 (320)
T ss_pred cccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 99999999765 58899999999999999999999998887766665554433 24455688999999999999999999
Q ss_pred CCH------HHHHhchhhhccc
Q 005298 256 PSA------KELLRHRFIRNAR 271 (703)
Q Consensus 256 PTa------~eLL~Hpff~~~~ 271 (703)
|++ ++++.||||....
T Consensus 239 ~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 239 LGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred CCCCCCCCHHHHHcCCCcCCCC
Confidence 998 9999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=395.81 Aligned_cols=251 Identities=30% Similarity=0.520 Sum_probs=219.1
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gG 96 (703)
++||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++++..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999986543 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCCC
Q 005298 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (703)
Q Consensus 97 sL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~ 176 (703)
+|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||+.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 99999988888999999999999999999999999999999999999999999999999998654333233345689999
Q ss_pred CCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCC
Q 005298 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERP 256 (703)
Q Consensus 177 Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RP 256 (703)
|+|||++.+. .++.++|||||||+||+|++|..||...+.......+... ...++..++..+.+||.+||.++|.+|+
T Consensus 161 y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 161 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-DIKFPRTLSADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred ccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-CccCCCCCCHHHHHHHHHHcCCCHHHcC
Confidence 9999999765 5899999999999999999999999877655554444332 2345667889999999999999999997
Q ss_pred -----CHHHHHhchhhhccc
Q 005298 257 -----SAKELLRHRFIRNAR 271 (703)
Q Consensus 257 -----Ta~eLL~Hpff~~~~ 271 (703)
++.++++||||....
T Consensus 239 ~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 239 GGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred CCCCCCHHHHhcCCCcCCCC
Confidence 899999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=383.39 Aligned_cols=254 Identities=26% Similarity=0.454 Sum_probs=213.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.++++++||||+++++++..++.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 479999999999999999999999999999999875432 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-ccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRRKT 170 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~~~~ 170 (703)
|+.++.|..+......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+.... .....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 99998887776666789999999999999999999999999999999999999999999999999987654321 12234
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---------------------CCC
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------------ENP 229 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------------~~~ 229 (703)
..|++.|+|||++.+. .++.++|||||||+||+|++|++||...+..+....+.. ...
T Consensus 161 ~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 161 YVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred cccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 6799999999999775 489999999999999999999999987544322111100 000
Q ss_pred C----------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 230 P----------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 230 ~----------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
+ .....++..+.+||.+||.+||.+|||++++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0112367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=399.94 Aligned_cols=257 Identities=27% Similarity=0.488 Sum_probs=217.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|++++||||+++++.|.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986432 1233567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc------
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT------ 164 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~------ 164 (703)
|||++|+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999997532100
Q ss_pred -------------------------------------ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh
Q 005298 165 -------------------------------------ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK 207 (703)
Q Consensus 165 -------------------------------------~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt 207 (703)
.......+||+.|||||++.+. .++.++||||||||||+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeeeccceeeehhh
Confidence 0001235799999999999765 58999999999999999999
Q ss_pred CCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHHHHHHHhccCCCCCC---CHHHHHhchhhhccc
Q 005298 208 GEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIRNAR 271 (703)
Q Consensus 208 G~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~dLI~~cL~~dP~~RP---Ta~eLL~Hpff~~~~ 271 (703)
|+.||...+.......+.... ..+....++..+.+||.+|+ .+|.+|+ ++.+++.||||....
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 999998877655443333211 11222357889999999976 5999999 999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=393.76 Aligned_cols=255 Identities=26% Similarity=0.476 Sum_probs=221.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
++|++++.||+|+||.||+|.+..+++.||||++.... .......+..|+.++.+++||||+++++++...+.+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987543 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~ 157 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANS 157 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCC
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875533 2345
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC----CCCc---chhhhHHHHHH
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQL---DEHFSRLMKEF 243 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~----~~~l---~~~is~~L~dL 243 (703)
.+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+.... .+.. ...++..+.+|
T Consensus 158 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l 236 (333)
T cd05600 158 VVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236 (333)
T ss_pred cccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence 6899999999999875 58999999999999999999999998776544433322111 1111 12568899999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
|.+||..+|.+||++.++++||||....
T Consensus 237 i~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 237 ITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred HHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 9999999999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=390.98 Aligned_cols=256 Identities=28% Similarity=0.484 Sum_probs=221.7
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
+|++++.||+|+||.||+|.+..+++.||||++.... .......+..|+.++..+ .||+|+++++++...+.+||||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999987543 223345567788888777 5899999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||+++|+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998654333333345
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... ..++..++..+.+||.+||.+
T Consensus 161 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~l~~ 238 (323)
T cd05616 161 FCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTK 238 (323)
T ss_pred CCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHHccc
Confidence 7899999999999765 58999999999999999999999998877666555554433 244567889999999999999
Q ss_pred CCCCCCC-----HHHHHhchhhhccc
Q 005298 251 VPAERPS-----AKELLRHRFIRNAR 271 (703)
Q Consensus 251 dP~~RPT-----a~eLL~Hpff~~~~ 271 (703)
+|.+|++ ..++++||||+...
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 239 HPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred CHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999997 48999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=394.80 Aligned_cols=257 Identities=30% Similarity=0.537 Sum_probs=222.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||+||+|.+..+++.||||++.... .......+..|+.++..++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999987543 1234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-----
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~----- 165 (703)
||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999987654332
Q ss_pred ------------------------cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee
Q 005298 166 ------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (703)
Q Consensus 166 ------------------------~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l 221 (703)
......+||+.|+|||++.+. .++.++||||||||||+|++|..||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 122346799999999999875 5899999999999999999999999887765544
Q ss_pred eccCCC---CCCCcchhhhHHHHHHHHHHhccCCCCCCC-HHHHHhchhhhccc
Q 005298 222 FIIPRE---NPPQLDEHFSRLMKEFVSLCLKKVPAERPS-AKELLRHRFIRNAR 271 (703)
Q Consensus 222 ~~I~~~---~~~~l~~~is~~L~dLI~~cL~~dP~~RPT-a~eLL~Hpff~~~~ 271 (703)
..+... ...+....+++.+.+||.+||. +|.+||+ +.++++||||....
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID 292 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence 444331 1111223368999999999997 9999999 99999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=398.39 Aligned_cols=257 Identities=29% Similarity=0.501 Sum_probs=217.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||+||+|.+..+++.||||++.... .......+..|+.++.+++||||+++++++.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999986543 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-----
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~----- 165 (703)
|||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999986542110
Q ss_pred ------------------------------cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCC
Q 005298 166 ------------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL 215 (703)
Q Consensus 166 ------------------------------~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~ 215 (703)
......+||+.|+|||++.+. .++.++|||||||+||||++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 001245899999999999765 5899999999999999999999999887
Q ss_pred CccceeeccCCCC-CCCcc--hhhhHHHHHHHHHHhccCCC---CCCCHHHHHhchhhhccc
Q 005298 216 HPMRVLFIIPREN-PPQLD--EHFSRLMKEFVSLCLKKVPA---ERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 216 ~~~~~l~~I~~~~-~~~l~--~~is~~L~dLI~~cL~~dP~---~RPTa~eLL~Hpff~~~~ 271 (703)
+.......+.... ...++ ..++..+++||.+|+. +|. .||++++|++||||....
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 7666555544321 11122 2468899999998765 344 468999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=381.93 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=216.8
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.|++++.||+|+||+||+|.+..+++.||||.+..... ......+.+|+.++++++|+||++++++|.+++.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48999999999999999999999999999999865432 2233467789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|+.+|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVR 159 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Ceec
Confidence 9999999988754 346899999999999999999999999999999999999999999999999998764322 2223
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee---eccCCCCCCCcchhhhHHHHHHHHH
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---FIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l---~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
..+||+.|+|||++.+. .++.++|||||||+||+|++|+.||...+..... ..........++..++..+.+||.+
T Consensus 160 ~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 160 GRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred CCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence 46799999999999865 5899999999999999999999999865432211 1111222334556788999999999
Q ss_pred HhccCCCCCCC-----HHHHHhchhhhccc
Q 005298 247 CLKKVPAERPS-----AKELLRHRFIRNAR 271 (703)
Q Consensus 247 cL~~dP~~RPT-----a~eLL~Hpff~~~~ 271 (703)
||.++|.+||+ ++++++||||....
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 99999999997 89999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=397.91 Aligned_cols=257 Identities=30% Similarity=0.535 Sum_probs=219.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+|..++||||++++++|.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999996542 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc----
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---- 166 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~---- 166 (703)
|||.+|+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999865421110
Q ss_pred ----------------------------------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCC
Q 005298 167 ----------------------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPL 212 (703)
Q Consensus 167 ----------------------------------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF 212 (703)
.....+||+.|+|||++... .++.++|||||||++|+|++|.+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHHHHhhcCCCCC
Confidence 01134799999999998765 5899999999999999999999999
Q ss_pred CCCCccceeeccCCCC-CCC--cchhhhHHHHHHHHHHhccCCCCCCC---HHHHHhchhhhccc
Q 005298 213 ADLHPMRVLFIIPREN-PPQ--LDEHFSRLMKEFVSLCLKKVPAERPS---AKELLRHRFIRNAR 271 (703)
Q Consensus 213 ~~~~~~~~l~~I~~~~-~~~--l~~~is~~L~dLI~~cL~~dP~~RPT---a~eLL~Hpff~~~~ 271 (703)
...+.......+.... ... ....+++.+++||.+||. +|.+|++ +.+++.||||....
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 8877655444433221 111 123568899999999996 8999998 99999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=397.10 Aligned_cols=255 Identities=25% Similarity=0.455 Sum_probs=222.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCC-cEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg-~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
.+|++++.||+|+||.||+|.+..++ ..||||++.... .....+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 47999999999999999999977655 689999986432 233456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|||+.+|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||++..+.. ...
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~---~~~ 186 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---RTY 186 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC---Ccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999875532 223
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
..+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...+.......+.... ..++..++..++++|.+||.
T Consensus 187 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~ 264 (340)
T PTZ00426 187 TLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IYFPKFLDNNCKHLMKKLLS 264 (340)
T ss_pred eecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcc
Confidence 56899999999999765 58899999999999999999999998877655555554433 24456678899999999999
Q ss_pred cCCCCCC-----CHHHHHhchhhhcccc
Q 005298 250 KVPAERP-----SAKELLRHRFIRNARK 272 (703)
Q Consensus 250 ~dP~~RP-----Ta~eLL~Hpff~~~~~ 272 (703)
.+|.+|+ +++++++||||....+
T Consensus 265 ~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 265 HDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred cCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 9999995 8999999999987654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=389.01 Aligned_cols=258 Identities=25% Similarity=0.464 Sum_probs=229.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
....|++.++||+|.|+.||++.+..||+.+|+|+++... .....+.+.+|+.|-+.|+|||||+|++.+......|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4568999999999999999999999999999999987654 233568899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC---CCeeEeccccchhhhhccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~---g~VKL~DFGlA~~~~~~~~ 166 (703)
||+|+|++|..-|-.+.-++|..+..+++||+.+|.|||.+||||||+||+|+|+... .-+||+|||++..+. ...
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~ 167 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGE 167 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Ccc
Confidence 9999999998766555678999999999999999999999999999999999999643 359999999998876 444
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEF 243 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~dL 243 (703)
....++|||.|||||++... .|+..+|||++|||||-||.|.+||++.+....+..|.... +.+...++++.+++|
T Consensus 168 ~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred ccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 55568999999999999775 59999999999999999999999999988888887776543 444567899999999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
|++||..||.+|+|+.|.|+|||+.+.
T Consensus 247 vrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999754
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=396.75 Aligned_cols=260 Identities=30% Similarity=0.471 Sum_probs=230.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
..|++++.||.|.-|+||+|....++..+|||++++.. ..+.+.+.+.|-+||..++||.++.||..|+.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 47999999999999999999999999999999997665 3445678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh-----
Q 005298 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR----- 163 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~----- 163 (703)
|||.||+|..+++++ ..|++..+++|+.+++.||+|||-.|||+|||||+||||-++|+|.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 999999999999764 5799999999999999999999999999999999999999999999999999643210
Q ss_pred ----------------------------c-c----------------------cccccccCCCCCCchhhhccccCCccc
Q 005298 164 ----------------------------T-I----------------------SRRKTFVGTPFWMAPEVIQNSEGYNEK 192 (703)
Q Consensus 164 ----------------------------~-~----------------------~~~~~~iGTp~Y~APEvl~~~~~~s~k 192 (703)
. . ...+.++||-.|+|||++.+. +.+.+
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-GHgsA 315 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-GHGSA 315 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC-CCCch
Confidence 0 0 011346899999999999885 69999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc-chhhhHHHHHHHHHHhccCCCCCCC----HHHHHhchhh
Q 005298 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-DEHFSRLMKEFVSLCLKKVPAERPS----AKELLRHRFI 267 (703)
Q Consensus 193 sDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l-~~~is~~L~dLI~~cL~~dP~~RPT----a~eLL~Hpff 267 (703)
+|||+|||+|||||.|..||.+.+..+++..|....+... ...++..+++||+++|.+||.+|.. |.||.+||||
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFF 395 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccc
Confidence 9999999999999999999999999999888876543222 2267899999999999999999998 9999999999
Q ss_pred hccccC
Q 005298 268 RNARKS 273 (703)
Q Consensus 268 ~~~~~~ 273 (703)
+..+|.
T Consensus 396 ~gVnWa 401 (459)
T KOG0610|consen 396 EGVNWA 401 (459)
T ss_pred cCCChh
Confidence 998765
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=390.15 Aligned_cols=251 Identities=28% Similarity=0.487 Sum_probs=218.1
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
++||+|+||.||+|.+..+++.||||++.... .......+..|+.++..+ +||||++++++|...+.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999986532 233455677888888866 799999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 99999998888999999999999999999999999999999999999999999999999999875433333344568999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
.|+|||++.+. .++.++|||||||++|+|++|..||...+....+..+..... .++..++..+.+||.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~ll~~~L~~dp~~R 238 (321)
T cd05591 161 DYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV-LYPVWLSKEAVSILKAFMTKNPNKR 238 (321)
T ss_pred cccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhccCHHHc
Confidence 99999999765 589999999999999999999999998877666665554332 3445678899999999999999999
Q ss_pred C-------CHHHHHhchhhhccc
Q 005298 256 P-------SAKELLRHRFIRNAR 271 (703)
Q Consensus 256 P-------Ta~eLL~Hpff~~~~ 271 (703)
| ++.++++||||....
T Consensus 239 ~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 239 LGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred CCCCCCCCCHHHHhcCCccCCCC
Confidence 9 999999999997653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=390.28 Aligned_cols=251 Identities=27% Similarity=0.497 Sum_probs=215.0
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHh-CCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQ-CRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~-L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
++||+|+||.||+|.++.+|..||||++.... .......+..|+.++.. ++||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999999999999999987542 12334566778888875 4899999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999864332223334578999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... .+.++..++..+++||.+||..||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R 238 (316)
T cd05620 161 DYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHYPRWITKESKDILEKLFERDPTRR 238 (316)
T ss_pred CccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999765 5899999999999999999999999877665555444333 334555688999999999999999999
Q ss_pred CCH-HHHHhchhhhccc
Q 005298 256 PSA-KELLRHRFIRNAR 271 (703)
Q Consensus 256 PTa-~eLL~Hpff~~~~ 271 (703)
|++ ++++.||||....
T Consensus 239 ~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 239 LGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CCChHHHHcCCCcCCCC
Confidence 997 5888999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=399.78 Aligned_cols=258 Identities=26% Similarity=0.496 Sum_probs=218.8
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
+.|++++.||+|+||+||+|++..+++.||||++.... .......+.+|+.++++++|||||+++++|.+++.+||||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999986543 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc------
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT------ 164 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~------ 164 (703)
|||++|+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999997532100
Q ss_pred -----------------------------------------ccccccccCCCCCCchhhhccccCCccccchhhHHHHHH
Q 005298 165 -----------------------------------------ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVI 203 (703)
Q Consensus 165 -----------------------------------------~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILy 203 (703)
.......+||+.|+|||++.+. .|+.++||||||||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCeeeEEechHHHH
Confidence 0001235799999999999765 5899999999999999
Q ss_pred HHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHHHHHHHhccCCCCCCC---HHHHHhchhhhcccc
Q 005298 204 EMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVPAERPS---AKELLRHRFIRNARK 272 (703)
Q Consensus 204 ELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~dLI~~cL~~dP~~RPT---a~eLL~Hpff~~~~~ 272 (703)
||++|.+||...++......+.... ..+....+++.+.++|.+|+ .+|.+|++ +.+++.||||.....
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 9999999998877655444433211 11223467889999999976 59999997 999999999987643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=378.69 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=225.5
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-HHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~-~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|..++.||+|.||.||+|++..||+.||||.++..+..+ ......+||++|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 47899999999999999999999999999999998776433 23567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 92 yv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|+ ..+|...|+.. ..|+...++.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+++.+..+......
T Consensus 82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 99 57999999764 57899999999999999999999999999999999999999999999999999988766655555
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-----------------------
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----------------------- 227 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~----------------------- 227 (703)
.+-|.+|+|||++.+...|+..+||||.|||+.||+-|.+.|.+.++.+.+..|...
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~ 240 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ 240 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence 588999999999999999999999999999999999999999988776666544211
Q ss_pred CCC-C---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 228 NPP-Q---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 228 ~~~-~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.|. . +-...+..+.+|+.+||..||.+|+++.|+|+|+||...
T Consensus 241 ~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 241 FPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred CCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 011 1 112346778999999999999999999999999999863
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=389.84 Aligned_cols=252 Identities=28% Similarity=0.490 Sum_probs=214.2
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
++||+|+||.||+|.+..+++.||||+++... .......+..|+.++.++ +||||++++++|.+.+.+|||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999997543 233456688999999998 799999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
|+|..++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999865333333344578999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--------ceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM--------RVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~--------~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
.|+|||++.+. .++.++|||||||+||+|++|..||...... .............++..++..+.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 239 (329)
T cd05588 161 NYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239 (329)
T ss_pred cccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 99999999775 5899999999999999999999999632211 11112222233445667889999999999
Q ss_pred hccCCCCCCC------HHHHHhchhhhccc
Q 005298 248 LKKVPAERPS------AKELLRHRFIRNAR 271 (703)
Q Consensus 248 L~~dP~~RPT------a~eLL~Hpff~~~~ 271 (703)
|.++|.+|++ +.++++||||....
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 240 LNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred hccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 9999999987 78999999997653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=392.39 Aligned_cols=251 Identities=29% Similarity=0.524 Sum_probs=217.8
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gG 96 (703)
+.||+|+||.||+|.+..+|+.||||++.... .......+..|+.++..++||||+++++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999987543 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 97 sL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
+|..++.....+++..+..++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||++.............+||+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 999999888899999999999999999999997 7999999999999999999999999999865433333334568999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+... ...++..+++.+.+||.+||.+||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R 238 (325)
T cd05594 161 EYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLSGLLKKDPKQR 238 (325)
T ss_pred ccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHhhcCHHHh
Confidence 99999999765 5899999999999999999999999877655544444332 234556788999999999999999999
Q ss_pred C-----CHHHHHhchhhhccc
Q 005298 256 P-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 256 P-----Ta~eLL~Hpff~~~~ 271 (703)
+ ++.++++||||....
T Consensus 239 ~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 239 LGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CCCCCCCHHHHhcCCCcCCCC
Confidence 7 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=388.80 Aligned_cols=257 Identities=28% Similarity=0.485 Sum_probs=217.2
Q ss_pred CceEEEEEeecCceEEEEEEEc---CCCcEEEEEEeccCC---ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~---~tg~~VAIKvi~~~~---~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~l 86 (703)
+|++++.||+|+||.||++.+. .+++.||||++.... .....+.+..|+.+++++ +||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5999999999999999999874 478999999986432 223356788899999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-
Q 005298 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~- 165 (703)
|+||||+.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987543222
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc----eeeccCCCCCCCcchhhhHHHH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR----VLFIIPRENPPQLDEHFSRLMK 241 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~----~l~~I~~~~~~~l~~~is~~L~ 241 (703)
......+||+.|+|||++.+...++.++||||||||||+|++|..||....... ....+.. ..+.++..++..+.
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPSFIGPEAQ 239 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHH
Confidence 222346899999999999865557889999999999999999999996543221 1112222 22345567889999
Q ss_pred HHHHHHhccCCCCCC-----CHHHHHhchhhhccc
Q 005298 242 EFVSLCLKKVPAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 242 dLI~~cL~~dP~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
+||.+||..||.+|| +++++++||||....
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999999999 889999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=388.02 Aligned_cols=252 Identities=28% Similarity=0.500 Sum_probs=218.1
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
+.||+|+||+||+|.+..+++.||||++.... .......+..|+.++..+ +||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999987542 223456677899999888 699999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 99999998888999999999999999999999999999999999999999999999999999865333323334568999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... ..++..++..+.+||.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R 238 (318)
T cd05570 161 DYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-VRYPRWLSKEAKSILKSFLTKNPEKR 238 (318)
T ss_pred cccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHccCCHHHc
Confidence 99999999775 58899999999999999999999998776655554444333 24456788999999999999999999
Q ss_pred CCH-----HHHHhchhhhcccc
Q 005298 256 PSA-----KELLRHRFIRNARK 272 (703)
Q Consensus 256 PTa-----~eLL~Hpff~~~~~ 272 (703)
|++ .+++.||||....+
T Consensus 239 ~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 239 LGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CCCCCCCHHHHhcCCCcCCCCH
Confidence 999 99999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=388.94 Aligned_cols=252 Identities=28% Similarity=0.507 Sum_probs=217.7
Q ss_pred EEEEeecCceEEEEEEEc---CCCcEEEEEEeccCC---ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 18 LELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~---~tg~~VAIKvi~~~~---~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
++.||+|+||.||++.+. .+++.||||++.... .......+..|+.+|+.++||||++++++|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 468999999999999874 478999999986532 22334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
|+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.............
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99999999999988899999999999999999999999999999999999999999999999999986543333334456
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccC
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~d 251 (703)
+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+.... ..++..++..+.+||.+||.++
T Consensus 161 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~ 238 (323)
T cd05584 161 CGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKKLLKRN 238 (323)
T ss_pred CCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHcccC
Confidence 899999999999765 48899999999999999999999998877665555554432 2455677899999999999999
Q ss_pred CCCCC-----CHHHHHhchhhhccc
Q 005298 252 PAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 252 P~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
|.+|| ++.+++.||||....
T Consensus 239 p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 239 PSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred HhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999 899999999998653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=385.98 Aligned_cols=257 Identities=34% Similarity=0.607 Sum_probs=219.6
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||+|+||.||++++..++..||+|++...........+.+|+.+|++++||||+++++++..++.+|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 57899999999999999999999999999999999766555556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~-gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+... ....
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 161 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS 161 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--cccc
Confidence 999999999999888899999999999999999999986 6999999999999999999999999998755332 2235
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc--------------------------
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------------------------- 224 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I-------------------------- 224 (703)
.+||+.|+|||++.+. .++.++|||||||+||+|++|+.||...........+
T Consensus 162 ~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd06649 162 FVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV 240 (331)
T ss_pred CCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccc
Confidence 6899999999999875 5899999999999999999999999654332111000
Q ss_pred --------------------CCCCCCC-cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 225 --------------------PRENPPQ-LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 225 --------------------~~~~~~~-l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
....++. ....++..+++||.+||.+||++|||+.+|++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0001111 1124678899999999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=387.05 Aligned_cols=251 Identities=30% Similarity=0.538 Sum_probs=215.4
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHh-CCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQ-CRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~-L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
+.||+|+||+||+|.+..+++.||||++.... ..........|+.++.. ++||||+++++++.+.+.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999987542 12334556678888876 4899999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
|+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999865332222334568999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... +.++..++..+++||.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R 238 (316)
T cd05619 161 DYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVREPERR 238 (316)
T ss_pred cccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhccCHhhc
Confidence 99999999765 58999999999999999999999998877655555544333 23455688899999999999999999
Q ss_pred CCHH-HHHhchhhhccc
Q 005298 256 PSAK-ELLRHRFIRNAR 271 (703)
Q Consensus 256 PTa~-eLL~Hpff~~~~ 271 (703)
|++. +++.||||....
T Consensus 239 ~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 239 LGVKGDIRQHPFFREID 255 (316)
T ss_pred CCChHHHHcCcccCCCC
Confidence 9996 899999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=385.66 Aligned_cols=257 Identities=27% Similarity=0.453 Sum_probs=210.5
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----CEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----TKLW 87 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~-----~~ly 87 (703)
+|++.+.||+|+||.||+|++..++..||||++.... .......+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999999999999999986432 223345688999999999999999999988643 3589
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 166 (703)
+||||| +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999 579999998888899999999999999999999999999999999999999999999999999875432211
Q ss_pred --ccccccCCCCCCchhhhccc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeec--------------------
Q 005298 167 --RRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI-------------------- 223 (703)
Q Consensus 167 --~~~~~iGTp~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~-------------------- 223 (703)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||...+....+..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 12346899999999998652 3588899999999999999999999976543221110
Q ss_pred -------cCCCCCCCcc---hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 224 -------IPRENPPQLD---EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 224 -------I~~~~~~~l~---~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
+....+..+. ..++..+.+||.+||..+|.+|||+.++++||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 0111111111 23567789999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=390.43 Aligned_cols=262 Identities=48% Similarity=0.911 Sum_probs=243.3
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
.....-|.++..||+|+||.||+++++.+|..||||.+... ..++.+.+||.|+.+++.|++|+||+.|.....+||
T Consensus 29 K~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 29 KPPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred CChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 34455689999999999999999999999999999998754 457889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 89 IMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~-~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
|||||..|+..++++ ++.+|.+.++..+++..++||+|||...-||||||..|||++.+|++||+|||.+.++.....+
T Consensus 106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 999999999999996 5678999999999999999999999999999999999999999999999999999999888888
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--chhhhHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFVS 245 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l--~~~is~~L~dLI~ 245 (703)
.++.+|||.|||||++... +|+.++||||||++..||..|++||.+.+++..++.|+...|+.+ ++.++.++.+||+
T Consensus 186 RNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR 264 (502)
T ss_pred hCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence 8999999999999999876 599999999999999999999999999999999999998777765 4678999999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhccccCh
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRNARKSP 274 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~~~~~~ 274 (703)
.||.++|++|-|+-++++|||+++.....
T Consensus 265 ~CLiK~PE~R~TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCEHTFIKNAPGCD 293 (502)
T ss_pred HHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence 99999999999999999999998875443
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=396.11 Aligned_cols=257 Identities=29% Similarity=0.504 Sum_probs=216.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++++++|||||+++++|.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999986432 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc----
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---- 166 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~---- 166 (703)
||++||+|.+++.....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999853211000
Q ss_pred -------------------------------------------ccccccCCCCCCchhhhccccCCccccchhhHHHHHH
Q 005298 167 -------------------------------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVI 203 (703)
Q Consensus 167 -------------------------------------------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILy 203 (703)
.....+||+.|+|||++.+. .++.++||||||||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCceeeEecchhhh
Confidence 00125799999999999765 5899999999999999
Q ss_pred HHHhCCCCCCCCCccceeeccCCC-CCCCcc--hhhhHHHHHHHHHHhccCCCCC---CCHHHHHhchhhhccc
Q 005298 204 EMAKGEPPLADLHPMRVLFIIPRE-NPPQLD--EHFSRLMKEFVSLCLKKVPAER---PSAKELLRHRFIRNAR 271 (703)
Q Consensus 204 ELLtG~~PF~~~~~~~~l~~I~~~-~~~~l~--~~is~~L~dLI~~cL~~dP~~R---PTa~eLL~Hpff~~~~ 271 (703)
||++|.+||...+....+..+... ....++ ..++..+++||.+||. +|.+| +++.+++.||||....
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 999999999877665544444321 111222 2578899999999997 66665 5999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=388.12 Aligned_cols=267 Identities=31% Similarity=0.528 Sum_probs=242.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|..+++||+|.||+|-+|+.+.+++.||||++++.- ..+++.....|-.+|+.++||++..|...|+..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 58999999999999999999999999999999987654 4566788889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||++||.|+.++.+...|++...+.|...|+.||.|||+++||+||||.+|+|+|++|++||+|||+|+..........+
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kT 327 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKT 327 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceecc
Confidence 99999999999999899999999999999999999999999999999999999999999999999999876666677789
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
+||||.|+|||++... .|+.++|+|.+|||||||++|++||...+.......|.... ..++..++++++.|+..+|.+
T Consensus 328 FCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-~kFPr~ls~eAktLLsGLL~k 405 (516)
T KOG0690|consen 328 FCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-LKFPRTLSPEAKTLLSGLLKK 405 (516)
T ss_pred ccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-ccCCccCCHHHHHHHHHHhhc
Confidence 9999999999999775 69999999999999999999999999888777666665433 367788999999999999999
Q ss_pred CCCCCC-----CHHHHHhchhhhccccChhHHHHhh
Q 005298 251 VPAERP-----SAKELLRHRFIRNARKSPRLLERIR 281 (703)
Q Consensus 251 dP~~RP-----Ta~eLL~Hpff~~~~~~~~l~e~i~ 281 (703)
||.+|. .+.+|.+|+||..+.+.......+.
T Consensus 406 dP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~ 441 (516)
T KOG0690|consen 406 DPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIE 441 (516)
T ss_pred ChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccC
Confidence 999997 4899999999999877665555544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=394.58 Aligned_cols=260 Identities=27% Similarity=0.508 Sum_probs=235.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
...+|++.+.||+|.||+|.+|.+...|+.||||.|++.. .++.+-.+.+||+||..|+||||+.+|++|+..+.++|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3458999999999999999999999999999999998766 44556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||||..+|.|.+|+.+.+.|++.+++.||+||..|+.|||.++++|||||.+|||+|.++++||+||||+..+.. ....
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-~kfL 209 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-KKFL 209 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc-ccHH
Confidence 999999999999999999999999999999999999999999999999999999999999999999999876643 3456
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
.+|||+|.|.+||++.+..+-++.+|.|||||+||-|+.|..||.+.+...++.+|..+.... ..-+..+.-||++||
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--P~~PSdA~gLIRwmL 287 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--PETPSDASGLIRWML 287 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--CCCCchHHHHHHHHH
Confidence 789999999999999998877899999999999999999999999999888888888765332 234567888999999
Q ss_pred ccCCCCCCCHHHHHhchhhhccccC
Q 005298 249 KKVPAERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~~~~ 273 (703)
..+|++|.|+.+|..|=|++-....
T Consensus 288 mVNP~RRATieDiAsHWWvNwgy~~ 312 (668)
T KOG0611|consen 288 MVNPERRATIEDIASHWWVNWGYNM 312 (668)
T ss_pred hcCcccchhHHHHhhhheeeccccc
Confidence 9999999999999999887654433
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=386.15 Aligned_cols=251 Identities=29% Similarity=0.465 Sum_probs=213.9
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHH-HHHhCCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEIS-VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~-ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
++||+|+||+||+|.+..+|+.||||++..... ......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 479999999999999999999999999865421 222344445544 56889999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
++|..++.....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 99999999888999999999999999999999999999999999999999999999999999865433333334568999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+... +..+...++..+.+||.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (323)
T cd05575 161 EYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK-PLRLKPNISVSARHLLEGLLQKDRTKR 238 (323)
T ss_pred hhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHhhcCHHhC
Confidence 99999999775 5899999999999999999999999887665555444433 234455678999999999999999999
Q ss_pred CCH----HHHHhchhhhccc
Q 005298 256 PSA----KELLRHRFIRNAR 271 (703)
Q Consensus 256 PTa----~eLL~Hpff~~~~ 271 (703)
|++ .+++.||||....
T Consensus 239 ~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 239 LGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CCCCCCHHHHHcCCCcCCCC
Confidence 987 6999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=382.63 Aligned_cols=258 Identities=26% Similarity=0.456 Sum_probs=224.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-HHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~-~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~lyLV 89 (703)
.+|+++..|++|+||.||+|+|+.|++.||+|.++...... ..-.-.+||.+|.+++|||||.+.++.... +.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 48999999999999999999999999999999998776322 223456899999999999999999988754 579999
Q ss_pred EeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 90 MEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||||+ .+|..++..- .+|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+..+....
T Consensus 156 Me~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred HHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence 99995 5899999764 489999999999999999999999999999999999999999999999999999998887777
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC--C------------------
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--N------------------ 228 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~--~------------------ 228 (703)
+..+-|.||+|||++++.+.|+..+||||+||||.||+++++.|.+....+.+.+|... .
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 78889999999999999999999999999999999999999999988776666554210 0
Q ss_pred -CCC---------cch-hhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 229 -PPQ---------LDE-HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 229 -~~~---------l~~-~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+. +.. .++....+|+..+|..||.+|.||.|.|+|.||....
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 000 001 1457788999999999999999999999999998753
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=388.89 Aligned_cols=251 Identities=30% Similarity=0.485 Sum_probs=213.9
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC---CCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC---RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 21 LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L---~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
||+|+||+||+|.+..+++.||||++.... ..........|..++..+ .||||+++++++...+.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999986432 122334455677777665 699999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 99999999888999999999999999999999999999999999999999999999999999865433333345678999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
.|+|||++.+...++.++|||||||+||+|++|..||...+.......+...........++..+.+||.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence 99999999766568899999999999999999999998876655555554433322234578899999999999999999
Q ss_pred C----CHHHHHhchhhhccc
Q 005298 256 P----SAKELLRHRFIRNAR 271 (703)
Q Consensus 256 P----Ta~eLL~Hpff~~~~ 271 (703)
| ++.++++||||....
T Consensus 241 ~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 241 LGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCCCHHHHhcCccccCCC
Confidence 8 799999999998654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=396.77 Aligned_cols=259 Identities=31% Similarity=0.561 Sum_probs=230.9
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTK 85 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~--~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~ 85 (703)
......|++.+.||+|.||.||+|+++.||+.||+|++.+.... ...+.+.+|+.||+++. |||||.++++|.+...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 34456899999999999999999999999999999999766532 24578999999999998 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC----CCeeEeccccchhh
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN----GDVKVADFGVSAQL 161 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~----g~VKL~DFGlA~~~ 161 (703)
+|||||+|.||.|++.+... .+++..+..++.||+.++.|||+.||+||||||+|||+... +.+|++|||++...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999776 49999999999999999999999999999999999999743 47999999999887
Q ss_pred hhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhH
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSR 238 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~ 238 (703)
.. .......||||.|+|||++... .|+..+||||+||++|.|++|.+||...........|.... .......++.
T Consensus 190 ~~-~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 190 KP-GERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred cC-CceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 66 4566788999999999999764 59999999999999999999999999988766666666553 3344567899
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 239 ~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+++||+.||..||.+|+|+.++|+|||+...
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999998765
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=390.96 Aligned_cols=254 Identities=33% Similarity=0.529 Sum_probs=215.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++++.||+|+||.||+|.+..+++.||||++...........+.+|+.+++.++|+||+++++++...+.+|+||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 47899999999999999999999999999999987655555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
+++++|... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..........+
T Consensus 154 ~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 229 (353)
T PLN00034 154 MDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV 229 (353)
T ss_pred CCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccc
Confidence 999998753 3467888899999999999999999999999999999999999999999999876644333334568
Q ss_pred CCCCCCchhhhcc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccce---eeccCCCCCCCcchhhhHHHHHHHH
Q 005298 173 GTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV---LFIIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 173 GTp~Y~APEvl~~----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~---l~~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
||+.|+|||++.. ..+++.++|||||||+||+|++|+.||.......+ ...+.....+..+..++..+++||.
T Consensus 230 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 309 (353)
T PLN00034 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFIS 309 (353)
T ss_pred cCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHH
Confidence 9999999998743 22345689999999999999999999974332221 1222233344555678899999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhcc
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+||..+|.+||++.|||+||||...
T Consensus 310 ~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 310 CCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHccCChhhCcCHHHHhcCcccccC
Confidence 9999999999999999999999865
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=387.00 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=223.9
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEec-cCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe-----C
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID-LEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-----Q 83 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~-~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~-----~ 83 (703)
.....|..++.||+|+||.|+.+.++.+|+.||||.+. .....-..++..+|+.+|+.++|+||+.+++++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 35567888999999999999999999999999999986 23345557889999999999999999999999876 3
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
+.+|+|+|+| +.+|...|+.+..|+++.+..+++||++||.|+|+.+|+||||||.|||++.+..+||||||+|+....
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 5689999999 789999999988899999999999999999999999999999999999999999999999999987643
Q ss_pred --cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-------------
Q 005298 164 --TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN------------- 228 (703)
Q Consensus 164 --~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~------------- 228 (703)
.....+.++-|.||+|||++.....|+..+||||+||||.|||+|++.|.+.+....+..|....
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 12334568899999999999988889999999999999999999999998876555443332110
Q ss_pred --------------CCC---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 229 --------------PPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 229 --------------~~~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+.+ +-.+.++.+.+|+.+||..||.+|+|++|+|.||||...
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 111 113567889999999999999999999999999999754
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=382.78 Aligned_cols=252 Identities=28% Similarity=0.497 Sum_probs=215.4
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
+.||+|+||+||+|.+..+++.||||++.... .......+..|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997543 233456788999999888 699999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
++|..++.....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999865333223334578999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc------cceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP------MRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~------~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
.|+|||++.+. .++.++|||||||+||+|++|..||..... ......+....+..++..++..+.++|.+||.
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 239 (327)
T cd05617 161 NYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239 (327)
T ss_pred ccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999765 589999999999999999999999964321 12222222334445667788999999999999
Q ss_pred cCCCCCCC------HHHHHhchhhhccc
Q 005298 250 KVPAERPS------AKELLRHRFIRNAR 271 (703)
Q Consensus 250 ~dP~~RPT------a~eLL~Hpff~~~~ 271 (703)
+||.+|++ +.+++.||||....
T Consensus 240 ~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 240 KDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred cCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 99999997 57999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=385.49 Aligned_cols=252 Identities=29% Similarity=0.501 Sum_probs=213.1
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
+.||+|+||+||+|.+..+++.||||++.... .......+..|+.++.++ +||||+++++++...+.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999987542 233456678899988876 799999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
++|..++.....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999865433333334578999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--------ceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM--------RVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~--------~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
.|+|||++.+. .++.++|||||||++|+|++|..||...... .............++..++..+.+||.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~ 239 (329)
T cd05618 161 NYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239 (329)
T ss_pred cccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 99999999775 5889999999999999999999999632111 11111112233345667889999999999
Q ss_pred hccCCCCCCC------HHHHHhchhhhccc
Q 005298 248 LKKVPAERPS------AKELLRHRFIRNAR 271 (703)
Q Consensus 248 L~~dP~~RPT------a~eLL~Hpff~~~~ 271 (703)
|.+||.+||+ +.++++||||+...
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 240 LNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred hcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 9999999998 58999999998653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=390.70 Aligned_cols=258 Identities=29% Similarity=0.512 Sum_probs=218.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||.||+|.+..+++.||||++.... .......+..|+.++.+++||||+++++.+.+++.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 37999999999999999999999999999999986432 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-----
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----- 165 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~----- 165 (703)
|||+||+|.+++.+...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999986442110
Q ss_pred ------------------------------cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCC
Q 005298 166 ------------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL 215 (703)
Q Consensus 166 ------------------------------~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~ 215 (703)
......+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeecccCCCCCCCC
Confidence 001245899999999999775 5899999999999999999999999887
Q ss_pred CccceeeccCCCC-CCCcc--hhhhHHHHHHHHHHhccCCCCCC---CHHHHHhchhhhcccc
Q 005298 216 HPMRVLFIIPREN-PPQLD--EHFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIRNARK 272 (703)
Q Consensus 216 ~~~~~l~~I~~~~-~~~l~--~~is~~L~dLI~~cL~~dP~~RP---Ta~eLL~Hpff~~~~~ 272 (703)
+.......+.... ...++ ..++..+++||.+|+ .+|.+|+ ++.+++.||||....+
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 7665554443221 11111 246889999999977 5999998 5899999999987643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=383.26 Aligned_cols=258 Identities=30% Similarity=0.458 Sum_probs=219.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++.+.||+|+||+||+|.+..+|+.||||+++.... ......+.+|+.+++.++||||+++++++.+.+.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 379999999999999999999999999999999875432 334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-cc
Q 005298 91 EYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~ 168 (703)
||+++++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+||||+.+|.+||+|||++..+..... ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999999875 6899999999999999999999999999999999999999999999999999876543222 12
Q ss_pred ccccCCCCCCchhhhcc-----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CC--CcchhhhHHH
Q 005298 169 KTFVGTPFWMAPEVIQN-----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PP--QLDEHFSRLM 240 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~-----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~-~~--~l~~~is~~L 240 (703)
...+||+.|+|||++.. ...++.++|||||||+||+|++|..||...+....+..+.... .. +....++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence 23579999999999863 3357889999999999999999999998776555444433211 11 1123578899
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+||.+||. +|.+||++.+++.||||....
T Consensus 241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 241 LDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred HHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 999999997 999999999999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=380.55 Aligned_cols=256 Identities=28% Similarity=0.485 Sum_probs=220.4
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyLV~ 90 (703)
+|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+..|+.++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999987542 2234566778889998886 577889999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||+++|+|.+++.....+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 99999999999998889999999999999999999999999999999999999999999999999998754333233345
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...+.......+.... ..++..++..+.+++.+||.+
T Consensus 161 ~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~ 238 (323)
T cd05615 161 FCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICKGLMTK 238 (323)
T ss_pred ccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHccc
Confidence 6799999999999765 58999999999999999999999998877655555544332 244567888999999999999
Q ss_pred CCCCCCC-----HHHHHhchhhhccc
Q 005298 251 VPAERPS-----AKELLRHRFIRNAR 271 (703)
Q Consensus 251 dP~~RPT-----a~eLL~Hpff~~~~ 271 (703)
+|.+|++ ..++++||||....
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 239 HPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred CHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 9999997 58999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=379.04 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=214.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++++.||+|+||.||+|.++.+++.||||.++..........+.+|+.++++++||||+++++++..++..|+||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999999999999999987654433345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 93 v~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
+.+ +|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 164 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE 164 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccc
Confidence 965 78887755 3468999999999999999999999999999999999999999999999999986544333333345
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------------CCC
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------------------ENP 229 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~----------------------~~~ 229 (703)
.+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+....+.. ..+
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07872 165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFP 244 (309)
T ss_pred cccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcC
Confidence 7899999999987655688999999999999999999999976654322211100 000
Q ss_pred C-------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 230 P-------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 230 ~-------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
. .....++..+++||.+||..||.+|||+.++++||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred ccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 0 0112467789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=391.02 Aligned_cols=249 Identities=35% Similarity=0.594 Sum_probs=218.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcE-EEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-EEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-VAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-KLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~-VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~-~lyLV 89 (703)
..+.+.+.||.|+||+||+|.+. |.. ||||++.... .......+.+|+.+|.+|+|||||+++|++.... .++||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 35566677999999999999988 555 9999997554 2223678999999999999999999999999887 79999
Q ss_pred EeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcC-ceeeeeccceEEecCCC-CeeEeccccchhhhhcc
Q 005298 90 MEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG-KIHRDIKAANILLTENG-DVKVADFGVSAQLTRTI 165 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~g-IVHRDIKPeNILLd~~g-~VKL~DFGlA~~~~~~~ 165 (703)
|||+++|+|.+++.. ...++...+..|+.||++|+.|||+++ ||||||||+||||+.++ ++||||||+++......
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999999987 688999999999999999999999999 99999999999999997 99999999997765443
Q ss_pred cccccccCCCCCCchhhhcc-ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCcchhhhHHHHHH
Q 005298 166 SRRKTFVGTPFWMAPEVIQN-SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~-~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~-~~~~~~l~~~is~~L~dL 243 (703)
.......||+.|||||++.+ ...|+.++||||||++||||+||+.||...........+. ....+.++..+++.+..+
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l 278 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSL 278 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence 33344789999999999985 2469999999999999999999999999998766555554 555667777799999999
Q ss_pred HHHHhccCCCCCCCHHHHHh
Q 005298 244 VSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~ 263 (703)
|..||..||..||++.+|+.
T Consensus 279 ~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 279 MERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999986
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=399.58 Aligned_cols=258 Identities=36% Similarity=0.560 Sum_probs=238.8
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE-EEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK-LWII 89 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~-lyLV 89 (703)
-.+|..++++|+|+||.+++++++..+..|++|.+.... .........+|+.+++++.|||||.+++.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 368999999999999999999999999999999998776 33344578899999999999999999999999888 9999
Q ss_pred EeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 90 MEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
|+||+||+|.+.|.+. ..|+++.+..|+.||+.||.|||++.|+|||||+.|||+++++.|||+|||+++.+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 9999999999999653 57999999999999999999999999999999999999999999999999999998877656
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
..+++|||.||+||++.+. .|+.++|||||||++|||++-+++|...+......+|......+++..++.+++.+|..|
T Consensus 163 a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~ 241 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSM 241 (426)
T ss_pred hheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHH
Confidence 7789999999999999886 599999999999999999999999999998888889988888889999999999999999
Q ss_pred hccCCCCCCCHHHHHhchhhhcc
Q 005298 248 LKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
|.++|..||++.+||.+|.+...
T Consensus 242 l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 242 LRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred hhcCCccCCCHHHHhhChhhhhH
Confidence 99999999999999999887644
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=389.33 Aligned_cols=260 Identities=26% Similarity=0.458 Sum_probs=220.4
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
..+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.+++.+|||
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 358999999999999999999999999999999986432 222345678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-cc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~ 168 (703)
||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ ..
T Consensus 122 ~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~ 200 (370)
T cd05596 122 MEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200 (370)
T ss_pred EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccC
Confidence 999999999999875 4689999999999999999999999999999999999999999999999999876543221 22
Q ss_pred ccccCCCCCCchhhhccc---cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCcc--hhhhHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNS---EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLD--EHFSRLMKE 242 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~---~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~-~~~l~--~~is~~L~d 242 (703)
...+||+.|+|||++.+. ..++.++|||||||+||+|++|.+||...+....+..+.... ...++ ..++..+++
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKD 280 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHH
Confidence 356899999999998653 237889999999999999999999998877655555443321 11222 257899999
Q ss_pred HHHHHhccCCCC--CCCHHHHHhchhhhcccc
Q 005298 243 FVSLCLKKVPAE--RPSAKELLRHRFIRNARK 272 (703)
Q Consensus 243 LI~~cL~~dP~~--RPTa~eLL~Hpff~~~~~ 272 (703)
||.+||..+|.+ |+++.+++.||||+...+
T Consensus 281 li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 281 LICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred HHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 999999999988 999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=406.75 Aligned_cols=266 Identities=45% Similarity=0.814 Sum_probs=241.8
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.-|+|+..||.|+||+||+|.++.++-..|.|+|... ....++.+.-||.||..|+||+||+|++.|..++.+||+.||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 4678999999999999999999999999999998654 456788899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 93 v~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
|.||-...++-. +..|.+.+|..+++|+|.||.|||+++|||||||..|||++-+|.|+|+|||.+...........+|
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 999999988754 5689999999999999999999999999999999999999999999999999998777777778899
Q ss_pred cCCCCCCchhhhccc----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--chhhhHHHHHHHH
Q 005298 172 VGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFVS 245 (703)
Q Consensus 172 iGTp~Y~APEvl~~~----~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l--~~~is~~L~dLI~ 245 (703)
+|||+|||||++.+. ..|++++||||||++|.||..+.+|....+++.++.+|.+..||.+ +.+++..+.+|+.
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk 270 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLK 270 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHH
Confidence 999999999997532 4599999999999999999999999999999999999999888765 5689999999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhccccChhHHHH
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRLLER 279 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~e~ 279 (703)
+||.+||..||++.+||+||||.+......+.+.
T Consensus 271 ~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ireL 304 (1187)
T KOG0579|consen 271 RCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIREL 304 (1187)
T ss_pred HHHhcCCccCCCHHHHhhCcccccCCcchHHHHH
Confidence 9999999999999999999999977554444433
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=399.45 Aligned_cols=266 Identities=44% Similarity=0.788 Sum_probs=235.9
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
.+...|.-++.||.|+||.||.|++..+...||||.+.... .....+.+.+||.+|.+|+|||+|.|.+||..+...|
T Consensus 23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW 102 (948)
T ss_pred CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence 34457888999999999999999999999999999987654 3344678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
|||||| -|+-.+++.- ..+|-+.+|..|..+.+.||.|||+++.||||||..|||++..|.|||+|||.+....
T Consensus 103 LVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---- 177 (948)
T KOG0577|consen 103 LVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---- 177 (948)
T ss_pred HHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC----
Confidence 999999 5677777753 4689999999999999999999999999999999999999999999999999886653
Q ss_pred ccccccCCCCCCchhhhccc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcc-hhhhHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD-EHFSRLMKEF 243 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~--~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~-~~is~~L~dL 243 (703)
..++|+|||+|||||+|+.. ..|+.++||||||++..||...++|+..+|-+..++.|.....|.+. ..++..+.+|
T Consensus 178 PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 178 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence 34689999999999998642 45999999999999999999999999999999999888877766654 6889999999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhccccChhHHHHh
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~e~i 280 (703)
|..||.+-|.+|||.+++|+|+|....+....+.+.|
T Consensus 258 vd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLI 294 (948)
T KOG0577|consen 258 VDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLI 294 (948)
T ss_pred HHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHH
Confidence 9999999999999999999999998777665555543
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=379.93 Aligned_cols=257 Identities=34% Similarity=0.624 Sum_probs=218.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||.|+||.||++.+..++..||+|++...........+.+|+.++++++||||++++++|.+++.+|+||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 35799999999999999999999999999999999876655555678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~-gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
||+.+++|.+++...+.+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++..+... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~ 160 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN 160 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--ccc
Confidence 9999999999998888899999999999999999999975 7999999999999999999999999998755332 223
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee---------------------------
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--------------------------- 222 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~--------------------------- 222 (703)
..+|++.|+|||++.+. .++.++|||||||++|+|++|..||..........
T Consensus 161 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 161 SFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred cCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 46799999999999765 58899999999999999999999997543211100
Q ss_pred -----------------ccCCCCCCCcc-hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 223 -----------------IIPRENPPQLD-EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 223 -----------------~I~~~~~~~l~-~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+....++.++ ..++..+++||.+||.+||.+|||+.+++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00011111111 2356789999999999999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=380.35 Aligned_cols=251 Identities=29% Similarity=0.425 Sum_probs=213.5
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHH-HHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEI-SVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei-~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
++||+|+||.||+|.+..+++.||||++..... ......+..|+ .+++.++||||+++++++.+.+.+|||||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999865431 22234455555 467889999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
++|..++.....+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.............+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999875433333334578999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... +..++...+..+.++|.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (321)
T cd05603 161 EYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK-PLQLPGGKTVAACDLLVGLLHKDQRRR 238 (321)
T ss_pred ccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHccCCHhhc
Confidence 99999999764 5899999999999999999999999887655554444432 345556778899999999999999999
Q ss_pred CCH----HHHHhchhhhccc
Q 005298 256 PSA----KELLRHRFIRNAR 271 (703)
Q Consensus 256 PTa----~eLL~Hpff~~~~ 271 (703)
|++ .++++|+||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 239 LGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CCCCCCHHHHhCCCCcCCCC
Confidence 875 5999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=383.40 Aligned_cols=252 Identities=27% Similarity=0.492 Sum_probs=217.2
Q ss_pred EEEEeecCceEEEEEEE---cCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 18 LELIGRGSFGDVYKAFD---KELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d---~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
++.||+|+||.||++.+ ..+|+.||||++..... ......+..|+.++++++||||+++++++..++.+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36899999999999976 35789999999875432 223456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccC
Q 005298 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173 (703)
Q Consensus 94 ~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iG 173 (703)
++++|.+++.+...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+|
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 99999999988888999999999999999999999999999999999999999999999999998765443333445789
Q ss_pred CCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCC
Q 005298 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPA 253 (703)
Q Consensus 174 Tp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~ 253 (703)
|+.|+|||++.+. .++.++|||||||+||+|++|+.||...+.......+.... ..++..++..+.+||.+||.+||.
T Consensus 161 ~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 161 TVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred ChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHh
Confidence 9999999999764 57899999999999999999999998876655555544332 244566889999999999999999
Q ss_pred CCCC-----HHHHHhchhhhccc
Q 005298 254 ERPS-----AKELLRHRFIRNAR 271 (703)
Q Consensus 254 ~RPT-----a~eLL~Hpff~~~~ 271 (703)
+||+ +.+++.||||....
T Consensus 239 ~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 239 NRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred HcCCCCCCCHHHHhCCCCcCCCC
Confidence 9999 78899999998753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=375.78 Aligned_cols=257 Identities=31% Similarity=0.541 Sum_probs=229.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-------ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCC
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-------SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-------~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~ 84 (703)
.+|+-.+.||+|..+.|.+|+++.+|..+|+|++.... .....+...+|+.||+++ .||||++++++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 47888899999999999999999999999999986543 123356677899999998 6999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
.+++|+|.|..|.|++++...-.++|...+.||+||+.|+.|||.++||||||||+|||++.+-++||+|||+++++...
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999999988654
Q ss_pred ccccccccCCCCCCchhhhcc-----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC---Ccchhh
Q 005298 165 ISRRKTFVGTPFWMAPEVIQN-----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP---QLDEHF 236 (703)
Q Consensus 165 ~~~~~~~iGTp~Y~APEvl~~-----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~---~l~~~i 236 (703)
.+....||||+|+|||.+.+ ..+|+..+|+|++|||||-||.|.+||+....+-++..|..+... +-..++
T Consensus 177 -ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi 255 (411)
T KOG0599|consen 177 -EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI 255 (411)
T ss_pred -hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence 45567899999999998753 356889999999999999999999999988877777777765532 334578
Q ss_pred hHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 237 s~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+...++||.+||+.||.+|+|++|+|.||||...
T Consensus 256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred cccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 8999999999999999999999999999999643
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=389.17 Aligned_cols=259 Identities=27% Similarity=0.495 Sum_probs=217.9
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
..+|++++.||+|+||.||++.+..+++.||+|++.... .......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999999999999999986432 223345678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-cc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~ 168 (703)
||||++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... ..
T Consensus 122 ~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~ 200 (370)
T cd05621 122 MEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200 (370)
T ss_pred EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceec
Confidence 999999999999976 4689999999999999999999999999999999999999999999999999876533221 22
Q ss_pred ccccCCCCCCchhhhcccc---CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCc--chhhhHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSE---GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQL--DEHFSRLMKE 242 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~---~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~-~~~l--~~~is~~L~d 242 (703)
.+.+||+.|+|||++.... .++.++|||||||+||+|++|.+||...+.......+.... ...+ ...++..+++
T Consensus 201 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~ 280 (370)
T cd05621 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKN 280 (370)
T ss_pred ccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHH
Confidence 4568999999999987532 37789999999999999999999998876655544443321 1122 2356889999
Q ss_pred HHHHHhccCCCC--CCCHHHHHhchhhhccc
Q 005298 243 FVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (703)
Q Consensus 243 LI~~cL~~dP~~--RPTa~eLL~Hpff~~~~ 271 (703)
+|.+||..++.+ |+++.++++||||+...
T Consensus 281 li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 281 LICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred HHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 999999855543 89999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=370.59 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=210.7
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCH
Q 005298 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (703)
Q Consensus 21 LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL 98 (703)
||+|+||+||+|.+..+++.||||++..... ....+.+..|+.++++++||||+++++++..+..+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999999999999999999864432 22345678899999999999999999999999999999999999999
Q ss_pred HHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCC
Q 005298 99 ADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (703)
Q Consensus 99 ~~~l~----~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGT 174 (703)
..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...........||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 98874 24569999999999999999999999999999999999999999999999999987654433333456899
Q ss_pred CCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc----eeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR----VLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 175 p~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~----~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ....+. ..+..++..++..+.+|+.+||..
T Consensus 161 ~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 161 PGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL-NDSVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred cCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhc-ccCCCCcccCCHHHHHHHHHHhcC
Confidence 999999999875 58899999999999999999999997643221 111121 123344567889999999999999
Q ss_pred CCCCCC-----CHHHHHhchhhhccc
Q 005298 251 VPAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 251 dP~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
+|.+|| +++++++||||+...
T Consensus 239 ~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred CHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 999999 899999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=379.97 Aligned_cols=258 Identities=31% Similarity=0.476 Sum_probs=222.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCC-eeeeEEEEEeCC------
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQT------ 84 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPn-IV~L~~~~~~~~------ 84 (703)
..|+.++.||+|+||+||+|+++.+|+.||+|+++.... +.......+|+.+|+.|+|+| ||.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 458888899999999999999999999999999987754 334566789999999999999 999999999877
Q ss_pred EEEEEEeccCCCCHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchh
Q 005298 85 KLWIIMEYMAGGSVADLIQSGP----PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~----~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
.+|+||||+ ..+|..++.... .++...++.+++||+.||+|||+++|+||||||+||||+..|.+||+|||+|+.
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 899999999 579999997654 578889999999999999999999999999999999999999999999999997
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--------------
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------- 226 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~-------------- 226 (703)
+..+.......++|.+|+|||++.+...|+..+||||+|||++||+++++.|.+....+.+..|..
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 776666666779999999999999998899999999999999999999999988766555443311
Q ss_pred ----CC--------CCCcch---hhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 227 ----EN--------PPQLDE---HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 227 ----~~--------~~~l~~---~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.. +..+.. .......+++.+||+.+|.+|.++..+|.||||....
T Consensus 250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 00 001111 1224788999999999999999999999999998764
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=381.43 Aligned_cols=251 Identities=29% Similarity=0.465 Sum_probs=213.2
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHH-HHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEI-SVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei-~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
+.||+|+||+||+|++..+++.||||++..... ......+..|. .+++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999999999999999999865321 12223344444 457889999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
++|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+||+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 99999999888899999999999999999999999999999999999999999999999999875443333344678999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
.|+|||++.+. .++.++|||||||+||+|++|.+||...+....+..+... +..+...++..+.++|.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (325)
T cd05602 161 EYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPNITNSARHLLEGLLQKDRTKR 238 (325)
T ss_pred cccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-CcCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 99999999775 5889999999999999999999999887766555444332 334455788999999999999999999
Q ss_pred CCHH----HHHhchhhhccc
Q 005298 256 PSAK----ELLRHRFIRNAR 271 (703)
Q Consensus 256 PTa~----eLL~Hpff~~~~ 271 (703)
+++. ++++|+||....
T Consensus 239 ~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 239 LGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred CCCCCCHHHHhcCcccCCCC
Confidence 9865 899999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=380.20 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=212.7
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHH-HHHhCCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEIS-VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~-ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
++||+|+||+||+|.+..+|+.||||++.... .......+..|.. +++.++||||+++++++...+.+||||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999986542 1223344555554 57789999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
++|..++.....+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.............+||+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 99999998888999999999999999999999999999999999999999999999999999865433223334568999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
.|+|||++.+. .++.++|||||||+||+|++|.+||...+.......+.... ..+...++..+.++|.+||.++|.+|
T Consensus 161 ~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~ll~~~p~~R 238 (325)
T cd05604 161 EYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LVLRPGASLTAWSILEELLEKDRQRR 238 (325)
T ss_pred hhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-ccCCCCCCHHHHHHHHHHhccCHHhc
Confidence 99999999775 58899999999999999999999998876655555444332 23344678889999999999999999
Q ss_pred CCH----HHHHhchhhhccc
Q 005298 256 PSA----KELLRHRFIRNAR 271 (703)
Q Consensus 256 PTa----~eLL~Hpff~~~~ 271 (703)
|++ .++++||||....
T Consensus 239 ~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 239 LGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CCCCCCHHHHhcCCCcCCCC
Confidence 976 6999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=369.18 Aligned_cols=252 Identities=27% Similarity=0.451 Sum_probs=203.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcC-CCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhC---CCCCeeeeEEEEEe-----
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEESE-DEIEDIQKEISVLSQC---RSPYITEYYGSYLH----- 82 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~-tg~~VAIKvi~~~~~~-~~~~~l~~Ei~ILk~L---~HPnIV~L~~~~~~----- 82 (703)
.+|++++.||+|+||.||+|.+.. .++.||||++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 379999999999999999999864 4788999998654322 2234556777777765 69999999998863
Q ss_pred CCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchh
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999995 6899988653 4589999999999999999999999999999999999999999999999999865
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-------------
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------- 227 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~------------- 227 (703)
.... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+....+..+...
T Consensus 160 ~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 160 YSFQ-MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred ccCC-cccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 5332 223456799999999999765 5889999999999999999999999876554333222110
Q ss_pred ---------CCC----CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 228 ---------NPP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 228 ---------~~~----~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.+. .+...++..+++||.+||..+|++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 000 0112467788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=378.33 Aligned_cols=259 Identities=28% Similarity=0.457 Sum_probs=215.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||.||++.+..+++.||||++.... .......+.+|+.++..++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999986432 2234566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-cc
Q 005298 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~ 168 (703)
||+.|++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999976 56799999999999999999999999999999999999999999999999999865433222 12
Q ss_pred ccccCCCCCCchhhhcc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC----CCCCcchhhhHHH
Q 005298 169 KTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----NPPQLDEHFSRLM 240 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~----~~~~l~~~is~~L 240 (703)
...+||+.|+|||++.. ...++.++|||||||+||+|++|..||...+.......+... ..+.....++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 23579999999999863 234788999999999999999999999876654443333221 1122223578899
Q ss_pred HHHHHHHhccCCCC--CCCHHHHHhchhhhccc
Q 005298 241 KEFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (703)
Q Consensus 241 ~dLI~~cL~~dP~~--RPTa~eLL~Hpff~~~~ 271 (703)
++||.+||..++.+ |+++.+++.||||....
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 99999988764443 78999999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=362.28 Aligned_cols=253 Identities=41% Similarity=0.678 Sum_probs=213.5
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHH-HHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE-IEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~-~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
|++.+.||+|+||+||++.+..+++.||+|++........ .....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999987653332 234456999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccC
Q 005298 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173 (703)
Q Consensus 94 ~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iG 173 (703)
.+++|.+++.....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..............+
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 160 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG 160 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999997788999999999999999999999999999999999999999999999999998654333334456789
Q ss_pred CCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC------CcchhhhHHHHHHHHHH
Q 005298 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP------QLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 174 Tp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~------~l~~~is~~L~dLI~~c 247 (703)
++.|+|||++.....++.++||||||+++|+|++|..||...........+...... ......+..+.++|..|
T Consensus 161 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 240 (260)
T PF00069_consen 161 TPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKM 240 (260)
T ss_dssp SGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHH
Confidence 999999999873446899999999999999999999999877322222211111100 11112247899999999
Q ss_pred hccCCCCCCCHHHHHhchhh
Q 005298 248 LKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~Hpff 267 (703)
|..+|.+||++.++++||||
T Consensus 241 l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 241 LSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp SSSSGGGSTTHHHHHTSGGG
T ss_pred ccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=395.57 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=207.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-------
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------- 83 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~------- 83 (703)
...+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+|+.++|||||+++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 4468999999999999999999999999999999885432 2345799999999999999999987542
Q ss_pred -CEEEEEEeccCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC-CeeEecccc
Q 005298 84 -TKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGV 157 (703)
Q Consensus 84 -~~lyLV~Eyv~gGsL~~~l~----~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g-~VKL~DFGl 157 (703)
..+|+||||++ ++|.+++. ....+++..++.|+.||+.||.|||++|||||||||+||||+.++ .+||+|||+
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 24779999996 57776664 356799999999999999999999999999999999999998664 799999999
Q ss_pred chhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC----------
Q 005298 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---------- 227 (703)
Q Consensus 158 A~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~---------- 227 (703)
+..+... ......+||+.|+|||++.+...|+.++|||||||+||+|++|.+||.+.+..+.+..+...
T Consensus 218 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 218 AKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred chhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 9765432 22335689999999999877666899999999999999999999999876544332222100
Q ss_pred ----------CC--------CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 228 ----------NP--------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 228 ----------~~--------~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+ ..++...+..+.+||.+||.++|.+|||+.|+|.||||...+
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00 012234577899999999999999999999999999998653
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=362.75 Aligned_cols=259 Identities=72% Similarity=1.184 Sum_probs=230.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++.+.||.|+||.||+|.+..++..||||++...........+.+|+.+++.++||||+++++++..+..+|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47999999999999999999999999999999987665455567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
+.+++|.+++... ++++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++..+...........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV 159 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccccc
Confidence 9999999999865 899999999999999999999999999999999999999999999999999877654433344568
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchh-hhHHHHHHHHHHhccC
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH-FSRLMKEFVSLCLKKV 251 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~-is~~L~dLI~~cL~~d 251 (703)
|++.|++||++.+.. ++.++|||||||++|+|++|..||...+.......+....++.+... ++..+.++|.+||..+
T Consensus 160 ~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~ 238 (274)
T cd06609 160 GTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKD 238 (274)
T ss_pred CCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCC
Confidence 899999999998754 89999999999999999999999987776666555655555555555 8899999999999999
Q ss_pred CCCCCCHHHHHhchhhhccccC
Q 005298 252 PAERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 252 P~~RPTa~eLL~Hpff~~~~~~ 273 (703)
|.+|||++++++||||......
T Consensus 239 p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 239 PKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred hhhCcCHHHHhhChhhcCCCcc
Confidence 9999999999999999876554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=366.24 Aligned_cols=254 Identities=30% Similarity=0.493 Sum_probs=230.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++.+.||+|-||.||+|+.+.++-.||+|++-+... .....++.+|++|...|+||||+++|++|.+...+||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 589999999999999999999999999999999855442 223468899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 91 EYMAGGSVADLIQ--SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~--~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||..+|.|...++ ...++++.....|++|++.||.|||.++||||||||+|+|++..|.+||+|||.+.... ....
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~~kR 179 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SNKR 179 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--CCCc
Confidence 9999999999998 66789999999999999999999999999999999999999999999999999986543 4567
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
.+.|||..|.+||...+. .++..+|+|++|++.||++.|.+||......+.+..|.+.. ..++..++..+.++|.+||
T Consensus 180 ~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~-~~~p~~is~~a~dlI~~ll 257 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD-LKFPSTISGGAADLISRLL 257 (281)
T ss_pred eeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-ccCCcccChhHHHHHHHHh
Confidence 789999999999999875 58999999999999999999999999988777777776543 3556889999999999999
Q ss_pred ccCCCCCCCHHHHHhchhhhcc
Q 005298 249 KKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.++|.+|.+..|++.|||+...
T Consensus 258 ~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 258 VKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ccCccccccHHHHhhhHHHHhc
Confidence 9999999999999999999753
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=355.29 Aligned_cols=253 Identities=34% Similarity=0.596 Sum_probs=224.0
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|.+.+.||+|+||.||+|.+..+++.|++|.+.... .......+.+|+.++++++||||+++++++...+.+|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5899999999999999999999999999999986543 344567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 93 v~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999999763 57899999999999999999999999999999999999999999999999998766544333445
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
..|++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.....+.++..++..+.++|.+||..
T Consensus 161 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08529 161 IVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239 (256)
T ss_pred cccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccC
Confidence 6799999999999775 488999999999999999999999987776555555555555566667889999999999999
Q ss_pred CCCCCCCHHHHHhchhh
Q 005298 251 VPAERPSAKELLRHRFI 267 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpff 267 (703)
+|.+||++.++++|||+
T Consensus 240 ~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 240 DYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CcccCcCHHHHhhCCCC
Confidence 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=357.76 Aligned_cols=254 Identities=39% Similarity=0.704 Sum_probs=219.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC----hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~----~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
.+|++.+.||.|+||.||+|.+..+++.||||++..... ......+.+|+.++++++||||+++++++..++.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 579999999999999999999999999999999865432 2234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc-
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~- 167 (703)
|+||+++++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998654322111
Q ss_pred --cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCcchhhhHHHHHHH
Q 005298 168 --RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 168 --~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~-~~~~~~l~~~is~~L~dLI 244 (703)
.....|++.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+. ......++..++..+.+||
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 1245788999999999875 48899999999999999999999998765544333322 2234456667889999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhh
Q 005298 245 SLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.+||.++|.+|||+.++++|+||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=376.13 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=217.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||.||++.++.+++.||||++.... .......+..|+.++..++|+||+++++++.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986432 2233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-cc
Q 005298 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~ 168 (703)
||+.+|+|.+++.+ ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999976 46799999999999999999999999999999999999999999999999999865433222 22
Q ss_pred ccccCCCCCCchhhhcc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC----CCCcchhhhHHH
Q 005298 169 KTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRLM 240 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~----~~~l~~~is~~L 240 (703)
...+||+.|+|||++.. ...++.++|||||||+||||++|+.||...+....+..+.... .+.....++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 34589999999999863 3357889999999999999999999998877655555443321 122234678999
Q ss_pred HHHHHHHhccCCCC--CCCHHHHHhchhhhccc
Q 005298 241 KEFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (703)
Q Consensus 241 ~dLI~~cL~~dP~~--RPTa~eLL~Hpff~~~~ 271 (703)
++||.+||..++.+ |+++.++++||||....
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 99999999765444 68999999999998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=355.42 Aligned_cols=253 Identities=30% Similarity=0.548 Sum_probs=219.3
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe-CCEEEEEEe
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKLWIIME 91 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~-~~~lyLV~E 91 (703)
.|++++.||+|+||.||++.+..+++.||||.+.... .......+.+|+.++++++||||+++++.+.. +..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5999999999999999999999999999999986543 23445678899999999999999999998864 456899999
Q ss_pred ccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 9999999999875 34689999999999999999999999999999999999999999999999999876544333344
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
...|++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.....+.++..++..+.+||.+||.
T Consensus 161 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 239 (257)
T cd08223 161 TLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239 (257)
T ss_pred cccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhc
Confidence 56789999999998765 48889999999999999999999998766555444444444445667788999999999999
Q ss_pred cCCCCCCCHHHHHhchhh
Q 005298 250 KVPAERPSAKELLRHRFI 267 (703)
Q Consensus 250 ~dP~~RPTa~eLL~Hpff 267 (703)
.+|.+||++.++++||||
T Consensus 240 ~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 240 KRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCcccCCCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=361.63 Aligned_cols=265 Identities=63% Similarity=1.090 Sum_probs=233.1
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
...|+.++.||.|+||.||+|.+..++..||||++...........+.+|+.+++++.||||+++++++.+++..|+|||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 45788999999999999999999999999999998866556667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
|+.+++|.+++.. .++++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..+..........
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence 9999999999875 578999999999999999999999999999999999999999999999999986654333233345
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccC
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~d 251 (703)
.++..|+|||++.+. .++.++|+|||||++|+|++|..||....+......+....++.+...++..+.+||.+||..+
T Consensus 162 ~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (277)
T cd06640 162 VGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD 240 (277)
T ss_pred cCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccC
Confidence 789999999998765 4889999999999999999999999887776666666556666777788999999999999999
Q ss_pred CCCCCCHHHHHhchhhhccccChhHHH
Q 005298 252 PAERPSAKELLRHRFIRNARKSPRLLE 278 (703)
Q Consensus 252 P~~RPTa~eLL~Hpff~~~~~~~~l~e 278 (703)
|.+||++.+++.|+||.........+.
T Consensus 241 p~~Rp~~~~il~~~~~~~~~~~~~~~~ 267 (277)
T cd06640 241 PSFRPTAKELLKHKFIVKNAKKTSYLT 267 (277)
T ss_pred cccCcCHHHHHhChHhhhcchhhhHHH
Confidence 999999999999999987765444333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=385.98 Aligned_cols=249 Identities=27% Similarity=0.366 Sum_probs=207.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++++.||+|+||.||+|++..+++.||||... ...+.+|+.++++|+|||||+++++|..+...|+|+|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 58999999999999999999999999999999753 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc-ccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTF 171 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~-~~~~~~~ 171 (703)
+ +++|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||++...... .......
T Consensus 165 ~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~ 243 (391)
T PHA03212 165 Y-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243 (391)
T ss_pred C-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccc
Confidence 9 5789999988888999999999999999999999999999999999999999999999999998643221 1223356
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-------eeeccC-------------------
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-------VLFIIP------------------- 225 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~-------~l~~I~------------------- 225 (703)
+||+.|+|||++.+. .++.++|||||||+||+|++|..||....... .+..+.
T Consensus 244 ~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 244 AGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred cCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 899999999999765 58999999999999999999998875432110 000000
Q ss_pred ----------CCCCC--Cc---chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 226 ----------RENPP--QL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 226 ----------~~~~~--~l---~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
...+. .. ...++..+.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 00000 00 01346689999999999999999999999999999764
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=383.64 Aligned_cols=260 Identities=27% Similarity=0.481 Sum_probs=218.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
...+|++++.||+|+||.||+|.++.+++.||+|++.... .......+.+|+.+++.++||||+++++++..++.+|+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3479999999999999999999999999999999986432 22334567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-cc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~ 167 (703)
|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.+|++||+|||++..+.... ..
T Consensus 121 v~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~ 199 (371)
T cd05622 121 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199 (371)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc
Confidence 9999999999999976 468999999999999999999999999999999999999999999999999987654322 12
Q ss_pred cccccCCCCCCchhhhcccc---CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSE---GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMK 241 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~---~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~ 241 (703)
....+||+.|+|||++.... .++.++|||||||+||+|++|.+||...+.......+.... ..+....++..++
T Consensus 200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 279 (371)
T cd05622 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279 (371)
T ss_pred ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHH
Confidence 23568999999999987532 37889999999999999999999998877655544443321 1122346889999
Q ss_pred HHHHHHhccCCCC--CCCHHHHHhchhhhccc
Q 005298 242 EFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (703)
Q Consensus 242 dLI~~cL~~dP~~--RPTa~eLL~Hpff~~~~ 271 (703)
+||..||...+.+ |+++.+|++|+||++..
T Consensus 280 ~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 280 NLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred HHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 9999999844433 78999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=394.15 Aligned_cols=257 Identities=27% Similarity=0.487 Sum_probs=223.0
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCC-CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKEL-NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~t-g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...|.+.+.||+|+||.||+|.+..+ +..||+|++.... ......+..|+.+|+.++|||||+++++|..++.+||||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 34599999999999999999999887 7889999875443 344567788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 91 Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
||++||+|.+++.. ..++++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++..+.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999987753 45799999999999999999999999999999999999999999999999999876543221
Q ss_pred --ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHH
Q 005298 167 --RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 167 --~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI 244 (703)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+....+..+.......++..++..+.+||
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 303 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL 303 (478)
T ss_pred cccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence 23456899999999999764 589999999999999999999999988776666655555555555667889999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+||.++|.+||++.+++.|+|++..
T Consensus 304 ~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 304 DPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHhccChhhCcCHHHHHhCHHHHHH
Confidence 99999999999999999999999754
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=366.25 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=216.0
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~--~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
+|++.++||+|+||+||++.+..+++.||||++...... .....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 589999999999999999999999999999998654321 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|+.+++|..++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIR 159 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Cccc
Confidence 99999999888543 46999999999999999999999999999999999999999999999999998654322 2223
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc---CCCCCCCcchhhhHHHHHHHHH
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII---PRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I---~~~~~~~l~~~is~~L~dLI~~ 246 (703)
..+|++.|+|||++.+. .++.++|||||||++|+|++|..||...........+ .......++..++..+.+||.+
T Consensus 160 ~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 160 GRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred cccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence 45899999999999765 5889999999999999999999999875543221111 1122334456688999999999
Q ss_pred HhccCCCCCC-----CHHHHHhchhhhccc
Q 005298 247 CLKKVPAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 247 cL~~dP~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
||..||.+|| ++++++.||||....
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 9999999999 899999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=354.57 Aligned_cols=255 Identities=48% Similarity=0.901 Sum_probs=221.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++.+.||.|+||+||+|.+..++..|++|++...........+.+|+.+++.++|+||+++++.+..++.+|+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999999899999999987655444678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc--
Q 005298 93 MAGGSVADLIQSG---PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-- 167 (703)
Q Consensus 93 v~gGsL~~~l~~~---~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~-- 167 (703)
+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999999999764 45899999999999999999999999999999999999999999999999998766543222
Q ss_pred --cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcc-----hhhhHHH
Q 005298 168 --RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD-----EHFSRLM 240 (703)
Q Consensus 168 --~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~-----~~is~~L 240 (703)
....+|++.|++||++.....++.++|+|||||++|+|++|+.||...+.......+....++.+. ..++..+
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHH
Confidence 134578999999999876656889999999999999999999999877665444443333332222 2567889
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.+||.+||.++|.+||++.+|++||||
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=369.00 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=214.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++++.||.|+||.||+|.+..+++.||||.+...........+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999999999999999987654443445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 93 v~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
+. ++|..++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.............
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE 164 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccccc
Confidence 96 588888765 4578999999999999999999999999999999999999999999999999986554333333345
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---------------------CCCCC
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---------------------RENPP 230 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~---------------------~~~~~ 230 (703)
.+++.|+|||++.+...++.++|||||||++|+|++|++||...+..+....+. ....+
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (301)
T cd07873 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244 (301)
T ss_pred ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccC
Confidence 689999999998776568889999999999999999999997654322111000 00000
Q ss_pred --------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 231 --------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 231 --------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.....++..+++||.+||..+|.+|||++++++||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 1123467889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=382.86 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=215.4
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-----EEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-----KLW 87 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~-----~ly 87 (703)
+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...+ .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999999999999999999986432 2234567889999999999999999999998876 789
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-c
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-S 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~ 166 (703)
+|+||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999995 6899988888889999999999999999999999999999999999999999999999999987543221 1
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--------------------
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------------- 226 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~-------------------- 226 (703)
.....++++.|+|||++.+...++.++||||||||+|+|++|++||...+....+..+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 223357899999999998766688999999999999999999999987665433322210
Q ss_pred -----CCCC------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 227 -----ENPP------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 227 -----~~~~------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
..++ .+....+..+.+||.+||..||.+|||+.++|.||||...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0011 12234577899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=362.88 Aligned_cols=264 Identities=45% Similarity=0.810 Sum_probs=225.9
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++++.||.|+||.||+|.+..++..||+|++... .....+.+..|+.++++++||||+++++++..+..+|+||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 456899999999999999999999989999999998654 3445577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 91 Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
||+++++|..++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 99999999999876 45799999999999999999999999999999999999999999999999998866544333334
Q ss_pred cccCCCCCCchhhhcc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--cchhhhHHHHHH
Q 005298 170 TFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEF 243 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~--l~~~is~~L~dL 243 (703)
...|++.|++||++.. ...++.++|||||||++|+|++|.+||...........+....++. .+..++..+.+|
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF 241 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence 5679999999999853 2336778999999999999999999998876655544444433322 245678899999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhccccChh
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~ 275 (703)
|.+||..+|.+||++.++++||||........
T Consensus 242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 273 (280)
T cd06611 242 LKSCLVKDPDDRPTAAELLKHPFVSDQSDNKA 273 (280)
T ss_pred HHHHhccChhhCcCHHHHhcChhhcccchhHH
Confidence 99999999999999999999999987654433
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=372.76 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=216.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||.||++.+..+++.||||++.... .......+.+|+.++..++|+||+++++++.+++..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986432 2233456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-cc
Q 005298 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~ 168 (703)
||+.||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... ..
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999976 56899999999999999999999999999999999999999999999999999876543222 12
Q ss_pred ccccCCCCCCchhhhccc----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC----CCCcchhhhHHH
Q 005298 169 KTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRLM 240 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~----~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~----~~~l~~~is~~L 240 (703)
...+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||...+.......+.... .+.....++..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~ 240 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence 235799999999998652 247889999999999999999999998776555444443221 122223568899
Q ss_pred HHHHHHHhccCCCC--CCCHHHHHhchhhhccc
Q 005298 241 KEFVSLCLKKVPAE--RPSAKELLRHRFIRNAR 271 (703)
Q Consensus 241 ~dLI~~cL~~dP~~--RPTa~eLL~Hpff~~~~ 271 (703)
++||.+||...+.+ |++++++++||||....
T Consensus 241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred HHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 99999999876544 46899999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=395.70 Aligned_cols=261 Identities=29% Similarity=0.448 Sum_probs=225.6
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC---
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--- 84 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~--- 84 (703)
.....+|++.+.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.++..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345679999999999999999999999999999999987654 3455677889999999999999999998776432
Q ss_pred -----EEEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecc
Q 005298 85 -----KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (703)
Q Consensus 85 -----~lyLV~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DF 155 (703)
.+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 37899999999999999864 347999999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcc
Q 005298 156 GVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD 233 (703)
Q Consensus 156 GlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~ 233 (703)
|++..+.... ......+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+....+..+.......++
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 9987654321 223457899999999999775 5899999999999999999999999887766665555555555667
Q ss_pred hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 234 ~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..+++.+.+||.+||..+|.+||++.+++.|||++..
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 7889999999999999999999999999999998754
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=385.60 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=232.8
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-HHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~-~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+-|.+.+.||+|-|+.|.+|++..||..||||++++.+.+. ...++.+|+..|+.+.|||||+||++..+..++|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 346889999999999999999999999999999998877433 3567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec-CCCCeeEeccccchhhhhccccc
Q 005298 91 EYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT-ENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd-~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|+-++|+|++||-++ ..+.|+.+++||.||+.|+.|||...+|||||||+||.+- +-|-|||.||||+..+. +..+.
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG~kL 175 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PGKKL 175 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-Ccchh
Confidence 999999999999654 5799999999999999999999999999999999998765 56999999999997764 44567
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
.+.||+..|-|||++++..+..+++||||||||||.|++|++||...++.+.+..|.. .....+.+++.++++||..||
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD-CKYtvPshvS~eCrdLI~sML 254 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD-CKYTVPSHVSKECRDLIQSML 254 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc-ccccCchhhhHHHHHHHHHHH
Confidence 7899999999999999988667889999999999999999999999999888887764 344678899999999999999
Q ss_pred ccCCCCCCCHHHHHhchhhhcc
Q 005298 249 KKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..||.+|.+.++|..++|++..
T Consensus 255 vRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 255 VRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred hcCchhhccHHHHhccccccCC
Confidence 9999999999999999999754
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.79 Aligned_cols=262 Identities=43% Similarity=0.766 Sum_probs=224.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++++.||.|+||.||+|.+..+++.||||.+...... ..+.+.+|+.+++.++||||++++++|..++.+|+||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 347999999999999999999999999999999998755432 3466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||+++++|.+++.+ ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++............
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 99999999999865 56899999999999999999999999999999999999999999999999998655433333344
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCcchhhhHHHHHHHHHHh
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~--~~~l~~~is~~L~dLI~~cL 248 (703)
..|++.|++||.+.+. .++.++|||||||++|+|++|..||...+.......+.... +...+..++..+.+||.+||
T Consensus 175 ~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 253 (297)
T cd06656 175 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253 (297)
T ss_pred ccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHc
Confidence 6789999999998764 58899999999999999999999998766544444333322 22234567888999999999
Q ss_pred ccCCCCCCCHHHHHhchhhhccccChh
Q 005298 249 KKVPAERPSAKELLRHRFIRNARKSPR 275 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~~~~~~ 275 (703)
..+|.+||++.++++||||...+....
T Consensus 254 ~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 254 EMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred cCChhhCcCHHHHhcCchhcccccccc
Confidence 999999999999999999987654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=357.73 Aligned_cols=258 Identities=51% Similarity=0.960 Sum_probs=225.8
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCCeeeeEEEEEeCCEEEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~---HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.|++++.||.|+||.||+|.+..+++.||||+++..........+.+|+.+++++. ||||+++++++..+..+|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58899999999999999999999999999999876555555677889999999997 999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||+.+++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++............
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccccc
Confidence 99999999999876 47999999999999999999999999999999999999999999999999998766544333445
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcch-hhhHHHHHHHHHHhc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE-HFSRLMKEFVSLCLK 249 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~-~is~~L~dLI~~cL~ 249 (703)
..|++.|+|||++.+...++.++|||||||++|+|++|..||...........+....++.+.. .++..+.+||.+||.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 240 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLD 240 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcC
Confidence 6799999999998765567889999999999999999999998776655554444444444444 378899999999999
Q ss_pred cCCCCCCCHHHHHhchhhhcccc
Q 005298 250 KVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 250 ~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
.+|.+||++.+++.|+||+....
T Consensus 241 ~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 241 EEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred CCcccCcCHHHHhhChHhhcccc
Confidence 99999999999999999987653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=356.22 Aligned_cols=257 Identities=48% Similarity=0.893 Sum_probs=217.4
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
.....+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++++..++.+|+
T Consensus 5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3455689999999999999999999999999999999865432 234568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||||+++++|.+++....++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..+.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987654333333
Q ss_pred ccccCCCCCCchhhhcc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCC--cchhhhHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQ--LDEHFSRLMKE 242 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~--~~~--l~~~is~~L~d 242 (703)
....|++.|+|||.+.. ...++.++|||||||++|+|++|..||....+......+.... ++. ....++..+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 45679999999998852 2346789999999999999999999997665443333222211 111 12356789999
Q ss_pred HHHHHhccCCCCCCCHHHHHhchh
Q 005298 243 FVSLCLKKVPAERPSAKELLRHRF 266 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~Hpf 266 (703)
||.+||..+|.+||++++|++|+|
T Consensus 244 li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 244 FVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=395.60 Aligned_cols=255 Identities=31% Similarity=0.515 Sum_probs=214.5
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-C-----CCeeeeEEEEEe
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-S-----PYITEYYGSYLH 82 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-H-----PnIV~L~~~~~~ 82 (703)
+....+|+++++||+|+||+|.+|.+..|++.||||+++.. .....+...|+.||..|+ | -|||+++++|..
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 34445999999999999999999999999999999998644 445677888999999997 4 589999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC--CCeeEeccccc
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN--GDVKVADFGVS 158 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~--g~VKL~DFGlA 158 (703)
.+++|||+|.+ ..+|.++++.+ ..|+...++.|+.||+.||.+||+.||||+|||||||||... ..|||+|||.+
T Consensus 260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 99999999999 68999999875 468999999999999999999999999999999999999864 47999999999
Q ss_pred hhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------
Q 005298 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------ 226 (703)
Q Consensus 159 ~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~------------ 226 (703)
+..... ..+++.+..|+|||+|++.. |+.+.||||||||++||++|.+.|.+.+..+.+..|..
T Consensus 339 c~~~q~---vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 339 CFESQR---VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccCCc---ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 876543 23789999999999999975 99999999999999999999999987655443322210
Q ss_pred ---------------------C----------------------CCCC-------cchhhhHHHHHHHHHHhccCCCCCC
Q 005298 227 ---------------------E----------------------NPPQ-------LDEHFSRLMKEFVSLCLKKVPAERP 256 (703)
Q Consensus 227 ---------------------~----------------------~~~~-------l~~~is~~L~dLI~~cL~~dP~~RP 256 (703)
. .|+. +...-...+.+||++||.+||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0 0000 0001124578999999999999999
Q ss_pred CHHHHHhchhhhcc
Q 005298 257 SAKELLRHRFIRNA 270 (703)
Q Consensus 257 Ta~eLL~Hpff~~~ 270 (703)
|+.|+|+||||...
T Consensus 495 tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 495 TPAQALNHPFLTGT 508 (586)
T ss_pred CHHHHhcCcccccc
Confidence 99999999999854
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=373.30 Aligned_cols=252 Identities=24% Similarity=0.435 Sum_probs=207.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC-
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ- 83 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~-----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~- 83 (703)
...+|++.+.||.|+||.||+|.+. .++..||||++...........+.+|+.++.++ +|||||+++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4568999999999999999999752 346789999987655455567789999999999 899999999988764
Q ss_pred CEEEEEEeccCCCCHHHHHHcC----------------------------------------------------------
Q 005298 84 TKLWIIMEYMAGGSVADLIQSG---------------------------------------------------------- 105 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~---------------------------------------------------------- 105 (703)
..+|+||||+++|+|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999998642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc--ccccccCCCCCCc
Q 005298 106 ----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMA 179 (703)
Q Consensus 106 ----~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~A 179 (703)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ......+++.|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 2477889999999999999999999999999999999999999999999999875532211 1123456788999
Q ss_pred hhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccc-eeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCC
Q 005298 180 PEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMR-VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPS 257 (703)
Q Consensus 180 PEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~-~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPT 257 (703)
||++.+. .++.++|||||||+||||++ |..||....... ....+........+..++..+.+||.+||..+|.+|||
T Consensus 245 PE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs 323 (338)
T cd05102 245 PESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT 323 (338)
T ss_pred cHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence 9999765 58999999999999999997 999998754322 22223333334445677889999999999999999999
Q ss_pred HHHHHh
Q 005298 258 AKELLR 263 (703)
Q Consensus 258 a~eLL~ 263 (703)
+.+|++
T Consensus 324 ~~el~~ 329 (338)
T cd05102 324 FSALVE 329 (338)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=363.26 Aligned_cols=265 Identities=65% Similarity=1.086 Sum_probs=230.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
..|++++.||.|+||.||+|.+..++..||||++.........+.+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45778889999999999999999999999999987665555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
+++++|.+++.. ..+++..++.++.||+.||.|||.+|++|+||+|+||+++.++.++|+|||++..+...........
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhccc
Confidence 999999999865 5789999999999999999999999999999999999999999999999999876544333333457
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCC
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP 252 (703)
|+..|+|||++.+. .++.++|||||||++|+|++|..||....+......+....++.+...++..+.+||.+||..+|
T Consensus 163 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06642 163 GTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP 241 (277)
T ss_pred CcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCc
Confidence 89999999999765 58889999999999999999999998776655555555555556666788899999999999999
Q ss_pred CCCCCHHHHHhchhhhccccChhHHHH
Q 005298 253 AERPSAKELLRHRFIRNARKSPRLLER 279 (703)
Q Consensus 253 ~~RPTa~eLL~Hpff~~~~~~~~l~e~ 279 (703)
.+||++.+++.||||.........+..
T Consensus 242 ~~Rp~~~~il~~~~~~~~~~~~~~~~~ 268 (277)
T cd06642 242 RFRPTAKELLKHKFITRYTKKTSFLTE 268 (277)
T ss_pred ccCcCHHHHHHhHHHHHHhhhHHHHHH
Confidence 999999999999999877665544443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=359.33 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=214.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|++++.||.|+||.||+|.+..+++.||||++..... ....+.+.+|+.++++++||||+++++++.....+|+|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 479999999999999999999999999999999864432 2223557889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
|++++.|..++.....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence 99999999988777789999999999999999999999999999999999999999999999999987665433333456
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------------CCC
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------------------ENP 229 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~----------------------~~~ 229 (703)
.++..|+|||++.+...++.++|||||||++|+|++|.+||.+....+....+.. ..+
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence 7899999999987655678899999999999999999999986654322211100 000
Q ss_pred C-----C---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 230 P-----Q---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 230 ~-----~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
. . ....++..+.+||.+||.++|++||++.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 0 012457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=361.63 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=202.8
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-HHHHHHHHHHHHHhC---CCCCeeeeEEEEEe-----CC
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-EIEDIQKEISVLSQC---RSPYITEYYGSYLH-----QT 84 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~-~~~~l~~Ei~ILk~L---~HPnIV~L~~~~~~-----~~ 84 (703)
+|++++.||+|+||+||+|.++.+++.||||.+....... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 6999999999999999999999999999999987543221 123455677777665 79999999998865 34
Q ss_pred EEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 85 KLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
.+++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 6899999996 5898888653 358999999999999999999999999999999999999999999999999987654
Q ss_pred hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------- 226 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------- 226 (703)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||........+..+..
T Consensus 160 ~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 160 CQ-MALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred Cc-ccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 32 222345789999999999765 589999999999999999999999976544322211100
Q ss_pred --CC-----C---CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 227 --EN-----P---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 227 --~~-----~---~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.. + ..+...++..+.+||.+||.+||.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0 01123467788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=361.21 Aligned_cols=263 Identities=45% Similarity=0.802 Sum_probs=223.0
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++++.||.|+||.||+|.+..++..|++|++... .....+.+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 346899999999999999999999999999999998754 3445677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 91 Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
||+++++|..++.. ...+++..+..++.||+.+|.|||+++|+||||||+||+++.++.+||+|||++...........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 99999999988754 46789999999999999999999999999999999999999999999999998865443333334
Q ss_pred cccCCCCCCchhhhcc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CcchhhhHHHHHH
Q 005298 170 TFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEF 243 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~--~l~~~is~~L~dL 243 (703)
...+++.|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+....++ ..+..++..+.+|
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF 248 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence 5678999999999852 223678899999999999999999999876654444333332222 2345677889999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhccccCh
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSP 274 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~ 274 (703)
|.+||..+|.+||++.++++||||......+
T Consensus 249 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 249 LKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred HHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 9999999999999999999999998765544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=361.19 Aligned_cols=255 Identities=28% Similarity=0.525 Sum_probs=223.8
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++.+.||.|+||.||++.+..+++.||||++.... .......+.+|+.+++++.||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999986543 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||+++++|.+++.....+++..+..++.||+.||.|||++||+|+||+|.||||+.++.+||+|||++...... ...
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~ 157 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYT 157 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCC
Confidence 99999999999988889999999999999999999999999999999999999999999999999998765433 334
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+|++.|++||.+.+. .++.++||||||+++|+|++|..||...........+.. ....++..++..++++|.+||..
T Consensus 158 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~ 235 (290)
T cd05580 158 LCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE-GKVRFPSFFSPDAKDLIRNLLQV 235 (290)
T ss_pred CCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCccCCccCCHHHHHHHHHHccC
Confidence 6799999999998765 578899999999999999999999987765444444433 23345567789999999999999
Q ss_pred CCCCCC-----CHHHHHhchhhhcccc
Q 005298 251 VPAERP-----SAKELLRHRFIRNARK 272 (703)
Q Consensus 251 dP~~RP-----Ta~eLL~Hpff~~~~~ 272 (703)
+|.+|+ +++++++||||....+
T Consensus 236 ~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 236 DLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred CHHHccCcccCCHHHHHcCcccccCCH
Confidence 999999 9999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=374.11 Aligned_cols=255 Identities=28% Similarity=0.451 Sum_probs=207.4
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC----
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT---- 84 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~---- 84 (703)
....+|++++.||+|+||.||+|.+..+|..||||++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45679999999999999999999999999999999986543 2334567789999999999999999999987543
Q ss_pred --EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 85 --KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 85 --~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
.+|+||||+++ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999965 5666654 358999999999999999999999999999999999999999999999999986543
Q ss_pred hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------- 226 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------- 226 (703)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+....+..+..
T Consensus 175 ~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 175 TN-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred cC-ccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 22 222346899999999999775 588999999999999999999999986643221111000
Q ss_pred ------CCC-------------------CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 227 ------ENP-------------------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 227 ------~~~-------------------~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
..+ .......+..+++||.+||..||.+|||+.|+|.||||..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000 0011123567899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=354.85 Aligned_cols=253 Identities=36% Similarity=0.685 Sum_probs=219.7
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--------HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--------DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~--------~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
+|.+...||.|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 578889999999999999999999999999988654321 224578899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
.++||||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987654211
Q ss_pred ------cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHH
Q 005298 166 ------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL 239 (703)
Q Consensus 166 ------~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~ 239 (703)
.......|++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.....+.++..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 111235689999999998765 4788999999999999999999999877655544444444455566778899
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 240 MKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
+.++|.+||.++|.+||++.+|++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=357.98 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=209.7
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999999999999999865432 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 93 MAGGSVADLIQSG---PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 93 v~gGsL~~~l~~~---~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
+. ++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++...........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 96 6888888642 5689999999999999999999999999999999999999999999999999875543333333
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC------------------------
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP------------------------ 225 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~------------------------ 225 (703)
...+++.|+|||++.+...++.++|||||||++|+|++|.+||...........+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 45678999999998766567889999999999999999999997654322111000
Q ss_pred -CCC---CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 226 -REN---PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 226 -~~~---~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
... .......++..+.+||.+||..||.+|||+.+|+.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000 001122467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=375.53 Aligned_cols=260 Identities=23% Similarity=0.432 Sum_probs=212.6
Q ss_pred cchhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-
Q 005298 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ- 83 (703)
Q Consensus 6 ~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~- 83 (703)
...-....+|++++.||.|+||.||+|.+..+++.||||++..... ......+.+|+.++++++||||++++++|...
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 8 KTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred HHHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 3344566799999999999999999999999999999999865432 22345677899999999999999999988643
Q ss_pred -----CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccc
Q 005298 84 -----TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 84 -----~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
...|+++|++ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3579999998 8899988764 57999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-----------
Q 005298 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----------- 227 (703)
Q Consensus 159 ~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~----------- 227 (703)
..... .....+||+.|+|||++.+...++.++|||||||+||+|++|..||...+....+..+...
T Consensus 166 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 166 RQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred eecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 76532 2335689999999999987556889999999999999999999999765432222111000
Q ss_pred ---------------CCC----CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 228 ---------------NPP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 228 ---------------~~~----~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+. ......++.+.+||.+||..||.+|||+.++|.||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 000 0011245668899999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=356.81 Aligned_cols=253 Identities=49% Similarity=0.910 Sum_probs=215.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++.+.||.|+||.||+|.+..+++.||||+++.... .....+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 489999999999999999999999999999999876532 3345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
+++++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..............
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 167 (267)
T cd06645 88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI 167 (267)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccccc
Confidence 99999999998888999999999999999999999999999999999999999999999999999876543333334568
Q ss_pred CCCCCCchhhhcc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC--CCCCc--chhhhHHHHHHHHH
Q 005298 173 GTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--NPPQL--DEHFSRLMKEFVSL 246 (703)
Q Consensus 173 GTp~Y~APEvl~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~--~~~~l--~~~is~~L~dLI~~ 246 (703)
|++.|+|||++.. ...++.++|||||||++|+|++|..||....+......+... .++.. ...++..+.+||.+
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (267)
T cd06645 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKM 247 (267)
T ss_pred CcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHH
Confidence 9999999999742 234788999999999999999999999765543332222111 11111 12467889999999
Q ss_pred HhccCCCCCCCHHHHHhchh
Q 005298 247 CLKKVPAERPSAKELLRHRF 266 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~Hpf 266 (703)
||..+|.+||++.+|+.|||
T Consensus 248 ~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 248 ALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HccCCchhCcCHHHHhcCCC
Confidence 99999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=350.48 Aligned_cols=254 Identities=54% Similarity=0.961 Sum_probs=220.0
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++.+.||.|+||.||+|.+..+++.|++|++...... ..+.+.+|+.++++++||||+++++++..++.+|++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 46899999999999999999999999999999998765433 56788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 92 yv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|+.+++|.+++... ..+++..+..++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++..+.........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99999999999776 78999999999999999999999999999999999999999999999999998776544334445
Q ss_pred ccCCCCCCchhhhccc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC--CC--CCcchhhhHHHHHHH
Q 005298 171 FVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--NP--PQLDEHFSRLMKEFV 244 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~--~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~--~~--~~l~~~is~~L~dLI 244 (703)
.+++..|++||++... ..++.++|||||||++|+|++|.+||....+......+... .+ ......++..+.+||
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI 240 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence 6899999999998654 14788999999999999999999999877655444333322 11 122345678899999
Q ss_pred HHHhccCCCCCCCHHHHHhchh
Q 005298 245 SLCLKKVPAERPSAKELLRHRF 266 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpf 266 (703)
.+||..+|..|||+.+|+.|+|
T Consensus 241 ~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 241 KKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHcCCChhhCCCHHHHhcCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=362.62 Aligned_cols=255 Identities=37% Similarity=0.639 Sum_probs=216.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++.+.||+|+||.||++.+..++..||+|.+...........+.+|+.++++++||||++++++|..++.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 37999999999999999999999999999999987654555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
+++++|.+++.....+++..+..++.||+.||.|||+ ++++|+||||+|||++.++.+||+|||++...... .....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~ 158 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSF 158 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccccC
Confidence 9999999999888889999999999999999999997 69999999999999999999999999998654322 22456
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-------------------------
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------------- 226 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~------------------------- 226 (703)
+|++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+..
T Consensus 159 ~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 159 VGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 899999999998764 488999999999999999999999965432221111100
Q ss_pred -----------CCCCCcc-hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 227 -----------ENPPQLD-EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 227 -----------~~~~~l~-~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..++..+ ..++..+++||.+||..+|.+||++.+|++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0011111 2367789999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.11 Aligned_cols=256 Identities=47% Similarity=0.864 Sum_probs=215.6
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC-----
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ----- 83 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~----- 83 (703)
.+.+.|++.+.||+|+||.||+|.+..+++.||||++..... ....+..|+.++.++ +||||++++++|...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 467789999999999999999999999999999999865432 235678899999998 699999999998753
Q ss_pred -CEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchh
Q 005298 84 -TKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 84 -~~lyLV~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
..+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4689999999999999999753 4689999999999999999999999999999999999999999999999999876
Q ss_pred hhhcccccccccCCCCCCchhhhccc----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCcchh
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEH 235 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~----~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~-~~~l~~~ 235 (703)
............|++.|+|||++... ..++.++|||||||++|+|++|..||...........+.... +......
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 54333344557899999999998632 247889999999999999999999997665444333332222 2223345
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
++..+.+||.+||..+|.+|||+.++++||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 77899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=388.50 Aligned_cols=253 Identities=23% Similarity=0.398 Sum_probs=203.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC------CCeeeeEEEEEeC-
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS------PYITEYYGSYLHQ- 83 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H------PnIV~L~~~~~~~- 83 (703)
...+|++++.||+|+||+||+|.+..+++.||||+++... .....+..|+.+++.+.| ++|++++++|..+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 3578999999999999999999999999999999986432 223445667777777654 4589999988765
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCC--------------
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENG-------------- 148 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g-------------- 148 (703)
..+|||||++ |++|.+++.+.+.+++..+..|+.||+.||.|||+ .|||||||||+||||+.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 5789999999 78999999888899999999999999999999998 5999999999999998765
Q ss_pred --CeeEeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC
Q 005298 149 --DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR 226 (703)
Q Consensus 149 --~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~ 226 (703)
.+||+|||++.... ......+||+.|+|||++.+. .|+.++|||||||+||||++|++||...+....+..+..
T Consensus 284 ~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 284 PCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CceEEECCCCccccCc---cccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 49999999875432 223457899999999999875 589999999999999999999999987654332221110
Q ss_pred C---CC-----------------------CCc-c--------------hhhhHHHHHHHHHHhccCCCCCCCHHHHHhch
Q 005298 227 E---NP-----------------------PQL-D--------------EHFSRLMKEFVSLCLKKVPAERPSAKELLRHR 265 (703)
Q Consensus 227 ~---~~-----------------------~~l-~--------------~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hp 265 (703)
. .+ +.. + ......+.+||.+||++||.+|||+.|+|+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 0 00 000 0 01134577999999999999999999999999
Q ss_pred hhhcc
Q 005298 266 FIRNA 270 (703)
Q Consensus 266 ff~~~ 270 (703)
||...
T Consensus 440 ~~~~~ 444 (467)
T PTZ00284 440 YVLKY 444 (467)
T ss_pred ccccc
Confidence 99763
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=359.52 Aligned_cols=258 Identities=43% Similarity=0.787 Sum_probs=221.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++++.||.|+||.||+|++..++..|+||.+...... ..+.+.+|+.+++.+.||||+++++.|..+...|+||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 346999999999999999999999999999999998765433 3467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++............
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 99999999999865 56899999999999999999999999999999999999999999999999998765433333344
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCcchhhhHHHHHHHHHHh
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~--~~~l~~~is~~L~dLI~~cL 248 (703)
..|++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+.... +...+..++..+.+||.+||
T Consensus 176 ~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (296)
T cd06654 176 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (296)
T ss_pred ccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence 5799999999998764 47899999999999999999999998766544333222222 22234567888999999999
Q ss_pred ccCCCCCCCHHHHHhchhhhccc
Q 005298 249 KKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.++|.+||++.+++.||||...+
T Consensus 255 ~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 255 DMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred cCCcccCcCHHHHhhChhhhccC
Confidence 99999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=355.30 Aligned_cols=259 Identities=65% Similarity=1.116 Sum_probs=226.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.-|++++.||.|+||.||+|.+..++..||||++...........+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45889999999999999999999999999999987655555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
+.+++|.+++.. ..+++..+..++.||+.+|.|||++|++|+||||.||+++.++.++|+|||++..+...........
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence 999999999875 5789999999999999999999999999999999999999999999999999865543322333457
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCC
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP 252 (703)
|+..|++||++.+. .++.++|||||||++|+|++|..||...........+....++.+...++..+.++|.+||..+|
T Consensus 163 ~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 241 (277)
T cd06641 163 GTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 241 (277)
T ss_pred CCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 89999999998764 47889999999999999999999998776655555555555556667788999999999999999
Q ss_pred CCCCCHHHHHhchhhhccccC
Q 005298 253 AERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 253 ~~RPTa~eLL~Hpff~~~~~~ 273 (703)
.+||++.++++||||.+....
T Consensus 242 ~~Rp~~~~~l~~~~~~~~~~~ 262 (277)
T cd06641 242 SFRPTAKELLKHKFIVRFAKK 262 (277)
T ss_pred hhCcCHHHHHhCHHHhhhhhc
Confidence 999999999999999876443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=359.79 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=214.3
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.|++.+.||+|+||+||++.+..+++.||||.+..... ......+..|+.++++++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999865432 2223557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|+.+++|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIK 159 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-cccc
Confidence 99999999988543 36899999999999999999999999999999999999999999999999998654322 1223
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc---eeeccCCCCCCCcchhhhHHHHHHHHH
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR---VLFIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~---~l~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
..+|++.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+.......++..++..+.+||..
T Consensus 160 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 160 GRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred CCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHH
Confidence 45799999999999765 48999999999999999999999997643211 111121222233445678899999999
Q ss_pred HhccCCCCCCC-----HHHHHhchhhhcc
Q 005298 247 CLKKVPAERPS-----AKELLRHRFIRNA 270 (703)
Q Consensus 247 cL~~dP~~RPT-----a~eLL~Hpff~~~ 270 (703)
||..+|.+||| +.++++||||...
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 99999999999 9999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=349.88 Aligned_cols=253 Identities=33% Similarity=0.587 Sum_probs=221.9
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|++++.||.|+||.||++.+..+|+.||||.+.... .......+.+|+.++++++||||+++++++...+..|+|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 6999999999999999999999999999999986543 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 93 v~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
+.+++|.+++... ..+++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++............
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 9999999998653 36899999999999999999999999999999999999999999999999998765443333334
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
..|++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.....+..+..++..+.++|.+||..
T Consensus 161 ~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08218 161 CIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR 239 (256)
T ss_pred ccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhC
Confidence 5789999999998765 478899999999999999999999987766665555555555556677889999999999999
Q ss_pred CCCCCCCHHHHHhchhh
Q 005298 251 VPAERPSAKELLRHRFI 267 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpff 267 (703)
+|.+||++.++++||||
T Consensus 240 ~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 240 NPRDRPSVNSILEKNFI 256 (256)
T ss_pred ChhhCcCHHHHhhCcCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=349.41 Aligned_cols=250 Identities=31% Similarity=0.549 Sum_probs=220.6
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
+|++.+.||.|+||.||++.+..++..||+|.++........+.+..|+.++++++||||+++++++..++.+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 58999999999999999999999999999999876655556778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 94 AGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 94 ~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.............
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence 99999998864 3468999999999999999999999999999999999999999999999999987654433333456
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccC
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~d 251 (703)
.|++.|+|||++.+. .++.++||||||+++|+|++|..||...+.......+.......++..++..+.+||.+||.++
T Consensus 161 ~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (255)
T cd08219 161 VGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRN 239 (255)
T ss_pred cCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCC
Confidence 799999999998765 4889999999999999999999999877665555555555555566778889999999999999
Q ss_pred CCCCCCHHHHHhc
Q 005298 252 PAERPSAKELLRH 264 (703)
Q Consensus 252 P~~RPTa~eLL~H 264 (703)
|.+||++.+|+.-
T Consensus 240 P~~Rp~~~~il~~ 252 (255)
T cd08219 240 PRSRPSATTILSR 252 (255)
T ss_pred cccCCCHHHHhhc
Confidence 9999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=348.27 Aligned_cols=253 Identities=32% Similarity=0.555 Sum_probs=223.2
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|+++++||.|+||.||.+.+..++..|++|.+.... .......+.+|+.++++++|+||+++++++.+.+.+++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 6999999999999999999999999999999987554 344556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 93 v~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|++++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++............
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999999764 56899999999999999999999999999999999999999999999999998766444333345
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
..|++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+...........++..+.++|.+||.+
T Consensus 161 ~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (256)
T cd08221 161 VVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ 239 (256)
T ss_pred cCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence 6799999999998765 478899999999999999999999988766665555555555555567889999999999999
Q ss_pred CCCCCCCHHHHHhchhh
Q 005298 251 VPAERPSAKELLRHRFI 267 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpff 267 (703)
+|.+||++.++++|+|+
T Consensus 240 ~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 240 DPEKRPTADEVLDQPLL 256 (256)
T ss_pred CcccCCCHHHHhhCcCC
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=373.44 Aligned_cols=255 Identities=28% Similarity=0.489 Sum_probs=217.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--C---E
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--T---K 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~---~ 85 (703)
..-.|+..+++|.|+||.||+|+...+++.||||.+-... ..-.+|+.||++++|||||+|..+|... + +
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 3447899999999999999999999999999999975443 1234689999999999999999998753 2 4
Q ss_pred EEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC-CCeeEeccccchh
Q 005298 86 LWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQ 160 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~-g~VKL~DFGlA~~ 160 (703)
+.+|||||+ .+|..+++. +..++...++-|++||++||.|||+.||+||||||.|||||.+ |.+||||||.|+.
T Consensus 97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 578999994 699998874 5789999999999999999999999999999999999999976 9999999999988
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC------------C
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------N 228 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~------------~ 228 (703)
+... ....+++.|..|+|||.+.+...|+.+.||||.||||.||+-|++.|.+.+..+++..|.+- +
T Consensus 176 L~~~-epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 176 LVKG-EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eccC-CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 8654 33467899999999999999999999999999999999999999999987665555433210 0
Q ss_pred C-------C---------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 229 P-------P---------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 229 ~-------~---------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
+ + .+....++++.+|+.++|..+|.+|.++.|++.||||...+.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 0 0 133456889999999999999999999999999999987654
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=367.03 Aligned_cols=256 Identities=32% Similarity=0.580 Sum_probs=207.7
Q ss_pred eEEEEEeec--CceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 16 SSLELIGRG--SFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 16 ~il~~LG~G--sfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+++++||+| +|++||++.+..+|+.||||+++.... ......+.+|+.+++.++||||++++++|..++..|+||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 367899999 789999999999999999999976543 34456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc---
Q 005298 93 MAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--- 167 (703)
Q Consensus 93 v~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~--- 167 (703)
+++++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999965 346899999999999999999999999999999999999999999999999865433211110
Q ss_pred ----cccccCCCCCCchhhhccc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--------------
Q 005298 168 ----RKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-------------- 228 (703)
Q Consensus 168 ----~~~~iGTp~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~-------------- 228 (703)
.....++..|+|||++.+. ..++.++|||||||++|+|++|..||................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 1123577889999998753 358899999999999999999999997543221110000000
Q ss_pred -------------------------------CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 229 -------------------------------PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 229 -------------------------------~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.......+++.+.+||.+||+.||.+|||++++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0011234567899999999999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=356.80 Aligned_cols=258 Identities=45% Similarity=0.785 Sum_probs=220.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
..|++++.||.|+||.||+|.+..++..|++|.+.... ......+.+|+.+++.++||||+++++++..++..|+|+||
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 34789999999999999999999999999999986543 44567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 93 v~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
+.+++|..++.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.............
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence 999999998754 5679999999999999999999999999999999999999999999999999987654333333456
Q ss_pred cCCCCCCchhhhcc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CcchhhhHHHHHHHH
Q 005298 172 VGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEFVS 245 (703)
Q Consensus 172 iGTp~Y~APEvl~~----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~--~l~~~is~~L~dLI~ 245 (703)
.|++.|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+....++ ..+..++..+.+||.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK 243 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence 79999999999842 234678999999999999999999999877665544444332222 234567889999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhccc
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
+||..+|.+||++.++++||||....
T Consensus 244 ~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 244 KCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHccCChhhCcCHHHHhcCCCEeccC
Confidence 99999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=358.86 Aligned_cols=253 Identities=26% Similarity=0.450 Sum_probs=208.1
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|++++.||.|+||.||+|.+..+|+.||+|.+...... .....+.+|+.++++++||||+++++++.+.+.+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 699999999999999999999999999999998654322 2235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 93 v~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
+. ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 96 578777754 5679999999999999999999999999999999999999999999999999987654333333345
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeecc------------------CC-CCC--
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFII------------------PR-ENP-- 229 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-~~~l~~I------------------~~-~~~-- 229 (703)
.+++.|+|||++.+...++.++|||||||++|+|++|..||..... ...+..+ .. ...
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence 7899999999987766678999999999999999999988643322 1111100 00 000
Q ss_pred -------CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 230 -------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 230 -------~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
......++..+.+||.+||..+|.+|||+++++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 01112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=347.65 Aligned_cols=253 Identities=36% Similarity=0.592 Sum_probs=221.7
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe--CCEEEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWIIM 90 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--~~~lyLV~ 90 (703)
+|++++.||.|+||.||++.+..++..||+|++.... .....+.+..|+.++++++||||+++++++.. +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999986543 34456778899999999999999999998764 45789999
Q ss_pred eccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH-----hcCceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLH-----NEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 91 Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLH-----s~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
||+++++|.+++.. ..++++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999865 467999999999999999999999 899999999999999999999999999998876
Q ss_pred hhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHH
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~ 241 (703)
...........|++.|++||++... .++.++||||||+++|+|++|..||...+.......+.....+.++..++..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN 239 (265)
T ss_pred cCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHH
Confidence 5443323456799999999999765 488899999999999999999999988765555555555555667778899999
Q ss_pred HHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 242 EFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
+++.+||..+|.+||++.+|++|||+
T Consensus 240 ~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 240 EVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=372.42 Aligned_cols=254 Identities=27% Similarity=0.430 Sum_probs=208.0
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC------
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------ 83 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~------ 83 (703)
...+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4579999999999999999999999999999999986543 233456778899999999999999999988653
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
..+|+||||+. ++|..++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 35799999996 577777753 588999999999999999999999999999999999999999999999999875533
Q ss_pred cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC--------------
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP-------------- 229 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~-------------- 229 (703)
. ......+||+.|+|||++.+. .++.++|||||||+||+|++|+.||...+....+..+.....
T Consensus 179 ~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 179 S-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred C-CcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 2 122346899999999999775 589999999999999999999999987654332222111000
Q ss_pred ---------------------------CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 230 ---------------------------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 230 ---------------------------~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
.......+..+++||.+||..||.+|||+.++|+||||..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0001123457899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=371.26 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=208.0
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ----- 83 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~----- 83 (703)
....+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35679999999999999999999999999999999986543 333456778899999999999999999988654
Q ss_pred -CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 84 -TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 84 -~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
...|+||||+++ +|...+.. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999965 67766643 58999999999999999999999999999999999999999999999999987553
Q ss_pred hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------- 226 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------- 226 (703)
.. ......+||+.|+|||++.+. .++.++|||||||+||+|++|+.||...+.......+..
T Consensus 171 ~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 171 TS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred Cc-cccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 32 222356899999999999765 589999999999999999999999976543221110000
Q ss_pred ------CC-------------------CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 227 ------EN-------------------PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 227 ------~~-------------------~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.. ........+..+++||.+||..||.+|||+.|+|+||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 00 000112235678999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=347.05 Aligned_cols=257 Identities=40% Similarity=0.712 Sum_probs=225.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++.+.||.|++|.||+|.+..+++.|+||++...........+.+|+.++.+++||||+++++++...+.+|+||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 37999999999999999999999999999999987665445567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
+++++|.+++.....+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 160 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF 160 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence 9999999999888889999999999999999999999 999999999999999999999999999987665443333356
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCC---ccceeeccCCCCCCCcchh-hhHHHHHHHHHH
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH---PMRVLFIIPRENPPQLDEH-FSRLMKEFVSLC 247 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~---~~~~l~~I~~~~~~~l~~~-is~~L~dLI~~c 247 (703)
.++..|+|||.+... .++.++||||||+++|+|++|..||.... .......+.....+..+.. ++..+.++|..|
T Consensus 161 ~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 239 (264)
T cd06623 161 VGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239 (264)
T ss_pred eecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHH
Confidence 789999999998765 58899999999999999999999997764 2233333334444445555 889999999999
Q ss_pred hccCCCCCCCHHHHHhchhhhcc
Q 005298 248 LKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
|..+|.+||++.++++||||+..
T Consensus 240 l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 240 LQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ccCChhhCCCHHHHHhCHHHHhc
Confidence 99999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=350.54 Aligned_cols=255 Identities=50% Similarity=0.914 Sum_probs=216.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCC-----
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT----- 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~----- 84 (703)
..++|++.+.||.|+||.||+|.+..+++.|++|++..... ..+.+.+|+.+++++ .||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 56799999999999999999999999999999999875532 346789999999999 7999999999997644
Q ss_pred -EEEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccch
Q 005298 85 -KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 85 -~lyLV~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
.+|+||||+++++|.+++.. +..+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 58999999999999999864 4579999999999999999999999999999999999999999999999999987
Q ss_pred hhhhcccccccccCCCCCCchhhhccc----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--c
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--D 233 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~~----~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l--~ 233 (703)
.............|++.|+|||++... ..++.++|||||||+||+|++|.+||...........+....++.+ +
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCch
Confidence 654433334456799999999988542 2467889999999999999999999987665554444444333222 2
Q ss_pred hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 234 ~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
..++..+++||.+||..||.+|||+.++++|||+
T Consensus 242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 242 ENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 3477899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=356.81 Aligned_cols=258 Identities=33% Similarity=0.643 Sum_probs=221.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++++.||.|+||.||+|.+..++..||+|.+...........+.+|+.++++++||||+++++++...+.+|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36899999999999999999999999999999987654555567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 93 MAGGSVADLIQSG---PPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 93 v~gGsL~~~l~~~---~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
+++++|..++... ..+++..+..++.||+.||.|||+ ++|+|+||||+|||++.++.+||+|||++..+... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 158 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LA 158 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--cc
Confidence 9999999998763 379999999999999999999996 59999999999999999999999999998655322 22
Q ss_pred ccccCCCCCCchhhhcccc-----CCccccchhhHHHHHHHHHhCCCCCCCCCcccee---eccCCCCCCCcchhhhHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSE-----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---FIIPRENPPQLDEHFSRLM 240 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~-----~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l---~~I~~~~~~~l~~~is~~L 240 (703)
....|++.|+|||++.+.. .++.++|||||||++|+|++|..||......... ..+....++.++..++..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence 3457899999999985432 2578899999999999999999999765433322 2233445556666789999
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
.+||.+||..+|.+||++.+++.||||...+.
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred HHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 99999999999999999999999999976643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=357.38 Aligned_cols=248 Identities=24% Similarity=0.389 Sum_probs=205.5
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCH
Q 005298 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (703)
Q Consensus 21 LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL 98 (703)
||+|+||.||++.++.+|+.||+|++..... ......+..|+.++++++||||+++++++..+..+|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999999999999999864321 12234456799999999999999999999999999999999999999
Q ss_pred HHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCCC
Q 005298 99 ADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (703)
Q Consensus 99 ~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~ 176 (703)
..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ......|++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCC
Confidence 9888543 358999999999999999999999999999999999999999999999999986654321 2234579999
Q ss_pred CCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----ceeeccCCCCCCCcchhhhHHHHHHHHHHhccCC
Q 005298 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM----RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 177 Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~----~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP 252 (703)
|+|||++.+.. ++.++|||||||+||+|++|..||...... .....+...........++..+++||.+||.++|
T Consensus 160 y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P 238 (277)
T cd05607 160 YMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKP 238 (277)
T ss_pred ccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCH
Confidence 99999997764 899999999999999999999999764321 1222222222222234678899999999999999
Q ss_pred CCCCCH----HHHHhchhhhcc
Q 005298 253 AERPSA----KELLRHRFIRNA 270 (703)
Q Consensus 253 ~~RPTa----~eLL~Hpff~~~ 270 (703)
.+||++ ++++.|+||+..
T Consensus 239 ~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 239 EDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hhCCCCccchhhhhcChhhcCC
Confidence 999999 778899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=354.25 Aligned_cols=252 Identities=35% Similarity=0.641 Sum_probs=213.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|+++++||.|+||.||+|++..+++.||||++...........+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36899999999999999999999999999999987654455556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
+++++|..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+... .....+
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~~ 154 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYV 154 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCCC
Confidence 999999765 45789999999999999999999999999999999999999999999999998755332 223468
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-------eeeccCCCCCCC-cchhhhHHHHHHH
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-------VLFIIPRENPPQ-LDEHFSRLMKEFV 244 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~-------~l~~I~~~~~~~-l~~~is~~L~dLI 244 (703)
|++.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+....++. ....++..+.+||
T Consensus 155 ~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (279)
T cd06619 155 GTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233 (279)
T ss_pred CChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence 99999999999765 48899999999999999999999996533211 111111111222 2234678899999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+||..+|.+||++.+++.||||....
T Consensus 234 ~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 234 TQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHhhCChhhCCCHHHHhcCccccccc
Confidence 999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=354.71 Aligned_cols=251 Identities=26% Similarity=0.431 Sum_probs=218.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCC-----cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELN-----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg-----~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
.+|++++.||+|+||.||+|.+...+ ..||+|.+...........+.+|+.++.+++||||+++++++......|
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 47999999999999999999886655 7899999876655556677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCee
Q 005298 88 IIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~----------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VK 151 (703)
++|||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+|
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEE
Confidence 999999999999999764 4578899999999999999999999999999999999999999999
Q ss_pred Eeccccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC
Q 005298 152 VADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (703)
Q Consensus 152 L~DFGlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~ 228 (703)
|+|||++....... .......+++.|+|||++.+. .++.++|||||||+||||++ |..||......+....+....
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999986543221 112234678899999998765 48999999999999999998 999998877777666666666
Q ss_pred CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 229 ~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
....+..++..+.+|+.+||..+|.+||++.+|+++
T Consensus 244 ~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 244 LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 666677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=346.69 Aligned_cols=252 Identities=58% Similarity=0.999 Sum_probs=218.8
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++.+.||.|+||.||+|.+..++..|++|.+.... ..+.+.+|+.++++++||||+++++++..+..+|+++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 468999999999999999999999989999999986442 26789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 92 yv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|+.+++|.+++.. ...+++..+..++.||+.||.|||..+|+|+||+|.||+++.++.++|+|||++............
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 9999999999975 467899999999999999999999999999999999999999999999999998776544333344
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CcchhhhHHHHHHHHHHh
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~--~l~~~is~~L~dLI~~cL 248 (703)
..|+..|++||++.+. .++.++|||||||++|+|++|..||...........+...... ..+..++..+.+||.+||
T Consensus 159 ~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd06612 159 VIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL 237 (256)
T ss_pred ccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence 5689999999998765 5889999999999999999999999876654443333322222 223467788999999999
Q ss_pred ccCCCCCCCHHHHHhchhh
Q 005298 249 KKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff 267 (703)
..+|.+|||+.++|.||||
T Consensus 238 ~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 238 VKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hcChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=346.27 Aligned_cols=253 Identities=41% Similarity=0.750 Sum_probs=219.7
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC----ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~----~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
+|+..+.||.|+||+||+|.+..++..|+||.+.... .......+.+|+.+++.++||||+++++++..+..+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5888899999999999999999899999999986543 233457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
+||+++++|.+++.+...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAK 159 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-ccc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999886553322 234
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-CCCCCcchhhhHHHHHHHHHHh
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-ENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~-~~~~~l~~~is~~L~dLI~~cL 248 (703)
...|++.|++||.+.....++.++|+|||||++|+|++|..||...........+.. ...+.++..++..+.+||.+||
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence 567899999999986643378899999999999999999999987665444444333 2344556678899999999999
Q ss_pred ccCCCCCCCHHHHHhchhh
Q 005298 249 KKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff 267 (703)
..+|.+||++.+++.|||+
T Consensus 240 ~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 240 QRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hcCcccCcCHHHHhcCCCC
Confidence 9999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=351.16 Aligned_cols=254 Identities=41% Similarity=0.707 Sum_probs=219.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++.+.||.|+||.||+|.++.+++.||+|.+...........+.+|+.+++++.||||+++++++...+.+|+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36889999999999999999999999999999987765555667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 93 MAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 93 v~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
+.+++|.+++... ..+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++......... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~ 158 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--T 158 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--c
Confidence 9999999999875 789999999999999999999999 99999999999999999999999999998766433222 2
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCC-----ccceeeccCCCCCCCcchh-hhHHHHHHH
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH-----PMRVLFIIPRENPPQLDEH-FSRLMKEFV 244 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~-----~~~~l~~I~~~~~~~l~~~-is~~L~dLI 244 (703)
..|+..|++||++.+. .++.++|||||||++|+|++|..||.... .......+.....+.++.. ++..+.+||
T Consensus 159 ~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (265)
T cd06605 159 FVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237 (265)
T ss_pred ccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence 6889999999998765 58899999999999999999999997652 1122222223333344444 888999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
..||..+|.+|||+.+++.||||+.
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 238 NLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHcCCCchhCcCHHHHhhCchhhc
Confidence 9999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=410.38 Aligned_cols=283 Identities=27% Similarity=0.417 Sum_probs=237.4
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
..+|+|+++||+|+||.|.+++.+.|++.||||++++-. .......|+.|..||...+.+-||.++..|++++++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 358999999999999999999999999999999987532 123346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-ccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRR 168 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~~ 168 (703)
|||++||+|-.++.+..++|+..+++|+..|+.||+-||+.|+|||||||+|||||..|+|||+|||.|..+...+ -..
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s 233 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS 233 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence 9999999999999998899999999999999999999999999999999999999999999999999987776433 334
Q ss_pred ccccCCCCCCchhhhccc----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-CCCCcc--hhhhHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-NPPQLD--EHFSRLMK 241 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~----~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~-~~~~l~--~~is~~L~ 241 (703)
...+|||-|++||+++.. ..|+..+||||+||+|||||.|..||+...-..++.+|... +...+| ..+|..++
T Consensus 234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeak 313 (1317)
T KOG0612|consen 234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAK 313 (1317)
T ss_pred ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHH
Confidence 567999999999999632 34889999999999999999999999998888888777643 112222 45899999
Q ss_pred HHHHHHhccCCCCCCC---HHHHHhchhhhccccChhHHHHhhcCCCCCCCCCCCCCCCc
Q 005298 242 EFVSLCLKKVPAERPS---AKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPING 298 (703)
Q Consensus 242 dLI~~cL~~dP~~RPT---a~eLL~Hpff~~~~~~~~l~e~i~~~~~~~~~~~~~~~~~~ 298 (703)
+||.++|+ +|..|.. ++++..||||....| ..+.+ ..+|..|....+++..++
T Consensus 314 dLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W-~~iR~--~~pP~vPevssd~DTsnF 369 (1317)
T KOG0612|consen 314 DLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW-DNIRE--SVPPVVPEVSSDDDTSNF 369 (1317)
T ss_pred HHHHHHhc-ChhhhcccccHHHHHhCccccCCCh-hhhhh--cCCCCCCcCCCCCccccc
Confidence 99999775 5789988 999999999998866 22222 123444555545544443
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=361.49 Aligned_cols=246 Identities=26% Similarity=0.429 Sum_probs=193.9
Q ss_pred EEEEeecCceEEEEEEEc--CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe--CCEEEEEEecc
Q 005298 18 LELIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWIIMEYM 93 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~--~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--~~~lyLV~Eyv 93 (703)
.+.||+|+||.||+|.++ .+++.||||.+..... ...+.+|+.+|++++||||++++++|.. +..+|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 358999999999999976 4678999999865432 2446789999999999999999999865 45789999999
Q ss_pred CCCCHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe----cCCCCeeEeccccchh
Q 005298 94 AGGSVADLIQSG---------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL----TENGDVKVADFGVSAQ 160 (703)
Q Consensus 94 ~gGsL~~~l~~~---------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL----d~~g~VKL~DFGlA~~ 160 (703)
. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++..
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 4 6888887532 258999999999999999999999999999999999999 4557899999999876
Q ss_pred hhhccc---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccce---------eeccCC--
Q 005298 161 LTRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV---------LFIIPR-- 226 (703)
Q Consensus 161 ~~~~~~---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~---------l~~I~~-- 226 (703)
+..... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||........ +..+..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 543221 223468999999999998766689999999999999999999999964332100 000000
Q ss_pred CCC-----------C------------------------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 227 ENP-----------P------------------------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 227 ~~~-----------~------------------------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
..+ + ......+..+.+||.+||.+||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 0 0001123568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=356.89 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=214.6
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh----HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~----~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
+|++.+.||.|+||.||+|.+..+++.||||.+...... .....+..|+.++++++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999999999999998755422 2234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 90 MEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|||+ +++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 999999998766 89999999999999999999999999999999999999999999999999987665433333
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------------
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------------- 226 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------------- 226 (703)
....+++.|+|||++.+...++.++|||||||++|+|++|.+||........+..+..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 3456788999999987655678899999999999999999888876554322211100
Q ss_pred CCCC-----CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 227 ENPP-----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 227 ~~~~-----~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
...+ .....++..+.+||.+||.++|.+|||+.+++.|+||.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 0000 0113456789999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.52 Aligned_cols=256 Identities=43% Similarity=0.768 Sum_probs=220.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++.+.||.|+||.||+|++..+++.|+||.+..... ...+.+.+|+.+++.++||||+++++++...+.+|+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 579999999999999999999999999999999865433 2356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
+.+++|..++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..............
T Consensus 98 ~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 176 (296)
T cd06655 98 LAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176 (296)
T ss_pred cCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcC
Confidence 999999999875 4689999999999999999999999999999999999999999999999999876544333333457
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCcchhhhHHHHHHHHHHhcc
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~--~~~l~~~is~~L~dLI~~cL~~ 250 (703)
|++.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+.... ....+..++..+.+||.+||..
T Consensus 177 ~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 255 (296)
T cd06655 177 GTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEM 255 (296)
T ss_pred CCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhc
Confidence 89999999998764 48889999999999999999999998776544333332221 2233456788999999999999
Q ss_pred CCCCCCCHHHHHhchhhhccc
Q 005298 251 VPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpff~~~~ 271 (703)
+|.+||++.+|+.||||+..+
T Consensus 256 dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 256 DVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ChhhCCCHHHHhhChHhhhcc
Confidence 999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=348.85 Aligned_cols=252 Identities=38% Similarity=0.724 Sum_probs=215.0
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-----ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-----~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
+|++.+.||.|+||+||+|.+. +++.||||.+.... .......+.+|+.++++++|+||+++++++.+.+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4888999999999999999874 68999999986443 12334678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc---
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--- 165 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~--- 165 (703)
|+||+.+++|.+++.+..++++..+..++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987543211
Q ss_pred ---cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--CCCCCcchhhhHHH
Q 005298 166 ---SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR--ENPPQLDEHFSRLM 240 (703)
Q Consensus 166 ---~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~--~~~~~l~~~is~~L 240 (703)
.......|++.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.. ...+.++..++..+
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 112235789999999998765 488999999999999999999999987654433322221 22344566788999
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.+||.+||.++|.+||++.+++.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.48 Aligned_cols=258 Identities=31% Similarity=0.493 Sum_probs=219.5
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~--~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++.+.||.|+||.||+|.+..+++.||||.+...... .....+..|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3799999999999999999999999999999998765433 35667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc---
Q 005298 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--- 165 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~--- 165 (703)
||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999999753 579999999999999999999999999999999999999999999999999876442211
Q ss_pred --------------------------cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc
Q 005298 166 --------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR 219 (703)
Q Consensus 166 --------------------------~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~ 219 (703)
.....++|+..|+|||++.+. .++.++|||||||++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 011235789999999999765 58899999999999999999999998776554
Q ss_pred eeeccCCCCC-CCcchhhhHHHHHHHHHHhccCCCCCCC----HHHHHhchhhhccc
Q 005298 220 VLFIIPRENP-PQLDEHFSRLMKEFVSLCLKKVPAERPS----AKELLRHRFIRNAR 271 (703)
Q Consensus 220 ~l~~I~~~~~-~~l~~~is~~L~dLI~~cL~~dP~~RPT----a~eLL~Hpff~~~~ 271 (703)
.+..+..... ......++..+.+||.+||.++|.+||+ ++++|.||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 4443332221 1122237899999999999999999999 99999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=352.44 Aligned_cols=256 Identities=48% Similarity=0.881 Sum_probs=215.7
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEe------
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH------ 82 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~------ 82 (703)
.+.+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 35579999999999999999999999999999999986542 3345688899999998 79999999999863
Q ss_pred CCEEEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchh
Q 005298 83 QTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
...+|+||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 4678999999999999999965 34688999999999999999999999999999999999999999999999999876
Q ss_pred hhhcccccccccCCCCCCchhhhcc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC-cchh
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ-LDEH 235 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~-l~~~ 235 (703)
............|++.|+|||++.. ...++.++|||||||++|+|++|..||....+......+....++. ....
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKK 250 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccc
Confidence 5433333445689999999999853 2347789999999999999999999998766544444333332222 2345
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
++..+.+||.+||..+|.+|||+.+|++||||
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 78899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.18 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=215.6
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.|+..+.||.|+||+||+|.+..+++.||+|.+..... ......+.+|+.++++++|+||+++++++..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999865432 2234557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|+.+++|..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~ 159 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIR 159 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cccc
Confidence 9999999988854 346999999999999999999999999999999999999999999999999988654322 1223
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---CCCCCCcchhhhHHHHHHHHH
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---RENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~---~~~~~~l~~~is~~L~dLI~~ 246 (703)
...|++.|+|||++.+. .++.++|||||||++|+|++|..||...........+. ......+...++..+.+|+..
T Consensus 160 ~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred CCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence 45799999999999765 58899999999999999999999998765432221111 111223445678889999999
Q ss_pred HhccCCCCCCC-----HHHHHhchhhhccc
Q 005298 247 CLKKVPAERPS-----AKELLRHRFIRNAR 271 (703)
Q Consensus 247 cL~~dP~~RPT-----a~eLL~Hpff~~~~ 271 (703)
||.++|.+||+ +.+++.|+||+...
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 99999999999 89999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=348.31 Aligned_cols=254 Identities=39% Similarity=0.703 Sum_probs=214.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC----ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe--CCEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~----~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--~~~l 86 (703)
.+|++.+.||+|+||.||+|.+..++..|++|++.... .......+.+|+.++++++||||+++++++.. +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999986542 22345678899999999999999999999876 4678
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-
Q 005298 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~- 165 (703)
|+++||+.+++|.+++.....+++..+..++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++..+....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999986543211
Q ss_pred --cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCcchhhhHHHHH
Q 005298 166 --SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMKE 242 (703)
Q Consensus 166 --~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~-~~~~~~l~~~is~~L~d 242 (703)
.......|+..|+|||++.+. .++.++|||||||++|+|++|+.||...........+. ....+.++..++..+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 111235689999999999764 48899999999999999999999998765444333322 22334556677888999
Q ss_pred HHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 243 FVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
|| .||..+|.+||++++|++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=347.51 Aligned_cols=254 Identities=31% Similarity=0.588 Sum_probs=216.3
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-----hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-----~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
+|+..+.||+|+||.||++.+..+++.||+|++..... ......+.+|+.++++++||||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58899999999999999999999999999999865431 1235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC-CeeEeccccchhhhhcccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g-~VKL~DFGlA~~~~~~~~~ 167 (703)
|+||+.+++|.+++....++++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888999999999999999999999999999999999999998775 5999999998765433211
Q ss_pred ----cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc----CCCCCCCcchhhhHH
Q 005298 168 ----RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII----PRENPPQLDEHFSRL 239 (703)
Q Consensus 168 ----~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I----~~~~~~~l~~~is~~ 239 (703)
.....|+..|+|||++.+. .++.++|||||||++|+|++|..||...........+ .....+.++..++..
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1235789999999998764 5889999999999999999999999754432221111 112334556678899
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 240 MKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
+.++|.+||..+|.+||++.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=351.83 Aligned_cols=256 Identities=46% Similarity=0.821 Sum_probs=215.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC-----C
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ-----T 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~-----~ 84 (703)
+..+|++.+.||.|+||.||+|.+..+++.||||++.... .....+..|+.++.++ +||||+++++++... .
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 4678999999999999999999999999999999986442 2245677899999998 899999999998754 3
Q ss_pred EEEEEEeccCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchh
Q 005298 85 KLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~----~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
.+|+||||+++++|.++++ ....+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 6899999999999999885 346789999999999999999999999999999999999999999999999999876
Q ss_pred hhhcccccccccCCCCCCchhhhcccc----CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--ch
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSE----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DE 234 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~----~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l--~~ 234 (703)
............|++.|+|||++.... .++.++|||||||++|+|++|.+||...+....+..+....++.+ +.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE 257 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence 543332333467899999999986432 257899999999999999999999987765554444443333222 34
Q ss_pred hhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 235 ~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
.++..+.+||.+||.++|.+||++.+|+.||||+
T Consensus 258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 5677899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=351.24 Aligned_cols=255 Identities=46% Similarity=0.836 Sum_probs=212.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEE-----eCC
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYL-----HQT 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~-----~~~ 84 (703)
...+|++++.||+|+||.||+|.+..+++.||||++.... .....+..|+.+++++ +||||+++++++. .++
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 5579999999999999999999999999999999976432 2235678899999999 6999999999884 346
Q ss_pred EEEEEEeccCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchh
Q 005298 85 KLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~----~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
.+|+||||+++++|.+++. ....+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceee
Confidence 7899999999999999874 345789999999999999999999999999999999999999999999999999876
Q ss_pred hhhcccccccccCCCCCCchhhhccc----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--cch
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDE 234 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~----~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~--l~~ 234 (703)
+...........|++.|+|||++... ..++.++|||||||++|+|++|..||........+..+....++. .+.
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE 253 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCC
Confidence 54333333445799999999998532 337889999999999999999999998776544443333322221 234
Q ss_pred hhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 235 ~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.++..+.+||.+||..+|.+|||+.+|++|+||
T Consensus 254 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 467789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=343.93 Aligned_cols=252 Identities=32% Similarity=0.532 Sum_probs=219.8
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|++++.||.|+||.||+|.+..++..||||++.... .......+.+|+.++++++||||+++++.+..++.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 6999999999999999999999999999999987653 334567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC-CCeeEeccccchhhhhcccccc
Q 005298 93 MAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 93 v~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~-g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
+++++|.+++... ..+++..+..++.|++.+|.|||++||+|+||||+||+++.+ +.+||+|||++....... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-ccc
Confidence 9999999999763 458999999999999999999999999999999999999865 458999999987654322 223
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
...|++.|+|||.+... .++.++||||||+++|+|++|..||...+.......+.......++..++..+.++|.+||.
T Consensus 160 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 238 (256)
T cd08220 160 TVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLN 238 (256)
T ss_pred ccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHcc
Confidence 45789999999998764 47889999999999999999999998876655555555555555666789999999999999
Q ss_pred cCCCCCCCHHHHHhchhh
Q 005298 250 KVPAERPSAKELLRHRFI 267 (703)
Q Consensus 250 ~dP~~RPTa~eLL~Hpff 267 (703)
.+|.+|||+.+++.||||
T Consensus 239 ~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 239 LDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CChhhCCCHHHHhhCCCC
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.84 Aligned_cols=251 Identities=21% Similarity=0.355 Sum_probs=214.0
Q ss_pred CCCceEEEEEeecCceEEEEEEEc---CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~---~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
..+|++.+.||+|+||.||+|.+. ..+..||+|.++..........+.+|+.++++++||||+++++++..++..|+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457999999999999999999865 45679999999866555556778899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-c
Q 005298 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-S 166 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~ 166 (703)
||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||.+....... .
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 99999999999999763 579999999999999999999999999999999999999999999999999865432211 1
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
......+++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+..++..+.+++.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLML 242 (266)
T ss_pred cccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11123456789999998765 58999999999999999775 99999887766655555555444556778899999999
Q ss_pred HHhccCCCCCCCHHHHHh
Q 005298 246 LCLKKVPAERPSAKELLR 263 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~ 263 (703)
.||..+|.+||++.+|++
T Consensus 243 ~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 243 DCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHcCCCchhCCCHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.44 Aligned_cols=253 Identities=28% Similarity=0.464 Sum_probs=211.4
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
+|++++.||.|++|.||+|.+..+|..||||++...........+.+|+.++++++||||+++++++...+..||||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 69999999999999999999999999999999876654444566778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 94 AGGSVADLIQSG---PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 94 ~gGsL~~~l~~~---~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
.+ +|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++............
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 74 888888653 46899999999999999999999999999999999999999999999999998755433222334
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---------------------CCCC
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---------------------RENP 229 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~---------------------~~~~ 229 (703)
..+++.|++||++.+...++.++|||+|||++|+|++|.+||...+..+....+. ...+
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 5678999999998766567889999999999999999999997665432211110 0000
Q ss_pred C-------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 230 P-------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 230 ~-------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
. .+...++..+.++|.+||..+|.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 0112456788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=352.02 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=207.9
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
+..+|++++.||+|+||.||+|.+..+|..||||++...........+.+|+.+++.++|+||+++++++..++..|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 35789999999999999999999999999999999865543333446678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 91 Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
||+. ++|..++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...........
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 9995 667666543 45688999999999999999999999999999999999999999999999999875443333334
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceeec------------------cCC----
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFI------------------IPR---- 226 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~-~~l~~------------------I~~---- 226 (703)
...+++.|+|||++.+...++.++|||||||++|+|++|..||...... +.+.. +..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 4578999999999876555788999999999999999999999755421 00000 000
Q ss_pred ---CC-CCCcc-----hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 227 ---EN-PPQLD-----EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 227 ---~~-~~~l~-----~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.. +..+. ...+..+.+||.+||..+|.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 00000 0125678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=345.66 Aligned_cols=254 Identities=38% Similarity=0.670 Sum_probs=214.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC----ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~----~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~l 86 (703)
.+|++.+.||+|+||.||+|.+..++..||||++.... .......+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 58999999999999999999999999999999886432 223456888999999999999999999998763 578
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc--
Q 005298 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-- 164 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~-- 164 (703)
|+||||+++++|.+++.....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999999999988788999999999999999999999999999999999999999999999999988654321
Q ss_pred -ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-CCCCcchhhhHHHHH
Q 005298 165 -ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLMKE 242 (703)
Q Consensus 165 -~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~-~~~~l~~~is~~L~d 242 (703)
........|+..|+|||++.+. .++.++|||||||++|+|++|..||...........+... ..+..+..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 1122345789999999999764 4889999999999999999999999876544333332222 233456678888999
Q ss_pred HHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 243 FVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
+|.+||. +|.+||++++|++|||++
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=351.43 Aligned_cols=254 Identities=29% Similarity=0.538 Sum_probs=212.6
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|++.+.||.|+||.||+|.+..+|+.||||++..... ......+.+|+.++++++||||+++++++..+..+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 69999999999999999999999999999999876542 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-cccc
Q 005298 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKT 170 (703)
Q Consensus 93 v~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~~~ 170 (703)
+ +++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 9999999864 46799999999999999999999999999999999999999999999999999876543321 1234
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------------------
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------------ 226 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~------------------------ 226 (703)
..|+..|+|||++.+...++.++|||||||++|+|++|.+||........+..+..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 57899999999987665678999999999999999999888866543222111100
Q ss_pred C-CCC----CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 227 E-NPP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 227 ~-~~~----~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
. ... ......+..+.+||.+||..+|.+||+++++|.||||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 000 01124568899999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=355.04 Aligned_cols=255 Identities=31% Similarity=0.512 Sum_probs=213.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|++++.||.|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++..++..|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 479999999999999999999999999999999764432 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
|++++.|..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY 160 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence 99999999988777779999999999999999999999999999999999999999999999999987654443333456
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---------------------CCCC
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------------ENPP 230 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------------~~~~ 230 (703)
.++..|+|||++.+...++.++|||||||++|+|++|.+||...........+.. ...+
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07846 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240 (286)
T ss_pred cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence 7899999999987655578899999999999999999999965442211110000 0000
Q ss_pred ---------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 231 ---------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 231 ---------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.....++..+.+||.+||..+|.+||++.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=352.01 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=206.5
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++.+.||.|+||.||+|.++.+++.||||.+...........+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 68999999999999999999999999999999986544322234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 93 MAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 93 v~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
+. ++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.............
T Consensus 85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (291)
T cd07844 85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE 163 (291)
T ss_pred CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccccc
Confidence 97 5899988653 468999999999999999999999999999999999999999999999999986543222222234
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeecc---------------C----------
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFII---------------P---------- 225 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-~~~l~~I---------------~---------- 225 (703)
.+++.|+|||++.+...++.++|||||||++|+|++|..||..... .+....+ .
T Consensus 164 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07844 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSF 243 (291)
T ss_pred ccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccc
Confidence 5788999999987655688899999999999999999999975541 1100000 0
Q ss_pred -CCCCCCcc---hhhh--HHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 226 -RENPPQLD---EHFS--RLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 226 -~~~~~~l~---~~is--~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
...+..+. ..++ ..+.++|.+||.++|.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 244 PFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000000 1223 678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=353.91 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=210.1
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|++++.||.|+||.||+|++..++..||||.+..... ......+.+|+.++++++||||+++++++..++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 59999999999999999999999999999999865432 22335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 93 MAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 93 v~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
+. ++|..++.. ...+++..+..++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++............
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 95 689988864 457899999999999999999999999999999999999999999999999998765433333334
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------------------
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------------ 226 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~------------------------ 226 (703)
..+++.|+|||++.+...++.++|||||||++|+|+||+.||...+.......+..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 56789999999987665578899999999999999999999976543322211100
Q ss_pred -CCC---CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 227 -ENP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 227 -~~~---~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
... ......++..++++|.+||..||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000 00112456788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=348.42 Aligned_cols=252 Identities=26% Similarity=0.507 Sum_probs=219.4
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
+|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.++++++||||+++++++..+..+|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5999999999999999999999999999999987543 22456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
|+.|++|..++....++++..+..|+.||+.||.|||.++++|+||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 159 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTST 159 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-ccccc
Confidence 99999999999887789999999999999999999999999999999999999999999999999987654321 23446
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~--~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
.|+..|++||++... .++.++|+||||+++|+|++|..||..... ...............+..++..+.++|.+||.
T Consensus 160 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (258)
T cd05578 160 SGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLE 238 (258)
T ss_pred CCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHcc
Confidence 789999999999765 488999999999999999999999987663 22222222223345556788999999999999
Q ss_pred cCCCCCCCH--HHHHhchhh
Q 005298 250 KVPAERPSA--KELLRHRFI 267 (703)
Q Consensus 250 ~dP~~RPTa--~eLL~Hpff 267 (703)
.+|.+||++ .+++.||||
T Consensus 239 ~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 239 RDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CChhHcCCccHHHHhcCCCC
Confidence 999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=353.09 Aligned_cols=259 Identities=44% Similarity=0.791 Sum_probs=222.5
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||.|+||.||++.+..++..||||.+..... ...+.+.+|+.++++++||||+++++++...+..|+|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 4699999999999999999999999999999999865432 234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
|+++++|.+++.+ ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.............
T Consensus 97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~ 175 (293)
T cd06647 97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (293)
T ss_pred cCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccc
Confidence 9999999999875 468899999999999999999999999999999999999999999999999887654433333456
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CcchhhhHHHHHHHHHHhc
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~--~l~~~is~~L~dLI~~cL~ 249 (703)
.|++.|++||.+... .++.++|||||||++|+|++|..||...+.......+.....+ ..+..++..+++||.+||.
T Consensus 176 ~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 254 (293)
T cd06647 176 VGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 254 (293)
T ss_pred cCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHcc
Confidence 789999999998764 4788999999999999999999999877665544444322222 2234577889999999999
Q ss_pred cCCCCCCCHHHHHhchhhhccccC
Q 005298 250 KVPAERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 250 ~dP~~RPTa~eLL~Hpff~~~~~~ 273 (703)
.+|.+||++.+++.|+||+..+..
T Consensus 255 ~~p~~Rp~~~~il~h~~~~~~~~~ 278 (293)
T cd06647 255 MDVEKRGSAKELLQHPFLKIAKPL 278 (293)
T ss_pred CChhhCcCHHHHhcCHHHhcCccc
Confidence 999999999999999999877643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=401.94 Aligned_cols=269 Identities=29% Similarity=0.487 Sum_probs=221.8
Q ss_pred CcccccchhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEE
Q 005298 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGS 79 (703)
Q Consensus 1 m~~i~~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~ 79 (703)
|+-.-...+..-.+|++++.||+|+||+||+|.+..++..||+|++.... .......+..|+.+|++|+|||||+++++
T Consensus 1 Mp~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred CCccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 45445556667789999999999999999999999999999999987554 33456778899999999999999999998
Q ss_pred EEe--CCEEEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhc-------CceeeeeccceEEecC
Q 005298 80 YLH--QTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNE-------GKIHRDIKAANILLTE 146 (703)
Q Consensus 80 ~~~--~~~lyLV~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~-------gIVHRDIKPeNILLd~ 146 (703)
|.. ...+|||||||.+++|.++|.. ...+++..++.|+.||+.||.|||.. +||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 865 4579999999999999999864 35799999999999999999999985 4999999999999964
Q ss_pred -----------------CCCeeEeccccchhhhhcccccccccCCCCCCchhhhccc-cCCccccchhhHHHHHHHHHhC
Q 005298 147 -----------------NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKG 208 (703)
Q Consensus 147 -----------------~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLtG 208 (703)
.+.+||+|||++..+... ......+||+.|+|||++... ..++.++||||||||||+|++|
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 235899999998765322 222346899999999998643 3478899999999999999999
Q ss_pred CCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 209 EPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 209 ~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..||...+....+..+....+......++..+.+||..||.++|.+||++.|+|.|+||...
T Consensus 240 k~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 240 KTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 99998665544333332222322234568899999999999999999999999999999865
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=342.41 Aligned_cols=254 Identities=38% Similarity=0.730 Sum_probs=217.2
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|++.+.||.|+||.||+|.+..+++.|+||++..... ......+..|+.+++.++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999999999999999876543 24577899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc----
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR---- 168 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~---- 168 (703)
+++++|.+++.....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 9999999999888789999999999999999999999999999999999999999999999999987654332211
Q ss_pred ccccCCCCCCchhhhcccc--CCccccchhhHHHHHHHHHhCCCCCCCCC-ccceeeccCCCCCCCcch--hhhHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSE--GYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQLDE--HFSRLMKEF 243 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~--~~s~ksDVWSLGvILyELLtG~~PF~~~~-~~~~l~~I~~~~~~~l~~--~is~~L~dL 243 (703)
....+++.|++||++.... .++.++||||||+++|+|++|..||.... .......+.....+.++. .++..+.+|
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDF 240 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHH
Confidence 1356889999999987542 27889999999999999999999997653 222222333333333443 348889999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhh
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
|.+||..+|.+||++.+++.|||+
T Consensus 241 i~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 241 LDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHccCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=370.24 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=207.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcC--CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~--tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
...+|++++.||.|+||.||+|.... ++..||||.+... ....+|+.+|++++|||||+++++|.....+|+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 44579999999999999999997643 5688999987543 234679999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc--
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-- 166 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-- 166 (703)
||||+. ++|.+++.....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||++..+.....
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 999994 78999998778899999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccce---eecc-------------------
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV---LFII------------------- 224 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~---l~~I------------------- 224 (703)
.....+||+.|+|||++.+. .|+.++|||||||+||+|++|..||........ +..+
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 12246799999999999765 588999999999999999999999976532110 0000
Q ss_pred -------C--CCCCCCc-----chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 225 -------P--RENPPQL-----DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 225 -------~--~~~~~~l-----~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
. ...+... ...++..+.+||.+||..+|.+|||+.++|.||||...
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0 0000001 12346678999999999999999999999999999764
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=339.22 Aligned_cols=253 Identities=38% Similarity=0.637 Sum_probs=224.1
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|++.+.||.|+||.||++.+..++..|++|++..... ......+.+|+.+++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 69999999999999999999999999999999876543 34567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 93 MAGGSVADLIQSG----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 93 v~gGsL~~~l~~~----~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9999999999763 779999999999999999999999999999999999999999999999999987665443333
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
....|++.|+|||.+... .++.++||||||+++|+|++|..||...........+.......++..++..+.++|.+||
T Consensus 161 ~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 239 (258)
T cd08215 161 KTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239 (258)
T ss_pred cceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence 456899999999998765 4888999999999999999999999877655555555555556666788899999999999
Q ss_pred ccCCCCCCCHHHHHhchhh
Q 005298 249 KKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff 267 (703)
..+|.+|||+.++|+||||
T Consensus 240 ~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 240 QKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=343.25 Aligned_cols=253 Identities=32% Similarity=0.589 Sum_probs=218.4
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|++.+.||.|+||.||+|.+..+|..||+|.+.... .....+.+.+|+.++++++||||+++++.+.....+|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 6899999999999999999999999999999986543 123446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC-CeeEeccccchhhhhcccccc
Q 005298 93 MAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 93 v~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g-~VKL~DFGlA~~~~~~~~~~~ 169 (703)
+.+++|.+++.... .+++..+..++.||+.||.|||+++++|+||||+||+++.++ .+||+|||++...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 99999999987543 579999999999999999999999999999999999999875 469999999876654333333
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
...|++.|+|||++... .++.++|||||||++|+|++|..||...+.......+...........++..+.++|.+||.
T Consensus 161 ~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 161 TCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239 (257)
T ss_pred ccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence 45689999999998765 48899999999999999999999998776555554444444445556778899999999999
Q ss_pred cCCCCCCCHHHHHhchhh
Q 005298 250 KVPAERPSAKELLRHRFI 267 (703)
Q Consensus 250 ~dP~~RPTa~eLL~Hpff 267 (703)
.+|.+|||+.++++||||
T Consensus 240 ~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 240 VSPRDRPSITSILKRPFL 257 (257)
T ss_pred cChhhCcCHHHHhhCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=371.32 Aligned_cols=324 Identities=25% Similarity=0.375 Sum_probs=257.6
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyL 88 (703)
...|..+.+||+|+||+|.++..+.+.+.||||++++.- -++..+-...|..+|... +-|.+++++.+|++-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357899999999999999999999999999999987553 123345555677787776 46899999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|||||.||+|--+|+.-++|.|..+..|+.+|+-||=|||++|||+||||.+|||++.+|+|||+|||+++.........
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TT 507 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTT 507 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998766666667
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
.++||||.|+|||++... .|+..+|||++||+|||||.|++||.+.+..++...|...+. .++..++.++..+++..|
T Consensus 508 kTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv-syPKslSkEAv~ickg~l 585 (683)
T KOG0696|consen 508 KTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV-SYPKSLSKEAVAICKGLL 585 (683)
T ss_pred eeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC-cCcccccHHHHHHHHHHh
Confidence 789999999999999764 699999999999999999999999999988887777765443 567899999999999999
Q ss_pred ccCCCCCCC-----HHHHHhchhhhccccChhHHHHhhcCCCCCCCCCCCCCCCcccccccCCCceeeeccCCcchhhhh
Q 005298 249 KKVPAERPS-----AKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVKVVRDKRSEETVQV 323 (703)
Q Consensus 249 ~~dP~~RPT-----a~eLL~Hpff~~~~~~~~l~e~i~~~~~~~~~~~~~~~~~~~~~~ge~s~~v~~~r~~r~~et~q~ 323 (703)
.+.|.+|.. -.+|-.||||+.+.+.. +-.+-.++|..|...-.....|.+................-.....|.
T Consensus 586 tK~P~kRLGcg~~ge~di~~H~FFR~iDWek-~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD~~v~~nldq~ 664 (683)
T KOG0696|consen 586 TKHPGKRLGCGPEGERDIREHPFFRRIDWEK-LERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPDKLVMMNLDQS 664 (683)
T ss_pred hcCCccccCCCCccccchhhCcchhhccHHH-HhhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCchHHHHhcCchh
Confidence 999999975 36899999999875432 222222333333222223334444444333222211111111124456
Q ss_pred ccCCccccccccccc
Q 005298 324 SSQGQTVRNAGWNFS 338 (703)
Q Consensus 324 ~~~g~s~~n~~~~fs 338 (703)
-+.|+++.|+.|-..
T Consensus 665 eF~gFsfvNpefv~~ 679 (683)
T KOG0696|consen 665 EFEGFSFVNPEFVKP 679 (683)
T ss_pred hcCceeeeChhhcCC
Confidence 678999998877443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=344.73 Aligned_cols=248 Identities=31% Similarity=0.589 Sum_probs=214.9
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCH
Q 005298 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (703)
Q Consensus 21 LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL 98 (703)
||.|+||.||+|.+..+++.||||++..... ....+.+.+|+.++++++||||+++++.+.++..+|+|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999999999999999875442 24457789999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCCCCC
Q 005298 99 ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178 (703)
Q Consensus 99 ~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~ 178 (703)
.+++.+...+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++....... ......|++.|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYV 159 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCcc
Confidence 9999888889999999999999999999999999999999999999999999999999987664332 223457899999
Q ss_pred chhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCC--ccceeeccCC-CCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH--PMRVLFIIPR-ENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 179 APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~--~~~~l~~I~~-~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
+||++... .++.++|+||||+++|+|++|..||.... .......+.. ......+..++..+.+||.+||..+|.+|
T Consensus 160 ~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 238 (262)
T cd05572 160 APEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238 (262)
T ss_pred ChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhC
Confidence 99998764 48899999999999999999999998765 3333333332 23334455568899999999999999999
Q ss_pred CC-----HHHHHhchhhhcc
Q 005298 256 PS-----AKELLRHRFIRNA 270 (703)
Q Consensus 256 PT-----a~eLL~Hpff~~~ 270 (703)
|+ +.|+++||||...
T Consensus 239 ~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 239 LGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred cCCcccCHHHHhcChhhhCC
Confidence 99 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=337.95 Aligned_cols=253 Identities=45% Similarity=0.764 Sum_probs=223.5
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|++.+.||.|+||.||++.+..+++.|+||.+..... ......+.+|++++.+++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999999999999999865542 24567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
+++++|.+++.....+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++..............
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence 99999999998888999999999999999999999999999999999999999999999999999876654433334567
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCC
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP 252 (703)
|+..|++||.+.+.. ++.++|||+||+++|+|++|..||...........+.....+.++..++..+.++|.+||..+|
T Consensus 161 ~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 239 (254)
T cd06627 161 GTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDP 239 (254)
T ss_pred cchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCCh
Confidence 899999999987654 8889999999999999999999998766544444444444455666788999999999999999
Q ss_pred CCCCCHHHHHhchhh
Q 005298 253 AERPSAKELLRHRFI 267 (703)
Q Consensus 253 ~~RPTa~eLL~Hpff 267 (703)
++||++.+++.||||
T Consensus 240 ~~R~~~~~~l~~~~~ 254 (254)
T cd06627 240 NLRPTAKQLLKHPWI 254 (254)
T ss_pred hhCcCHHHHhcCCCC
Confidence 999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=350.91 Aligned_cols=256 Identities=34% Similarity=0.614 Sum_probs=219.4
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||+|+||+||++.+..+++.||+|++...........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 35799999999999999999999999999999998765544556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|+++++|.+++...+.+++..+..++.|++.+|.|||+ ++++|+||||+||+++.++.++|+|||++...... ....
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~~~ 161 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IADT 161 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--ccCc
Confidence 99999999999888889999999999999999999997 69999999999999999999999999997654322 1234
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----------ceeeccCCCCCCCcch-hhhH
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-----------RVLFIIPRENPPQLDE-HFSR 238 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~-----------~~l~~I~~~~~~~l~~-~is~ 238 (703)
.+|+..|+|||++.+. .++.++|||||||++|+|++|..||...... .....+....++.++. .++.
T Consensus 162 ~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd06620 162 FVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240 (284)
T ss_pred cccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence 6899999999998765 5889999999999999999999999865432 1222222223333333 3788
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 239 ~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+.+||.+||.++|.+|||+.++++|+||...
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 89999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=352.21 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=209.2
Q ss_pred CCceEE--EEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe----CC
Q 005298 13 SRFSSL--ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QT 84 (703)
Q Consensus 13 ~~Y~il--~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~----~~ 84 (703)
.+++.. ..||+|+++.||+|.. +|+.||||++..... ....+.+.+|+.+|++++|||||++++++.+ ..
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 344444 7899999999999987 589999999875432 2235778899999999999999999999877 35
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
.+++||||+++|+|.+++.....+++.....++.|++.||.|||. .+++||||||+|||++.++.+||+|||++..+..
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 789999999999999999988889999999999999999999998 4999999999999999999999999999875533
Q ss_pred cccccccccCCCCCCchhhhccc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCcchhhhHHHH
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMK 241 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~-~~~~~~l~~~is~~L~ 241 (703)
. ....+|++.|+|||++.+. ..++.++|||||||++|||++|..||...+.......+. ....+.++..++..++
T Consensus 176 ~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 252 (283)
T PHA02988 176 P---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIK 252 (283)
T ss_pred c---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHH
Confidence 2 1245789999999998652 358999999999999999999999999877665555543 2233445556889999
Q ss_pred HHHHHHhccCCCCCCCHHHHHhc
Q 005298 242 EFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+||.+||..||.+|||+.+++..
T Consensus 253 ~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 253 CIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999999999999999863
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=378.98 Aligned_cols=260 Identities=25% Similarity=0.445 Sum_probs=233.1
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
...+.|.+++.||+|.|++|.++++..++..||||++++... ....+.+.+|+.+|+.|+|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 345689999999999999999999999999999999987663 3345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||||+.+|.+++|+.+++.+.+..++.+|.|++.|++|||+++|||||||.+||||+.+-++||+|||++..+. .....
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~~~~l 211 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-YGLML 211 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-ccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998776 44556
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
.++||++.|.|||++.+.++.++.+|+||+|++||-|+.|.+||.+.+-........... ..++..++.++.++|+++|
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk-~rIp~~ms~dce~lLrk~l 290 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK-YRIPFYMSCDCEDLLRKFL 290 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-ecccceeechhHHHHHHhh
Confidence 789999999999999998888899999999999999999999999876555444333322 2455667888999999999
Q ss_pred ccCCCCCCCHHHHHhchhhhccc
Q 005298 249 KKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.++|.+|++++++.+|.|.....
T Consensus 291 vl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 291 VLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred ccCccccCCHHHhhhhcccchhh
Confidence 99999999999999999997543
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=350.78 Aligned_cols=250 Identities=27% Similarity=0.444 Sum_probs=205.9
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHH---HhCCCCCeeeeEEEEEeCCEEEEEEeccC
Q 005298 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVL---SQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (703)
Q Consensus 20 ~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~IL---k~L~HPnIV~L~~~~~~~~~lyLV~Eyv~ 94 (703)
+||+|+||.||++.+..+++.||||++..... ........+|..++ ...+||||+.+++++..++..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999865432 11122333444333 34579999999999999999999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCC
Q 005298 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (703)
Q Consensus 95 gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGT 174 (703)
+++|.+++...+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++...... ......|+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGT 158 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCCC
Confidence 9999999988888999999999999999999999999999999999999999999999999998654322 22345799
Q ss_pred CCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc--eeeccCCCCCCCcchhhhHHHHHHHHHHhccCC
Q 005298 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR--VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 175 p~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~--~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP 252 (703)
+.|+|||.+.....++.++|||||||++|+|++|..||....... ............++..++..+.+||.+||.++|
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence 999999998654558899999999999999999999997543221 111122223345566788999999999999999
Q ss_pred CCCC-----CHHHHHhchhhhccc
Q 005298 253 AERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 253 ~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
.+|| +++++++||||+...
T Consensus 239 ~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 239 SKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHhcCCCCCCHHHHHhCccccCCC
Confidence 9999 699999999998765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.93 Aligned_cols=258 Identities=39% Similarity=0.726 Sum_probs=218.9
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
...|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.++++++||||+++++.+..++..|+|||
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 346677788999999999999999999999999986543 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
|+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.............
T Consensus 100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence 9999999998865 568999999999999999999999999999999999999999999999999987654433333456
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--cchhhhHHHHHHHHHHhc
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~--l~~~is~~L~dLI~~cL~ 249 (703)
.|++.|+|||++.+. .++.++|||||||++|+|++|..||...........+....++. ....++..+.+||.+||.
T Consensus 179 ~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 257 (292)
T cd06658 179 VGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV 257 (292)
T ss_pred ecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHcc
Confidence 799999999998764 48899999999999999999999998766544333332222222 223567889999999999
Q ss_pred cCCCCCCCHHHHHhchhhhcccc
Q 005298 250 KVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 250 ~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
.+|.+|||++++++||||.....
T Consensus 258 ~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 258 REPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred CChhHCcCHHHHhhChhhhccCC
Confidence 99999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=352.83 Aligned_cols=259 Identities=30% Similarity=0.510 Sum_probs=219.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||.|+||.||++.+..+++.|+||.+..... ......+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 479999999999999999999999999999999875532 234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc------
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT------ 164 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~------ 164 (703)
||++|++|.+++...+.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999987531100
Q ss_pred ---------ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCcc
Q 005298 165 ---------ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLD 233 (703)
Q Consensus 165 ---------~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~--~~~l~ 233 (703)
........|+..|+|||++... .++.++|||||||++|+|++|..||.+....+....+.... .+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0011134688899999998764 58999999999999999999999998766555444443322 12222
Q ss_pred hhhhHHHHHHHHHHhccCCCCCCC---HHHHHhchhhhcccc
Q 005298 234 EHFSRLMKEFVSLCLKKVPAERPS---AKELLRHRFIRNARK 272 (703)
Q Consensus 234 ~~is~~L~dLI~~cL~~dP~~RPT---a~eLL~Hpff~~~~~ 272 (703)
..++..+.+||.+||.++|.+||+ +.+++.||||.....
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 367889999999999999999998 799999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=348.58 Aligned_cols=263 Identities=48% Similarity=0.849 Sum_probs=225.9
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
.....|++.+.||.|+||.||+|.+..++..|++|++..... ....+.+|+.++++++|+||+++++++...+..|+|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 466789999999999999999999998999999999875543 456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 90 MEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
+||+++++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence 99999999999998866 89999999999999999999999999999999999999999999999999886554433333
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--chhhhHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL--DEHFSRLMKEFVSL 246 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l--~~~is~~L~dLI~~ 246 (703)
....+++.|++||++.+. .++.++|||||||++|+|++|..||...+.......+.....+.. ...++..+.+||.+
T Consensus 174 ~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK 252 (286)
T ss_pred ccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence 455788999999998765 488999999999999999999999987765544433333222222 23478899999999
Q ss_pred HhccCCCCCCCHHHHHhchhhhccccChh
Q 005298 247 CLKKVPAERPSAKELLRHRFIRNARKSPR 275 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~Hpff~~~~~~~~ 275 (703)
||..+|.+||++.+++.|+||...-+.+.
T Consensus 253 ~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 281 (286)
T cd06614 253 CLVKDPEKRPSAEELLQHPFLKKACPKEE 281 (286)
T ss_pred HhccChhhCcCHHHHhhChHhhccCchHh
Confidence 99999999999999999999988544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=352.09 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=204.5
Q ss_pred CCCceEEEEEeecCceEEEEEEEcC----------------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeee
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKE----------------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~----------------tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~ 75 (703)
..+|++.+.||+|+||.||+|.+.. ++..||||++...........+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999998642 345799999876555555678899999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCCHHHHHHcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeee
Q 005298 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSG-------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136 (703)
Q Consensus 76 L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~-------------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRD 136 (703)
+++++...+..|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+|||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 999999999999999999999999998643 2467788999999999999999999999999
Q ss_pred eccceEEecCCCCeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh--CCCCC
Q 005298 137 IKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPL 212 (703)
Q Consensus 137 IKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt--G~~PF 212 (703)
|||+|||++.++.+||+|||++..+..... ......+++.|+|||++... .++.++|||||||++|+|++ +..||
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 999999999999999999999875432211 11234567889999998765 48999999999999999986 66788
Q ss_pred CCCCccceeeccC-------CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 213 ADLHPMRVLFIIP-------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 213 ~~~~~~~~l~~I~-------~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
...........+. .......+..++..+.+||.+||..+|.+|||+.+|.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 7665443322111 11111223456788999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=365.99 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=199.6
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||+|+||.||+|.+..++..||+|+.... ....|+.++++++||||+++++++......|+|||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 34799999999999999999999999999999985432 23568999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 92 yv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|+. ++|..++.. ...+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||++...... .....
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~ 215 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLG 215 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-ccccc
Confidence 995 577777754 567999999999999999999999999999999999999999999999999998643221 22234
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc----------eeec-cC--CCCCCCc-----
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR----------VLFI-IP--RENPPQL----- 232 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~----------~l~~-I~--~~~~~~l----- 232 (703)
..||+.|+|||++.+. .++.++|||||||+||||+++..|+....+.. .+.. +. ...+..+
T Consensus 216 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 216 LAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred ccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 6799999999999775 58999999999999999998655543221110 0000 00 0000000
Q ss_pred -------------------------chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 233 -------------------------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 233 -------------------------~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
...++..+.+||.+||..||.+|||+.|+|+||||++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0134566778999999999999999999999999975
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=347.50 Aligned_cols=250 Identities=27% Similarity=0.417 Sum_probs=204.6
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeC--CEEEEEEe
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQ--TKLWIIME 91 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~--~~lyLV~E 91 (703)
|++++.||.|+||.||+|.+..+++.||||++.............+|+.++.++. ||||+++++++.+. +.+|+|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7899999999999999999999999999999865432222234457888898885 99999999999987 89999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 92 yv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|+. ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++. +.+||+|||++..+.... ....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~~~~ 157 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-PYTE 157 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-CcCC
Confidence 996 577777765 457899999999999999999999999999999999999999 999999999987654322 2234
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---------------------CCC
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------------ENP 229 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------------~~~ 229 (703)
..+++.|+|||++.....++.++|||||||++|+|++|.+||...+..+....+.. ..+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 57899999999876655678899999999999999999999977654322111100 000
Q ss_pred C-------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 230 P-------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 230 ~-------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
. .+...++..+.+||.+||.++|.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0 1123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=344.53 Aligned_cols=259 Identities=34% Similarity=0.610 Sum_probs=210.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHH-HHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISV-LSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~I-Lk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|++++.||+|+||.||+|.+..+|+.||||+++..........+..|+.+ ++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4799999999999999999999999999999998765433333455556664 677799999999999999999999999
Q ss_pred ccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhc-CceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 92 YMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 92 yv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~-gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
|++ ++|.+++.. ...+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 996 688777653 35789999999999999999999997 99999999999999999999999999987653321
Q ss_pred ccccccCCCCCCchhhhccc---cCCccccchhhHHHHHHHHHhCCCCCCCCC-ccceeeccCCCCCCCc-chhhhHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNS---EGYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQL-DEHFSRLMK 241 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~---~~~s~ksDVWSLGvILyELLtG~~PF~~~~-~~~~l~~I~~~~~~~l-~~~is~~L~ 241 (703)
......|+..|+|||++.+. ..++.++|||||||++|+|++|..||.... ....+..+.....+.+ ...++..+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 238 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQ 238 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHH
Confidence 12235789999999988642 346789999999999999999999996532 2222222222222222 245788999
Q ss_pred HHHHHHhccCCCCCCCHHHHHhchhhhccccC
Q 005298 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~ 273 (703)
+||.+||..+|.+||++.+++.||||......
T Consensus 239 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 239 DFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred HHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 99999999999999999999999999876544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=348.58 Aligned_cols=255 Identities=29% Similarity=0.518 Sum_probs=214.5
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|++.+.||.|+||.||+|.+..+++.||||+++.... ......+.+|+.++++++|+||+++++++..++.+|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 479999999999999999999999999999999865432 3335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-cccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKT 170 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~~~ 170 (703)
|++++.|..++.....+++..+..++.||+.||.|||.++++|+||+|+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 999888888777777899999999999999999999999999999999999999999999999999876654332 3345
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---------------------C-CC
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---------------------R-EN 228 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~---------------------~-~~ 228 (703)
.++++.|+|||++.....++.++||||||++||+|++|.+||......+.+..+. . ..
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 6789999999999876468899999999999999999999997653322111000 0 00
Q ss_pred CC---------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 229 PP---------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 229 ~~---------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
+. .++..++..+.+||.+||..+|.+||++.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1122347889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.33 Aligned_cols=254 Identities=35% Similarity=0.610 Sum_probs=211.8
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.++.....||+|+||.||+|.+..++..|++|.+.... ....+.+.+|+.++++++|+||+++++++..++.+|+|+||
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 45555678999999999999999999999999986553 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC-CCC--CHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC-CCCeeEeccccchhhhhccccc
Q 005298 93 MAGGSVADLIQSG-PPL--DEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 93 v~gGsL~~~l~~~-~~L--~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~-~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
+.+++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. .+.++|+|||++..........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence 9999999999764 456 88899999999999999999999999999999999986 6789999999986554332223
Q ss_pred ccccCCCCCCchhhhccc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccce-eecc-CCCCCCCcchhhhHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV-LFII-PRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~-l~~I-~~~~~~~l~~~is~~L~dLI~ 245 (703)
....|++.|+|||++... ..++.++||||||+++|+|++|..||........ ...+ .....+.++..++..+.+||.
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHH
Confidence 345689999999998653 2478899999999999999999999976432211 1111 112234456678889999999
Q ss_pred HHhccCCCCCCCHHHHHhchhh
Q 005298 246 LCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff 267 (703)
+||..+|.+|||+.+++.||||
T Consensus 247 ~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 247 RCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.79 Aligned_cols=255 Identities=31% Similarity=0.487 Sum_probs=208.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCE-----
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTK----- 85 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~----- 85 (703)
.+|++.+.||.|+||.||+|.+..+++.||||++..... ......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999999865432 223356788999999995 6999999999987665
Q ss_pred EEEEEeccCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC-CCCeeEeccccch
Q 005298 86 LWIIMEYMAGGSVADLIQS-----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSA 159 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~-----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~-~g~VKL~DFGlA~ 159 (703)
.|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999975 78888754 245899999999999999999999999999999999999998 8899999999987
Q ss_pred hhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-------------
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------- 226 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~------------- 226 (703)
.+...........+++.|+|||++.+...++.++|||||||++|+|++|.+||........+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 5543333333446789999999987655678999999999999999999999976554332211100
Q ss_pred -----------CCCC---CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 227 -----------ENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 227 -----------~~~~---~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
..+. .....++..+.+||.+||..+|.+||++.+++.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0000 01124678899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=352.60 Aligned_cols=245 Identities=25% Similarity=0.420 Sum_probs=192.5
Q ss_pred EEEeecCceEEEEEEEcC--CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe--CCEEEEEEeccC
Q 005298 19 ELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWIIMEYMA 94 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~--tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--~~~lyLV~Eyv~ 94 (703)
..||+|+||+||+|.+.. ++..||+|.+..... ...+.+|+.++++++||||+++++++.. +..+|+||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 589999999999999754 668999999865432 2456789999999999999999998864 567899999995
Q ss_pred CCCHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe----cCCCCeeEeccccchhh
Q 005298 95 GGSVADLIQS---------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL----TENGDVKVADFGVSAQL 161 (703)
Q Consensus 95 gGsL~~~l~~---------~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL----d~~g~VKL~DFGlA~~~ 161 (703)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 578877742 1358899999999999999999999999999999999999 45678999999998765
Q ss_pred hhccc---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccce------------------
Q 005298 162 TRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV------------------ 220 (703)
Q Consensus 162 ~~~~~---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~------------------ 220 (703)
..... .....+||+.|+|||++.+...++.++|||||||+||+|++|.+||........
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43221 223457899999999997755688999999999999999999999964321100
Q ss_pred ------eeccCC-------------CC---------CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 221 ------LFIIPR-------------EN---------PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 221 ------l~~I~~-------------~~---------~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
...+.. .. ........+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000000 00 000011224568889999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=347.34 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=215.6
Q ss_pred CCCceEEEEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~-----tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
..+|.+++.||+|+||.||+|.+.. ++..||||++.........+.+.+|+++++.+.||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3579999999999999999998753 46889999987665554567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeE
Q 005298 87 WIIMEYMAGGSVADLIQSG--------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV 152 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~--------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL 152 (703)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 9999999999999999754 34788999999999999999999999999999999999999999999
Q ss_pred eccccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCC
Q 005298 153 ADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENP 229 (703)
Q Consensus 153 ~DFGlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~ 229 (703)
+|||++....... .......+++.|+|||++.+. .++.++|||||||+||+|++ |..||...+.......+.....
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999986542211 111234567889999999775 48999999999999999998 9999988776666666655555
Q ss_pred CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 230 ~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
...+..++..+.+||.+||..+|.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 243 LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5556678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=344.41 Aligned_cols=254 Identities=33% Similarity=0.655 Sum_probs=213.1
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC---------hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES---------EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~---------~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~ 84 (703)
+|.+.+.||.|+||.||+|.+..+|+.||||.+..... ....+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68899999999999999999999999999998754321 112356788999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
.+++||||+.+++|.+++...+.+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998654322
Q ss_pred c--cccccccCCCCCCchhhhcccc-CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-----CCCCCcchhh
Q 005298 165 I--SRRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-----ENPPQLDEHF 236 (703)
Q Consensus 165 ~--~~~~~~iGTp~Y~APEvl~~~~-~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~-----~~~~~l~~~i 236 (703)
. .......|+..|+|||++.... .++.++||||||+++|+|++|..||...........+.. ..+......+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 1 1123356899999999987643 478899999999999999999999976544322222111 1122233456
Q ss_pred hHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 237 s~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
+..+.+||.+||.++|.+||++.++|+||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=354.52 Aligned_cols=259 Identities=27% Similarity=0.481 Sum_probs=211.9
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLW 87 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~ly 87 (703)
...+|++.+.||.|+||.||+|.+..+|+.||||++...... .....+.+|+.++++++|+||+++++++... +.+|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 346899999999999999999999999999999998654322 1223456799999999999999999998765 5789
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 9999996 588888765 46799999999999999999999999999999999999999999999999999876644323
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-------------------
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------------- 227 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~------------------- 227 (703)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 3333456888999999876666889999999999999999999999876554332221110
Q ss_pred ------CC-CCc---chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 228 ------NP-PQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 228 ------~~-~~l---~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+ ..+ ...+++.+.+||.+||..||.+|||+.+++.||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 00 000 01257888999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=348.61 Aligned_cols=257 Identities=41% Similarity=0.736 Sum_probs=220.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
..|...+.||.|++|.||++.+..+++.|+||++.... ....+.+.+|+.+++.++||||+++++++...+..|+|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 36777889999999999999999999999999986543 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
+.+++|.+++.. .++++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..............
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 999999999987 6799999999999999999999999999999999999999999999999998765543333334467
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcc--hhhhHHHHHHHHHHhcc
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~--~~is~~L~dLI~~cL~~ 250 (703)
|++.|+|||.+.+. .++.++|||||||++|+|++|..||...++......+....++... ..++..+.+||.+||..
T Consensus 177 ~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 255 (285)
T cd06648 177 GTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR 255 (285)
T ss_pred CCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence 99999999998764 4889999999999999999999999876655544444433332322 23778999999999999
Q ss_pred CCCCCCCHHHHHhchhhhcccc
Q 005298 251 VPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
+|.+||++.++++||||.+.+.
T Consensus 256 ~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 256 DPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=349.01 Aligned_cols=259 Identities=27% Similarity=0.463 Sum_probs=210.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|++.+.||.|+||+||+|.+..+|+.||||.+..... ......+.+|+.++++++||||+++++++.....+|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 479999999999999999999999999999999865432 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC-CCCeeEeccccchhhhhccccc
Q 005298 92 YMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 92 yv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~-~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|++ ++|.+++.... .+++..+..++.||+.||.|||+++|+|+||||+||+++. ++.+||+|||++..........
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 995 57888776543 3588899999999999999999999999999999999985 4579999999986554332223
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------------
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------------- 226 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------------- 226 (703)
....|++.|+|||++.+...++.++|||||||++|+|++|.+||........+..+..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 3457789999999987655678899999999999999999999976543322211100
Q ss_pred ---CCCCC---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 227 ---ENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 227 ---~~~~~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
..... ....++..+.++|.+||..+|.+||++.++++||||.+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 00000 11245778999999999999999999999999999987643
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=346.49 Aligned_cols=251 Identities=24% Similarity=0.412 Sum_probs=213.2
Q ss_pred CCceEEEEEeecCceEEEEEEEc----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDK----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
..|++.+.||+|+||+||+|.+. .++..|+||.+...........+.+|+.++++++||||+++++++..++..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46899999999999999999853 45688999998765555556788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCee
Q 005298 89 IMEYMAGGSVADLIQSG-----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~-----------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VK 151 (703)
||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEE
Confidence 99999999999998532 2478899999999999999999999999999999999999999999
Q ss_pred Eeccccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC
Q 005298 152 VADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (703)
Q Consensus 152 L~DFGlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~ 228 (703)
|+|||++....... .......++..|+|||++.+. .++.++|||||||+||+|++ |.+||...........+....
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 243 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999987653221 112234567789999998765 48899999999999999998 999998776655555554444
Q ss_pred CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 229 ~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
....+..++..+.++|.+||..+|.+||++.+|+++
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 244 LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 445566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=345.66 Aligned_cols=253 Identities=24% Similarity=0.410 Sum_probs=212.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~-----tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
..++|++.+.||+|+||.||+|.+.. ++..||||++...........+.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45689999999999999999998653 3578999998654444445678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecc
Q 005298 86 LWIIMEYMAGGSVADLIQSG----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~----------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DF 155 (703)
.++||||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCC
Confidence 99999999999999999652 23577889999999999999999999999999999999999999999999
Q ss_pred ccchhhhhcccc--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCc
Q 005298 156 GVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQL 232 (703)
Q Consensus 156 GlA~~~~~~~~~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l 232 (703)
|++......... .....+++.|+|||++.+. .++.++|||||||+||+|++ |..||...+.......+.....+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK 242 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 998654322111 1123567889999999764 58999999999999999998 7899988776665555544444555
Q ss_pred chhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 233 ~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 243 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66788899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=332.31 Aligned_cols=253 Identities=45% Similarity=0.799 Sum_probs=219.8
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CEEEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWIIM 90 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~lyLV~ 90 (703)
+|.+.+.||.|++|.||+|.+..+++.|+||++..... ....+.+.+|+.++++++||||+++++.+... ..+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58899999999999999999999999999999875542 34567889999999999999999999999988 8999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc--cc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~ 168 (703)
||+++++|.+++.....+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 9999999999998877999999999999999999999999999999999999999999999999999876654332 13
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccC-CCCCCCcchhhhHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIP-RENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-~~~l~~I~-~~~~~~l~~~is~~L~dLI~~ 246 (703)
....++..|++||.+.... ++.++||||||+++|+|++|..||..... ......+. ....+.++..++..+.+||.+
T Consensus 161 ~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 239 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239 (260)
T ss_pred cCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence 3467899999999987654 88999999999999999999999987651 12222222 133445666778999999999
Q ss_pred HhccCCCCCCCHHHHHhchhh
Q 005298 247 CLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~Hpff 267 (703)
||..+|.+||++.+++.||||
T Consensus 240 ~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 240 CLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred hCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=331.94 Aligned_cols=250 Identities=54% Similarity=0.964 Sum_probs=216.5
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
.|++.+.||.|+||.||++.+..++..|++|++..... .....+.+|+.++++++||||+++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 48899999999999999999999999999999876543 35678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 94 AGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 94 ~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
++++|.+++... ..+++..+..++.||+.+|.|||.+|++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 158 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMV 158 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-cccee
Confidence 999999999775 6899999999999999999999999999999999999999999999999999876644322 34567
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchh--hhHHHHHHHHHHhcc
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEH--FSRLMKEFVSLCLKK 250 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~--is~~L~dLI~~cL~~ 250 (703)
|+..|++||++... .++.++||||||++||+|++|..||...+.......+.....+.+... ++..+.+||.+||..
T Consensus 159 ~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 237 (253)
T cd05122 159 GTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237 (253)
T ss_pred cCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence 89999999998765 488899999999999999999999987754443333333333333322 378899999999999
Q ss_pred CCCCCCCHHHHHhchh
Q 005298 251 VPAERPSAKELLRHRF 266 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpf 266 (703)
+|.+|||+.++++|||
T Consensus 238 ~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 238 NPEKRPTAEQLLKHPF 253 (253)
T ss_pred ChhhCCCHHHHhcCCC
Confidence 9999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.40 Aligned_cols=262 Identities=45% Similarity=0.807 Sum_probs=219.5
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
.....|++.+.||.|+||+||+|.+..+++.||||++.... .......+.+|+.+++.++||||++++++|..++..|
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34568999999999999999999999999999999986443 2344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 88 IIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~-~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
+||||+. |+|.+++. ....+++..+..++.||+.||.|||++||+|+||+|.||+++.++.++|+|||++.....
T Consensus 92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~--- 167 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP--- 167 (307)
T ss_pred EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC---
Confidence 9999996 56766664 356799999999999999999999999999999999999999999999999998764422
Q ss_pred ccccccCCCCCCchhhhcc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc-chhhhHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-DEHFSRLMKEF 243 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l-~~~is~~L~dL 243 (703)
.....|++.|+|||++.. ...++.++||||||+++|+|++|.+||...+.......+....++.+ ...++..+.+|
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (307)
T cd06607 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNF 246 (307)
T ss_pred -CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 234678999999998752 23478899999999999999999999987766554444443333332 34578889999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhccccChhH
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRL 276 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l 276 (703)
|.+||..+|.+||++.+|+.||||.........
T Consensus 247 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~ 279 (307)
T cd06607 247 VDSCLQKIPQDRPSSEELLKHRFVLRERPPTVI 279 (307)
T ss_pred HHHHhcCChhhCcCHHHHhcChhhcccCCcHHH
Confidence 999999999999999999999999876543333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=350.27 Aligned_cols=254 Identities=25% Similarity=0.452 Sum_probs=210.8
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~lyLV 89 (703)
.+|++.+.||.|+||.||+|.+..+++.|+||.++..... .....+.+|+.++++++||||+++++++... +.+|||
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4799999999999999999999999999999998754422 2234567899999999999999999999887 899999
Q ss_pred EeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 90 MEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..........
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 99996 5999988764 459999999999999999999999999999999999999999999999999987665443333
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------------
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------------- 226 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------------- 226 (703)
....+++.|+|||++.+...++.++|||||||++|+|++|.+||...........+..
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK 243 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccc
Confidence 4457899999999987655578899999999999999999999976544322211100
Q ss_pred ----CC----CCCcchh-hhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 227 ----EN----PPQLDEH-FSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 227 ----~~----~~~l~~~-is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.. ...++.. ++..+.+||.+||..+|++|||+.|++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 244 TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00 0011122 57889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=345.45 Aligned_cols=253 Identities=25% Similarity=0.438 Sum_probs=214.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~-----tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
...+|++.+.||+|+||.||+|.+.. ++..|++|.+...........+..|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45689999999999999999999987 7889999998765555555678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC---CeeEecc
Q 005298 86 LWIIMEYMAGGSVADLIQSGP-------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVADF 155 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~-------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g---~VKL~DF 155 (703)
.|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+++++|+||||+|||++.++ .+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999999997643 589999999999999999999999999999999999998754 5999999
Q ss_pred ccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCc
Q 005298 156 GVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQL 232 (703)
Q Consensus 156 GlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l 232 (703)
|++..+..... ......+++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 242 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP 242 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 99876532111 11122345679999999765 48999999999999999996 9999987766555555544444455
Q ss_pred chhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 233 ~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+..++..+.+|+.+||..+|.+||++.++++|
T Consensus 243 ~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 243 PKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 66788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=381.03 Aligned_cols=250 Identities=36% Similarity=0.662 Sum_probs=221.6
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCHH
Q 005298 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVA 99 (703)
Q Consensus 20 ~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL~ 99 (703)
+||+|.||+||-|+|..|....|||-+.... ....+-+..||.+.++|+|.|||+++|++..++.+-|+||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 7999999999999999999999999987544 345677889999999999999999999999999999999999999999
Q ss_pred HHHHc-CCCC--CHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC-CCCeeEeccccchhhhhcccccccccCCC
Q 005298 100 DLIQS-GPPL--DEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 100 ~~l~~-~~~L--~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~-~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
.+++. -+++ +|..+.+|.+||++||.|||++.|||||||-+||||+. .|.+||+|||-++.+..-.....++.||.
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccch
Confidence 99975 4677 89999999999999999999999999999999999985 59999999999988876666667899999
Q ss_pred CCCchhhhcc-ccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccC-CCCCCCcchhhhHHHHHHHHHHhccCC
Q 005298 176 FWMAPEVIQN-SEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIP-RENPPQLDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 176 ~Y~APEvl~~-~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-~~~l~~I~-~~~~~~l~~~is~~L~dLI~~cL~~dP 252 (703)
.|||||++.. ..+|+.++|||||||++.||.||++||.+... ...+.++- ....|+++..++.+++.||.+|+.++|
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~ 820 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDP 820 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCc
Confidence 9999999953 45799999999999999999999999977643 22222221 234568889999999999999999999
Q ss_pred CCCCCHHHHHhchhhhcc
Q 005298 253 AERPSAKELLRHRFIRNA 270 (703)
Q Consensus 253 ~~RPTa~eLL~Hpff~~~ 270 (703)
.+||+|.++|.+||++..
T Consensus 821 ~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 821 CDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ccCccHHHhccCcccccC
Confidence 999999999999999876
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.22 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=207.7
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHH---HHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccC
Q 005298 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKE---ISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (703)
Q Consensus 20 ~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~--~~~~~l~~E---i~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~ 94 (703)
+||+|+||.||+|.+..+++.||||++...... ........| +.+++...||||+++++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999998654321 111222333 344555689999999999999999999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCC
Q 005298 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (703)
Q Consensus 95 gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGT 174 (703)
|++|..++...+.+++..++.|+.|++.||.|||+.+|+||||||+||+++.++.+||+|||++..+... .....+|+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGT 158 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCCC
Confidence 9999999988888999999999999999999999999999999999999999999999999998755332 22345899
Q ss_pred CCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccce--eeccCCCCCCCcchhhhHHHHHHHHHHhccCC
Q 005298 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV--LFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 175 p~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~--l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP 252 (703)
+.|+|||++.+...++.++|||||||++|+|++|..||........ ...........++..++..+.++|.+||..+|
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p 238 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 238 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence 9999999997654588999999999999999999999976532211 11111222344555678999999999999999
Q ss_pred CCCC-----CHHHHHhchhhhccccCh
Q 005298 253 AERP-----SAKELLRHRFIRNARKSP 274 (703)
Q Consensus 253 ~~RP-----Ta~eLL~Hpff~~~~~~~ 274 (703)
.+|| ++.++++||||.......
T Consensus 239 ~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 239 NRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred HhccCCCCCCHHHHHhCccccCCCchH
Confidence 9999 999999999998865433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=343.56 Aligned_cols=258 Identities=36% Similarity=0.654 Sum_probs=213.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~lyLV~ 90 (703)
.+|+.++.||.|++|.||+|.+..+++.||+|.+...........+.+|++++++++||||++++++|... +.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47999999999999999999999999999999987655545567789999999999999999999998653 4789999
Q ss_pred eccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 91 Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 99999999988653 4568999999999999999999999999999999999999999999999999986543322
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cceeeccCCCCCCCc------chh
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-----MRVLFIIPRENPPQL------DEH 235 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-----~~~l~~I~~~~~~~l------~~~ 235 (703)
.....++..|++||.+.+. .++.++|||||||++|+|++|..||..... .+....+.....+.+ ...
T Consensus 160 -~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd06621 160 -AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237 (287)
T ss_pred -cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence 1245688999999998765 588999999999999999999999976521 122222111111111 124
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccC
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~ 273 (703)
+++.+.+||.+||.++|.+|||+.|+++||||.+....
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred hHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 56789999999999999999999999999999766443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.59 Aligned_cols=259 Identities=23% Similarity=0.411 Sum_probs=213.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~-----tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
...+|++.+.||+|+||.||+|..+. .+..||+|.+...........+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45689999999999999999997652 3558999998755544445567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecc
Q 005298 86 LWIIMEYMAGGSVADLIQSG----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~----------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DF 155 (703)
.|+||||+.+|+|.+++... ..++...+..++.||+.||.|||+++|+||||||+|||++.++.++|+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcC
Confidence 99999999999999999642 23466788999999999999999999999999999999999999999999
Q ss_pred ccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCc
Q 005298 156 GVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQL 232 (703)
Q Consensus 156 GlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l 232 (703)
|++........ ......++..|+|||.+.+. .++.++|||||||++|||++ |.+||......+....+........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 242 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99865432211 11223457789999998765 48899999999999999998 7999987766555554444444445
Q ss_pred chhhhHHHHHHHHHHhccCCCCCCCHHHHHh------chhhhcc
Q 005298 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLR------HRFIRNA 270 (703)
Q Consensus 233 ~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~------Hpff~~~ 270 (703)
+..++..+.+||.+||..+|.+|||+.++++ ||||..+
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 243 PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 5567889999999999999999999999986 6766543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.87 Aligned_cols=245 Identities=28% Similarity=0.489 Sum_probs=215.5
Q ss_pred EEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~t---g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
+.||+|+||.||+|.+... +..|+||++...........+.+|+.++..++|+||+++++++.....+++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999866 8999999997665544578899999999999999999999999999999999999999
Q ss_pred CCHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-
Q 005298 96 GSVADLIQSG---------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (703)
Q Consensus 96 GsL~~~l~~~---------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~- 165 (703)
++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999999875 789999999999999999999999999999999999999999999999999987664432
Q ss_pred -cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 166 -SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 166 -~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
.......+++.|+|||.+... .++.++|||||||++|+|++ |..||...........+........+..++..+.++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYEL 239 (262)
T ss_pred cccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHH
Confidence 222345678999999998765 58999999999999999998 699998887666666665555556667789999999
Q ss_pred HHHHhccCCCCCCCHHHHHhc
Q 005298 244 VSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~H 264 (703)
|.+||..+|.+||++.+++.+
T Consensus 240 i~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 240 MLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=339.19 Aligned_cols=244 Identities=27% Similarity=0.430 Sum_probs=206.6
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCH
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL 98 (703)
+.||+|+||.||+|.+..+++.||+|.+......+....+.+|+.++++++||||+++++++.....+|+||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999999999999999986555555567889999999999999999999999999999999999999999
Q ss_pred HHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc--cccccCCC
Q 005298 99 ADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--RKTFVGTP 175 (703)
Q Consensus 99 ~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~--~~~~iGTp 175 (703)
.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......... .....++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 160 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence 9999754 46899999999999999999999999999999999999999999999999998654321110 01112345
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~ 254 (703)
.|+|||.+.+. .++.++|||||||++|+|++ |.+||...........+....+...+..++..+.+||.+||.++|.+
T Consensus 161 ~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (252)
T cd05084 161 KWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQ 239 (252)
T ss_pred eecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhh
Confidence 69999998765 48889999999999999997 99999776655544444444445566677899999999999999999
Q ss_pred CCCHHHHHh
Q 005298 255 RPSAKELLR 263 (703)
Q Consensus 255 RPTa~eLL~ 263 (703)
|||+.++++
T Consensus 240 Rps~~~~~~ 248 (252)
T cd05084 240 RPSFSTVHQ 248 (252)
T ss_pred CcCHHHHHH
Confidence 999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=338.56 Aligned_cols=251 Identities=32% Similarity=0.550 Sum_probs=211.8
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
++|++.+.||.|+||.||+|.+..+++.||||.+.... .......+.+|+.+++.++||||+++++++.+.+..|+|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999999999999999876432 3344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 91 Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
||+++++|.+++.. ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999998852 35589999999999999999999999999999999999999999999999999876543333
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cceeeccCCCC-CCCcchhhhHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPREN-PPQLDEHFSRLMKEF 243 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~--~~~l~~I~~~~-~~~l~~~is~~L~dL 243 (703)
......|++.|+|||.+.+. .++.++||||||+++|+|++|..||..... ......+.... ++.....++..+.+|
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL 240 (267)
T ss_pred HHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 33346789999999998765 478899999999999999999999965432 22223332222 333345678889999
Q ss_pred HHHHhccCCCCCCCHHHHHhc
Q 005298 244 VSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~H 264 (703)
|.+||..+|.+||++.++++.
T Consensus 241 i~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 241 VSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999973
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=369.62 Aligned_cols=268 Identities=26% Similarity=0.403 Sum_probs=230.7
Q ss_pred cccchhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEE
Q 005298 4 LAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYL 81 (703)
Q Consensus 4 i~~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~ 81 (703)
+.+++...-+.|+.-++||+|+||.||-|+.+.||+-||+|.+.+... .........|..||.+++.++||.+-..|.
T Consensus 176 ~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe 255 (591)
T KOG0986|consen 176 WLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE 255 (591)
T ss_pred HHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence 344555556789999999999999999999999999999998854432 222345668999999999999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccch
Q 005298 82 HQTKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 82 ~~~~lyLV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
+.+.+|||+..|+||+|.-+|-+.+ .|++..+++|+.+|+.||++||..+||+|||||+|||+|+.|+|.|+|+|||+
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEE
Confidence 9999999999999999999997655 79999999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---ceeeccCCCCCCCcchhh
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---RVLFIIPRENPPQLDEHF 236 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~---~~l~~I~~~~~~~l~~~i 236 (703)
.+... ......+||.+|||||++.+.. |+...|+|+|||+||||+.|+.||...... +.+.......+..++..+
T Consensus 336 ei~~g-~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kF 413 (591)
T KOG0986|consen 336 EIPEG-KPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKF 413 (591)
T ss_pred ecCCC-CccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccccc
Confidence 77544 3334459999999999998865 999999999999999999999999765432 223333445666788999
Q ss_pred hHHHHHHHHHHhccCCCCCCC-----HHHHHhchhhhccccC
Q 005298 237 SRLMKEFVSLCLKKVPAERPS-----AKELLRHRFIRNARKS 273 (703)
Q Consensus 237 s~~L~dLI~~cL~~dP~~RPT-----a~eLL~Hpff~~~~~~ 273 (703)
++++++|++.+|.+||.+|.. ++++.+||||+...+.
T Consensus 414 S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 414 SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 999999999999999999974 7899999999987543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=339.81 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=214.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~t---g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
.+|++.+.||+|+||.||+|.+..+ ...||||++...........+..|+.++++++||||+++++++...+..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5799999999999999999998754 4589999987665555567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 90 MEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|||+.+++|.+++... +.+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence 9999999999999663 478999999999999999999999999999999999999999999999999987764221111
Q ss_pred c--cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHH
Q 005298 169 K--TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 169 ~--~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
. ...+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...........+......+.+..++..+.+|+.
T Consensus 164 ~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 242 (266)
T cd05033 164 TTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLML 242 (266)
T ss_pred eccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 1 22346789999998764 58899999999999999997 99999877666555555544444445677899999999
Q ss_pred HHhccCCCCCCCHHHHHhc
Q 005298 246 LCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~H 264 (703)
+||..+|.+||++.+|+++
T Consensus 243 ~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 243 DCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHcCCCcccCcCHHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=365.37 Aligned_cols=250 Identities=24% Similarity=0.427 Sum_probs=206.8
Q ss_pred CCceEEEEEeecCceEEEEEEEcCC-----CcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~t-----g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~l 86 (703)
.+|++.+.||+|+||.||+|++..+ +..||||++...........+.+|+.+++.+ +|||||+++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4799999999999999999986544 3579999997665555667889999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcC-------------------------------------------------------------
Q 005298 87 WIIMEYMAGGSVADLIQSG------------------------------------------------------------- 105 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~------------------------------------------------------------- 105 (703)
|+|||||.+|+|.+++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999998542
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc--ccccccCC
Q 005298 106 ---------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGT 174 (703)
Q Consensus 106 ---------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~~~~iGT 174 (703)
.++++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......++
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 2478889999999999999999999999999999999999999999999999875533211 11123456
Q ss_pred CCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeec-cCCCCCCCcchhhhHHHHHHHHHHhccCC
Q 005298 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI-IPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 175 p~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~-I~~~~~~~l~~~is~~L~dLI~~cL~~dP 252 (703)
+.|||||++... .++.++|||||||++|+|++ |..||........... +........+..+++.+.++|.+||..+|
T Consensus 278 ~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 356 (374)
T cd05106 278 VKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEP 356 (374)
T ss_pred cceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCCh
Confidence 779999999764 58999999999999999997 9999987654332222 22222333445568899999999999999
Q ss_pred CCCCCHHHHHh
Q 005298 253 AERPSAKELLR 263 (703)
Q Consensus 253 ~~RPTa~eLL~ 263 (703)
.+||++.+|++
T Consensus 357 ~~RPs~~~l~~ 367 (374)
T cd05106 357 TERPTFSQISQ 367 (374)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.65 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=209.9
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCH
Q 005298 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (703)
Q Consensus 21 LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL 98 (703)
||.|+||+||+|.+..+|+.||||++.... .......+..|+.++++++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999999999999999986533 222345667899999999999999999999999999999999999999
Q ss_pred HHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCCC
Q 005298 99 ADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176 (703)
Q Consensus 99 ~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~ 176 (703)
.+++.... .+++..+..++.||+.||.|||.+|++|+||+|+|||++.++.++|+|||++...... .......++..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCC
Confidence 99997655 7999999999999999999999999999999999999999999999999988655332 22234568899
Q ss_pred CCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccce---eeccCCCCCCCcchhhhHHHHHHHHHHhccCCC
Q 005298 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV---LFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPA 253 (703)
Q Consensus 177 Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~---l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~ 253 (703)
|++||++.+.. ++.++|||||||++|+|++|+.||........ +.......+..++..+++.+.++|.+||..+|.
T Consensus 160 y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 238 (277)
T cd05577 160 YMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238 (277)
T ss_pred cCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChh
Confidence 99999987754 88899999999999999999999976543111 111112233445566789999999999999999
Q ss_pred CCC-----CHHHHHhchhhhccc
Q 005298 254 ERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 254 ~RP-----Ta~eLL~Hpff~~~~ 271 (703)
+|| ++.+++.||||....
T Consensus 239 ~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 239 KRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred HccCCCcccHHHHHhChhhhcCC
Confidence 999 899999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=356.55 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=210.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----CE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----TK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~-----~~ 85 (703)
.+.+|++.+.||+|+||.||+|++..+|+.||||++...........+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4679999999999999999999999999999999986543344456678899999999999999999987654 35
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
.|+|+||+. ++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 899999995 588888754 579999999999999999999999999999999999999999999999999987553321
Q ss_pred c---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc---------------C--
Q 005298 166 S---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII---------------P-- 225 (703)
Q Consensus 166 ~---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I---------------~-- 225 (703)
. .....+|++.|+|||++.+...++.++|||||||++|+|++|++||...+.......+ .
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 1 1123578999999999876556889999999999999999999999765422111000 0
Q ss_pred ----------CCCCCC---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 226 ----------RENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 226 ----------~~~~~~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
...... ....++..+.+||.+||..+|.+|||+.++++||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000 1123567799999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=351.87 Aligned_cols=256 Identities=39% Similarity=0.722 Sum_probs=218.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
..|+....||.|+||.||++.+..+++.||||++..... ...+.+.+|+.+++.+.||||+++++++..++..|+|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 467777889999999999999999999999999865432 2346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
+++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..........+
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence 999999998765 5689999999999999999999999999999999999999999999999999876544333344568
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CcchhhhHHHHHHHHHHhcc
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~--~l~~~is~~L~dLI~~cL~~ 250 (703)
|++.|+|||++.+. .++.++|||||||++|+|++|+.||........+..+.....+ .....++..+.+||.+||..
T Consensus 179 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~ 257 (297)
T cd06659 179 GTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257 (297)
T ss_pred cCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence 99999999999765 4889999999999999999999999866554443333222211 22345678899999999999
Q ss_pred CCCCCCCHHHHHhchhhhccc
Q 005298 251 VPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpff~~~~ 271 (703)
+|.+||++.+++.||||.+..
T Consensus 258 ~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 258 EPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred CcccCcCHHHHhhChhhccCC
Confidence 999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.79 Aligned_cols=248 Identities=32% Similarity=0.536 Sum_probs=207.8
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHH-HHhCCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISV-LSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~I-Lk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
+.||.|+||.||+|.+..+++.||||++..... ......+..|..+ ...++||||+++++++..++.+|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999999865431 2222334455444 4556899999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
++|..++.....+++..+..++.||+.||.|||+++++|+||+|.|||++.++.++|+|||++..... .....|++
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~ 157 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTP 157 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCc
Confidence 99999998888899999999999999999999999999999999999999999999999998765432 23457899
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC---CCCCcchhhhHHHHHHHHHHhccCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---NPPQLDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~---~~~~l~~~is~~L~dLI~~cL~~dP 252 (703)
.|++||.+.+.. ++.++||||||+++|+|++|.+||...+.......+... .+......++..+.+||.+||..+|
T Consensus 158 ~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 236 (260)
T cd05611 158 DYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236 (260)
T ss_pred CccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCH
Confidence 999999997754 889999999999999999999999877655444333221 2223344678999999999999999
Q ss_pred CCCC---CHHHHHhchhhhccc
Q 005298 253 AERP---SAKELLRHRFIRNAR 271 (703)
Q Consensus 253 ~~RP---Ta~eLL~Hpff~~~~ 271 (703)
.+|| +++|++.||||.+..
T Consensus 237 ~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 237 AKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred HHccCCCcHHHHHcChHhhcCC
Confidence 9999 458999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=346.54 Aligned_cols=252 Identities=31% Similarity=0.491 Sum_probs=209.5
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
|++++.||.|++|.||+|.+..+|..||||++...... .....+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 78899999999999999999999999999998755322 22356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 94 AGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 94 ~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
+ ++|.+++.... .+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.............
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 4 68999987765 79999999999999999999999999999999999999999999999999986554332222334
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-------------------------CC
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------------------------PR 226 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I-------------------------~~ 226 (703)
.+++.|+|||++.+...++.++|||||||++|+|++|.+||...+.......+ ..
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 67899999998876555788999999999999999999999765432211111 00
Q ss_pred CC---CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 227 EN---PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 227 ~~---~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.. .......++..+.++|.+||..+|.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00 011123566889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.59 Aligned_cols=251 Identities=23% Similarity=0.371 Sum_probs=209.6
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCc----EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~----~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
..+|++++.||+|+||.||+|.+..++. .||||++.........+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 4689999999999999999999876555 48999987555555567888999999999999999999998764 578
Q ss_pred EEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 88 IIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
+|+||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999999999764 4689999999999999999999999999999999999999999999999999876543222
Q ss_pred cc--ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 167 RR--KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 167 ~~--~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
.. ....++..|++||++.+. .++.++|||||||+||||++ |..||...........+......+.+..++..+.++
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 243 (316)
T ss_pred ceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 11 123346789999999765 58999999999999999997 999998765544433333333334455677889999
Q ss_pred HHHHhccCCCCCCCHHHHHhc
Q 005298 244 VSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~H 264 (703)
|.+||..+|.+||++.+++.+
T Consensus 244 i~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 244 MVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=339.32 Aligned_cols=251 Identities=26% Similarity=0.442 Sum_probs=213.8
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCC-----CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~t-----g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
..+|++.+.||.|+||.||+|.+... +..||||.+...........+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 45899999999999999999998754 4889999986555445566788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccc
Q 005298 87 WIIMEYMAGGSVADLIQSG----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFG 156 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~----------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFG 156 (703)
|+||||+.+++|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcc
Confidence 9999999999999999642 246788999999999999999999999999999999999999999999999
Q ss_pred cchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcc
Q 005298 157 VSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLD 233 (703)
Q Consensus 157 lA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~ 233 (703)
++..+..... ......++..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+........+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP 243 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCC
Confidence 9875533221 12234678899999998764 48899999999999999998 99999877666555555544445556
Q ss_pred hhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 234 ~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
..++..+.+||.+||..+|.+|||+.+|+.
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 244 ENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 677899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=373.55 Aligned_cols=249 Identities=27% Similarity=0.356 Sum_probs=202.2
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
+..|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++|+|||||++++++..++..|||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4589999999999999999999999999999996432 335689999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc--cc
Q 005298 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RR 168 (703)
Q Consensus 92 yv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~ 168 (703)
++. ++|..++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 994 688888765 35799999999999999999999999999999999999999999999999999875532211 12
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--------ceeeccCC------CCCC----
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM--------RVLFIIPR------ENPP---- 230 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~--------~~l~~I~~------~~~~---- 230 (703)
...+||+.|+|||++.+. .++.++||||||||||||++|..|+...... .....+.. ..+.
T Consensus 320 ~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred cccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 245799999999999775 5899999999999999999988665332110 01111100 0000
Q ss_pred ----------------C-----c--chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 231 ----------------Q-----L--DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 231 ----------------~-----l--~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
. . ...++..+.+||.+||..||.+|||+.|||+||||+.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 0 0123457899999999999999999999999999964
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=363.52 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=206.2
Q ss_pred CCceEEEEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d-----~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~l 86 (703)
.+|++.+.||+|+||.||+|.+ ..++..||||+++........+.+.+|+.+|..+ +|||||+++++|...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3799999999999999999974 3567799999987555445567788999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcC-------------------------------------------------------------
Q 005298 87 WIIMEYMAGGSVADLIQSG------------------------------------------------------------- 105 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~------------------------------------------------------------- 105 (703)
|+|||||++|+|.+++...
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999999999998642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc--cc
Q 005298 106 --------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--RK 169 (703)
Q Consensus 106 --------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~--~~ 169 (703)
..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ..
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 14788899999999999999999999999999999999999999999999998755332111 11
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccce-eeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV-LFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~-l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
...++..|+|||++.+. .++.++|||||||+||+|++ |..||........ ...+........+...+..+.+||.+|
T Consensus 275 ~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 353 (375)
T cd05104 275 NARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSC 353 (375)
T ss_pred CCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHH
Confidence 23456679999999765 58999999999999999997 8999976543322 222222222333445678899999999
Q ss_pred hccCCCCCCCHHHHHhc
Q 005298 248 LKKVPAERPSAKELLRH 264 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~H 264 (703)
|..+|++||++.+|++.
T Consensus 354 l~~dP~~RPs~~eil~~ 370 (375)
T cd05104 354 WDADPLKRPTFKQIVQL 370 (375)
T ss_pred ccCChhHCcCHHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=346.27 Aligned_cols=253 Identities=24% Similarity=0.406 Sum_probs=204.9
Q ss_pred CceEEEEEeecCceEEEEEEEcC--CCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLW 87 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~--tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~ly 87 (703)
+|++.+.||.|+||.||+|.+.. ++..||||.+.... .......+.+|+.++++++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 89999999987532 122245678899999999999999999999988 8899
Q ss_pred EEEeccCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC----CCCeeEeccccc
Q 005298 88 IIMEYMAGGSVADLIQS-----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE----NGDVKVADFGVS 158 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~-----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~----~g~VKL~DFGlA 158 (703)
+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 467776642 236899999999999999999999999999999999999999 899999999998
Q ss_pred hhhhhccc---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccce---------------
Q 005298 159 AQLTRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV--------------- 220 (703)
Q Consensus 159 ~~~~~~~~---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~--------------- 220 (703)
........ .....++++.|+|||++.+...++.++|||||||+||+|++|.+||........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76543222 123457899999999987766688999999999999999999999975543220
Q ss_pred ------------------eec---cCC-C-CC-CCcc------hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 221 ------------------LFI---IPR-E-NP-PQLD------EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 221 ------------------l~~---I~~-~-~~-~~l~------~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
... ... . .+ ..+. ...+..+.++|.+||..+|.+|||+.+++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 000 000 0 00 0000 1345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=337.40 Aligned_cols=248 Identities=33% Similarity=0.565 Sum_probs=212.4
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCH
Q 005298 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (703)
Q Consensus 21 LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL 98 (703)
||.|+||.||++.+..+|+.|+||++..... ......+.+|+.++++++||||+++++.+..+..+|+|+||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999999999999865432 24467788999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc--------cccc
Q 005298 99 ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--------RRKT 170 (703)
Q Consensus 99 ~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~--------~~~~ 170 (703)
.+++.+.+.+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998877899999999999999999999999999999999999999999999999999865433211 2234
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcch--hhhHHHHHHHHHHh
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE--HFSRLMKEFVSLCL 248 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~--~is~~L~dLI~~cL 248 (703)
..+++.|++||.+.... ++.++||||||+++|+|++|..||...........+..... ..+. .++..+.+||.+||
T Consensus 161 ~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l 238 (265)
T cd05579 161 IVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI-EWPEDVEVSDEAIDLISKLL 238 (265)
T ss_pred cccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc-CCCccccCCHHHHHHHHHHh
Confidence 57889999999987654 88899999999999999999999987765554444433221 1222 24889999999999
Q ss_pred ccCCCCCCCH---HHHHhchhhhcc
Q 005298 249 KKVPAERPSA---KELLRHRFIRNA 270 (703)
Q Consensus 249 ~~dP~~RPTa---~eLL~Hpff~~~ 270 (703)
..+|.+|||+ .++|+||||...
T Consensus 239 ~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 239 VPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred cCCHhhcCCCccHHHHhcCccccCC
Confidence 9999999999 999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.54 Aligned_cols=257 Identities=36% Similarity=0.628 Sum_probs=211.5
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|+..+.||+|+||.||++.+..+++.||||.+...........+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 367778899999999999999999999999999876654555677889999999996 9999999999999999999999
Q ss_pred ccCCCCHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 92 YMAGGSVADLIQ-----SGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 92 yv~gGsL~~~l~-----~~~~L~e~~i~~i~~QLl~AL~yLHs~-gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
|+. ++|.++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 995 46555432 246799999999999999999999974 99999999999999999999999999987654332
Q ss_pred cccccccCCCCCCchhhhccc--cCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCCCc----chhhhH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQL----DEHFSR 238 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~--~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-~~~l~~I~~~~~~~l----~~~is~ 238 (703)
. .....|++.|+|||++.+. ..++.++|||||||++|+|++|++||..... ......+....++.+ ...++.
T Consensus 163 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd06616 163 A-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSP 241 (288)
T ss_pred c-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCH
Confidence 2 2234789999999999765 3688999999999999999999999976542 122222222222222 235788
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 239 ~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+.+||.+||.++|.+|||+++|+.||||+...
T Consensus 242 ~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 242 SFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=333.87 Aligned_cols=251 Identities=35% Similarity=0.558 Sum_probs=221.0
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|++.+.||.|+||.||++.+..+++.|+||++.... .......+.+|+.++++++||||+++++++......|+|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999999999999987543 334456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 93 MAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 93 v~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
+++++|..++.. ...+++..+..++.||+.||.|||++|++|+||+|.||+++.++.+||+|||++...... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~ 158 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MA 158 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cc
Confidence 999999999866 457899999999999999999999999999999999999999999999999998765443 22
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
....|++.|++||.+.+. .++.++|+||||+++|+|++|+.||...+.......+.....+.++..++..+.++|.+||
T Consensus 159 ~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237 (256)
T ss_pred ccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHc
Confidence 345789999999999765 4788999999999999999999999887765555555555555666788999999999999
Q ss_pred ccCCCCCCCHHHHHhchhh
Q 005298 249 KKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff 267 (703)
..+|.+||++.++++||++
T Consensus 238 ~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 238 QVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCcccCCCHHHHhcCCCC
Confidence 9999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.69 Aligned_cols=251 Identities=21% Similarity=0.367 Sum_probs=214.5
Q ss_pred CCceEEEEEeecCceEEEEEEEcCC-----CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~t-----g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
.+|++++.||+|+||.||+|.+..+ +..||||++...........+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 3588899999999999999987543 57899999976554445577889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCee
Q 005298 88 IIMEYMAGGSVADLIQS----------------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~----------------~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VK 151 (703)
+++||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 99999999999999853 23588889999999999999999999999999999999999999999
Q ss_pred Eeccccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC
Q 005298 152 VADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (703)
Q Consensus 152 L~DFGlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~ 228 (703)
|+|||++....... .......+++.|+|||++... .++.++|||||||++|||++ |..||...........+....
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999987553221 112234567899999998765 48899999999999999998 889998877766666666666
Q ss_pred CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 229 ~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
....+..++..+.+|+..||..+|.+||++.+|+..
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 244 VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 556677889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=355.45 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=208.4
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ----- 83 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~----- 83 (703)
....+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||++++++|...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 45689999999999999999999999999999999986432 233445677899999999999999999998754
Q ss_pred -CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 84 -TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 84 -~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
...|+||||+. ++|.+++... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 35799999995 5888887653 8999999999999999999999999999999999999999999999999987653
Q ss_pred hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------- 226 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------- 226 (703)
.. .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 170 ~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 170 TS-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CC-CCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 32 122345789999999999775 589999999999999999999999976543221111100
Q ss_pred ----------CCCC----------------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 227 ----------ENPP----------------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 227 ----------~~~~----------------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
.... ......+..+.+||.+||..||.+|||+.++|.||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0000 001134667899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=333.20 Aligned_cols=250 Identities=32% Similarity=0.540 Sum_probs=211.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++.+.||.|+||.||+|.+..+|+.||+|.++... .......+.+|+.++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999999999999999886433 2334577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 91 Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
||+++++|..++.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999999864 35689999999999999999999999999999999999999999999999999865543333
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cceeeccCCCCCCCcch-hhhHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPRENPPQLDE-HFSRLMKEF 243 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~--~~~l~~I~~~~~~~l~~-~is~~L~dL 243 (703)
......|++.|+|||.+.+. .++.++|||||||++|+|++|..||..... ......+.....+..+. .++..+.++
T Consensus 162 ~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240 (267)
T ss_pred ccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHH
Confidence 33446789999999998764 488899999999999999999999965431 12222332222333333 678899999
Q ss_pred HHHHhccCCCCCCCHHHHHh
Q 005298 244 VSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~ 263 (703)
|.+||..+|.+||++.+|++
T Consensus 241 i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.25 Aligned_cols=253 Identities=30% Similarity=0.525 Sum_probs=218.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyLV 89 (703)
++|++.+.||.|+||.||+|.+..++..||||++.... .......+..|+.+++++. ||||+++++++...+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999986532 2334567889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc----
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI---- 165 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~---- 165 (703)
|||+.+++|.+++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999987554322
Q ss_pred ----------------cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC
Q 005298 166 ----------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP 229 (703)
Q Consensus 166 ----------------~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~ 229 (703)
.......|+..|++||++... .++.++||||||+++|+|++|..||...........+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~ 238 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK-LE 238 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-cC
Confidence 122345788999999998764 488899999999999999999999987664433333321 22
Q ss_pred CCcchhhhHHHHHHHHHHhccCCCCCCCH----HHHHhchhh
Q 005298 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSA----KELLRHRFI 267 (703)
Q Consensus 230 ~~l~~~is~~L~dLI~~cL~~dP~~RPTa----~eLL~Hpff 267 (703)
..++..++..+.+||..||..+|.+||++ .++++||||
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 23445678899999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=337.79 Aligned_cols=250 Identities=26% Similarity=0.457 Sum_probs=213.5
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|.+.+.||.|+||.||+|.+..+++.||+|++... ......+.+|+.++++++||||+++++++..+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 45799999999999999999999999999999998643 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc-
Q 005298 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR- 168 (703)
Q Consensus 92 yv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~- 168 (703)
|+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99999999999653 368999999999999999999999999999999999999999999999999987654321111
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+........+..++..+.++|.+|
T Consensus 163 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 241 (263)
T cd05052 163 AGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRAC 241 (263)
T ss_pred CCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 122346679999998765 58889999999999999998 9999987766555555554445556677889999999999
Q ss_pred hccCCCCCCCHHHHHhc
Q 005298 248 LKKVPAERPSAKELLRH 264 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~H 264 (703)
|..+|.+||++.++++.
T Consensus 242 l~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 242 WQWNPSDRPSFAEIHQA 258 (263)
T ss_pred ccCCcccCCCHHHHHHH
Confidence 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.92 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=213.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----C
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----T 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~-----~ 84 (703)
+..+|++++.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 4568999999999999999999999999999999986532 222345677899999999999999999988654 3
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
.+|||+||+. ++|.+++.....+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999995 789999988889999999999999999999999999999999999999999999999999998765433
Q ss_pred ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee----------------------
Q 005298 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF---------------------- 222 (703)
Q Consensus 165 ~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~---------------------- 222 (703)
........++..|+|||++.....++.++|||||||++|+|++|.+||...+......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 2333456789999999998764458899999999999999999999997543211000
Q ss_pred -----ccCCCCCC---CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 223 -----IIPRENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 223 -----~I~~~~~~---~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+...... .....++..+.+||.+||..+|.+|||+.++++||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000000 1123567889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=335.62 Aligned_cols=253 Identities=36% Similarity=0.677 Sum_probs=216.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC----ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~----~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~l 86 (703)
.+|++.+.||+|+||.||+|.+..++..||||.+.... .......+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875432 234456888999999999999999999998764 568
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-
Q 005298 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~- 165 (703)
++|+||+.+++|.+++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999987653211
Q ss_pred --cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-CCCCCcchhhhHHHHH
Q 005298 166 --SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-ENPPQLDEHFSRLMKE 242 (703)
Q Consensus 166 --~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~-~~~~~l~~~is~~L~d 242 (703)
.......|+..|+|||++.+. .++.++|||||||++|+|++|..||...........+.. ...+.++..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 112245789999999998764 478899999999999999999999987655444433332 2345567788999999
Q ss_pred HHHHHhccCCCCCCCHHHHHhchhh
Q 005298 243 FVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
||.+||. +|..||++.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 47999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=342.40 Aligned_cols=253 Identities=24% Similarity=0.469 Sum_probs=213.0
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCC-----cEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCC
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELN-----KDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg-----~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~ 84 (703)
...+|++.+.||+|+||.||++.+...+ ..||+|.+...........+.+|+.+++++ +||||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4468999999999999999999886543 789999987655555567788999999999 8999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC
Q 005298 85 KLWIIMEYMAGGSVADLIQS----------------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG 148 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~----------------~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g 148 (703)
.+|+||||+.+++|..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC
Confidence 99999999999999999964 24688999999999999999999999999999999999999999
Q ss_pred CeeEeccccchhhhhcccc--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccC
Q 005298 149 DVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIP 225 (703)
Q Consensus 149 ~VKL~DFGlA~~~~~~~~~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~ 225 (703)
.+||+|||++..+...... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||......+....+.
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 248 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998765432111 1122356779999998664 58899999999999999997 999998776655555444
Q ss_pred CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 226 ~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.......+..++..+.+|+.+||..+|.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 249 EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 444444455678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=346.90 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=208.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcE--EEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKD--VAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~--VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV 89 (703)
.+|++.+.||+|+||.||+|.+..++.. +++|.+...........+.+|+.++.++ +||||+++++++..++.+|+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5899999999999999999999877764 5777765444455567888999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEe
Q 005298 90 MEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~----------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~ 153 (703)
|||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeC
Confidence 99999999999996532 57899999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCc
Q 005298 154 DFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQL 232 (703)
Q Consensus 154 DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l 232 (703)
|||++...... .......+++.|+|||++.+. .++.++|||||||+||+|++ |.+||...+..+....+........
T Consensus 167 dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 244 (303)
T cd05088 167 DFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 244 (303)
T ss_pred ccccCcccchh-hhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCC
Confidence 99997532211 111122346679999998664 58899999999999999998 9999987665554444443333344
Q ss_pred chhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 233 ~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+..++..+.+||.+||..+|.+||++.+++.+
T Consensus 245 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 245 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 45678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=344.39 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=203.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-------
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT------- 84 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~------- 84 (703)
.+|++++.||.|+||.||+|.+..+++.||||.+..... ......+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 479999999999999999999999999999999865432 222345668999999999999999999987653
Q ss_pred -EEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 85 -KLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 85 -~lyLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
..|+||||+. ++|..++... ..+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+.
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 4599999995 5788777653 478999999999999999999999999999999999999999999999999987553
Q ss_pred hccc----ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---C--------
Q 005298 163 RTIS----RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---E-------- 227 (703)
Q Consensus 163 ~~~~----~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---~-------- 227 (703)
.... ......++..|+|||++.+...++.++||||||+++|+|++|.+||...+.......+.. .
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 3221 112356788999999987655578899999999999999999999976543221111000 0
Q ss_pred -----------CCCC----c-----chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 228 -----------NPPQ----L-----DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 228 -----------~~~~----l-----~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.+.. . ....+..+.+||.+||..+|.+|||++++|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0000 0 01124567899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=342.10 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=212.6
Q ss_pred CCCceEEEEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d-----~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
..+|.+.+.||.|+||+||++.+ ..++..||+|.+.... ......+.+|+.+++++.||||+++++++...+.+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 35899999999999999999985 3356679999886543 34466789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCC-------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEe
Q 005298 87 WIIMEYMAGGSVADLIQSGP-------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~-------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~ 153 (703)
|+||||+.+++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 99999999999999997543 48999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCC
Q 005298 154 DFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPP 230 (703)
Q Consensus 154 DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~ 230 (703)
|||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++ |.+||...........+......
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~ 241 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999875432211 11223457889999998764 58899999999999999998 99999887766666666555555
Q ss_pred CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 231 ~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
..+..++..+.+|+.+||..+|.+|||+.+++.
T Consensus 242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 556678889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.69 Aligned_cols=253 Identities=28% Similarity=0.435 Sum_probs=215.0
Q ss_pred hCCCceEE-EEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEe----CC
Q 005298 11 AGSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH----QT 84 (703)
Q Consensus 11 ~~~~Y~il-~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~----~~ 84 (703)
...+|.+- ++||-|-.|+|..|.++.|++.+|+|++... +..++|+++..+. .|||||.++++|.. ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 44577776 6899999999999999999999999997532 5577899887776 59999999998864 56
Q ss_pred EEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC---CCeeEeccccch
Q 005298 85 KLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSA 159 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~---g~VKL~DFGlA~ 159 (703)
++.||||+++||.|+..|+.++ .|+|.++..|++||+.||.|||+.+|.||||||+|+|.... ..+||+|||||+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 7899999999999999998765 59999999999999999999999999999999999999754 469999999998
Q ss_pred hhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc----eeeccCC---CCCCCc
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR----VLFIIPR---ENPPQL 232 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~----~l~~I~~---~~~~~l 232 (703)
..... ....+.|.||+|.|||++-. +.|+...|+||+||+||-||+|.+||+...... +...|.. ..|.+-
T Consensus 213 ~t~~~-~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 213 ETQEP-GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred ccCCC-ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 65543 34557899999999999855 569999999999999999999999998775532 2223332 234455
Q ss_pred chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 233 ~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
...+|+..+++|+++|..+|.+|.|+.+++.|||+....
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 568899999999999999999999999999999997653
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=344.55 Aligned_cols=250 Identities=26% Similarity=0.437 Sum_probs=210.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCc--EEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~--~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV 89 (703)
.+|++.++||+|+||.||+|.+..++. .+++|.++........+.+.+|+.++.++ +||||+++++++...+.+|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999999887765 47888876444444567788999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEe
Q 005298 90 MEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~----------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~ 153 (703)
+||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999999996532 48889999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCc
Q 005298 154 DFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQL 232 (703)
Q Consensus 154 DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l 232 (703)
|||++....... .......+..|+|||++... .++.++|||||||++|+|++ |..||...........+........
T Consensus 162 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (297)
T cd05089 162 DFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239 (297)
T ss_pred CcCCCcccccee-ccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 999875332111 11112335579999998764 58899999999999999997 9999988776665555555444455
Q ss_pred chhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 233 ~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+..++..+.+||.+||..+|.+||+++++++.
T Consensus 240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=334.36 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=209.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++.+.||+|+||.||++..+. +..||+|.+..... ....+.+|+.++++++||||+++++++...+.+|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 469999999999999999998764 56899998764332 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc-ccc
Q 005298 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKT 170 (703)
Q Consensus 93 v~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~-~~~ 170 (703)
+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 999999999975 356899999999999999999999999999999999999999999999999988754322111 112
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
..++..|+|||++.+. .++.++||||||+++|+|++ |+.||...+.......+........+...+..+.+||.+||.
T Consensus 161 ~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~ 239 (256)
T cd05114 161 AKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWH 239 (256)
T ss_pred CCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcc
Confidence 3456689999998764 58899999999999999999 999998877666666665554444455677889999999999
Q ss_pred cCCCCCCCHHHHHh
Q 005298 250 KVPAERPSAKELLR 263 (703)
Q Consensus 250 ~dP~~RPTa~eLL~ 263 (703)
.+|.+||++.++++
T Consensus 240 ~~p~~Rps~~~l~~ 253 (256)
T cd05114 240 EKPEGRPTFAELLR 253 (256)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=336.05 Aligned_cols=250 Identities=30% Similarity=0.538 Sum_probs=210.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++.+.||.|+||.||+|.+..++..||||.+.... .......+.+|+.+++.+.||||+++++++..++.+++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 47899999999999999999999999999999876533 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 91 EYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 91 Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998863 45689999999999999999999999999999999999999999999999998876543333
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cceeeccCCCCCC-CcchhhhHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPRENPP-QLDEHFSRLMKEF 243 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~--~~~l~~I~~~~~~-~l~~~is~~L~dL 243 (703)
......|++.|+|||++.+. .++.++||||||+++|+|++|..||..... ......+.....+ .....++..+.+|
T Consensus 162 ~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 240 (267)
T ss_pred ccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHH
Confidence 33346799999999999764 488899999999999999999999975432 1222222222222 2334678899999
Q ss_pred HHHHhccCCCCCCCHHHHHh
Q 005298 244 VSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~ 263 (703)
|.+||..+|.+|||+.+|++
T Consensus 241 i~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 241 VNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHhcCCCcccCCCHHHHHH
Confidence 99999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=336.60 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=211.8
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCC---cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg---~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
..+|++.+.||+|+||.||+|.+..++ ..||||.++..........+..|+.++++++||||+++++++..++..|+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 358999999999999999999986544 37999998765555556788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||||+++++|.+++... ..+++..+..++.||+.||.|||+++++||||||+|||++.++.++|+|||++..+......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999999999764 46899999999999999999999999999999999999999999999999998765432211
Q ss_pred cc---cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 168 RK---TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 168 ~~---~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
.. ...++..|++||++.+. .++.++|+|||||++|+|++ |..||...........+......+.+..++..+.++
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQL 241 (267)
T ss_pred eeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHH
Confidence 11 12235679999999764 58999999999999999886 999998776555554454444344455678899999
Q ss_pred HHHHhccCCCCCCCHHHHHh
Q 005298 244 VSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~ 263 (703)
+.+||.++|.+||++.++++
T Consensus 242 i~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 242 MLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHcccCchhCCCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=341.23 Aligned_cols=249 Identities=26% Similarity=0.454 Sum_probs=210.2
Q ss_pred CceEEEEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~-----tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
+|++.+.||+|+||.||+|.+.. ....|++|.+...........+.+|+.+++.+.||||+++++++...+..|+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 2357999988766555556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe
Q 005298 89 IMEYMAGGSVADLIQSG------------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~------------------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL 144 (703)
|+||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999998642 247889999999999999999999999999999999999
Q ss_pred cCCCCeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCcccee
Q 005298 145 TENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL 221 (703)
Q Consensus 145 d~~g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l 221 (703)
+.++.+||+|||++........ ......++..|+|||++.+. .++.++|||||||++|+|++ |..||....+....
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999875432211 11223567789999998764 58899999999999999998 99999877766555
Q ss_pred eccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 222 ~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
..+........+..++..+.+||..||..+|.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 240 NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 444443334445677889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=337.12 Aligned_cols=249 Identities=27% Similarity=0.427 Sum_probs=214.9
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++.+.||.|+||.||+|.+.. +..|++|++..... .....+..|+.+++.++||||+++++++...+.+|+|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 4579999999999999999999988 89999999875532 235678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 9999999999975 34689999999999999999999999999999999999999999999999999876543322222
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
...++..|++||++... .++.++||||||+++|+|++ |..||...+.......+........+..++..+.++|.+||
T Consensus 163 ~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 241 (261)
T cd05148 163 DKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECW 241 (261)
T ss_pred CCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHc
Confidence 33467789999998764 58889999999999999998 89999877766655555554455556778899999999999
Q ss_pred ccCCCCCCCHHHHHh
Q 005298 249 KKVPAERPSAKELLR 263 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~ 263 (703)
..+|.+|||+.+|++
T Consensus 242 ~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 242 AAEPEDRPSFKALRE 256 (261)
T ss_pred CCCchhCcCHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=340.20 Aligned_cols=247 Identities=32% Similarity=0.585 Sum_probs=208.7
Q ss_pred eEEEEEeecCceEEEEEEEc----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 16 SSLELIGRGSFGDVYKAFDK----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 16 ~il~~LG~GsfG~Vyka~d~----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
++.+.||.|.||.||+|... ..+..|+||++.........+.+.+|+.++++++||||+++++++...+.+++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999988 45778999999765566667899999999999999999999999998888999999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc--ccc
Q 005298 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT--ISR 167 (703)
Q Consensus 92 yv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~--~~~ 167 (703)
||.+|+|.+++... ..+++..+..|+.||+.||.|||+++|+|+||+|.|||++.++.+||+|||++...... ...
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999886 78999999999999999999999999999999999999999999999999998765221 111
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
.....+...|+|||.+.... ++.++||||||++||||++ |..||...+.......+........+..++..+.++|..
T Consensus 162 ~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQ 240 (259)
T ss_dssp STTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHH
T ss_pred cccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHH
Confidence 22345778899999997754 8999999999999999999 789998887777666665555566677889999999999
Q ss_pred HhccCCCCCCCHHHHHh
Q 005298 247 CLKKVPAERPSAKELLR 263 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~ 263 (703)
||..+|.+||++.+|++
T Consensus 241 C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 241 CWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HT-SSGGGS--HHHHHH
T ss_pred HcCCChhhCcCHHHHHh
Confidence 99999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=338.05 Aligned_cols=251 Identities=23% Similarity=0.379 Sum_probs=210.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCc----EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~----~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
...+|++++.||.|+||+||+|.+..++. .||||++...........+.+|+.++..+.||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 34689999999999999999999877666 4899998766555566788899999999999999999998875 457
Q ss_pred EEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
++++||+++|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 899999999999999976 4579999999999999999999999999999999999999999999999999987654322
Q ss_pred cc--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHH
Q 005298 166 SR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (703)
Q Consensus 166 ~~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~d 242 (703)
.. .....+++.|++||++.+. .++.++|||||||++|||++ |..||...........+........+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred ceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHH
Confidence 11 1112346789999999765 58899999999999999998 99999876554444444444444445667889999
Q ss_pred HHHHHhccCCCCCCCHHHHHh
Q 005298 243 FVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~ 263 (703)
+|.+||..+|++||++.+++.
T Consensus 243 li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 243 IMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=333.60 Aligned_cols=249 Identities=24% Similarity=0.425 Sum_probs=210.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++++.||+|+||.||+|.+. .+..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 3468999999999999999999875 46779999876432 23567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-c
Q 005298 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~ 167 (703)
||+.+++|.+++.. ...+++..+..++.||+.||.|||+++++||||||+||+++.++.++|+|||++........ .
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999999999965 35688999999999999999999999999999999999999999999999999876543211 1
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
.....++..|+|||++... .++.++|||||||++|+|++ |..||...........+......+....++..+.+||.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05072 161 REGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKT 239 (261)
T ss_pred cCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 1223456789999998765 48889999999999999998 999998776655555554444444455688899999999
Q ss_pred HhccCCCCCCCHHHHHh
Q 005298 247 CLKKVPAERPSAKELLR 263 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~ 263 (703)
||..+|.+||+++++++
T Consensus 240 ~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 240 CWKEKAEERPTFDYLQS 256 (261)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=344.56 Aligned_cols=252 Identities=23% Similarity=0.430 Sum_probs=210.7
Q ss_pred CCCceEEEEEeecCceEEEEEEEcC-------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKE-------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ 83 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~-------tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~ 83 (703)
..+|.+.+.||+|+||.||++.+.. +...||+|++...........+..|+.+++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4689999999999999999998653 23579999987654455567788999999999 799999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~----------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~ 147 (703)
+.+|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 99999999999999999997532 47889999999999999999999999999999999999999
Q ss_pred CCeeEeccccchhhhhcccc--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeecc
Q 005298 148 GDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII 224 (703)
Q Consensus 148 g~VKL~DFGlA~~~~~~~~~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I 224 (703)
+.+||+|||++..+...... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 255 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 99999999998655322111 1112345789999999764 58899999999999999998 88999776654444444
Q ss_pred CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 225 ~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
........+..++..+.+||.+||..+|.+||++.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 256 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4444445556788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=351.74 Aligned_cols=259 Identities=27% Similarity=0.476 Sum_probs=213.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe----CCE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QTK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~----~~~ 85 (703)
++.+|++.+.||.|+||.||+|.+..+|..||||++..... ......+.+|+.+|++++||||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 45799999999999999999999999999999999865432 2335667789999999999999999998763 457
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
+|+||||+. ++|.+++.....+++..+..++.||+.||.|||.+||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 899999995 6899999887889999999999999999999999999999999999999999999999999986554322
Q ss_pred cc----cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-----------------
Q 005298 166 SR----RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII----------------- 224 (703)
Q Consensus 166 ~~----~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I----------------- 224 (703)
.. ....+|+..|+|||++.....++.++|||||||++|+|++|.+||...+....+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 11 123578999999999876556889999999999999999999999765432111100
Q ss_pred ----------CCCCCCC---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 225 ----------PRENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 225 ----------~~~~~~~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
....... +...++..+.+||.+||..+|.+||++.+++.||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 0000000 113457889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=348.59 Aligned_cols=253 Identities=32% Similarity=0.550 Sum_probs=204.4
Q ss_pred EEEeec--CceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRG--SFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~G--sfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
..||+| +||+||++.+..+|+.||||++.... .....+.+.+|+.+++.++||||++++++|..++.+|+|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 99999999999999999999987654 344567889999999999999999999999999999999999999
Q ss_pred CCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc-----
Q 005298 96 GSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR----- 168 (703)
Q Consensus 96 GsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~----- 168 (703)
++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 9999999764 358999999999999999999999999999999999999999999999998654332211111
Q ss_pred --ccccCCCCCCchhhhccc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC------------------
Q 005298 169 --KTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------------ 227 (703)
Q Consensus 169 --~~~iGTp~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~------------------ 227 (703)
....++..|++||++.+. ..++.++|||||||++|+|++|.+||...........+...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 112356679999998753 34788999999999999999999999765322211110000
Q ss_pred ----------------------------CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 228 ----------------------------NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 228 ----------------------------~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
........++..+.+||.+||..+|.+|||+.++|+||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 00111234677899999999999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=333.89 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=209.2
Q ss_pred ceEEEEEeecCceEEEEEEEcC---CCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE-----
Q 005298 15 FSSLELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK----- 85 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~---tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~----- 85 (703)
|++.+.||+|+||.||+|.... ++..||||++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6789999999999999998765 34789999987543 34456788999999999999999999998876554
Q ss_pred -EEEEEeccCCCCHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccc
Q 005298 86 -LWIIMEYMAGGSVADLIQSG------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 86 -lyLV~Eyv~gGsL~~~l~~~------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
.++|+||+.+++|..++... ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999999988432 36899999999999999999999999999999999999999999999999998
Q ss_pred hhhhhcccc--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchh
Q 005298 159 AQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEH 235 (703)
Q Consensus 159 ~~~~~~~~~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~ 235 (703)
......... .....++..|++||++... .++.++|||||||++|||++ |.+||......+....+........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED 239 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcC
Confidence 755332211 1122356789999998654 58999999999999999999 9999988776666555555555556678
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
++..+.++|.+||..+|.+||++.+++++
T Consensus 240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 240 CLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=353.49 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=208.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEe-C
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH-Q 83 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~-----tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~-~ 83 (703)
...+|++.+.||.|+||.||+|.+.. +++.||+|++.........+.+.+|+.++.++ +||||+++++++.. +
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 45689999999999999999997543 45789999987655555567788999999999 89999999998865 4
Q ss_pred CEEEEEEeccCCCCHHHHHHcC----------------------------------------------------------
Q 005298 84 TKLWIIMEYMAGGSVADLIQSG---------------------------------------------------------- 105 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~---------------------------------------------------------- 105 (703)
..+|++|||+.+++|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 6789999999999999998542
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc--ccccccCCCCCCch
Q 005298 106 ---PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAP 180 (703)
Q Consensus 106 ---~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~AP 180 (703)
.++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 2688999999999999999999999999999999999999999999999999876532211 12234567889999
Q ss_pred hhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccce-eeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCH
Q 005298 181 EVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV-LFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (703)
Q Consensus 181 Evl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~-l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa 258 (703)
|++.+. .++.++|||||||+||+|++ |..||........ ...+........+..++..+.+++.+||+.+|++||++
T Consensus 245 E~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 245 ESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 999775 58999999999999999997 9999976543222 22223333334445677889999999999999999999
Q ss_pred HHHHhc
Q 005298 259 KELLRH 264 (703)
Q Consensus 259 ~eLL~H 264 (703)
.+|++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=350.00 Aligned_cols=257 Identities=28% Similarity=0.429 Sum_probs=215.7
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-----EEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-----KLW 87 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~-----~ly 87 (703)
+|++.+.||.|+||.||+|++..++..||||++..... ....+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999865432 344567889999999999999999999988775 789
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc--
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-- 165 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-- 165 (703)
+||||+. ++|..++....++++..+..++.||+.||.|||++||+|+||||.|||++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999996 5899999888899999999999999999999999999999999999999999999999999987654432
Q ss_pred -cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC----------------
Q 005298 166 -SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---------------- 228 (703)
Q Consensus 166 -~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---------------- 228 (703)
.......+++.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 123345789999999999876468899999999999999999999997765433221111100
Q ss_pred -----------C---CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 229 -----------P---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 229 -----------~---~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
+ ......++..+.+||.+||.++|.+||++.+++.||||...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0 001123578899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=333.70 Aligned_cols=243 Identities=24% Similarity=0.415 Sum_probs=206.7
Q ss_pred EEeecCceEEEEEEE--cCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCC
Q 005298 20 LIGRGSFGDVYKAFD--KELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (703)
Q Consensus 20 ~LG~GsfG~Vyka~d--~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gG 96 (703)
.||+|+||.||+|.+ ..++..||||++..... ....+.+..|+.+++.+.||||+++++++. .+..++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 45688999999865432 344577899999999999999999999875 45679999999999
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc---cccccC
Q 005298 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR---RKTFVG 173 (703)
Q Consensus 97 sL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~---~~~~iG 173 (703)
+|.+++.....+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++......... .....+
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 99999988788999999999999999999999999999999999999999999999999998765432211 112344
Q ss_pred CCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCC
Q 005298 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 174 Tp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP 252 (703)
++.|+|||.+... .++.++|||||||++|||++ |.+||...........+.....+..+..++..+.+||.+||..+|
T Consensus 161 ~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p 239 (257)
T cd05116 161 PVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239 (257)
T ss_pred CccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCc
Confidence 6789999998654 58889999999999999998 999998877666666666655556677889999999999999999
Q ss_pred CCCCCHHHHHhc
Q 005298 253 AERPSAKELLRH 264 (703)
Q Consensus 253 ~~RPTa~eLL~H 264 (703)
.+||++.+|.+.
T Consensus 240 ~~Rp~~~~i~~~ 251 (257)
T cd05116 240 DERPGFAVVELR 251 (257)
T ss_pred hhCcCHHHHHHH
Confidence 999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.38 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=213.0
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCc---EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~---~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
..+|+..+.||+|+||.||+|.++.++. .||||.+.........+.+..|+.++++++||||+++++++...+..|+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4589999999999999999999876654 7999998765555556788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+|||++.++.+||+|||++.........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 9999999999999975 457899999999999999999999999999999999999999999999999998655332211
Q ss_pred cc---cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 168 RK---TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 168 ~~---~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
.. ....++.|+|||++... .++.++|||||||++|+|++ |..||...+.......+......+....++..+.+|
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 242 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQL 242 (268)
T ss_pred ceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 11 11234579999998765 48899999999999999997 999998777666665555444444455678899999
Q ss_pred HHHHhccCCCCCCCHHHHHh
Q 005298 244 VSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~ 263 (703)
+.+||..+|.+||++.+|++
T Consensus 243 i~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 243 MLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.18 Aligned_cols=243 Identities=24% Similarity=0.406 Sum_probs=206.4
Q ss_pred EEEeecCceEEEEEEEcCCC---cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg---~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
+.||+|+||.||+|++..++ ..||+|.+...........+..|+.+++++.||||+++++++. .+..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999876654 7899999876655445677899999999999999999999875 5568999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc---ccc
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK---TFV 172 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~---~~i 172 (703)
++|.+++.....+++..+..++.||+.||.|||.++++|+||||+|||++.++.+||+|||++..+........ ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence 99999998878899999999999999999999999999999999999999999999999999876543222111 112
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccC
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~d 251 (703)
++..|+|||.+... .++.++|||||||+||+|++ |.+||...+.......+....+...+..++..+.+||.+||..+
T Consensus 160 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 238 (257)
T cd05060 160 WPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYR 238 (257)
T ss_pred ccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCC
Confidence 34679999998765 58999999999999999998 99999887766555555555455566678899999999999999
Q ss_pred CCCCCCHHHHHh
Q 005298 252 PAERPSAKELLR 263 (703)
Q Consensus 252 P~~RPTa~eLL~ 263 (703)
|.+||++.++++
T Consensus 239 p~~Rp~~~~l~~ 250 (257)
T cd05060 239 PEDRPTFSELES 250 (257)
T ss_pred hhhCcCHHHHHH
Confidence 999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.56 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=206.2
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCc--EEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC------CE
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNK--DVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------TK 85 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~--~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~------~~ 85 (703)
|.+.+.||+|+||.||+|.+..++. .||||.++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4577899999999999999887765 69999986543 344567888999999999999999999977532 24
Q ss_pred EEEEEeccCCCCHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccch
Q 005298 86 LWIIMEYMAGGSVADLIQS------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~------~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
.++||||+.+|+|..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 6899999999999998742 2358999999999999999999999999999999999999999999999999987
Q ss_pred hhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhh
Q 005298 160 QLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHF 236 (703)
Q Consensus 160 ~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~i 236 (703)
.+..... ......+++.|++||++... .++.++|||||||++|+|++ |..||...........+........+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC 239 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 6543211 11223567789999998765 58999999999999999999 89999877665555555544444455678
Q ss_pred hHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 237 SRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 237 s~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+..+.++|.+||..+|.+|||+.+|+++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 240 LDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.89 Aligned_cols=248 Identities=29% Similarity=0.510 Sum_probs=213.6
Q ss_pred ceEEEEEeecCceEEEEEEEcCCC----cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELN----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg----~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
|++.+.||.|+||.||++.+...+ ..||+|++...........+..|+.+++.++||||+++++++.+.+..|++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 467899999999999999998766 8999999976655446778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 91 EYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~--L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||+.+++|.+++..... +++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 99999999999976554 9999999999999999999999999999999999999999999999999987654331111
Q ss_pred c-cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHH
Q 005298 169 K-TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 169 ~-~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
. ...+++.|++||.+.. ..++.++|||||||++|+|++ |.+||...+.......+........+..++..+.+++.+
T Consensus 161 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (258)
T smart00219 161 KKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQ 239 (258)
T ss_pred cccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1 1236789999999865 458999999999999999998 899998776655555555555555566688999999999
Q ss_pred HhccCCCCCCCHHHHHh
Q 005298 247 CLKKVPAERPSAKELLR 263 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~ 263 (703)
||..+|.+|||+.++++
T Consensus 240 ~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 240 CWAEDPEDRPTFSELVE 256 (258)
T ss_pred HCcCChhhCcCHHHHHh
Confidence 99999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.39 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=209.2
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCC----------------cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeee
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELN----------------KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg----------------~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~ 75 (703)
..+|++++.||+|+||.||+|.+..++ ..||+|++.........+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 358999999999999999999877644 5689999876665666778999999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCCHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe
Q 005298 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-----------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (703)
Q Consensus 76 L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~-----------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL 144 (703)
+++++..+...++||||+.+++|..++.... .+++..++.++.||+.||.|||++||+|+||||+|||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 9999999999999999999999999997755 78999999999999999999999999999999999999
Q ss_pred cCCCCeeEeccccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh--CCCCCCCCCccce
Q 005298 145 TENGDVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPLADLHPMRV 220 (703)
Q Consensus 145 d~~g~VKL~DFGlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt--G~~PF~~~~~~~~ 220 (703)
+.++.++|+|||++....... .......+++.|+|||++... .++.++|||||||++|+|++ |..||........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 999999999999986543221 112234567889999998764 48999999999999999998 7788876654443
Q ss_pred eeccCCC-------CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 221 LFIIPRE-------NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 221 l~~I~~~-------~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
+..+... .....+..++..+.+||.+||..+|.+|||+.+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 3222111 111223456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=343.70 Aligned_cols=256 Identities=39% Similarity=0.695 Sum_probs=215.2
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccC
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~ 94 (703)
|.....||+|+||.||++.+..++..||||++.... ......+.+|+.+++.++||||+++++++...+..|+||||++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 344467999999999999999999999999986433 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCC
Q 005298 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (703)
Q Consensus 95 gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGT 174 (703)
+++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..............|+
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 9999998764 568999999999999999999999999999999999999999999999999876554332233446789
Q ss_pred CCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--cchhhhHHHHHHHHHHhccCC
Q 005298 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 175 p~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~--l~~~is~~L~dLI~~cL~~dP 252 (703)
+.|++||++... .++.++|+|||||++|+|++|..||...........+....+.. ....++..+.+||.+||..+|
T Consensus 180 ~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 180 PYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred ccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCc
Confidence 999999998664 47889999999999999999999998765544333332222222 223567889999999999999
Q ss_pred CCCCCHHHHHhchhhhccccC
Q 005298 253 AERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 253 ~~RPTa~eLL~Hpff~~~~~~ 273 (703)
.+||++.+++.||||......
T Consensus 259 ~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 259 AQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred ccCcCHHHHhcChHHhccCCC
Confidence 999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.69 Aligned_cols=249 Identities=35% Similarity=0.601 Sum_probs=201.6
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccC-CChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCHHHHHH
Q 005298 25 SFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ 103 (703)
Q Consensus 25 sfG~Vyka~d~~tg~~VAIKvi~~~-~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~ 103 (703)
+++.||.+++..+++.||||++... ........+.+|+.++++++||||+++++++...+..|++|||+.+++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4466677777778999999998765 244556789999999999999999999999999999999999999999999997
Q ss_pred cC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-------ccccccCC
Q 005298 104 SG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-------RRKTFVGT 174 (703)
Q Consensus 104 ~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-------~~~~~iGT 174 (703)
.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+........ ......++
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence 53 4689999999999999999999999999999999999999999999999998765432111 11234678
Q ss_pred CCCCchhhhccc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceee-cc----------------------------
Q 005298 175 PFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-II---------------------------- 224 (703)
Q Consensus 175 p~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~-~I---------------------------- 224 (703)
..|+|||++... ..++.++|||||||++|+|++|..||.......... .+
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
T cd08216 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNE 251 (314)
T ss_pred ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccccc
Confidence 889999998653 347889999999999999999999997654322110 00
Q ss_pred ----CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccC
Q 005298 225 ----PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 225 ----~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~ 273 (703)
...........++..+.+||..||..+|.+|||+.++|+||||+..+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~ 304 (314)
T cd08216 252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR 304 (314)
T ss_pred ccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence 0001112233556789999999999999999999999999999877533
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.11 Aligned_cols=257 Identities=28% Similarity=0.499 Sum_probs=214.4
Q ss_pred CceEEEEEeecCceEEEEEEEc---CCCcEEEEEEeccCC---ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~---~tg~~VAIKvi~~~~---~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~l 86 (703)
+|++.+.||.|+||.||+|.+. .+|..||+|++.... .....+.+.+|+.+++++ +||||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999875 478999999986432 122346678899999999 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-
Q 005298 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~- 165 (703)
|+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccCCCCCCchhhhccc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccc----eeeccCCCCCCCcchhhhHHH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMR----VLFIIPRENPPQLDEHFSRLM 240 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~----~l~~I~~~~~~~l~~~is~~L 240 (703)
.......|+..|++||.+... ..++.++||||||+++|+|++|..||....... ....+.. ..+.++..++..+
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 239 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALA 239 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccCCHHH
Confidence 122346789999999998653 246788999999999999999999996433221 1112222 2234456688899
Q ss_pred HHHHHHHhccCCCCCC-----CHHHHHhchhhhccc
Q 005298 241 KEFVSLCLKKVPAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
.+||.+||..+|.+|| ++.+++.||||....
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999999997 899999999998875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=342.33 Aligned_cols=262 Identities=43% Similarity=0.786 Sum_probs=218.3
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
...|.....||+|+||+||+|.+..++..|+||++.... .......+.+|+.++++++||||+++++++.+....|+|
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 345788899999999999999999999999999986543 234456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|||+. ++|.+++.. ..++++..+..++.||+.+|.|||++||+|+||||+||+++.++.+||+|||++.... ..
T Consensus 100 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----~~ 174 (313)
T cd06633 100 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----PA 174 (313)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC----CC
Confidence 99995 577776654 5679999999999999999999999999999999999999999999999999875432 22
Q ss_pred ccccCCCCCCchhhhcc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC-CCcchhhhHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP-PQLDEHFSRLMKEFVS 245 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~-~~l~~~is~~L~dLI~ 245 (703)
....|+..|+|||++.. ...++.++|||||||+||+|++|.+||...+.......+..... ......++..+++||.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 35678999999999853 23478899999999999999999999987765554444433322 2233456788999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhccccChhHHH
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~e 278 (703)
+||.++|.+||++.+++.||||+..+....+.+
T Consensus 255 ~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~~~~ 287 (313)
T cd06633 255 YCLQKIPQERPASAELLRHDFVRRDRPARVLID 287 (313)
T ss_pred HHccCChhhCcCHHHHhcCcccCCCchhHHHHH
Confidence 999999999999999999999987665444433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=331.97 Aligned_cols=249 Identities=25% Similarity=0.435 Sum_probs=210.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||+|+||.||+|.+.. ++.||||.+..... ..+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 34689999999999999999999764 57899999865432 2456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc-
Q 005298 91 EYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~- 167 (703)
||+.+++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999999997644 7899999999999999999999999999999999999999999999999998765422111
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
.....++..|+|||++.+. .++.++||||||+++|+|++ |+.||...........+........+..++..+.+++.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 161 REGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred cCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 1112234579999998764 58899999999999999999 999998877666555555544444556778999999999
Q ss_pred HhccCCCCCCCHHHHHh
Q 005298 247 CLKKVPAERPSAKELLR 263 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~ 263 (703)
||..+|.+||++.+|++
T Consensus 240 ~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 240 CWKEDPDDRPTFETLQW 256 (261)
T ss_pred HhhcCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=349.63 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=212.2
Q ss_pred hhCCCceEE-EEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHH-------------HHHHHHHHHHHHhCCCCCeee
Q 005298 10 AAGSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE-------------IEDIQKEISVLSQCRSPYITE 75 (703)
Q Consensus 10 ~~~~~Y~il-~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~-------------~~~l~~Ei~ILk~L~HPnIV~ 75 (703)
....+|..+ +.||.|+||+||+|.+..+++.||||++........ ...+.+|+.++++++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 355688754 779999999999999999999999999865432110 124678999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecc
Q 005298 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (703)
Q Consensus 76 L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DF 155 (703)
+++++..++..|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999999996 699999988888999999999999999999999999999999999999999999999999
Q ss_pred ccchhhhh--------------cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee
Q 005298 156 GVSAQLTR--------------TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (703)
Q Consensus 156 GlA~~~~~--------------~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l 221 (703)
|++..... .........+++.|+|||++.+...++.++|||||||++|+|++|.+||...+....+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99865541 1111123457889999999977656789999999999999999999999876543322
Q ss_pred eccCC------------------------CCCCC---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 222 FIIPR------------------------ENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 222 ~~I~~------------------------~~~~~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..+.. ..+.. .....+..+.+||.+||.++|.+||+++++|.||||+..
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 11100 00000 112346789999999999999999999999999999754
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=342.65 Aligned_cols=255 Identities=28% Similarity=0.480 Sum_probs=204.5
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-HHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-------
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCRSPYITEYYGSYLHQ------- 83 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~-~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~------- 83 (703)
-.+|++.+.||.|+||.||+|.+..+++.||||++......+ ....+.+|+.++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 479999999999999999999999999999999986543221 234567899999999999999999987543
Q ss_pred -CEEEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 84 -TKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 84 -~~lyLV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
..+|+|+||+.+ +|...+.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 357999999964 66666654 457999999999999999999999999999999999999999999999999998754
Q ss_pred hhccc-----------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-----
Q 005298 162 TRTIS-----------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP----- 225 (703)
Q Consensus 162 ~~~~~-----------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~----- 225 (703)
..... ......|++.|+|||++.+...++.++|||||||++|+|++|++||...+.......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 32211 11234678899999998765568899999999999999999999997655432211110
Q ss_pred ---------------------CCCCCCcc---hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 226 ---------------------RENPPQLD---EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 226 ---------------------~~~~~~l~---~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
...++.+. ..+...+.+||.+||..+|.+|||+.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00011111 2344678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.31 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=208.6
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CEEEEEEe
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLWIIME 91 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~lyLV~E 91 (703)
|++++.||.|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++... +..|+|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 789999999999999999999999999999997653 223345678899999999999999999999988 89999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-ccc
Q 005298 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~~ 169 (703)
|++ ++|..++... ..+++..++.++.||+.||.|||.+|++|+||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 996 5899888765 5899999999999999999999999999999999999999999999999999876644321 122
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC----------------------
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---------------------- 227 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~---------------------- 227 (703)
...++..|+|||.+.+...++.++||||||+++|+|++|..||...+....+..+...
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 3467889999998876556789999999999999999999999766543222111100
Q ss_pred CCCC--------cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 228 NPPQ--------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 228 ~~~~--------l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.... +...++..+.++|.+||..+|.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0000 011137789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.38 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=207.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCc----EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~----~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
.+|++++.||+|+||+||+|.+..++. .|++|.+...........+..|+.+++++.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 589999999999999999999987776 477787754434445567888999999999999999999875 456789
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-
Q 005298 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 166 (703)
++||+.+|+|.+++.. ...+++..+..|+.||+.||.|||+++++||||||+|||++.++.+||+|||++........
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 9999999999999975 45789999999999999999999999999999999999999999999999999875532211
Q ss_pred -ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHH
Q 005298 167 -RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 167 -~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI 244 (703)
......++..|++||++.+. .++.++|||||||++|||++ |..||...........+.....+..+..++..+.+++
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 244 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVM 244 (279)
T ss_pred cccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHH
Confidence 12234577889999999765 48999999999999999998 9999987765554444444444444455677889999
Q ss_pred HHHhccCCCCCCCHHHHHh
Q 005298 245 SLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~ 263 (703)
.+||..+|.+|||+.++++
T Consensus 245 ~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 245 VKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHcCCCcccCcCHHHHHH
Confidence 9999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=341.45 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=208.3
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC----
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT---- 84 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~---- 84 (703)
....+|++.+.||.|+||.||+|.++.+|+.||||+++.... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 345689999999999999999999999999999999875432 223356778999999999999999999987655
Q ss_pred ------EEEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecccc
Q 005298 85 ------KLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (703)
Q Consensus 85 ------~lyLV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGl 157 (703)
.+|+|+||+++ +|..++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 79999999975 67776664 34799999999999999999999999999999999999999999999999999
Q ss_pred chhhhhccc-ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---CCC----
Q 005298 158 SAQLTRTIS-RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---ENP---- 229 (703)
Q Consensus 158 A~~~~~~~~-~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---~~~---- 229 (703)
+........ ......+++.|++||++.+...++.++|||||||++|+|++|++||...+....+..+.. ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 876543221 112235688899999987655578899999999999999999999976543322211100 000
Q ss_pred ----------------------CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 230 ----------------------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 230 ----------------------~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
......++..+.+||.+||..+|.+||++.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 00112467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=337.12 Aligned_cols=252 Identities=30% Similarity=0.506 Sum_probs=210.9
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
|++.+.||.|++|.||+|.+..+++.|++|.+...... .....+..|+.++++++||||+++++++..++.+|+|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 77899999999999999999999999999998654422 34567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 94 AGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 94 ~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
++ +|.+++.. ...+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++..............
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 65 78877765 46899999999999999999999999999999999999999999999999999876654332333457
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--------------------------
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------------------- 226 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~-------------------------- 226 (703)
++..|++||.+.+...++.++||||||++||+|++|+.||...+..+.+..+..
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 889999999987764688999999999999999999999976554322111100
Q ss_pred CCC---CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 227 ENP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 227 ~~~---~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
... ......++..+.+||.+||.++|.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 000 01223467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=363.52 Aligned_cols=246 Identities=25% Similarity=0.436 Sum_probs=216.5
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
.+++++.||+|-||+||.|.... ...||+|.++.... ..+.+.+|+.||++|+|+|||+|+++|..++.+||||||+
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 56778899999999999999874 45899999865421 2356779999999999999999999999999999999999
Q ss_pred CCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc-c
Q 005298 94 AGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK-T 170 (703)
Q Consensus 94 ~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~-~ 170 (703)
..|+|.++++. +..+...+...++.||++|++||+++++|||||-..||||+.++.+||+||||++.+........ .
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 99999999986 56799999999999999999999999999999999999999999999999999985433222111 1
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
..-...|.|||.+... .++.++|||||||+||||+| |+.||......+++..+.++...+.|..+|..+.+++..||.
T Consensus 364 ~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~ 442 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWH 442 (468)
T ss_pred CCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhh
Confidence 1224559999999876 49999999999999999997 999999999999999999999888999999999999999999
Q ss_pred cCCCCCCCHHHHHh
Q 005298 250 KVPAERPSAKELLR 263 (703)
Q Consensus 250 ~dP~~RPTa~eLL~ 263 (703)
.+|++|||++.+..
T Consensus 443 ~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 443 EDPEDRPTFETLRE 456 (468)
T ss_pred CCcccCCCHHHHHH
Confidence 99999999997653
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.80 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=203.1
Q ss_pred CCceEEEEE--eecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELI--GRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~L--G~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV 89 (703)
.+|++.+.+ |.|+||.||++.++.++..||+|++....... .|+.+...+ +||||++++++|...+.+|+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 577777776 99999999999999999999999986442211 122222222 799999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC-CeeEeccccchhhhhccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g-~VKL~DFGlA~~~~~~~~~~ 168 (703)
|||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---- 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---- 163 (267)
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC----
Confidence 99999999999998878999999999999999999999999999999999999999988 9999999988654322
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccce----eeccCCCCCCCcchhhhHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV----LFIIPRENPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~----l~~I~~~~~~~l~~~is~~L~dLI 244 (703)
....|++.|+|||++.+. .++.++|||||||++|+|++|..||........ +.... .........++..+.+||
T Consensus 164 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 241 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFV 241 (267)
T ss_pred ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHH
Confidence 345789999999999765 488999999999999999999999975433221 11111 222344457889999999
Q ss_pred HHHhccCCCCCCC-HHHHHhchhhhc
Q 005298 245 SLCLKKVPAERPS-AKELLRHRFIRN 269 (703)
Q Consensus 245 ~~cL~~dP~~RPT-a~eLL~Hpff~~ 269 (703)
.+||..+|.+||+ ++++|+||||.+
T Consensus 242 ~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 242 QSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHhccChhhCCchHHHHhcCCcccC
Confidence 9999999999996 699999999963
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=333.03 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=211.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCc---EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~---~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
..|++.+.||+|+||.||+|.+..+++ .||||++...........+..|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 468999999999999999999887664 69999987655566677899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc-
Q 005298 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~- 167 (703)
|||+.+++|.+++.. .+.+++..++.++.|++.||.|||++|++|+||||+|||++.++.+||+|||++.........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 999999999999975 456899999999999999999999999999999999999999999999999987654322111
Q ss_pred -ccccc---CCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHH
Q 005298 168 -RKTFV---GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (703)
Q Consensus 168 -~~~~i---GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~d 242 (703)
..... .+..|++||++... .++.++|||||||++|||++ |..||...+.......+......+.+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 242 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQ 242 (269)
T ss_pred ccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHH
Confidence 11111 24579999999765 48899999999999999886 99999887766555555444444445567888999
Q ss_pred HHHHHhccCCCCCCCHHHHHh
Q 005298 243 FVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~ 263 (703)
++.+||.++|.+||++.+|+.
T Consensus 243 li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 243 LMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.94 Aligned_cols=250 Identities=23% Similarity=0.369 Sum_probs=211.6
Q ss_pred CCCceEEEEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~-----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
..+|.+.+.||+|+||.||+|.+. .++..|++|.+.... ......+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 357999999999999999999854 345679999876433 33346788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCe
Q 005298 87 WIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDV 150 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~----------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~V 150 (703)
++||||+++++|.+++..+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999997542 38899999999999999999999999999999999999999999
Q ss_pred eEeccccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCC
Q 005298 151 KVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE 227 (703)
Q Consensus 151 KL~DFGlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~ 227 (703)
+|+|||++....... .......|++.|+|||++.+. .++.++|||||||++|+|++ |..||...+.......+...
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 241 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG 241 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence 999999986543221 112234678899999998764 58899999999999999998 99999877766655555555
Q ss_pred CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 228 ~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.....+..++..+.+||.+||..+|.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 554555667889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.53 Aligned_cols=251 Identities=26% Similarity=0.465 Sum_probs=212.5
Q ss_pred CCCceEEEEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~-----tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
..+|++++.||.|+||.||+|.+.. ++..||||++...........+.+|+.+++++.||||+++++++..+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4589999999999999999998753 67899999987665555567789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe
Q 005298 87 WIIMEYMAGGSVADLIQSG----------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~----------------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL 144 (703)
|+||||+.+++|.+++... ..+++..+..++.||+.||.|||.++++||||||.|||+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 9999999999999999643 247888999999999999999999999999999999999
Q ss_pred cCCCCeeEeccccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCcccee
Q 005298 145 TENGDVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL 221 (703)
Q Consensus 145 d~~g~VKL~DFGlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l 221 (703)
+.++.++|+|||++..+.... .......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||......+..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~ 242 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI 242 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999986543221 111223456779999998765 58999999999999999997 88899877666655
Q ss_pred eccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 222 ~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
..+........+..++..+.+||.+||..+|.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 243 YYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 555555444455677899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=331.87 Aligned_cols=248 Identities=24% Similarity=0.389 Sum_probs=208.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++++.||+|+||.||++.+.. +..||||.+..... ....+.+|+.++++++||||+++++++.....+|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 469999999999999999998764 45699998864332 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc-ccc
Q 005298 93 MAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKT 170 (703)
Q Consensus 93 v~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~-~~~ 170 (703)
+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||||.|||++.++.+||+|||++......... ...
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9999999999763 47899999999999999999999999999999999999999999999999988654332111 111
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
..++..|++||++.+. .++.++|||||||+||+|++ |..||...+.......+........+...+..+.+++.+||.
T Consensus 161 ~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 239 (256)
T cd05113 161 SKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWH 239 (256)
T ss_pred CccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 2356779999999765 48899999999999999998 999998776655555555544444455678899999999999
Q ss_pred cCCCCCCCHHHHHhc
Q 005298 250 KVPAERPSAKELLRH 264 (703)
Q Consensus 250 ~dP~~RPTa~eLL~H 264 (703)
.+|.+||++.+|+.+
T Consensus 240 ~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 240 EKAEERPTFQQLLSS 254 (256)
T ss_pred CCcccCCCHHHHHHh
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=334.35 Aligned_cols=252 Identities=34% Similarity=0.573 Sum_probs=214.8
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC----ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~----~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
+|.+.+.||+|+||.||++.+..++..+++|+++... .......+..|+.++++++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6999999999999999999998887777777765322 222344577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 90 MEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
+||+.+++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998853 457999999999999999999999999999999999999975 679999999987654433
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
.......|++.|++||.+.+. .++.++|+||||+++|+|++|..||...........+.....+..+..++..+.++|.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 333456789999999998664 4788999999999999999999999876655555555455555666788899999999
Q ss_pred HHhccCCCCCCCHHHHHhchhh
Q 005298 246 LCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff 267 (703)
+||..+|.+||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=341.38 Aligned_cols=253 Identities=23% Similarity=0.429 Sum_probs=211.6
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcC-------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKE-------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYL 81 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~-------tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~ 81 (703)
....+|.+.+.||+|+||.||+|.+.. ....||+|++...........+..|+.+++++ .||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 345689999999999999999998642 34579999987655555567788999999999 6999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec
Q 005298 82 HQTKLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT 145 (703)
Q Consensus 82 ~~~~lyLV~Eyv~gGsL~~~l~~~----------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd 145 (703)
..+.+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 999999999999999999999653 3488899999999999999999999999999999999999
Q ss_pred CCCCeeEeccccchhhhhcccc--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceee
Q 005298 146 ENGDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLF 222 (703)
Q Consensus 146 ~~g~VKL~DFGlA~~~~~~~~~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~ 222 (703)
.++.+||+|||++......... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||..........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999998755322111 1122345679999998764 58899999999999999998 899998776655555
Q ss_pred ccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 223 IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 223 ~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.+........+..++..+.+||.+||..+|.+||++.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 55544444555677889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=331.46 Aligned_cols=243 Identities=25% Similarity=0.416 Sum_probs=204.8
Q ss_pred EEeecCceEEEEEEEc--CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCC
Q 005298 20 LIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGS 97 (703)
Q Consensus 20 ~LG~GsfG~Vyka~d~--~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGs 97 (703)
.||+|+||.||+|.+. ..+..||||++.........+.+.+|+.++++++||||+++++++. ...+|+||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999875 4466799999876655555677899999999999999999999875 457899999999999
Q ss_pred HHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc---ccccC
Q 005298 98 VADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR---KTFVG 173 (703)
Q Consensus 98 L~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~---~~~iG 173 (703)
|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......... ....+
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW 160 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence 9999874 4679999999999999999999999999999999999999999999999999987543322111 11223
Q ss_pred CCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCC
Q 005298 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 174 Tp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP 252 (703)
++.|+|||++... .++.++|||||||++|+|++ |..||...........+........+..++..+.++|.+||..+|
T Consensus 161 ~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~ 239 (257)
T cd05115 161 PLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKW 239 (257)
T ss_pred CcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 5789999998764 48899999999999999996 999998887766666565555556667788999999999999999
Q ss_pred CCCCCHHHHHhc
Q 005298 253 AERPSAKELLRH 264 (703)
Q Consensus 253 ~~RPTa~eLL~H 264 (703)
++||++.+|++.
T Consensus 240 ~~Rp~~~~i~~~ 251 (257)
T cd05115 240 EDRPNFAKVEER 251 (257)
T ss_pred hhCcCHHHHHHH
Confidence 999999999763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=328.96 Aligned_cols=245 Identities=27% Similarity=0.439 Sum_probs=211.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||.|+||.||+|... |+.||||.+..... ..+.+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 3568999999999999999999875 88999999865433 4577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 91 EYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||+++++|.+++.... .+++..+..++.|++.||.|||.+||+|+||||+|||++.++.+||+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999999997655 799999999999999999999999999999999999999999999999999876532211
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
...++..|+|||++... .++.++||||||+++|+|++ |..||...........+........+..++..+.+||.+|
T Consensus 158 -~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 158 -SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred -cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence 23456679999998765 48889999999999999997 9999987765555444444444455567789999999999
Q ss_pred hccCCCCCCCHHHHHh
Q 005298 248 LKKVPAERPSAKELLR 263 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~ 263 (703)
|..+|.+||++.++++
T Consensus 236 l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 236 WELDPAKRPTFKQLRE 251 (256)
T ss_pred hccChhhCcCHHHHHH
Confidence 9999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=348.13 Aligned_cols=261 Identities=26% Similarity=0.429 Sum_probs=214.2
Q ss_pred cchhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005298 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (703)
Q Consensus 6 ~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~ 84 (703)
........+|++++.||+|+||.||+|.+..++..||||++.... .......+.+|+.++++++||||+++++++..+.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred hhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 334446679999999999999999999999999999999986432 2333456889999999999999999999987654
Q ss_pred ------EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccc
Q 005298 85 ------KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 85 ------~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
.+|+||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 468999999 7899998875 67999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-----------
Q 005298 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----------- 227 (703)
Q Consensus 159 ~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~----------- 227 (703)
..... ......+++.|++||++.+...++.++|||||||++|+|++|..||...+.......+...
T Consensus 166 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 166 RQTDS---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccccc---CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 65432 2234578999999999876445788999999999999999999999865432222111100
Q ss_pred ----------------CC---CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 228 ----------------NP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 228 ----------------~~---~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+ ..+...++..+.++|.+||..+|.+|||+.+++.||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 00 011234567899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=331.07 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=208.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++.+.||+|+||.||+|.++ ++..+|||++...... ...+.+|+.++++++||||+++++++...+..|+||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 46899999999999999999886 4678999998643321 24577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc-cc
Q 005298 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR-KT 170 (703)
Q Consensus 93 v~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~-~~ 170 (703)
+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 999999999975 3578999999999999999999999999999999999999999999999999886543221111 11
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
..++..|+|||++.+. .++.++|||||||+||+|++ |.+||...........+........+..++..+.+++.+||.
T Consensus 161 ~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 239 (256)
T cd05059 161 TKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWH 239 (256)
T ss_pred CCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 1234579999998765 58899999999999999998 899998766655555555444445556688999999999999
Q ss_pred cCCCCCCCHHHHHhc
Q 005298 250 KVPAERPSAKELLRH 264 (703)
Q Consensus 250 ~dP~~RPTa~eLL~H 264 (703)
.+|.+|||+.++++.
T Consensus 240 ~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 240 EKPEDRPAFKKLLSQ 254 (256)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=340.69 Aligned_cols=257 Identities=44% Similarity=0.791 Sum_probs=216.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
....|+..+.||+|+||.||++.+..++..||||++.... .......+.+|+.++++++||||+++++++..++..|+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 3456899999999999999999999999999999986543 23445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 89 IMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~-~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||||+.| +|.+++. ...++++..+..++.||+.||.|||+++|+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 9999965 7777664 356799999999999999999999999999999999999999999999999998754322
Q ss_pred cccccCCCCCCchhhhcc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCcchhhhHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEHFSRLMKEFV 244 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~-~~~l~~~is~~L~dLI 244 (703)
.....|++.|+|||++.. ...++.++|||||||++|+|++|..||...+.......+.... +......++..+++||
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 234578999999999852 2347889999999999999999999998776555444444333 2233446788899999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
.+||..+|.+||++.++++|+|+.....
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHccCCcccCcCHHHHHhChhhhccCc
Confidence 9999999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.51 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=211.0
Q ss_pred CCCceEEEEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~-----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
..+|++.+.||+|+||.||++... .++..||+|.+... .......+.+|+.+++.+.||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 357899999999999999999743 35778999987644 344567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCee
Q 005298 87 WIIMEYMAGGSVADLIQSGP---------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~---------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VK 151 (703)
|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence 99999999999999997643 488999999999999999999999999999999999999999999
Q ss_pred Eeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC
Q 005298 152 VADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (703)
Q Consensus 152 L~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~ 228 (703)
|+|||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++ |.+||...........+....
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 999999864432111 11223457889999998765 58999999999999999998 999998776665555555544
Q ss_pred CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 229 ~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
+...+..++..+.+||.+||.++|.+||++.+|+.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 44555678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.06 Aligned_cols=256 Identities=26% Similarity=0.475 Sum_probs=208.0
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-------
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------- 83 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~------- 83 (703)
.+.+|++.+.||.|+||.||+|.+..++..||+|++..... .....+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 46899999999999999999999999999999999866543 3456788999999999999999999876653
Q ss_pred -------CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC-CCCeeEecc
Q 005298 84 -------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADF 155 (703)
Q Consensus 84 -------~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~-~g~VKL~DF 155 (703)
..+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35799999996 589988865 57999999999999999999999999999999999999985 457899999
Q ss_pred ccchhhhhccc---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-----
Q 005298 156 GVSAQLTRTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----- 227 (703)
Q Consensus 156 GlA~~~~~~~~---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~----- 227 (703)
|++..+..... ......|+..|+|||++.....++.++|||||||++|+|++|..||...+.......+...
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99865432211 1122468899999998866556888999999999999999999999765532222111100
Q ss_pred -------------------CCC-----CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 228 -------------------NPP-----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 228 -------------------~~~-----~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
... .+...++..+.+||.+||..+|.+|||+.+++.||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 000 011246778999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.53 Aligned_cols=254 Identities=22% Similarity=0.425 Sum_probs=213.1
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEc-------CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDK-------ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYL 81 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~-------~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~ 81 (703)
....+|.+.+.||+|+||.||+|... ..+..||||++...........+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34568999999999999999999753 235579999987554455567889999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec
Q 005298 82 HQTKLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT 145 (703)
Q Consensus 82 ~~~~lyLV~Eyv~gGsL~~~l~~~----------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd 145 (703)
....+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 999999999999999999999753 2477888999999999999999999999999999999999
Q ss_pred CCCCeeEeccccchhhhhcccc--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceee
Q 005298 146 ENGDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLF 222 (703)
Q Consensus 146 ~~g~VKL~DFGlA~~~~~~~~~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~ 222 (703)
.++.+||+|||++..+...... .....+++.|+|||++.+. .++.++|||||||+||+|++ |..||......+...
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999998765332111 1223567789999999764 58899999999999999998 889998776666555
Q ss_pred ccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 223 IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 223 ~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.+........+..++..+.+||.+||..+|.+||++.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 251 LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 555444444556788999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=329.74 Aligned_cols=248 Identities=27% Similarity=0.469 Sum_probs=208.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
....|++++.||.|+||.||+|.+. +++.||+|.+..... ....+.+|+.++++++||||+++++++ ..+..|+||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~ 79 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIIT 79 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEE
Confidence 4568999999999999999999876 478899999875433 245788999999999999999999986 456789999
Q ss_pred eccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-cc
Q 005298 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~ 167 (703)
||+.+++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 99999999999865 3468999999999999999999999999999999999999999999999999986554221 11
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
.....++..|+|||++... .++.++||||||+++|+|++ |.+||...+.......+........+..++..+.+||.+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05067 160 REGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRL 238 (260)
T ss_pred ccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 1233467789999998764 48889999999999999998 999998776655555544444445566778899999999
Q ss_pred HhccCCCCCCCHHHHHh
Q 005298 247 CLKKVPAERPSAKELLR 263 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~ 263 (703)
||..+|.+||++++++.
T Consensus 239 ~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 239 CWKEKPEERPTFEYLRS 255 (260)
T ss_pred HccCChhhCCCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=340.34 Aligned_cols=256 Identities=32% Similarity=0.584 Sum_probs=225.1
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+.+++..||.|+-|+|+++..+.+|...|||.+....+..+..++.+.+.++.+.+ .|+||+++++|..+...+|.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 45677889999999999999999999999999998888888899999999887775 89999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH-hcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLH-NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 93 v~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLH-s~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
| +..+..++++ .++++|..+-++...++.||.||. .++|||||+||+|||+|..|++||||||++..+...... ..
T Consensus 173 M-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-tr 250 (391)
T KOG0983|consen 173 M-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-TR 250 (391)
T ss_pred H-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc-cc
Confidence 9 4566666654 578999999999999999999998 458999999999999999999999999999887655332 33
Q ss_pred ccCCCCCCchhhhcc--ccCCccccchhhHHHHHHHHHhCCCCCCCCC-ccceeeccCCCCCCCcch--hhhHHHHHHHH
Q 005298 171 FVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQLDE--HFSRLMKEFVS 245 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~-~~~~l~~I~~~~~~~l~~--~is~~L~dLI~ 245 (703)
..|.+.|||||-+.- ...|+.++||||||++|+||.||..||...+ +.+++.++....||.++. .+++.+.+|+.
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~ 330 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVK 330 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHH
Confidence 579999999999853 2458899999999999999999999998864 567777887777877764 48999999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhccc
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.||.+|+.+||...++|+|||+....
T Consensus 331 ~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 331 DCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHhhcCcccCcchHHHhcCcceeecc
Confidence 99999999999999999999997654
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=331.71 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=207.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||+|+||.||+|.+..+ ..||||++..... ....+.+|+.++++++||||+++++++. ....|+||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 79 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence 346799999999999999999998765 4599999875332 2356889999999999999999999874 45689999
Q ss_pred eccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc-
Q 005298 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~- 167 (703)
||+.+++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++..+......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999999753 45899999999999999999999999999999999999999999999999998655332211
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
.....++..|++||++.+. .++.++|||||||++|+|++ |..||...........+....+......++..+.+||.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred ccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 1123467789999998765 48999999999999999999 899998776655555554444445556788999999999
Q ss_pred HhccCCCCCCCHHHHHh
Q 005298 247 CLKKVPAERPSAKELLR 263 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~ 263 (703)
||.++|.+||++.++++
T Consensus 239 ~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 239 CWRKEPEERPTFEYLQA 255 (262)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=327.59 Aligned_cols=245 Identities=33% Similarity=0.582 Sum_probs=213.8
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCH
Q 005298 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (703)
Q Consensus 21 LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL 98 (703)
||.|+||.||++.+..+++.||+|++..... ......+..|+.++++++||||+++++.+..+..+|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999998999999999875542 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCCCCC
Q 005298 99 ADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178 (703)
Q Consensus 99 ~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~ 178 (703)
.+++.....+++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++..............++..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 99998888899999999999999999999999999999999999999999999999999876544322334567899999
Q ss_pred chhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCH
Q 005298 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (703)
Q Consensus 179 APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa 258 (703)
+||.+.+. .++.++|+|+||+++|+|++|..||...........+.. ....++..++..+.+||.+||..+|.+||++
T Consensus 161 ~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~ 238 (250)
T cd05123 161 APEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPTKRLGS 238 (250)
T ss_pred ChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCc
Confidence 99998765 478899999999999999999999977665444444433 3345566678999999999999999999999
Q ss_pred ---HHHHhchhh
Q 005298 259 ---KELLRHRFI 267 (703)
Q Consensus 259 ---~eLL~Hpff 267 (703)
.+++.||||
T Consensus 239 ~~~~~l~~~~~f 250 (250)
T cd05123 239 GGAEEIKAHPFF 250 (250)
T ss_pred ccHHHHHhCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=325.37 Aligned_cols=244 Identities=25% Similarity=0.410 Sum_probs=205.6
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCH
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL 98 (703)
++||.|+||.||+|... ++..||+|++...........+.+|+.++++++||||+++++++...+..|+||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46999999999999865 58899999987655555556788999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc-ccccCCCC
Q 005298 99 ADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR-KTFVGTPF 176 (703)
Q Consensus 99 ~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~-~~~iGTp~ 176 (703)
.+++.. ...+++..+..++.|++.+|.|||++|++|+||||+||+++.++.+||+|||++.......... ....+++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 999865 3468999999999999999999999999999999999999999999999999986543221111 12244677
Q ss_pred CCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 177 Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
|+|||++... .++.++|||||||++|+|++ |..||...........+........+..++..+.+|+.+||..+|.+|
T Consensus 160 y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (250)
T cd05085 160 WTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238 (250)
T ss_pred ccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 9999998764 48889999999999999998 999998776555544454444445556788999999999999999999
Q ss_pred CCHHHHHhc
Q 005298 256 PSAKELLRH 264 (703)
Q Consensus 256 PTa~eLL~H 264 (703)
|++.++++.
T Consensus 239 p~~~~l~~~ 247 (250)
T cd05085 239 PKFSELQKE 247 (250)
T ss_pred CCHHHHHHH
Confidence 999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=325.97 Aligned_cols=243 Identities=28% Similarity=0.439 Sum_probs=206.5
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCH
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL 98 (703)
+.||.|+||.||++.+.. ++.||+|++...........+.+|+.++++++||||+++++++......|+||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999988 9999999987665555567889999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc--cccccCCC
Q 005298 99 ADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--RKTFVGTP 175 (703)
Q Consensus 99 ~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~--~~~~iGTp 175 (703)
.+++.. ...+++..+..++.|++.+|.|||+++++||||||+|||++.++.+||+|||++......... .....++.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 999965 456899999999999999999999999999999999999999999999999998654321111 11223456
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~ 254 (703)
.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+..++..+.+||.+||..+|.+
T Consensus 160 ~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 238 (251)
T cd05041 160 KWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238 (251)
T ss_pred ccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhh
Confidence 79999998765 58899999999999999998 89999877655544444443344455677889999999999999999
Q ss_pred CCCHHHHHh
Q 005298 255 RPSAKELLR 263 (703)
Q Consensus 255 RPTa~eLL~ 263 (703)
||++.++++
T Consensus 239 Rp~~~ell~ 247 (251)
T cd05041 239 RPSFSEIYN 247 (251)
T ss_pred CcCHHHHHH
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=346.01 Aligned_cols=261 Identities=22% Similarity=0.405 Sum_probs=212.5
Q ss_pred ccchhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC
Q 005298 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (703)
Q Consensus 5 ~~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~ 83 (703)
.+.......+|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3344567789999999999999999999999999999999986543 222346678899999999999999999988643
Q ss_pred ------CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecccc
Q 005298 84 ------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (703)
Q Consensus 84 ------~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGl 157 (703)
...|++++++ +++|.++++. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccc
Confidence 3478888888 7899988865 4699999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-----------
Q 005298 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------- 226 (703)
Q Consensus 158 A~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~----------- 226 (703)
+..... ......|++.|+|||++.+...++.++|||||||++|+|++|.+||...+.......+..
T Consensus 167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 167 ARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred cccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 865432 223457899999999987655688899999999999999999999976543322111100
Q ss_pred ----------------C---CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 227 ----------------E---NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 227 ----------------~---~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
. .........+..+.+||.+||.++|.+||++.+++.||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 0 0000111346789999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=327.60 Aligned_cols=242 Identities=28% Similarity=0.460 Sum_probs=206.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEE-eCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL-HQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~-~~~~lyLV~E 91 (703)
.+|++.+.||+|+||.||++... |..||+|.+.... ..+.+.+|+.++++++|+||+++++++. .++..|+|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 47999999999999999999765 7889999986432 2456889999999999999999999765 4567999999
Q ss_pred ccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 92 YMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---~~ 157 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QD 157 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc---CC
Confidence 999999999997643 4889999999999999999999999999999999999999999999999998654322 12
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
...++..|+|||++... .++.++|||||||++|+|++ |..||...........+.....+..+..++..+.+||.+||
T Consensus 158 ~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 158 TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred CCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHh
Confidence 33456789999998764 58899999999999999997 99999877665555555555555566778899999999999
Q ss_pred ccCCCCCCCHHHHHh
Q 005298 249 KKVPAERPSAKELLR 263 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~ 263 (703)
..+|.+|||+.++++
T Consensus 237 ~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 237 HLDAATRPSFLQLRE 251 (256)
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=357.09 Aligned_cols=252 Identities=22% Similarity=0.389 Sum_probs=208.1
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCC-----CcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTK 85 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~t-----g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~ 85 (703)
..+|++.+.||+|+||.||+|.+... +..||||++.........+.+.+|+.+|+++. |||||+++++|.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 45788999999999999999987543 34799999976655555678899999999996 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC------------------------------------------------------------
Q 005298 86 LWIIMEYMAGGSVADLIQSG------------------------------------------------------------ 105 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~------------------------------------------------------------ 105 (703)
+|||||||++|+|.+++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999988542
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC
Q 005298 106 ------------------------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD 149 (703)
Q Consensus 106 ------------------------------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~ 149 (703)
..+++..+..++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE
Confidence 24778889999999999999999999999999999999999999
Q ss_pred eeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccce-eeccC
Q 005298 150 VKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV-LFIIP 225 (703)
Q Consensus 150 VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~-l~~I~ 225 (703)
+||+|||++........ ......+++.|+|||++.+. .++.++|||||||+||+|++ |..||........ ...+.
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~ 354 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHh
Confidence 99999999875532211 12234577889999999765 58999999999999999997 9999976543222 22233
Q ss_pred CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 226 ~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.......+..++..+.++|.+||..+|.+||++.+|.+.
T Consensus 355 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 355 SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 333344556788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=358.97 Aligned_cols=262 Identities=26% Similarity=0.474 Sum_probs=225.5
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
+-.+-|..++.||-|+||+|.++...+|...||+|.+++.. ..+.+..++.|..||..-+++-||+||..|++.+++|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 34457899999999999999999999999999999987655 3455678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 166 (703)
+||+|+.||+|-.+|-+-+-|+|..+++|+.+|..|+++.|..|+|||||||+|||||.+|+|||.|||||+-+.....
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999999999999999889999999999999999999999999999999999999999999999999999965421100
Q ss_pred -----------------------------------------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHH
Q 005298 167 -----------------------------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM 205 (703)
Q Consensus 167 -----------------------------------------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyEL 205 (703)
.....+||+.|+|||+|... +|+..+|+||.|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHHH
Confidence 01135799999999999875 699999999999999999
Q ss_pred HhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHHHHHHHhccCCCCCCC---HHHHHhchhhhccccC
Q 005298 206 AKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVPAERPS---AKELLRHRFIRNARKS 273 (703)
Q Consensus 206 LtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~dLI~~cL~~dP~~RPT---a~eLL~Hpff~~~~~~ 273 (703)
+.|.+||-...+....+++..+. .......+++++.++|.+++ .++..|.. ++||..||||+.+...
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFS 937 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchH
Confidence 99999999888877777665543 12334678999999998844 55788874 7889999999987543
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=331.98 Aligned_cols=249 Identities=24% Similarity=0.413 Sum_probs=201.2
Q ss_pred CCc-eEEEEEeecCceEEEEEE----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CE
Q 005298 13 SRF-SSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TK 85 (703)
Q Consensus 13 ~~Y-~il~~LG~GsfG~Vyka~----d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~ 85 (703)
.+| ++++.||+|+||+||++. ...++..||+|++...........+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 999999999999998764 34578899999987654444556788999999999999999999988753 46
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 8999999999999999976 469999999999999999999999999999999999999999999999999987654322
Q ss_pred cc---cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--cee-------------eccCCC
Q 005298 166 SR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM--RVL-------------FIIPRE 227 (703)
Q Consensus 166 ~~---~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~--~~l-------------~~I~~~ 227 (703)
.. .....++..|++||++... .++.++|||||||++|+|++|..||...... ... ..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 11 1123456779999998765 4889999999999999999999998643211 000 001111
Q ss_pred CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 228 ~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.....+..++..+.+|+.+||..+|.+|||+++++.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 122234567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=332.97 Aligned_cols=252 Identities=31% Similarity=0.508 Sum_probs=210.5
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
|++.+.||.|+||.||+|++..+++.||+|++.... .....+.+..|+.++++++||||+++++++...+.+|+|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 778899999999999999999999999999987653 2223466778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 94 AGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 94 ~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
. ++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..............
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 7 5899999876 5899999999999999999999999999999999999999999999999999876654433333456
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---------------------CCC--
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------------ENP-- 229 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------------~~~-- 229 (703)
++..|+|||.+.+...++.++|||||||++|+|++|.+||...+....+..+.. ..+
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF 239 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence 788899999987665688999999999999999999999976543222111100 000
Q ss_pred --C---CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 230 --P---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 230 --~---~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
. .....++..+.+||.+||..+|.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0 0111346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=328.85 Aligned_cols=247 Identities=25% Similarity=0.431 Sum_probs=208.0
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||+|+||.||+|.+. .+..||+|.+...... .+.+.+|+.++++++||||+++++++. ....|+|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 457999999999999999999876 4677999998654332 356889999999999999999999875 556899999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-cc
Q 005298 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (703)
Q Consensus 92 yv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~ 168 (703)
|+.+++|.+++... ..+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||++..+..... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 99999999999753 4689999999999999999999999999999999999999999999999999865533211 11
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....++..|+|||++.+. .++.++||||||+++|+|++ |.+||...+.......+........+..++..+.+||.+|
T Consensus 161 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05070 161 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQC 239 (260)
T ss_pred cCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence 123456789999998764 48899999999999999999 9999988776666666655555556677889999999999
Q ss_pred hccCCCCCCCHHHHHh
Q 005298 248 LKKVPAERPSAKELLR 263 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~ 263 (703)
|.++|.+|||+.++++
T Consensus 240 l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 240 WKKDPEERPTFEYLQS 255 (260)
T ss_pred cccCcccCcCHHHHHH
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=368.97 Aligned_cols=260 Identities=48% Similarity=0.899 Sum_probs=237.8
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEe-----C
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH-----Q 83 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~-----~ 83 (703)
.....|+|.++||.|.+|.||++.++.+++.+|||+...... ..+.+..|++||+.+ +|||++.+|++|.. +
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 356789999999999999999999999999999999866543 346678899999887 68999999999874 5
Q ss_pred CEEEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 84 TKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
+.+|||||||.||+.-++++. +.++.|+.|..|++.++.||.+||.+.+||||||-.|||++.+|.|||+|||++.++
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 689999999999999999975 568999999999999999999999999999999999999999999999999999999
Q ss_pred hhcccccccccCCCCCCchhhhccccC----CccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcc--hh
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQNSEG----YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EH 235 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~~~~----~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~--~~ 235 (703)
.......++++|||+|||||++.+.+. |+.++|+||||++..||--|.+|+.+..++..+.+|.+..||.+. ..
T Consensus 174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence 988888999999999999999976543 677899999999999999999999999999999999998888764 68
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
++..+.+||..||.+|..+||+..++|+|||+....
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 899999999999999999999999999999998554
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=331.19 Aligned_cols=243 Identities=28% Similarity=0.458 Sum_probs=202.5
Q ss_pred EEEeecCceEEEEEEEcCCCc--EEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~--~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
++||+|+||.||+|.+..++. .+++|.+.........+.+.+|+.++.++ +||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999988776 46888876544455567888999999999 899999999999999999999999999
Q ss_pred CCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccch
Q 005298 96 GSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 96 GsL~~~l~~~~----------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
++|.+++.... .+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999997532 47899999999999999999999999999999999999999999999999975
Q ss_pred hhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhH
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSR 238 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~ 238 (703)
..... ........++.|+|||++... .++.++|||||||++|+|++ |..||...+.......+........+..++.
T Consensus 161 ~~~~~-~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05047 161 GQEVY-VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 238 (270)
T ss_pred ccchh-hhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCH
Confidence 32211 111122346679999998664 58899999999999999997 9999987665555554544444444556788
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 239 LMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 239 ~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.+.+++.+||..+|.+|||+.+++.
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 239 EVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHH
Confidence 8999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=358.27 Aligned_cols=237 Identities=32% Similarity=0.552 Sum_probs=210.2
Q ss_pred eEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 16 ~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
..++-||.|+.|.||+|+.+ ++.||||+++ +.-..+|+-|++|+||||+.|.++|...-.+|||||||..
T Consensus 127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~--------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVR--------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhhhccCcccceeeeecc--CceehhHHHh--------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 34567999999999999876 8899999875 2334578999999999999999999999999999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCC
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp 175 (703)
|-|.++++.+.++.......|..+|+.|+.|||.++|||||||.=||||..+..|||+|||-+.....- .....|+||.
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTV 275 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTV 275 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhH
Confidence 999999999999999999999999999999999999999999999999999999999999988766443 3445689999
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-CCCCcchhhhHHHHHHHHHHhccCCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLMKEFVSLCLKKVPAE 254 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~-~~~~l~~~is~~L~dLI~~cL~~dP~~ 254 (703)
.|||||+|.+. .++.|+|||||||||||||||..||.+.+....+.-+-.. ...+.+..+++.++-||+.||.-.|..
T Consensus 276 aWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRN 354 (904)
T KOG4721|consen 276 AWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRN 354 (904)
T ss_pred hhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCC
Confidence 99999999875 6999999999999999999999999988776655443322 234566788999999999999999999
Q ss_pred CCCHHHHHhc
Q 005298 255 RPSAKELLRH 264 (703)
Q Consensus 255 RPTa~eLL~H 264 (703)
||++.+||.|
T Consensus 355 RPSFrqil~H 364 (904)
T KOG4721|consen 355 RPSFRQILLH 364 (904)
T ss_pred CccHHHHHHH
Confidence 9999999998
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=330.54 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=213.0
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCc----EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~----~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
...+|++.+.||+|+||.||+|.++.+|. .||+|++...........+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 34689999999999999999999877665 6899998766555566788899999999999999999999887 789
Q ss_pred EEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999999999999763 569999999999999999999999999999999999999999999999999987654322
Q ss_pred cccc--cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHH
Q 005298 166 SRRK--TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (703)
Q Consensus 166 ~~~~--~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~d 242 (703)
.... ...++..|++||.+... .++.++|||||||++|||++ |..||......+....+........+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM 242 (279)
T ss_pred cceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 1111 12235679999998654 58899999999999999998 99999887766655555555444555667788999
Q ss_pred HHHHHhccCCCCCCCHHHHHh
Q 005298 243 FVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~ 263 (703)
++.+||..+|..||++.++++
T Consensus 243 ~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 243 VLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=325.61 Aligned_cols=249 Identities=25% Similarity=0.422 Sum_probs=211.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||.|+||.||+|.+.. +..||||.+..... ....+.+|+.++++++||||+++++++......|+||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 35689999999999999999999764 57899999875432 2356889999999999999999999999989999999
Q ss_pred eccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-cc
Q 005298 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~ 167 (703)
||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..+.... ..
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999999764 368999999999999999999999999999999999999999999999999986553211 11
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
.....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||........+..+........+..++..+.+++.+
T Consensus 161 ~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 161 REGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQ 239 (261)
T ss_pred hhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 1122346789999998764 58899999999999999998 999998877666666665544445555678899999999
Q ss_pred HhccCCCCCCCHHHHHh
Q 005298 247 CLKKVPAERPSAKELLR 263 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~ 263 (703)
||..+|.+||++++++.
T Consensus 240 ~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 240 CWDKDPEERPTFEYLQS 256 (261)
T ss_pred HcccCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=336.88 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=208.0
Q ss_pred CCceEEEEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d-----~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~l 86 (703)
.+|++.+.||+|+||.||++.+ ..++..||||++.........+.+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4899999999999999999975 3356689999987655455567889999999999 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 87 WIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
|+||||+.+++|.+++.... .+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..+...
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 194 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence 99999999999999997533 3899999999999999999999999999999999999999999999999998755332
Q ss_pred cc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceee-ccCCCCCCCcchhhhHHH
Q 005298 165 IS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLF-IIPRENPPQLDEHFSRLM 240 (703)
Q Consensus 165 ~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~-~I~~~~~~~l~~~is~~L 240 (703)
.. ......+++.|+|||++.+. .++.++|||||||++|+|++ |..||.......... .+........+..++..+
T Consensus 195 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (302)
T cd05055 195 SNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEI 273 (302)
T ss_pred CceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHH
Confidence 11 11223567889999998765 48899999999999999998 999997765433222 222222333445678899
Q ss_pred HHHHHHHhccCCCCCCCHHHHHh
Q 005298 241 KEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.+||.+||.++|.+|||+.++++
T Consensus 274 ~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 274 YDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=330.71 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=212.9
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcC----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe-CCE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKE----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~----tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~-~~~ 85 (703)
...+|++.++||+|+||.||+|.+.. ++..|++|++...........+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35689999999999999999999876 3688999998765556667888999999999999999999998766 567
Q ss_pred EEEEEeccCCCCHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecccc
Q 005298 86 LWIIMEYMAGGSVADLIQSG--------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~--------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGl 157 (703)
.++++||+.+++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~ 163 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence 89999999999999998653 4589999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccc--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcch
Q 005298 158 SAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDE 234 (703)
Q Consensus 158 A~~~~~~~~~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~ 234 (703)
+..+...... .....++..|+|||++.+. .++.++|||||||++|+|++ |.+||...+.......+..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05043 164 SRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPI 242 (280)
T ss_pred cccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCC
Confidence 8755322111 1223467789999999764 58899999999999999998 999998877666555444444444455
Q ss_pred hhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 235 HFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 235 ~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.++..+.+++.+||..+|.+|||+.+++.
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 243 NCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 67889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=342.50 Aligned_cols=252 Identities=22% Similarity=0.437 Sum_probs=211.0
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCC-------CcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKEL-------NKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ 83 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~t-------g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~ 83 (703)
..+|++.+.||+|+||.||+|.+... +..||+|++...........+.+|+.+++++ +||||+++++++..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35799999999999999999986432 2369999987554455567889999999999 799999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~----------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~ 147 (703)
+.+|+|+||+.+++|.+++.... .++...+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 99999999999999999997532 47788899999999999999999999999999999999999
Q ss_pred CCeeEeccccchhhhhcccc--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeecc
Q 005298 148 GDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII 224 (703)
Q Consensus 148 g~VKL~DFGlA~~~~~~~~~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I 224 (703)
+.+||+|||++......... .....++..|+|||++.+. .++.++|||||||+||+|++ |..||...+..+....+
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 249 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 249 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999998654322111 1122345679999999764 58899999999999999998 89999887766665555
Q ss_pred CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 225 ~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
........+..++..+.+||.+||..+|.+||++.+++.+
T Consensus 250 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 250 KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5444445556778899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=329.63 Aligned_cols=251 Identities=23% Similarity=0.420 Sum_probs=211.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~-----tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
.+|++++.||.|+||+||+|..+. ..+.|++|.+...........+.+|+.++++++||||+++++++.+....|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 589999999999999999999754 356899999876554445678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccc
Q 005298 88 IIMEYMAGGSVADLIQSGP---------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~---------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
+||||+++++|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999999997655 7999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhc-ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC-CCCcchh
Q 005298 159 AQLTRT-ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN-PPQLDEH 235 (703)
Q Consensus 159 ~~~~~~-~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~-~~~l~~~ 235 (703)
...... ........+++.|++||.+.+. .++.++|||||||++|+|++ |..||...........+.... ....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCC
Confidence 643221 1122334667889999998765 47889999999999999998 889997766555444443222 1223456
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
++..+.++|.+||..+|.+||++.+++..
T Consensus 244 ~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 244 CPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 78899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=327.16 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=206.6
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++.+.||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+.++++++||||+++++++. .+..|+|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 46799999999999999999988765 4699998764332 2356788999999999999999999875 556899999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-cc
Q 005298 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (703)
Q Consensus 92 yv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~ 168 (703)
|+.+++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999999753 3588999999999999999999999999999999999999999999999999865532211 11
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....++..|+|||++... .++.++|||||||++|+|++ |..||...........+........+..++..+.+||.+|
T Consensus 161 ~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (260)
T cd05069 161 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC 239 (260)
T ss_pred CCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence 223466789999988764 48899999999999999999 9999988776665555555444455667889999999999
Q ss_pred hccCCCCCCCHHHHHh
Q 005298 248 LKKVPAERPSAKELLR 263 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~ 263 (703)
|.++|.+||+++++++
T Consensus 240 l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 240 WKKDPDERPTFEYIQS 255 (260)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=345.61 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=211.9
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC--CE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ--TK 85 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~--~~ 85 (703)
....+|++.+.||.|+||.||+|.+..+++.||||.+.... .......+.+|+.+++++ +||||++++++|... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35578999999999999999999999999999999885432 223345677899999999 999999999988654 46
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
+|+||||+. ++|..++..+ .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 899999996 5999999875 88999999999999999999999999999999999999999999999999987553322
Q ss_pred -----cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc----------------
Q 005298 166 -----SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII---------------- 224 (703)
Q Consensus 166 -----~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I---------------- 224 (703)
.....+.|++.|+|||++.+...++.++|||||||++|+|++|.+||...........+
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 12234578999999999876566888999999999999999999999765432211111
Q ss_pred -----------CCC---CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 225 -----------PRE---NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 225 -----------~~~---~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
... ........++..+.+||.+||..+|.+|||+.++++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000 0111122367889999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=337.98 Aligned_cols=257 Identities=43% Similarity=0.780 Sum_probs=216.1
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
.....|...+.||.|+||.||+|++..++..||||.+.... .......+.+|+.+++.++|+||+++++++......|
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 34557899999999999999999999999999999986432 3344567888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 88 IIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~-~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
+||||+. ++|.+++. ...++++..+..++.||+.||.|||+++++||||||.|||++.++.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence 9999996 57777664 456799999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccCCCCCCchhhhcc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCcchhhhHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEHFSRLMKEF 243 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~-~~~l~~~is~~L~dL 243 (703)
.....|++.|+|||++.. ...++.++|||||||++|+|++|..||...+.......+.... +......++..+.+|
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 234578999999999853 2347889999999999999999999998766544444433333 223345688899999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
|.+||.++|.+||++.+++.|||+....
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCccccccC
Confidence 9999999999999999999999997754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=341.63 Aligned_cols=259 Identities=28% Similarity=0.494 Sum_probs=226.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV 89 (703)
..|.++++||+|+|++|.++..+.|.+.||||++++.- .+..+.-++.|..+..+- +||++|-++.+|+++..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 48999999999999999999999999999999987653 333455667788888776 799999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
.||++||+|--++++..+||++.++.|...|+.||.|||++|||+||||.+||||+..|++||.|+|+|+.--.+.....
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~ts 409 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTS 409 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987766777778
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCC-------CCCccceeeccCCCCCCCcchhhhHHHHH
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLA-------DLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~-------~~~~~~~l~~I~~~~~~~l~~~is~~L~d 242 (703)
++||||.|.|||++.+. .|+..+|+|+|||+|+||+.|+.||. +.+..+.+.++.......++..++-.+..
T Consensus 410 tfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~ 488 (593)
T KOG0695|consen 410 TFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASH 488 (593)
T ss_pred cccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHH
Confidence 99999999999999886 59999999999999999999999995 33444455555444444566667777778
Q ss_pred HHHHHhccCCCCCC------CHHHHHhchhhhcccc
Q 005298 243 FVSLCLKKVPAERP------SAKELLRHRFIRNARK 272 (703)
Q Consensus 243 LI~~cL~~dP~~RP------Ta~eLL~Hpff~~~~~ 272 (703)
+++..|.+||.+|. ...++..|+||+.+.+
T Consensus 489 vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 489 VLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred HHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 88888999999996 4789999999996643
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=343.14 Aligned_cols=252 Identities=27% Similarity=0.493 Sum_probs=214.4
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEEEEeccCCCC
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYMAGGS 97 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyLV~Eyv~gGs 97 (703)
++||+|+|+.|-.|+...+|..||||++.++. -....++.+|++++.++. |+||++|+++|+++..+|||||.|.||.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 68999999999999999999999999998874 344678899999999995 9999999999999999999999999999
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC---CeeEeccccchhhhhc-------ccc
Q 005298 98 VADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVADFGVSAQLTRT-------ISR 167 (703)
Q Consensus 98 L~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g---~VKL~DFGlA~~~~~~-------~~~ 167 (703)
|..+|+++.-|+|.++..+.+.|+.||+|||.+||.||||||+|||....+ -||||||.|...+... ...
T Consensus 163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~ 242 (463)
T KOG0607|consen 163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE 242 (463)
T ss_pred HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc
Confidence 999999999999999999999999999999999999999999999997665 4899999987544211 112
Q ss_pred cccccCCCCCCchhhhc----cccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------------ceeeccCCCC
Q 005298 168 RKTFVGTPFWMAPEVIQ----NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---------------RVLFIIPREN 228 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~----~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~---------------~~l~~I~~~~ 228 (703)
..+.+|+..|||||+.. ....|+.+.|.||||||||-||+|.+||.+.-.. .+...|..+.
T Consensus 243 L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk 322 (463)
T KOG0607|consen 243 LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 322 (463)
T ss_pred ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC
Confidence 33568999999999864 2245899999999999999999999999754221 1223344332
Q ss_pred ---CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 229 ---PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 229 ---~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
|..-..+++.+.+++|..+|.+++..|.++.+++.|||++...
T Consensus 323 YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 323 YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 3333457899999999999999999999999999999998763
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=332.81 Aligned_cols=251 Identities=27% Similarity=0.476 Sum_probs=206.9
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEEEEecc
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
|++.+.||.|+||+||+|++..+++.|+||.+.............+|+..++++. ||||+++++++..++..|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999999999999999865433222334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 94 AGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 94 ~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
+++|.+++.... .+++..+..++.||+.+|.|||++|++|+||+|.||+++.++.++|+|||++...... ......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-~~~~~~ 158 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-PPYTDY 158 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-CCcCCC
Confidence 789999887654 7899999999999999999999999999999999999999999999999998755332 222345
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-------------------------
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------------- 226 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~------------------------- 226 (703)
.|+..|+|||++.....++.++||||||+++|+|++|.+||......+....+..
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 7899999999986655688999999999999999999999976544322211100
Q ss_pred -CCCCCc---chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 227 -ENPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 227 -~~~~~l---~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
..+..+ ....+..+.+||.+||..+|.+|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000000 11225779999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=346.69 Aligned_cols=256 Identities=24% Similarity=0.445 Sum_probs=213.2
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE---
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK--- 85 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~--- 85 (703)
....+|++.+.||.|+||.||+|.+..++..||||++.... .......+.+|+.+++++.||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45679999999999999999999999999999999986543 22334667789999999999999999998876654
Q ss_pred ---EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 86 ---LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 86 ---lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
.|+|+||+ +++|.+++.. .++++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999999 6799999876 579999999999999999999999999999999999999999999999999987653
Q ss_pred hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC---------------
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--------------- 227 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~--------------- 227 (703)
.. .....+++.|+|||.+.+...++.++|||||||++|+|++|..||...+....+..+...
T Consensus 170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred cc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 32 334678999999999876445788999999999999999999999766543322221110
Q ss_pred ------------CCCC---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 228 ------------NPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 228 ------------~~~~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.... ....++..+.+||.+||..+|.+|||+.+|+.||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 0000 112357889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=334.28 Aligned_cols=258 Identities=35% Similarity=0.616 Sum_probs=209.9
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
..+|++.+.||.|+||.||+|.+..+++.||||.+...........+..|+.++.++ .||||+++++++.+...+|+||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 358999999999999999999999999999999997655444455666777766666 4999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||+. ++|..++.. ...+++..+..++.||+.||.|||+ +||+||||+|+||+++.++.+||+|||++..+..... .
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-~ 171 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-K 171 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc-c
Confidence 9994 577777755 4579999999999999999999997 6999999999999999999999999999876543222 2
Q ss_pred ccccCCCCCCchhhhccc---cCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCCCcc--hhhhHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNS---EGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLD--EHFSRLMKE 242 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~---~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-~~~l~~I~~~~~~~l~--~~is~~L~d 242 (703)
....+++.|+|||++.+. ..++.++||||||+++|+|++|+.||..... .+.+..+.....+..+ ..++..+.+
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCS 251 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Confidence 234678899999998654 2377899999999999999999999975332 2222222222222222 246788999
Q ss_pred HHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 243 FVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
||.+||..+|.+||++.+++.||||...+
T Consensus 252 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 252 FVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 99999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=332.50 Aligned_cols=251 Identities=21% Similarity=0.404 Sum_probs=204.0
Q ss_pred CCceEEEEEeecCceEEEEEEE----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFD----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d----~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~l 86 (703)
..|++++.||+|+||.||+|.. ..++..||+|.+...........+.+|+.+++++.||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3579999999999999999974 4578899999987665555567899999999999999999999998875 578
Q ss_pred EEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
|+||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999999664 468999999999999999999999999999999999999999999999999987654322
Q ss_pred c---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------------ceeeccCCC
Q 005298 166 S---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---------------RVLFIIPRE 227 (703)
Q Consensus 166 ~---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~---------------~~l~~I~~~ 227 (703)
. ......|+..|+|||++.+. .++.++|||||||++|+|+++..|+...... .....+...
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 1 11235677789999998765 4889999999999999999987765321100 000011111
Q ss_pred CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 228 ~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.....+..++..+.+||.+||..+|.+||++.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2223345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=333.69 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=204.5
Q ss_pred CCCceEEEEEeecCceEEEEEEEcC----------------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeee
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKE----------------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~----------------tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~ 75 (703)
..+|++.+.||+|+||.||++.+.. ++..||||++...........+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4689999999999999999986543 345799999876555555678899999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCCHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe
Q 005298 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-----------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (703)
Q Consensus 76 L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~-----------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL 144 (703)
+++++...+..|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999999997532 36678899999999999999999999999999999999
Q ss_pred cCCCCeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh--CCCCCCCCCccce
Q 005298 145 TENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPLADLHPMRV 220 (703)
Q Consensus 145 d~~g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt--G~~PF~~~~~~~~ 220 (703)
+.++.++|+|||++..+..... ......+++.|++||++... .++.++|||||||++|||++ |..||......+.
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 9999999999999875532211 11223456789999988765 58999999999999999998 7889976654433
Q ss_pred eeccC-------CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 221 LFIIP-------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 221 l~~I~-------~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
..... .......+..++..+.+||.+||..+|.+||++.+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 22110 11111223456788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=362.91 Aligned_cols=285 Identities=26% Similarity=0.485 Sum_probs=248.6
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
-.+++++..||-|+||.|=++........+|+|++++.. ...+.+++..|..||..++.|+||++|..|.+...+|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 357888999999999999999887766679999987665 344567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
||-|-||.|+..++.++.|++..+++|+..+++|++|||++|||+|||||+|++++.+|-+||.|||+|+.+... .+.-
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-~KTw 577 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-RKTW 577 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-Ccee
Confidence 999999999999999999999999999999999999999999999999999999999999999999999988654 4456
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCcchhhhHHHHHHHHHHh
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~-~~~l~~~is~~L~dLI~~cL 248 (703)
++||||.|+|||++++. +.+..+|.|+||+++||||+|.+||.+.+++..+..|.++. ...+|..+++.+.+||+++.
T Consensus 578 TFcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LC 656 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLC 656 (732)
T ss_pred eecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHH
Confidence 89999999999999985 68999999999999999999999999999999999988764 34567889999999999999
Q ss_pred ccCCCCCCC-----HHHHHhchhhhccccChhHHHHhhcCCCCCCCCCCCCCCCcc
Q 005298 249 KKVPAERPS-----AKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGV 299 (703)
Q Consensus 249 ~~dP~~RPT-----a~eLL~Hpff~~~~~~~~l~e~i~~~~~~~~~~~~~~~~~~~ 299 (703)
.-+|.+|.. +.+|-+|.||....+ ..+..+...+|..+....|.+..+++
T Consensus 657 r~~P~ERLG~~~~gI~DIkkH~Wf~gfdw-eglr~~~L~pPi~~~va~ptD~s~Fd 711 (732)
T KOG0614|consen 657 RDNPTERLGYQKGGINDIKKHRWFEGFDW-EGLRSRTLPPPIIPSVANPTDVSNFD 711 (732)
T ss_pred hcCcHhhhccccCChHHHHhhhhhhcCCh-hhhhhccCCCCccccCCCcccchhcc
Confidence 999999985 899999999987643 33444444555555555555544443
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=395.94 Aligned_cols=259 Identities=37% Similarity=0.671 Sum_probs=230.1
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.-++.---.||.|.||.||.|++..+|...|||-++.+.. ......+.+|+.+|..|+|||||++|++-...+..||+|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3366666789999999999999999999999998876653 334577899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc----c
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----S 166 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~----~ 166 (703)
|||+||+|.++++.++..+|...+.|..|++.||.|||++|||||||||+|||++.+|.+|++|||.|..+.... +
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 999999999999998889999999999999999999999999999999999999999999999999987665432 2
Q ss_pred ccccccCCCCCCchhhhcccc--CCccccchhhHHHHHHHHHhCCCCCCCCC-ccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSE--GYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~--~~s~ksDVWSLGvILyELLtG~~PF~~~~-~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
..+...|||.|||||++.+.. +...++||||||||+.||+||+.||...+ ....++.+-.+-.|++|..++.+-++|
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dF 1473 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDF 1473 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHH
Confidence 234578999999999998653 46678999999999999999999998764 556677777777889999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
|..||..||++|.++.||++|.|-+..
T Consensus 1474 le~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1474 LEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHhcCchhhhHHHHHHHhhccccc
Confidence 999999999999999999999877654
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=368.45 Aligned_cols=252 Identities=26% Similarity=0.430 Sum_probs=208.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEE-EEEe---C--
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYG-SYLH---Q-- 83 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~-~~~~---~-- 83 (703)
...+++|.++|.+|||+.||+|.+...|..||+|.+-.. .+..++.+.+||.+|++|. |+|||.|++ .... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 345899999999999999999999998899999998655 6777899999999999997 999999999 3322 1
Q ss_pred -CEEEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeeeeccceEEecCCCCeeEeccccc
Q 005298 84 -TKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 84 -~~lyLV~Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~g--IVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
-.++|.||||.||.|-++|.. ...|++.++++||.|+++||.+||... |||||||-|||||+.+|+.||||||.+
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 247899999999999999974 356999999999999999999999997 999999999999999999999999988
Q ss_pred hhhhhccccc---------ccccCCCCCCchhhhccc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC
Q 005298 159 AQLTRTISRR---------KTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE 227 (703)
Q Consensus 159 ~~~~~~~~~~---------~~~iGTp~Y~APEvl~~~--~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~ 227 (703)
+-........ .....|+.|++||++.-. ...+.|+|||+|||+||-||....||.+......+.. .
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng---~ 270 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNG---N 270 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEec---c
Confidence 6443222111 123579999999997532 3478999999999999999999999987644333221 1
Q ss_pred CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchh
Q 005298 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266 (703)
Q Consensus 228 ~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpf 266 (703)
+..+....++..+++||+.||+.+|.+||++-|++.+-|
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 111222578999999999999999999999999998643
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=326.10 Aligned_cols=245 Identities=25% Similarity=0.419 Sum_probs=200.6
Q ss_pred EEEeecCceEEEEEEEcC---CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEE-eCCEEEEEEeccC
Q 005298 19 ELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL-HQTKLWIIMEYMA 94 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~---tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~-~~~~lyLV~Eyv~ 94 (703)
+.||+|+||.||+|.+.. .+..||||.+...........+.+|+.+++.++||||+++++++. .++..|+||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998754 346799999865444455678889999999999999999999775 4566899999999
Q ss_pred CCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc----cccc
Q 005298 95 GGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI----SRRK 169 (703)
Q Consensus 95 gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~----~~~~ 169 (703)
+++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+.... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 160 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence 99999999763 456788889999999999999999999999999999999999999999999986543211 1111
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
...+++.|+|||++... .++.++|||||||++|||++ |.+||...+.......+....++..+..++..+.+++..||
T Consensus 161 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 239 (262)
T cd05058 161 GAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCW 239 (262)
T ss_pred cCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHc
Confidence 23467789999998765 58899999999999999999 56777766655544444444444555667889999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q 005298 249 KKVPAERPSAKELLRH 264 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~H 264 (703)
..+|++||++.+|+..
T Consensus 240 ~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 240 HPKPEMRPTFSELVSR 255 (262)
T ss_pred CCChhhCCCHHHHHHH
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=345.27 Aligned_cols=257 Identities=27% Similarity=0.466 Sum_probs=208.9
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ----- 83 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~----- 83 (703)
....+|.+.+.||.|+||.||+|++..+|+.||||++.... .......+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 34579999999999999999999999999999999986533 222345678999999999999999999998754
Q ss_pred -CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 84 -TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 84 -~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
..+|+|+||+. .+|..++ ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 92 FQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 35699999995 5787765 3468999999999999999999999999999999999999999999999999986542
Q ss_pred hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC---------------
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--------------- 227 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~--------------- 227 (703)
. ......|++.|+|||++.+...++.++|||||||+||+|++|+.||...+....+..+...
T Consensus 169 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 169 A---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred C---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 2 2234578999999999876445888999999999999999999999875532222111100
Q ss_pred --------CC----CC---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 228 --------NP----PQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 228 --------~~----~~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
.+ .. ....++..+.+||.+||..+|.+||++.+++.||||...+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 00 01235677899999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.14 Aligned_cols=250 Identities=29% Similarity=0.438 Sum_probs=203.9
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhC---CCCCeeeeEEEEEeCCE-----
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQC---RSPYITEYYGSYLHQTK----- 85 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-~~~~~l~~Ei~ILk~L---~HPnIV~L~~~~~~~~~----- 85 (703)
|++.+.||.|+||.||+|.+..++..||||++...... .....+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78999999999999999999989999999998754322 2234566788777666 69999999999998776
Q ss_pred EEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 86 LWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
+|++|||+. ++|.+++.... .+++..++.++.||+.||.|||+++++|+||+|+|||++.++.+||+|||++.....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 999999996 58998887643 589999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-----------------
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------------- 226 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~----------------- 226 (703)
.. ......+++.|+|||++.+. .++.++|||||||++|+|++|.+||......+.+..+..
T Consensus 160 ~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 160 EM-ALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred Cc-ccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 22 22334688999999999775 488999999999999999999999987654332221110
Q ss_pred ------CCC---CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 227 ------ENP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 227 ------~~~---~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
... ......++..+.+||.+||..+|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000 01112456778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.59 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=210.8
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~t---g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
..+|.+.+.||.|+||.||+|.+... ...|+||.+.........+.+.+|+.+++++.||||+++++++.+ ...|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 45799999999999999999987654 457999998755545566788999999999999999999998875 55789
Q ss_pred EEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 89 IMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||||+++++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+|||++..+.+||+|||++.........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence 999999999999997643 6899999999999999999999999999999999999999999999999998655332111
Q ss_pred -cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHH
Q 005298 168 -RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 168 -~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
.....+++.|+|||.+... .++.++|||||||++|+|++ |..||...........+........+..++..+.+||.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (270)
T cd05056 164 KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 242 (270)
T ss_pred ecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 1122345689999998654 58899999999999999986 99999877665555555555555566778899999999
Q ss_pred HHhccCCCCCCCHHHHHhc
Q 005298 246 LCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~H 264 (703)
+||..+|.+|||+.+++..
T Consensus 243 ~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 243 KCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.53 Aligned_cols=256 Identities=23% Similarity=0.407 Sum_probs=207.6
Q ss_pred CceEEEEEeecCceEEEEEEEcCC--CcEEEEEEeccCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC----CE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKEL--NKDVAIKVIDLEE-SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ----TK 85 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~t--g~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~----~~ 85 (703)
+|++.+.||.|+||.||++.+..+ +..||||++.... .....+.+.+|+.+++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999988 9999999986432 222345677899999999 599999999975432 45
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
+|+++||+. ++|..++.....+++..++.++.||+.||.|||.+||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 789999995 7999999888899999999999999999999999999999999999999999999999999987553221
Q ss_pred c----ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC----------------
Q 005298 166 S----RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---------------- 225 (703)
Q Consensus 166 ~----~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~---------------- 225 (703)
. .....+|++.|+|||++.+...++.++|||||||++|+|++|.+||...+.......+.
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 12335799999999998765568899999999999999999999997654321111000
Q ss_pred -----------CCCCC---CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 226 -----------RENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 226 -----------~~~~~---~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..... .....++..+.+||.+||..+|.+|||+.+++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 00001 1112346789999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=376.48 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=206.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 58999999999999999999999999999999986543 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccch
Q 005298 91 EYMAGGSVADLIQSG-----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~-----------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
||++|++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998641 235567788999999999999999999999999999999999999999999987
Q ss_pred hhhhc------------------ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee
Q 005298 160 QLTRT------------------ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (703)
Q Consensus 160 ~~~~~------------------~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l 221 (703)
..... .......+||+.|||||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 55211 0111235799999999999775 4899999999999999999999999775443332
Q ss_pred eccCCCCCCCc--chhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 222 FIIPRENPPQL--DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 222 ~~I~~~~~~~l--~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.......+... ...+++.+.+++.+||.++|.+||+..+.+.+
T Consensus 241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22111112111 23678889999999999999999877666554
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=356.68 Aligned_cols=263 Identities=27% Similarity=0.461 Sum_probs=225.5
Q ss_pred CceEE--EEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 14 RFSSL--ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 14 ~Y~il--~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
-|+|. ++||.|-||+||-|+++.+|+.||||+|++.. ......+++.|+.||.++.||.||.+...|++.+.+++||
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 35554 79999999999999999999999999997665 3344578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC---CCeeEeccccchhhhhcc
Q 005298 91 EYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 91 Eyv~gGsL~~~l--~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~---g~VKL~DFGlA~~~~~~~ 165 (703)
|.+. |++.+.| ...++|++....+++.||+.||.|||-++|||+||||+|||+... .++||||||+|+.+...
T Consensus 643 EKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk- 720 (888)
T KOG4236|consen 643 EKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK- 720 (888)
T ss_pred hhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence 9995 5555555 346899999999999999999999999999999999999999754 57999999999887643
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCCCcchhhhHHHHHHH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-~~~l~~I~~~~~~~l~~~is~~L~dLI 244 (703)
......+|||.|+|||++.+. +|+..-||||+|||+|--|.|..||.+..+ .+.+.......|+....+++..+.+||
T Consensus 721 sFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlI 799 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLI 799 (888)
T ss_pred hhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHH
Confidence 455678999999999999875 699999999999999999999999976432 233333334456677789999999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhccccChhHHHH
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRNARKSPRLLER 279 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~e~ 279 (703)
..+|+..-.+|.+.++.|.|||+++...+..+.+.
T Consensus 800 n~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRel 834 (888)
T KOG4236|consen 800 NNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLREL 834 (888)
T ss_pred HHHHHHHHHHhcchHhhccchhhhcchHHHHHHHH
Confidence 99999999999999999999999988766655543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=334.73 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=204.7
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCC--------------cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELN--------------KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg--------------~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~ 77 (703)
..+|++.+.||+|+||.||+|.+..++ ..||||++...........+.+|+.++++++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 458999999999999999999876432 359999987655555667899999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHcCC------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec
Q 005298 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGP------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT 145 (703)
Q Consensus 78 ~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd 145 (703)
+++...+..|+||||+.+++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+|||++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 99999999999999999999999986431 468889999999999999999999999999999999999
Q ss_pred CCCCeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh--CCCCCCCCCcccee
Q 005298 146 ENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK--GEPPLADLHPMRVL 221 (703)
Q Consensus 146 ~~g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt--G~~PF~~~~~~~~l 221 (703)
.++.+||+|||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+.....
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~ 242 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence 999999999999865432211 11223457789999998765 48999999999999999988 67888766543332
Q ss_pred eccC-------CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 222 FIIP-------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 222 ~~I~-------~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
..+. .......+..++..+.+||.+||..+|.+||++.+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 243 ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2211 11112233456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=344.52 Aligned_cols=252 Identities=25% Similarity=0.419 Sum_probs=204.2
Q ss_pred CCCceEEEEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEe-CC
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH-QT 84 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d-----~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~-~~ 84 (703)
..+|++.+.||+|+||.||+|++ ..+++.||||+++..........+.+|+.++.++ +||||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45899999999999999999985 3467899999997655555567788999999999 68999999998865 45
Q ss_pred EEEEEEeccCCCCHHHHHHcC-----------------------------------------------------------
Q 005298 85 KLWIIMEYMAGGSVADLIQSG----------------------------------------------------------- 105 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~----------------------------------------------------------- 105 (703)
.+|+|||||++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 689999999999999998642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc--ccccccCCC
Q 005298 106 --------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTP 175 (703)
Q Consensus 106 --------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~~~~iGTp 175 (703)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......+++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 2367788899999999999999999999999999999999999999999999875432211 111234567
Q ss_pred CCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccc-eeeccCCCCCCCcchhhhHHHHHHHHHHhccCCC
Q 005298 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMR-VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPA 253 (703)
Q Consensus 176 ~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~-~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~ 253 (703)
.|+|||++.+. .++.++|||||||++|+|++ |..||....... ....+........+..+++.+.+++..||..+|.
T Consensus 246 ~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~ 324 (343)
T cd05103 246 KWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPS 324 (343)
T ss_pred ceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 89999998764 58899999999999999996 999997654322 2222222223333445678899999999999999
Q ss_pred CCCCHHHHHhc
Q 005298 254 ERPSAKELLRH 264 (703)
Q Consensus 254 ~RPTa~eLL~H 264 (703)
+||++.+|++|
T Consensus 325 ~Rps~~eil~~ 335 (343)
T cd05103 325 QRPTFSELVEH 335 (343)
T ss_pred hCcCHHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=357.73 Aligned_cols=258 Identities=25% Similarity=0.484 Sum_probs=207.2
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEE-eccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCC
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKV-IDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQT 84 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKv-i~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~ 84 (703)
+...-+..|++++.||.||.+.||+++.-+. +.||+|. .........+.-+..|+.+|.+|+ |.+||+||++-..++
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 3345567999999999999999999988764 4455554 444456667889999999999995 899999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~-L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
.+|+||||- ..+|..+|+.+.. ++.-.++.|..||+.|+.++|.+||||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 999999998 5799999987654 34358899999999999999999999999999999984 57999999999987654
Q ss_pred cccc--cccccCCCCCCchhhhccccC----------CccccchhhHHHHHHHHHhCCCCCCCCC-ccceeeccCCC---
Q 005298 164 TISR--RKTFVGTPFWMAPEVIQNSEG----------YNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRE--- 227 (703)
Q Consensus 164 ~~~~--~~~~iGTp~Y~APEvl~~~~~----------~s~ksDVWSLGvILyELLtG~~PF~~~~-~~~~l~~I~~~--- 227 (703)
..+. ..+.+||+.||+||.+..... .+.++||||||||||+|+.|++||.... ....+..|...
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 3222 234699999999999864321 4578999999999999999999997653 22333333221
Q ss_pred -CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 228 -NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 228 -~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
..+.++.. .++.++++.||.+||.+||++.+||+|||++.
T Consensus 592 Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 592 IEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 11222222 22999999999999999999999999999986
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.29 Aligned_cols=243 Identities=26% Similarity=0.419 Sum_probs=204.0
Q ss_pred EEEeecCceEEEEEEEcC-CC--cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDKE-LN--KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~-tg--~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
+.||.|+||.||+|.+.. .+ ..||||.+.........+.+.+|+.++++++||||+++++.+.. ..+++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 33 36999998766554566789999999999999999999999988 899999999999
Q ss_pred CCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc---ccc
Q 005298 96 GSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR---RKT 170 (703)
Q Consensus 96 GsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~---~~~ 170 (703)
++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+...... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 99999997654 6899999999999999999999999999999999999999999999999998766432211 112
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCC-CCCCCcchhhhHHHHHHHHHHh
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPR-ENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~-~~~~~l~~~is~~L~dLI~~cL 248 (703)
..++..|+|||++... .++.++|||||||++|+|++ |..||...+..+....+.. ......+..++..+.+++.+||
T Consensus 160 ~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd05040 160 LKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCW 238 (257)
T ss_pred CCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHC
Confidence 4577889999998764 48899999999999999998 9999987665554443332 1222334567889999999999
Q ss_pred ccCCCCCCCHHHHHh
Q 005298 249 KKVPAERPSAKELLR 263 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~ 263 (703)
..+|++||++.+++.
T Consensus 239 ~~~p~~Rps~~~~~~ 253 (257)
T cd05040 239 AHNPADRPTFAALRE 253 (257)
T ss_pred CCCcccCCCHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=327.41 Aligned_cols=244 Identities=27% Similarity=0.497 Sum_probs=204.3
Q ss_pred EEEeecCceEEEEEEEcCCC------cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 19 ELIGRGSFGDVYKAFDKELN------KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg------~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+.||.|+||.||+|.+.... ..||||.+...........+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36999999999999986544 789999886554444566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC-----CeeEeccccchh
Q 005298 93 MAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-----DVKVADFGVSAQ 160 (703)
Q Consensus 93 v~gGsL~~~l~~~-------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g-----~VKL~DFGlA~~ 160 (703)
+++++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+|||++.++ .++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999999642 3478899999999999999999999999999999999999877 899999999865
Q ss_pred hhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhh
Q 005298 161 LTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFS 237 (703)
Q Consensus 161 ~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is 237 (703)
+.... .......++..|+|||++.+. .++.++|||||||++|+|++ |..||...+.......+........+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCP 239 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccch
Confidence 43221 111233567889999999765 48999999999999999998 999998776655555544444445556788
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 238 RLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
..+.+||.+||.++|.+||++.++++
T Consensus 240 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 240 DKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999999976
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=358.38 Aligned_cols=251 Identities=29% Similarity=0.497 Sum_probs=216.2
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
++..+.+.+...||.|.||+||+|.+.. .||||+++... .+...+.|+.|+.++++-+|.||+-+.|+|..... .
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 4455677889999999999999998864 59999998776 55678999999999999999999999999988877 9
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-
Q 005298 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~- 165 (703)
||+.||+|.+|+.++.- ...|.....+.|++||++|+.|||.++|||||||..||||.+++.|||+||||+.......
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999999999999964 3579999999999999999999999999999999999999999999999999987554332
Q ss_pred -cccccccCCCCCCchhhhccc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC----CCCcchhhhH
Q 005298 166 -SRRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSR 238 (703)
Q Consensus 166 -~~~~~~iGTp~Y~APEvl~~~--~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~----~~~l~~~is~ 238 (703)
......-|...|||||++... ..|+..+||||||||+|||++|.+||...+....+..+-++. .......++.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHH
Confidence 222345688899999998643 348899999999999999999999999777777777776663 1223346778
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 239 LMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 239 ~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.+++|+..||..++++||.+.+||.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999999999986
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=321.53 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=208.2
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++.+.||.|+||.||++.+.. +..+|||.+...... ...+.+|+.++++++||||+++++++......|+|||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 3589999999999999999998864 778999988644322 3467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc-cc
Q 005298 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~-~~ 169 (703)
|+.+++|.+++... ..+++..+..++.|++.+|.|||+++++|+||||+||+++.++.+||+|||++......... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999999753 56899999999999999999999999999999999999999999999999988654322111 11
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
...++..|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+...+..+.+|+.+||
T Consensus 160 ~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l 238 (256)
T cd05112 160 GTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCW 238 (256)
T ss_pred CCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHc
Confidence 23456789999998764 58889999999999999998 99999877655555555443333334456888999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q 005298 249 KKVPAERPSAKELLRH 264 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~H 264 (703)
..+|.+||++.+++++
T Consensus 239 ~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 239 KERPEDRPSFSLLLHQ 254 (256)
T ss_pred ccChhhCCCHHHHHHh
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=370.94 Aligned_cols=147 Identities=33% Similarity=0.603 Sum_probs=137.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||+||+|.+..+++.||||++.... .......+..|+.+++.++||||+++++++.....+||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 58999999999999999999999999999999986543 3344577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccch
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
||+.|++|.+++...+.+++..++.|+.||+.||.|||.++||||||||+||||+.++.+||+|||++.
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999888889999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.96 Aligned_cols=257 Identities=29% Similarity=0.497 Sum_probs=211.6
Q ss_pred CceEEEEEeecCceEEEEEEEc---CCCcEEEEEEeccCCC---hHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEES---EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~---~tg~~VAIKvi~~~~~---~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~l 86 (703)
+|++.+.||+|+||.||++.+. .+++.||||++..... ......+..|+.++.++ +||||+++++++..+..+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 4678999999864321 22345678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
|+||||+.+++|.+++.....+++..+..++.|++.+|.|||+.+++|+||||.||+++.++.++|+|||++..+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998778899999999999999999999999999999999999999999999999999865543221
Q ss_pred -ccccccCCCCCCchhhhcccc-CCccccchhhHHHHHHHHHhCCCCCCCCCccc----eeeccCCCCCCCcchhhhHHH
Q 005298 167 -RRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHPMR----VLFIIPRENPPQLDEHFSRLM 240 (703)
Q Consensus 167 -~~~~~iGTp~Y~APEvl~~~~-~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~----~l~~I~~~~~~~l~~~is~~L 240 (703)
......|++.|++||.+.+.. .++.++||||||+++|+|++|..||....... ....+.. ..+..+..++..+
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 239 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPKTMSAEA 239 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-cCCCCCcccCHHH
Confidence 122356899999999986542 36789999999999999999999996433211 1111111 1224455678899
Q ss_pred HHHHHHHhccCCCCCCC---HHHHHhchhhhccc
Q 005298 241 KEFVSLCLKKVPAERPS---AKELLRHRFIRNAR 271 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPT---a~eLL~Hpff~~~~ 271 (703)
.+||.+||..+|.+||| +.++|+||||+...
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 99999999999999998 56789999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.59 Aligned_cols=244 Identities=24% Similarity=0.415 Sum_probs=195.4
Q ss_pred EEEeecCceEEEEEEEcC--CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCC
Q 005298 19 ELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~--tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gG 96 (703)
+.||+|+||.||+|.... ....|++|.+...........+.+|+.+++.++||||+++++.+.....+|+||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999996543 456789998765555555667889999999999999999999999999999999999999
Q ss_pred CHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc--cccc
Q 005298 97 SVADLIQSGP-----PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRRK 169 (703)
Q Consensus 97 sL~~~l~~~~-----~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~~ 169 (703)
+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 9999997643 24678889999999999999999999999999999999999999999999975432211 1112
Q ss_pred cccCCCCCCchhhhcc------ccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCC-----CCCCcchhhh
Q 005298 170 TFVGTPFWMAPEVIQN------SEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE-----NPPQLDEHFS 237 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~------~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~-----~~~~l~~~is 237 (703)
...+++.|+|||++.. ...++.++|||||||++|+|++ |..||....+...+..+... ..+.+...++
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 3356778999999753 2246789999999999999998 88899876654433332221 1233445678
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 238 RLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
..+.+++..|+ .+|.+|||+++|++
T Consensus 241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 241 DRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHHHh-cCcccccCHHHHHH
Confidence 88999999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=362.09 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=194.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCC-CcEEEEEEe--------------cc--CCChHHHHHHHHHHHHHHhCCCCCe
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKEL-NKDVAIKVI--------------DL--EESEDEIEDIQKEISVLSQCRSPYI 73 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~t-g~~VAIKvi--------------~~--~~~~~~~~~l~~Ei~ILk~L~HPnI 73 (703)
...+|++++.||+|+||+||+|..+.. +..+++|.+ .+ .........+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 346899999999999999999876542 222222211 00 1122334568899999999999999
Q ss_pred eeeEEEEEeCCEEEEEEeccCCCCHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC
Q 005298 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSG-----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG 148 (703)
Q Consensus 74 V~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~-----~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g 148 (703)
|++++++...+..|+|+|++ +++|..++... .......++.|+.||+.||.|||++|||||||||+||||+.++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999999999999999999 46777776432 2344667889999999999999999999999999999999999
Q ss_pred CeeEeccccchhhhhccc-ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCC-CCCc--cceeecc
Q 005298 149 DVKVADFGVSAQLTRTIS-RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLA-DLHP--MRVLFII 224 (703)
Q Consensus 149 ~VKL~DFGlA~~~~~~~~-~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~-~~~~--~~~l~~I 224 (703)
.+||+|||++..+..... .....+||+.|+|||++.+. .++.++||||||||||||++|..++. .... ...+..+
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999876643322 22346899999999999775 58999999999999999999876543 2211 1111000
Q ss_pred C------CC-CC-------------------CCc-----chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 225 P------RE-NP-------------------PQL-----DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 225 ~------~~-~~-------------------~~l-----~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
. .. .+ ..+ ...++..+.++|.+||..||.+|||+.|+|.||||....
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 0 00 00 000 012455678889999999999999999999999997653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=345.68 Aligned_cols=251 Identities=29% Similarity=0.488 Sum_probs=201.1
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-EEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-KLWI 88 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~-~lyL 88 (703)
.++.+|.-..+||+|+||.||+|.... |..||||.+....... ...|..|+.++.+++|||||+|+|||.+.+ ..+|
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 456799999999999999999998876 4999999876554432 455999999999999999999999999998 5999
Q ss_pred EEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcC---ceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 89 IMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEG---KIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~g---IVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
|+||+.+|+|.+++.... +++|....+|+.++++||+|||... ||||||||+|||||.+.++||+|||+|.....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 999999999999997654 8999999999999999999999853 99999999999999999999999999954432
Q ss_pred cccccccc-cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccce---ee---------ccCCCCCC
Q 005298 164 TISRRKTF-VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV---LF---------IIPRENPP 230 (703)
Q Consensus 164 ~~~~~~~~-iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~---l~---------~I~~~~~~ 230 (703)
......+. .||.+|++||++... ..+.++|||||||+|.||++|+.+.....+... .. .+.....+
T Consensus 230 ~~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~ 308 (361)
T KOG1187|consen 230 GDTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDP 308 (361)
T ss_pred cccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCC
Confidence 12222222 899999999999764 589999999999999999999988864321111 00 01111111
Q ss_pred Ccc-hhh-----hHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 231 QLD-EHF-----SRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 231 ~l~-~~i-----s~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.+. ..+ -..+..+..+|+..+|..||++.|+++
T Consensus 309 ~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 309 RLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 221 122 223667788899999999999999865
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.97 Aligned_cols=251 Identities=20% Similarity=0.356 Sum_probs=207.3
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCc----EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~----~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
..+|++++.||.|+||.||+|.+..++. .||+|++...........+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 4689999999999999999999887776 57899886555444455788999999999999999999988754 468
Q ss_pred EEEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 88 IIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
+|+||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+.....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 9999999999999987644 689999999999999999999999999999999999999999999999999876543221
Q ss_pred c--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 167 R--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 167 ~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
. .....++..|++||++.+. .++.++|||||||++|||++ |..||...........+........+..++..+.++
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMV 243 (303)
T ss_pred ccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 1 1223457789999998764 58899999999999999997 999997765444333343333334445567889999
Q ss_pred HHHHhccCCCCCCCHHHHHhc
Q 005298 244 VSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~H 264 (703)
+..||..+|++||++.++++.
T Consensus 244 i~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 244 MVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=321.61 Aligned_cols=236 Identities=24% Similarity=0.422 Sum_probs=193.8
Q ss_pred EEEeecCceEEEEEEEcCCC----------cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 19 ELIGRGSFGDVYKAFDKELN----------KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg----------~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
+.||+|+||.||+|.+..++ ..|++|++...... ...+.+|+.++++++||||+++++++.. ...|+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46999999999999998776 35788876544322 5778899999999999999999999888 77899
Q ss_pred EEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC-------CeeEeccccchh
Q 005298 89 IMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-------DVKVADFGVSAQ 160 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g-------~VKL~DFGlA~~ 160 (703)
||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 999999999999998766 799999999999999999999999999999999999999887 799999999876
Q ss_pred hhhcccccccccCCCCCCchhhhccc-cCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhH
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSR 238 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~ 238 (703)
... .....++..|+|||++... ..++.++|||||||++|+|++ |..||................ ..+.....
T Consensus 158 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~ 231 (259)
T cd05037 158 VLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH--RLPMPDCA 231 (259)
T ss_pred ccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC--CCCCCCch
Confidence 533 2235678889999998765 358889999999999999999 688887664332222221111 11112237
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 239 LMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 239 ~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.+.+||.+||..+|.+|||+.++++
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 8899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=321.21 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=208.5
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
....+|++.+.||+|+||.||++.+.. +..||+|.+... ......+.+|+.++++++|+||+++++++.. ...|+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 356799999999999999999998654 567999987643 2335678899999999999999999999887 778999
Q ss_pred EeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-
Q 005298 90 MEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 166 (703)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999999999975 34678889999999999999999999999999999999999999999999998865532211
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
......++..|+|||++... .++.++|||||||++|+|++ |..||...+.......+...........++..+.+++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 237 (260)
T ss_pred cccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHH
Confidence 11123456779999998764 58889999999999999998 99999877665555555544444555678889999999
Q ss_pred HHhccCCCCCCCHHHHHh
Q 005298 246 LCLKKVPAERPSAKELLR 263 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~ 263 (703)
+||.++|.+||++.+++.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 238 RCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=323.32 Aligned_cols=244 Identities=24% Similarity=0.367 Sum_probs=195.7
Q ss_pred EEEeecCceEEEEEEEc--CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCC
Q 005298 19 ELIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGG 96 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~--~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gG 96 (703)
+.||+|+||.||+|... .++..+|+|.+...........+.+|+.++++++||||+++++++.+...+|+||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999864 3567899999876654445567888999999999999999999999999999999999999
Q ss_pred CHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc--ccc
Q 005298 97 SVADLIQSG-----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRK 169 (703)
Q Consensus 97 sL~~~l~~~-----~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~~ 169 (703)
+|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 999999642 2456778889999999999999999999999999999999999999999999864432211 112
Q ss_pred cccCCCCCCchhhhcccc------CCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccC-----CCCCCCcchhhh
Q 005298 170 TFVGTPFWMAPEVIQNSE------GYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIP-----RENPPQLDEHFS 237 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~------~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~-----~~~~~~l~~~is 237 (703)
...|++.|+|||++.... .++.++|||||||++|+|++ |..||......+...... ....+.+...++
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence 346788899999986421 25789999999999999996 999997765443322111 111223334567
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 238 RLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
..+.+++..|+ .+|.+|||+++|+.
T Consensus 241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 241 DRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred hHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 88999999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=336.04 Aligned_cols=255 Identities=27% Similarity=0.469 Sum_probs=209.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe-CCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~-~~~lyL 88 (703)
...+|++++.||.|+||.||+|.+..+++.||||++.... .......+..|+.++++++||||++++++|.. ....|+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 5678999999999999999999999999999999886433 22334677899999999999999999999876 567899
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|+||+ +++|..++.. .++++..+..++.||+.||.|||+++|+|+||||.|||++.++.++|+|||++..... ..
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~~ 162 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---QM 162 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---Cc
Confidence 99999 6789988865 5689999999999999999999999999999999999999999999999999865422 22
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee---------------e-----------
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---------------F----------- 222 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l---------------~----------- 222 (703)
....+++.|++||++.+...++.++|||||||++|+|++|.+||......... .
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 34578899999999876456889999999999999999999999765431110 0
Q ss_pred -ccCCCCCCCc---chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 223 -IIPRENPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 223 -~I~~~~~~~l---~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
......+.+. ...++..+.++|.+||..+|.+||++.+++.||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0000011111 12457889999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=327.28 Aligned_cols=239 Identities=25% Similarity=0.451 Sum_probs=195.8
Q ss_pred EEEeecCceEEEEEEEcCCCc-------EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 19 ELIGRGSFGDVYKAFDKELNK-------DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~-------~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
+.||.|+||.||+|.+..++. .|++|.+.... ....+.+..|+.+++.+.||||+++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 369999999999999866544 48888875432 3345678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC--------eeEeccccchhhh
Q 005298 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD--------VKVADFGVSAQLT 162 (703)
Q Consensus 92 yv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~--------VKL~DFGlA~~~~ 162 (703)
|+.+|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99999999999764 45899999999999999999999999999999999999987764 6999999875443
Q ss_pred hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCCCcchhhhHHHH
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG-~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~ 241 (703)
. .....+++.|+|||++.+...++.++|||||||++|+|++| .+||............. ....++...+..+.
T Consensus 160 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (258)
T cd05078 160 P----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE--DRHQLPAPKWTELA 233 (258)
T ss_pred C----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH--ccccCCCCCcHHHH
Confidence 2 23457899999999998755688999999999999999998 56666554433222111 12234445667899
Q ss_pred HHHHHHhccCCCCCCCHHHHHhc
Q 005298 242 EFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+||.+||..+|.+|||+++|++.
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.94 Aligned_cols=248 Identities=24% Similarity=0.442 Sum_probs=199.7
Q ss_pred CCceEEEEEeecCceEEEEEE----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe--CCEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~----d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--~~~l 86 (703)
..|++++.||+|+||.||+|. +..++..||||.+.... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 479999999999999999997 44578899999986543 4445778999999999999999999998754 3568
Q ss_pred EEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999999999753 568999999999999999999999999999999999999999999999999987653321
Q ss_pred cc---cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee-----------------ccC
Q 005298 166 SR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-----------------IIP 225 (703)
Q Consensus 166 ~~---~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~-----------------~I~ 225 (703)
.. .....++..|+|||++.+. .++.++|||||||++|||++|..|+..... .... .+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHHHHHHh
Confidence 11 1112344569999999765 488999999999999999998777643211 0000 011
Q ss_pred CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 226 ~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.......+..++..+.+||.+||..+|++|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11222334567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=348.59 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=207.7
Q ss_pred CCceEEEEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~-----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~l 86 (703)
.+|.+.+.||+|+||.||+|++. .+++.||||+++........+.+.+|+.+|.++. |||||+++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 47888899999999999999864 3457899999976655555567889999999997 99999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCC------------------------------------------------------------
Q 005298 87 WIIMEYMAGGSVADLIQSGP------------------------------------------------------------ 106 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~------------------------------------------------------------ 106 (703)
|||||||.+|+|.+++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999996431
Q ss_pred --------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC
Q 005298 107 --------------------------------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG 148 (703)
Q Consensus 107 --------------------------------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g 148 (703)
.+++..+..|+.||+.||.|||+++|+||||||+|||++.++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence 356778899999999999999999999999999999999999
Q ss_pred CeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCcccee-ecc
Q 005298 149 DVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL-FII 224 (703)
Q Consensus 149 ~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l-~~I 224 (703)
.+||+|||++..+..... ......+++.|+|||++... .++.++|||||||++|||++ |..||......+.. ..+
T Consensus 277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~ 355 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355 (401)
T ss_pred EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH
Confidence 999999999875432211 12234678899999999764 58899999999999999998 89999765543332 222
Q ss_pred CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 225 ~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.....+..+..++..+.+||.+||.++|.+||++.+|+..
T Consensus 356 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 356 KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2333334455678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=319.61 Aligned_cols=241 Identities=25% Similarity=0.441 Sum_probs=203.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++++++||||+++++++..+ ..|+||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 5799999999999999999864 68899999986432 235688999999999999999999998654 47999999
Q ss_pred cCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 93 MAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 93 v~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
+.+++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...... ...
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---~~~ 156 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDN 156 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---CCC
Confidence 99999999997643 5899999999999999999999999999999999999999999999999988653221 122
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
...+..|+|||++.+. .++.++|||||||++|+|++ |.+||...........+...........++..+.+||.+||.
T Consensus 157 ~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (254)
T cd05083 157 SKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE 235 (254)
T ss_pred CCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcC
Confidence 3456789999998764 58899999999999999997 999998776655555554444444456788999999999999
Q ss_pred cCCCCCCCHHHHHh
Q 005298 250 KVPAERPSAKELLR 263 (703)
Q Consensus 250 ~dP~~RPTa~eLL~ 263 (703)
.+|..||++++|+.
T Consensus 236 ~~p~~Rp~~~~l~~ 249 (254)
T cd05083 236 TEPKKRPSFHKLRE 249 (254)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=322.69 Aligned_cols=239 Identities=23% Similarity=0.384 Sum_probs=192.8
Q ss_pred EEEeecCceEEEEEEEcC------------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 19 ELIGRGSFGDVYKAFDKE------------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~------------tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
+.||+|+||.||+|.... ....|++|++.... ......+.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 468999999999998532 23468899875443 33445778899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC-------eeEeccccc
Q 005298 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD-------VKVADFGVS 158 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~-------VKL~DFGlA 158 (703)
++||||+++++|..++.. ...+++..+..++.||+.||.|||+++|+||||||+||||+.++. ++|+|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 999999999999999875 457999999999999999999999999999999999999987654 899999987
Q ss_pred hhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHH-hCCCCCCCCCccceeeccCCCCCCCcchhhh
Q 005298 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFS 237 (703)
Q Consensus 159 ~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELL-tG~~PF~~~~~~~~l~~I~~~~~~~l~~~is 237 (703)
..... .....|+..|+|||++.....++.++|||||||+||+|+ +|..||............. .. .......+
T Consensus 160 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~-~~~~~~~~ 233 (262)
T cd05077 160 ITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE-GQ-CMLVTPSC 233 (262)
T ss_pred ccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh-cC-ccCCCCCh
Confidence 65432 234568899999999875556899999999999999997 6888887654322211111 11 11222345
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 238 RLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
..+.+||.+||..+|.+||++.+|+++
T Consensus 234 ~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 234 KELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=320.39 Aligned_cols=249 Identities=28% Similarity=0.547 Sum_probs=207.3
Q ss_pred CceEEEEEeecCceEEEEEEEcC-CCcEEEEEEeccCC---------ChHHHHHHHHHHHHHHh-CCCCCeeeeEEEEEe
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEE---------SEDEIEDIQKEISVLSQ-CRSPYITEYYGSYLH 82 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~-tg~~VAIKvi~~~~---------~~~~~~~l~~Ei~ILk~-L~HPnIV~L~~~~~~ 82 (703)
.|++.+.||+|+||.||+|.+.. +++.||||.+.... .......+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 78899999875432 23345567788888865 799999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEecccc
Q 005298 83 QTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGV 157 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~----~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGl 157 (703)
++..|+||||+++++|.+++. ....+++..++.++.||+.+|.|||. .+++|+||||.|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999999874 34579999999999999999999996 7899999999999999999999999999
Q ss_pred chhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc-chhh
Q 005298 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-DEHF 236 (703)
Q Consensus 158 A~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l-~~~i 236 (703)
+....... ......|+..|++||.+.+. .++.++||||||+++|+|++|.+||...+.......+........ ...+
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd08528 161 AKQKQPES-KLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238 (269)
T ss_pred eeeccccc-ccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence 87654332 33456789999999999764 488999999999999999999999977655444333333222222 2357
Q ss_pred hHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 237 SRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 237 s~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+..+.+||.+||..||.+||++.++..+
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 8899999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=326.09 Aligned_cols=238 Identities=24% Similarity=0.385 Sum_probs=192.3
Q ss_pred EEeecCceEEEEEEEcC------------------------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeee
Q 005298 20 LIGRGSFGDVYKAFDKE------------------------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75 (703)
Q Consensus 20 ~LG~GsfG~Vyka~d~~------------------------tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~ 75 (703)
.||+|+||.||+|.... ....|++|++.... ......+.+|+.++++++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 59999999999997532 12468899886443 233456788999999999999999
Q ss_pred eEEEEEeCCEEEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC------
Q 005298 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG------ 148 (703)
Q Consensus 76 L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g------ 148 (703)
+++++......|+||||+++++|..++.. .+.+++..+..++.||+.||.|||+++|+||||||.|||++..+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 99999999999999999999999999865 56789999999999999999999999999999999999998654
Q ss_pred -CeeEeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHH-hCCCCCCCCCccceeeccCC
Q 005298 149 -DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR 226 (703)
Q Consensus 149 -~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELL-tG~~PF~~~~~~~~l~~I~~ 226 (703)
.+||+|||++...... ....+++.|+|||++.+...++.++|||||||++|||+ +|..||....+......+..
T Consensus 161 ~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 236 (274)
T cd05076 161 PFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK 236 (274)
T ss_pred ceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh
Confidence 3899999987543221 23467889999999876556889999999999999985 79999987654332221111
Q ss_pred CCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 227 ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 227 ~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
...++...+..+.+||.+||..+|.+||++.+|+++
T Consensus 237 --~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 237 --KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred --ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 112223345679999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=319.18 Aligned_cols=229 Identities=20% Similarity=0.306 Sum_probs=192.7
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCHHHHHH
Q 005298 24 GSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ 103 (703)
Q Consensus 24 GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~ 103 (703)
|.||.||++.+..+++.||+|.+.... ....|...+....||||+++++++...+..|+||||++|++|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999999999999999986542 22344555566679999999999999999999999999999999998
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCCCCCchhhh
Q 005298 104 SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI 183 (703)
Q Consensus 104 ~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl 183 (703)
....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .....++..|+|||++
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~ 154 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEVG 154 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCccc
Confidence 8788999999999999999999999999999999999999999999999999987554332 2234567889999988
Q ss_pred ccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCH-----
Q 005298 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA----- 258 (703)
Q Consensus 184 ~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa----- 258 (703)
... .++.++||||+||++|+|++|..||...... +.......++..++..+++||.+||..||.+||++
T Consensus 155 ~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~ 228 (237)
T cd05576 155 GIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGV 228 (237)
T ss_pred CCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccch
Confidence 654 4788999999999999999999988643211 11111123445678899999999999999999985
Q ss_pred HHHHhchhh
Q 005298 259 KELLRHRFI 267 (703)
Q Consensus 259 ~eLL~Hpff 267 (703)
++++.||||
T Consensus 229 ~~~~~h~~~ 237 (237)
T cd05576 229 EDIKSHPFF 237 (237)
T ss_pred HHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=320.87 Aligned_cols=250 Identities=25% Similarity=0.442 Sum_probs=204.2
Q ss_pred CCceEEEEEeecCceEEEEEEEc----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe--CCEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDK----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--~~~l 86 (703)
..|++++.||+|+||.||+|... .++..||||++...........+.+|+.+++.+.||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 57889999999999999999864 34889999998766544456789999999999999999999999887 5689
Q ss_pred EEEEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 99999999999999997644 69999999999999999999999999999999999999999999999999987664221
Q ss_pred cc---cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccce---------------eeccCCC
Q 005298 166 SR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV---------------LFIIPRE 227 (703)
Q Consensus 166 ~~---~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~---------------l~~I~~~ 227 (703)
.. .....++..|++||.+.+. .++.++|||||||++|+|++|..||........ ...+...
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242 (284)
T ss_pred cceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence 11 1123455679999998765 588999999999999999999999865321110 0111112
Q ss_pred CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 228 ~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.....+..++..+.+|+.+||..+|.+|||+.+|++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222233456788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=313.10 Aligned_cols=256 Identities=26% Similarity=0.457 Sum_probs=217.4
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-HHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-EIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~-~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
+|..++.||+|.||+||+++++.+++.||+|.++....++ ......+||.+|+.|+|.|||+++++...++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 6778899999999999999999999999999998776433 345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 93 v~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
| ..+|..+... ++.++.+.++.++.|+++||.|||++++.|||+||.|+||+.+|.+||+|||+++-++.+.......
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae 161 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence 9 5688888754 6789999999999999999999999999999999999999999999999999999887776555666
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCC------------------CC-CC
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE------------------NP-PQ 231 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~------------------~~-~~ 231 (703)
+-|.+|++|.++.+.+-|+...|+||.|||+.|+.. |.+.|++.+-.+.+..|-+. .+ |.
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ 241 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPI 241 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCC
Confidence 789999999999998889999999999999999984 77778776554444333110 00 01
Q ss_pred cc---------hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 232 LD---------EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 232 l~---------~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
++ ..+...-++++.++|.-+|..|++++..++||||.+.
T Consensus 242 ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 242 YPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 11 1223345789999999999999999999999999764
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.66 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=203.4
Q ss_pred ceEEEEEeecCceEEEEEEEc---CCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC------
Q 005298 15 FSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT------ 84 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~---~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~------ 84 (703)
|++.++||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 357899999986543 3344677889999999999999999999886532
Q ss_pred EEEEEEeccCCCCHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccc
Q 005298 85 KLWIIMEYMAGGSVADLIQSG------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
..++++||+.+++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 347899999999999887421 25789999999999999999999999999999999999999999999999998
Q ss_pred hhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchh
Q 005298 159 AQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEH 235 (703)
Q Consensus 159 ~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~ 235 (703)
........ ......+++.|++||.+... .++.++|||||||++|+|++ |.+||...+.......+........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPD 239 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence 76532211 11223456789999998764 58889999999999999999 8999987765554444444333344456
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
++..+.+++.+||..+|.+||++.+++..
T Consensus 240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=318.38 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=208.8
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-----
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----- 84 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~----- 84 (703)
.-+++|++.+.||+|||+-||++.+..++..||+|.+.... .+..+...+|++..++++||||++++++...+.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 34579999999999999999999999999999999998776 556788999999999999999999998766443
Q ss_pred EEEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeeeeccceEEecCCCCeeEeccccc
Q 005298 85 KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~g--IVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
..||++.|...|+|.+.+.. +.-++|.++..|+.+|++||.+||+.. ++||||||.|||+...+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 48999999999999999864 347999999999999999999999998 999999999999999999999999988
Q ss_pred hhhhhcccc---------cccccCCCCCCchhhhccc--cCCccccchhhHHHHHHHHHhCCCCCCCCCc--cceeeccC
Q 005298 159 AQLTRTISR---------RKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIP 225 (703)
Q Consensus 159 ~~~~~~~~~---------~~~~iGTp~Y~APEvl~~~--~~~s~ksDVWSLGvILyELLtG~~PF~~~~~--~~~l~~I~ 225 (703)
+........ ...-..|..|+|||.+... ...+.++|||||||+||+|+.|..||..... ..+...+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 754321111 1123578999999998643 2367899999999999999999999975432 12222232
Q ss_pred CCC-CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 226 REN-PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 226 ~~~-~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
... ..+-...++..+.+||+.||+.||.+||++.+++.+
T Consensus 257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 211 112223489999999999999999999999999875
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.47 Aligned_cols=255 Identities=20% Similarity=0.307 Sum_probs=197.5
Q ss_pred ccchhhhCCCceEEEEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHH----------HHHHHHHHHHHhCCCC
Q 005298 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEI----------EDIQKEISVLSQCRSP 71 (703)
Q Consensus 5 ~~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~t---g~~VAIKvi~~~~~~~~~----------~~l~~Ei~ILk~L~HP 71 (703)
.++.+..+.+|++.++||+|+||+||+|.+..+ +..+|+|+.......... .....+...+..+.|+
T Consensus 4 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~ 83 (294)
T PHA02882 4 IPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL 83 (294)
T ss_pred eeeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence 456667788999999999999999999999887 778888875433321111 1122333455677899
Q ss_pred CeeeeEEEEEeCC----EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC
Q 005298 72 YITEYYGSYLHQT----KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (703)
Q Consensus 72 nIV~L~~~~~~~~----~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~ 147 (703)
||+++++++.... ..++++|++ ..++.+++.....+++..+..|+.||+.||.|||+++|+||||||+|||++.+
T Consensus 84 ~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 84 GIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN 162 (294)
T ss_pred CCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 9999999776543 347888888 45788887766668899999999999999999999999999999999999999
Q ss_pred CCeeEeccccchhhhhcc-------cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-
Q 005298 148 GDVKVADFGVSAQLTRTI-------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR- 219 (703)
Q Consensus 148 g~VKL~DFGlA~~~~~~~-------~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~- 219 (703)
+.++|+|||++..+.... .......||+.|+|||++.+. .++.++|||||||+||+|++|.+||.......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999987653211 112235799999999999775 58999999999999999999999998763221
Q ss_pred --------eeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 220 --------VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 220 --------~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
....+.... ......++.+.+++..|+..+|.+||++.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGK--IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhHHHHHHHhhhhh--hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111222111 112345788999999999999999999999985
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.70 Aligned_cols=243 Identities=21% Similarity=0.371 Sum_probs=194.0
Q ss_pred EEeecCceEEEEEEEcCC--CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCC
Q 005298 20 LIGRGSFGDVYKAFDKEL--NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGS 97 (703)
Q Consensus 20 ~LG~GsfG~Vyka~d~~t--g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGs 97 (703)
.||+|+||.||++..... ...+++|.+...........+.+|+.+++.++||||+++++++......|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 345678877655545556789999999999999999999999999999999999999999
Q ss_pred HHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc--ccccccc
Q 005298 98 VADLIQSG----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT--ISRRKTF 171 (703)
Q Consensus 98 L~~~l~~~----~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~--~~~~~~~ 171 (703)
|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...... .......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 161 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCC
Confidence 99999753 34677788999999999999999999999999999999999999999999987532211 1122345
Q ss_pred cCCCCCCchhhhccc------cCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC-----CCCcchhhhHH
Q 005298 172 VGTPFWMAPEVIQNS------EGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN-----PPQLDEHFSRL 239 (703)
Q Consensus 172 iGTp~Y~APEvl~~~------~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~-----~~~l~~~is~~ 239 (703)
+|++.|+|||++... ..++.++|||||||++|||++ |..||......+.+..+.... .+.+...++..
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (268)
T cd05086 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSER 241 (268)
T ss_pred cCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHH
Confidence 788999999987531 125678999999999999996 577887666544443332221 23334457888
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHh
Q 005298 240 MKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
+.+++..|| .+|.+||++++|++
T Consensus 242 ~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 242 WYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHh-hCcccCCCHHHHHH
Confidence 999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=370.86 Aligned_cols=254 Identities=30% Similarity=0.529 Sum_probs=206.6
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe---------
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--------- 82 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--------- 82 (703)
..+|+.+++||+||||.||+|+++-+|+.||||.|...........+.+|+.+|.+|+|||||+||..|.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 35789999999999999999999999999999999887766667889999999999999999999965520
Q ss_pred ----------------------------------------------C---------------------------------
Q 005298 83 ----------------------------------------------Q--------------------------------- 83 (703)
Q Consensus 83 ----------------------------------------------~--------------------------------- 83 (703)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CEEEEEEeccCCCCHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHhcC
Q 005298 84 -------------------------------TKLWIIMEYMAGGSVADLIQSGPPL-DEMSIACILRDLLHAIEYLHNEG 131 (703)
Q Consensus 84 -------------------------------~~lyLV~Eyv~gGsL~~~l~~~~~L-~e~~i~~i~~QLl~AL~yLHs~g 131 (703)
..+||-||||+..+|.+++.++... ....++.+|+||+.||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 2368899999999999999876655 57789999999999999999999
Q ss_pred ceeeeeccceEEecCCCCeeEeccccchhhh------------------hcccccccccCCCCCCchhhhcccc--CCcc
Q 005298 132 KIHRDIKAANILLTENGDVKVADFGVSAQLT------------------RTISRRKTFVGTPFWMAPEVIQNSE--GYNE 191 (703)
Q Consensus 132 IVHRDIKPeNILLd~~g~VKL~DFGlA~~~~------------------~~~~~~~~~iGTp~Y~APEvl~~~~--~~s~ 191 (703)
||||||||.|||++.+++|||+|||+++... ......+..+||..|+|||++.+.. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998621 0011234578999999999998766 5999
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCC-CccceeeccCCCCCCCc---chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 192 KADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPRENPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 192 ksDVWSLGvILyELLtG~~PF~~~-~~~~~l~~I~~~~~~~l---~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
|+|||||||||+||+. ||... .....+..+.....|.. ...--+.-..+|.+||.+||.+||||.|+|++.||
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ll 874 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELL 874 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCC
Confidence 9999999999999984 46432 22233333333332222 22233445779999999999999999999999998
Q ss_pred h
Q 005298 268 R 268 (703)
Q Consensus 268 ~ 268 (703)
.
T Consensus 875 p 875 (1351)
T KOG1035|consen 875 P 875 (1351)
T ss_pred C
Confidence 6
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.89 Aligned_cols=258 Identities=26% Similarity=0.463 Sum_probs=208.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCc----EEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCCeeeeEEEEEe-CCEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~----~VAIKvi~~~~~~-~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~-~~~l 86 (703)
..|+++..||+|+||.||+|..+.++. .+|||.++-++.. ..-...-+|+.+++.|+||||+.|..+|.. +.++
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 379999999999999999997766543 7899998765422 223456789999999999999999999988 8899
Q ss_pred EEEEeccCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC----CCeeEecccc
Q 005298 87 WIIMEYMAGGSVADLIQS-----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN----GDVKVADFGV 157 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~-----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~----g~VKL~DFGl 157 (703)
|+++||.+ -+|.++|+- ...++...++.|++||+.|+.|||++.|+||||||.||||..+ |.|||+|||+
T Consensus 104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 99999996 588888853 3468999999999999999999999999999999999999987 8999999999
Q ss_pred chhhhhccccc---ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------ceeeccC
Q 005298 158 SAQLTRTISRR---KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---------RVLFIIP 225 (703)
Q Consensus 158 A~~~~~~~~~~---~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~---------~~l~~I~ 225 (703)
++.+..+.... ...+-|.+|+|||++++...|+.+.|||++|||+.||||-++.|.+.... +.+..|.
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 99887665443 34577999999999999999999999999999999999999988653210 0111110
Q ss_pred C--CCC-----------CCc-----------------c------hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 226 R--ENP-----------PQL-----------------D------EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 226 ~--~~~-----------~~l-----------------~------~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
. +.| |.. . ..-++...+|+.+||..||.+|+|+++.|+|+||..
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 0 000 000 0 001234778999999999999999999999999986
Q ss_pred cc
Q 005298 270 AR 271 (703)
Q Consensus 270 ~~ 271 (703)
..
T Consensus 343 d~ 344 (438)
T KOG0666|consen 343 DP 344 (438)
T ss_pred CC
Confidence 53
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=356.92 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=223.2
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~-----tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~ 83 (703)
+....+-+..+.||+|+||+||+|+-.. ....||||.++.....+..+.|++|+++|..|+|||||+|+|+|..+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 3344567888999999999999997543 45689999998877777889999999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC
Q 005298 84 TKLWIIMEYMAGGSVADLIQSG--------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD 149 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~--------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~ 149 (703)
+.+|+|||||..|+|.++|... .+|+..+...|+.||+.|++||-++.+|||||-..|+||..+-.
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 9999999999999999999632 23889999999999999999999999999999999999999999
Q ss_pred eeEeccccchhhhhccccc-c-cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCC
Q 005298 150 VKVADFGVSAQLTRTISRR-K-TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPR 226 (703)
Q Consensus 150 VKL~DFGlA~~~~~~~~~~-~-~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~ 226 (703)
|||+||||++.+....... . ...=...||+||.|...+ |+.++||||+||||||+++ |+-||.+....+++..|..
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 9999999998765432111 0 112256799999998864 9999999999999999996 9999999999999999998
Q ss_pred CCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHH
Q 005298 227 ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262 (703)
Q Consensus 227 ~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL 262 (703)
+...+.+..+|..+.+|+..||..+|.+||++.||-
T Consensus 721 g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 721 GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 888889999999999999999999999999999984
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.48 Aligned_cols=250 Identities=28% Similarity=0.473 Sum_probs=215.5
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCC----cEEEEEEecc--CCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELN----KDVAIKVIDL--EESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg----~~VAIKvi~~--~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
.+-.+.+.||+|+||+||+|..+..+ ..||||..+. ......+..+.+|..+|++++|||||++||+......+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34556699999999999999877542 2389999875 23566778899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
|||||+|.||+|.+++++.+ .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||++.......
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 99999999999999999877 49999999999999999999999999999999999999999999999999986543111
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeecc-CCCCCCCcchhhhHHHHHH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII-PRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I-~~~~~~~l~~~is~~L~dL 243 (703)
.......-...|+|||.+... .|+.++|||||||++||+++ |..||.+....+....| ....+...+...+..+..+
T Consensus 317 ~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~ 395 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV 395 (474)
T ss_pred eccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence 111011234679999999876 69999999999999999997 88899999988888888 5566667777889999999
Q ss_pred HHHHhccCCCCCCCHHHHHh
Q 005298 244 VSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~ 263 (703)
+..|+..+|+.||++.++.+
T Consensus 396 ~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 396 MKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHhccCChhhccCHHHHHH
Confidence 99999999999999999976
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=360.63 Aligned_cols=253 Identities=26% Similarity=0.477 Sum_probs=222.3
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCC-----cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELN-----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg-----~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~ 84 (703)
....+.++.+.||+|.||.||.|...... ..||||.++..........|.+|..+|+.++|||||+++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 44567889999999999999999876533 2499999988878888999999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecccc
Q 005298 85 KLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~-------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGl 157 (703)
..+|++|||+||+|..+|++. ..+....+..++.||++|+.||+++++|||||-..|+||+....|||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999864 3588999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccccccc--cCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcch
Q 005298 158 SAQLTRTISRRKTF--VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDE 234 (703)
Q Consensus 158 A~~~~~~~~~~~~~--iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~ 234 (703)
|+.+.......... .-...|||||.+... .++.++|||||||+|||+++ |..||.+.+..+++.....+.....+.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~ 927 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS 927 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence 98654332211111 123569999999875 69999999999999999997 999999999988887666666777788
Q ss_pred hhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 235 HFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 235 ~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.++..+.+++..||..+|++||++..|++
T Consensus 928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999999999999999997
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=345.95 Aligned_cols=243 Identities=29% Similarity=0.456 Sum_probs=210.3
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...|++...||.|+|+.|-.+.+..+++.+++|++.... .+..+|+.++... +||||+++++.+.++.+.|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 458889999999999999999999999999999997652 3345677665554 7999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe-cCCCCeeEeccccchhhhhcccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL-d~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|++.|+.|.+.+.....+. ..+..|+.||+.||.|||++|||||||||+|||+ +..|+++|+|||++...... ..
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~ 471 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CD 471 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---hc
Confidence 9999999999988766555 7888999999999999999999999999999999 58899999999998876544 23
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~-~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
+.|-|..|.|||++.. ..|+.++||||||++||+||+|..||...... +....| ..+.+...+|..+++||.+||
T Consensus 472 tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---~~~~~s~~vS~~AKdLl~~LL 547 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---QMPKFSECVSDEAKDLLQQLL 547 (612)
T ss_pred ccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh---cCCccccccCHHHHHHHHHhc
Confidence 4577889999999985 46999999999999999999999999766544 222222 344555889999999999999
Q ss_pred ccCCCCCCCHHHHHhchhh
Q 005298 249 KKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff 267 (703)
+.||.+|+++.+++.||||
T Consensus 548 ~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 548 QVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cCChhhCcChhhhccCcch
Confidence 9999999999999999999
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.62 Aligned_cols=256 Identities=34% Similarity=0.563 Sum_probs=219.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+.+-+..||.|+||+|++-.++.+|+..|||.++......+..++.+|.+...+- +.||||++||.+..++..||.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 35566778999999999999999999999999999888777788889898876554 68999999999999999999999
Q ss_pred ccCCCCHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 92 YMAGGSVADLIQ-----SGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 92 yv~gGsL~~~l~-----~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
+| ..+|..+-+ .+..++|..+-.|....+.||+||.. .+||||||||+||||+..|.|||||||+|.++....
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 99 567776553 35679999999999999999999985 589999999999999999999999999998876554
Q ss_pred cccccccCCCCCCchhhhcccc-CCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCCCcc-----hhhhH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLD-----EHFSR 238 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~-~~s~ksDVWSLGvILyELLtG~~PF~~~~~-~~~l~~I~~~~~~~l~-----~~is~ 238 (703)
.. ..-.|...|||||-+.... +|+.++||||||++|||+.||..||...+. .+.+..+..+.|+.+. .+++.
T Consensus 223 Ak-T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 223 AK-TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred Hh-hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 33 2347999999999997554 489999999999999999999999987654 4556666666666543 35788
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 239 ~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+..||..||.+|-..||...+++++||++..
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 99999999999999999999999999999764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=297.03 Aligned_cols=241 Identities=41% Similarity=0.666 Sum_probs=204.9
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCHHHHHHc
Q 005298 25 SFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS 104 (703)
Q Consensus 25 sfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~ 104 (703)
+||.||+|.+..+++.|++|++...........+.+|+.++++++|+||+++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999999999999987654433267889999999999999999999999999999999999999999999987
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCCCCCchhhhc
Q 005298 105 GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184 (703)
Q Consensus 105 ~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~ 184 (703)
...+++..+..++.+++.+|.|||..+++|+||+|.||+++.++.++|+|||++....... ......++..|++||.+.
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~ 159 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLL 159 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHc
Confidence 6679999999999999999999999999999999999999999999999999987654332 233567899999999987
Q ss_pred cccCCccccchhhHHHHHHHHHhCCCCCCC-CCccceeeccCCCCCCCcchh--hhHHHHHHHHHHhccCCCCCCCHHHH
Q 005298 185 NSEGYNEKADIWSLGITVIEMAKGEPPLAD-LHPMRVLFIIPRENPPQLDEH--FSRLMKEFVSLCLKKVPAERPSAKEL 261 (703)
Q Consensus 185 ~~~~~s~ksDVWSLGvILyELLtG~~PF~~-~~~~~~l~~I~~~~~~~l~~~--is~~L~dLI~~cL~~dP~~RPTa~eL 261 (703)
.. .++.++|||+||+++|+|++|..||.. .+.......+........... ++..+.+|+.+||..+|.+||++.++
T Consensus 160 ~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 160 GK-GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA 238 (244)
T ss_pred cC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence 54 578899999999999999999999977 333333333322222222111 78899999999999999999999999
Q ss_pred Hhchhh
Q 005298 262 LRHRFI 267 (703)
Q Consensus 262 L~Hpff 267 (703)
++||||
T Consensus 239 ~~~~~~ 244 (244)
T smart00220 239 LQHPFF 244 (244)
T ss_pred hhCCCC
Confidence 999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=344.70 Aligned_cols=210 Identities=31% Similarity=0.523 Sum_probs=184.1
Q ss_pred ccchhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005298 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (703)
Q Consensus 5 ~~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~ 84 (703)
..++......+...+.||+|+||.||+++++.+|+.||||.++........+..-+|+++|++|+|||||+++++-.+..
T Consensus 5 ~~l~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 5 PVLTSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKF 84 (732)
T ss_pred cccccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence 44556666788888999999999999999999999999999987665566788889999999999999999999766544
Q ss_pred ------EEEEEEeccCCCCHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC--CC--Cee
Q 005298 85 ------KLWIIMEYMAGGSVADLIQS---GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE--NG--DVK 151 (703)
Q Consensus 85 ------~lyLV~Eyv~gGsL~~~l~~---~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~--~g--~VK 151 (703)
..++|||||.||+|..++++ ...|++.+++.++..|..||.|||++|||||||||.||++-. +| ..|
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEe
Confidence 46899999999999999965 457999999999999999999999999999999999999853 34 379
Q ss_pred EeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCC
Q 005298 152 VADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL 215 (703)
Q Consensus 152 L~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~ 215 (703)
|+|||.|+.+... .....++||+.|.+||++.....|+..+|.|||||++|++.||..||...
T Consensus 165 LtDfG~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 165 LTDFGAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred eecccccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9999999877544 46677899999999999986567999999999999999999999999543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.48 Aligned_cols=257 Identities=26% Similarity=0.438 Sum_probs=209.6
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC--CC----eeeeEEEE
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PY----ITEYYGSY 80 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H--Pn----IV~L~~~~ 80 (703)
+.+....+|++++.||+|.||.|-.+.+..++..||||+++-. ....+...-|+++|.++.+ |+ +|.+.++|
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 4566678999999999999999999999999999999998633 3334556779999999943 33 78888899
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC------------
Q 005298 81 LHQTKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE------------ 146 (703)
Q Consensus 81 ~~~~~lyLV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~------------ 146 (703)
.-.++.|||+|.+ |-++++++..+. +++...++.+.+||++++.|||+.+++|-||||+|||+..
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999999 779999998754 7999999999999999999999999999999999999841
Q ss_pred --------CCCeeEeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Q 005298 147 --------NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM 218 (703)
Q Consensus 147 --------~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~ 218 (703)
.-.|+|+|||.|+... ....+.+.|..|+|||++++- +++.++||||+||||+||++|...|....+.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceec---cCcceeeeccccCCchheecc-CcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 2258999999886543 233577899999999999986 5999999999999999999999999776544
Q ss_pred c---eeeccCCCCCC------------------------------------Ccc------hhhhHHHHHHHHHHhccCCC
Q 005298 219 R---VLFIIPRENPP------------------------------------QLD------EHFSRLMKEFVSLCLKKVPA 253 (703)
Q Consensus 219 ~---~l~~I~~~~~~------------------------------------~l~------~~is~~L~dLI~~cL~~dP~ 253 (703)
+ ++..|....|. ++. ...-..|.+||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 4 22222211110 000 01123488999999999999
Q ss_pred CCCCHHHHHhchhhhcc
Q 005298 254 ERPSAKELLRHRFIRNA 270 (703)
Q Consensus 254 ~RPTa~eLL~Hpff~~~ 270 (703)
+|+|+.|+|.||||...
T Consensus 396 ~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLREALSHPFFARL 412 (415)
T ss_pred ccccHHHHhcCHHhhcC
Confidence 99999999999999764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=339.12 Aligned_cols=255 Identities=25% Similarity=0.329 Sum_probs=178.1
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCC----CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEE------EE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKEL----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGS------YL 81 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~t----g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~------~~ 81 (703)
..+|++.+.||+|+||.||+|.+..+ +..||||.+...... +....| .+....+.+++.++.. ..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45899999999999999999999998 999999987543211 111111 1222223333332222 23
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcCCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCceeeeeccce
Q 005298 82 HQTKLWIIMEYMAGGSVADLIQSGPP--------------------LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAAN 141 (703)
Q Consensus 82 ~~~~lyLV~Eyv~gGsL~~~l~~~~~--------------------L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeN 141 (703)
.+..+|||+||+.+++|.+++..... ..+..+..|+.||+.||.|||+++||||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 56679999999999999999875321 1234567899999999999999999999999999
Q ss_pred EEecC-CCCeeEeccccchhhhhcc-cccccccCCCCCCchhhhcccc---------------------CCccccchhhH
Q 005298 142 ILLTE-NGDVKVADFGVSAQLTRTI-SRRKTFVGTPFWMAPEVIQNSE---------------------GYNEKADIWSL 198 (703)
Q Consensus 142 ILLd~-~g~VKL~DFGlA~~~~~~~-~~~~~~iGTp~Y~APEvl~~~~---------------------~~s~ksDVWSL 198 (703)
|||+. ++.+||+|||++..+.... .....++|++.|||||++.... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 5799999999997553221 1234578999999999764321 13456799999
Q ss_pred HHHHHHHHhCCCCCCCCCcc-------------ceeeccCCCCCCCcc------hhhhHHHHHHHHHHhccCCCCCCCHH
Q 005298 199 GITVIEMAKGEPPLADLHPM-------------RVLFIIPRENPPQLD------EHFSRLMKEFVSLCLKKVPAERPSAK 259 (703)
Q Consensus 199 GvILyELLtG~~PF~~~~~~-------------~~l~~I~~~~~~~l~------~~is~~L~dLI~~cL~~dP~~RPTa~ 259 (703)
|||||||+++..|+...... .+...+.....+.+. ........+||.+||.+||.+|||+.
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~ 445 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK 445 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence 99999999987765432100 000000000000000 11123456899999999999999999
Q ss_pred HHHhchhhhccc
Q 005298 260 ELLRHRFIRNAR 271 (703)
Q Consensus 260 eLL~Hpff~~~~ 271 (703)
++|+||||....
T Consensus 446 e~L~Hpff~~~~ 457 (566)
T PLN03225 446 AALAHPYFDREG 457 (566)
T ss_pred HHhCCcCcCCCC
Confidence 999999997643
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.56 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=210.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe-------
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH------- 82 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~------- 82 (703)
-.++|+-+..||.|.||+||+|+.+.+|+.||+|++-..+ .........+|+.||..|+|+|++.++++|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 4568999999999999999999999999999999764432 22223456789999999999999999987753
Q ss_pred -CCEEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchh
Q 005298 83 -QTKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 83 -~~~lyLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
...+|+||.+|+ .+|.-++... .+|+..+|..++.+++.||.|+|...|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 345899999995 5888888654 6899999999999999999999999999999999999999999999999999966
Q ss_pred hhhcc----cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-------CC-
Q 005298 161 LTRTI----SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------EN- 228 (703)
Q Consensus 161 ~~~~~----~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~-------~~- 228 (703)
+.... ..+...+-|.+|++||.+++...|+++.|||..||||.||+++.+.|.+......+..|.. ..
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 54321 1123346699999999999999999999999999999999999998876655444433311 00
Q ss_pred -------------CCCcch-------------hhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 229 -------------PPQLDE-------------HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 229 -------------~~~l~~-------------~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.++++. .-.++..+|+..+|..||.+|+++.+++.|.||+.-.
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 011111 1124677999999999999999999999999997643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.37 Aligned_cols=260 Identities=24% Similarity=0.432 Sum_probs=213.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC------ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe-C
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE------SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-Q 83 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~------~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~-~ 83 (703)
...+|-++.+||+|+|++||+|+|....++||||+-.+.+ ..+.....-+|..|.+.|+||-||++|++|.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 4468889999999999999999999999999999864433 12234556689999999999999999999975 5
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc--CceeeeeccceEEecC---CCCeeEeccccc
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE--GKIHRDIKAANILLTE---NGDVKVADFGVS 158 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~--gIVHRDIKPeNILLd~---~g~VKL~DFGlA 158 (703)
+.+|-|+|||+|.+|.-|++.+..+++.+++.|+.||+.||.||... .|||-||||.|||+-. .|.+||.||||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 67899999999999999999999999999999999999999999976 5999999999999954 378999999999
Q ss_pred hhhhhcccc-------cccccCCCCCCchhhhccc---cCCccccchhhHHHHHHHHHhCCCCCCCCCccc-e--eeccC
Q 005298 159 AQLTRTISR-------RKTFVGTPFWMAPEVIQNS---EGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-V--LFIIP 225 (703)
Q Consensus 159 ~~~~~~~~~-------~~~~iGTp~Y~APEvl~~~---~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~-~--l~~I~ 225 (703)
+.+...... .....||.||++||.+.-. ...+.++||||+|||+|.+|.|+.||....... . ...|.
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 877533211 2236899999999987643 346789999999999999999999997543221 1 11222
Q ss_pred CCCCC--CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 226 RENPP--QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 226 ~~~~~--~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+.... +....++.+++.||++||....++|....++..||||...
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 22211 2235688999999999999999999999999999999753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=331.42 Aligned_cols=260 Identities=50% Similarity=0.921 Sum_probs=236.6
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
....+|+++.++|.|+||.||+++|+.+++..|+|++++.... ...-+++|+-+++.++|||||.|++.|...+.+||+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 4567999999999999999999999999999999999887643 457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
||||.||+|++.-.-.+++++.++.+..+..++||.|||+.|-+|||||-.|||++..|.+||.|||.+..++....+..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence 99999999999988889999999999999999999999999999999999999999999999999999999988888888
Q ss_pred cccCCCCCCchhhhc--cccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC--CCc--chhhhHHHHHH
Q 005298 170 TFVGTPFWMAPEVIQ--NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP--PQL--DEHFSRLMKEF 243 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~--~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~--~~l--~~~is~~L~dL 243 (703)
.++|||+|||||+.. ...+|...+|||++|++..|+-.-++|..+..++..++...+..+ +.+ +...+..+.+|
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f 250 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF 250 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence 999999999999853 234689999999999999999999999999888888877765543 333 34678899999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
++.||.++|++||+++.+|.|||....
T Consensus 251 vK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 251 VKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHhcCCCccCCChhhheeceeeccc
Confidence 999999999999999999999999765
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=321.64 Aligned_cols=243 Identities=28% Similarity=0.463 Sum_probs=214.1
Q ss_pred EEEEeecCceEEEEEEEcCC----CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 18 LELIGRGSFGDVYKAFDKEL----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~t----g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
.+.||.|-||.||+|+...- .-.||||+.+.....+..+.|..|..+|++++|||||+++|+|. +...|||||++
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~WivmEL~ 472 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVMELA 472 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEEecc
Confidence 35799999999999986432 34699999887777777899999999999999999999999985 45689999999
Q ss_pred CCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 94 AGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 94 ~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
.-|.|..|++.+ ..|+......|.+||+.||.|||+..+|||||-..||||....-|||+|||+++.+..... +....
T Consensus 473 ~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y-YkaS~ 551 (974)
T KOG4257|consen 473 PLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY-YKASR 551 (974)
T ss_pred cchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch-hhccc
Confidence 999999999865 4799999999999999999999999999999999999999998999999999987654322 22223
Q ss_pred C--CCCCCchhhhccccCCccccchhhHHHHHHHHH-hCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 173 G--TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 173 G--Tp~Y~APEvl~~~~~~s~ksDVWSLGvILyELL-tG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
| ..-|||||.+.-. .++.++|||.|||+|||++ .|..||.+....+++..|.++...+++..+|+.+..|+.+||.
T Consensus 552 ~kLPIKWmaPESINfR-rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWa 630 (974)
T KOG4257|consen 552 GKLPIKWMAPESINFR-RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWA 630 (974)
T ss_pred cccceeecCccccchh-cccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhc
Confidence 3 3459999998654 5999999999999999977 5999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCHHHHHh
Q 005298 250 KVPAERPSAKELLR 263 (703)
Q Consensus 250 ~dP~~RPTa~eLL~ 263 (703)
.+|.+||++.+|..
T Consensus 631 yeP~kRPrftei~~ 644 (974)
T KOG4257|consen 631 YEPSKRPRFTEIKA 644 (974)
T ss_pred cCcccCCcHHHHHH
Confidence 99999999988865
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=335.61 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=227.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCC---cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg---~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
+...|.++||.|.||+||+|..+..| ..||||.++....+.....|..|+.||.+++||||++|.|+....+...||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45678899999999999999988665 479999999888888889999999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-c
Q 005298 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~ 167 (703)
+|||++|.|..+|+. .+.|...++..+++.|+.|+.||-+.|+|||||-..||||+.+-..|++||||++.+..... .
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 999999999999975 46799999999999999999999999999999999999999999999999999987754432 2
Q ss_pred cccccC--CCCCCchhhhccccCCccccchhhHHHHHHHHH-hCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHH
Q 005298 168 RKTFVG--TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 168 ~~~~iG--Tp~Y~APEvl~~~~~~s~ksDVWSLGvILyELL-tG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI 244 (703)
+.+.-| ...|.|||.|... .++.++||||+|+||||.+ .|..||+++...+++..|..+...+.+..+|..|.+|+
T Consensus 789 ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLM 867 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLM 867 (996)
T ss_pred ccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHH
Confidence 233333 3569999999876 4999999999999999955 69999999999999999999998888899999999999
Q ss_pred HHHhccCCCCCCCHHHHHhc
Q 005298 245 SLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~H 264 (703)
..||++|-.+||.+.||+.+
T Consensus 868 ldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 868 LDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999975
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=298.16 Aligned_cols=252 Identities=23% Similarity=0.440 Sum_probs=211.6
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeC--CEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQ--TKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~--~~lyL 88 (703)
..+|++++.+|+|.|++||.|++..+++.++||+++..+ ...+++|+.||..|. ||||++++++..+. ....|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 358999999999999999999999999999999986543 467999999999997 99999999999875 46789
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC-CCeeEeccccchhhhhcccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~-g~VKL~DFGlA~~~~~~~~~ 167 (703)
|+||+++.+...+. ..|+...++.+++||+.||+|||+.||+|||+||.|++||.. ..++|+|+|+|... .+...
T Consensus 113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY-Hp~~e 188 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKE 188 (338)
T ss_pred HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhc-CCCce
Confidence 99999988888775 558899999999999999999999999999999999999975 56999999998765 44566
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCC-CCCccceeeccCC----------------CCCC
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLA-DLHPMRVLFIIPR----------------ENPP 230 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~-~~~~~~~l~~I~~----------------~~~~ 230 (703)
.+..+.+..|--||++...+.|++.-|+|||||+|..|+..+-||. +.+..+.+.+|.+ ..++
T Consensus 189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 6778899999999999998889999999999999999999988874 3333333322211 0011
Q ss_pred Cc--------------------chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 231 QL--------------------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 231 ~l--------------------~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+ ..-.++++.+|+.++|..|-.+|+||.|++.||||....
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 11 012358899999999999999999999999999997653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.42 Aligned_cols=257 Identities=24% Similarity=0.403 Sum_probs=210.5
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC------CCeeeeEEEE
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS------PYITEYYGSY 80 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H------PnIV~L~~~~ 80 (703)
+++....+|.+....|+|-|++|..|.+...|..||||+|... +-....=+.|++||++|+. -|+++|+-.|
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 4566778999999999999999999999999999999999643 3334555789999999963 5899999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC-CCeeEeccc
Q 005298 81 LHQTKLWIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFG 156 (703)
Q Consensus 81 ~~~~~lyLV~Eyv~gGsL~~~l~~~~---~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~-g~VKL~DFG 156 (703)
...+++|||||-+ ..+|.+++++.+ .|....++.|+.||+.||..|..+||+|.||||.||||+.. ..+||||||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 9999999999999 679999998754 58889999999999999999999999999999999999976 568999999
Q ss_pred cchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-----------
Q 005298 157 VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP----------- 225 (703)
Q Consensus 157 lA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~----------- 225 (703)
.|...... ....+.-+..|.|||++++. .|++..|+||+||+||||+||+..|++.....++....
T Consensus 583 SA~~~~en--eitPYLVSRFYRaPEIiLG~-~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 583 SASFASEN--EITPYLVSRFYRAPEIILGL-PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccccc--cccHHHHHHhccCcceeecC-cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 98765443 23345668889999999997 49999999999999999999999998764433321100
Q ss_pred ----------------------------------CCCC-----------CCcch---hhhHHHHHHHHHHhccCCCCCCC
Q 005298 226 ----------------------------------RENP-----------PQLDE---HFSRLMKEFVSLCLKKVPAERPS 257 (703)
Q Consensus 226 ----------------------------------~~~~-----------~~l~~---~is~~L~dLI~~cL~~dP~~RPT 257 (703)
...| +.++. .+-..+++|+.+||..||++|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 0000 00111 12235889999999999999999
Q ss_pred HHHHHhchhhhc
Q 005298 258 AKELLRHRFIRN 269 (703)
Q Consensus 258 a~eLL~Hpff~~ 269 (703)
+.|+|+||||..
T Consensus 740 ~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQALKHPFITE 751 (752)
T ss_pred HHHHhcCCcccC
Confidence 999999999963
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=315.08 Aligned_cols=256 Identities=23% Similarity=0.388 Sum_probs=222.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCC-C--cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKEL-N--KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~t-g--~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
..+...+.+.||.|.||.|++|.+... | ..||||++...........|.+|+.+|.+|.|||+++|||+..+ ..+.
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 345667788999999999999998753 3 46999999877655577899999999999999999999999887 7789
Q ss_pred EEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 88 IIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
+|||++++|+|.+.+.+ ...|....+..|+.||+.|+.||.++++|||||-..||||-....||||||||.+.+....
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999999976 4578899999999999999999999999999999999999998899999999988776543
Q ss_pred ccccccc----CCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHH
Q 005298 166 SRRKTFV----GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240 (703)
Q Consensus 166 ~~~~~~i----GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L 240 (703)
..+ .+. -...|.|||.|... .++.++|||++||+||||++ |+-||.+.....++..|.......-+..++..+
T Consensus 267 d~Y-vm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedI 344 (1039)
T KOG0199|consen 267 DMY-VMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDI 344 (1039)
T ss_pred cce-EecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHH
Confidence 332 221 24569999999876 49999999999999999996 899999999999999998777777788999999
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
.++++.||..+|++|||+..|.+.-++..
T Consensus 345 Y~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 345 YQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 99999999999999999999986544443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=318.50 Aligned_cols=258 Identities=21% Similarity=0.366 Sum_probs=187.4
Q ss_pred CCCceEEEEEeecCceEEEEEEEc----------------CCCcEEEEEEeccCCChH-------------HHHHHHHHH
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDK----------------ELNKDVAIKVIDLEESED-------------EIEDIQKEI 62 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~----------------~tg~~VAIKvi~~~~~~~-------------~~~~l~~Ei 62 (703)
..+|++.++||+|+||.||+|.+. ..++.||||.+....... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 459999999999999999999752 245689999986543111 012233477
Q ss_pred HHHHhCCCCCe-----eeeEEEEEe--------CCEEEEEEeccCCCCHHHHHHcC------------------------
Q 005298 63 SVLSQCRSPYI-----TEYYGSYLH--------QTKLWIIMEYMAGGSVADLIQSG------------------------ 105 (703)
Q Consensus 63 ~ILk~L~HPnI-----V~L~~~~~~--------~~~lyLV~Eyv~gGsL~~~l~~~------------------------ 105 (703)
.++.+++|.++ ++++++|.. .+..||||||+.+++|.+++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776554 677776653 35689999999999999988632
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc-cccccCCCCCCchhhhc
Q 005298 106 PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKTFVGTPFWMAPEVIQ 184 (703)
Q Consensus 106 ~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~-~~~~iGTp~Y~APEvl~ 184 (703)
..+++..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++..+...... .....+|+.|+|||++.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 12356778899999999999999999999999999999999999999999998654322111 11224589999999985
Q ss_pred cccC-------------------Cc--cccchhhHHHHHHHHHhCCC-CCCCCCccce-----------eeccCC-CCCC
Q 005298 185 NSEG-------------------YN--EKADIWSLGITVIEMAKGEP-PLADLHPMRV-----------LFIIPR-ENPP 230 (703)
Q Consensus 185 ~~~~-------------------~s--~ksDVWSLGvILyELLtG~~-PF~~~~~~~~-----------l~~I~~-~~~~ 230 (703)
.... |+ .+.||||+|||||+|++|.+ ||........ ...+.. ....
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~ 463 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF 463 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence 4221 12 24799999999999999986 7753211110 001111 1111
Q ss_pred CcchhhhHHHHHHHHHHhccCC---CCCCCHHHHHhchhhhc
Q 005298 231 QLDEHFSRLMKEFVSLCLKKVP---AERPSAKELLRHRFIRN 269 (703)
Q Consensus 231 ~l~~~is~~L~dLI~~cL~~dP---~~RPTa~eLL~Hpff~~ 269 (703)
.....++...++||.+||.++| .+|+|++|+|.||||..
T Consensus 464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 2234578899999999999876 68999999999999964
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=314.65 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=216.1
Q ss_pred cccchhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC
Q 005298 4 LAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (703)
Q Consensus 4 i~~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~ 83 (703)
+..+.+.+.....+.+.||+|-||+|.+|+-.. +..||||.++.....+....|.+||++|.+|+|||||+++++|..+
T Consensus 529 ~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 529 GPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred CcchhhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 345666677788999999999999999998764 7999999998887777778999999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
+.+++|+||++.|+|..++..+. .+.......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccc
Confidence 99999999999999999998763 3355667779999999999999999999999999999999999999999999855
Q ss_pred hhccccc--ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHH--hCCCCCCCCCccceeeccC-------CCCCC
Q 005298 162 TRTISRR--KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA--KGEPPLADLHPMRVLFIIP-------RENPP 230 (703)
Q Consensus 162 ~~~~~~~--~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELL--tG~~PF~~~~~~~~l~~I~-------~~~~~ 230 (703)
....... ...+-...|||||.+...+ ++.++|+|+||++|||++ +...||....+........ ....+
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 4322111 1234567899999998865 999999999999999965 6889998876655443321 11223
Q ss_pred CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 231 ~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
..+.-++..+.+++.+||..+-.+||++++|..
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 345677888999999999999999999999965
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=339.25 Aligned_cols=237 Identities=19% Similarity=0.320 Sum_probs=189.8
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
..|...++||+|+||.||+|.+..++..||||.+..... ....|+.++++++|||||+++++|.+.+..|+||||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 356777899999999999999999999999999864332 123468899999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH---NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLH---s~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
+++|+|.++++. +++..+..|+.||+.||+||| +.+|+||||||+||+++.++..++. ||....... ..
T Consensus 765 ~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~ 836 (968)
T PLN00113 765 IEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DT 836 (968)
T ss_pred CCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----CC
Confidence 999999999964 899999999999999999999 6699999999999999988887775 665433211 12
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-----ee-------------eccCCCCCCC
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-----VL-------------FIIPRENPPQ 231 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~-----~l-------------~~I~~~~~~~ 231 (703)
...||+.|||||++.+. .++.++|||||||+||||++|+.||....... +. ..... ....
T Consensus 837 ~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 914 (968)
T PLN00113 837 KCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR-GDVS 914 (968)
T ss_pred CccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc-CCCC
Confidence 34789999999998765 58999999999999999999999985432110 00 00000 0111
Q ss_pred cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 232 l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
........+.+++.+||..+|.+|||+.|+++.
T Consensus 915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 222334567889999999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=327.42 Aligned_cols=254 Identities=29% Similarity=0.445 Sum_probs=199.5
Q ss_pred EEEEeecCceE-EEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 18 LELIGRGSFGD-VYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 18 l~~LG~GsfG~-Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
.+++|.|+.|+ ||+|... |+.||||.+- ........+||..|+.. .|||||++|+.-.++...||..|.| .
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLL----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHh----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 36789999986 7999876 8899999874 33356788999999998 5999999999999999999999999 6
Q ss_pred CCHHHHHHcCC-CC---CHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC---C--CCeeEeccccchhhhhccc
Q 005298 96 GSVADLIQSGP-PL---DEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---N--GDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 96 GsL~~~l~~~~-~L---~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~---~--g~VKL~DFGlA~~~~~~~~ 166 (703)
.+|.+++.... .+ .....+.++.|++.||+|||+.+||||||||.||||+. + ..++|+|||+|+.+.....
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 79999998741 11 11446788999999999999999999999999999986 3 3689999999988754432
Q ss_pred ---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCC--CcchhhhHHH
Q 005298 167 ---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPP--QLDEHFSRLM 240 (703)
Q Consensus 167 ---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG-~~PF~~~~~~~~l~~I~~~~~~--~l~~~is~~L 240 (703)
...+..||-+|+|||++.... -..++||||||||+|+.++| .+||.+....+. .|..++.. .+...-..++
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchHHH
Confidence 234567999999999998764 56789999999999998875 999976543221 22222211 1111111189
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhchhhhccccChhHHHHhh
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIR 281 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~e~i~ 281 (703)
.+||.+||.++|..||+|.++|.||||+...+.-.++..+.
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvS 784 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVS 784 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhh
Confidence 99999999999999999999999999998765555554433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=294.25 Aligned_cols=133 Identities=28% Similarity=0.481 Sum_probs=115.3
Q ss_pred hhhC-CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----C---CCeeeeEEE
Q 005298 9 EAAG-SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----S---PYITEYYGS 79 (703)
Q Consensus 9 ~~~~-~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-----H---PnIV~L~~~ 79 (703)
+... ++|.+.+.||+|-|++||+|.|....+.||||+++.. ....+....||.+|++++ | .+||+|++.
T Consensus 73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 3344 7999999999999999999999999999999998632 334566778999999883 3 479999999
Q ss_pred EEe----CCEEEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEe
Q 005298 80 YLH----QTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILL 144 (703)
Q Consensus 80 ~~~----~~~lyLV~Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILL 144 (703)
|.. +.++|+|+|++ |.+|..+|.. ...++...++.|++||+.||+|||. .||||-||||+|||+
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 975 56899999999 7888888865 4579999999999999999999995 599999999999999
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=306.08 Aligned_cols=244 Identities=27% Similarity=0.494 Sum_probs=215.1
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccC
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~ 94 (703)
......||.|-||.||.|+++.-...||||.++.. .-.++.|..|..+|+.++|||+|+|+++|..+-.+|||+|||.
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 34456899999999999999998999999998643 3347889999999999999999999999999999999999999
Q ss_pred CCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 95 GGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 95 gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
.|+|.+|+++. ..++...+.+++.||..|++||..+++|||||-..|.||..+..||++||||++.+.... +....
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT--YTAHA 424 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT--YTAHA 424 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc--eeccc
Confidence 99999999764 357778888999999999999999999999999999999999999999999998875432 22233
Q ss_pred C---CCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 173 G---TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 173 G---Tp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
| ..-|.|||-+... .++.++|||+|||+|||+.| |-.||.+.+-..++..+.++..-.-+..+++.+.+|++.||
T Consensus 425 GAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW 503 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACW 503 (1157)
T ss_pred CccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHh
Confidence 3 4569999998764 58999999999999999986 88999999888888888888877778899999999999999
Q ss_pred ccCCCCCCCHHHHHh
Q 005298 249 KKVPAERPSAKELLR 263 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~ 263 (703)
++.|.+||++.+|-+
T Consensus 504 ~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 504 NWSPSDRPSFAEIHQ 518 (1157)
T ss_pred cCCcccCccHHHHHH
Confidence 999999999998854
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=293.45 Aligned_cols=255 Identities=28% Similarity=0.438 Sum_probs=209.4
Q ss_pred hhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC--
Q 005298 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-- 84 (703)
Q Consensus 8 ~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~-- 84 (703)
..+...+|.-++.+|.|.- .|.-+.|.-++++||||.+.... ......+.++|..++..++|+||++++.+|.-..
T Consensus 12 ~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 12 TFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred ceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 3455679999999999999 88889999999999999875432 2233567889999999999999999999997654
Q ss_pred ----EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchh
Q 005298 85 ----KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 85 ----~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
..|+||||+ ..+|...+. -.++-+.+..|++|++.|+.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 91 ~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 91 EEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 479999999 578888886 4578889999999999999999999999999999999999999999999999875
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-------------
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------- 227 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~------------- 227 (703)
.... -....++.|..|.|||++.+.. |...+||||+||++.||++|+..|.+.+..+.+.++...
T Consensus 168 e~~~-~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTD-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcc-cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 5433 2345688999999999999875 999999999999999999999999876544433332110
Q ss_pred ---------CC----CCcch---------------hhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 228 ---------NP----PQLDE---------------HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 228 ---------~~----~~l~~---------------~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
.+ ..+.. .-+..+++++.+||..+|++|.+++++|+||||+
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 00 00000 1134688999999999999999999999999997
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=254.80 Aligned_cols=213 Identities=46% Similarity=0.771 Sum_probs=188.9
Q ss_pred EeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCHHH
Q 005298 21 IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVAD 100 (703)
Q Consensus 21 LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL~~ 100 (703)
||.|.+|.||++.+..+++.++||++...........+.+|+.+++.+.|++|+++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999988999999998765443245789999999999999999999999999999999999999999999
Q ss_pred HHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC-CCCeeEeccccchhhhhcccccccccCCCCCC
Q 005298 101 LIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRRKTFVGTPFWM 178 (703)
Q Consensus 101 ~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~-~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~ 178 (703)
++... ..+++..+..++.+++.+|.|||+.|++|+||+|.||+++. ++.++|+|||.+..............+...|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM 160 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCcc
Confidence 99875 57899999999999999999999999999999999999999 89999999999876543321233456889999
Q ss_pred chhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCH
Q 005298 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (703)
Q Consensus 179 APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa 258 (703)
+||.+.....++.+.|+|+||++||+| ..+.+++..||..+|.+||++
T Consensus 161 ~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~~R~~~ 208 (215)
T cd00180 161 APEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPEKRPSA 208 (215)
T ss_pred ChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcccCcCH
Confidence 999987643578899999999999999 678999999999999999999
Q ss_pred HHHHhch
Q 005298 259 KELLRHR 265 (703)
Q Consensus 259 ~eLL~Hp 265 (703)
.++++|+
T Consensus 209 ~~l~~~~ 215 (215)
T cd00180 209 KEILEHL 215 (215)
T ss_pred HHHhhCC
Confidence 9999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=271.10 Aligned_cols=218 Identities=33% Similarity=0.592 Sum_probs=186.4
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEEec
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
...-+..||+|+||.|-+.++..+|...|+|.+...-..+...++.+|+.+..+. ..|++|.+|+.+......||.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3445678999999999999999999999999998777777788899999987776 689999999999999999999999
Q ss_pred cCCCCHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 93 MAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 93 v~gGsL~~~l----~~~~~L~e~~i~~i~~QLl~AL~yLHs~-gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
| ..+|..+- +.++.++|..+-+|+..+++||.|||++ .|||||+||+||||+.+|+|||||||.+..+......
T Consensus 127 M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 127 M-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred h-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 9 56777654 4678899999999999999999999976 8999999999999999999999999998777654332
Q ss_pred cccccCCCCCCchhhhcc---ccCCccccchhhHHHHHHHHHhCCCCCCCC-CccceeeccCCCCCCCcc
Q 005298 168 RKTFVGTPFWMAPEVIQN---SEGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPRENPPQLD 233 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~---~~~~s~ksDVWSLGvILyELLtG~~PF~~~-~~~~~l~~I~~~~~~~l~ 233 (703)
..-.|.-.|||||.+.. ..+|+.++||||||++|+||.+++.||... .+...+.++....+|.++
T Consensus 206 -t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 206 -TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred -HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCc
Confidence 12468889999998753 246899999999999999999999999754 466677777776666665
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=309.53 Aligned_cols=250 Identities=28% Similarity=0.496 Sum_probs=212.5
Q ss_pred CCceEEEEEeecCceEEEEEEEcC-------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCC
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKE-------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~-------tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~ 84 (703)
.+.++.+.||.|.||.|++|.-.. ....||||.++......+.+.+..|+++|+.+ +||||+.+++++...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 345666799999999999996431 15679999998777667788999999999998 5999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC
Q 005298 85 KLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG 148 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~----------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g 148 (703)
.+++|+||+..|+|.++++... .++...+..+++||+.|++||++.++|||||-..||||+.+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 9999999999999999997654 388899999999999999999999999999999999999999
Q ss_pred CeeEeccccchhhhhccccc-ccccCC--CCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCC-ccceeec
Q 005298 149 DVKVADFGVSAQLTRTISRR-KTFVGT--PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLH-PMRVLFI 223 (703)
Q Consensus 149 ~VKL~DFGlA~~~~~~~~~~-~~~iGT--p~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~-~~~~l~~ 223 (703)
.+||+|||+++......... ....|+ ..|||||.+.. ..|+.++||||+||+||||++ |..||.+.. ..+.+..
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 99999999997544322111 112232 33999999987 469999999999999999997 899998855 4445556
Q ss_pred cCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 224 I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
+..+.....+.+++.++.+|++.||..+|++||++.++.+
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 7777777888899999999999999999999999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-33 Score=286.77 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=210.1
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccC-CChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-----EEEE
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-----KLWI 88 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~-~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~-----~lyL 88 (703)
.+-.+.||.|+||.||-+.|..+|+.||+|++... ..-.....+.+|+++|.-++|.|++..++..+-.+ .+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34468899999999999999999999999987422 22333567889999999999999999999877654 4688
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|+|++ ..+|..+|-.-..++.+.++-+++||++||.|||+.+|.||||||.|+|++.+..+||||||+++.........
T Consensus 135 ~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 99999 67899999888899999999999999999999999999999999999999999999999999997654332222
Q ss_pred -ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---------------------
Q 005298 169 -KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR--------------------- 226 (703)
Q Consensus 169 -~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~--------------------- 226 (703)
...+-|.+|+|||++.+...|+.++||||+|||+.|||..+..|...++...+..|..
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 2245688999999999998999999999999999999999999988877665544421
Q ss_pred --C--CCCCcc--------hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 227 --E--NPPQLD--------EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 227 --~--~~~~l~--------~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
. .++.++ .....+...++..+|..+|.+|.+..+.+.|+++...+
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 0 011111 12234567888899999999999999999999987653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=298.22 Aligned_cols=200 Identities=31% Similarity=0.502 Sum_probs=180.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-------hHHHHHHHHHHHHHHhCC---CCCeeeeEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQCR---SPYITEYYGSYLH 82 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-------~~~~~~l~~Ei~ILk~L~---HPnIV~L~~~~~~ 82 (703)
..|..++.||.|+||.|++|+++.....|+||.|.+... +..+..+-.||.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 369999999999999999999999999999999865542 112334567999999998 9999999999999
Q ss_pred CCEEEEEEecc-CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 83 QTKLWIIMEYM-AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 83 ~~~lyLV~Eyv-~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
++.+||+||-- +|.+|+++|..++.++|.++..||+|+..|+++||+.||||||||-+||.++.+|-+||+|||.+...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 99999999964 57899999999999999999999999999999999999999999999999999999999999988765
Q ss_pred hhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCC
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD 214 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~ 214 (703)
.. +...+++||..|.|||++.+.++.+..-|||+||++||-++....||+.
T Consensus 721 ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 721 KS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 43 3456799999999999999988888999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=254.64 Aligned_cols=215 Identities=37% Similarity=0.639 Sum_probs=184.2
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccC
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~ 94 (703)
|.+.+.||.|++|.||++.+..+++.|+||.+...........+.+|+..+++++|+||+++++++......++++||+.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 67889999999999999999998999999998765433356788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-ccccccc
Q 005298 95 GGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRRKTFV 172 (703)
Q Consensus 95 gGsL~~~l~~~~~-L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~~~~~i 172 (703)
+++|.+++..... +++..+..++.+++.+|.|||.++++|+||+|.||+++.++.++|+|||++....... .......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 9999999987666 8999999999999999999999999999999999999999999999999987664432 1223467
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCC-CCcc-ceeeccCCCCC
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLAD-LHPM-RVLFIIPRENP 229 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~-~~~~-~~l~~I~~~~~ 229 (703)
++..|++||.+.....++.++|||+||+++|+|++|+.||.. .+.. .+...+....+
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 889999999984334577899999999999999999999977 3433 44555554443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=286.72 Aligned_cols=257 Identities=29% Similarity=0.449 Sum_probs=206.8
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcC---CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTK 85 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~---tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~ 85 (703)
.....|.++..||.|.|++||++.+.. ..+.||+|.+...... ..+..|+++|..+. +.||+++.+++..++.
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 344689999999999999999999887 7889999998766543 56899999999995 8999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC-CCCeeEeccccchhhhhc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~-~g~VKL~DFGlA~~~~~~ 164 (703)
..+|+||++.....++... ++...++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||++......
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999999999999999865 778999999999999999999999999999999999985 478899999998621100
Q ss_pred c------c-------c-------------------------------cccccCCCCCCchhhhccccCCccccchhhHHH
Q 005298 165 I------S-------R-------------------------------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGI 200 (703)
Q Consensus 165 ~------~-------~-------------------------------~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGv 200 (703)
. . . .....||++|+|||++......+.++||||.||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 0 0 011369999999999987777889999999999
Q ss_pred HHHHHHhCCCCCCCCCc-ccee-------------------ec--cCC-CC----------------------------C
Q 005298 201 TVIEMAKGEPPLADLHP-MRVL-------------------FI--IPR-EN----------------------------P 229 (703)
Q Consensus 201 ILyELLtG~~PF~~~~~-~~~l-------------------~~--I~~-~~----------------------------~ 229 (703)
|+.-++++.+||..... ...+ .. +.. .+ .
T Consensus 267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~ 346 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER 346 (418)
T ss_pred eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence 99999999999853211 0000 00 000 00 0
Q ss_pred CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 230 ~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
......++..+.+|+.+||..||.+|+|++++|+||||.....
T Consensus 347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred ccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 0011234557899999999999999999999999999986543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=299.72 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=217.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCC----cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELN----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg----~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
...+..++||.|+||+||+|++.-.| -+||||++...........+..|+-+|.+|+|||+++|++++.... +.|
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 35667789999999999999885444 4799999877666666788999999999999999999999998766 889
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
|++|+++|+|.+|++. +.++-......|..||++|+.|||++.+|||||-..||||..-.++||.|||++..+......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999975 457888999999999999999999999999999999999999999999999999888766555
Q ss_pred cccccC--CCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHH
Q 005298 168 RKTFVG--TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 168 ~~~~iG--Tp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI 244 (703)
.....| .+-|||-|.+... .|+.++|||||||++|||+| |..||.+....+.-..+.+.....-+..++-++.-++
T Consensus 855 y~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 555444 3559999998775 59999999999999999886 9999998887777777777777777788899999999
Q ss_pred HHHhccCCCCCCCHHHHHh
Q 005298 245 SLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~ 263 (703)
.+||..|+..||+++++..
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=281.25 Aligned_cols=242 Identities=25% Similarity=0.436 Sum_probs=189.4
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHh--CCCCCeeeeEEEEEeCC----EEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ--CRSPYITEYYGSYLHQT----KLW 87 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~--L~HPnIV~L~~~~~~~~----~ly 87 (703)
..+++++||+|.||.||+|... ++.||||++.. ...+.++.|.+|.+. ++|+||++|+++-.... .++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred chhhHHHhhcCccceeehhhcc--CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 5567899999999999999776 69999999864 346778888888776 57999999999776555 799
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc---------CceeeeeccceEEecCCCCeeEeccccc
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE---------GKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~---------gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
||+||.+.|+|.+|++. ..+++....+++..|++||+|||+. .|+|||||..||||..+++..|+|||||
T Consensus 285 LVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999999999987 5689999999999999999999963 5999999999999999999999999999
Q ss_pred hhhhhcc--cccccccCCCCCCchhhhccccCCc-----cccchhhHHHHHHHHHhCCCCCC--CCCcc-----------
Q 005298 159 AQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYN-----EKADIWSLGITVIEMAKGEPPLA--DLHPM----------- 218 (703)
Q Consensus 159 ~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s-----~ksDVWSLGvILyELLtG~~PF~--~~~~~----------- 218 (703)
..+.... .....-+||..|||||++.+.-.+. .++||||+|.|||||++.-.-+. ...+.
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 8775332 2233468999999999997654443 35899999999999997533221 11111
Q ss_pred ----ceeec-cCCCCCCCcchhh-----hHHHHHHHHHHhccCCCCCCCHHHHH
Q 005298 219 ----RVLFI-IPRENPPQLDEHF-----SRLMKEFVSLCLKKVPAERPSAKELL 262 (703)
Q Consensus 219 ----~~l~~-I~~~~~~~l~~~i-----s~~L~dLI~~cL~~dP~~RPTa~eLL 262 (703)
++... +.+...|.++..+ ...+.+.+..||..||+-|.|+.=+.
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 11111 1122334444322 35688999999999999999975554
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=274.94 Aligned_cols=249 Identities=24% Similarity=0.440 Sum_probs=194.9
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHH--hCCCCCeeeeEEEEEeCC
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLS--QCRSPYITEYYGSYLHQT 84 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk--~L~HPnIV~L~~~~~~~~ 84 (703)
+|-++.....+++.||+|.||+||+|.+. |+.||||++.... ...+.+|.+|.. .|+|+||+.|++.-..++
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 35667788999999999999999999987 8999999985432 355777777776 469999999998765443
Q ss_pred ----EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc--------CceeeeeccceEEecCCCCeeE
Q 005298 85 ----KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE--------GKIHRDIKAANILLTENGDVKV 152 (703)
Q Consensus 85 ----~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~--------gIVHRDIKPeNILLd~~g~VKL 152 (703)
++|||++|.+.|+|++|+.+ ..++.+...+++..++.||+|||-. .|.|||||..||||.++|...|
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 68999999999999999998 7799999999999999999999953 4999999999999999999999
Q ss_pred eccccchhhhhc----ccccccccCCCCCCchhhhccccCC----c-cccchhhHHHHHHHHHh----------CCCCCC
Q 005298 153 ADFGVSAQLTRT----ISRRKTFVGTPFWMAPEVIQNSEGY----N-EKADIWSLGITVIEMAK----------GEPPLA 213 (703)
Q Consensus 153 ~DFGlA~~~~~~----~~~~~~~iGTp~Y~APEvl~~~~~~----s-~ksDVWSLGvILyELLt----------G~~PF~ 213 (703)
+|+|||...... ....+..+||-.|||||+|...-.. + ..+||||||.||||++. -++||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999765433 1234567999999999998643211 1 35899999999999875 267887
Q ss_pred CCCcccee-------eccCCCCCCCcch-----hhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 214 DLHPMRVL-------FIIPRENPPQLDE-----HFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 214 ~~~~~~~l-------~~I~~~~~~~l~~-----~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
+..+.+-. .-+.+ ..|.++. ..-..+-++++.||..+|.-|.|+--|.+
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~-~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQK-LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCCCCCCHHHHhcceeecc-cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 66443211 11111 1222222 23345778999999999999999877754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=303.77 Aligned_cols=199 Identities=18% Similarity=0.279 Sum_probs=147.6
Q ss_pred hCCC-CCeeeeEEEE-------EeCCEEEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeee
Q 005298 67 QCRS-PYITEYYGSY-------LHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137 (703)
Q Consensus 67 ~L~H-PnIV~L~~~~-------~~~~~lyLV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDI 137 (703)
.+.| +||+.++++| .....++++|||+ +++|.+++.. ...+++..++.|++||+.||.|||++|||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4455 5788888877 2335678889988 6799999965 456999999999999999999999999999999
Q ss_pred ccceEEecCC-------------------CCeeEeccccchhhhhcc----------------cccccccCCCCCCchhh
Q 005298 138 KAANILLTEN-------------------GDVKVADFGVSAQLTRTI----------------SRRKTFVGTPFWMAPEV 182 (703)
Q Consensus 138 KPeNILLd~~-------------------g~VKL~DFGlA~~~~~~~----------------~~~~~~iGTp~Y~APEv 182 (703)
||+||||+.. +.+||+|||++....... ......+||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999643 456666666664321000 00112468999999999
Q ss_pred hccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHH
Q 005298 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261 (703)
Q Consensus 183 l~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~-~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eL 261 (703)
+.+. .|+.++|||||||+||||++|.+||..... ....+... .++.... ......+++.+||.++|.+||++.||
T Consensus 187 ~~~~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 187 DNGS-SSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILL-NWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hccC-CCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhh-cCHHHHHHHHHhCCCChhhCcChHHH
Confidence 9875 489999999999999999999998764321 11111111 1111111 23446788999999999999999999
Q ss_pred Hhchhhhcc
Q 005298 262 LRHRFIRNA 270 (703)
Q Consensus 262 L~Hpff~~~ 270 (703)
|+||||...
T Consensus 263 l~h~~~~~~ 271 (793)
T PLN00181 263 LQSEFINEP 271 (793)
T ss_pred hhchhhhhh
Confidence 999999753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=232.79 Aligned_cols=252 Identities=38% Similarity=0.609 Sum_probs=207.3
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH--HHHHHHHHHHHHHhCCCC-CeeeeEEEEEeCCEEEEEEe
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED--EIEDIQKEISVLSQCRSP-YITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~--~~~~l~~Ei~ILk~L~HP-nIV~L~~~~~~~~~lyLV~E 91 (703)
|.+.+.||.|+|+.||++.+. ..+++|.+....... ....+.+|+.++..+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999988 789999987665433 467899999999999988 79999999988888999999
Q ss_pred ccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC-CeeEeccccchhhhhccc-
Q 005298 92 YMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTIS- 166 (703)
Q Consensus 92 yv~gGsL~~~l~~~~---~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g-~VKL~DFGlA~~~~~~~~- 166 (703)
|+.+++|.+++.... .+++..+..++.|++.++.|+|..+++||||||+||+++..+ .++++|||++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887764 799999999999999999999999999999999999999988 799999999875543321
Q ss_pred -----ccccccCCCCCCchhhhccc--cCCccccchhhHHHHHHHHHhCCCCCCCCCc----cceeeccCCCCCC----C
Q 005298 167 -----RRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHP----MRVLFIIPRENPP----Q 231 (703)
Q Consensus 167 -----~~~~~iGTp~Y~APEvl~~~--~~~s~ksDVWSLGvILyELLtG~~PF~~~~~----~~~l~~I~~~~~~----~ 231 (703)
.....+||+.|++||.+... ..+....|+|++|++++++++|..||..... ......+.....+ .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 23567899999999999873 4688899999999999999999999876653 2222222221211 1
Q ss_pred cchh----hhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 232 LDEH----FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 232 l~~~----is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
.... ....+.+++..|+..+|..|.+..+...++|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 1111 1257899999999999999999999988866543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=229.81 Aligned_cols=160 Identities=36% Similarity=0.496 Sum_probs=129.2
Q ss_pred CCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCC
Q 005298 96 GSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (703)
Q Consensus 96 GsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGT 174 (703)
|+|.+++.. +.++++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence 689999986 456999999999999999999999998 999999999999999 9988655332 23789
Q ss_pred CCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccce-eeccC----CCCCC--CcchhhhH--HHHHHHH
Q 005298 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV-LFIIP----RENPP--QLDEHFSR--LMKEFVS 245 (703)
Q Consensus 175 p~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~-l~~I~----~~~~~--~l~~~is~--~L~dLI~ 245 (703)
+.|||||++.+. .|+.++|||||||+||||++|..||........ +..+. ...+. .....++. .+.+||.
T Consensus 68 ~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 68 PYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred ccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999999875 589999999999999999999999976543221 11111 11110 12334554 6999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhc
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
+||..+|.+||++.++++|+|+..
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHHH
Confidence 999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=252.02 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=214.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCC-----CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe-CCEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~t-----g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~-~~~l 86 (703)
.++++..++-+|.||.||.|++.+. .+.|.+|.++....+-++..+..|..++..+.|||+..+.+++.. ....
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 4688899999999999999987653 345778888777777778889999999999999999999998765 4577
Q ss_pred EEEEeccCCCCHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccc
Q 005298 87 WIIMEYMAGGSVADLIQS--------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~--------~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
++++.+..-|+|..++.. ...++..++..++.||..|++|||++||||.||-..|.+|++.-+|||+|-.++
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhc
Confidence 888999999999999972 124667788889999999999999999999999999999999999999999988
Q ss_pred hhhhhccccc--ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchh
Q 005298 159 AQLTRTISRR--KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEH 235 (703)
Q Consensus 159 ~~~~~~~~~~--~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~ 235 (703)
+.+....... ..--....||+||.+.+. .|+.++|+|||||+||||+| |+.||.+.++.++...+..+....-+.+
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~N 522 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFN 522 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCC
Confidence 7654321110 001224569999999886 59999999999999999987 9999999999999999998888888889
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
+|+++..++..||...|++||+++|+..
T Consensus 523 CPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 523 CPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9999999999999999999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=276.01 Aligned_cols=257 Identities=27% Similarity=0.404 Sum_probs=207.1
Q ss_pred Cc-eEEEEEeecCceEEEEEEEcCCCcEEEEEEecc----CCCh-HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 14 RF-SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL----EESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 14 ~Y-~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~----~~~~-~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
+| ....++|.|++|.|+.+........++.|.+.. .... .....+..|+.+-..|.||||+..+..+.+....+
T Consensus 318 ~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~ 397 (601)
T KOG0590|consen 318 KYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL 397 (601)
T ss_pred ccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch
Confidence 45 456789999999998888877777677665542 1111 22233778888889999999998888877777666
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
-+||||++ +|+.++.....+...++..++.||+.||.|||+.||.||||||+||+++..|.+||+|||.+..+..+...
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 67999999 99999998889999999999999999999999999999999999999999999999999998766443332
Q ss_pred ----cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee-cc----C---CCCCCCcchh
Q 005298 168 ----RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF-II----P---RENPPQLDEH 235 (703)
Q Consensus 168 ----~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~-~I----~---~~~~~~l~~~ 235 (703)
....+|+-.|+|||++...++....+||||+|++++.|++|+.||......+..+ .. . ...+..+...
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 3457899999999999887755567899999999999999999997654443321 11 0 1123334456
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
++...+.+|.+||+++|.+|.|+++|++.+||+.+.
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 788899999999999999999999999999998763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=242.65 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=192.4
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEE-EEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYG-SYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~-~~~~~~~lyL 88 (703)
....|.|.+.||+|.||.+.+|.++.++..+++|.+.... ..+..|.+|...--.| .|.||+.-|+ .|++-+.+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 3468999999999999999999999999999999986553 3357788888765555 5899998887 6777888999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC--CCCeeEeccccchhhhhccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE--NGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~--~g~VKL~DFGlA~~~~~~~~ 166 (703)
++||++-|+|..-+.. ..+-|.....++.|++.||+|||++++||||||.+||||-. ...|||||||+....+....
T Consensus 100 ~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred eeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence 9999999999998865 55889999999999999999999999999999999999953 35799999998755433221
Q ss_pred ccccccCCCCCCchhhhcccc----CCccccchhhHHHHHHHHHhCCCCCCCCCcccee----eccCCCC---CCCcchh
Q 005298 167 RRKTFVGTPFWMAPEVIQNSE----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL----FIIPREN---PPQLDEH 235 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~----~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l----~~I~~~~---~~~l~~~ 235 (703)
. .--+..|.+||++.... ...+.+|||.||+|+|.+|||.+||.....++.. .+-.... .|..-..
T Consensus 179 ~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~ 255 (378)
T KOG1345|consen 179 Y---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNP 255 (378)
T ss_pred h---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcc
Confidence 1 22356689999865321 2456789999999999999999999743221111 0111111 1222345
Q ss_pred hhHHHHHHHHHHhccCCCCC---CCHHHHHhchhhh
Q 005298 236 FSRLMKEFVSLCLKKVPAER---PSAKELLRHRFIR 268 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~R---PTa~eLL~Hpff~ 268 (703)
+++.+..+.++-|.+++++| -++....+..|..
T Consensus 256 fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 256 FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 67888899999999999999 4555555555553
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=237.73 Aligned_cols=248 Identities=23% Similarity=0.292 Sum_probs=196.5
Q ss_pred CceEEEEEeecCceEEEEEEEcCCC-cEEEEEEeccCCChHHHHHHHHHHHHHHhCCC----CCeeeeEEEE-EeCCEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEESEDEIEDIQKEISVLSQCRS----PYITEYYGSY-LHQTKLW 87 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg-~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H----PnIV~L~~~~-~~~~~ly 87 (703)
+|++.+.||+|+||.||+|.+..++ ..+|+|+.......... .+..|+.++..+.. +++..+++.. ..+...|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 8999999999999999999998875 68999987654322222 68889999998873 6899999999 4778899
Q ss_pred EEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC-----CCeeEeccccch-
Q 005298 88 IIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-----GDVKVADFGVSA- 159 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~-----g~VKL~DFGlA~- 159 (703)
|||+.+ |.+|.++.... +.|+...+..++.|++.+|.+||+.|+|||||||.|+++... ..+.|.|||+++
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 999999 89999998654 579999999999999999999999999999999999999865 359999999998
Q ss_pred -hhhhccc-------c-cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---CC
Q 005298 160 -QLTRTIS-------R-RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---RE 227 (703)
Q Consensus 160 -~~~~~~~-------~-~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~---~~ 227 (703)
.+..... . ...+.||..|.++....+.+ .+.+.|+||++.++.+|+.|.+||...........+. ..
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 3221111 1 22466999999999998864 8999999999999999999999997665332222111 11
Q ss_pred CCCC-cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 228 NPPQ-LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 228 ~~~~-l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.... +....+..+..+...+-..+...+|....+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1111 233456777888888877899999998888753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=260.11 Aligned_cols=242 Identities=25% Similarity=0.456 Sum_probs=207.7
Q ss_pred EEeecCceEEEEEEE---cCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEEEEeccC
Q 005298 20 LIGRGSFGDVYKAFD---KELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYMA 94 (703)
Q Consensus 20 ~LG~GsfG~Vyka~d---~~tg~~VAIKvi~~~~~~-~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyLV~Eyv~ 94 (703)
++|.|+||.|+++.. .+.|..||+|+.++.... ........|..++..++ ||++|+++..|+.+..+|++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998643 456889999998655421 11226677888898887 9999999999999999999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCC
Q 005298 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174 (703)
Q Consensus 95 gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGT 174 (703)
||.|...+.....+.+.....+...++.+++++|..+|+|||+|++||+++.+|++++.|||+++....... .|||
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~cgt 156 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----ACGT 156 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----cccc
Confidence 999999999888999999999999999999999999999999999999999999999999999887654432 2999
Q ss_pred CCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCC
Q 005298 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAE 254 (703)
Q Consensus 175 p~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~ 254 (703)
..|||||++. ++...+|+||||+++|+|++|..||.. +....|.+.. ...+..++..+++++..++.++|..
T Consensus 157 ~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~-~~~p~~l~~~a~~~~~~l~~r~p~n 228 (612)
T KOG0603|consen 157 YEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE-LEMPRELSAEARSLFRQLFKRNPEN 228 (612)
T ss_pred hhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-cCCchhhhHHHHHHHHHHHhhCHHH
Confidence 9999999997 367889999999999999999999987 4455555433 3567889999999999999999999
Q ss_pred CCC-----HHHHHhchhhhccccC
Q 005298 255 RPS-----AKELLRHRFIRNARKS 273 (703)
Q Consensus 255 RPT-----a~eLL~Hpff~~~~~~ 273 (703)
|.. +.++++|+||+.+.+.
T Consensus 229 rLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 229 RLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HhccCcchhHHHhccchheeeeHh
Confidence 974 5899999999987543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=240.43 Aligned_cols=166 Identities=19% Similarity=0.223 Sum_probs=132.2
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcC-CCcEEEEEEeccCC----ChHHHHHHHHHHHHHHhCCCCCeee-eEEEEEeC
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITE-YYGSYLHQ 83 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~-tg~~VAIKvi~~~~----~~~~~~~l~~Ei~ILk~L~HPnIV~-L~~~~~~~ 83 (703)
....+|++.+.||+|+||+||+|++.. +++.||||++.... .......+.+|+.+|++|+|+||++ +++ .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence 345689999999999999999999876 68888999875331 2334567999999999999999985 443 2
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeee-ccceEEecCCCCeeEeccccchhhh
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI-KAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDI-KPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
+..|||||||+|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||++..+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 457999999999999732 11 11 1568899999999999999999999 9999999989999999999998654
Q ss_pred hcccc--------cccccCCCCCCchhhhccc
Q 005298 163 RTISR--------RKTFVGTPFWMAPEVIQNS 186 (703)
Q Consensus 163 ~~~~~--------~~~~iGTp~Y~APEvl~~~ 186 (703)
..... ....++++.|++||++...
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 32211 1245788999999988643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=217.86 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=199.9
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyL 88 (703)
+++-+|++.+.||+|+||..|.|.+.-++++||||.-... ....++..|....+.|. .++|...|.+..++.+-.|
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 6778999999999999999999999999999999985433 23467888999988886 5999999999999999999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC-----CCeeEeccccchhhh
Q 005298 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-----GDVKVADFGVSAQLT 162 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~-----g~VKL~DFGlA~~~~ 162 (703)
|+|++ |.+|.++..- +..|+...+..++.|++.-++|+|++.+|+|||||+|+||... ..|.|+|||+|+.+.
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99999 8888888753 5679999999999999999999999999999999999999754 359999999999886
Q ss_pred hccccc-------ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCC---ccceeeccCCCC----
Q 005298 163 RTISRR-------KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH---PMRVLFIIPREN---- 228 (703)
Q Consensus 163 ~~~~~~-------~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~---~~~~l~~I~~~~---- 228 (703)
.+.+.. ....||..||+-.-..+.+ .+.+.|+-|||-|++++|-|.+||.+.. ....+.+|-...
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 654432 3457999999998888875 7889999999999999999999997653 233334443221
Q ss_pred CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHH
Q 005298 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261 (703)
Q Consensus 229 ~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eL 261 (703)
...+...+|.++...+.-.-..+-.+-|..+=+
T Consensus 260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 260 IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 122345677777776666666666667776443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=211.33 Aligned_cols=244 Identities=22% Similarity=0.327 Sum_probs=195.7
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC-CCeeeeEEEEEeCCEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H-PnIV~L~~~~~~~~~lyL 88 (703)
.++++|++++.||.|+||.+|.|+....|..||||+-.... ...++..|..+.+.|.+ ..|..+..+..+...-.+
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 46789999999999999999999999999999999854322 23567789999999975 788888888889999999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC---CCCeeEeccccchhhhhc
Q 005298 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~---~g~VKL~DFGlA~~~~~~ 164 (703)
||+++ |.+|.++..- ...|+...+.-++-|++.-|+|+|.+++|||||||+|+|+.- ...+.|+|||+++.+...
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 99999 8899998752 457899999999999999999999999999999999999963 356999999999876543
Q ss_pred ccc-------cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---ceeeccCCC----CCC
Q 005298 165 ISR-------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---RVLFIIPRE----NPP 230 (703)
Q Consensus 165 ~~~-------~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~---~~l~~I~~~----~~~ 230 (703)
.+. .....||..|.+-....+.+ .+.+.|+-|+|.+|.++.-|.+||.+.... ..+.+|... .+.
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE 246 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence 222 23457999999988877654 678899999999999999999999876432 223333322 122
Q ss_pred CcchhhhHHHHHHHHHHhccCCCCCCCH
Q 005298 231 QLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (703)
Q Consensus 231 ~l~~~is~~L~dLI~~cL~~dP~~RPTa 258 (703)
.+-..+|.++.-.+.-|-..--++-|..
T Consensus 247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 247 VLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred HHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 3445677888888888877777777764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=238.80 Aligned_cols=227 Identities=30% Similarity=0.528 Sum_probs=179.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
....|..+++|..|+||.||.++++.+.+.+|+|+ ++++. +.+ +|+....+|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l------ilR--nilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL------ILR--NILTFAGNPFVV---------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch------hhh--ccccccCCccee----------------
Confidence 34689999999999999999999999999999955 32220 111 145555566666
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc----
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---- 166 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~---- 166 (703)
|+-..+++.-++++.+. +.+++|||+.||+|||+||+|.||+.-|++|+.|||+.+.......
T Consensus 136 -----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 56666666667777654 7899999999999999999999999999999999999764321100
Q ss_pred -----------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--Ccc
Q 005298 167 -----------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLD 233 (703)
Q Consensus 167 -----------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~--~l~ 233 (703)
.....||||.|.|||++... +|+..+|||++|+|+||++-|..||.+..+.+++..+...... +-.
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d 281 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED 281 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC
Confidence 01235999999999999764 6999999999999999999999999999888777665544322 225
Q ss_pred hhhhHHHHHHHHHHhccCCCCCC---CHHHHHhchhhhccccChhH
Q 005298 234 EHFSRLMKEFVSLCLKKVPAERP---SAKELLRHRFIRNARKSPRL 276 (703)
Q Consensus 234 ~~is~~L~dLI~~cL~~dP~~RP---Ta~eLL~Hpff~~~~~~~~l 276 (703)
..++++++++|.++|..+|..|. .+-++.+|+||+...+...+
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~ll 327 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLL 327 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhh
Confidence 57789999999999999999995 57889999999987665433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=203.34 Aligned_cols=140 Identities=20% Similarity=0.227 Sum_probs=112.1
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HH-----------------------HHHHHHHHHHHHhCCCCC
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DE-----------------------IEDIQKEISVLSQCRSPY 72 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~--~~-----------------------~~~l~~Ei~ILk~L~HPn 72 (703)
...||.|+||.||+|.+. +|+.||||+++..... .. ......|+.++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 8999999998654211 00 123345999999998877
Q ss_pred eeeeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhcCceeeeeccceEEecCCCCee
Q 005298 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL-HNEGKIHRDIKAANILLTENGDVK 151 (703)
Q Consensus 73 IV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yL-Hs~gIVHRDIKPeNILLd~~g~VK 151 (703)
|...+.+.... .||||||++|++|...+....++++..+..++.||+.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 75443332222 389999999988876654557899999999999999999999 799999999999999998 57899
Q ss_pred Eeccccchhh
Q 005298 152 VADFGVSAQL 161 (703)
Q Consensus 152 L~DFGlA~~~ 161 (703)
|+|||++...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=205.30 Aligned_cols=233 Identities=21% Similarity=0.314 Sum_probs=152.8
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCC----------CCeeeeEEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS----------PYITEYYGSYL 81 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~H----------PnIV~L~~~~~ 81 (703)
.+...+.||.|+++.||.+.+..||+.+|||++.... .....+.+++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 5566789999999999999999999999999985444 23456777777755555432 12222222222
Q ss_pred ---------eC---C-----EEEEEEeccCCCCHHHHHH---cCCC----CCHHHHHHHHHHHHHHHHHHHhcCceeeee
Q 005298 82 ---------HQ---T-----KLWIIMEYMAGGSVADLIQ---SGPP----LDEMSIACILRDLLHAIEYLHNEGKIHRDI 137 (703)
Q Consensus 82 ---------~~---~-----~lyLV~Eyv~gGsL~~~l~---~~~~----L~e~~i~~i~~QLl~AL~yLHs~gIVHRDI 137 (703)
.. . +.+++|+-+ .++|..++. .... +.......+..|+++.+++||.+|+||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 236777777 578888764 2221 222233445589999999999999999999
Q ss_pred ccceEEecCCCCeeEeccccchhhhhcccccccccCCCCCCchhhhccc-------cCCccccchhhHHHHHHHHHhCCC
Q 005298 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS-------EGYNEKADIWSLGITVIEMAKGEP 210 (703)
Q Consensus 138 KPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~-------~~~s~ksDVWSLGvILyELLtG~~ 210 (703)
||+|+|++.+|.++|+||+.....+... .....+..|.+||..... -.++.+.|.|+||+++|.|++|..
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999999999999765443321 113456789999977442 136788999999999999999999
Q ss_pred CCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 211 PLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 211 PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
||........... ....+. ++|..++.||..+|.++|.+|
T Consensus 249 Pf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9986543322211 122344 789999999999999999887
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=193.97 Aligned_cols=142 Identities=18% Similarity=0.227 Sum_probs=114.3
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-------------------------HHHHHHHHHHHHHHhCCCC
Q 005298 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-------------------------DEIEDIQKEISVLSQCRSP 71 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-------------------------~~~~~l~~Ei~ILk~L~HP 71 (703)
+.+.||.|+||.||+|.+. +|+.||||+++..... -....+..|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999988 8999999998754210 0022346899999999999
Q ss_pred CeeeeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCe
Q 005298 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDV 150 (703)
Q Consensus 72 nIV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~V 150 (703)
+|.....+.... .||||||++|+++...+....+++...+..++.|++.+|.+||. +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 886555444333 48999999988655443344678899999999999999999999 9999999999999998 7899
Q ss_pred eEeccccchhhh
Q 005298 151 KVADFGVSAQLT 162 (703)
Q Consensus 151 KL~DFGlA~~~~ 162 (703)
+|+|||++..+.
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999986553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.2e-22 Score=202.11 Aligned_cols=175 Identities=16% Similarity=0.231 Sum_probs=135.8
Q ss_pred hhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHH------HHHHHHHHHhCCCCCeeeeEEE
Q 005298 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIED------IQKEISVLSQCRSPYITEYYGS 79 (703)
Q Consensus 8 ~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~--~~~~~------l~~Ei~ILk~L~HPnIV~L~~~ 79 (703)
.....++|+++++||.|+||.||++.+ ++..||||++...... ..... +.+|+..+.+|.||+|+.+.++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 345678999999999999999999644 4778999999654422 22233 5789999999999999999998
Q ss_pred EEeC--------CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCee
Q 005298 80 YLHQ--------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (703)
Q Consensus 80 ~~~~--------~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VK 151 (703)
+... +..+|||||++|.+|.++.. +++ ..+.+|+.+|..||..|++||||||+||+++.+| ++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 7643 35799999999999988732 333 3466999999999999999999999999999988 99
Q ss_pred EeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHH
Q 005298 152 VADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA 206 (703)
Q Consensus 152 L~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELL 206 (703)
|+|||........... ..++.. ..|+.++|+|+||++|..+.
T Consensus 175 liDfg~~~~~~e~~a~------------d~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK------------DRIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH------------HHHHHH-hHhcccccccceeEeehHHH
Confidence 9999976544211110 112333 34678999999999987764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-21 Score=192.31 Aligned_cols=189 Identities=15% Similarity=0.110 Sum_probs=143.2
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC---hHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEEEE
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES---EDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~---~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyLV~ 90 (703)
+.+...|++|+||+||.+.. .+.+|+.+.+....- .-....+.+|+++|++|. |++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 45778999999999997765 477888777654332 111235789999999995 5889999885 4469999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeee-ccceEEecCCCCeeEeccccchhhhhcccc--
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI-KAANILLTENGDVKVADFGVSAQLTRTISR-- 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDI-KPeNILLd~~g~VKL~DFGlA~~~~~~~~~-- 167 (703)
||+.|.+|...+.. . ...++.|++.+|.+||.+||+|||| ||+|||++.+|.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999999765422 1 2357889999999999999999999 799999999999999999999754322210
Q ss_pred -----------cccccCCCCCCchhhhccccCCc-cccchhhHHHHHHHHHhCCCCCCCCC
Q 005298 168 -----------RKTFVGTPFWMAPEVIQNSEGYN-EKADIWSLGITVIEMAKGEPPLADLH 216 (703)
Q Consensus 168 -----------~~~~iGTp~Y~APEvl~~~~~~s-~ksDVWSLGvILyELLtG~~PF~~~~ 216 (703)
..-...++.|+.|+...-....+ ...++++.|+-+|.++|+..|+...+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00123688899999754332233 45688899999999999999876543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-22 Score=231.95 Aligned_cols=243 Identities=22% Similarity=0.304 Sum_probs=183.4
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC---hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES---EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~---~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
+|...+.||.+-|=+|.+|++.+ |. |+||++-+... -....+...|++ ...++|||++++.-+...+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78899999999999999998874 44 99999855542 223344445555 66679999999999888888899999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc---cc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI---SR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~---~~ 167 (703)
+|+ .-+|++.+..++-+...+-+.|++||+.||.-||..||+|||||.+||||+.-+.+.|+||..-+...-+. ..
T Consensus 101 qyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 999 56999999888888888999999999999999999999999999999999999999999998654332111 11
Q ss_pred ccccc----CCCCCCchhhhcccc----------CCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCC---CC
Q 005298 168 RKTFV----GTPFWMAPEVIQNSE----------GYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE---NP 229 (703)
Q Consensus 168 ~~~~i----GTp~Y~APEvl~~~~----------~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~---~~ 229 (703)
...+. .-.+|.|||-+.... ..++++||||+||+++||++ |.+||.-. .+.....+ .+
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGNADDP 255 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccCccCH
Confidence 11122 234599999875421 15678999999999999876 78888421 11111111 11
Q ss_pred CCcchhh-hHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 230 PQLDEHF-SRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 230 ~~l~~~i-s~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
..+-..+ +..++++|..|++.||.+|.+|++.|+.
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111111 2358999999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.1e-20 Score=186.06 Aligned_cols=134 Identities=19% Similarity=0.265 Sum_probs=108.8
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-----CCCCeeeeEEEEEeCC---E-EE
Q 005298 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-----RSPYITEYYGSYLHQT---K-LW 87 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-----~HPnIV~L~~~~~~~~---~-ly 87 (703)
-.+.||+|+||.||. ++.++.. +||++..... .....+.+|+.+++.+ .||||+++|+++.++. . +.
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 357899999999995 7777666 6999876432 2346789999999999 6799999999999874 4 33
Q ss_pred EEEec--cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHhcCceeeeeccceEEecCC----CCeeEecccc
Q 005298 88 IIMEY--MAGGSVADLIQSGPPLDEMSIACILRDLLHAI-EYLHNEGKIHRDIKAANILLTEN----GDVKVADFGV 157 (703)
Q Consensus 88 LV~Ey--v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL-~yLHs~gIVHRDIKPeNILLd~~----g~VKL~DFGl 157 (703)
+|+|| +.+++|.+++++. .+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5579999999774 57666 36688888888 99999999999999999999743 3799999543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-20 Score=196.88 Aligned_cols=188 Identities=27% Similarity=0.375 Sum_probs=144.0
Q ss_pred CCCCeeeeEEEEEe---------------------------CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHH
Q 005298 69 RSPYITEYYGSYLH---------------------------QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLL 121 (703)
Q Consensus 69 ~HPnIV~L~~~~~~---------------------------~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl 121 (703)
+|||||+++.+|.+ ...+|+||..+ ..+|..|+..+. .+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 59999999988752 33589999888 469999997744 55667778899999
Q ss_pred HHHHHHHhcCceeeeeccceEEecC--C--CCeeEeccccchhhhh------cccccccccCCCCCCchhhhccccCCc-
Q 005298 122 HAIEYLHNEGKIHRDIKAANILLTE--N--GDVKVADFGVSAQLTR------TISRRKTFVGTPFWMAPEVIQNSEGYN- 190 (703)
Q Consensus 122 ~AL~yLHs~gIVHRDIKPeNILLd~--~--g~VKL~DFGlA~~~~~------~~~~~~~~iGTp~Y~APEvl~~~~~~s- 190 (703)
+|+.|||.+||.|||+|.+||||.- + ..+.|+|||.|---.. .....-..-|.-.-||||+.....+..
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999999953 3 3589999997632111 001112245788899999986543211
Q ss_pred ----cccchhhHHHHHHHHHhCCCCCCCCCcccee-eccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCH
Q 005298 191 ----EKADIWSLGITVIEMAKGEPPLADLHPMRVL-FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (703)
Q Consensus 191 ----~ksDVWSLGvILyELLtG~~PF~~~~~~~~l-~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa 258 (703)
.++|.|++|.+.||+++...||+....+-.. ........|.++..+++.+++++..+|+.||.+|++.
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 3789999999999999999999874432211 1233445677889999999999999999999999984
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=186.46 Aligned_cols=144 Identities=22% Similarity=0.229 Sum_probs=116.2
Q ss_pred CCceEEEEEeecCceEEEEEE-EcCCCcEEEEEEeccCCCh-----------------------HHHHHHHHHHHHHHhC
Q 005298 13 SRFSSLELIGRGSFGDVYKAF-DKELNKDVAIKVIDLEESE-----------------------DEIEDIQKEISVLSQC 68 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~-d~~tg~~VAIKvi~~~~~~-----------------------~~~~~l~~Ei~ILk~L 68 (703)
.-|++.+.||.|+||.||+|. +..+|+.||||+++..... .....+..|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358999999999999999999 6678999999998654210 0113467899999999
Q ss_pred CCC--CeeeeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcC-ceeeeeccceEEec
Q 005298 69 RSP--YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG-KIHRDIKAANILLT 145 (703)
Q Consensus 69 ~HP--nIV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~g-IVHRDIKPeNILLd 145 (703)
.+. .+.++++. ...||||||+.|.+|..++.....+....+..++.||+.+|.+||.+| |+||||||+||+++
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 753 34444432 235899999999888876645566777778899999999999999999 99999999999999
Q ss_pred CCCCeeEeccccchhh
Q 005298 146 ENGDVKVADFGVSAQL 161 (703)
Q Consensus 146 ~~g~VKL~DFGlA~~~ 161 (703)
++.++|+|||++...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 889999999987644
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-19 Score=210.17 Aligned_cols=241 Identities=25% Similarity=0.322 Sum_probs=179.1
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCCeeeeEEEEEeCCE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGSYLHQTK 85 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~---HPnIV~L~~~~~~~~~ 85 (703)
+..+.+|.|-+.||+|+||+||+|.... |+.||+|+-+.... -.++--.+++.+|+ -+.|..+..++.-.+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP----WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc----eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3445699999999999999999999887 99999999654431 11222334455555 2456777777777888
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC-------CCeeEeccccc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-------GDVKVADFGVS 158 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~-------g~VKL~DFGlA 158 (703)
-+||+||.+.|+|.++++....+++..+..+..||+.-|++||..+|||+||||+|+||... --++|+|||.+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 89999999999999999988899999999999999999999999999999999999999532 24999999988
Q ss_pred hhhh--hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhh
Q 005298 159 AQLT--RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF 236 (703)
Q Consensus 159 ~~~~--~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~i 236 (703)
..+. .........++|-.+-++|+..+. .+++.+|.|.|+.++|-||.|++-= -.+...+. ....++..+
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~y~q-~~~g~~~~------~~~~~~Ry~ 920 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGKYME-VKNGSSWM------VKTNFPRYW 920 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHHHHH-hcCCccee------ccccchhhh
Confidence 6553 233445567899999999999876 5999999999999999999997532 00100000 011122222
Q ss_pred h-HHHHHHHHHHhccCCCCCCCHHHHH
Q 005298 237 S-RLMKEFVSLCLKKVPAERPSAKELL 262 (703)
Q Consensus 237 s-~~L~dLI~~cL~~dP~~RPTa~eLL 262 (703)
. ....+|+..+|..+-..=|...+|.
T Consensus 921 ~~~~W~~~F~~lLN~~~~~~p~l~~lr 947 (974)
T KOG1166|consen 921 KRDMWNKFFDLLLNPDCDTLPNLQELR 947 (974)
T ss_pred hHHHHHHHHHHHhCcCcccchhHHHHH
Confidence 2 2345778888884444445555543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.2e-21 Score=219.40 Aligned_cols=258 Identities=26% Similarity=0.354 Sum_probs=214.9
Q ss_pred CCCceEEEEEeecCceEEEEEEEcC-CCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~-tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyL 88 (703)
...|.+.+.||+|+|+.|-...+.. ....+|+|.+.... ......++..|..+-+.+. |+|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 5579999999999999999887743 45667788775543 4455677888999999997 9999999999999999999
Q ss_pred EEeccCCCCHHHHH-HcCC-CCCHHHHHHHHHHHHHHHHHHH-hcCceeeeeccceEEecCCC-CeeEeccccchhhhh-
Q 005298 89 IMEYMAGGSVADLI-QSGP-PLDEMSIACILRDLLHAIEYLH-NEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTR- 163 (703)
Q Consensus 89 V~Eyv~gGsL~~~l-~~~~-~L~e~~i~~i~~QLl~AL~yLH-s~gIVHRDIKPeNILLd~~g-~VKL~DFGlA~~~~~- 163 (703)
+++|..|++++..+ .... .++......++.|+..+|.|+| ..++.|+||||+|.+++..+ .+++.|||+|..+..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999999999 5554 7888899999999999999999 99999999999999999999 999999999987765
Q ss_pred cccc--cccccC-CCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeec--cCC--CCCCCcchhh
Q 005298 164 TISR--RKTFVG-TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI--IPR--ENPPQLDEHF 236 (703)
Q Consensus 164 ~~~~--~~~~iG-Tp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~--I~~--~~~~~l~~~i 236 (703)
.... ....+| ++.|+|||.+.+..+.....|+||+|+++.-|++|..||.........+. +.. .........+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSI 258 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccC
Confidence 2222 234688 99999999998766678899999999999999999999976543332211 111 1123445678
Q ss_pred hHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 237 s~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
+....+++.++|..+|..|.+.+++..++|+..
T Consensus 259 ~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 259 SDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ChhhhhcccccccCCchhccccccccccccccc
Confidence 888999999999999999999999999999986
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=172.85 Aligned_cols=135 Identities=25% Similarity=0.393 Sum_probs=114.6
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--h-----HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--E-----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~-----~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
++.||+|++|.||+|.+ .|..|+||+...... . .....+.+|+.++..+.|++|+....++...+..++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999987 578899998653221 1 11346778999999999999988777777888899999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccch
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
||++|++|.+++..... ....++.+|+.+|.+||..|++|+|++|.|||++ ++.++|+|||++.
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 99999999999875332 7889999999999999999999999999999999 7889999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.9e-18 Score=167.65 Aligned_cols=131 Identities=24% Similarity=0.358 Sum_probs=107.6
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeccCCC-------hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 20 ~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-------~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.||+|+||.||+|.. ++..|++|+...... .....++.+|+.++..+.|++|....-++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 578899998643221 11235678899999999988766555556667778999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchh
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
++|++|.+++..... .++.||+.+|.+||..|++|+|++|.||+++ ++.++|+|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765321 8899999999999999999999999999999 78999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-19 Score=196.44 Aligned_cols=176 Identities=27% Similarity=0.451 Sum_probs=135.1
Q ss_pred CEEEEEEeccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchh
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~---~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
.++||.|++|...+|.++|.+.. ..+......++.|+..+++| +|.+|+|+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 35899999999999999997543 46677899999999999999 9999999999999999999999999999876
Q ss_pred hhhcc------cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCC-Cc
Q 005298 161 LTRTI------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPP-QL 232 (703)
Q Consensus 161 ~~~~~------~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~-~l 232 (703)
..... .......||.+||+||+|.+. .|+.++|||+||+|||||+. -...|... .....+..+..+ .+
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGIIPPEF 481 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCCCChHH
Confidence 54332 234456899999999999885 59999999999999999987 23333221 122222222222 12
Q ss_pred chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 233 ~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
... .+.-..|+.+||.+.|.+||++.+.-.|+|.
T Consensus 482 ~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 482 LQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 222 2334579999999999999987777777664
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.4e-19 Score=179.92 Aligned_cols=239 Identities=22% Similarity=0.392 Sum_probs=190.1
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
..++..|...-.|+.|+|++. |..+++|+++.... ...-..|..|.-.|+-+.||||+.+++.|...-++.++..|+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 344556777888999999887 56677788765542 223356778888889999999999999999999999999999
Q ss_pred CCCCHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhcC--ceeeeeccceEEecCCCCeeEe--ccccchhhhhcccc
Q 005298 94 AGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVA--DFGVSAQLTRTISR 167 (703)
Q Consensus 94 ~gGsL~~~l~~~~~--L~e~~i~~i~~QLl~AL~yLHs~g--IVHRDIKPeNILLd~~g~VKL~--DFGlA~~~~~~~~~ 167 (703)
+-|+|+.++..... .+..++..++..|++|+.|||+.. |..--|....|+||++-+.+|. |--++-+
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq------- 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------- 342 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-------
Confidence 99999999987553 577889999999999999999885 4455688889999988766653 3322211
Q ss_pred cccccCCCCCCchhhhccccCC--ccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCcchhhhHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGY--NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~--s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~-~~~~~~l~~~is~~L~dLI 244 (703)
.....-.|.||+||.++..... -..+|+|||+++|+||.|...||.+..+++.-.+|. .+....++..+++.+..++
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM 422 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence 1123457899999999764321 246899999999999999999999999888766664 3446677889999999999
Q ss_pred HHHhccCCCCCCCHHHHH
Q 005298 245 SLCLKKVPAERPSAKELL 262 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL 262 (703)
.-|+..||.+||.+..|+
T Consensus 423 ~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHhcCCCCcCCCcceeh
Confidence 999999999999988876
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.4e-18 Score=167.99 Aligned_cols=138 Identities=23% Similarity=0.244 Sum_probs=110.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh---------------------HHHHHHHHHHHHHHhCCCC
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE---------------------DEIEDIQKEISVLSQCRSP 71 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~---------------------~~~~~l~~Ei~ILk~L~HP 71 (703)
..|.+.+.||.|+||.||++.+. +|+.||||+++..... ........|+.++..+.|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred chhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 35899999999999999999875 7999999987643210 0112356789999999877
Q ss_pred C--eeeeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC
Q 005298 72 Y--ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD 149 (703)
Q Consensus 72 n--IV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~ 149 (703)
+ ++.+++ ....++||||++|++|..+... .....++.+|+.++.++|..||+||||||+||+|+.++.
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 4 444443 2455999999999999876431 345678899999999999999999999999999999999
Q ss_pred eeEeccccchhh
Q 005298 150 VKVADFGVSAQL 161 (703)
Q Consensus 150 VKL~DFGlA~~~ 161 (703)
++|+|||++...
T Consensus 164 ~~liDfg~~~~~ 175 (198)
T cd05144 164 IYIIDWPQMVST 175 (198)
T ss_pred EEEEECCccccC
Confidence 999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.2e-17 Score=187.84 Aligned_cols=136 Identities=23% Similarity=0.322 Sum_probs=111.5
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccC--CC-----hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ES-----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~--~~-----~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
.|...+.||+|+||+||++.+... .+++|+.... .. ....+.+.+|+.++++++|++|+..+.++......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 456678999999999999987643 3444432111 11 11235688999999999999999888887777788
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchh
Q 005298 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
++||||++|++|.+++. ....++.||+.+|.|||++||+||||||+|||+ .++.++|+|||++..
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999885 457789999999999999999999999999999 577899999998754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.8e-17 Score=182.90 Aligned_cols=199 Identities=23% Similarity=0.467 Sum_probs=156.2
Q ss_pred HHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCc-eeeeeccceE
Q 005298 65 LSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGK-IHRDIKAANI 142 (703)
Q Consensus 65 Lk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gI-VHRDIKPeNI 142 (703)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.. ...+++.....+++.|+.||.|||.-.| +|+.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999987 5578888999999999999999998765 9999999999
Q ss_pred EecCCCCeeEeccccchhhhh--cccccccccCCCCCCchhhhccccC------CccccchhhHHHHHHHHHhCCCCCCC
Q 005298 143 LLTENGDVKVADFGVSAQLTR--TISRRKTFVGTPFWMAPEVIQNSEG------YNEKADIWSLGITVIEMAKGEPPLAD 214 (703)
Q Consensus 143 LLd~~g~VKL~DFGlA~~~~~--~~~~~~~~iGTp~Y~APEvl~~~~~------~s~ksDVWSLGvILyELLtG~~PF~~ 214 (703)
+++....+||.|||+...... .........-...|.|||.+..... .+.+.||||+|+++||+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999998765432 0011111223456999999876421 35678999999999999999999976
Q ss_pred CCcc----ceeeccCC-CCC---CCcc--hhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 215 LHPM----RVLFIIPR-ENP---PQLD--EHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 215 ~~~~----~~l~~I~~-~~~---~~l~--~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.... +....+.+ ... |.+. ..+++.+..++..||..+|..||+++++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 4322 23333333 221 1111 145567999999999999999999988754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-16 Score=156.85 Aligned_cols=132 Identities=22% Similarity=0.308 Sum_probs=98.9
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHH---------------------HHHHHHHHHHhCCCCC--
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIE---------------------DIQKEISVLSQCRSPY-- 72 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~--~~~~---------------------~l~~Ei~ILk~L~HPn-- 72 (703)
.+.||+|+||+||+|.+. +++.||||++...... .... ....|...+.++.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 7999999998653211 1111 1135666666665433
Q ss_pred eeeeEEEEEeCCEEEEEEeccCCCC-----HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecC
Q 005298 73 ITEYYGSYLHQTKLWIIMEYMAGGS-----VADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTE 146 (703)
Q Consensus 73 IV~L~~~~~~~~~lyLV~Eyv~gGs-----L~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~ 146 (703)
+.+++++ ...++||||++++. |.+... . ..+..++.+++.++.++|. ++|+|+||||+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-----~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-----L-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhh-----c-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-
Confidence 4455543 24599999999844 333221 1 6788999999999999999 9999999999999999
Q ss_pred CCCeeEeccccchhh
Q 005298 147 NGDVKVADFGVSAQL 161 (703)
Q Consensus 147 ~g~VKL~DFGlA~~~ 161 (703)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 889999999988544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=147.12 Aligned_cols=132 Identities=20% Similarity=0.288 Sum_probs=113.5
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC--CCeeeeEEEEEeCCEEEEEEeccC
Q 005298 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PYITEYYGSYLHQTKLWIIMEYMA 94 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H--PnIV~L~~~~~~~~~lyLV~Eyv~ 94 (703)
+++.||.|.++.||++.... ..++||++..... ...+..|+.+++.+.| .++++++.++...+..|++|||+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 56889999999999999864 7899999865433 4568899999999976 589999998888889999999999
Q ss_pred CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc---CceeeeeccceEEecCCCCeeEeccccchh
Q 005298 95 GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE---GKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 95 gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~---gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
|+.+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+.++|+|||++..
T Consensus 77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8877654 5567788899999999999985 699999999999999989999999998743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=157.26 Aligned_cols=135 Identities=20% Similarity=0.260 Sum_probs=106.0
Q ss_pred EEEe-ecCceEEEEEEEcCCCcEEEEEEeccCCC------------hHHHHHHHHHHHHHHhCCCCCe--eeeEEEEEeC
Q 005298 19 ELIG-RGSFGDVYKAFDKELNKDVAIKVIDLEES------------EDEIEDIQKEISVLSQCRSPYI--TEYYGSYLHQ 83 (703)
Q Consensus 19 ~~LG-~GsfG~Vyka~d~~tg~~VAIKvi~~~~~------------~~~~~~l~~Ei~ILk~L~HPnI--V~L~~~~~~~ 83 (703)
.+|| .|+.|+||++... +..++||.+..... ......+.+|+.++.+|.|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 5688 8999999998775 78899998743210 1223567889999999998775 6677664433
Q ss_pred C-E---EEEEEeccCC-CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccc
Q 005298 84 T-K---LWIIMEYMAG-GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 84 ~-~---lyLV~Eyv~g-GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
. . .+|||||++| .+|.+++.. .++++.. +.||+.+|.+||.+||+||||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2 3599999997 699999865 4566543 578999999999999999999999999998889999999986
Q ss_pred hh
Q 005298 159 AQ 160 (703)
Q Consensus 159 ~~ 160 (703)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 43
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.6e-16 Score=173.96 Aligned_cols=254 Identities=22% Similarity=0.215 Sum_probs=198.5
Q ss_pred CCCceEEEEEee--cCceEEEEEEE--cCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCE
Q 005298 12 GSRFSSLELIGR--GSFGDVYKAFD--KELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTK 85 (703)
Q Consensus 12 ~~~Y~il~~LG~--GsfG~Vyka~d--~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~ 85 (703)
...|.+...+|. |.+|.||.+.. ..++..+|+|.-+.... ...-..-.+|+...+.++ |+|+++.+..|...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 346778899999 99999999988 88899999998322211 111223345666666664 9999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCC-CCHHHHHHHHHHHHH----HHHHHHhcCceeeeeccceEEecCC-CCeeEeccccch
Q 005298 86 LWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLH----AIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSA 159 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~-L~e~~i~~i~~QLl~----AL~yLHs~gIVHRDIKPeNILLd~~-g~VKL~DFGlA~ 159 (703)
.|+-+|+| +.+|..++..... +++..++.++.++.. ||.++|+.+++|-|+||.||++..+ ...+++|||+..
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 99999999 5889998877655 899999999999999 9999999999999999999999998 789999999987
Q ss_pred hhhhccccccc-----ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcch
Q 005298 160 QLTRTISRRKT-----FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE 234 (703)
Q Consensus 160 ~~~~~~~~~~~-----~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~ 234 (703)
.+....-.... ..|...|++||.+.+. ++...|||+||.++.+-.++..++.......+...-....+..+-.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 76543211111 2578889999998753 7889999999999999888877665442222221111113334445
Q ss_pred hhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 235 ~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
..+..+...+..|+..+|..|++++.++.|+++.
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 5667777799999999999999999999998886
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1e-15 Score=179.49 Aligned_cols=262 Identities=23% Similarity=0.376 Sum_probs=211.7
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
...|.+++-+-.|+++.++.+.-..+|...++|+..+... ....+.+..+-.++-...+|.++..+..+......+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 3467888889999999999998888887778777543321 11233444444555555678888888777788899999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh------
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR------ 163 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~------ 163 (703)
++|+.+++|...++.-+..+++.++.++..+.++++|||...++|+|++|.|+|+..+|+.++.|||......-
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 99999999999999888899999999999999999999999999999999999999999999999984221100
Q ss_pred c----------------------c---cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Q 005298 164 T----------------------I---SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM 218 (703)
Q Consensus 164 ~----------------------~---~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~ 218 (703)
. . .......||+.|.+||.+.+.. .+..+|+|++|+++++.++|.+||....+.
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 0 0012357999999999998865 788899999999999999999999999888
Q ss_pred ceeeccCCCCCCCc--chhhhHHHHHHHHHHhccCCCCCCCHH---HHHhchhhhccccCh
Q 005298 219 RVLFIIPRENPPQL--DEHFSRLMKEFVSLCLKKVPAERPSAK---ELLRHRFIRNARKSP 274 (703)
Q Consensus 219 ~~l~~I~~~~~~~l--~~~is~~L~dLI~~cL~~dP~~RPTa~---eLL~Hpff~~~~~~~ 274 (703)
+....|.....++. +...+..+++++..+|..+|.+|..+. ++-.|+||+...+..
T Consensus 1042 ~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 88887776665443 356788899999999999999999877 899999999876543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-13 Score=156.29 Aligned_cols=183 Identities=19% Similarity=0.302 Sum_probs=141.6
Q ss_pred ceEEEEEeecCceEEE-EEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 15 FSSLELIGRGSFGDVY-KAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vy-ka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
|.+ ....-++.+ +| .|..+.++.+|.|.+.+.... ...+.+.+-++-|+.|+||||++|++.+...+.+|||+|-|
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV 91 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV 91 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc
Confidence 444 333333333 44 567778899999999876654 44567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH-NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 94 ~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLH-s~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
..|..++++ +....+...++||+.||.||| ..+++|++|.-.-|+|+..|..||++|.++..............
T Consensus 92 --~Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~ 166 (690)
T KOG1243|consen 92 --RPLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLY 166 (690)
T ss_pred --ccHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccch
Confidence 478888876 347788888999999999998 66899999999999999999999999998754432221112222
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhC
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG 208 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG 208 (703)
---.|..|+.+.... ...|.|-|||++++++.|
T Consensus 167 ~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 167 LIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhcccChhhcCccc---cchhhhhHHHHHHHHhCc
Confidence 233467777664322 457999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.3e-14 Score=159.13 Aligned_cols=143 Identities=20% Similarity=0.289 Sum_probs=98.8
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh---------------------------------HHHHHH
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE---------------------------------DEIEDI 58 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~---------------------------------~~~~~l 58 (703)
...|+. +.||.|++|+||+|+.+.+|+.||||+++..-.. +....+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 346776 7899999999999999988999999998643110 111223
Q ss_pred HHHHH------HHHhC----CCCCeeeeEEEEEe-CCEEEEEEeccCCCCHHHH--HHcCC----CCCHHHHHHHHHHHH
Q 005298 59 QKEIS------VLSQC----RSPYITEYYGSYLH-QTKLWIIMEYMAGGSVADL--IQSGP----PLDEMSIACILRDLL 121 (703)
Q Consensus 59 ~~Ei~------ILk~L----~HPnIV~L~~~~~~-~~~lyLV~Eyv~gGsL~~~--l~~~~----~L~e~~i~~i~~QLl 121 (703)
.+|+. .+.++ .+.+.+.+-.+|.+ ....+||||||+|+.|.++ +...+ .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 33333 33333 23333443343332 4456899999999999874 33322 345555666666665
Q ss_pred HHHHHHHhcCceeeeeccceEEecCCC----CeeEeccccchhhh
Q 005298 122 HAIEYLHNEGKIHRDIKAANILLTENG----DVKVADFGVSAQLT 162 (703)
Q Consensus 122 ~AL~yLHs~gIVHRDIKPeNILLd~~g----~VKL~DFGlA~~~~ 162 (703)
..|++|+|+||.||+++.+| .++++|||++..+.
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 58999999999999999887 99999999987654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.1e-13 Score=149.25 Aligned_cols=139 Identities=22% Similarity=0.345 Sum_probs=95.7
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHH---------------------------------HH------HHH
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE---------------------------------IE------DIQ 59 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~---------------------------------~~------~l~ 59 (703)
+.||.|++|+||+|..+ +|+.||||+.+..-.... .. .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999876 599999999754321100 00 123
Q ss_pred HHHHHHHhC----C-CCCeeeeEEEE-EeCCEEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 005298 60 KEISVLSQC----R-SPYITEYYGSY-LHQTKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLH-AIEYLHNEG 131 (703)
Q Consensus 60 ~Ei~ILk~L----~-HPnIV~L~~~~-~~~~~lyLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~-AL~yLHs~g 131 (703)
+|...+.++ . +++|. +-.+| ......+|||||++|++|.++.... ..++ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 344444444 2 33332 22222 2234569999999999999876431 1222 2345555555 478899999
Q ss_pred ceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 132 KIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 132 IVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
++|+|+||.||+++.+|.++|+|||++..+.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999986654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.6e-14 Score=148.77 Aligned_cols=204 Identities=22% Similarity=0.325 Sum_probs=144.0
Q ss_pred HHHHhCCCCCeeeeEEEEEeCC-----EEEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcC--
Q 005298 63 SVLSQCRSPYITEYYGSYLHQT-----KLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEG-- 131 (703)
Q Consensus 63 ~ILk~L~HPnIV~L~~~~~~~~-----~lyLV~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~g-- 131 (703)
.-|-++.|-|||+++.+|.+.+ ...++.||++.|+|..+|++ ...+......+|+-||+.||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3355667999999999997654 47899999999999999975 346889999999999999999999884
Q ss_pred ceeeeeccceEEecCCCCeeEeccccchhhh--hcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh
Q 005298 132 KIHRDIKAANILLTENGDVKVADFGVSAQLT--RTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK 207 (703)
Q Consensus 132 IVHRDIKPeNILLd~~g~VKL~DFGlA~~~~--~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt 207 (703)
|+|+++....|++..+|-+||.---...... ... .......|-++|.+||.=... ..+.++|||+||++..+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t-n~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT-NTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccc-ccccchhhhhhhHHHHHHHH
Confidence 9999999999999999988875322111100 000 011123567889999975443 35678999999999999987
Q ss_pred CCCCC-CCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 208 GEPPL-ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 208 G~~PF-~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
+..-- ........-..|..... .+. ...-+.+|.+||+..|..||++..++.||.+-+..
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~-~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVII-GLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred heeccCCCcceeehhhhhhhhee-ecc---CccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 75432 11111111111111000 000 11235789999999999999999999999875543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=7e-13 Score=127.36 Aligned_cols=127 Identities=17% Similarity=0.209 Sum_probs=96.7
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCee-eeEEEEEeCCEEEEEEeccCCC
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT-EYYGSYLHQTKLWIIMEYMAGG 96 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV-~L~~~~~~~~~lyLV~Eyv~gG 96 (703)
++.|+.|.++.||++... +..|++|+...... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 567899999999999865 78899999754321 123467899999988665544 444433 33458999999998
Q ss_pred CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCc-----eeeeeccceEEecCCCCeeEeccccch
Q 005298 97 SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK-----IHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 97 sL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gI-----VHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
++... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 77 ~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 87653 11123567899999999999985 9999999999998 6789999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.2e-13 Score=150.99 Aligned_cols=250 Identities=22% Similarity=0.216 Sum_probs=188.4
Q ss_pred hCCCceEEEEEeecCceEEEEEEEc-CCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDK-ELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~-~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~ly 87 (703)
...+|-++..||.|.|+.||.+... .++..|++|-+...-. ......-..|+-+...+ .|.+++.++..|......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3468999999999999999998755 6788999997643221 11112223455555555 5899999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC-CCeeEeccccchhhhhccc
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~-g~VKL~DFGlA~~~~~~~~ 166 (703)
|-.|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||..+.+....
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~- 421 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS- 421 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec-
Confidence 999999999998887655678899999999999999999999999999999999999886 788999999876532221
Q ss_pred ccccccCCCCCC-chhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHH
Q 005298 167 RRKTFVGTPFWM-APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 167 ~~~~~iGTp~Y~-APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
....+.-.++ .+|++.....+..+.|+++||..+++.++|...-.... ....|.....+..+.. ..++..+.+
T Consensus 422 --~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p~~~~~-~~~~q~~~k 495 (524)
T KOG0601|consen 422 --GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTPNLPGL-KLQLQVLLK 495 (524)
T ss_pred --ccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeecccccCCCch-HHhhhhhhh
Confidence 1233444455 36666655568889999999999999999875433322 2223333333333333 388999999
Q ss_pred HHhccCCCCCCCHHHHHhchhh
Q 005298 246 LCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.++.+++..||.+.++..|.-|
T Consensus 496 v~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 496 VMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhcCCccccchhhhhhcccchh
Confidence 9999999999999999887544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.3e-12 Score=127.29 Aligned_cols=140 Identities=20% Similarity=0.209 Sum_probs=102.2
Q ss_pred EEEEeecCceEEEEEEEcC------CCcEEEEEEeccCC------------C---------hHHHHHHH----HHHHHHH
Q 005298 18 LELIGRGSFGDVYKAFDKE------LNKDVAIKVIDLEE------------S---------EDEIEDIQ----KEISVLS 66 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~------tg~~VAIKvi~~~~------------~---------~~~~~~l~----~Ei~ILk 66 (703)
...||.|.-+.||.|.... .+..+|||+.+... . .+....+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998654 35799999864221 0 11122333 8999999
Q ss_pred hCCC--CCeeeeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhcCceeeeeccceEE
Q 005298 67 QCRS--PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL-HNEGKIHRDIKAANIL 143 (703)
Q Consensus 67 ~L~H--PnIV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yL-Hs~gIVHRDIKPeNIL 143 (703)
++.. -++..++++ ..-+|||||+.+..+....-+...+++..+..++.|++.+|..| |..||||+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8853 455566654 45689999997654432222234566677888899999999999 8999999999999999
Q ss_pred ecCCCCeeEeccccchhhh
Q 005298 144 LTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 144 Ld~~g~VKL~DFGlA~~~~ 162 (703)
++ ++.+.|+|||.+....
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 96 4689999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.8e-11 Score=119.58 Aligned_cols=140 Identities=17% Similarity=0.241 Sum_probs=106.8
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC--CCeeeeEEEEEeC---CEEEEEEec
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PYITEYYGSYLHQ---TKLWIIMEY 92 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H--PnIV~L~~~~~~~---~~lyLV~Ey 92 (703)
++.|+.|.++.||++.... |..|++|+............+..|+.+++.+.+ ..+.+++.+.... +..|+||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3678999999999998754 689999997544321234568899999999976 3456777766553 367899999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN------------------------------------------- 129 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs------------------------------------------- 129 (703)
++|.+|...+.. ..+++.....++.+++.+|.+||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999988876532 356777777777788888877773
Q ss_pred -------------cCceeeeeccceEEecC--CCCeeEeccccch
Q 005298 130 -------------EGKIHRDIKAANILLTE--NGDVKVADFGVSA 159 (703)
Q Consensus 130 -------------~gIVHRDIKPeNILLd~--~g~VKL~DFGlA~ 159 (703)
..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999998 5678999999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4e-10 Score=111.99 Aligned_cols=131 Identities=21% Similarity=0.322 Sum_probs=100.6
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEec-cCC-C---hH--HHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID-LEE-S---ED--EIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~-~~~-~---~~--~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+++|+-+.+|.+... |.++++|.-. +.. . +. ...+..+|..++.++.--.|...+=++.+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 46789999999999654 5567777532 211 1 11 13567789999999875555544545567778899999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccch
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
|++|..|.+++... ...+++.+-.-+.-||..||||+||.++||++..++ +.++||||+.
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 99999999998764 256777788888999999999999999999997654 9999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.5e-09 Score=119.19 Aligned_cols=212 Identities=15% Similarity=0.210 Sum_probs=153.5
Q ss_pred ceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe----CCEEEEEEeccCC-CCHHH
Q 005298 26 FGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QTKLWIIMEYMAG-GSVAD 100 (703)
Q Consensus 26 fG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~----~~~lyLV~Eyv~g-GsL~~ 100 (703)
-.+.|++....+|..|++|.+...... .....-.-+++++++.|+|||++.++|.+ +..++||++|.++ ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 357899999999999999998322211 11122345788999999999999999984 4578999999875 67887
Q ss_pred HHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 101 LIQS---------------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 101 ~l~~---------------~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
+.-. +...+|..+|.|+.||..||.++|+.|+..+-|.|.+||++.+..++|...|+...+....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 6521 3457899999999999999999999999999999999999988888888777543332211
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCC-CCCCCccceeeccCCCCCCCcchhhhHHHHHHH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPP-LADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~P-F~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI 244 (703)
+ |-+... .+-|.=.||.+++.|.||..- +........ -...+...++.+++++|
T Consensus 448 -------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s-------~~~~I~~~yS~D~rn~v 502 (655)
T KOG3741|consen 448 -------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSS-------HLTRITTTYSTDLRNVV 502 (655)
T ss_pred -------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHH-------HHHHhhhhhhHHHHHHH
Confidence 0 223222 356888999999999998532 111110000 01123456788899999
Q ss_pred HHHhccCCCCCCCHHHHHhc
Q 005298 245 SLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~H 264 (703)
..+...++.+ -++.+++.+
T Consensus 503 ~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 503 EYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHhcCccc-ccHHHHHHH
Confidence 9998888876 677888776
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.6e-09 Score=105.11 Aligned_cols=141 Identities=28% Similarity=0.355 Sum_probs=107.2
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-----Ch--HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-----SE--DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-----~~--~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
.+.+|-+|+-+.|+++.+. |+...||.-.... .+ -...+.++|+.+|.++.--.|.-..=+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 7889999999999999775 8888888632111 11 1245778999999998755554444456666777899
Q ss_pred EeccCC-CCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC---CeeEeccccch
Q 005298 90 MEYMAG-GSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVADFGVSA 159 (703)
Q Consensus 90 ~Eyv~g-GsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g---~VKL~DFGlA~ 159 (703)
|||++| .++.+++... ..........+++.|-+.|.-||.++|||+||..+||+|..+| .+.|+|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999976 4788888653 2333344478999999999999999999999999999998664 35899999863
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.3e-08 Score=107.49 Aligned_cols=130 Identities=15% Similarity=0.101 Sum_probs=92.7
Q ss_pred EEEEEEEcCCCcEEEEEEeccCCChHHHH----------HHHHHHHHHHhCCCC--CeeeeEEEEEe-----CCEEEEEE
Q 005298 28 DVYKAFDKELNKDVAIKVIDLEESEDEIE----------DIQKEISVLSQCRSP--YITEYYGSYLH-----QTKLWIIM 90 (703)
Q Consensus 28 ~Vyka~d~~tg~~VAIKvi~~~~~~~~~~----------~l~~Ei~ILk~L~HP--nIV~L~~~~~~-----~~~lyLV~ 90 (703)
.|+++.. .|+.|.||............ ...+|...+.+|..- ..++++.++.. ....+|||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555543 37789999764322111111 367888888777422 22233333332 23578999
Q ss_pred eccCCC-CHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC-------CCCeeEeccccch
Q 005298 91 EYMAGG-SVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-------NGDVKVADFGVSA 159 (703)
Q Consensus 91 Eyv~gG-sL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~-------~g~VKL~DFGlA~ 159 (703)
|++++. +|.+++.. ..+.+......++.+|...+.-||..||+|+|+++.||||+. ++.+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999886 89999864 345667788899999999999999999999999999999975 3579999999763
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.3e-08 Score=102.05 Aligned_cols=126 Identities=28% Similarity=0.418 Sum_probs=83.7
Q ss_pred EEEEEEEcCCCcEEEEEEeccCCC-------------------------hHHHHHHHHHHHHHHhCCCC--CeeeeEEEE
Q 005298 28 DVYKAFDKELNKDVAIKVIDLEES-------------------------EDEIEDIQKEISVLSQCRSP--YITEYYGSY 80 (703)
Q Consensus 28 ~Vyka~d~~tg~~VAIKvi~~~~~-------------------------~~~~~~l~~Ei~ILk~L~HP--nIV~L~~~~ 80 (703)
.||.|.... |..+|||+.+.... .-.....++|+..|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 489998854 88999998643210 01134567899999999765 45666543
Q ss_pred EeCCEEEEEEeccC--CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHhcCceeeeeccceEEecCCCCeeEecccc
Q 005298 81 LHQTKLWIIMEYMA--GGSVADLIQSGPPLDEMSIACILRDLLHAIEY-LHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (703)
Q Consensus 81 ~~~~~lyLV~Eyv~--gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~y-LHs~gIVHRDIKPeNILLd~~g~VKL~DFGl 157 (703)
..+ +|||||++ |..+..+.... ++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||.
T Consensus 79 -~~~--~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 79 -NRN--VIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp -ETT--EEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred -eCC--EEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 333 79999998 66666554321 2245567788888885555 579999999999999999877 899999997
Q ss_pred chhh
Q 005298 158 SAQL 161 (703)
Q Consensus 158 A~~~ 161 (703)
+...
T Consensus 153 av~~ 156 (188)
T PF01163_consen 153 AVDS 156 (188)
T ss_dssp EEET
T ss_pred ceec
Confidence 7543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=8.3e-10 Score=126.51 Aligned_cols=150 Identities=19% Similarity=0.331 Sum_probs=111.1
Q ss_pred HHHHHHHHHHhc-CceeeeeccceEEecCCCCeeEeccccchhhhhccc----ccc-----cccCCCCCCchhhhccccC
Q 005298 119 DLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS----RRK-----TFVGTPFWMAPEVIQNSEG 188 (703)
Q Consensus 119 QLl~AL~yLHs~-gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~----~~~-----~~iGTp~Y~APEvl~~~~~ 188 (703)
+...|+.|+|.. ++||++|.|++|.++..|.+||+.|+++.....+.. .+. ...-...|.|||++.. ..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 344899999966 899999999999999999999999998754432111 000 1134566999999987 45
Q ss_pred CccccchhhHHHHHHHHH-hCCCCCCCCCccceeeccC----CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 189 YNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIP----RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 189 ~s~ksDVWSLGvILyELL-tG~~PF~~~~~~~~l~~I~----~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.+.++|+|||||++|.+. .|+.-+...+.. ..+.+. ......+...++.++++-|.++|..++.-||++..++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 788999999999999999 555555443221 111111 11122344678899999999999999999999999999
Q ss_pred chhhhcc
Q 005298 264 HRFIRNA 270 (703)
Q Consensus 264 Hpff~~~ 270 (703)
-|||.+.
T Consensus 265 ~~ff~D~ 271 (700)
T KOG2137|consen 265 IPFFSDP 271 (700)
T ss_pred ccccCCc
Confidence 9999654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.3e-08 Score=102.74 Aligned_cols=135 Identities=27% Similarity=0.341 Sum_probs=104.3
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC---------------------hHHHHHHHHHHHHHHhCCCC--
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES---------------------EDEIEDIQKEISVLSQCRSP-- 71 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~---------------------~~~~~~l~~Ei~ILk~L~HP-- 71 (703)
+.+...||-|.-+.||.|.+. .|.++|||.=+.... .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456688999999999999988 599999997432110 01123567899999998654
Q ss_pred CeeeeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCee
Q 005298 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (703)
Q Consensus 72 nIV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VK 151 (703)
.|.+.++. +.-.+||||++|-.|... +++.+....++..|+.-+.-+-..||||+|+.+-|||++.+|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 56666543 556899999999777754 234566777788888888888899999999999999999999999
Q ss_pred Eeccccch
Q 005298 152 VADFGVSA 159 (703)
Q Consensus 152 L~DFGlA~ 159 (703)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99997553
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.9e-09 Score=122.48 Aligned_cols=242 Identities=28% Similarity=0.395 Sum_probs=176.5
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCC-eeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPn-IV~L~~~~~~~~~lyLV~E 91 (703)
..|....-+++|+++++||.+...+...+ .+++... ....-++++|.+++||| .+.+++-+..+...+|+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 34555566789999999999887766666 7776433 45667899999999999 8888888888899999999
Q ss_pred ccCCC-C-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 92 YMAGG-S-VADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 92 yv~gG-s-L~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
++.++ + ....-...-.+.+.+...+.+.-+++|+|+|+---+|+| ||+..+ +.+++.||+....+.... ..+
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~ 388 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPR 388 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccc
Confidence 99877 1 111111112344556667777888999999998778998 888765 679999999887776543 456
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCcch--hhhHHHH-HHHH
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDE--HFSRLMK-EFVS 245 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~-~~~l~~--~is~~L~-dLI~ 245 (703)
+..+++.+++||+.... .+..+.|+|++|+--.+|--|.+|-.. +......+.... .+.+.. ..+.... ++..
T Consensus 389 t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~ 465 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPA 465 (829)
T ss_pred cCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCcc
Confidence 78999999999988775 488899999999988888878777544 333333332221 111111 1122222 4788
Q ss_pred HHhccCCCCCCCHHHHHhchhhhcc
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.|+...|..++....++.|.+|..+
T Consensus 466 ~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 466 PCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred cccCCCCCCCcchhhHHHHHHhccC
Confidence 8999999999999999999999765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.2e-07 Score=101.75 Aligned_cols=240 Identities=16% Similarity=0.255 Sum_probs=153.1
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHh-CCCCCeee--------eEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CRSPYITE--------YYGSYLH 82 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~-L~HPnIV~--------L~~~~~~ 82 (703)
+.--...+.||+|+.+.+|-.-.. +.. +.|+......... . +-+..|.. -.||-+.. |++- ..
T Consensus 10 ge~i~~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~~-a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~ 81 (637)
T COG4248 10 GEPIPPGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAAQ-A---QKVAELAATPDAPLLNYRVAWPQATLHGG-RR 81 (637)
T ss_pred CcccCCCccccCCccceeeecchh--hch-hheeecCCCchHH-H---HHHHHhccCCCCcchhhhhcccHHHhhCC-Cc
Confidence 333445578999999999976322 223 3466543332211 1 11233333 35665433 2221 11
Q ss_pred CCEEEEEEeccCCCC-HHHHH------HcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecc
Q 005298 83 QTKLWIIMEYMAGGS-VADLI------QSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGs-L~~~l------~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DF 155 (703)
...+-++|..+.|.. ...+. +......+..+....+.|+.+..-||..|.+-+|+.++|||+..++.|.|.|-
T Consensus 82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcc
Confidence 223778888887652 22222 12345788999999999999999999999999999999999999999999986
Q ss_pred ccchhhhhcccccccccCCCCCCchhhhc-----cccCCccccchhhHHHHHHHHHhC-CCCCCCCCc-------cc---
Q 005298 156 GVSAQLTRTISRRKTFVGTPFWMAPEVIQ-----NSEGYNEKADIWSLGITVIEMAKG-EPPLADLHP-------MR--- 219 (703)
Q Consensus 156 GlA~~~~~~~~~~~~~iGTp~Y~APEvl~-----~~~~~s~ksDVWSLGvILyELLtG-~~PF~~~~~-------~~--- 219 (703)
..-.. ........+.+|.+.|.+||.-. +. .-+...|.|.||+++++||.| .+||.+... .+
T Consensus 162 Dsfqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~-~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 162 DSFQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGF-ERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred cceee-ccCCceEecccCccccCCHHHhcccccccc-CCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 53222 23334455678999999999632 21 245678999999999998876 999976421 11
Q ss_pred ----eeeccCC--C-CCCC---cchhhhHHHHHHHHHHhccC--CCCCCCHHHH
Q 005298 220 ----VLFIIPR--E-NPPQ---LDEHFSRLMKEFVSLCLKKV--PAERPSAKEL 261 (703)
Q Consensus 220 ----~l~~I~~--~-~~~~---l~~~is~~L~dLI~~cL~~d--P~~RPTa~eL 261 (703)
..+.-.. . .+++ ...-+++.++.++.+|+... +.-|||++.-
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 0000000 0 1111 11346788999999998743 6689998653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.4e-08 Score=97.96 Aligned_cols=104 Identities=24% Similarity=0.301 Sum_probs=82.8
Q ss_pred HHHHHHHHHHHhCCC--CCeeeeEEEEEeC----CEEEEEEeccCC-CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 005298 56 EDIQKEISVLSQCRS--PYITEYYGSYLHQ----TKLWIIMEYMAG-GSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128 (703)
Q Consensus 56 ~~l~~Ei~ILk~L~H--PnIV~L~~~~~~~----~~lyLV~Eyv~g-GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLH 128 (703)
....+|...+..|.. -.+++.+.+.... ...+||+|++++ .+|.+++.....++......++.++...+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 467788887777642 2234444444432 245899999988 489999987555778888999999999999999
Q ss_pred hcCceeeeeccceEEecCCC---CeeEeccccch
Q 005298 129 NEGKIHRDIKAANILLTENG---DVKVADFGVSA 159 (703)
Q Consensus 129 s~gIVHRDIKPeNILLd~~g---~VKL~DFGlA~ 159 (703)
.+||+|+|++|.|||++.++ .+.|+||+-+.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 99999999999999999887 79999999654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.2e-06 Score=85.49 Aligned_cols=136 Identities=21% Similarity=0.346 Sum_probs=83.3
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCC--CeeeeEEEEEe---CCEEEEEEec
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP--YITEYYGSYLH---QTKLWIIMEY 92 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HP--nIV~L~~~~~~---~~~lyLV~Ey 92 (703)
++.|+.|..+.||++.... ..+++|+.... .....+..|+.+++.|... .+.+++..... ....+++|+|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 5789999999999998875 49999997543 3456788899988887533 34566654432 3457999999
Q ss_pred cCCCCHHH----------------HHH---cC----CCCCHHH------HHH---H------------HHHHHH-HHHHH
Q 005298 93 MAGGSVAD----------------LIQ---SG----PPLDEMS------IAC---I------------LRDLLH-AIEYL 127 (703)
Q Consensus 93 v~gGsL~~----------------~l~---~~----~~L~e~~------i~~---i------------~~QLl~-AL~yL 127 (703)
++|..+.. .+. .. .++.... ... . +..+.. .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99988887 111 11 1111100 000 0 111222 33344
Q ss_pred Hh-------cCceeeeeccceEEec-CCCCeeEeccccc
Q 005298 128 HN-------EGKIHRDIKAANILLT-ENGDVKVADFGVS 158 (703)
Q Consensus 128 Hs-------~gIVHRDIKPeNILLd-~~g~VKL~DFGlA 158 (703)
+. ..++|+|+.|.|||++ .++.+.|+||+.+
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 32 3599999999999999 5666789999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.1e-06 Score=100.44 Aligned_cols=206 Identities=22% Similarity=0.289 Sum_probs=149.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE----EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 005298 53 DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL----WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128 (703)
Q Consensus 53 ~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l----yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLH 128 (703)
..+.....|...+.++.|+|++.++.+-...... .+..|+|..-++...++.-+.++....+.+..+++.||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 4455666788889999999999999987765433 344689999999999999999999999999999999999999
Q ss_pred hcCceeeeeccc---eEEecCCCCeeEe--ccccchhhhhcccccccccCCCCCCchhhhccccCCcc--ccchhhHHHH
Q 005298 129 NEGKIHRDIKAA---NILLTENGDVKVA--DFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE--KADIWSLGIT 201 (703)
Q Consensus 129 s~gIVHRDIKPe---NILLd~~g~VKL~--DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~--ksDVWSLGvI 201 (703)
+....|.-+... +-.++..+.+.++ ||+....+..... .....-+..|.+||...... +.. ..|+|.+|..
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLL 381 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCcccccccccccccc-chhhhhhHHHHHHHH
Confidence 997666655554 4444555667666 8887766543322 22345566788888776532 333 3699999999
Q ss_pred HHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 202 VIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 202 LyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+..+..|..+-..... ....++..+...+.+++.+|+.-++++|+++.+++.|+|.+..
T Consensus 382 ~~~~~~~~~i~~~~~~----------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV----------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred HhhhhhcCcccccccc----------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 9999887654321110 0111111222267888999999999999999999999998754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.1e-06 Score=87.75 Aligned_cols=136 Identities=18% Similarity=0.197 Sum_probs=98.8
Q ss_pred eecCceEEEEEEEcCCCcEEEEEEeccC--CC---hHHHHHHHHHHHHHHhCCC--CCeeeeEEEEEe--C--CEEEEEE
Q 005298 22 GRGSFGDVYKAFDKELNKDVAIKVIDLE--ES---EDEIEDIQKEISVLSQCRS--PYITEYYGSYLH--Q--TKLWIIM 90 (703)
Q Consensus 22 G~GsfG~Vyka~d~~tg~~VAIKvi~~~--~~---~~~~~~l~~Ei~ILk~L~H--PnIV~L~~~~~~--~--~~lyLV~ 90 (703)
|+||.+.|+..... |..|-+|.-... .. +.....+.+|+..|.+|.. -.+.++..+... + -..+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56899999997654 446888874311 00 2234678899999988843 124444422111 1 2468999
Q ss_pred eccCC-CCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC--eeEeccccch
Q 005298 91 EYMAG-GSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD--VKVADFGVSA 159 (703)
Q Consensus 91 Eyv~g-GsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~--VKL~DFGlA~ 159 (703)
|-+.| .+|.+++... .+.+......++.+|...|.-||..|+.|+|+.+.|||++.+|. |+++||.-+.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98754 6899988663 35577778899999999999999999999999999999987777 9999998543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.3e-06 Score=85.93 Aligned_cols=139 Identities=19% Similarity=0.240 Sum_probs=91.7
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHH--HH------HHHHHHHHHHhCC---CCCeeeeE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE--IE------DIQKEISVLSQCR---SPYITEYY 77 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~--~~------~l~~Ei~ILk~L~---HPnIV~L~ 77 (703)
.....+|++++++-......|.+..- .|..+++|..+......+ .. ...+++..+.++. -..++.++
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 45567999999999888777766643 478999998754332111 11 1122333333332 22333333
Q ss_pred EEEE-----eCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeE
Q 005298 78 GSYL-----HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV 152 (703)
Q Consensus 78 ~~~~-----~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL 152 (703)
-+.. -....+|||||++|..|.++.. +++ .+...|.+++.-||..|++|+|++|.|++++.+ .+++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~i 175 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRI 175 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEE
Confidence 3222 2345678999999998887632 333 244567778999999999999999999999865 4999
Q ss_pred eccccc
Q 005298 153 ADFGVS 158 (703)
Q Consensus 153 ~DFGlA 158 (703)
+||+..
T Consensus 176 ID~~~k 181 (229)
T PF06176_consen 176 IDTQGK 181 (229)
T ss_pred EECccc
Confidence 999853
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.4e-06 Score=99.72 Aligned_cols=140 Identities=24% Similarity=0.343 Sum_probs=92.4
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh---------------------------------HHHHH------HH
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE---------------------------------DEIED------IQ 59 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~---------------------------------~~~~~------l~ 59 (703)
..|+.++-|+||+|+.+. |+.||||+.+..-.+ ...+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 578999999999999886 999999996432100 01112 22
Q ss_pred HHHHHHHhC-----CCCCeeeeEEEEEeCCEEEEEEeccCCCCHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHhcCc
Q 005298 60 KEISVLSQC-----RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEGK 132 (703)
Q Consensus 60 ~Ei~ILk~L-----~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l--~~~~~L~e~~i~~i~~QLl~AL~yLHs~gI 132 (703)
+|..-+.++ +.|+|.--.=++.-.+.-+|+|||++|..+.++. +. ..++...+...+.++. +..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 333333333 2344433333333455669999999999999884 33 4455444433333321 233344899
Q ss_pred eeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 133 IHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 133 VHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
+|.|.+|.||+++.+|.+.+.|||+...+.
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCC
Confidence 999999999999999999999999976554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.4e-06 Score=86.92 Aligned_cols=134 Identities=16% Similarity=0.188 Sum_probs=84.5
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCC--eeeeEEEEEeCCEEEEEEeccCC
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY--ITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPn--IV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
...||.|..+.||+. .+..+++|+...... ...+.+|.++++.+..-. +.+.+++....+..++|||+++|
T Consensus 6 ~~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 6 WTQTGEGGNGESYTH----KTGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred heeecCCCCcceeEe----cCCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 367899999999984 255688998764332 345688999998886433 46777777777888999999998
Q ss_pred CC-HHHH--------------HHc------C---CCCCHHH-HHHHHHH----------HHH-HHHHHHh----cCceee
Q 005298 96 GS-VADL--------------IQS------G---PPLDEMS-IACILRD----------LLH-AIEYLHN----EGKIHR 135 (703)
Q Consensus 96 Gs-L~~~--------------l~~------~---~~L~e~~-i~~i~~Q----------Ll~-AL~yLHs----~gIVHR 135 (703)
.+ +... +.. . ...+... ...+..+ +.. ...+|.. ..++|+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 64 2111 110 0 0111111 0111000 111 1222221 247899
Q ss_pred eeccceEEecCCCCeeEeccccch
Q 005298 136 DIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 136 DIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
|+.|.||+++.++ +.|+||+.+.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.3e-06 Score=84.75 Aligned_cols=133 Identities=17% Similarity=0.172 Sum_probs=82.8
Q ss_pred EeecCc-eEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEEEEeccCCCCH
Q 005298 21 IGRGSF-GDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYMAGGSV 98 (703)
Q Consensus 21 LG~Gsf-G~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL 98 (703)
|-.|.+ ..||++... +..++||+..... ...+.+|+.+++.+. +--+.+++++....+..++||||++|.+|
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 344444 789999654 4688899865332 245677888888874 34466777777766778999999999877
Q ss_pred HHHHH-------------------cC----CCCCHH--HHHHHHH--------------------HHHHHHHHHH-----
Q 005298 99 ADLIQ-------------------SG----PPLDEM--SIACILR--------------------DLLHAIEYLH----- 128 (703)
Q Consensus 99 ~~~l~-------------------~~----~~L~e~--~i~~i~~--------------------QLl~AL~yLH----- 128 (703)
..... .- .++... ....... .+...+..|-
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 74420 00 011100 0000000 0111122221
Q ss_pred --hcCceeeeeccceEEecCCCCeeEeccccch
Q 005298 129 --NEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 129 --s~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1248999999999999988778899999763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.4e-06 Score=84.94 Aligned_cols=138 Identities=20% Similarity=0.297 Sum_probs=92.1
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh---------------------HHHH--HHHHHHHHHHhCC--CCC
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE---------------------DEIE--DIQKEISVLSQCR--SPY 72 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~---------------------~~~~--~l~~Ei~ILk~L~--HPn 72 (703)
...|..|.-+.||+|... .+..||||+++..... ..+. =..+|+.-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 346667777889999763 4889999997543211 0011 1235677777764 333
Q ss_pred eeeeEEEEEeCCEEEEEEeccCCCCHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCe
Q 005298 73 ITEYYGSYLHQTKLWIIMEYMAGGSVA-DLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDV 150 (703)
Q Consensus 73 IV~L~~~~~~~~~lyLV~Eyv~gGsL~-~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~V 150 (703)
+.+.+.+. .-.|||||+...-+- -.|+ .-++...++..+..++++.+.-|-. .++||+||..-|||+. ++.+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 44444432 348999999543111 0111 1233344788888999999998876 8999999999999998 7889
Q ss_pred eEeccccchhhh
Q 005298 151 KVADFGVSAQLT 162 (703)
Q Consensus 151 KL~DFGlA~~~~ 162 (703)
.|+|||-+....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999875543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.4e-05 Score=96.91 Aligned_cols=82 Identities=15% Similarity=0.182 Sum_probs=58.7
Q ss_pred EEEEEeecCceEEEEEEEcCCC--cEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCe--eeeEEEEEeC---CEEEE
Q 005298 17 SLELIGRGSFGDVYKAFDKELN--KDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYI--TEYYGSYLHQ---TKLWI 88 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~tg--~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnI--V~L~~~~~~~---~~lyL 88 (703)
.++.|+.|.+..+|+......+ ..+++|+............+.+|+.+|+.|. |++| .+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4678899999999998765432 4678887644322222356889999999995 6665 7777777654 46799
Q ss_pred EEeccCCCCH
Q 005298 89 IMEYMAGGSV 98 (703)
Q Consensus 89 V~Eyv~gGsL 98 (703)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999988653
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=8.3e-07 Score=108.60 Aligned_cols=214 Identities=14% Similarity=0.079 Sum_probs=151.4
Q ss_pred HHHHHHHHHHHhCCCCCeeeeEEEEEe--CCEEEEEEeccCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh
Q 005298 56 EDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWIIMEYMAGGSVADLIQSG----PPLDEMSIACILRDLLHAIEYLHN 129 (703)
Q Consensus 56 ~~l~~Ei~ILk~L~HPnIV~L~~~~~~--~~~lyLV~Eyv~gGsL~~~l~~~----~~L~e~~i~~i~~QLl~AL~yLHs 129 (703)
+....|...++...|++++..+.-... ....|++++||.+|.+++.|-++ .++.+.-+.....+.+.+..-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 334456666777899999887765543 34569999999999999998543 455666666666666777777775
Q ss_pred c-----CceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHH
Q 005298 130 E-----GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIE 204 (703)
Q Consensus 130 ~-----gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyE 204 (703)
. -.+|+++|+.|.+|..+.++|++++|+.+.............+++.|+.|++...-+ ++.++|+|..|+-+|+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHH
Confidence 4 279999999999999999999999999885544445556678999999999987654 7788999999999999
Q ss_pred HHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 205 MAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 205 LLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+..|..+|........-..+.....-.++.-.|.++......+|-+.-..||.-..++..+.|...
T Consensus 1433 rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1433 RSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVG 1498 (2724)
T ss_pred HhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccccc
Confidence 999988885432222222222222222222223334444445555556789998888887776443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=3.4e-05 Score=76.80 Aligned_cols=132 Identities=23% Similarity=0.264 Sum_probs=91.7
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
.-+..+.|++|.+|.||+|.+. |..+|+|+-.. +.....+..|+++|..+...++.+=+-.|- ..++.|||+
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~---ds~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i 94 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR---DSPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYI 94 (201)
T ss_pred hhhhhhhhhcccccEEEEeecc--CceEEEEEecC---CcchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhh
Confidence 3355678999999999999876 67999998543 344678999999999998777654333222 224559999
Q ss_pred CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeec-cceEEecCCCCeeEeccccchh
Q 005298 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK-AANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 94 ~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIK-PeNILLd~~g~VKL~DFGlA~~ 160 (703)
+|-.|.++.... + +.-+..+++.---|-..||-|+.|. |..++|-.++.+.|+||.-|+.
T Consensus 95 ~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998888775421 2 2233344455444566789888886 4444444555899999998763
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.93 E-value=2.7e-05 Score=89.35 Aligned_cols=139 Identities=24% Similarity=0.349 Sum_probs=88.7
Q ss_pred EEEeecCceEEEEEEEcCCCcEEEEEEeccCCC------------------------------hHHHHHHHHHHHH----
Q 005298 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES------------------------------EDEIEDIQKEISV---- 64 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~------------------------------~~~~~~l~~Ei~I---- 64 (703)
+.||.-+.|+||+|+.+. |+.||||+-+..-. ++..+.+..|+..
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999987 99999998422110 1111222233322
Q ss_pred ------HHhCCCCC------eeeeEEEEEeCCEEEEEEeccCCCCHHHH--HHcCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 005298 65 ------LSQCRSPY------ITEYYGSYLHQTKLWIIMEYMAGGSVADL--IQSGPPLDEMSIACILRDLLHAIEYLHNE 130 (703)
Q Consensus 65 ------Lk~L~HPn------IV~L~~~~~~~~~lyLV~Eyv~gGsL~~~--l~~~~~L~e~~i~~i~~QLl~AL~yLHs~ 130 (703)
.+.+.|-+ |.++|-.+ ....+|+||||+|..+.++ |.+ ..++...+...+.++. +.-|-..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~--~~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAY--LEQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHH--HHHHHhc
Confidence 23334544 44444332 3456999999999877664 333 3355554444333332 2233457
Q ss_pred CceeeeeccceEEecC----CCCeeEeccccchhhhh
Q 005298 131 GKIHRDIKAANILLTE----NGDVKVADFGVSAQLTR 163 (703)
Q Consensus 131 gIVHRDIKPeNILLd~----~g~VKL~DFGlA~~~~~ 163 (703)
|++|+|-+|.||++.. ++.+.|.|||+...+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999984 56799999999766543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00011 Score=74.93 Aligned_cols=127 Identities=24% Similarity=0.350 Sum_probs=90.5
Q ss_pred CCCceEEEEEeecCc-eEEEEEEEcCCCcEEEEEEecc---CCC-------h----------HHHHHHHHHHHHHHhC--
Q 005298 12 GSRFSSLELIGRGSF-GDVYKAFDKELNKDVAIKVIDL---EES-------E----------DEIEDIQKEISVLSQC-- 68 (703)
Q Consensus 12 ~~~Y~il~~LG~Gsf-G~Vyka~d~~tg~~VAIKvi~~---~~~-------~----------~~~~~l~~Ei~ILk~L-- 68 (703)
+.+++.++.||.|.. |.||++... |+.||+|++.. ... . ....-|..|.....+|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 368999999999999 999999776 78999999321 110 0 1123466777776666
Q ss_pred -CCCCe--eeeEEEEEeCC------------------EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Q 005298 69 -RSPYI--TEYYGSYLHQT------------------KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127 (703)
Q Consensus 69 -~HPnI--V~L~~~~~~~~------------------~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yL 127 (703)
.+.++ |++|+++.-.. ...||.||+.... .+.. .-+.+|++-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHH
Confidence 45566 99999884321 2367888886543 2222 3355677788899
Q ss_pred HhcCceeeeeccceEEecCCCCeeEeccccc
Q 005298 128 HNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 128 Hs~gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
|..||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999974 3578999853
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00016 Score=73.38 Aligned_cols=129 Identities=21% Similarity=0.343 Sum_probs=93.7
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccCC---------------ChHHHHHHHHHHHHHHhCC------CCCeeee
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE---------------SEDEIEDIQKEISVLSQCR------SPYITEY 76 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~---------------~~~~~~~l~~Ei~ILk~L~------HPnIV~L 76 (703)
...||.|+.=.||.-- .....+||+..... ......+..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3578999998888752 24457899886554 1112355666776666655 7899999
Q ss_pred EEEEEeCCEEEEEEeccC------CCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC--C
Q 005298 77 YGSYLHQTKLWIIMEYMA------GGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN--G 148 (703)
Q Consensus 77 ~~~~~~~~~lyLV~Eyv~------gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~--g 148 (703)
||+.+++..+-+|+|.+. ..+|.++++. +.+++ .+ ...|-.-..||-.++|+.+||+|.||++... +
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 999999999999999864 3479999965 44665 33 3344455678899999999999999999754 2
Q ss_pred --CeeEec
Q 005298 149 --DVKVAD 154 (703)
Q Consensus 149 --~VKL~D 154 (703)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.88 E-value=4.2e-05 Score=78.56 Aligned_cols=74 Identities=14% Similarity=0.271 Sum_probs=46.7
Q ss_pred EEEEeecCce-EEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCC---CeeeeEEEEEeC---CEEEEEE
Q 005298 18 LELIGRGSFG-DVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP---YITEYYGSYLHQ---TKLWIIM 90 (703)
Q Consensus 18 l~~LG~GsfG-~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HP---nIV~L~~~~~~~---~~lyLV~ 90 (703)
++.|+.|+.. .||+. +..+++|+..... ....+.+|+.+|..|... -+.++++..... ...|++|
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 3567766666 59986 2357788754322 235788899999887531 344444433322 2358899
Q ss_pred eccCCCCHH
Q 005298 91 EYMAGGSVA 99 (703)
Q Consensus 91 Eyv~gGsL~ 99 (703)
++++|.++.
T Consensus 74 ~~i~G~~l~ 82 (235)
T cd05155 74 RWLEGETAT 82 (235)
T ss_pred EeecCCCCC
Confidence 999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00023 Score=72.61 Aligned_cols=75 Identities=17% Similarity=0.278 Sum_probs=49.2
Q ss_pred EEEEeecCceEEEEEEEcC-CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCC-eeeeEEEEEeCCEEEEEEeccCC
Q 005298 18 LELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~-tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPn-IV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
++.|..|-...||++.... .+..|++|+...... ..-...+|+.+++.+...+ +++++..+. + .+||||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence 5678889899999997553 357899998653321 1123457888888885433 344444332 2 479999998
Q ss_pred CCH
Q 005298 96 GSV 98 (703)
Q Consensus 96 GsL 98 (703)
.++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00071 Score=72.60 Aligned_cols=81 Identities=19% Similarity=0.218 Sum_probs=58.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC---CCeeeeEEEEEe---CCEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS---PYITEYYGSYLH---QTKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H---PnIV~L~~~~~~---~~~l 86 (703)
..-.-++.||.|..+.||...... + .+++|+.+... ....+..|...|+.|.- ..+.++++++.. .+..
T Consensus 14 ~~~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 14 EKLSRVECISEQPYAALWALYDSQ-G-NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred hhhheeeecCCccceeEEEEEcCC-C-CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 355667889999999999986543 3 57778754211 12568889999988843 467788887754 3668
Q ss_pred EEEEeccCCCCH
Q 005298 87 WIIMEYMAGGSV 98 (703)
Q Consensus 87 yLV~Eyv~gGsL 98 (703)
+||||+++|.++
T Consensus 89 ~LVmE~i~G~~~ 100 (297)
T PRK10593 89 VLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCEec
Confidence 999999998765
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00034 Score=73.95 Aligned_cols=149 Identities=15% Similarity=0.129 Sum_probs=88.8
Q ss_pred ccchhhhC-CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCC--CeeeeEE---
Q 005298 5 AGLQEAAG-SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP--YITEYYG--- 78 (703)
Q Consensus 5 ~~l~~~~~-~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HP--nIV~L~~--- 78 (703)
..+....+ .+..-++.|..|....+|++... +..+++|+... . ....+..|+.++..|.+- .+++++.
T Consensus 5 ~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~-~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~ 78 (296)
T cd05153 5 ASFLADYDLGELLSFEGISAGIENTNYFVTTD--SGRYVLTLFEK-V---SAEELPFFLALLDHLAERGLPVPRPIADRD 78 (296)
T ss_pred HHHHHHcCCCchhheecccCccccceEEEEeC--CCcEEEEEcCC-C---ChHhccHHHHHHHHHHHCCCCCCccccCCC
Confidence 33334334 34555778888888899998653 45789998754 1 134567788887777432 2444443
Q ss_pred ---EEEeCCEEEEEEeccCCCCHHH----H-------HHc------C--CC------CCHHHH--H--------HHHHHH
Q 005298 79 ---SYLHQTKLWIIMEYMAGGSVAD----L-------IQS------G--PP------LDEMSI--A--------CILRDL 120 (703)
Q Consensus 79 ---~~~~~~~lyLV~Eyv~gGsL~~----~-------l~~------~--~~------L~e~~i--~--------~i~~QL 120 (703)
+....+..++|++|++|..+.. . +.+ . .. ..+... . .....+
T Consensus 79 g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 158 (296)
T cd05153 79 GEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALL 158 (296)
T ss_pred CcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence 2233556789999999876531 1 100 0 00 000000 0 011112
Q ss_pred HHHHHHHHh-------cCceeeeeccceEEecCCCCeeEeccccch
Q 005298 121 LHAIEYLHN-------EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 121 l~AL~yLHs-------~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
..++.++.. .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 334444443 369999999999999987777899999753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00016 Score=72.64 Aligned_cols=99 Identities=19% Similarity=0.171 Sum_probs=79.6
Q ss_pred HHHHHHHHhCCC-CCeeeeEEEEEeCCEEEEEEeccCCCCHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHh---cC
Q 005298 59 QKEISVLSQCRS-PYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAIEYLHN---EG 131 (703)
Q Consensus 59 ~~Ei~ILk~L~H-PnIV~L~~~~~~~~~lyLV~Eyv~gGsL~~~---l~~~~~L~e~~i~~i~~QLl~AL~yLHs---~g 131 (703)
..|.-+|..+.+ +++++++|+|- .++|.||+..+.+... +......++..+..|+.+++..+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888876 79999999882 2678999987655421 1122346899999999999999999987 35
Q ss_pred ceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 132 KIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 132 IVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
+.-.|++|+|+-|+.+|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0011 Score=74.28 Aligned_cols=79 Identities=19% Similarity=0.188 Sum_probs=56.0
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEeccC-----C-ChHHHHHHHHHHHHHHhCC---CCCeeeeEEEEEeCCEEE
Q 005298 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-----E-SEDEIEDIQKEISVLSQCR---SPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~-----~-~~~~~~~l~~Ei~ILk~L~---HPnIV~L~~~~~~~~~ly 87 (703)
..+.||.|.+..||++.+...++.|+||.-... . -.-..++...|.+.|..+. ..++++++.+ +.+..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 357899999999999998754468999984311 0 0123567778888888763 3457777766 456679
Q ss_pred EEEeccCCCC
Q 005298 88 IIMEYMAGGS 97 (703)
Q Consensus 88 LV~Eyv~gGs 97 (703)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999997643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0016 Score=69.79 Aligned_cols=137 Identities=16% Similarity=0.213 Sum_probs=75.7
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----CCCeeeeEE---EEEeCCEEEE
Q 005298 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----SPYITEYYG---SYLHQTKLWI 88 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-----HPnIV~L~~---~~~~~~~lyL 88 (703)
-++.|+.|....+|++... +..+++|++. .... ..+..|+.++..|. .|.++.-.+ +....+..++
T Consensus 26 ~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~ 99 (319)
T PRK05231 26 SLKGIAEGIENSNFFLTTT--QGEYVLTLFE-RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAA 99 (319)
T ss_pred ccchhccccccceEEEEeC--CCcEEEEEec-cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEE
Confidence 3566778888899998654 3368999875 2222 23344555555542 333332110 1233567899
Q ss_pred EEeccCCCCHH-----------HHHHc----CCCC--------C--H-HHH-H-----------HHHHH-HHHHHHHHH-
Q 005298 89 IMEYMAGGSVA-----------DLIQS----GPPL--------D--E-MSI-A-----------CILRD-LLHAIEYLH- 128 (703)
Q Consensus 89 V~Eyv~gGsL~-----------~~l~~----~~~L--------~--e-~~i-~-----------~i~~Q-Ll~AL~yLH- 128 (703)
++||++|..+. ..+.+ ...+ . + ... . ..+.+ +-..+..+.
T Consensus 100 l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (319)
T PRK05231 100 IVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLAS 179 (319)
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhc
Confidence 99999887431 11110 0000 0 1 010 0 01111 111222332
Q ss_pred ------hcCceeeeeccceEEecCCCCeeEeccccch
Q 005298 129 ------NEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 129 ------s~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
..++||+|++|.|||++.+..+-|+||+.++
T Consensus 180 ~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 180 AAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2379999999999999866556899999764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00025 Score=73.65 Aligned_cols=132 Identities=17% Similarity=0.258 Sum_probs=77.1
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCe-eeeEEEEEeCCEEEEEEeccCCCCH
Q 005298 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIMEYMAGGSV 98 (703)
Q Consensus 20 ~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnI-V~L~~~~~~~~~lyLV~Eyv~gGsL 98 (703)
.+..|-...+|+.. ..+..+++|+....... ..-...+|..+++.+....+ .+++... . -++||||++|..+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~ 75 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA-LGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI 75 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc-ccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence 35567888999886 34678889975432211 10135778899988864333 3333332 2 3789999998765
Q ss_pred HH--------------HHHc-------CCCCCH-HHHHHHHHHH---------HHHHHHHHh--------cCceeeeecc
Q 005298 99 AD--------------LIQS-------GPPLDE-MSIACILRDL---------LHAIEYLHN--------EGKIHRDIKA 139 (703)
Q Consensus 99 ~~--------------~l~~-------~~~L~e-~~i~~i~~QL---------l~AL~yLHs--------~gIVHRDIKP 139 (703)
.. .+.+ ..+++. ..+..+..++ ...+..+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 32 1111 111221 2222322222 111222222 1489999999
Q ss_pred ceEEecCCCCeeEeccccch
Q 005298 140 ANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 140 eNILLd~~g~VKL~DFGlA~ 159 (703)
.||+++.++ +.|+||..+.
T Consensus 156 ~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 156 YNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CcEEEeCCC-CEEEeccccC
Confidence 999999877 7899999764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.001 Score=71.19 Aligned_cols=140 Identities=18% Similarity=0.217 Sum_probs=82.2
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCC--CeeeeEEE------EEeCCEE
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP--YITEYYGS------YLHQTKL 86 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HP--nIV~L~~~------~~~~~~l 86 (703)
...++.++.|....||++... +..+++|+....... ..+..|+.++..|... .+++++.. ....+..
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred ceeccccCCccccceEEEEeC--CCcEEEEEecCCCCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 445777888888899988643 336888987543222 3345666777666321 13444331 1224567
Q ss_pred EEEEeccCCCCHH-----------HHHHc----CCCC--------CHHHHH---------------HHHHHHHHHHHHHH
Q 005298 87 WIIMEYMAGGSVA-----------DLIQS----GPPL--------DEMSIA---------------CILRDLLHAIEYLH 128 (703)
Q Consensus 87 yLV~Eyv~gGsL~-----------~~l~~----~~~L--------~e~~i~---------------~i~~QLl~AL~yLH 128 (703)
++++||++|..+. ..+.. ...+ ...... .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 9999999885432 11110 0001 001000 00112334455554
Q ss_pred h-------cCceeeeeccceEEecCCCCeeEeccccch
Q 005298 129 N-------EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 129 s-------~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
. .++||+|+++.||+++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 579999999999999988777899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00087 Score=71.23 Aligned_cols=76 Identities=18% Similarity=0.305 Sum_probs=50.0
Q ss_pred EEEEeecCceEEEEEEEcC------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCe-eeeEEEEEeCCEEEEEE
Q 005298 18 LELIGRGSFGDVYKAFDKE------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~------tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnI-V~L~~~~~~~~~lyLV~ 90 (703)
++.|..|-...||++.... .++.|++|+..... .......+|+.++..+....+ .+++.++. + .+|+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~ 76 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE 76 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence 4567778888999987543 36789999965432 122456788888888753333 35555443 2 3689
Q ss_pred eccCCCCHH
Q 005298 91 EYMAGGSVA 99 (703)
Q Consensus 91 Eyv~gGsL~ 99 (703)
||++|..+.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 999887764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0013 Score=72.20 Aligned_cols=142 Identities=18% Similarity=0.219 Sum_probs=96.9
Q ss_pred eEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-----------------------C-hHHHHH-HHHHHHHHHhCCC
Q 005298 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-----------------------S-EDEIED-IQKEISVLSQCRS 70 (703)
Q Consensus 16 ~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-----------------------~-~~~~~~-l~~Ei~ILk~L~H 70 (703)
.|..+|..|.-+.||.|... .|..+|||+++..- . ...+.. ...|+.-|++|+.
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 45567889999999999765 48889999863210 1 111111 2357777888876
Q ss_pred CCeeeeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hcCceeeeeccceEEecCCCC
Q 005298 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH-NEGKIHRDIKAANILLTENGD 149 (703)
Q Consensus 71 PnIV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLH-s~gIVHRDIKPeNILLd~~g~ 149 (703)
..|...--+.... -+|||+|+.+.....-.-+...++...+..+-.|++.-+.-|. .+++||.||.--|+|+ .+|.
T Consensus 226 aGIP~PePIlLk~--hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 226 AGIPCPEPILLKN--HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred cCCCCCCceeeec--ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 5544333222222 3899999954333222223456788889998889988888875 6689999999999999 5678
Q ss_pred eeEeccccchhh
Q 005298 150 VKVADFGVSAQL 161 (703)
Q Consensus 150 VKL~DFGlA~~~ 161 (703)
+.|+|.+-+...
T Consensus 303 lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 303 LYIIDVSQSVEH 314 (520)
T ss_pred EEEEEccccccC
Confidence 999999866433
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.00023 Score=76.89 Aligned_cols=135 Identities=21% Similarity=0.314 Sum_probs=95.5
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--------h---------HH--H--HHHHHHHHHHHhCC-CC
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--------E---------DE--I--EDIQKEISVLSQCR-SP 71 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--------~---------~~--~--~~l~~Ei~ILk~L~-HP 71 (703)
=+.+...||-|.-+.||.+-+.. |++.++|+-++... . .. + -...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 45677899999999999998875 89999996322210 0 00 1 12346888888874 32
Q ss_pred C-eeeeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCe
Q 005298 72 Y-ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDV 150 (703)
Q Consensus 72 n-IV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~V 150 (703)
. |.+.++ -+..++|||++.|-.|....+- ..+..+...|+.-+.-|-.+|+||+|+.--||+|+.++.+
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 2 333333 3556899999999888765422 2234455566666777889999999999999999999999
Q ss_pred eEeccccch
Q 005298 151 KVADFGVSA 159 (703)
Q Consensus 151 KL~DFGlA~ 159 (703)
+++||--+.
T Consensus 242 ~vIDFPQmv 250 (465)
T KOG2268|consen 242 VVIDFPQMV 250 (465)
T ss_pred EEeechHhh
Confidence 999997543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0015 Score=74.24 Aligned_cols=170 Identities=21% Similarity=0.293 Sum_probs=108.7
Q ss_pred HHHHHHHHHhCCCCCeeeeEEEEEeC-CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeee
Q 005298 58 IQKEISVLSQCRSPYITEYYGSYLHQ-TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136 (703)
Q Consensus 58 l~~Ei~ILk~L~HPnIV~L~~~~~~~-~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRD 136 (703)
+.-...+++.+.|+|...++++-... ....+|+|++ +.+|.+++..+. +-..... .+++.|-
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~~- 91 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLHL- 91 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------cccccee-
Confidence 44456788999999999999877653 4578999999 789999987654 3221111 2222221
Q ss_pred eccceEEecCCCCeeEeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCC
Q 005298 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH 216 (703)
Q Consensus 137 IKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~ 216 (703)
| .++++| -++. ...+.+ ++++|||++|.++.+++-|..-|....
T Consensus 92 ----~-------~~~~td-~~~t-------~~~~~~-----------------~pKsdVwsl~~i~~el~L~~~l~~~~~ 135 (725)
T KOG1093|consen 92 ----N-------IIYITD-HFLT-------KYPSPI-----------------GPKSDVWSLGFIILELYLGISLEAELT 135 (725)
T ss_pred ----h-------hhhccc-cccc-------cCCCCC-----------------CcchhhhhHHHHHHHHHHhhHHHHHHH
Confidence 2 223333 1110 001111 148999999999999999988876655
Q ss_pred ccceeeccCCCCCCC-----------cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccChhHHHHhh
Q 005298 217 PMRVLFIIPRENPPQ-----------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIR 281 (703)
Q Consensus 217 ~~~~l~~I~~~~~~~-----------l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~e~i~ 281 (703)
..+.+..+.+-.... +-..++..+.++...|+...|..||...++.+++-|....+.+.. +.+.
T Consensus 136 ~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~~~t~-e~~~ 210 (725)
T KOG1093|consen 136 ESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYKDLTV-EMRA 210 (725)
T ss_pred HHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHhhhhH-HHHH
Confidence 544444443322111 112344556788889999999999999999999999887544443 4433
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0066 Score=64.58 Aligned_cols=30 Identities=20% Similarity=0.379 Sum_probs=24.8
Q ss_pred CceeeeeccceEEecCCCC-eeEeccccchh
Q 005298 131 GKIHRDIKAANILLTENGD-VKVADFGVSAQ 160 (703)
Q Consensus 131 gIVHRDIKPeNILLd~~g~-VKL~DFGlA~~ 160 (703)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999997555 56999997643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0079 Score=65.44 Aligned_cols=146 Identities=16% Similarity=0.224 Sum_probs=87.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC--CCeeeeEEEEEeCC--EEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PYITEYYGSYLHQT--KLWI 88 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H--PnIV~L~~~~~~~~--~lyL 88 (703)
....+++.+-.|..-.+|...+. ++.+++..-.............+|+.+++.+.- .-+...+++|.++. ..|.
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 35566677755544556666554 888898822123334456778889999988753 23445555665555 6699
Q ss_pred EEeccCCCCHH------------------HHHHc-------C-------CCCCHHHHHHHHH--------------HHHH
Q 005298 89 IMEYMAGGSVA------------------DLIQS-------G-------PPLDEMSIACILR--------------DLLH 122 (703)
Q Consensus 89 V~Eyv~gGsL~------------------~~l~~-------~-------~~L~e~~i~~i~~--------------QLl~ 122 (703)
||+|++|..+. ++|.. + ......++..+.. .+..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 99999883222 12210 0 0001111111111 2223
Q ss_pred HHHHHHhc--------CceeeeeccceEEecCCCCeeEeccccchh
Q 005298 123 AIEYLHNE--------GKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 123 AL~yLHs~--------gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
-..||+.+ .++|+|+.+.||+|+.++-+-|.||+++..
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 34455543 489999999999999988899999998754
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.012 Score=65.17 Aligned_cols=81 Identities=15% Similarity=0.233 Sum_probs=52.2
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEe----ccC--CChHHHHHHHHHHHHHHhCC--CC-CeeeeEEEEEeCCEEEEEE
Q 005298 20 LIGRGSFGDVYKAFDKELNKDVAIKVI----DLE--ESEDEIEDIQKEISVLSQCR--SP-YITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 20 ~LG~GsfG~Vyka~d~~tg~~VAIKvi----~~~--~~~~~~~~l~~Ei~ILk~L~--HP-nIV~L~~~~~~~~~lyLV~ 90 (703)
.||.|....||++.+...++.|+||.- +.. .-+-...+..-|...|+... -| .++++|. .+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 579999999999998654478999963 211 11223456667888887653 24 4555554 3566668999
Q ss_pred eccCC-CCHHHHH
Q 005298 91 EYMAG-GSVADLI 102 (703)
Q Consensus 91 Eyv~g-GsL~~~l 102 (703)
|+++. ..|...+
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 99854 3344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.046 Score=58.00 Aligned_cols=28 Identities=39% Similarity=0.561 Sum_probs=24.8
Q ss_pred cCceeeeeccceEEecCCCCeeEeccccc
Q 005298 130 EGKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 130 ~gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
.+++|+|+.+.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999987 67899999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.011 Score=66.27 Aligned_cols=83 Identities=19% Similarity=0.307 Sum_probs=55.2
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEe----ccCC-ChHHHHHHHHHHHHHHhCC--CC-CeeeeEEEEEeCCEEEEE
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVI----DLEE-SEDEIEDIQKEISVLSQCR--SP-YITEYYGSYLHQTKLWII 89 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi----~~~~-~~~~~~~l~~Ei~ILk~L~--HP-nIV~L~~~~~~~~~lyLV 89 (703)
++.||.|.-..||++.+...++.|+||.- +... -.-..++..-|..+|+.+. -| +++++|. .+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 67899999999999998544678999963 2111 1223566777888888763 24 4555664 356667899
Q ss_pred EeccCC-CCHHHHH
Q 005298 90 MEYMAG-GSVADLI 102 (703)
Q Consensus 90 ~Eyv~g-GsL~~~l 102 (703)
||+++. ..|.+.+
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 999854 2344443
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.075 Score=57.04 Aligned_cols=29 Identities=14% Similarity=0.211 Sum_probs=26.7
Q ss_pred CceeeeeccceEEecCCCCeeEeccccch
Q 005298 131 GKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 131 gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
++||+|+.+.|||++.++.+.|+||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999999899999999764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.017 Score=63.36 Aligned_cols=136 Identities=15% Similarity=0.228 Sum_probs=80.5
Q ss_pred EEEEEeecCceEEEEEEEcC----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCe-eeeEEEEEeCCEEEEEEe
Q 005298 17 SLELIGRGSFGDVYKAFDKE----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~----tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnI-V~L~~~~~~~~~lyLV~E 91 (703)
-+..|-.|-...+|++.... .++.|++|+..... ...+ ....|..+++.+..-++ .++++.+..+ .|.|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 44556568888999986432 34789999875432 2222 23678888888854333 3445554322 5799
Q ss_pred ccCCCCHHHH--------------HHc----C---C--CCCHHHHHHHHHHHH-----------------HHHHHH----
Q 005298 92 YMAGGSVADL--------------IQS----G---P--PLDEMSIACILRDLL-----------------HAIEYL---- 127 (703)
Q Consensus 92 yv~gGsL~~~--------------l~~----~---~--~L~e~~i~~i~~QLl-----------------~AL~yL---- 127 (703)
|+++.+|... +++ . . ......+..++.++. ..+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9988776421 110 0 0 111334444432221 112222
Q ss_pred H----hcCceeeeeccceEEecC-CCCeeEeccccc
Q 005298 128 H----NEGKIHRDIKAANILLTE-NGDVKVADFGVS 158 (703)
Q Consensus 128 H----s~gIVHRDIKPeNILLd~-~g~VKL~DFGlA 158 (703)
. ...++|+|+++.|||++. ++.+.|+||..+
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya 229 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYA 229 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhc
Confidence 1 125899999999999986 468999999865
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.015 Score=63.33 Aligned_cols=137 Identities=17% Similarity=0.215 Sum_probs=79.3
Q ss_pred EEEEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCe-eeeEEEEEeCCEEEEEEec
Q 005298 17 SLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~t---g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnI-V~L~~~~~~~~~lyLV~Ey 92 (703)
.++.|..|-...+|++..... +..|++|+..... . ..-.-.+|+.+++.+..-+| +++++++. .+ +|.+|
T Consensus 18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~f 91 (330)
T PLN02421 18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-D-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSF 91 (330)
T ss_pred EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-C-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehh
Confidence 344555588888999875432 3489999875332 1 12234678888888865444 35555542 22 58999
Q ss_pred cCCCCHHH-------HH-------Hc--CCC------C-CHHHHHHHHHHHH----------------------HHHHHH
Q 005298 93 MAGGSVAD-------LI-------QS--GPP------L-DEMSIACILRDLL----------------------HAIEYL 127 (703)
Q Consensus 93 v~gGsL~~-------~l-------~~--~~~------L-~e~~i~~i~~QLl----------------------~AL~yL 127 (703)
++|.+|.. .+ ++ ..+ + ....+..++.++. .-+..+
T Consensus 92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 171 (330)
T PLN02421 92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL 171 (330)
T ss_pred hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence 98776532 11 11 011 1 1233333333321 112222
Q ss_pred H----hcC----ceeeeeccceEEecC-CCCeeEeccccch
Q 005298 128 H----NEG----KIHRDIKAANILLTE-NGDVKVADFGVSA 159 (703)
Q Consensus 128 H----s~g----IVHRDIKPeNILLd~-~g~VKL~DFGlA~ 159 (703)
. ..+ ++|.|+.+.|||++. ++.++|+||..|.
T Consensus 172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 112 699999999999975 4789999999763
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.075 Score=59.83 Aligned_cols=82 Identities=20% Similarity=0.131 Sum_probs=54.8
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC---Ch---HHHHHHHHHHHHHHhCC---CCCeeeeEEEEEeCCEEE
Q 005298 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE---SE---DEIEDIQKEISVLSQCR---SPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~---~~---~~~~~l~~Ei~ILk~L~---HPnIV~L~~~~~~~~~ly 87 (703)
..+.||.|....||++.+. +..|+||.-.... .. ....+...|...|+.+. ..++.+++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4678999999999999874 4569999753111 01 12455556677776653 247788888766 4468
Q ss_pred EEEeccCC--CCHHHHH
Q 005298 88 IIMEYMAG--GSVADLI 102 (703)
Q Consensus 88 LV~Eyv~g--GsL~~~l 102 (703)
++|||+++ ..|.+-+
T Consensus 112 lvME~L~~~~~ilr~~L 128 (418)
T PLN02756 112 IGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEeecCCcceehhhhh
Confidence 88999976 3454443
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.12 Score=55.44 Aligned_cols=83 Identities=16% Similarity=0.217 Sum_probs=51.1
Q ss_pred hhhhCCCc--eEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCCeeeeEEEEEe
Q 005298 8 QEAAGSRF--SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGSYLH 82 (703)
Q Consensus 8 ~~~~~~~Y--~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~---HPnIV~L~~~~~~ 82 (703)
.+..+..+ +-.+.|+.|....+|... .+++.|.||+-... ....+..|..-|+.|. .-.+++.+.+...
T Consensus 10 ~~~~~~~~~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~ 83 (288)
T PF03881_consen 10 SEQLGADFKITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEY 83 (288)
T ss_dssp HHHHTS-----EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-
T ss_pred HHHhCCCCceeeeEecCCCChhheEEEE--CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 34445554 445789999999999986 56889999997522 2355777888887773 4557788888887
Q ss_pred CCEEEEEEeccCCC
Q 005298 83 QTKLWIIMEYMAGG 96 (703)
Q Consensus 83 ~~~lyLV~Eyv~gG 96 (703)
.+..||||||++.+
T Consensus 84 ~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 84 DDDAFLLLEFLEMG 97 (288)
T ss_dssp SSCCEEEEE-----
T ss_pred cCCceEEEEeecCC
Confidence 77789999999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.04 Score=60.84 Aligned_cols=111 Identities=15% Similarity=0.272 Sum_probs=74.7
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~-gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
....|++|++- |++|.-+ ..-..+++..|+++++..+.-+..+ ..-|||+.-.||||+ .|+|.|+||-+++.-
T Consensus 298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 34568888887 6666543 2345788999999998888777755 688999999999999 899999999998732
Q ss_pred hhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCC
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGE 209 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~ 209 (703)
... . .+---..--|-.+.+.. +...+||- .|--|+.|.
T Consensus 372 ~~q-~----~isy~rldhp~lF~G~d--d~QFeIYr---lMr~l~~g~ 409 (488)
T COG5072 372 YSQ-G----IISYNRLDHPDLFNGVD--DYQFEIYR---LMRRLLKGR 409 (488)
T ss_pred cCC-c----eeeccccCchhhhcCcc--ceeeeHHH---HHHHHhcCc
Confidence 211 1 11111223455565543 56678886 455555543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.04 Score=57.24 Aligned_cols=85 Identities=16% Similarity=0.133 Sum_probs=60.0
Q ss_pred HHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc--Cce
Q 005298 56 EDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE--GKI 133 (703)
Q Consensus 56 ~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~--gIV 133 (703)
..+..+..++.++. .|+++..- ....+-+++|+|-.. ... ...++.-=+..|.-.|+. +.+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~------------~i~-~~N~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI------------KIN-FSNFITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc------------ccc-hhHHHHHhHHHHHHhhccCCCee
Confidence 45677889988876 48888732 445678999999421 111 111222224677788843 699
Q ss_pred eeeeccceEEecCCCCeeEecccc
Q 005298 134 HRDIKAANILLTENGDVKVADFGV 157 (703)
Q Consensus 134 HRDIKPeNILLd~~g~VKL~DFGl 157 (703)
|+|..|+||+-|+.|.+||.|=+.
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred cCCCChhheeecCCCCEEecChhh
Confidence 999999999999999999999763
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.2 Score=62.70 Aligned_cols=138 Identities=17% Similarity=0.264 Sum_probs=76.8
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-------CCCCeeeeEE-----EEEe-CC
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-------RSPYITEYYG-----SYLH-QT 84 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-------~HPnIV~L~~-----~~~~-~~ 84 (703)
++.|+ |..-.+|++... +|..|++|+.+..... ..+..|..+|..| ..|.+++-.+ .... ++
T Consensus 30 ~~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~~~---~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G 104 (1013)
T PRK06148 30 ATPLD-GERDLNFRLTTD-DGADYILKIVNPSEPR---VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDG 104 (1013)
T ss_pred EeecC-CcCCceEEEEeC-CCCeEEEEEcCCccch---hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCC
Confidence 35675 456778888643 4778999998754332 2233344444333 3445444321 1111 22
Q ss_pred --EEEEEEeccCCCCHHHH-------HH--------------cC------CCCCH-----------------HHHHHHHH
Q 005298 85 --KLWIIMEYMAGGSVADL-------IQ--------------SG------PPLDE-----------------MSIACILR 118 (703)
Q Consensus 85 --~lyLV~Eyv~gGsL~~~-------l~--------------~~------~~L~e-----------------~~i~~i~~ 118 (703)
..+.+++|++|..|.+. +. .. ..+.| ...+.++.
T Consensus 105 ~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~ 184 (1013)
T PRK06148 105 EPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVE 184 (1013)
T ss_pred ceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHH
Confidence 56778999999877651 10 00 01111 11122233
Q ss_pred HHHHHHH-----HHH--hcCceeeeeccceEEecCCC--Cee-Eeccccchh
Q 005298 119 DLLHAIE-----YLH--NEGKIHRDIKAANILLTENG--DVK-VADFGVSAQ 160 (703)
Q Consensus 119 QLl~AL~-----yLH--s~gIVHRDIKPeNILLd~~g--~VK-L~DFGlA~~ 160 (703)
+++..+. .+. ..++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 185 ~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 185 RFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3333222 121 24799999999999999775 454 999998753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.25 Score=53.71 Aligned_cols=71 Identities=17% Similarity=0.115 Sum_probs=41.7
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCC--Ceee---eEE--EEEeCCEEEEEEeccCCC
Q 005298 24 GSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP--YITE---YYG--SYLHQTKLWIIMEYMAGG 96 (703)
Q Consensus 24 GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HP--nIV~---L~~--~~~~~~~lyLV~Eyv~gG 96 (703)
+.-..||++... ++..|++|+...... ....+..|+.++..|... .|+. .-+ +...++..+.|+++++|.
T Consensus 36 s~eN~vy~v~~~-~~~~~vlKv~r~~~~--~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 36 SYENRVYQFGDE-DGRRVVAKFYRPERW--SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred cccceEEEEecC-CCCEEEEEEcCcccC--CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 344568988653 367799998753321 234566777777665311 1222 111 223356788899999876
Q ss_pred C
Q 005298 97 S 97 (703)
Q Consensus 97 s 97 (703)
.
T Consensus 113 ~ 113 (325)
T PRK11768 113 A 113 (325)
T ss_pred C
Confidence 4
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.042 Score=55.46 Aligned_cols=29 Identities=34% Similarity=0.627 Sum_probs=20.4
Q ss_pred CceeeeeccceEEe-cCCCCeeEeccccch
Q 005298 131 GKIHRDIKAANILL-TENGDVKVADFGVSA 159 (703)
Q Consensus 131 gIVHRDIKPeNILL-d~~g~VKL~DFGlA~ 159 (703)
-++|.|+.|.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 47899999999999 778999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.23 Score=55.45 Aligned_cols=78 Identities=15% Similarity=0.205 Sum_probs=46.6
Q ss_pred eEEEEEeecCceEEEEEEEcCC-CcE-----EEEEEeccCCChHHHHHHHHHHHHHHhCCCCCe-eeeEEEEEeCCEEEE
Q 005298 16 SSLELIGRGSFGDVYKAFDKEL-NKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWI 88 (703)
Q Consensus 16 ~il~~LG~GsfG~Vyka~d~~t-g~~-----VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnI-V~L~~~~~~~~~lyL 88 (703)
..++.|..|-...+|++..... +.. |.+++.. ......-.-.+|+.+++.|...++ .++++.+. -++
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g--~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~ 126 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS--TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFT 126 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEecc--CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEE
Confidence 3455666688899999975432 222 4444321 111111234568999999875554 45555543 269
Q ss_pred EEeccCCCCHH
Q 005298 89 IMEYMAGGSVA 99 (703)
Q Consensus 89 V~Eyv~gGsL~ 99 (703)
|.||++|.+|.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 99999987764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.66 E-value=0.85 Score=50.12 Aligned_cols=134 Identities=18% Similarity=0.283 Sum_probs=77.4
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCC---eeeeEE----EEEeCCEEEEE
Q 005298 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPY---ITEYYG----SYLHQTKLWII 89 (703)
Q Consensus 20 ~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~---HPn---IV~L~~----~~~~~~~lyLV 89 (703)
.|.. .-..||++.... |+ +++|+...... ...+..|..+|..|. .+- |..+=| .+..+...+-|
T Consensus 33 ~l~s-~eN~~f~~~~~~-g~-~iLki~~~~~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l 106 (331)
T COG2334 33 GLNS-EENSNFRVQTED-GR-YILKIYRPGWT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL 106 (331)
T ss_pred cccc-ccCceEEEEecC-CC-eEEEEecCCCC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence 3444 455688887664 33 39999876522 345666777777663 221 222222 11112377889
Q ss_pred EeccCCCCHHH-----HH-------H------cCC---------CCCHH----HH---------HHHHHHHHHHHHHHHh
Q 005298 90 MEYMAGGSVAD-----LI-------Q------SGP---------PLDEM----SI---------ACILRDLLHAIEYLHN 129 (703)
Q Consensus 90 ~Eyv~gGsL~~-----~l-------~------~~~---------~L~e~----~i---------~~i~~QLl~AL~yLHs 129 (703)
++|++|..+.. .+ . ++. ...+. .. .....++...++.+.+
T Consensus 107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~ 186 (331)
T COG2334 107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA 186 (331)
T ss_pred EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence 99999887772 11 0 000 11121 00 0122244444555543
Q ss_pred c--------C--ceeeeeccceEEecCCCC-eeEeccccch
Q 005298 130 E--------G--KIHRDIKAANILLTENGD-VKVADFGVSA 159 (703)
Q Consensus 130 ~--------g--IVHRDIKPeNILLd~~g~-VKL~DFGlA~ 159 (703)
. + +||+|+.|.|||++.+.. +.++|||.|+
T Consensus 187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2 3 999999999999998874 8999999763
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.32 Score=51.44 Aligned_cols=72 Identities=14% Similarity=0.160 Sum_probs=43.6
Q ss_pred eecCceEEEEEEEcC----C----CcEEEEEEeccCCC----hHHHHHHHHHHHHHHhCC-------------CCCeeee
Q 005298 22 GRGSFGDVYKAFDKE----L----NKDVAIKVIDLEES----EDEIEDIQKEISVLSQCR-------------SPYITEY 76 (703)
Q Consensus 22 G~GsfG~Vyka~d~~----t----g~~VAIKvi~~~~~----~~~~~~l~~Ei~ILk~L~-------------HPnIV~L 76 (703)
|.|-.|.+|++.-.. + ...++||....... ......+.+|+.+...+- ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 667778888875532 2 34688998752211 112356778887765441 1245666
Q ss_pred EEEEEeCCEEEEEEecc
Q 005298 77 YGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 77 ~~~~~~~~~lyLV~Eyv 93 (703)
+.........+||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 66665555789999865
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=92.49 E-value=0.029 Score=63.83 Aligned_cols=72 Identities=28% Similarity=0.523 Sum_probs=64.1
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~ 83 (703)
...|+...++|.|+||+|+.+.++..+..+|||.|.+.+.........+|+.-+.++.|++|++++..|..+
T Consensus 48 a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 48 ANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecC
Confidence 358899999999999999999999888899999998887776777888899999999999999999988753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 703 | ||||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-92 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-92 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-91 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-91 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-89 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-87 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-69 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-62 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-59 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-58 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-55 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-55 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-55 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-54 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-54 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-54 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-54 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-54 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-53 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-53 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-52 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-49 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-49 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-45 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-43 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-43 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-43 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-43 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-43 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-42 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-42 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-35 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-35 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-34 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-31 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-31 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-31 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-30 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-30 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-30 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-30 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-30 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-30 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-29 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-29 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-29 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-29 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-29 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-29 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-29 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-29 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-29 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-29 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-29 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-29 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-29 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-29 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-29 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-28 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-28 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-28 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-28 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-28 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-28 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-28 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-28 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-28 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-28 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-28 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-28 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-28 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-28 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-28 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-28 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-28 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-28 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-27 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-27 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-26 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-26 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-26 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-26 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-26 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-25 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-25 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-25 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-25 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-25 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-25 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-25 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-25 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-25 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-25 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-25 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-25 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-25 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-25 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-25 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-25 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-25 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-24 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-24 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-24 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-24 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-24 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-24 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-24 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-24 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-24 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-23 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-23 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-23 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-23 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-23 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-23 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-23 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-23 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-23 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-23 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-23 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-23 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-23 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-23 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-23 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-23 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-23 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-23 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-22 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-22 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-22 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-22 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-22 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-22 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-22 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-22 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-22 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-22 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-22 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-22 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-22 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-22 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-22 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-22 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-22 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-22 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-22 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-22 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-22 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-22 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-22 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-22 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-22 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-22 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-22 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-22 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-22 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-22 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-22 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-22 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-22 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-22 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-22 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-22 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-22 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-22 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-22 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-22 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-22 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-22 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-22 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-22 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-22 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-22 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-22 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-22 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-22 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-22 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-22 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-22 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-21 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-21 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-21 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-21 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-21 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-21 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-21 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-21 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-21 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-21 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-21 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-21 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-21 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-21 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-21 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-21 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-21 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-21 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-21 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-20 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-20 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-20 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-20 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-20 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-20 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-20 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-20 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-20 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-19 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-19 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-19 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-19 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-19 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-19 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-19 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-19 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-19 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-19 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-19 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-19 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-19 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-19 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-19 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-19 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-19 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-18 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-18 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-18 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-18 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-18 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-18 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-18 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-18 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-18 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-18 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-18 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-18 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-18 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-18 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-18 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-18 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-18 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-18 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-18 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-18 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-18 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-18 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-18 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-18 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-17 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-17 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-17 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-17 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-17 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-17 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-17 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-17 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-17 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-17 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-17 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-17 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-17 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-17 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-17 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-17 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-17 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-16 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-16 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-16 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-16 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-15 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-15 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-15 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-15 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-14 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-14 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-14 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-14 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-14 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-14 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 8e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-13 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 8e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-10 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-09 |
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 494 bits (1274), Expect = e-172
Identities = 175/282 (62%), Positives = 224/282 (79%), Gaps = 3/282 (1%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
F+ LE IG+GSFG+V+K D K VAIK+IDLEE+EDEIEDIQ+EI+VLSQC SPY
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+T+YYGSYL TKLWIIMEY+ GGS DL++ G PLDE IA ILR++L ++YLH+E K
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKK 140
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIKAAN+LL+E+G+VK+ADFGV+ QLT T +R TFVGTPFWMAPEVI+ S Y+ K
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSK 199
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
ADIWSLGIT IE+A+GEPP ++LHPM+VLF+IP+ NPP L+ ++S+ +KEFV CL K P
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 259
Query: 253 AERPSAKELLRHRFI-RNARKSPRLLERIRERPKYPIQEEPD 293
+ RP+AKELL+H+FI RNA+K+ L E I ++ ++ D
Sbjct: 260 SFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHD 301
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 480 bits (1237), Expect = e-167
Identities = 123/289 (42%), Positives = 177/289 (61%), Gaps = 22/289 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ E+IG G+ V A+ + VAIK I+LE+ + ++++ KEI +SQC P
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP--------LDEMSIACILRDLLHAI 124
I YY S++ + +LW++M+ ++GGSV D+I+ LDE +IA ILR++L +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-----SRRKTFVGTPFWMA 179
EYLH G+IHRD+KA NILL E+G V++ADFGVSA L RKTFVGTP WMA
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----- 234
PEV++ GY+ KADIWS GIT IE+A G P PM+VL + + +PP L+
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDK 254
Query: 235 ----HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLER 279
+ + ++ +SLCL+K P +RP+A ELLRH+F + A+ L E+
Sbjct: 255 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 479 bits (1234), Expect = e-166
Identities = 121/285 (42%), Positives = 178/285 (62%), Gaps = 9/285 (3%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ + +G G+FG VYKA +KE A KVI+ + SE+E+ED EI +L+ C PYI
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYI 78
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGK 132
+ G+Y H KLWI++E+ GG+V ++ L E I + R +L A+ +LH++
Sbjct: 79 VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 138
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI----QNSEG 188
IHRD+KA N+L+T GD+++ADFGVSA+ +T+ +R +F+GTP+WMAPEV+
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 198
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSL 246
Y+ KADIWSLGIT+IEMA+ EPP +L+PMRVL I + +PP L +S ++F+ +
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKI 258
Query: 247 CLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEE 291
L K P RPSA +LL H F+ + + L E + K + EE
Sbjct: 259 ALDKNPETRPSAAQLLEHPFVSSITSNKALRELV-AEAKAEVMEE 302
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 468 bits (1206), Expect = e-162
Identities = 133/315 (42%), Positives = 201/315 (63%), Gaps = 22/315 (6%)
Query: 3 DLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEI 62
DL+ L++ AG F +EL+G G++G VYK + + AIKV+D+ DE E+I++EI
Sbjct: 15 DLSALRDPAG-IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEI 71
Query: 63 SVLSQ-CRSPYITEYYGSYLHQ------TKLWIIMEYMAGGSVADLIQS--GPPLDEMSI 113
++L + I YYG+++ + +LW++ME+ GSV DLI++ G L E I
Sbjct: 72 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI 131
Query: 114 ACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
A I R++L + +LH IHRDIK N+LLTEN +VK+ DFGVSAQL RT+ RR TF+G
Sbjct: 132 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG 191
Query: 174 TPFWMAPEVIQNSE----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP 229
TP+WMAPEVI E Y+ K+D+WSLGIT IEMA+G PPL D+HPMR LF+IPR
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 251
Query: 230 PQL-DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRE-----R 283
P+L + +S+ + F+ CL K ++RP+ ++L++H FIR+ ++ ++++ +
Sbjct: 252 PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTK 311
Query: 284 PKYPIQEEPDTPING 298
K ++E + +G
Sbjct: 312 KKRGEKDETEYEYSG 326
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 467 bits (1203), Expect = e-161
Identities = 141/283 (49%), Positives = 185/283 (65%), Gaps = 7/283 (2%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
F LE +G GS+G VYKA KE + VAIK + +E ++++I KEIS++ QC SP++
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHV 86
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGK 132
+YYGSY T LWI+MEY GSV+D+I+ L E IA IL+ L +EYLH K
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIKA NILL G K+ADFGV+ QLT T+++R T +GTPFWMAPEVIQ GYN
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNCV 205
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKK 250
ADIWSLGIT IEMA+G+PP AD+HPMR +F+IP PP E +S +FV CL K
Sbjct: 206 ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVK 265
Query: 251 VPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPD 293
P +R +A +LL+H F+R+A+ L + I E ++ +
Sbjct: 266 SPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQES 308
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 462 bits (1191), Expect = e-159
Identities = 115/288 (39%), Positives = 172/288 (59%), Gaps = 12/288 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL--EESEDEIEDIQKEISVLSQCRS 70
FS L IG GSFG VY A D ++ VAIK + ++S ++ +DI KE+ L + R
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHN 129
P +Y G YL + W++MEY GS +DL++ PL E+ IA + L + YLH+
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSE-- 187
IHRD+KA NILL+E G VK+ DFG ++ + +FVGTP+WMAPEVI +
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANSFVGTPYWMAPEVILAMDEG 228
Query: 188 GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-DEHFSRLMKEFVSL 246
Y+ K D+WSLGIT IE+A+ +PPL +++ M L+ I + P L H+S + FV
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288
Query: 247 CLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDT 294
CL+K+P +RP+++ LL+HRF+ R +++ I +R K ++E +
Sbjct: 289 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI-QRTKDAVRELDNL 335
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 458 bits (1180), Expect = e-158
Identities = 115/272 (42%), Positives = 171/272 (62%), Gaps = 5/272 (1%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+++ E IG+G+ G VY A D ++VAI+ ++L++ + E I EI V+ + ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-ELIINEILVMRENKNPN 78
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I Y SYL +LW++MEY+AGGS+ D++ +DE IA + R+ L A+E+LH+
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQV 137
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIK+ NILL +G VK+ DFG AQ+T S+R T VGTP+WMAPEV+ Y K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPK 196
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKK 250
DIWSLGI IEM +GEPP + +P+R L++I P+L E S + ++F++ CL+
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 256
Query: 251 VPAERPSAKELLRHRFIRNARKSPRLLERIRE 282
+R SAKELL+H+F++ A+ L I
Sbjct: 257 DVEKRGSAKELLQHQFLKIAKPLSSLTPLIAA 288
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 454 bits (1171), Expect = e-157
Identities = 105/276 (38%), Positives = 161/276 (58%), Gaps = 5/276 (1%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
S IG GS G V A +K + VA+K++DL + + E + E+ ++ +
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR-ELLFNEVVIMRDYQHFN 103
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ E Y SYL +LW++ME++ GG++ D++ L+E IA + +L A+ YLH +G
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQGV 162
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
IHRDIK+ +ILLT +G VK++DFG AQ+++ + +RK+ VGTP+WMAPEVI S Y +
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRS-LYATE 221
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKK 250
DIWSLGI VIEM GEPP P++ + + PP+L S ++++F+ L +
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281
Query: 251 VPAERPSAKELLRHRFIRNARKSPRLLERIRERPKY 286
P ER +A+ELL H F+ L+ I+ K
Sbjct: 282 DPQERATAQELLDHPFLLQTGLPECLVPLIQLYRKQ 317
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 439 bits (1130), Expect = e-149
Identities = 88/346 (25%), Positives = 150/346 (43%), Gaps = 63/346 (18%)
Query: 13 SRFSSLELIGRG--SFGDVYKAFDKELNKDVAIKVIDLEESEDE-IEDIQKEISVLSQCR 69
+ L +IG+G V A K + V ++ I+LE +E + +Q E+ V
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYL 127
P I Y +++ +LW++ +MA GS DLI + ++E++IA IL+ +L A++Y+
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-------FVGTPFWMAP 180
H+ G +HR +KA++IL++ +G V ++ + + R++ V W++P
Sbjct: 145 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 181 EVI-QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD------ 233
EV+ QN +GY+ K+DI+S+GIT E+A G P D+ ++L P L
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 234 ---------------------------------------EHFSRLMKEFVSLCLKKVPAE 254
FS FV CL++ P
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324
Query: 255 RPSAKELLRHRFIRNARKSPR-----LLERIRERPKYPIQEEPDTP 295
RPSA LL H F + ++ LL + + + D
Sbjct: 325 RPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHS 370
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 401 bits (1033), Expect = e-136
Identities = 94/302 (31%), Positives = 149/302 (49%), Gaps = 23/302 (7%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISV-LSQCRSPYI 73
L IGRG++G V K K + +A+K I E E + + ++ V + PYI
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHN 129
++YG+ + WI ME M+ + E + I + A+ +L
Sbjct: 84 VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 130 EGKI-HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS-- 186
KI HRDIK +NILL +G++K+ DFG+S QL +I++ G +MAPE I S
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT-RDAGCRPYMAPERIDPSAS 202
Query: 187 -EGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFIIPRENPPQL----DEHFSRLM 240
+GY+ ++D+WSLGIT+ E+A G P + + L + + +PPQL + FS
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSF 262
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP--------RLLERIRERPKYPIQEEP 292
FV+LCL K ++RP KELL+H FI + ++L+++ P P+ +
Sbjct: 263 INFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSPMYVDH 322
Query: 293 DT 294
Sbjct: 323 HH 324
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 391 bits (1007), Expect = e-132
Identities = 85/310 (27%), Positives = 146/310 (47%), Gaps = 25/310 (8%)
Query: 2 ADLAGLQEAAGSRFSS-------LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE 54
G G R+ + L +G G+ G V+K ++ +A+K + +++E
Sbjct: 7 GKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE 66
Query: 55 IEDIQKEISVL-SQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSI 113
+ I ++ V+ PYI + +G+++ T ++I ME M + + P+ E +
Sbjct: 67 NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL 126
Query: 114 ACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172
+ ++ A+ YL + G IHRD+K +NILL E G +K+ DFG+S +L ++
Sbjct: 127 GKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD-RSA 185
Query: 173 GTPFWMAPEVIQNSE----GYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRE 227
G +MAPE I + Y+ +AD+WSLGI+++E+A G+ P + VL + +E
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245
Query: 228 NPPQL--DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP--------RLL 277
PP L FS + FV CL K +RP +LL H FI+ ++
Sbjct: 246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVM 305
Query: 278 ERIRERPKYP 287
+ P
Sbjct: 306 AKTESPRSGP 315
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 390 bits (1003), Expect = e-131
Identities = 77/271 (28%), Positives = 113/271 (41%), Gaps = 15/271 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +GRGSFG+V++ DK+ A+K + LE E E+ + SP I
Sbjct: 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVACAGLSSPRI 112
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
YG+ + I ME + GGS+ LI+ L E L L +EYLH +
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172
Query: 134 HRDIKAANILLTENG-DVKVADFGVSAQLT-----RTISRRKTFVGTPFWMAPEVIQNSE 187
H D+KA N+LL+ +G + DFG + L +++ GT MAPEV+
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK- 231
Query: 188 GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVS 245
+ K DIWS ++ M G P + I E PP + + L + +
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQ 291
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRL 276
L+K P R SA EL R
Sbjct: 292 EGLRKEPVHRASAMELRRKVGKALQEVGGLK 322
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 386 bits (994), Expect = e-130
Identities = 90/269 (33%), Positives = 148/269 (55%), Gaps = 8/269 (2%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
++G+G++G VY D +AIK I +S + + +EI++ + I +Y G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR-YSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQS--GP-PLDEMSIACILRDLLHAIEYLHNEGKIHR 135
S+ + I ME + GGS++ L++S GP +E +I + +L ++YLH+ +HR
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 136 DIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI-QNSEGYNEKA 193
DIK N+L+ T +G +K++DFG S +L +TF GT +MAPE+I + GY + A
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 194 DIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPREN-PPQLDEHFSRLMKEFVSLCLKKV 251
DIWSLG T+IEMA G+PP +L P +F + P++ E S K F+ C +
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPD 266
Query: 252 PAERPSAKELLRHRFIRNARKSPRLLERI 280
P +R A +LL F++ + K + ++
Sbjct: 267 PDKRACANDLLVDEFLKVSSKKKKTQPKL 295
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 386 bits (993), Expect = e-130
Identities = 84/270 (31%), Positives = 133/270 (49%), Gaps = 11/270 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISV-LSQCRSPYI 73
+ +GRG++G V K + +A+K I + E + + ++ + + P+
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAIEYLHNE 130
+YG+ + +WI ME M I G + E + I ++ A+E+LH++
Sbjct: 69 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 131 GK-IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ---NS 186
IHRD+K +N+L+ G VK+ DFG+S L +++ G +MAPE I N
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD-IDAGCKPYMAPERINPELNQ 187
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPRENPPQL-DEHFSRLMKEFV 244
+GY+ K+DIWSLGIT+IE+A P P + L + E PQL + FS +F
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247
Query: 245 SLCLKKVPAERPSAKELLRHRFIRNARKSP 274
S CLKK ERP+ EL++H F
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFFTLHESKG 277
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 365 bits (938), Expect = e-121
Identities = 94/304 (30%), Positives = 150/304 (49%), Gaps = 47/304 (15%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
F + +G G+ G V+K K +A K+I LE I +E+ VL +C SPYI
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI- 133
+YG++ ++ I ME+M GGS+ +++ + E + + ++ + YL + KI
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRD+K +NIL+ G++K+ DFGVS QL ++ +FVGT +M+PE +Q Y+ ++
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG-THYSVQS 211
Query: 194 DIWSLGITVIEMAKGEPPLA--------------------------------------DL 215
DIWS+G++++EMA G P+ D
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271
Query: 216 HPMRVLF----IIPRENPPQLD-EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270
P +F I E PP+L FS ++FV+ CL K PAER K+L+ H FI+ +
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331
Query: 271 RKSP 274
Sbjct: 332 DAEE 335
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 357 bits (918), Expect = e-119
Identities = 65/285 (22%), Positives = 119/285 (41%), Gaps = 32/285 (11%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQ-CRS 70
+ F LE IG G FG V+K + AIK + ++ +E+ + +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEY 126
++ Y+ ++ + I EY GGS+AD I E + +L + + Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 127 LHNEGKIHRDIKAANILLTENGD-------------------VKVADFGVSAQLTRTISR 167
+H+ +H DIK +NI ++ K+ D G ++ S
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----SS 186
Query: 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE 227
+ G ++A EV+Q + + KADI++L +TV+ A EP + I +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIRQG 243
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272
P++ + S+ E + + + P RPSA L++H + +A +
Sbjct: 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-115
Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 14/261 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
IGRGSF VYK D E +VA + + ++ E + ++E +L + P I +Y
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 78 GSYLHQTK----LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK- 132
S+ K + ++ E M G++ ++ + + R +L +++LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 133 -IHRDIKAANILLT-ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRD+K NI +T G VK+ D G++ S K +GTP +MAPE+ + E Y+
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYE--EKYD 207
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFII--PRENPPQLDEHFSRLMKEFVSLCL 248
E D+++ G+ ++EMA E P ++ ++ P D+ +KE + C+
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267
Query: 249 KKVPAERPSAKELLRHRFIRN 269
++ ER S K+LL H F +
Sbjct: 268 RQNKDERYSIKDLLNHAFFQE 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-111
Identities = 81/302 (26%), Positives = 151/302 (50%), Gaps = 35/302 (11%)
Query: 13 SRFSS----LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
R++S + ++G+G+FG V KA + ++ AIK I +E+++ I E+ +L+
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASL 59
Query: 69 RSPYITEYYGSYLHQ-------------TKLWIIMEYMAGGSVADLIQS-GPPLDEMSIA 114
Y+ YY ++L + + L+I MEY G++ DLI S
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 115 CILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--------- 165
+ R +L A+ Y+H++G IHRD+K NI + E+ +VK+ DFG++ + R++
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 166 -----SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMR 219
+ +GT ++A EV+ + YNEK D++SLGI EM + ++ ++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILK 239
Query: 220 VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLER 279
L + E PP D++ ++ K+ + L + P +RP A+ LL ++ + + E
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEA 299
Query: 280 IR 281
++
Sbjct: 300 LK 301
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 330 bits (847), Expect = e-108
Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 10/273 (3%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS 70
+ F + IGRG F +VY+A VA+K + + + D KEI +L Q
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEY 126
P + +YY S++ +L I++E G ++ +I+ + E ++ L A+E+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
+H+ +HRDIK AN+ +T G VK+ D G+ + + + VGTP++M+PE I
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE- 210
Query: 187 EGYNEKADIWSLGITVIEMAKGEPP-LADLHPMRVLF--IIPRENPPQLDEHFSRLMKEF 243
GYN K+DIWSLG + EMA + P D + L I + PP +H+S +++
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRL 276
V++C+ P +RP + +A + L
Sbjct: 271 VNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-104
Identities = 82/306 (26%), Positives = 150/306 (49%), Gaps = 4/306 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
++ L+ IG GSFG E + IK I++ S E E+ ++E++VL+ + P
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNE 130
I +Y S+ L+I+M+Y GG + I Q G E I + A++++H+
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
+HRDIK+ NI LT++G V++ DFG++ L T+ + +GTP++++PE+ +N + YN
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYN 203
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
K+DIW+LG + E+ + ++ I + P + H+S ++ VS K+
Sbjct: 204 NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKR 263
Query: 251 VPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVK 310
P +RPS +L FI + + I E + + + ++
Sbjct: 264 NPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSIS 323
Query: 311 VVRDKR 316
V+ ++
Sbjct: 324 VMPAQK 329
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-104
Identities = 69/262 (26%), Positives = 117/262 (44%), Gaps = 15/262 (5%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQ-CRS 70
F L +G GS+G+V+K KE + A+K + E+ + +
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHN 129
P ++ L++ E G S+ + G L E + LRD L A+ +LH+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+G +H D+K ANI L G K+ DFG+ +L + G P +MAPE++Q Y
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQG--SY 232
Query: 190 NEKADIWSLGITVIEMAKGEPP---LADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
AD++SLG+T++E+A +R ++ PP+ S ++ + +
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL-----PPEFTAGLSSELRSVLVM 287
Query: 247 CLKKVPAERPSAKELLRHRFIR 268
L+ P R +A+ LL +R
Sbjct: 288 MLEPDPKLRATAEALLALPVLR 309
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = 7e-98
Identities = 72/286 (25%), Positives = 124/286 (43%), Gaps = 32/286 (11%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
G F +ELIG G FG V+KA + K IK + E ++E+ L++
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHV 64
Query: 72 YITEYYGSYL----------------HQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSI 113
I Y G + L+I ME+ G++ I + G LD++
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 114 ACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
+ + ++Y+H++ I+RD+K +NI L + VK+ DFG+ L +R G
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTRSKG 183
Query: 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD 233
T +M+PE I + + Y ++ D+++LG+ + E+ +
Sbjct: 184 TLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFTDLRDGIIS 237
Query: 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLER 279
+ F + K + L K P +RP+ E+LR + +KSP ER
Sbjct: 238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW--KKSPEKNER 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 2e-91
Identities = 75/298 (25%), Positives = 129/298 (43%), Gaps = 30/298 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ F ++ +GRG FG V++A +K + + AIK I L E E + +E+ L++ P
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 73 ITEYYGSYLHQTK------------LWIIMEYMAGGSVADLIQ---SGPPLDEMSIACIL 117
I Y+ ++L + L+I M+ ++ D + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF------ 171
+ A+E+LH++G +HRD+K +NI T + VKV DFG+ + + +
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 172 ------VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP 225
VGT +M+PE I Y+ K DI+SLG+ + E+ P + +R L +
Sbjct: 185 ARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDVR 241
Query: 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRER 283
P L V L P ERP A ++ + + + + R R R
Sbjct: 242 NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSR 299
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-88
Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 13/268 (4%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPY 72
+ L IG GS+G K K K + K +D +E E + + E+++L + + P
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 73 ITEYYGSYLHQT--KLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEY 126
I YY + +T L+I+MEY GG +A +I + LDE + ++ L A++
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 127 LHNEGK-----IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPE 181
H +HRD+K AN+ L +VK+ DFG++ L S KTFVGTP++M+PE
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186
Query: 182 VIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241
+ YNEK+DIWSLG + E+ PP + I ++ +S +
Sbjct: 187 QMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 245
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRN 269
E ++ L RPS +E+L + I
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 2e-86
Identities = 76/338 (22%), Positives = 153/338 (45%), Gaps = 23/338 (6%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR- 69
G +S L+ IG G V++ +++ + AIK ++LEE ++ + EI+ L++ +
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 70 -SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
S I Y + ++++ME + ++ +D +++L A+ +H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMAPEVIQNS 186
G +H D+K AN L+ +G +K+ DFG++ Q+ T + + VGT +M PE I++
Sbjct: 126 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 187 ----------EGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPREN-PPQLDE 234
+ K+D+WSLG + M G+ P + + + L I N + +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR-NARKSPRLLERIRERPKYPIQEEPD 293
+ +++ + CLK+ P +R S ELL H +++ ++ + E KY + +
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVG 304
Query: 294 TPINGVRAVGEASGTVKVVRDKRSEETVQVSSQGQTVR 331
+N ++ +A+ T+ S + R
Sbjct: 305 --LNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKR 340
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 4e-84
Identities = 68/275 (24%), Positives = 134/275 (48%), Gaps = 20/275 (7%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR- 69
G +S L+ IG G V++ +++ + AIK ++LEE ++ + EI+ L++ +
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 70 -SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
S I Y + ++++ME + ++ +D +++L A+ +H
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMAPEVIQNS 186
G +H D+K AN L+ +G +K+ DFG++ Q+ T + + VGT +M PE I++
Sbjct: 145 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 187 ----------EGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLF-IIPRENPPQLDE 234
+ K+D+WSLG + M G+ P + + + L II + + +
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269
+ +++ + CLK+ P +R S ELL H +++
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 265 bits (678), Expect = 3e-82
Identities = 75/338 (22%), Positives = 152/338 (44%), Gaps = 23/338 (6%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR- 69
G +S L+ IG G V++ +++ + AIK ++LEE ++ + EI+ L++ +
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 70 -SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
S I Y + ++++ME + ++ +D +++L A+ +H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLT--RTISRRKTFVGTPFWMAPEVIQNS 186
G +H D+K AN L+ +G +K+ DFG++ Q+ T + + VG +M PE I++
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 187 ----------EGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPREN-PPQLDE 234
+ K+D+WSLG + M G+ P + + + L I N + +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR-NARKSPRLLERIRERPKYPIQEEPD 293
+ +++ + CLK+ P +R S ELL H +++ ++ + E KY + +
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQ--L 349
Query: 294 TPINGVRAVGEASGTVKVVRDKRSEETVQVSSQGQTVR 331
+N ++ +A+ T+ S + R
Sbjct: 350 VGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKR 387
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 4e-73
Identities = 64/298 (21%), Positives = 128/298 (42%), Gaps = 24/298 (8%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPY 72
F +++G G+ G + N+DVA+K I E +E+ +L + P
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPN 79
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEG 131
+ Y+ + + +I +E ++ + ++ + +L+ + +LH+
Sbjct: 80 VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 132 KIHRDIKAANILLTENGD-----VKVADFGVSAQLT---RTISRRKTFVGTPFWMAPEVI 183
+HRD+K NIL++ ++DFG+ +L + SRR GT W+APE++
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 184 QNS--EGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSR 238
E DI+S G + ++G P + ++ + ++H
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDV 258
Query: 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPI 296
+ +E + + P +RPSAK +L+H F + K + + + +R + +E D PI
Sbjct: 259 IARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIE---KESLDGPI 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 4e-72
Identities = 76/257 (29%), Positives = 136/257 (52%), Gaps = 18/257 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
E IG GSFG V++A DVA+K++ ++ + + + +E++++ + R P I +
Sbjct: 43 EKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQ---SGPPLDEMSIACILRDLLHAIEYLHNEGK-- 132
G+ L I+ EY++ GS+ L+ + LDE + D+ + YLHN
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
+HR++K+ N+L+ + VKV DFG+S T K+ GTP WMAPEV+++ E NEK
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEK 219
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-----PPQLDEHFSRLMKEFVSLC 247
+D++S G+ + E+A + P +L+P +V+ + + P L+ + +++ C
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG----C 275
Query: 248 LKKVPAERPSAKELLRH 264
P +RPS ++
Sbjct: 276 WTNEPWKRPSFATIMDL 292
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-69
Identities = 59/274 (21%), Positives = 102/274 (37%), Gaps = 22/274 (8%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
+ ++ +G G F V A+K I E +D E+ Q+E + P
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR-EEAQREADMHRLFNHP 86
Query: 72 YITEYYGSYLHQT----KLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHA 123
I L + + W+++ + G++ + I G L E I +L +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK---------TFVGT 174
+E +H +G HRD+K NILL + G + D G Q + + T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 175 PFWMAPEVIQNSEG--YNEKADIWSLGITVIEMAKGEPP--LADLHPMRVLFIIPRENPP 230
+ APE+ +E+ D+WSLG + M GE P + V + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
S + + ++ + P +RP LL
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 4e-67
Identities = 77/272 (28%), Positives = 131/272 (48%), Gaps = 32/272 (11%)
Query: 15 FSSLEL---IGRGSFGDVYKAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQC 68
F+ L L IG G FG VY+AF +VA+K E+ IE++++E + +
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
+ P I G L + L ++ME+ GG + ++ G + + + + YLH
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLH 122
Query: 129 NEGK---IHRDIKAANILLTE--------NGDVKVADFGVSAQLTRTISRRKTFVGTPFW 177
+E IHRD+K++NIL+ + N +K+ DFG++ + RT + + G W
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAYAW 180
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-----PPQL 232
MAPEVI+ S +++ +D+WS G+ + E+ GE P + + V + + P
Sbjct: 181 MAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC 239
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
E F++LM++ C P RPS +L
Sbjct: 240 PEPFAKLMED----CWNPDPHSRPSFTNILDQ 267
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 6e-67
Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 39/272 (14%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE------IEDIQKEISVLSQCRSPY 72
+ IG+G FG V+K + VAIK + L +SE E ++ Q+E+ ++S P
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEG 131
I + YG + ++ME++ G + + P+ ++ D+ IEY+ N+
Sbjct: 85 IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 132 K--IHRDIKAANILLTENGD-----VKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
+HRD+++ NI L + KVADFG+S Q ++ +G WMAPE I
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SGLLGNFQWMAPETIG 199
Query: 185 -NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI-----------IPRENPPQL 232
E Y EKAD +S + + + GE P + ++ FI IP + PP+L
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL 259
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+++ C P +RP +++
Sbjct: 260 ----RNVIEL----CWSGDPKKRPHFSYIVKE 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-66
Identities = 55/286 (19%), Positives = 112/286 (39%), Gaps = 40/286 (13%)
Query: 15 FSSLEL---IGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRS 70
F L + G+++K + D+ +KV+ + + S + D +E L
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 71 PYITEYYGSYLH--QTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEY 126
P + G+ +I +M GS+ +++ +D+ D+ + +
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 127 LHNEGK--IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
LH + + ++++ E+ +++ V + P W+APE +Q
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVAPEALQ 181
Query: 185 N--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-----PPQLDEHFS 237
+ AD+WS + + E+ E P ADL M + + E PP + H S
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS 241
Query: 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRER 283
+LMK C+ + PA+RP ++ LE+++++
Sbjct: 242 KLMKI----CMNEDPAKRPKFDMIVPI------------LEKMQDK 271
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-66
Identities = 84/282 (29%), Positives = 135/282 (47%), Gaps = 20/282 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS 70
F +G+G FG+VY A +K+ +A+KV+ + +++E+ + S R
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P I YG + T++++I+EY G+V +Q DE A + +L +A+ Y H++
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRDIK N+LL G++K+ADFG S SRR GT ++ PE+I+ ++
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIEGR-MHD 185
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPM-------RVLFIIPRENPPQLDEHFSRLMKEF 243
EK D+WSLG+ E G+PP RV F P + ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------FVTEGARDL 237
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPK 285
+S LK P++RP +E+L H +I P + K
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK 279
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 3e-66
Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 39/298 (13%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
E++G+G FG K +E + + +K + + E+ KE+ V+ P + ++ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+L I EY+ GG++ +I+S +D+ + YLH+ IHRD+
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTIS--------------RRKTFVGTPFWMAPEVI 183
+ N L+ EN +V VADFG++ + + +R T VG P+WMAPE+I
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN------PPQLDEHFS 237
Y+EK D++S GI + E+ D P + F + PP F
Sbjct: 195 NG-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFF 253
Query: 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTP 295
+ C P +RPS +L LE +R + P
Sbjct: 254 PITVR----CCDLDPEKRPSFVKLEHW------------LETLRMHLAGHLPLGPQLE 295
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 6e-66
Identities = 67/288 (23%), Positives = 129/288 (44%), Gaps = 19/288 (6%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCR 69
R+ +G+G F ++ D + + A K++ + E + EIS+
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
++ ++G + +++++E S+ +L + L E LR ++ +YLH
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
IHRD+K N+ L E+ +VK+ DFG++ ++ R+K GTP ++APEV+ G+
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GH 192
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPM-------RVLFIIPRENPPQLDEHFSRLMKE 242
+ + D+WS+G + + G+PP + + IP +H + +
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--------KHINPVAAS 244
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRL-LERIRERPKYPIQ 289
+ L+ P RP+ ELL F + RL + + P++ I
Sbjct: 245 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 292
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 8e-66
Identities = 83/267 (31%), Positives = 130/267 (48%), Gaps = 33/267 (12%)
Query: 15 FSSLEL---IGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
+ +E+ +GRG+FG V KA + KDVAIK I ESE E + E+ LS+ P
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQI---ESESERKAFIVELRQLSRVNHP 61
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYLH 128
I + YG+ L+ + ++MEY GGS+ +++ PL + A + + YLH
Sbjct: 62 NIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 129 NEGK---IHRDIKAANILLTENGDV-KVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVI 183
+ IHRD+K N+LL G V K+ DFG + I T G+ WMAPEV
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMAPEVF 175
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLH--PMRVLFIIPR----ENPPQLDEHFS 237
+ Y+EK D++S GI + E+ P ++ R+++ + L +
Sbjct: 176 EG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234
Query: 238 RLMKEFVSLCLKKVPAERPSAKELLRH 264
LM C K P++RPS +E+++
Sbjct: 235 SLMTR----CWSKDPSQRPSMEEIVKI 257
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 3e-65
Identities = 66/302 (21%), Positives = 127/302 (42%), Gaps = 18/302 (5%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCR 69
R+ +G+G F ++ D + + A K++ + E + EIS+
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
++ ++G + +++++E S+ +L + L E LR ++ +YLH
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
IHRD+K N+ L E+ +VK+ DFG++ ++ R+K GTP ++APEV+ G+
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GH 218
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPM-------RVLFIIPRENPPQLDEHFSRLMKE 242
+ + D+WS+G + + G+PP + + IP +H + +
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP--------KHINPVAAS 270
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAV 302
+ L+ P RP+ ELL F + RL P + + +
Sbjct: 271 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330
Query: 303 GE 304
Sbjct: 331 TV 332
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-64
Identities = 62/273 (22%), Positives = 125/273 (45%), Gaps = 31/273 (11%)
Query: 15 FSSLEL---IGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRS 70
F LE+ IG+G FG VY + +VAI++ID+E +ED+++ ++E+ Q R
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN 129
+ + G+ + L II G ++ +++ LD I ++++ + YLH
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-----FVGTPFWMAPEVIQ 184
+G +H+D+K+ N+ +NG V + DFG+ + + R+ G +APE+I+
Sbjct: 149 KGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 185 NS--------EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-----PRENPPQ 231
+++ +D+++LG E+ E P +++ + P +
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG 267
Query: 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ + S ++ C ERP+ +L+
Sbjct: 268 MGKEISDILLF----CWAFEQEERPTFTKLMDM 296
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-63
Identities = 72/267 (26%), Positives = 126/267 (47%), Gaps = 21/267 (7%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSP 71
F L+G+GSF VY+A +VAIK+ID + ++ +Q E+ + Q + P
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 72 YITEYYGSYLH-QTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN 129
I E Y Y +++++E G + +++ P E + ++ + YLH+
Sbjct: 72 SILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
G +HRD+ +N+LLT N ++K+ADFG++ QL + T GTP +++PE+ S +
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS-AH 189
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPM-------RVLFIIPRENPPQLDEHFSRLMKE 242
++D+WSLG + G PP + +P S K+
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP--------SFLSIEAKD 241
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRN 269
+ L++ PA+R S +L H F+
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMSR 268
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 5e-63
Identities = 72/269 (26%), Positives = 123/269 (45%), Gaps = 20/269 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS 70
F +G+G FG+VY A +K+ +A+KV+ + E +++EI + S R
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P I Y + + ++++++E+ G + +Q DE A + +L A+ Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRDIK N+L+ G++K+ADFG S RR+T GT ++ PE+I+ ++
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMIEGK-THD 190
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPM-------RVLFIIPRENPPQLDEHFSRLMKEF 243
EK D+W G+ E G PP V P S K+
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP--------FLSDGSKDL 242
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARK 272
+S L+ P +R K ++ H +++ +
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSR 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-61
Identities = 72/268 (26%), Positives = 135/268 (50%), Gaps = 26/268 (9%)
Query: 15 FSSLEL---IGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRS 70
+ + IG GSFG VYK + + DVA+K++++ + +++ + E+ VL + R
Sbjct: 23 DGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN 129
I + G +L I+ ++ G S+ + + + + I R ++YLH
Sbjct: 80 VNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSE 187
+ IHRD+K+ NI L E+ VK+ DFG++ + +R + + G+ WMAPEVI+ +
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 188 G--YNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFIIPREN--------PPQLDEHF 236
Y+ ++D+++ GI + E+ G+ P ++++ +++ ++ R + +
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258
Query: 237 SRLMKEFVSLCLKKVPAERPSAKELLRH 264
RLM E CLKK ERPS +L
Sbjct: 259 KRLMAE----CLKKKRDERPSFPRILAE 282
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 4e-61
Identities = 54/303 (17%), Positives = 110/303 (36%), Gaps = 45/303 (14%)
Query: 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVL 65
G Q + + +++G+G+ +V++ K+ AIKV + ++ +E VL
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVL 61
Query: 66 SQCRSPYITEYYGSYLHQTK--LWIIMEYMAGGSVADLI---QSGPPLDEMSIACILRDL 120
+ I + + T +IME+ GS+ ++ + L E +LRD+
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGD----VKVADFGVSAQLTRTISRRKTFVGTPF 176
+ + +L G +HR+IK NI+ D K+ DFG + +L + + GT
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEE 180
Query: 177 WMAPEVIQ-------NSEGYNEKADIWSLGITVIEMAKGEPP------------------ 211
++ P++ + + + Y D+WS+G+T A G P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 212 ----------LADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
+ + + L L+ ++ L+ + +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 262 LRH 264
Sbjct: 301 FAE 303
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 2e-58
Identities = 74/340 (21%), Positives = 127/340 (37%), Gaps = 93/340 (27%)
Query: 13 SRFSS----LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
SR+ + ++ +GRG FG V++A +K + + AIK I L E E + +E+ L++
Sbjct: 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 69 RSPYITEYYGSYL-----------------------------HQTKLWIIMEYMAGGSVA 99
P I Y+ ++L + + M S
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 100 DLIQSGPPLDEMSIACI---------LRDLLH----------------------AIEYLH 128
+ + P I L+D ++ A+E+LH
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF------------VGTPF 176
++G +HRD+K +NI T + VKV DFG+ + + + VGT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-------RVLFIIPRENP 229
+M+PE I + Y+ K DI+SLG+ + E+ L+ R++ +
Sbjct: 242 YMSPEQIHGN-NYSHKVDIFSLGLILFEL---------LYSFSTQMERVRIITDVRNLKF 291
Query: 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269
P L V L P ERP A +++ + N
Sbjct: 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-58
Identities = 54/303 (17%), Positives = 110/303 (36%), Gaps = 45/303 (14%)
Query: 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVL 65
G Q + + +++G+G+ +V++ K+ AIKV + ++ +E VL
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVL 61
Query: 66 SQCRSPYITEYYGSYLHQTK--LWIIMEYMAGGSVADLI---QSGPPLDEMSIACILRDL 120
+ I + + T +IME+ GS+ ++ + L E +LRD+
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGD----VKVADFGVSAQLTRTISRRKTFVGTPF 176
+ + +L G +HR+IK NI+ D K+ DFG + +L + + GT
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEE 180
Query: 177 WMAPEVIQ-------NSEGYNEKADIWSLGITVIEMAKGEPP------------------ 211
++ P++ + + + Y D+WS+G+T A G P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 212 ----------LADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
+ + + L L+ ++ L+ + +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 262 LRH 264
Sbjct: 301 FAE 303
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 2e-57
Identities = 77/310 (24%), Positives = 134/310 (43%), Gaps = 50/310 (16%)
Query: 21 IGRGSFGDVYKAFDKELNKDVAIKVID----------------LEESEDEIEDIQKEISV 64
+ +G F + ++ NK A+K + + + +D + E+ +
Sbjct: 39 LNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 65 LSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMS--------IACI 116
++ ++ Y G + +++II EYM S+ + LD+ I CI
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 117 LRDLLHAIEYLHNEGKI-HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTP 175
++ +L++ Y+HNE I HRD+K +NIL+ +NG VK++DFG S + + K GT
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGSRGTY 214
Query: 176 FWMAPEVIQNSEGY-NEKADIWSLGITVIEMAKGEPPLADLHPMRVLF------------ 222
+M PE N Y K DIWSLGI + M P + + LF
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL 274
Query: 223 -------IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275
+ + + S +F+ L L+K PAER ++++ L+H ++ +
Sbjct: 275 DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED- 333
Query: 276 LLERIRERPK 285
L E +E K
Sbjct: 334 LREFSKELYK 343
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-57
Identities = 64/318 (20%), Positives = 121/318 (38%), Gaps = 41/318 (12%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS- 70
R ++ G F VY+A D ++ A+K + E E I +E+ + +
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN-RAIIQEVCFMKKLSGH 85
Query: 71 PYITEYYGSYL-------HQTKLWIIMEYMAGGSVADLI---QSGPPLDEMSIACILRDL 120
P I ++ + ++++ + G + + + +S PL ++ I
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 121 LHAIEYLHNEGK--IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK--------- 169
A++++H + IHRD+K N+LL+ G +K+ DFG + ++
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 170 ---TFVGTPFWMAPEVIQNSEG--YNEKADIWSLGITVIEMAKGEPPLADLHPMRVL--- 221
T TP + PE+I EK DIW+LG + + + P D +R++
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265
Query: 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF----IRNARKSPRLL 277
+ IP + + + L+ P ER S E++ RN +
Sbjct: 266 YSIP-PHDT-----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319
Query: 278 ERIRERPKYPIQEEPDTP 295
E + + Y P
Sbjct: 320 ELLEQNGGYGSATLSRGP 337
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 5e-57
Identities = 73/334 (21%), Positives = 141/334 (42%), Gaps = 44/334 (13%)
Query: 1 MADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK 60
+A++ +++ + S +++G GS G V + VA+K + + D +
Sbjct: 3 IANIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLI----DFCDIALM 57
Query: 61 EISVLSQC-RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-------GPPLDEMS 112
EI +L++ P + YY S L+I +E ++ DL++S E +
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 113 IACILRDLLHAIEYLHNEGKIHRDIKAANILLT-------------ENGDVKVADFGVSA 159
+LR + + +LH+ IHRD+K NIL++ EN + ++DFG+
Sbjct: 117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 160 QL----TRTISRRKTFVGTPFWMAPEVIQNS------EGYNEKADIWSLG-ITVIEMAKG 208
+L + + GT W APE+++ S DI+S+G + ++KG
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 209 EPPLADLHP-----MRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
+ P D + +R +F + D + +S + P +RP+A ++LR
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLH-DRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295
Query: 264 HRFIRNARKSPRLLERIRERPKYPIQEEPDTPIN 297
H K L ++ +R + ++ P +
Sbjct: 296 HPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLM 329
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 9e-57
Identities = 68/263 (25%), Positives = 116/263 (44%), Gaps = 16/263 (6%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G G+FGDV+ ++ + IK I+ + S+ +E I+ EI VL P I + +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPP----LDEMSIACILRDLLHAIEYLHNEGKIH 134
+ ++I+ME GG + + I S L E +A +++ +++A+ Y H++ +H
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 135 RDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
+D+K NIL + +K+ DFG++ GT +MAPEV +
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKRD--VTF 204
Query: 192 KADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVSLC 247
K DIWS G + + G P V P + + +
Sbjct: 205 KCDIWSAGVVMYF-LLTGCLPFTGTSLEEVQQKA-TYKEPNYAVECRPLTPQAVDLLKQM 262
Query: 248 LKKVPAERPSAKELLRHRFIRNA 270
L K P RPSA ++L H + + A
Sbjct: 263 LTKDPERRPSAAQVLHHEWFKQA 285
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 195 bits (496), Expect = 2e-56
Identities = 71/305 (23%), Positives = 126/305 (41%), Gaps = 54/305 (17%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID----LEESEDEIEDIQKEISVLSQCRSPYIT 74
IG+GS+G V A + + AIK+++ + + ++E I+ E+ ++ + P I
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQS------------------------------ 104
Y Y + + ++ME GG + D +
Sbjct: 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 105 ----------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT--ENGDVKV 152
E I+ I+R + A+ YLHN+G HRDIK N L + ++ ++K+
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKL 211
Query: 153 ADFGVSAQLTRT----ISRRKTFVGTPFWMAPEVIQ-NSEGYNEKADIWSLGITVIEMAK 207
DFG+S + + T GTP+++APEV+ +E Y K D WS G+ + +
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 208 GEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
G P ++ + + + S L ++ +S L + ER A L+H
Sbjct: 272 GAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331
Query: 265 RFIRN 269
+I
Sbjct: 332 PWISQ 336
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 4e-56
Identities = 51/284 (17%), Positives = 98/284 (34%), Gaps = 30/284 (10%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELN-----KDVAIKVIDLEESEDEIEDIQKEIS 63
+ L+G G+F VY+A +LN + +KV + E + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLME 119
Query: 64 VLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-----SGPPLDEMSIACILR 118
L ++Y ++L Q ++ E + G++ + I + + +
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 119 DLLHAIEYLHNEGKIHRDIKAANILLT-----------ENGDVKVADFGVSAQLT--RTI 165
+L+ IE +H+ IH DIK N +L + + + D G S +
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP 225
+ T + E++ N + +N + D + + TV M G
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269
P LD + EF + L + +LLR + +
Sbjct: 299 FRRLPHLD-----MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-55
Identities = 71/264 (26%), Positives = 128/264 (48%), Gaps = 12/264 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
+ +G G++G+V DK + + AIK+I S + +E++VL P I + Y
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ + +++ME GG + D I +E+ A I++ +L + YLH +HRD+
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDL 162
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K N+LL ++ +K+ DFG+SA + K +GT +++APEV++ Y+EK D
Sbjct: 163 KPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRKK--YDEKCD 219
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLKK 250
+WS+G+ + + G PP +L + + D + S K+ + L+
Sbjct: 220 VWSIGVILFILLAGYPPFGGQTDQEILRKV-EKGKYTFDSPEWKNVSEGAKDLIKQMLQF 278
Query: 251 VPAERPSAKELLRHRFIRNARKSP 274
R SA++ L H +I+
Sbjct: 279 DSQRRISAQQALEHPWIKEMCSKK 302
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-55
Identities = 74/265 (27%), Positives = 134/265 (50%), Gaps = 13/265 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPYITEY 76
++G+GSFG+V DK ++ A+KVI + + + E + +E+ +L Q P I +
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
Y + + +++ E GG + D I S E+ A I+R +L I Y+H +HRD
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151
Query: 137 IKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
+K N+LL ++ ++++ DFG+S + + K +GT +++APEV+ + Y+EK
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHGT--YDEKC 208
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLK 249
D+WS G+ + + G PP + +L + + + S K+ + L
Sbjct: 209 DVWSTGVILYILLSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESAKDLIRKMLT 267
Query: 250 KVPAERPSAKELLRHRFIRNARKSP 274
VP+ R SA++ L H +I+ K
Sbjct: 268 YVPSMRISARDALDHEWIQTYTKEQ 292
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 5e-55
Identities = 71/264 (26%), Positives = 121/264 (45%), Gaps = 14/264 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
IGRGS+G+V A K A K I ED ++ ++EI ++ P I Y
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
++ T ++++ME GG + + + E A I++D+L A+ Y H HRD+K
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 133
Query: 139 AANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
N L + +K+ DFG++A+ +T VGTP++++P+V++ Y + D
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEGL--YGPECDE 190
Query: 196 WSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLKK 250
WS G + + + G PP + V+ I RE E + S + + L K
Sbjct: 191 WSAGVMMYV-LLCGYPPFSAPTDSEVMLKI-REGTFTFPEKDWLNVSPQAESLIRRLLTK 248
Query: 251 VPAERPSAKELLRHRFIRNARKSP 274
P +R ++ + L H + S
Sbjct: 249 SPKQRITSLQALEHEWFEKQLSSS 272
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 8e-55
Identities = 75/272 (27%), Positives = 124/272 (45%), Gaps = 20/272 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID----LEESEDEIEDIQKEISVLSQCRSPYIT 74
E+IG+G F V + ++E + A+K++D ED+++E S+ + P+I
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEYLHNE 130
E +Y L+++ E+M G + I +G E + +R +L A+ Y H+
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 131 GKIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSE 187
IHRD+K +LL + VK+ FGV+ QL + VGTP +MAPEV+ E
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV-KRE 208
Query: 188 GYNEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF----SRLMKE 242
Y + D+W G I I ++ G P LF + +++ S K+
Sbjct: 209 PYGKPVDVWGCGVILFILLS-GCLPFYGTKER--LFEGIIKGKYKMNPRQWSHISESAKD 265
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
V L PAER + E L H +++ +
Sbjct: 266 LVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-54
Identities = 71/259 (27%), Positives = 127/259 (49%), Gaps = 12/259 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
++G+GSFG+V K D+ ++ A+KVI+ + I +E+ +L + P I + +
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ +I+ E GG + D I E A I++ + I Y+H +HRD+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K NILL ++ D+K+ DFG+S + ++ K +GT +++APEV++ + Y+EK D
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT--YDEKCD 204
Query: 195 IWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLKK 250
+WS G+ + + G PP + +L + D S K+ + L
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEYDILKRV-ETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 251 VPAERPSAKELLRHRFIRN 269
P+ R +A + L H +I+
Sbjct: 264 HPSLRITATQCLEHPWIQK 282
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-54
Identities = 66/300 (22%), Positives = 134/300 (44%), Gaps = 41/300 (13%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYY 77
+++G G+ V + +++ A+K+I+ + + +E+ +L QC+ + E
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR-SRVFREVEMLYQCQGHRNVLELI 77
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ + + +++ E M GGS+ I +E+ + +++D+ A+++LHN+G HRD+
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRR-------KTFVGTPFWMAPEVIQ--- 184
K NIL + VK+ DF + + + T G+ +MAPEV++
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 185 -NSEGYNEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM-- 240
+ Y+++ D+WSLG I I + G PP + P + F +
Sbjct: 198 EEASIYDKRCDLWSLGVILYI-LLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 241 ----------------KEFVSLCLKKVPAERPSAKELLRHRFIRNARK-----SPRLLER 279
K+ +S L + +R SA ++L+H +++ +P +L+R
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQR 316
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-54
Identities = 70/292 (23%), Positives = 128/292 (43%), Gaps = 55/292 (18%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
LE +G+G +G+V++ ++VA+K+ + + + E+ R I +
Sbjct: 13 LECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFI 68
Query: 78 GSYLH----QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK- 132
S + T+LW+I Y GS+ D +Q LD +S I+ + + +LH E
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 133 -------IHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFVGTPFWMAPE 181
HRD+K+ NIL+ +NG +AD G++ +++ ++ VGT +MAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 182 VIQNS-----EGYNEKADIWSLGITVIEMAKG----------EPPLADLHPMRVLFIIPR 226
V+ + ++ DIW+ G+ + E+A+ +PP D+ P F R
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 227 EN----------PPQLDEH-----FSRLMKEFVSLCLKKVPAERPSAKELLR 263
+ P + ++LMKE C + P+ R +A + +
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE----CWYQNPSARLTALRIKK 295
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-54
Identities = 62/264 (23%), Positives = 98/264 (37%), Gaps = 14/264 (5%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT--- 74
E +G G FG V + ++ + VAIK E S E EI ++ + P +
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 75 ---EYYGSYLHQTKLWIIMEYMAGGSVADLI---QSGPPLDEMSIACILRDLLHAIEYLH 128
+ + MEY GG + + ++ L E I +L D+ A+ YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 129 NEGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
IHRD+K NI+L K+ D G + +L + FVGT ++APE+++
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQ 197
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245
+ Y D WS G E G P RE + + L
Sbjct: 198 -KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKF 256
Query: 246 LCLKKVPAERPSAKELLRHRFIRN 269
+ P R+++
Sbjct: 257 SSVLPTPNHLSGILAGKLERWLQC 280
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-54
Identities = 64/270 (23%), Positives = 129/270 (47%), Gaps = 13/270 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
E +G+G+F V + K + A K+I+ ++ S + + +++E + + + P I +
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
S ++ +++ + + GG + + I + E + ++ +L +I Y H+ G +HR++
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 131
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K N+LL + VK+ADFG++ ++ + F GTP +++PEV+ + Y++ D
Sbjct: 132 KPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVL-KKDPYSKPVD 189
Query: 195 IWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLK 249
IW+ G I I + G PP D R+ I + + K + L
Sbjct: 190 IWACGVILYI-LLVGYPPFWDEDQHRLYAQI-KAGAYDYPSPEWDTVTPEAKSLIDSMLT 247
Query: 250 KVPAERPSAKELLRHRFIRNARKSPRLLER 279
P +R +A + L+ +I N + + R
Sbjct: 248 VNPKKRITADQALKVPWICNRERVASAIHR 277
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-54
Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 14/260 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
++G+GSFG+V K D+ ++ A+KVI+ + I +E+ +L + P I + +
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ +I+ E GG + D I E A I++ + I Y+H +HRD+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K NILL ++ D+K+ DFG+S + ++ K +GT +++APEV++ + Y+EK D
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT--YDEKCD 204
Query: 195 IWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLK 249
+WS G I I + G PP + +L + D S K+ + L
Sbjct: 205 VWSAGVILYI-LLSGTPPFYGKNEYDILKRV-ETGKYAFDLPQWRTISDDAKDLIRKMLT 262
Query: 250 KVPAERPSAKELLRHRFIRN 269
P+ R +A + L H +I+
Sbjct: 263 FHPSLRITATQCLEHPWIQK 282
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-54
Identities = 72/286 (25%), Positives = 130/286 (45%), Gaps = 43/286 (15%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID-------------------------LEESED 53
+ IG+GS+G V A+++ N A+KV+ +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 54 EIEDIQKEISVLSQCRSPYITEYYG--SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEM 111
IE + +EI++L + P + + ++ L+++ E + G V ++ P L E
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSED 137
Query: 112 SIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171
+DL+ IEYLH + IHRDIK +N+L+ E+G +K+ADFGVS + + +
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT 197
Query: 172 VGTPFWMAPEVIQNSE-GYN-EKADIWSLGITVIEMAKGEPPLADLHPMRVL-------F 222
VGTP +MAPE + + ++ + D+W++G+T+ G+ P D M +
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQAL 257
Query: 223 IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268
P + + +K+ ++ L K P R E+ H ++
Sbjct: 258 EFPDQ------PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 6e-54
Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 21/271 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYY 77
+ +G GSF K K+ N+ A+K+I + + QKEI+ L C P I + +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIIS----KRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ Q +++ME + GG + + I+ E + I+R L+ A+ ++H+ G +HRD+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDL 132
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K N+L T +N ++K+ DFG + KT T + APE++ N GY+E D
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGYDESCD 191
Query: 195 IWSLG-ITVIEMAKGEPPLAD------LHPMRVLFIIPRENPPQLDE----HFSRLMKEF 243
+WSLG I M G+ P + ++ + + S+ K+
Sbjct: 192 LWSLGVILYT-MLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
+ L P +R L + ++++ +
Sbjct: 251 IQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-53
Identities = 77/283 (27%), Positives = 136/283 (48%), Gaps = 11/283 (3%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
S E++G G FG V+K + +A K+I +D E+++ EISV++Q +
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHANLI 149
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ Y ++ + + ++MEY+ GG + D +I L E+ ++ + I ++H +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL 209
Query: 134 HRDIKAANILLT--ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
H D+K NIL + +K+ DFG++ + + K GTP ++APEV+ N + +
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVV-NYDFVSF 267
Query: 192 KADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVSLC 247
D+WS+G I + + G P + L I DE F S KEF+S
Sbjct: 268 PTDMWSVGVIAYM-LLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQE 290
L K + R SA E L+H ++ + + RL + ++ Q+
Sbjct: 327 LIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSDAQD 369
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 4e-53
Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 16/269 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQCRSPYI 73
E +G G F V K K K+ A K I E+I++E+++L + R P I
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ + ++T + +I+E ++GG + D + L E L+ +L + YLH++
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIA 130
Query: 134 HRDIKAANILLT----ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
H D+K NI+L N +K+ DFG++ ++ + K GTP ++APE++ N E
Sbjct: 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIV-NYEPL 188
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVS 245
+AD+WS+G IT I + G P L I N +E+F S L K+F+
Sbjct: 189 GLEADMWSIGVITYI-LLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIR 247
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSP 274
L K P R + + L H +I+ R+
Sbjct: 248 RLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-53
Identities = 84/275 (30%), Positives = 131/275 (47%), Gaps = 22/275 (8%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID--------LEESEDEIEDIQKEISVLSQCRS 70
E++GRG V + K K+ A+K+ID EE ++ E KE+ +L +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 71 -PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
P I + +Y T +++ + M G + D + L E I+R LL I LH
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS--- 186
+HRD+K NILL ++ ++K+ DFG S QL + + GTP ++APE+I+ S
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMND 201
Query: 187 --EGYNEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRL 239
GY ++ D+WS G I + G PP M +L +I N P+ D +S
Sbjct: 202 NHPGYGKEVDMWSTGVIMYT-LLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD-DYSDT 259
Query: 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
+K+ VS L P +R +A+E L H F +
Sbjct: 260 VKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-53
Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 16/275 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQCRSPYI 73
E +G G F V K +K + A K I E+I++E+S+L Q +
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ Y ++T + +I+E ++GG + D + L E ++ +L + YLH +
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIA 137
Query: 134 HRDIKAANILLT----ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
H D+K NI+L +K+ DFG++ ++ K GTP ++APE++ N E
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIV-NYEPL 195
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVS 245
+AD+WS+G IT I + G P L I + +E F S L K+F+
Sbjct: 196 GLEADMWSIGVITYI-LLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIR 254
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280
L K +R + +E LRH +I ++ R
Sbjct: 255 KLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRE 289
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 6e-53
Identities = 69/293 (23%), Positives = 119/293 (40%), Gaps = 57/293 (19%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPYITEY 76
++ IG+G +G+V+ K + VA+KV + +E + EI R I +
Sbjct: 42 VKQIGKGRYGEVWMG--KWRGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGF 96
Query: 77 YGS----YLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ T+L++I +Y GS+ D ++S LD S+ + + + +LH E
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 133 --------IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR----KTFVGTPFWMAP 180
HRD+K+ NIL+ +NG +AD G++ + + T VGT +M P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 181 EVIQ-----NSEGYNEKADIWSLGITVIEMAKG----------EPPLADLHPMRVLF--- 222
EV+ N AD++S G+ + E+A+ + P DL P +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 223 -----------IIPRE-NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
P + + +LM E C PA R +A + +
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTE----CWAHNPASRLTALRVKK 324
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 7e-53
Identities = 63/257 (24%), Positives = 120/257 (46%), Gaps = 10/257 (3%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+ +G G++G+V A ++ + VA+K++D++ + D E+I+KEI + + ++YG
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
++ +EY +GG + D I+ + E L+ + YLH G HRDIK
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGTPFWMAPEVIQNSEGYN-EKADI 195
N+LL E ++K++DFG++ R GT ++APE+++ ++ E D+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEPVDV 191
Query: 196 WSLGITVIEMAKGEPPLADLH-PMRVLF-IIPRE--NPPQLDEHFSRLMKEFVSLCLKKV 251
WS GI + M GE P + ++ P + + L +
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPLALLHKILVEN 249
Query: 252 PAERPSAKELLRHRFIR 268
P+ R + ++ + R+
Sbjct: 250 PSARITIPDIKKDRWYN 266
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 7e-53
Identities = 79/280 (28%), Positives = 131/280 (46%), Gaps = 18/280 (6%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID-------LEESEDEIEDIQKEISVLSQCRSP 71
+ +G G+ G+V AF+++ K VAI++I D +++ EI +L + P
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I + + +I++E M GG + D + L E + +L A++YLH G
Sbjct: 201 CIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 259
Query: 132 KIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS-- 186
IHRD+K N+LL+ E+ +K+ DFG S L T S +T GTP ++APEV+ +
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGT 318
Query: 187 EGYNEKADIWSLGITVIEMAKGEPP-LADLHPMRVLFIIPREN---PPQLDEHFSRLMKE 242
GYN D WSLG+ + G PP + + I P++ S +
Sbjct: 319 AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALD 378
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRE 282
V L P R + +E LRH ++++ + + + E
Sbjct: 379 LVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 418
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 9e-53
Identities = 82/282 (29%), Positives = 131/282 (46%), Gaps = 20/282 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID-------LEESEDEIEDIQKEISVLSQCRSP 71
+ +G G+ G+V AF+++ K VAIK+I D +++ EI +L + P
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I + + +I++E M GG + D + L E + +L A++YLH G
Sbjct: 76 CIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 132 KIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS-- 186
IHRD+K N+LL+ E+ +K+ DFG S L T S +T GTP ++APEV+ +
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGT 193
Query: 187 EGYNEKADIWSLG-ITVIEMAKGEPPL-ADLHPMRVLFIIPR---ENPPQLDEHFSRLMK 241
GYN D WSLG I I G PP + + I P++ S
Sbjct: 194 AGYNRAVDCWSLGVILFI-CLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRER 283
+ V L P R + +E LRH ++++ + + + E
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 294
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-52
Identities = 75/275 (27%), Positives = 132/275 (48%), Gaps = 23/275 (8%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID------------LEESEDEIEDIQKEISVLS 66
+G G++G+V +K + + AIKVI + E E+I EIS+L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 67 QCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY 126
P I + + + + +++ E+ GG + + I + DE A I++ +L I Y
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICY 161
Query: 127 LHNEGKIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI 183
LH +HRDIK NILL ++K+ DFG+S+ ++ + + +GT +++APEV+
Sbjct: 162 LHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVL 220
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRL 239
+ YNEK D+WS G+ + + G PP + ++ + + D + S
Sbjct: 221 KKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV-EKGKYYFDFNDWKNISDE 277
Query: 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
KE + L L +R +A+E L R+I+ +
Sbjct: 278 AKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNI 312
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 1e-52
Identities = 66/283 (23%), Positives = 127/283 (44%), Gaps = 14/283 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
++ E +GRG FG V++ + K K + + + ++KEIS+L+ R
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHRN 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I + S+ +L +I E+++G + + + S L+E I + + A+++LH+
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 132 KIHRDIKAANILLT--ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
H DI+ NI+ + +K+ +FG + QL + P + APEV +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVH-QHDVV 180
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVS 245
+ D+WSLG + + + G P +++ I +E F S +FV
Sbjct: 181 STATDMWSLGTLVYV-LLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARK--SPRLLERIRERPKY 286
L K R +A E L+H +++ + S +++ ++ R Y
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYY 282
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 1e-52
Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 16/284 (5%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQ 67
+ + E +G G F V K +K A K I EDI++E+S+L +
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 68 CRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
+ P + + Y ++T + +I+E +AGG + D + L E L+ +L+ + YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 128 HNEGKIHRDIKAANILLT----ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI 183
H+ H D+K NI+L +K+ DFG++ ++ + K GTP ++APE++
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIV 189
Query: 184 QNSEGYNEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRL 239
N E +AD+WS+G IT I + G P L + N DE+F S L
Sbjct: 190 -NYEPLGLEADMWSIGVITYI-LLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRER 283
K+F+ L K P +R + ++ L+H +I+ L +
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV 291
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-52
Identities = 68/308 (22%), Positives = 129/308 (41%), Gaps = 10/308 (3%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+ +G G++G+V A ++ + VA+K++D++ + D E+I+KEI + + ++YG
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
++ +EY +GG + D I+ + E L+ + YLH G HRDIK
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132
Query: 139 AANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGTPFWMAPEVIQNSEGYN-EKADI 195
N+LL E ++K++DFG++ R GT ++APE+++ ++ E D+
Sbjct: 133 PENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-REFHAEPVDV 191
Query: 196 WSLGITVIEMAKGEPPLADLH-PMRVLF-IIPRE--NPPQLDEHFSRLMKEFVSLCLKKV 251
WS GI + M GE P + ++ P + + L +
Sbjct: 192 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPLALLHKILVEN 249
Query: 252 PAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVKV 311
P+ R + ++ + R+ K R+ I + +
Sbjct: 250 PSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRT 309
Query: 312 VRDKRSEE 319
S+E
Sbjct: 310 PGSGWSKE 317
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 6e-52
Identities = 70/267 (26%), Positives = 127/267 (47%), Gaps = 14/267 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRS-PYITEY 76
+ +GRG F V + K ++ A K + +D +I EI+VL +S P +
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNEGKIH 134
+ Y + +++ +I+EY AGG + L + + E + +++ +L + YLH +H
Sbjct: 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVH 154
Query: 135 RDIKAANILL---TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
D+K NILL GD+K+ DFG+S ++ + +GTP ++APE++ N +
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEIL-NYDPITT 212
Query: 192 KADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVSLC 247
D+W++G I + + P I + N +E F S+L +F+
Sbjct: 213 ATDMWNIGIIAYM-LLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSL 271
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSP 274
L K P +RP+A+ L H +++
Sbjct: 272 LVKNPEKRPTAEICLSHSWLQQWDFEN 298
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 8e-52
Identities = 65/265 (24%), Positives = 129/265 (48%), Gaps = 13/265 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
E +G+G+F V + K + A K+I+ ++ S + + +++E + + + P I +
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
S ++ +++ + + GG + + I + E + ++ +L +I Y H+ G +HR++
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 154
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K N+LL + VK+ADFG++ ++ + F GTP +++PEV++ Y++ D
Sbjct: 155 KPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKD-PYSKPVD 212
Query: 195 IWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRLMKEFVSLCLK 249
IW+ G I I + G PP D R+ I P+ D + K + L
Sbjct: 213 IWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPSPEWD-TVTPEAKSLIDSMLT 270
Query: 250 KVPAERPSAKELLRHRFIRNARKSP 274
P +R +A + L+ +I N +
Sbjct: 271 VNPKKRITADQALKVPWICNRERVA 295
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-51
Identities = 80/291 (27%), Positives = 133/291 (45%), Gaps = 20/291 (6%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-------ESEDEIEDIQKEISVLS 66
++S++ +G G+FG V+ A DKE NK+V +K I E + ++ + EI++LS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 67 QCRSPYITEYYGSYLHQTKLWIIME-YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
+ I + + +Q ++ME + +G + I P LDE + I R L+ A+
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
YL + IHRDIK NI++ E+ +K+ DFG +A L R TF GT + APEV+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMG 203
Query: 186 SEGYN-EKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLDEHFSRLMKEF 243
Y + ++WSLG+T+ + E P +L + P S+ +
Sbjct: 204 -NPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPY--------LVSKELMSL 254
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDT 294
VS L+ VP R + ++L+ ++ R P
Sbjct: 255 VSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSA 305
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-51
Identities = 62/270 (22%), Positives = 126/270 (46%), Gaps = 12/270 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYY 77
E +G+G+F V + ++ A +I+ ++ S + + +++E + + P I +
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
S + ++I + + GG + + I + E + ++ +L A+ + H G +HR++
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNL 136
Query: 138 KAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
K N+LL + VK+ADFG++ ++ F GTP +++PEV++ Y + D
Sbjct: 137 KPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVD 195
Query: 195 IWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLK 249
+W+ G I I + G PP D R+ I + + K+ ++ L
Sbjct: 196 LWACGVILYILLV-GYPPFWDEDQHRLYQQI-KAGAYDFPSPEWDTVTPEAKDLINKMLT 253
Query: 250 KVPAERPSAKELLRHRFIRNARKSPRLLER 279
P++R +A E L+H +I + + R
Sbjct: 254 INPSKRITAAEALKHPWISHRSTVASCMHR 283
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-51
Identities = 76/277 (27%), Positives = 119/277 (42%), Gaps = 37/277 (13%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYY 77
E IG GS+ + K N + A+K+ID D +EI +L + P I
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIID-----KSKRDPTEEIEILLRYGQHPNIITLK 82
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
Y ++++ E M GG + D I E + +L + +EYLH +G +HRD+
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDL 142
Query: 138 KAANILLTENGD----VKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
K +NIL + +++ DFG + QL T T ++APEV+ +GY+
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-ERQGYDAAC 201
Query: 194 DIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE---------------HFS 237
DIWSLG + M G P A+ P + P ++ S
Sbjct: 202 DIWSLGVLLYT-MLTGYTPFANG---------PDDTPEEILARIGSGKFSLSGGYWNSVS 251
Query: 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
K+ VS L P +R +A +LRH +I + + P
Sbjct: 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-51
Identities = 65/300 (21%), Positives = 137/300 (45%), Gaps = 13/300 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ LE +G G+FG V++ +K + K I+ D ++ EIS+++Q P
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPK 109
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + ++ + ++ +I+E+++GG + D + + E + +R ++++H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 132 KIHRDIKAANILLT--ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+H DIK NI+ + VK+ DFG++ +L K T + APE++ + E
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIV-DREPV 227
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVS 245
D+W++G + + + G P A + L + R + ++ F S K+F+
Sbjct: 228 GFYTDMWAIGVLGYV-LLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSP--RLLERIRERPKYPIQEEPDTPINGVRAVG 303
L+K P +R + + L H +++ + R+ + + I+E+ A+G
Sbjct: 287 NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIG 346
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-51
Identities = 76/283 (26%), Positives = 133/283 (46%), Gaps = 19/283 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
F +E++G G+F +V+ + K A+K I + + ++ EI+VL + +
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD-SSLENEIAVLKKIKHEN 67
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I Y T +++M+ ++GG + D I E + +++ +L A++YLH G
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 133 IHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRD+K N+L EN + + DFG+S T GTP ++APEV+ + Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVL-AQKPY 184
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPREN----PPQLDEHFSRLMKEFV 244
++ D WS+G IT I + G PP + ++ I P D S K+F+
Sbjct: 185 SKAVDCWSIGVITYI-LLCGYPPFYEETESKLFEKIKEGYYEFESPFWD-DISESAKDFI 242
Query: 245 SLCLKKVPAERPSAKELLRHRFIRNARKS-----PRLLERIRE 282
L+K P ER + ++ L H +I P + +I++
Sbjct: 243 CHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQIQK 285
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 7e-51
Identities = 65/292 (22%), Positives = 115/292 (39%), Gaps = 55/292 (18%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
E IG+G FG+V++ K ++VA+K+ E + EI R I +
Sbjct: 47 QESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFR--EAEIYQTVMLRHENILGFI 102
Query: 78 GSYLH----QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK- 132
+ T+LW++ +Y GS+ D + + + + + +LH E
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 133 -------IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR----KTFVGTPFWMAPE 181
HRD+K+ NIL+ +NG +AD G++ + VGT +MAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 182 VIQNSEG-----YNEKADIWSLGITVIEMAKG----------EPPLADLHPMRVLF---- 222
V+ +S ++ADI+++G+ E+A+ + P DL P
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 223 -----------IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
I R + +++M+E C A R +A + +
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRE----CWYANGAARLTALRIKK 329
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 9e-51
Identities = 77/275 (28%), Positives = 126/275 (45%), Gaps = 16/275 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQCRSPYI 73
E +G G F V K +K + A K I E+I++E+S+L Q P I
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ Y ++T + +I+E ++GG + D + L E ++ +L + YLH +
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIA 137
Query: 134 HRDIKAANILLT----ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
H D+K NI+L +K+ DFG++ ++ K GTP ++APE++ N E
Sbjct: 138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIV-NYEPL 195
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVS 245
+AD+WS+G IT I + G P L I + +E F S L K+F+
Sbjct: 196 GLEADMWSIGVITYI-LLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIR 254
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280
L K +R + +E LRH +I ++ R
Sbjct: 255 KLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRE 289
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 9e-51
Identities = 74/267 (27%), Positives = 131/267 (49%), Gaps = 21/267 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDL-------EESEDEIEDIQKEISVLSQCRS- 70
++IGRG V + + + A+K++++ E+ E+ E ++E +L Q
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P+I SY + ++++ + M G + D + L E I+R LL A+ +LH
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN 219
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS---- 186
+HRD+K NILL +N ++++DFG S L + + GTP ++APE+++ S
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDET 278
Query: 187 -EGYNEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLM 240
GY ++ D+W+ G I +A G PP + +L +I E Q S +
Sbjct: 279 HPGYGKEVDLWACGVILFTLLA-GSPPFWHRRQILMLRMI-MEGQYQFSSPEWDDRSSTV 336
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267
K+ +S L+ P R +A++ L+H F
Sbjct: 337 KDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-50
Identities = 33/300 (11%), Positives = 81/300 (27%), Gaps = 46/300 (15%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEY 76
E + G V+ D E +D A+KV + S E+E + + ++ E
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 77 YGSY--------------------------LHQTKLWIIMEYMAG------GSVADLIQS 104
++M + ++ +
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 105 GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164
+++ + L+ L ++G +H N+ + +G + + D ++
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-- 245
Query: 165 ISRRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPP-------LADLH 216
+R + E + S + + W LG+++ + P +
Sbjct: 246 -TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304
Query: 217 PMRVLFIIPRENPP-QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275
L + ++ +K + L R E + +
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEIS 364
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-50
Identities = 75/283 (26%), Positives = 138/283 (48%), Gaps = 20/283 (7%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEY 76
L+ IG+G+F V A ++VAIK+ID + + ++ + +E+ ++ P I +
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
+ + L++IMEY +GG V D + + + E R ++ A++Y H + +HRD
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRD 139
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN-EKADI 195
+KA N+LL + ++K+ADFG S + T + F G P + APE+ Q + Y+ + D+
Sbjct: 140 LKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQG-KKYDGPEVDV 197
Query: 196 WSLGITVIEMAKGEPPLADLHPM----RVL---FIIPRENPPQLDEHFSRLMKEFVSLCL 248
WSLG+ + + G P + RVL + IP + S + + L
Sbjct: 198 WSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP--------FYMSTDCENLLKRFL 249
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEE 291
P +R + +++++ R+I NA L+ E ++
Sbjct: 250 VLNPIKRGTLEQIMKDRWI-NAGHEEDELKPFVEPELDISDQK 291
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-50
Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 28/274 (10%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYY 77
+++G G G V + F + + A+K++ + ++E+ Q P+I
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY------DSPKARQEVDHHWQASGGPHIVCIL 88
Query: 78 GSY----LHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
Y + L IIME M GG + IQ E A I+RD+ AI++LH+
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN 148
Query: 132 KIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
HRD+K N+L T ++ +K+ DFG + + T+ + +T TP+++APEV+ E
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVL-GPEK 205
Query: 189 YNEKADIWSLG-ITVIEMAKGEPPLADLHPMRV---LFIIPRENPPQLDE----HFSRLM 240
Y++ D+WSLG I I + G PP + + R S
Sbjct: 206 YDKSCDMWSLGVIMYI-LLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 264
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
K+ + L LK P ER + + + H +I + P
Sbjct: 265 KQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 6e-50
Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 26/283 (9%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVID---LEESEDEIEDIQKEISVLSQCRSPYITE 75
+L+G GS+G V + D E A+K++ L + +++KEI +L + R + +
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 76 YYGSYLHQTK--LWIIMEYMAGGSVA--DLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++ K ++++MEY G D + L+ +EYLH++G
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGLEYLHSQG 129
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGTPFWMAPEVIQNSEGY 189
+H+DIK N+LLT G +K++ GV+ L + +T G+P + PE+ + +
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189
Query: 190 N-EKADIWSLGITVIEMAKGEPPLADLHPMRVL-------FIIPRENPPQLDEHFSRLMK 241
+ K DIWS G+T+ + G P + ++ + IP +
Sbjct: 190 SGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP--------GDCGPPLS 241
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERP 284
+ + L+ PA+R S +++ +H + R I P
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSP 284
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-49
Identities = 70/275 (25%), Positives = 127/275 (46%), Gaps = 14/275 (5%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+GRG+ VY+ K K A+KV+ ++ D+ + ++ EI VL + P I +
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDK-KIVRTEIGVLLRLSHPNIIKLKE 115
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
+ T++ +++E + GG + D I E A ++ +L A+ YLH G +HRD+K
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLK 175
Query: 139 AANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADI 195
N+L + +K+ADFG+S + KT GTP + APE++ Y + D+
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEIL-RGCAYGPEVDM 233
Query: 196 WSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE----HFSRLMKEFVSLCLKK 250
WS+G IT I + G P D + +F S K+ V +
Sbjct: 234 WSVGIITYILLC-GFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292
Query: 251 VPAERPSAKELLRHRFIRNARKSPRLLERIRERPK 285
P +R + + L+H ++ + ++ +++ +
Sbjct: 293 DPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQ 327
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 70/282 (24%), Positives = 132/282 (46%), Gaps = 25/282 (8%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F +++G GSF V A + +++ AIK+++ E+++ + +E V+S+ P+
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACI-LRDLLHAIEYLHNEG 131
+ Y ++ KL+ + Y G + I+ DE + +++ A+EYLH +G
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE-TCTRFYTAEIVSALEYLHGKG 150
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTR--TISRRKTFVGTPFWMAPEVIQNSEGY 189
IHRD+K NILL E+ +++ DFG + L+ +R +FVGT +++PE++ +
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSA 209
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--IIPRENPPQLDEHFSRLMKEFVSLC 247
+ +D+W+LG + ++ G PP + +F II + E F ++ V
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII--KLEYDFPEKFFPKARDLVEKL 266
Query: 248 LKKVPAERP------SAKELLRHRFIRN-------ARKSPRL 276
L +R L H F + + P+L
Sbjct: 267 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 308
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 2e-48
Identities = 62/270 (22%), Positives = 117/270 (43%), Gaps = 11/270 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ E +G G+FG V++ ++ + A K + D E ++KEI +S R P
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-KETVRKEIQTMSVLRHPT 215
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + ++ ++ +I E+M+GG + + + + E +R + + ++H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 132 KIHRDIKAANILLT--ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+H D+K NI+ T + ++K+ DFG++A L K GT + APEV +
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVA-EGKPV 333
Query: 190 NEKADIWSLG-ITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF---SRLMKEFVS 245
D+WS+G ++ I + G P + L + + D F S K+F+
Sbjct: 334 GYYTDMWSVGVLSYI-LLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSPR 275
L P R + + L H ++ R
Sbjct: 393 KLLLADPNTRMTIHQALEHPWLTPGNAPGR 422
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-48
Identities = 72/274 (26%), Positives = 124/274 (45%), Gaps = 27/274 (9%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYY 77
+++G G G V + F+K + A+K++ + ++E+ + + P+I
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRIV 121
Query: 78 GSY----LHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
Y + L I+ME + GG + IQ E + I++ + AI+YLH+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181
Query: 132 KIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
HRD+K N+L T N +K+ DFG + + T + T TP+++APEV+ E
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVL-GPEK 239
Query: 189 YNEKADIWSLG-ITVIEMAKGEPPLADLHPMRV---LFIIPRENPPQLDE----HFSRLM 240
Y++ D+WSLG I I + G PP H + + + R + S +
Sbjct: 240 YDKSCDMWSLGVIMYI-LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 298
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP 274
K + LK P +R + E + H +I + K P
Sbjct: 299 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-48
Identities = 35/298 (11%), Positives = 85/298 (28%), Gaps = 54/298 (18%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCR------- 69
++G+ +A D+E + + V E + I+ +++E+ L R
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 70 ------------------SPYITEYYGSYLHQT--KLWIIMEYMA------GGSVADLIQ 103
+ + + M G +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 104 SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163
+ L + + ++ + LH+ G +H ++ +I+L + G V + F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL----V 254
Query: 164 TISRRKTFVGTPFWMAPEVIQNSEG----------YNEKADIWSLGITVIEMAKGEPPLA 213
R + + PE+ D W+LG+ + + + P+
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314
Query: 214 DLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271
+ I R + + ++ + L+ +R + + R
Sbjct: 315 KDAALGGSEWIFRSCK-----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 7e-48
Identities = 40/317 (12%), Positives = 98/317 (30%), Gaps = 45/317 (14%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQ--------- 67
++G+ +A D+E + + V E + I+ +++E+ L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 68 -------------CRSPYITEYYGSYLHQTKLWIIMEYMA-----------GGSVADLIQ 103
+ P + L + +W++ + G +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 104 SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-T 162
+ L + + ++ + LH+ G +H ++ +I+L + G V + F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263
Query: 163 RTISRRKTFVGTPFWMAPEVIQNSEG----YNEKADIWSLGITVIEMAKGEPPLADLHPM 218
+S P A ++ + D W+LG+ + + + P D +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323
Query: 219 RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
I R + + ++ + L+ +R + + R
Sbjct: 324 GGSEWIFRSCK-----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAAL 378
Query: 279 RIRERPKYPIQEEPDTP 295
+ + P +E P
Sbjct: 379 PLYQTDGEPTREGGAPP 395
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-47
Identities = 73/266 (27%), Positives = 127/266 (47%), Gaps = 20/266 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPYITEY 76
+ +G G+FG V + VA+K+++ + S D + I++EI L R P+I +
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
Y T +++MEY++GG + D I ++EM + + +L A++Y H +HRD
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRD 136
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN-EKADI 195
+K N+LL + + K+ADFG+S + +T G+P + APEVI Y + DI
Sbjct: 137 LKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSCGSPNYAAPEVISG-RLYAGPEVDI 194
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVL-------FIIPRENPPQLDEHFSRLMKEFVSLCL 248
WS G+ + + G P D H + F IP + +R + + L
Sbjct: 195 WSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE--------YLNRSVATLLMHML 246
Query: 249 KKVPAERPSAKELLRHRFIRNARKSP 274
+ P +R + K++ H + + S
Sbjct: 247 QVDPLKRATIKDIREHEWFKQDLPSY 272
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 73/297 (24%), Positives = 114/297 (38%), Gaps = 30/297 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID----LEESEDE-IEDIQKEISVLSQ 67
+ + L+G+G FG V+ VAIKVI L S E+++L +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 68 CRS----PYITEYYGSYLHQTKLWIIMEY-MAGGSVADLIQSGPPLDEMSIACILRDLLH 122
+ P + + Q +++E + + D I PL E C ++
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 123 AIEYLHNEGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPE 181
AI++ H+ G +HRDIK NIL+ G K+ DFG A L F GT + PE
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDFDGTRVYSPPE 208
Query: 182 VIQNSEGYN-EKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLDEHFSRL 239
I Y+ A +WSLGI + +M G+ P + P H S
Sbjct: 209 WISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPA--------HVSPD 259
Query: 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPI 296
+ CL P+ RPS +E+L +++ + L P +
Sbjct: 260 CCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPL------NPSKGGPAPLAWSL 310
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-47
Identities = 66/308 (21%), Positives = 117/308 (37%), Gaps = 58/308 (18%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
LELIGRG +G VYK + VA+KV ++ I +K I +
Sbjct: 9 SLDLDNLKLLELIGRGRYGAVYKG--SLDERPVAVKVFSFANRQNFIN--EKNIYRVPLM 64
Query: 69 RSPYITEYYG-----SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHA 123
I + + + + ++MEY GS+ + D +S + +
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRG 123
Query: 124 IEYLHNEGK---------IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR------ 168
+ YLH E HRD+ + N+L+ +G ++DFG+S +LT R
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 169 --KTFVGTPFWMAPEVIQNS------EGYNEKADIWSLGITVIEMAKG------------ 208
+ VGT +MAPEV++ + E ++ D+++LG+ E+
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 209 -EPPLADLHP-------MRVLFIIPRENPP-----QLDEHFSRLMKEFVSLCLKKVPAER 255
+ M+VL ++ P + + R +KE + C + R
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 256 PSAKELLR 263
+A+
Sbjct: 304 LTAQXAEE 311
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-47
Identities = 74/263 (28%), Positives = 129/263 (49%), Gaps = 20/263 (7%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F ++ +G GSFG V KE A+K++D ++ +IE E +L P+
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMS----IACILRDLLHAIEYLH 128
+ + S+ + L+++MEY+AGG + ++ E A I+ EYLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEYLH 158
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
+ I+RD+K N+L+ + G ++V DFG + ++ R T GTP +APE+I + +G
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEALAPEIILS-KG 214
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
YN+ D W+LG+ + EMA G PP P+++ I + HFS +K+ + L
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-VSGKVRFPSHFSSDLKDLLRNLL 273
Query: 249 KKVPAER-----PSAKELLRHRF 266
+ +R ++ H++
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKW 296
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 58/301 (19%), Positives = 108/301 (35%), Gaps = 55/301 (18%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
LE+ RG FG V+KA N+ VA+K+ + + + E+ L
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKI--FPIQDKQSWQNEYEVYSLPGM 75
Query: 69 RSPYITEYYGS----YLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAI 124
+ I ++ G+ LW+I + GS++D ++ + + I + +
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARGL 134
Query: 125 EYLHNEGK----------IHRDIKAANILLTENGDVKVADFGVSAQL--TRTISRRKTFV 172
YLH + HRDIK+ N+LL N +ADFG++ + ++ V
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 173 GTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKG-----------EPPLADLHP 217
GT +MAPEV++ + + D++++G+ + E+A P +
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 218 MRVLF--------------IIPRE-NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262
++ ++E C R SA +
Sbjct: 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE----CWDHDAEARLSAGCVG 310
Query: 263 R 263
Sbjct: 311 E 311
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-46
Identities = 70/297 (23%), Positives = 127/297 (42%), Gaps = 24/297 (8%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE--IEDIQKEISVLSQCR 69
R+ ++ +G G VY A D LN VAIK I + E E ++ ++E+ SQ
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
I +++MEY+ G ++++ I+S PL + +L I++ H+
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 130 EGKIHRDIKAANILLTENGDVKVADFG-VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
+HRDIK NIL+ N +K+ DFG A ++++ +GT + +PE + E
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK-GEA 188
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--------IIPRENPPQLDEHFSRLM 240
+E DI+S+GI + EM GEPP + + + + + + S +
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV- 247
Query: 241 KEFVSLCLKKVPAERP-SAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPI 296
+ +K A R + +E+ + + R E Y + + +
Sbjct: 248 ---ILRATEKDKANRYKTIQEMKDD--LSSVLHENRANE-----DVYELDKMKTIAV 294
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 67/272 (24%), Positives = 108/272 (39%), Gaps = 22/272 (8%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQCRS-- 70
L+G G FG VY N VAIK ++ + E+ +L + S
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAG-GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
+ + +I+E + D I L E +L A+ + HN
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 167
Query: 130 EGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
G +HRDIK NIL+ G++K+ DFG A L + F GT + PE I+
Sbjct: 168 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRY-HR 224
Query: 189 YN-EKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
Y+ A +WSLGI + +M G+ P +R + S + +
Sbjct: 225 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ--------RVSSECQHLIRW 276
Query: 247 CLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
CL P++RP+ +E+ H ++++ E
Sbjct: 277 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-46
Identities = 74/273 (27%), Positives = 130/273 (47%), Gaps = 20/273 (7%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L++IGRG+F +V K+ + A+K+++ + E+ ++E VL +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACI-LRDLLHAIEYLHNE 130
IT+ + ++ + L+++MEY GG + L+ G + +A L +++ AI+ +H
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA-EMARFYLAEIVMAIDSVHRL 181
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR-KTFVGTPFWMAPEVIQNSEG- 188
G +HRDIK NILL G +++ADFG +L + R VGTP +++PE++Q G
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 189 -----YNEKADIWSLGITVIEMAKGEPPL--ADLHPM--RVLFIIPRENPPQLDEHFSRL 239
Y + D W+LG+ EM G+ P +++ + P +DE
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301
Query: 240 MKEFVSLCLKKVPAER---PSAKELLRHRFIRN 269
++F+ L P R A + H F
Sbjct: 302 ARDFIQRLLCP-PETRLGRGGAGDFRTHPFFFG 333
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-46
Identities = 70/307 (22%), Positives = 128/307 (41%), Gaps = 40/307 (13%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPY 72
++ + IG GS+G V+K +++ + VAIK E + I+ I +EI +L Q + P
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ + + +L ++ EY + +L + + E + I L A+ + H
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRRKTF---VGTPFWMAPEVIQNSEG 188
IHRD+K NIL+T++ +K+ DFG R + + V T ++ +PE++
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFG----FARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 189 YNEKADIWSLGITVIEMAKGEP--------------------------PLADLHPMRVLF 222
Y D+W++G E+ G P + +
Sbjct: 180 YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239
Query: 223 IIPRENPPQ-LDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
IP + L+ F + + L CL P ER + ++LL H + N R+ L
Sbjct: 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE-IEDLA 298
Query: 279 RIRERPK 285
+ ++P
Sbjct: 299 KEHDKPA 305
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 8e-46
Identities = 72/273 (26%), Positives = 125/273 (45%), Gaps = 23/273 (8%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F ++GRG FG+V+ K K A K ++ + + E +L++ S +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGS----VADLIQSGPPLDEMS----IACILRDLLHAI 124
I ++ +T L ++M M GG + ++ + P E A I+ +
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS----GL 302
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
E+LH I+RD+K N+LL ++G+V+++D G++ +L ++ K + GTP +MAPE++
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPP-LADLHPMRV--LFIIPRENPPQLDEHFSRLMK 241
E Y+ D ++LG+T+ EM P A + L E + FS K
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASK 421
Query: 242 EFVSLCLKKVPAER-----PSAKELLRHRFIRN 269
+F L+K P +R S L H R+
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 76/306 (24%), Positives = 142/306 (46%), Gaps = 41/306 (13%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ-KEISVLSQCRSPY 72
++ +L L+G GS+G V K +K+ + VAIK + + ++ I +EI +L Q R
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEG 131
+ + + +++ E++ ++ D ++ P LD + L +++ I + H+
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKTF---VGTPFWMAPEVIQNSE 187
IHRDIK NIL++++G VK+ DFG RT++ + + V T ++ APE++
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFG----FARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 188 GYNEKADIWSLGITVIEMAKGEP--------------------------PLADLHPMRVL 221
Y + D+W++G V EM GEP L + +P+
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260
Query: 222 FIIPRENPPQ-LDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRNARKSPRLL 277
+P + L+ + +L + + L CL P +RP ELL H F + + R
Sbjct: 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFS 320
Query: 278 ERIRER 283
+ ++ +
Sbjct: 321 QELQLK 326
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 68/269 (25%), Positives = 129/269 (47%), Gaps = 22/269 (8%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L IG+GSFG V + K A+K ++ ++ +E+ ++ KE+ ++ P+
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLHAIE 125
+ + S+ + ++++++ + GG DL +Q E + I ++ A++
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGG---DLRYHLQQNVHFKEETVKLFICELVM----ALD 129
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
YL N+ IHRD+K NILL E+G V + DF ++A L R ++ T GT +MAPE+ +
Sbjct: 130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSS 188
Query: 186 SE--GYNEKADIWSLGITVIEMAKGEPP--LADLHPMRVLFIIPRENPPQLDEHFSRLMK 241
+ GY+ D WSLG+T E+ +G P + + + +S+ M
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMV 248
Query: 242 EFVSLCLKKVPAER-PSAKELLRHRFIRN 269
+ L+ P +R ++ ++ +
Sbjct: 249 SLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 25/276 (9%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
E IGRG+FG+V+ + N VA+K D +E +L Q P I
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
G + ++I+ME + GG +++ G L ++ ++ D +EYL ++ IHRD
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT-PF-WMAPEVIQNSEGYNEKAD 194
+ A N L+TE +K++DFG+S + + + P W APE + Y+ ++D
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESD 297
Query: 195 IWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLK 249
+WS GI + E + G P +L + + + P + RLM++ C
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQ----CWA 353
Query: 250 KVPAERPSAKELLRHRFIRNARKSPRLLERIRERPK 285
P +RPS + + L+ IR+R +
Sbjct: 354 YEPGQRPSFSTIYQE------------LQSIRKRHR 377
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 23/283 (8%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPYITEY 76
E +G GSFG V A + + VA+K I + + D +++EIS L R P+I +
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
Y T + +++EY AGG + D I + E + ++ AIEY H +HRD
Sbjct: 75 YDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRD 133
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN-EKADI 195
+K N+LL +N +VK+ADFG+S + + KT G+P + APEVI + Y + D+
Sbjct: 134 LKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTSCGSPNYAAPEVING-KLYAGPEVDV 191
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVL-------FIIPRENPPQLDEHFSRLMKEFVSLCL 248
WS GI + M G P D + +++P + S + + +
Sbjct: 192 WSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP--------DFLSPGAQSLIRRMI 243
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEE 291
P +R + +E+ R + P L + E
Sbjct: 244 VADPMQRITIQEIRRDPWFN--VNLPDYLRPMEEVQGSYADSR 284
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-45
Identities = 85/295 (28%), Positives = 127/295 (43%), Gaps = 28/295 (9%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+ IG G+FG DK + VA+K I+ + DE ++Q+EI R P I +
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE--NVQREIINHRSLRHPNIVRFKE 83
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIK 138
L T L IIMEY +GG + + I + E + LL + Y H+ HRD+K
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLK 143
Query: 139 AANILLTEN--GDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN-EKADI 195
N LL + +K+ DFG S + S+ K+ VGTP ++APEV+ + Y+ + AD+
Sbjct: 144 LENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLR-QEYDGKIADV 201
Query: 196 WSLGITVIEMAKGEPPLADLHPM-----------RVLFIIPRENPPQLDEHFSRLMKEFV 244
WS G+T+ M G P D V + IP D S +
Sbjct: 202 WSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD------DIRISPECCHLI 255
Query: 245 SLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGV 299
S PA R S E+ H + + P L +EP+ P+ +
Sbjct: 256 SRIFVADPATRISIPEIKTHSWFL--KNLPADLMNESNTGSQ--FQEPEQPMQSL 306
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-45
Identities = 70/271 (25%), Positives = 136/271 (50%), Gaps = 31/271 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
+ +++IGRG+FG+V K K A+K++ E + +E +++ SP+
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMS---IACILRDLLHAIEYLHN 129
+ + + ++ L+++MEYM GG + +L+ + ++ + A +++ A++ +H+
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA----EVVLALDAIHS 186
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPFWMAPEVIQNSEG 188
G IHRD+K N+LL ++G +K+ADFG ++ + + R T VGTP +++PEV+++ G
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 189 ---YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245
Y + D WS+G+ + EM G+ P ++ +S++M S
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYA------------DSLVGT---YSKIMNHKNS 291
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRL 276
L AK L+ F+ + RL
Sbjct: 292 LTFPDDNDISKEAKNLIC-AFLTDREV--RL 319
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 7e-45
Identities = 81/271 (29%), Positives = 133/271 (49%), Gaps = 27/271 (9%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSPY 72
F L+L+G+G+FG V +K + A+K++ ++ ++DE+ E VL R P+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 73 ITEYYGSYLHQT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLHA 123
+T ++ QT +L +MEY GG +L + E A I+ A
Sbjct: 67 LTALKYAF--QTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIV----SA 117
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI 183
+EYLH+ ++RDIK N++L ++G +K+ DFG+ + + KTF GTP ++APEV+
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243
++ Y D W LG+ + EM G P + LF + + S K
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 244 VSLCLKKVPAER-----PSAKELLRHRFIRN 269
++ LKK P +R AKE++ HRF +
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 9e-45
Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L +G GSFG V+ + + A+KV+ E ++E E +LS P+
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACI-LRDLLHAIEYLHNEG 131
I +G++ ++++IM+Y+ GG + L++ +A ++ A+EYLH++
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN-PVAKFYAAEVCLALEYLHSKD 126
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQL-TRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
I+RD+K NILL +NG +K+ DFG + + T T GTP ++APEV+ YN
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTK-PYN 181
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
+ D WS GI + EM G P D + M+ I + F+ +K+ +S + +
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-LNAELRFPPFFNEDVKDLLSRLITR 240
Query: 251 VPAER-----PSAKELLRHRF 266
++R +++ H +
Sbjct: 241 DLSQRLGNLQNGTEDVKNHPW 261
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 76/278 (27%), Positives = 132/278 (47%), Gaps = 37/278 (13%)
Query: 15 FSSLELIGRGSFGDVY---KAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQC 68
F L ++G+G +G V+ K K A+KV+ + + + + E ++L +
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 69 RSPYITEYYGSYLH---QT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACI 116
+ P+I + L QT KL++I+EY++GG +L ++ E + +A I
Sbjct: 79 KHPFIVD-----LIYAFQTGGKLYLILEYLSGG---ELFMQLEREGIFMEDTACFYLAEI 130
Query: 117 LRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176
A+ +LH +G I+RD+K NI+L G VK+ DFG+ + + TF GT
Sbjct: 131 S----MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF 236
+MAPE++ G+N D WSLG + +M G PP + + + I + L +
Sbjct: 187 YMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI-LKCKLNLPPYL 244
Query: 237 SRLMKEFVSLCLKKVPAER-----PSAKELLRHRFIRN 269
++ ++ + LK+ A R A E+ H F R+
Sbjct: 245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 7e-44
Identities = 66/270 (24%), Positives = 117/270 (43%), Gaps = 21/270 (7%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE--IEDIQKEISVLSQCRSPYITE 75
L+GRG GDVY+A D + VA+K++ S D +Q+E + + P++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHR 135
+ +L++ M + G +A +++ PL I+R + A++ H G HR
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHR 158
Query: 136 DIKAANILLTENGDVKVADFGV-----SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
D+K NIL++ + + DFG+ +LT+ VGT ++MAPE S
Sbjct: 159 DVKPENILVSADDFAYLVDFGIASATTDEKLTQL----GNTVGTLYYMAPERFSESHA-T 213
Query: 191 EKADIWSLGITVIEMAKGEPP-LADLHPMRVLFIIPRENPPQLDEHFSRLMKEF---VSL 246
+ADI++L + E G PP D + V+ + P+ + F ++
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD--QLSVMGAHINQAIPRPSTVRPGIPVAFDAVIAR 271
Query: 247 CLKKVPAER-PSAKELLRHRFIRNARKSPR 275
+ K P +R + +L A +
Sbjct: 272 GMAKNPEDRYVTCGDLSAA--AHAALATAD 299
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-44
Identities = 73/267 (27%), Positives = 126/267 (47%), Gaps = 16/267 (5%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F L++IGRG+FG+V K +K A+K+++ E E ++E VL S +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACI-LRDLLHAIEYLHNEG 131
IT + ++ L+++M+Y GG + L+ +A L +++ AI+ +H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR-KTFVGTPFWMAPEVIQNSE--- 187
+HRDIK NIL+ NG +++ADFG +L + + VGTP +++PE++Q E
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 188 -GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--IIPRENPPQLDEHFSRLMKEFV 244
Y + D WSLG+ + EM GE P + + I+ + Q + + +
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHKERFQFPTQVTDVSENAK 314
Query: 245 SLC--LKKVPAER---PSAKELLRHRF 266
L L R ++ +H F
Sbjct: 315 DLIRRLICSREHRLGQNGIEDFKKHPF 341
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 9e-44
Identities = 72/283 (25%), Positives = 128/283 (45%), Gaps = 21/283 (7%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPYITEY 76
+ +G G+FG V + VA+K+++ + S D + I++EI L R P+I +
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136
Y + ++++MEY++GG + D I LDE + + +L ++Y H +HRD
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRD 141
Query: 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN-EKADI 195
+K N+LL + + K+ADFG+S + +T G+P + APEVI Y + DI
Sbjct: 142 LKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSCGSPNYAAPEVISG-RLYAGPEVDI 199
Query: 196 WSLGITVIEMAKGEPPLADLHPMRVL-------FIIPRENPPQLDEHFSRLMKEFVSLCL 248
WS G+ + + G P D H + F P ++ + + + L
Sbjct: 200 WSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP--------QYLNPSVISLLKHML 251
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEE 291
+ P +R + K++ H + + L I +E
Sbjct: 252 QVDPMKRATIKDIREHEWFKQDLPKY-LFPEDPSYSSTMIDDE 293
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 70/292 (23%), Positives = 119/292 (40%), Gaps = 55/292 (18%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYY 77
+++G G G V + F+K + A+K++ + ++E+ + + P+I
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRIV 77
Query: 78 GSY----LHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
Y + L I+ME + GG + IQ E + I++ + AI+YLH+
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 132 KIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
HRD+K N+L T N +K+ DFG A E E
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFG---------------------FAKETTG--EK 174
Query: 189 YNEKADIWSLG-ITVIEMAKGEPPLADLHPMRV---LFIIPRENPPQLDE----HFSRLM 240
Y++ D+WSLG I I + G PP H + + + R + S +
Sbjct: 175 YDKSCDMWSLGVIMYI-LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 233
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSP-------RLLERIRERPK 285
K + LK P +R + E + H +I + K P R+L+ +ER +
Sbjct: 234 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE 285
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 27/282 (9%)
Query: 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ F ++++G G+FG VYK +++ VAIK + S ++I E V++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYL 127
+P++ G L T + +I + M G + D + + + + + + YL
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFVG-TPF-WMAPE 181
+ +HRD+ A N+L+ VK+ DFG L + + G P WMA E
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFG----LAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 182 VIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHF 236
I + Y ++D+WS G+TV E M G P + + I+ + PP
Sbjct: 190 SILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248
Query: 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
+M++ C RP +E L F + AR R L
Sbjct: 249 YMIMRK----CWMIDADSRPKFRE-LIIEFSKMARDPQRYLV 285
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-43
Identities = 71/270 (26%), Positives = 118/270 (43%), Gaps = 20/270 (7%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPY 72
F ++G+G FG+V + K A K ++ + E +L + S +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI----QSGPPLDEMSIACI-LRDLLHAIEYL 127
+ +Y + L +++ M GG DL G + A ++ +E L
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGG---DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSE 187
H E ++RD+K NILL ++G ++++D G++ + K VGT +MAPEV++N E
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKN-E 360
Query: 188 GYNEKADIWSLGITVIEMAKGEPPLAD---LHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244
Y D W+LG + EM G+ P + + +E P + E FS +
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC 420
Query: 245 SLCLKKVPAER-----PSAKELLRHRFIRN 269
S L K PAER SA+E+ H +
Sbjct: 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 36/281 (12%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQ-CRSP 71
F L +IGRGS+ V K+ ++ A+KV+ +L +++I+ +Q E V Q P
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 72 YITEYYGSYLHQT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLH 122
++ + + QT +L+ ++EY+ GG DL +Q L E A I
Sbjct: 71 FLVGLHSCF--QTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEIS----L 121
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
A+ YLH G I+RD+K N+LL G +K+ D+G+ + R TF GTP ++APE+
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 181
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV--------LFIIPRENPPQLDE 234
++ E Y D W+LG+ + EM G P + LF + E ++
Sbjct: 182 LRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 240
Query: 235 HFSRLMKEFVSLCLKKVPAER------PSAKELLRHRFIRN 269
S + L K P ER ++ H F RN
Sbjct: 241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-42
Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 24/270 (8%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSPY 72
F L+L+G+G+FG V +K + A+K++ ++ ++DE+ E VL R P+
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLHAIE 125
+T S+ +L +MEY GG +L + E A I+ A++
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIV----SALD 262
Query: 126 YLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
YLH+E ++RD+K N++L ++G +K+ DFG+ + + + KTF GTP ++APEV++
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244
+ Y D W LG+ + EM G P + LF + + K +
Sbjct: 323 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAKSLL 380
Query: 245 SLCLKKVPAER----PS-AKELLRHRFIRN 269
S LKK P +R AKE+++HRF
Sbjct: 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 73/303 (24%), Positives = 132/303 (43%), Gaps = 21/303 (6%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE--IEDIQKEISVLSQCR 69
R+ E++G G +V+ A D ++DVA+KV+ + + D ++E +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 70 SPYITEYY--GSYLHQTKL--WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
P I Y G +I+MEY+ G ++ D++ + P+ ++ D A+
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGV---SAQLTRTISRRKTFVGTPFWMAPEV 182
+ H G IHRD+K ANI+++ VKV DFG+ A ++++ +GT +++PE
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL--- 239
+ + + ++D++SLG + E+ GEPP P+ V + RE+P L
Sbjct: 191 AR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 249
Query: 240 MKEFVSLCLKKVPAERP-SAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPING 298
+ V L K P R +A E+ + PK E + ++
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRAD--LVRVHNGEPPEA-----PKVLTDAERTSLLSS 302
Query: 299 VRA 301
Sbjct: 303 AAG 305
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 24/268 (8%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQC-RSP 71
F +++G+GSFG V+ A K+ N+ AIK + D+ +D++E E VLS P
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 72 YITEYYGSYLHQT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLH 122
++T + ++ QT L+ +MEY+ GG DL IQS D A I+
Sbjct: 79 FLTHMFCTF--QTKENLFFVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAEII----L 129
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
+++LH++G ++RD+K NILL ++G +K+ADFG+ + ++ TF GTP ++APE+
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
+ + YN D WS G+ + EM G+ P + I R + P + K+
Sbjct: 190 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RMDNPFYPRWLEKEAKD 247
Query: 243 FVSLCLKKVPAER-PSAKELLRHRFIRN 269
+ + P +R ++ +H R
Sbjct: 248 LLVKLFVREPEKRLGVRGDIRQHPLFRE 275
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-42
Identities = 78/279 (27%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQ-CRSP 71
F L +IGRGS+ V K+ ++ A++V+ +L +++I+ +Q E V Q P
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLHAI 124
++ + + +++L+ ++EY+ GG DL +Q L E A I A+
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEIS----LAL 166
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
YLH G I+RD+K N+LL G +K+ D+G+ + R TF GTP ++APE+++
Sbjct: 167 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV--------LFIIPRENPPQLDEHF 236
E Y D W+LG+ + EM G P + LF + E ++
Sbjct: 227 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285
Query: 237 SRLMKEFVSLCLKKVPAER------PSAKELLRHRFIRN 269
S + L K P ER ++ H F RN
Sbjct: 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-42
Identities = 68/267 (25%), Positives = 123/267 (46%), Gaps = 14/267 (5%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRS-- 70
FS +IGRG FG+VY + K A+K +D + + E +LS +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 71 -PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN 129
P+I ++ KL I++ M GG + + E + +++ +E++HN
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
++RD+K ANILL E+G V+++D G++ ++ + VGT +MAPEV+Q Y
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAY 368
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPM--RVLFIIPRENPPQLDEHFSRLMKEFVSLC 247
+ AD +SLG + ++ +G P + + +L + FS ++ +
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 428
Query: 248 LKKVPAER-----PSAKELLRHRFIRN 269
L++ R A+E+ F R+
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 80/273 (29%), Positives = 126/273 (46%), Gaps = 29/273 (10%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRS-P 71
F + ++G+GSFG V A KE A+KV+ D+ +D++E E +LS R+ P
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 72 YITEYYGSYLHQT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLH 122
++T+ + + QT +L+ +ME++ GG DL IQ DE A I+
Sbjct: 85 FLTQLFCCF--QTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEII----S 135
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
A+ +LH++G I+RD+K N+LL G K+ADFG+ + TF GTP ++APE+
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
+Q Y D W++G+ + EM G P LF +
Sbjct: 196 LQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLHEDATG 253
Query: 243 FVSLCLKKVPAER------PSAKELLRHRFIRN 269
+ + K P R +LRH F +
Sbjct: 254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 80/305 (26%), Positives = 136/305 (44%), Gaps = 28/305 (9%)
Query: 18 LELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+++G G FG+V K +K VAIK + + +E + D E S++ Q P I
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
G + I+ EYM GS+ L + + + +LR + ++YL + G +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGYN 190
HRD+ A NIL+ N KV+DFG+ L T G W +PE I + +
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FT 228
Query: 191 EKADIWSLGITVIE-MAKGEPPLADLHPMRVLFII--------PRENPPQLDEHFSRLMK 241
+D+WS GI + E M+ GE P ++ V+ + P + P L + +LM
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL--Y--QLML 284
Query: 242 EFVSLCLKKVPAERPSAKELLR--HRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGV 299
+ C +K RP ++++ + IRN S +++ RP + ++ + I
Sbjct: 285 D----CWQKDRNNRPKFEQIVSILDKLIRNP-GSLKIITSAAARPSNLLLDQSNVDITTF 339
Query: 300 RAVGE 304
R G+
Sbjct: 340 RTTGD 344
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 75/273 (27%), Positives = 132/273 (48%), Gaps = 19/273 (6%)
Query: 15 FSSLELIGRGSFGDVY---KAFDKELNKDVAIKVI---DLEESEDEIEDIQKEISVLSQC 68
F L+++G G++G V+ K + K A+KV+ + + E + E VL
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 69 -RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACI-LRDLLHAIEY 126
+SP++ + ++ +TKL +I++Y+ GG + + E I + +++ A+E+
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE-HEVQIYVGEIVLALEH 174
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVS-AQLTRTISRRKTFVGTPFWMAPEVIQ- 184
LH G I+RDIK NILL NG V + DFG+S + R F GT +MAP++++
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPP---LADLHPMRVLFIIPRENPPQLDEHFSRLMK 241
G+++ D WSLG+ + E+ G P + + + ++ P + S L K
Sbjct: 235 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 294
Query: 242 EFVSLCLKKVPAER-----PSAKELLRHRFIRN 269
+ + L K P +R A E+ H F +
Sbjct: 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 75/304 (24%), Positives = 124/304 (40%), Gaps = 57/304 (18%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQCRS 70
++ LE +G G++G VYKA D + + VA+K I L+ +EDE +EIS+L +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLD-AEDEGIPSTAIREISLLKELHH 78
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEY 126
P I + L ++ E+M DL + + L + I L LL + +
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKTF---VGTPFWMAPEV 182
H +HRD+K N+L+ +G +K+ADFG L R +++ V T ++ AP+V
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFG----LARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEP--------------------P----------L 212
+ S+ Y+ DIWS+G EM G+P P L
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250
Query: 213 ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRN 269
+E + L L P +R SA++ + H + ++
Sbjct: 251 PLWKQRT----FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
Query: 270 ARKS 273
Sbjct: 307 LDPQ 310
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 76/272 (27%), Positives = 130/272 (47%), Gaps = 28/272 (10%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQ-CRSP 71
F+ L ++G+GSFG V + K ++ A+K++ D+ +D++E E VL+ + P
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 72 YITEYYGSYLHQT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLH 122
++T+ + + QT +L+ +MEY+ GG DL IQ E A I
Sbjct: 82 FLTQLHSCF--QTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIA----I 132
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
+ +L ++G I+RD+K N++L G +K+ADFG+ + KTF GTP ++APE+
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEI 192
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
I + Y + D W+ G+ + EM G+ P LF E+ + S+
Sbjct: 193 IAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVA 250
Query: 243 FVSLCLKKVPAER-----PSAKELLRHRFIRN 269
+ K P +R +++ H F R
Sbjct: 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 2e-41
Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 48/295 (16%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQCRSP 71
++ LE IG G++G V+KA ++E ++ VA+K + L+ +DE +EI +L + +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHK 61
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYL 127
I + KL ++ E+ DL + LD + L LL + +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKTF---VGTPFWMAPEVI 183
H+ +HRD+K N+L+ NG++K+A+FG L R + + V T ++ P+V+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFG----LARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPL----ADLHPMRVLFII---PREN-------- 228
++ Y+ D+WS G E+A PL ++ +F + P E
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 229 -----------PPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRN 269
L +L L LK P +R SA+E L+H + +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 37/277 (13%)
Query: 15 FSSLELIGRGSFGDVY---KAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCR 69
F L+++G+GSFG V+ K + + A+KV+ + D + + E +L +
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 84
Query: 70 SPYITEYYGSYLH---QT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACIL 117
P+I + LH QT KL++I++++ GG DL + E +A +
Sbjct: 85 HPFIVK-----LHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFW 177
A+++LH+ G I+RD+K NILL E G +K+ DFG+S + + +F GT +
Sbjct: 137 ----LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFS 237
MAPEV+ G+ + AD WS G+ + EM G P + + + + + S
Sbjct: 193 MAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLGMPQFLS 250
Query: 238 RLMKEFVSLCLKKVPAER-----PSAKELLRHRFIRN 269
+ + + K+ PA R +E+ RH F
Sbjct: 251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQ-CRSP 71
F L++IG+GSFG V A K A+KV+ + E + I E +VL + + P
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 72 YITEYYGSYLHQT--KLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLH 122
++ + S+ QT KL+ +++Y+ GG +L +Q E A I
Sbjct: 100 FLVGLHFSF--QTADKLYFVLDYINGG---ELFYHLQRERCFLEPRARFYAAEIA----S 150
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
A+ YLH+ ++RD+K NILL G + + DFG+ + S TF GTP ++APEV
Sbjct: 151 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
+ + Y+ D W LG + EM G PP + + I P QL + + +
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI-LNKPLQLKPNITNSARH 268
Query: 243 FVSLCLKKVPAER----PSAKELLRHRFIRN 269
+ L+K +R E+ H F
Sbjct: 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-41
Identities = 60/267 (22%), Positives = 118/267 (44%), Gaps = 32/267 (11%)
Query: 18 LELIGRGSFGDVYKAFDKELNK-------DVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
E +G+G+F ++K +E+ +V +KV+D + + E + S++S+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFEAASMMSKLSH 71
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHN 129
++ YG + + ++ E++ GS+ L ++ ++ + + + L A+ +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 130 EGKIHRDIKAANILLT--------ENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAP 180
IH ++ A NILL +K++D G ++ T+ + W+ P
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG----ISITVLPKDILQ-ERIPWVPP 186
Query: 181 EVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIP---RENPPQLDEHF 236
E I+N + N D WS G T+ E + G+ PL+ L R L + P+ E
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELA 246
Query: 237 SRLMKEFVSLCLKKVPAERPSAKELLR 263
+ L+ C+ P RPS + ++R
Sbjct: 247 N-LINN----CMDYEPDHRPSFRAIIR 268
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 4e-41
Identities = 78/328 (23%), Positives = 129/328 (39%), Gaps = 62/328 (18%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE----IEDIQKEISVLSQCR 69
+ L+ +G G++ VYK K + VA+K I LE E I +E+S+L +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----REVSLLKDLK 58
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIE 125
I + + L ++ EY+ DL Q G ++ ++ L LL +
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRKTF---VGTPFWMAPE 181
Y H + +HRD+K N+L+ E G++K+ADFG L R S KT+ V T ++ P+
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFG----LARAKSIPTKTYDNEVVTLWYRPPD 170
Query: 182 VIQNSEGYNEKADIWSLGITVIEMAKGEP--------------------P---------- 211
++ S Y+ + D+W +G EMA G P P
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 212 LADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIR 268
+ P+ L H RL + L L+ R SA++ ++H F
Sbjct: 231 NEEFKTYN----YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
Query: 269 NARKSPRLLERIRER-PKYPIQEEPDTP 295
+ + L IQ + +
Sbjct: 287 SLGERIHKLPDTTSIFALKEIQLQKEAS 314
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 8e-41
Identities = 74/270 (27%), Positives = 128/270 (47%), Gaps = 24/270 (8%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQ-CRSP 71
F+ L ++G+GSFG V + K ++ A+K++ D+ +D++E E VL+ + P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMS----IACILRDLLHAI 124
++T+ + + +L+ +MEY+ GG DL IQ E A I +
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIA----IGL 455
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
+L ++G I+RD+K N++L G +K+ADFG+ + KTF GTP ++APE+I
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 515
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244
+ Y + D W+ G+ + EM G+ P LF E+ + S+
Sbjct: 516 Y-QPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAVAIC 573
Query: 245 SLCLKKVPAER-----PSAKELLRHRFIRN 269
+ K P +R +++ H F R
Sbjct: 574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-40
Identities = 77/294 (26%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQCRSP 71
++ LE IG G++G VYKA + + A+K I LE EDE +EIS+L + +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLE-KEDEGIPSTTIREISILKELKHS 60
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYL 127
I + Y + +L ++ E++ DL + L+ ++ L LL+ I Y
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKTF---VGTPFWMAPEVI 183
H+ +HRD+K N+L+ G++K+ADFG L R + + + T ++ AP+V+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFG----LARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------- 224
S+ Y+ DIWS+G EM G P + L I
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 225 ------PRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRN 269
P + L + + L LK P +R +AK+ L H + +
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 76/290 (26%), Positives = 119/290 (41%), Gaps = 20/290 (6%)
Query: 18 LELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
++IG G FG+VYK + VAIK + +E + D E ++ Q I
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
G + II EYM G++ L + + + +LR + ++YL N
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 168
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGY 189
+HRD+ A NIL+ N KV+DFG+S L T G W APE I + +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-F 227
Query: 190 NEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFV 244
+D+WS GI + E M GE P +L V+ I P +LM +
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQ-- 285
Query: 245 SLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDT 294
C ++ A RP ++ + ++P L+ + + P T
Sbjct: 286 --CWQQERARRPKFADI--VSILDKLIRAPDSLKTLADFDPRVSIRLPST 331
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 20/295 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ F ++++G G+FG VYK +++ VAIK + S ++I E V++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYL 127
+P++ G L T + +I + M G + D + + + + + + YL
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-TPF-WMAPEVIQN 185
+ +HRD+ A N+L+ VK+ DFG++ L G P WMA E I +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 186 SEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLM 240
Y ++D+WS G+TV E M G P + + I+ + PP +M
Sbjct: 194 RI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 252
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTP 295
+ C RP +EL + P+ I+ + + D+
Sbjct: 253 VK----CWMIDADSRPKFREL--IIEFSKMARDPQRYLVIQGDERMHLPSPTDSN 301
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 21/269 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
S + ++ IG G FG V+ + +K VAIK + E ED +E V+ + P
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKT--IREGAMSEEDFIEEAEVMMKLSHPK 64
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + YG L Q + ++ E+M G ++D L ++ + D+ + YL
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEG 188
IHRD+ A N L+ EN +KV+DFG++ + T GT F W +PEV S
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSFSR- 181
Query: 189 YNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEF 243
Y+ K+D+WS G+ + E ++G+ P + V+ I P H ++M
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH- 240
Query: 244 VSLCLKKVPAERPSAKELLRH--RFIRNA 270
C ++ P +RP+ LLR +
Sbjct: 241 ---CWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 73/286 (25%), Positives = 137/286 (47%), Gaps = 27/286 (9%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ + +G G +G+VY+ K+ + VA+K L+E E+E+ KE +V+ + + P
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ + G + +II E+M G++ D ++ + + + + + A+EYL +
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR---RKTFVGTPF---WMAPEVIQ 184
IHRD+ A N L+ EN VKVADFG L+R ++ G F W APE +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFG----LSRLMTGDTYTAH-AGAKFPIKWTAPESLA 185
Query: 185 NSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRL 239
++ ++ K+D+W+ G+ + E G P + +V ++ + E P E L
Sbjct: 186 YNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 244
Query: 240 MKEFVSLCLKKVPAERPSAKELLRH--RFIRNARKSPRLLERIRER 283
M+ C + P++RPS E+ + + + S + + + +R
Sbjct: 245 MRA----CWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKR 286
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 74/308 (24%), Positives = 121/308 (39%), Gaps = 55/308 (17%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ----KEISVLSQC 68
SR+ + IG G++G VYKA D VA+K + + + +E+++L +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 69 RS---PYITE-----YYGSYLHQTKLWIIMEYMAGGSVADL-----IQSGPPLDEMSIAC 115
+ P + + K+ ++ E++ DL P L +I
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKD 124
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF---V 172
++R L +++LH +HRD+K NIL+T G VK+ADFG L R S + V
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG----LARIYSYQMALTPVV 180
Query: 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------- 224
T ++ APEV+ S Y D+WS+G EM + +P L I
Sbjct: 181 VTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 225 ---------------PRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRF 266
P P + + + L L P +R SA L+H +
Sbjct: 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 267 IRNARKSP 274
+ +P
Sbjct: 300 LHKDEGNP 307
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-40
Identities = 75/316 (23%), Positives = 121/316 (38%), Gaps = 66/316 (20%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ--KEISVLSQCRS 70
S+F LE +G G++ VYK +K VA+K + L+ SE+ +EIS++ + +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD-SEEGT-PSTAIREISLMKELKH 62
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADL---------IQSGPPLDEMSIACILRDLL 121
I Y + KL ++ E+M DL + L+ + LL
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKTF---VGTPFW 177
+ + H +HRD+K N+L+ + G +K+ DFG L R TF V T ++
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFG----LARAFGIPVNTFSSEVVTLWY 174
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP--------------------P------ 211
AP+V+ S Y+ DIWS G + EM G+P P
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234
Query: 212 ----LADLHPMRVLF-------IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKE 260
L +P ++ LD + + + L P R SAK+
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN----PDMRLSAKQ 290
Query: 261 LLRHRFIRNARKSPRL 276
L H + +
Sbjct: 291 ALHHPWFAEYYHHASM 306
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-40
Identities = 72/258 (27%), Positives = 104/258 (40%), Gaps = 24/258 (9%)
Query: 18 LELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
IG G FGDV++ VAIK S+ E +E + Q P+I
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ G +WIIME G + L LD S+ L A+ YL ++ +
Sbjct: 80 KLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV 138
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT----PF-WMAPEVIQNSEG 188
HRDI A N+L++ N VK+ DFG L+R + + + P WMAPE I
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFG----LSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 193
Query: 189 YNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEF 243
+ +D+W G+ + E + G P + V+ I PP LM +
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK- 252
Query: 244 VSLCLKKVPAERPSAKEL 261
C P+ RP EL
Sbjct: 253 ---CWAYDPSRRPRFTEL 267
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-40
Identities = 63/272 (23%), Positives = 107/272 (39%), Gaps = 29/272 (10%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
E+IGRG FG VY + + A+K ++ E+ E ++ P +
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 75 EYYG-SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
G + +++ YM G + + + + + ++YL ++
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF 149
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTI-------SRRKTFVGTPF-WMAPEVIQ 184
+HRD+ A N +L E VKVADFG L R + KT P WMA E +Q
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 185 NSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRL 239
+ + K+D+WS G+ + E M +G PP D++ + + + P + +
Sbjct: 206 TQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 264
Query: 240 MKEFVSLCLKKVPAERPSAKELLRH--RFIRN 269
M + C RPS EL+
Sbjct: 265 MLK----CWHPKAEMRPSFSELVSRISAIFST 292
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-40
Identities = 67/338 (19%), Positives = 132/338 (39%), Gaps = 74/338 (21%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE---IEDIQKEISVLSQCR 69
S++ L IG+G+FG+V+KA ++ + VA+K + +E +E E I + +EI +L +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITAL-REIKILQLLK 74
Query: 70 SPYI--------TEYYGSYLHQTKLWIIMEYM----AGGSVADLIQSGP-PLDEMSIACI 116
+ T+ + ++++ ++ AG L+ + I +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-----LLSNVLVKFTLSEIKRV 129
Query: 117 LRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF 176
++ LL+ + Y+H +HRD+KAAN+L+T +G +K+ADFG L R S K +
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG----LARAFSLAKNSQPNRY 185
Query: 177 -------WM-APEVIQNSEGYNEKADIWSLGITVIEMAKGEP------------------ 210
W PE++ Y D+W G + EM P
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245
Query: 211 --------PLADLHPMRVLFIIPRENPPQLDEHFSRLMK-----EFVSLCLKKVPAERPS 257
P D + + + + ++ + ++ + + L PA+R
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 305
Query: 258 AKELLRHRFIRNA--RKSPRLLERIRERPKYPIQEEPD 293
+ + L H F + + + + +
Sbjct: 306 SDDALNHDFFWSDPMPSDLKGM------LSTHLTSMFE 337
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-40
Identities = 63/304 (20%), Positives = 118/304 (38%), Gaps = 25/304 (8%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
++ I G G +Y A D+ +N + V +K + + E L++
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH 138
Query: 71 PYITEYY-----GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
P I + + +I+MEY+ G S+ P+ E L ++L A+
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAE--AIAYLLEILPALS 196
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
YLH+ G ++ D+K NI+LTE +K+ D G +++ GTP + APE+++
Sbjct: 197 YLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRT 251
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245
G DI+++G T+ + P + + E+ P L + S +
Sbjct: 252 --GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----PEDDPVLKTYDS--YGRLLR 302
Query: 246 LCLKKVPAERP-SAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGE 304
+ P +R +A+E+ + + + RP P GV +
Sbjct: 303 RAIDPDPRQRFTTAEEMSAQ--LTGVLREVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVA 360
Query: 305 ASGT 308
+
Sbjct: 361 HTDV 364
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-40
Identities = 84/320 (26%), Positives = 130/320 (40%), Gaps = 20/320 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ L+++G G FG V+K + + V IKVI+ + + + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYL 127
+I G + L ++ +Y+ GS+ D + Q L + + + YL
Sbjct: 73 DHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG-TPF-WMAPEVIQN 185
G +HR++ A N+LL V+VADFGV+ L + TP WMA E I
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 186 SEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLM 240
+ Y ++D+WS G+TV E M G P A L V ++ + P +M
Sbjct: 192 GK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVM 250
Query: 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRE-RPKYPIQEEPDTPINGV 299
+ C RP+ KE L + F R AR PR L RE P EP N
Sbjct: 251 VK----CWMIDENIRPTFKE-LANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKK 305
Query: 300 RAVGEASGTVKVVRDKRSEE 319
E + + D +EE
Sbjct: 306 LEEVELEPELDLDLDLEAEE 325
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 75/285 (26%), Positives = 123/285 (43%), Gaps = 39/285 (13%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
L+ IG+G FGDV + VA+K I + + + E SV++Q R
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATA---QAFLAEASVMTQLRHSN 75
Query: 73 ITEYYGSYLHQT-KLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHN 129
+ + G + + L+I+ EYMA GS+ D ++S L + D+ A+EYL
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNS 186
+HRD+ A N+L++E+ KV+DFG LT+ S + W APE ++
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQD--TGKLPVKWTAPEALREK 189
Query: 187 EGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMK 241
+ ++ K+D+WS GI + E + G P + V+ + + + P +MK
Sbjct: 190 K-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 248
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKY 286
C A RPS +L LE I+ +
Sbjct: 249 N----CWHLDAAMRPSFLQLREQ------------LEHIKTHELH 277
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 76/298 (25%), Positives = 125/298 (41%), Gaps = 51/298 (17%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIED------IQKEISVLS 66
R+ L+ +G G F VYKA DK N+ VAIK I L E +D + +EI +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLG-HRSEAKDGINRTAL-REIKLLQ 67
Query: 67 QCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLH 122
+ P I ++ H++ + ++ ++M DL + L I + L
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-RKTF---VGTPFWM 178
+EYLH +HRD+K N+LL ENG +K+ADFG L ++ + + V T ++
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFG----LAKSFGSPNRAYTHQVVTRWYR 179
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLA---DLHPMRVLF------------- 222
APE++ + Y D+W++G + E+ P L DL + +F
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239
Query: 223 --------IIPRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRN 269
L FS + + L P R +A + L+ ++ N
Sbjct: 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-39
Identities = 71/258 (27%), Positives = 114/258 (44%), Gaps = 17/258 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G+G FG+V+ VAIK L+ E +E V+ + R
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ + Y + ++I+ EYM+ GS+ D ++ G L + + + + Y+
Sbjct: 241 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGY 189
+HRD++AANIL+ EN KVADFG++ + + P W APE +
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-F 358
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFV 244
K+D+WS GI + E+ KG P + VL + R PP+ E LM +
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ-- 416
Query: 245 SLCLKKVPAERPSAKELL 262
C +K P ERP+ + L
Sbjct: 417 --CWRKEPEERPTFEYLQ 432
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 68/283 (24%), Positives = 129/283 (45%), Gaps = 31/283 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ L+ +G G FG V K DVA+K+ ++E ++ +E + + P
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKG-QYDVAVKM--IKEGSMSEDEFFQEAQTMMKLSHPK 64
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ ++YG + ++I+ EY++ G + + L G L+ + + D+ + +L +
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEG 188
IHRD+ A N L+ + VKV+DFG++ + GT F W APEV +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV--GTKFPVKWSAPEVFHYFK- 181
Query: 189 YNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEF 243
Y+ K+D+W+ GI + E + G+ P V+ + + P + ++M
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYS- 240
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKY 286
C ++P +RP+ ++LL +E +RE+ K+
Sbjct: 241 ---CWHELPEKRPTFQQLLSS------------IEPLREKDKH 268
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 60/259 (23%), Positives = 108/259 (41%), Gaps = 21/259 (8%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD---VAIKVI--DLEESEDEIEDIQKEISVLSQCRSPYI 73
E +G GSFG V + + VA+K + D+ + ++D +E++ + +
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
YG L + ++ E GS+ D L + +++ + + YL ++
Sbjct: 84 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 142
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGY 189
IHRD+ A N+LL VK+ DFG+ L + W APE ++ +
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-F 201
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPREN-----PPQLDEHFSRLMKEF 243
+ +D W G+T+ EM G+ P L+ ++L I +E P + +M +
Sbjct: 202 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ- 260
Query: 244 VSLCLKKVPAERPSAKELL 262
C P +RP+ L
Sbjct: 261 ---CWAHKPEDRPTFVALR 276
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 21/268 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ L+ +G G FG V + DVAIK+ ++E ++ +E V+
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEK 80
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + YG Q ++II EYMA G + + L + + + +D+ A+EYL ++
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEG 188
+HRD+ A N L+ + G VKV+DFG+S + G+ F W PEV+ S+
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV--GSKFPVRWSPPEVLMYSK- 197
Query: 189 YNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEF 243
++ K+DIW+ G+ + E + G+ P I + P E +M
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS- 256
Query: 244 VSLCLKKVPAERPSAKELLRH--RFIRN 269
C + ERP+ K LL + +
Sbjct: 257 ---CWHEKADERPTFKILLSNILDVMDE 281
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 79/314 (25%), Positives = 124/314 (39%), Gaps = 70/314 (22%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE------IEDIQKEISVLS 66
R+ + +G G++G+VYKA D N+ VAIK I LE E+E I +E+S+L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE-HEEEGVPGTAI----REVSLLK 88
Query: 67 QCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHA 123
+ + I E H +L +I EY DL + P + I L L++
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 124 IEYLHNEGKIHRDIKAANILLT-----ENGDVKVADFGVSAQLTRTISR-RKTF---VGT 174
+ + H+ +HRD+K N+LL+ E +K+ DFG L R + F + T
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG----LARAFGIPIRQFTHEIIT 200
Query: 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP--------------------P--- 211
++ PE++ S Y+ DIWS+ EM P P
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260
Query: 212 -------LADLHPMRVLFIIPRENPPQLDEHFSRLMKE----FVSLCLKKVPAERPSAKE 260
L D P+ L L+ + ++ L+ P +R SAK
Sbjct: 261 TWPGVTALPDWKQSF-----PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315
Query: 261 LLRHRFIRNARKSP 274
L H + + P
Sbjct: 316 ALEHPYFSHNDFDP 329
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 63/270 (23%), Positives = 108/270 (40%), Gaps = 26/270 (9%)
Query: 18 LELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
++G G FG+VY+ +VA+K + + D E E ++ P+I
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ G + WIIME G + L ++ L +++ + A+ YL + +
Sbjct: 77 KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV 135
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT----PF-WMAPEVIQNSEG 188
HRDI NIL+ VK+ DFG L+R I + + P WM+PE I
Sbjct: 136 HRDIAVRNILVASPECVKLGDFG----LSRYIEDEDYYKASVTRLPIKWMSPESINFRR- 190
Query: 189 YNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEF 243
+ +D+W + + E+ G+ P L V+ ++ + P LM
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTR- 249
Query: 244 VSLCLKKVPAERPSAKELLRH--RFIRNAR 271
C P++RP EL+ + +
Sbjct: 250 ---CWDYDPSDRPRFTELVCSLSDVYQMEK 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-39
Identities = 69/288 (23%), Positives = 121/288 (42%), Gaps = 46/288 (15%)
Query: 18 LELIGRGSFGDVYKA----FDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
L+ +G+G+FG V + VA+K + +E+ + D ++EI +L + I
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNI 73
Query: 74 TEYYGSYLHQTK--LWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
+Y G + L +IMEY+ GS+ D L + +D + + + +EYL +
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FWMAPEVI 183
IHRD+ NIL+ VK+ DFG LT+ + + K F V P FW APE +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFG----LTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 184 QNSEGYNEKADIWSLGITVIEM----------------AKGEPPLADLHPMRVLFIIPR- 226
S+ ++ +D+WS G+ + E+ G + ++ ++
Sbjct: 190 TESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 227 ---ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH--RFIRN 269
P + +M E C +RPS ++L + N
Sbjct: 249 GRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRVDQIRDN 292
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-39
Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 39/285 (13%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
L+ IG+G FGDV + VA+K I + + + E SV++Q R
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATA---QAFLAEASVMTQLRHSN 247
Query: 73 ITEYYG-SYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHN 129
+ + G + L+I+ EYMA GS+ D ++S L + D+ A+EYL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNS 186
+HRD+ A N+L++E+ KV+DFG LT+ S + W APE ++
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFG----LTKEASSTQD--TGKLPVKWTAPEALREK 361
Query: 187 EGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMK 241
+ ++ K+D+WS GI + E+ G P + V+ + + + P +MK
Sbjct: 362 K-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMK 420
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKY 286
C A RP+ +L LE IR +
Sbjct: 421 N----CWHLDAATRPTFLQLREQ------------LEHIRTHELH 449
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 62/286 (21%), Positives = 115/286 (40%), Gaps = 44/286 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G G FG V + VA+K + E + I D++KEI +L I
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 74 TEYYG--SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
+Y G + + +IME++ GS+ + L ++ ++ + ++YL +
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FWMAPEVI 183
+HRD+ A N+L+ VK+ DFG LT+ I K + V FW APE +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFG----LTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 184 QNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPRENPP-----QLDEHFS 237
S+ + +D+WS G+T+ E + + + + + +
Sbjct: 202 MQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK 260
Query: 238 RL-------------MKEFVSLCLKKVPAERPSAKELLRH--RFIR 268
RL M++ C + P+ R S + L+ ++
Sbjct: 261 RLPCPPNCPDEVYQLMRK----CWEFQPSNRTSFQNLIEGFEALLK 302
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-38
Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 15/260 (5%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ + +G G +G+VY+ K+ + VA+K L+E E+E+ KE +V+ + + P
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ + G + +II E+M G++ D ++ + + + + + A+EYL +
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGY 189
IHR++ A N L+ EN VKVADFG+S +T P W APE + ++ +
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-F 396
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFV 244
+ K+D+W+ G+ + E+A G P + +V ++ + E P E LM+
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA-- 454
Query: 245 SLCLKKVPAERPSAKELLRH 264
C + P++RPS E+ +
Sbjct: 455 --CWQWNPSDRPSFAEIHQA 472
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 44/278 (15%)
Query: 18 LELIGRGSFGDVYKA----FDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
L+ +G+G+FG V + VA+K + +E+ + D ++EI +L + I
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNI 104
Query: 74 TEYYGSYLHQTK--LWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
+Y G + L +IMEY+ GS+ D L + +D + + + +EYL +
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FWMAPEVI 183
IHRD+ NIL+ VK+ DFG LT+ + + K + V P FW APE +
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFG----LTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 184 QNSEGYNEKADIWSLGITVIEM----------------AKGEPPLADLHPMRVLFIIPR- 226
S+ ++ +D+WS G+ + E+ G + ++ ++
Sbjct: 221 TESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279
Query: 227 ---ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261
P + +M E C +RPS ++L
Sbjct: 280 GRLPRPDGCPDEIYMIMTE----CWNNNVNQRPSFRDL 313
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 72/275 (26%), Positives = 113/275 (41%), Gaps = 19/275 (6%)
Query: 18 LELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
++IG G G+V + + VAIK + +E + D E S++ Q P I
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
G I+ EYM GS+ L M + +LR + + YL + G +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGYN 190
HRD+ A N+L+ N KV+DFG+S L T G W APE I ++
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FS 232
Query: 191 EKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVS 245
+D+WS G+ + E +A GE P ++ V+ + P +LM +
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLD--- 289
Query: 246 LCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280
C K A+RP ++ + +SP L
Sbjct: 290 -CWHKDRAQRPRFSQI--VSVLDALIRSPESLRAT 321
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 33/290 (11%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+E +G G FG+V+ + + VA+K L++ + E +++ Q +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKS--LKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ Y + ++II EYM GS+ D +++ G L + + + + ++
Sbjct: 70 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSE 187
IHRD++AANIL+++ K+ADFG++ + + G F W APE I
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAINYGT 186
Query: 188 GYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKE 242
+ K+D+WS GI + E+ G P + V+ + R P E +LM+
Sbjct: 187 -FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEP 292
C K+ P +RP+ L LE + Q +P
Sbjct: 246 ----CWKERPEDRPTFDYLRSV------------LEDFFTATEGQYQPQP 279
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 60/265 (22%), Positives = 109/265 (41%), Gaps = 29/265 (10%)
Query: 19 ELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
+IG+G FG VY + ++ AIK + ++E +E ++ P +
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 76 YYG-SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
G + +++ YM G + + + + +EYL + +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTI------SRRKTFVGTPF---WMAPEVIQ 184
HRD+ A N +L E+ VKVADFG L R I S ++ W A E +Q
Sbjct: 147 HRDLAARNCMLDESFTVKVADFG----LARDILDREYYSVQQH-RHARLPVKWTALESLQ 201
Query: 185 NSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRL 239
+ K+D+WS G+ + E + +G PP + P + + + P + ++
Sbjct: 202 TYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQV 260
Query: 240 MKEFVSLCLKKVPAERPSAKELLRH 264
M++ C + PA RP+ + L+
Sbjct: 261 MQQ----CWEADPAVRPTFRVLVGE 281
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-38
Identities = 72/270 (26%), Positives = 106/270 (39%), Gaps = 26/270 (9%)
Query: 18 LELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
IG G FGDV++ VAIK S+ E +E + Q P+I
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ G +WIIME G + L LD S+ L A+ YL ++ +
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV 513
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT----PF-WMAPEVIQNSEG 188
HRDI A N+L++ N VK+ DFG L+R + + + P WMAPE I
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFG----LSRYMEDSTYYKASKGKLPIKWMAPESINFRR- 568
Query: 189 YNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEF 243
+ +D+W G+ + E+ G P + V+ I PP LM +
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK- 627
Query: 244 VSLCLKKVPAERPSAKELLRH--RFIRNAR 271
C P+ RP EL + +
Sbjct: 628 ---CWAYDPSRRPRFTELKAQLSTILEEEK 654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 64/257 (24%), Positives = 117/257 (45%), Gaps = 25/257 (9%)
Query: 21 IGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G G+FG V + + K DVAIKV+ + + E++ +E ++ Q +PYI G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 79 SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ L ++ME GG + L+ + ++A +L + ++YL + +HRD+
Sbjct: 78 VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 136
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTISRR----KTFVGTPF---WMAPEVIQNSEGYN 190
A N+LL K++DFG L++ + + W APE I + ++
Sbjct: 137 AARNVLLVNRHYAKISDFG----LSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FS 191
Query: 191 EKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVS 245
++D+WS G+T+ E ++ G+ P + V+ I + E PP+ LM +
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSD--- 248
Query: 246 LCLKKVPAERPSAKELL 262
C +RP +
Sbjct: 249 -CWIYKWEDRPDFLTVE 264
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 60/254 (23%), Positives = 112/254 (44%), Gaps = 17/254 (6%)
Query: 21 IGRGSFGDVYKAF--DKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYY 77
+G G+FG V K + K++ K VA+K++ E ++ +++ E +V+ Q +PYI
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
G ++ ++ME G + +Q + + +I ++ + ++YL +HRD+
Sbjct: 85 GICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 143
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGYNEKAD 194
A N+LL K++DFG+S L + K + W APE I + ++ K+D
Sbjct: 144 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSD 202
Query: 195 IWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLK 249
+WS G+ + E + G+ P + V ++ + P LM C
Sbjct: 203 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL----CWT 258
Query: 250 KVPAERPSAKELLR 263
RP +
Sbjct: 259 YDVENRPGFAAVEL 272
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 5e-38
Identities = 71/258 (27%), Positives = 114/258 (44%), Gaps = 17/258 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G+G FG+V+ VAIK L+ E +E V+ + R
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ + Y + ++I+ EYM+ GS+ D ++ G L + + + + Y+
Sbjct: 324 LVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF-WMAPEVIQNSEGY 189
+HRD++AANIL+ EN KVADFG++ + + P W APE +
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-F 441
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFV 244
K+D+WS GI + E+ KG P + VL + R PP+ E LM +
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ-- 499
Query: 245 SLCLKKVPAERPSAKELL 262
C +K P ERP+ + L
Sbjct: 500 --CWRKEPEERPTFEYLQ 515
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-38
Identities = 62/279 (22%), Positives = 108/279 (38%), Gaps = 29/279 (10%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
E+IGRG FG VY + + A+K ++ E+ E ++ P +
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 75 EYYG-SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
G + +++ YM G + + + + + +++L ++
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 213
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTI-------SRRKTFVGTPF-WMAPEVIQ 184
+HRD+ A N +L E VKVADFG L R + KT P WMA E +Q
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFG----LARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 185 NSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRL 239
+ + K+D+WS G+ + E M +G PP D++ + + + P + +
Sbjct: 270 TQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 328
Query: 240 MKEFVSLCLKKVPAERPSAKELLRH--RFIRNARKSPRL 276
M + C RPS EL+ +
Sbjct: 329 MLK----CWHPKAEMRPSFSELVSRISAIFSTFIGEHYV 363
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 81/306 (26%), Positives = 121/306 (39%), Gaps = 45/306 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ +G G+FG+VY+ + D VA+K + SE + D E ++S+
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLH-AI------E 125
I G L +I+ME MAGG + ++ P + + DLLH A +
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 126 YLHNEGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTISR----RKTFVGT-PF- 176
YL IHRDI A N LLT G K+ DFG + R I R RK P
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAMLPVK 210
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFII--------PRE 227
WM PE + K D WS G+ + E+ G P VL + P+
Sbjct: 211 WMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN 269
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYP 287
P + R+M + C + P +RP+ + I + P ++ P
Sbjct: 270 CPGPV----YRIMTQ----CWQHQPEDRPNFAII--LERIEYCTQDPDVINTALPIEYGP 319
Query: 288 IQEEPD 293
+ EE +
Sbjct: 320 LVEEEE 325
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 66/283 (23%), Positives = 106/283 (37%), Gaps = 56/283 (19%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G G FG V N VA+K + + ++EI +L +I
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 74 TEYYG--SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAI------- 124
+Y G L ++MEY+ GS+ D + L LL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIG--------LAQLLLFAQQICEGM 147
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FW 177
YLH + IHRD+ A N+LL + VK+ DFG L + + + V FW
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG----LAKAVPEGHEYYRVREDGDSPVFW 203
Query: 178 MAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPP-----Q 231
APE ++ + + +D+WS G+T+ E+ + + L I + +
Sbjct: 204 YAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 232 LDEHFSRL-------------MKEFVSLCLKKVPAERPSAKEL 261
L E RL MK C + + RP+ + L
Sbjct: 263 LLERGERLPRPDKCPAEVYHLMKN----CWETEASFRPTFENL 301
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 9e-38
Identities = 72/277 (25%), Positives = 118/277 (42%), Gaps = 43/277 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +G+G+FG V L + VA+K + D+ D Q+EI +L S +I
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFI 86
Query: 74 TEYYG--SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
+Y G + L ++MEY+ G + D L + LD + + +EYL +
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF--VGTP-----FWMAPEVI 183
+HRD+ A NIL+ VK+ADFG L + + K + V P FW APE +
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFG----LAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 184 QNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPP-----QLDEHFS 237
++ ++ ++D+WS G+ + E+ + + + R+ P +L E
Sbjct: 203 SDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261
Query: 238 RL-------------MKEFVSLCLKKVPAERPSAKEL 261
RL MK C P +RPS L
Sbjct: 262 RLPAPPACPAEVHELMKL----CWAPSPQDRPSFSAL 294
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-37
Identities = 78/329 (23%), Positives = 140/329 (42%), Gaps = 61/329 (18%)
Query: 13 SRFSSLELIGRGSFGDVYKAFD-KELNKDVAIKVIDLEESEDE---IEDIQKEISVLSQC 68
++ + IG G++G V+KA D K + VA+K + ++ + +E + I +E++VL
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ-TGEEGMPLSTI-REVAVLRHL 68
Query: 69 RS---PYITE-----YYGSYLHQTKLWIIMEYMAGGSVADLIQ-----SGPPLDEMSIAC 115
+ P + +TKL ++ E++ DL P + +I
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKD 124
Query: 116 ILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF---V 172
++ LL +++LH+ +HRD+K NIL+T +G +K+ADFG L R S + V
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG----LARIYSFQMALTSVV 180
Query: 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------- 224
T ++ APEV+ S Y D+WS+G EM + +P + L I
Sbjct: 181 VTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239
Query: 225 ---------------PRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHR 265
++ +++ + + + L L K PA+R SA L H
Sbjct: 240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL-LLKCLTFNPAKRISAYSALSHP 298
Query: 266 FIRNARKSPRLLERIRERPKYPIQEEPDT 294
+ ++ + L+ P E +T
Sbjct: 299 YFQDLERCKENLD--SHLPPSQNTSELNT 325
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-37
Identities = 66/290 (22%), Positives = 120/290 (41%), Gaps = 33/290 (11%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ +G G FG+V+ A + + VA+K ++ +E E +V+ +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDK 244
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE 130
+ + + + ++II E+MA GS+ D ++S G + + + ++
Sbjct: 245 LVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSE 187
IHRD++AANIL++ + K+ADFG++ + + G F W APE I
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAINFGS 361
Query: 188 GYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKE 242
+ K+D+WS GI ++E+ G P + V+ + R P E +M
Sbjct: 362 -FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 420
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEP 292
C K P ERP+ + + L+ + +E P
Sbjct: 421 ----CWKNRPEERPTFEYIQSV------------LDDFYTATESQYEEIP 454
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 65/276 (23%), Positives = 121/276 (43%), Gaps = 40/276 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD---VAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPYI 73
++G+G FG V +A K+ + VA+K++ + + +IE+ +E + + + P++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 74 TEYYG------SYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLH----- 122
+ G + +I+ +M G + + + E L+ L+
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI-GENPFNLPLQTLVRFMVDI 146
Query: 123 --AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFVGTPF 176
+EYL + IHRD+ A N +L E+ V VADFG L+R I R+ +
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG----LSRKIYSGDYYRQG-CASKL 201
Query: 177 ---WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----EN 228
W+A E + ++ Y +D+W+ G+T+ E+ +G+ P A + + + +
Sbjct: 202 PVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ 260
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
PP+ E LM + C P +RPS L
Sbjct: 261 PPECMEEVYDLMYQ----CWSADPKQRPSFTCLRME 292
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-37
Identities = 39/282 (13%), Positives = 87/282 (30%), Gaps = 38/282 (13%)
Query: 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE--IEDIQKEISVLSQC 68
A R+ L G ++A D L++ VA+ +D + + +++ LS+
Sbjct: 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
P + + ++ E++ GGS+ ++ + P ++ L A + H
Sbjct: 89 DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA--IRAMQSLAAAADAAH 146
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
G + + ++ +GDV +A
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYPATMPDAN-------------------------- 180
Query: 189 YNEKADIWSLGITVIEMAKGEPPLAD---LHPMRVLFIIPRENPP---QLDEHFSRLMKE 242
+ DI +G ++ + PL + + P +D +
Sbjct: 181 --PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERP 284
+ ++ R ++ L + +L I E P
Sbjct: 239 VAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAP 280
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 67/276 (24%), Positives = 115/276 (41%), Gaps = 41/276 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYI 73
+++G G FG V + K+ + VA+K + L+ S+ EIE+ E + + P +
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 74 TEYYG-----SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLH----- 122
G S K +I+ +M G + L+ S I L+ LL
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP--LQTLLKFMVDI 156
Query: 123 --AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFVGTPF 176
+EYL N +HRD+ A N +L ++ V VADFG L++ I R+
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG----LSKKIYSGDYYRQG-RIAKM 211
Query: 177 ---WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR----EN 228
W+A E + + Y K+D+W+ G+T+ E+A +G P + + + +
Sbjct: 212 PVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P + +M C + P +RP+ L
Sbjct: 271 PEDCLDELYEIMYS----CWRTDPLDRPTFSVLRLQ 302
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 9e-37
Identities = 79/306 (25%), Positives = 120/306 (39%), Gaps = 45/306 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ +G G+FG+VY+ + D VA+K + SE + D E ++S+
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAI-------E 125
I G L +I++E MAGG + ++ P + + DLLH +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 126 YLHNEGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTISR----RKTFVGT-PF- 176
YL IHRDI A N LLT G K+ DFG + R I R RK P
Sbjct: 196 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRAGYYRKGGCAMLPVK 251
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFII--------PRE 227
WM PE + K D WS G+ + E+ G P VL + P+
Sbjct: 252 WMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKN 310
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYP 287
P + R+M + C + P +RP+ + I + P ++ P
Sbjct: 311 CPGPV----YRIMTQ----CWQHQPEDRPNFAII--LERIEYCTQDPDVINTALPIEYGP 360
Query: 288 IQEEPD 293
+ EE +
Sbjct: 361 LVEEEE 366
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 43/277 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G+GSFG VY+ K + KD VAIK ++ S E + E SV+ + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACIL--RDLLH------- 122
+ G +IME M G + L P + + ++
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFVGT-PF- 176
+ YL+ +HRD+ A N ++ E+ VK+ DFG +TR I RK G P
Sbjct: 150 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPVR 205
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVL-FII-------PRE 227
WM+PE +++ + +D+WS G+ + E+A E P L +VL F++ P
Sbjct: 206 WMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 264
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P L LM+ C + P RPS E++
Sbjct: 265 CPDML----FELMRM----CWQYNPKMRPSFLEIISS 293
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-36
Identities = 65/252 (25%), Positives = 117/252 (46%), Gaps = 17/252 (6%)
Query: 21 IGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G G+FG V + + K DVAIKV+ + + E++ +E ++ Q +PYI G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 79 SYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
+ L ++ME GG + L+ + ++A +L + ++YL + +HR++
Sbjct: 404 VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462
Query: 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPF---WMAPEVIQNSEGYNEKAD 194
A N+LL K++DFG+S L S + W APE I + ++ ++D
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSD 521
Query: 195 IWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQLDEHFSRLMKEFVSLCLK 249
+WS G+T+ E ++ G+ P + V+ I + E PP+ LM + C
Sbjct: 522 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSD----CWI 577
Query: 250 KVPAERPSAKEL 261
+RP +
Sbjct: 578 YKWEDRPDFLTV 589
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 53/298 (17%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRS 70
+ S +G G++G V A DK + VAIK + +SE + +E+ +L +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 71 PYITEYY------GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLL 121
+ S + +++M +M DL + E I ++ +L
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGL--KFSEEKIQYLVYQML 136
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAP 180
++Y+H+ G +HRD+K N+ + E+ ++K+ DFG L R T +V T ++ AP
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTRWYRAP 192
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGE---------------------PPLADLHPM- 218
EVI + YN+ DIWS+G + EM G+ P + +
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252
Query: 219 -----RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHRFI 267
+ +P+ + F R + L L+K+ +R +A + L H F
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADL-LEKMLELDVDKRLTAAQALTHPFF 309
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 64/280 (22%), Positives = 108/280 (38%), Gaps = 43/280 (15%)
Query: 18 LELIGRGSFGDVYKA-----FDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+E +G FG VYK E + VAIK + + E+ + E + ++ + P
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------LRDLLH- 122
+ G L +I Y + G + + L+ P D S D +H
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 123 AI------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFV 172
EYL + +H+D+ N+L+ + +VK++D G L R + +
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG----LFREVYAADYYKLL-G 188
Query: 173 GTPF---WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR-- 226
+ WMAPE I + ++ +DIWS G+ + E+ G P V+ +I
Sbjct: 189 NSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ 247
Query: 227 --ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P LM E C + P+ RP K++
Sbjct: 248 VLPCPDDCPAWVYALMIE----CWNEFPSRRPRFKDIHSR 283
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 67/279 (24%), Positives = 117/279 (41%), Gaps = 44/279 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G G+FG V+ A L+ VA+K + + + +D Q+E +L+ + +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEH 78
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------LRDLLH- 122
I ++YG L ++ EYM G + L GP + L +LH
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 123 ------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----RKTFV 172
+ YL ++ +HRD+ N L+ N VK+ DFG ++R + R
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG----MSRDVYSTDYYRVG-G 193
Query: 173 GTPF---WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR-- 226
T WM PE I + + ++D+WS G+ + E+ G+ P L V+ I +
Sbjct: 194 HTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 252
Query: 227 --ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
E P + +M C ++ P +R + KE+ +
Sbjct: 253 VLERPRVCPKEVYDVMLG----CWQREPQQRLNIKEIYK 287
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 74/283 (26%), Positives = 111/283 (39%), Gaps = 45/283 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ-CRSP 71
+ +G G+FG V +A L K VA+K++ E E + E+ VLS
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGS-----------VADLIQSGPPLDEMSIACILRDL 120
I G+ +I EY G S +++ +A L DL
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 121 LH-AI------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
L + +L ++ IHRD+ A NILLT K+ DFG L R I +V
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG----LARDIKNDSNYVV 203
Query: 174 T-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMR-VLFIIP 225
P WMAPE I N Y ++D+WS GI + E+ G P + +I
Sbjct: 204 KGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262
Query: 226 R----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+P +MK C P +RP+ K++++
Sbjct: 263 EGFRMLSPEHAPAEMYDIMKT----CWDADPLKRPTFKQIVQL 301
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 64/299 (21%), Positives = 122/299 (40%), Gaps = 52/299 (17%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRS 70
R+ +L +G G++G V AFD + VA+K + +S + +E+ +L +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 71 PYITEYY------GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLL 121
+ S ++++ M ADL ++ L + + ++ +L
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQK-LTDDHVQFLIYQIL 142
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAP 180
++Y+H+ IHRD+K +N+ + E+ ++K+ DFG L R + T +V T ++ AP
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG----LARHTADEMTGYVATRWYRAP 198
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGE---------------------PPLADLHPM- 218
E++ N YN+ DIWS+G + E+ G P L +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 219 -----RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHRFIR 268
+ + + F V L L+K+ +R +A + L H +
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDL-LEKMLVLDSDKRITAAQALAHAYFA 316
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 50/296 (16%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G G+FG V+ A L + VA+K + E SE +D Q+E +L+ + +
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQH 104
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI-------LRDLLHAI 124
I ++G L ++ EYM G + L GP ++ L LL
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 125 -------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-----RRKTFV 172
YL +HRD+ N L+ + VK+ DFG ++R I R
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG----MSRDIYSTDYYRVGGRT 220
Query: 173 GTPF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFII------ 224
P WM PE I + + ++D+WS G+ + E+ G+ P L + I
Sbjct: 221 MLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL 279
Query: 225 --PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
PR PP++ +M+ C ++ P +R S K++ R A+ P L+
Sbjct: 280 ERPRACPPEV----YAIMRG----CWQREPQQRHSIKDVH-ARLQALAQAPPVYLD 326
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 76/305 (24%), Positives = 126/305 (41%), Gaps = 54/305 (17%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
S F L+G G++G V A K + VAIK I+ + +EI +L +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 72 YITEYY-----GSYLHQTKLWIIMEYMAGGSVADLIQ--SGPPLDEMSIACILRDLLHAI 124
I + S+ + +++II E M DL + S L + I + L A+
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM------ 178
+ LH IHRD+K +N+L+ N D+KV DFG++ + + + G M
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 179 ----APEVIQNSEGYNEKADIWSLGITVIEMAKGEP----------------------PL 212
APEV+ S Y+ D+WS G + E+ P
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 213 ADLHPM------RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELL 262
DL + + +P L++ F R+ + + L L+++ PA+R +AKE L
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDL-LQRMLVFDPAKRITAKEAL 304
Query: 263 RHRFI 267
H ++
Sbjct: 305 EHPYL 309
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 87/294 (29%), Positives = 132/294 (44%), Gaps = 48/294 (16%)
Query: 19 ELIGRGSFGDVYKAF--DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CRSPYITE 75
++IG G+FG V KA L D AIK + S+D+ D E+ VL + P I
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 76 YYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------LRDLLH-AI- 124
G+ H+ L++ +EY G++ D L +S + + A + LLH A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 125 -----EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPF- 176
+YL + IHRD+ A NIL+ EN K+ADFG L+R +KT P
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG----LSRGQEVYVKKTMGRLPVR 206
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR----ENPPQ 231
WMA E + S Y +D+WS G+ + E ++ G P + + +P+ E P
Sbjct: 207 WMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 265
Query: 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPK 285
D+ LM++ C ++ P ERPS ++L L R+ E K
Sbjct: 266 CDDEVYDLMRQ----CWREKPYERPSFAQILVS------------LNRMLEERK 303
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 73/282 (25%), Positives = 130/282 (46%), Gaps = 44/282 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVLSQ-CR 69
+ +G G+FG V A ++KD VA+K++ + +E ++ D+ E+ ++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------LRDL 120
I G+ L++I+EY + G++ + L PP E S +DL
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 121 LH-AI------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
+ EYL ++ IHRD+ A N+L+TEN +K+ADFG L R I+ +
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG----LARDINNIDYYKK 215
Query: 174 T-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR 226
T P WMAPE + + Y ++D+WS G+ + E+ G P + + ++
Sbjct: 216 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
Query: 227 ----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ P +M++ C VP++RP+ K+L+
Sbjct: 275 GHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVED 312
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 71/298 (23%), Positives = 121/298 (40%), Gaps = 52/298 (17%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRS 70
+ + L+ +G G++G V A D VAIK + +SE + +E+ +L R
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 71 PYITEYY------GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLL 121
+ + T +++M +M DL ++ L E I ++ +L
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TDLGKLMKHEK-LGEDRIQFLVYQML 138
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAP 180
+ Y+H G IHRD+K N+ + E+ ++K+ DFG L R T +V T ++ AP
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG----LARQADSEMTGYVVTRWYRAP 194
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGE---------------------PPLADLHPM- 218
EVI N Y + DIWS+G + EM G+ PP + +
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254
Query: 219 -----RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHRFI 267
+ +P + V+L L+K+ +R +A E L H +
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNL-LEKMLVLDAEQRVTAGEALAHPYF 311
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 59/328 (17%), Positives = 121/328 (36%), Gaps = 78/328 (23%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP- 71
+R+ + +G G F V+ A D N VA+K++ + E + EI +L +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDAD 76
Query: 72 ----------YITEYYGSYLHQTKLW----IIMEYMAGGSVADLIQSGP--PLDEMSIAC 115
+I + + H+ ++ E + G ++ LI+ + + +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 116 ILRDLLHAIEYLHNEGK-IHRDIKAANILLTENGD------VKVADFGVSAQLTRTISRR 168
I + LL ++Y+H IH DIK N+L+ +K+AD G + +
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-- 193
Query: 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP--PLADLHP--------- 217
+ T + +PEV+ + + ADIWS + E+ G+ + H
Sbjct: 194 -NSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 218 --MRVLFIIPRE----------------------------------NPPQLDEHFSRLMK 241
+ +L +P + + ++ +
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRN 269
+F+S L+ P +R A L+ H ++++
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 75/302 (24%), Positives = 127/302 (42%), Gaps = 56/302 (18%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
G R+++L IG G++G V A+D VAIK I E + + +EI +L + R
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 72 YITEYY-----GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHA 123
I + ++I+ + M DL +++ L I L +L
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQH-LSNDHICYFLYQILRG 140
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-------FVGTPF 176
++Y+H+ +HRD+K +N+LL D+K+ DFG L R +V T +
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG----LARVADPDHDHTGFLTEYVATRW 196
Query: 177 WMAPEVIQNSEGYNEKADIWSLGITVIEMAKGE---------------------PPLADL 215
+ APE++ NS+GY + DIWS+G + EM P DL
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 216 HPM------RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPSAKELLRHR 265
+ + L +P +N + F + + L L K+ P +R ++ L H
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL-LDKMLTFNPHKRIEVEQALAHP 315
Query: 266 FI 267
++
Sbjct: 316 YL 317
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-33
Identities = 78/318 (24%), Positives = 137/318 (43%), Gaps = 46/318 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVLSQ-CR 69
+ +G G+FG V A L+KD VA+K++ + +E ++ D+ E+ ++ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------LRDL 120
I G+ L++I+EY + G++ + L PP E S +DL
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 121 LH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
+ +EYL ++ IHRD+ A N+L+TE+ +K+ADFG L R I +
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG----LARDIHHIDYYKK 249
Query: 174 T-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR 226
T P WMAPE + + Y ++D+WS G+ + E+ G P + + ++
Sbjct: 250 TTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 308
Query: 227 ----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH--RFIRNARKSPRLLERI 280
+ P +M++ C VP++RP+ K+L+ R +
Sbjct: 309 GHRMDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHH 364
Query: 281 RERPKYPIQEEPDTPING 298
Y I + NG
Sbjct: 365 HHHHDYDIPTTENLYFNG 382
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 49/287 (17%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ +G G FG V KA L VA+K++ S E+ D+ E +VL Q P+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------------- 116
+ + YG+ L +I+EY GS+ L +S +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 117 -LRDLLH-AI------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168
+ DL+ A +YL +HRD+ A NIL+ E +K++DFG L+R +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG----LSRDVYEE 203
Query: 169 KTFVGT-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVL 221
++V P WMA E + + Y ++D+WS G+ + E+ G P + P R+
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 222 FIIPR----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
++ E P E RLM + C K+ P +RP ++ +
Sbjct: 263 NLLKTGHRMERPDNCSEEMYRLMLQ----CWKQEPDKRPVFADISKD 305
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-33
Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 44/282 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVLSQ-CR 69
+ +G G FG V A ++KD VA+K++ + +E ++ D+ E+ ++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------LRDL 120
I G+ L++I+EY + G++ + L PP E S +DL
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 121 LH-AI------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
+ EYL ++ IHRD+ A N+L+TEN +K+ADFG L R I+ +
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG----LARDINNIDYYKK 261
Query: 174 T-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPR 226
T P WMAPE + + Y ++D+WS G+ + E+ G P + + ++
Sbjct: 262 TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 320
Query: 227 ----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ P +M++ C VP++RP+ K+L+
Sbjct: 321 GHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVED 358
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 70/305 (22%), Positives = 114/305 (37%), Gaps = 61/305 (20%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
RF + G+G+FG V +K VAIK + +++ ++Q + L+ P
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQ-IMQDLAVLHHPN 80
Query: 73 ITEYYGSYLHQTK-------LWIIMEYMAGGSVADL-------IQSGPPLDEMSIACILR 118
I + + + L ++MEY+ L + + I L
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 119 DLLHAIEYLHNEGK--IHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTFVG-- 173
L+ +I LH HRDIK N+L+ +G +K+ DFG + +S + V
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG----SAKKLSPSEPNVAYI 192
Query: 174 -TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEP--------------------P- 211
+ ++ APE+I ++ Y DIWS+G EM GEP P
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 212 ---LADLHPMRVLFIIPRENPPQLDEHFSRLMK-------EFVSLCLKKVPAERPSAKEL 261
L L+P + FS + +S L+ +P ER E
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312
Query: 262 LRHRF 266
L H +
Sbjct: 313 LCHPY 317
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 62/292 (21%), Positives = 119/292 (40%), Gaps = 46/292 (15%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
++ ++IG GSFG VY+A + + VAIK + ++ +E+ ++ + I
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 109
Query: 74 TEYY------GSYLHQTKLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHA 123
G + L ++++Y+ +V + ++ L + + + L +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 124 IEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
+ Y+H+ G HRDIK N+LL + +K+ DFG SA+ +++ + ++ APE+
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG-SAKQLVRGEPNVSYICSRYYRAPEL 227
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEP--------------------P----LADLHPM 218
I + Y D+WS G + E+ G+P P + +++P
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287
Query: 219 RVLFIIPRENPPQLDEHF----SRLMKEFVSLCLKKVPAERPSAKELLRHRF 266
F P+ + F S L+ P R + E H F
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 64/310 (20%), Positives = 109/310 (35%), Gaps = 64/310 (20%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQK---------E 61
S ++ I GS+G V D E VAIK V + + + E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 62 ISVLSQCRSPYITEYYGSYLHQTK-----LWIIMEYMAGGSVADL---IQSG-PPLDEMS 112
I +L+ P I ++H + L+++ E M DL I +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQH 135
Query: 113 IACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-- 170
I + +L + LH G +HRD+ NILL +N D+ + DF L R +
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN----LAREDTADANKT 191
Query: 171 -FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGE-------------------- 209
+V ++ APE++ +G+ + D+WS G + EM +
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251
Query: 210 -PPLADLHPMR-------VLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERPS 257
P + D+ + + + L + K+ P R S
Sbjct: 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDL-IAKMLEFNPQRRIS 310
Query: 258 AKELLRHRFI 267
++ LRH +
Sbjct: 311 TEQALRHPYF 320
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 74/311 (23%), Positives = 130/311 (41%), Gaps = 66/311 (21%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED------EI--------ED 57
GSR+ L+ +G G G V+ A D + +K VAIK I L + + EI ++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 58 IQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIA 114
I K +L +T+ GS ++I+ EYM DL ++ GP L E
Sbjct: 70 IVKVFEIL-GPSGSQLTDDVGSLTELNSVYIVQEYME----TDLANVLEQGP-LLEEHAR 123
Query: 115 CILRDLLHAIEYLHNEGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKT--- 170
+ LL ++Y+H+ +HRD+K AN+ + TE+ +K+ DFG L R + +
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG----LARIMDPHYSHKG 179
Query: 171 ----FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGE----------------- 209
+ T ++ +P ++ + Y + D+W+ G EM G+
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239
Query: 210 ----PPLADLHPM-----RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAERP 256
D + + E L + + +E V L+++ P +R
Sbjct: 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDF-LEQILTFSPMDRL 298
Query: 257 SAKELLRHRFI 267
+A+E L H ++
Sbjct: 299 TAEEALSHPYM 309
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-32
Identities = 75/303 (24%), Positives = 135/303 (44%), Gaps = 67/303 (22%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+++ ++IG GSFG V++A E ++ VAIK + ++ +E+ ++ + P
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-----RFKNRELQIMRIVKHPN 93
Query: 73 ITEYY------GSYLHQTKLWIIMEYMAGGSVADL-------IQSGPPLDEMSIACILRD 119
+ + G + L +++EY+ + + + + I +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 120 LLHAIEYLHNEGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTFVG---TP 175
LL ++ Y+H+ G HRDIK N+LL +G +K+ DFG SA + + + V +
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG-SA---KILIAGEPNVSYICSR 205
Query: 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-----------MRVL--- 221
++ APE+I + Y DIWS G + E+ +G+P L P ++VL
Sbjct: 206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP----LFPGESGIDQLVEIIKVLGTP 261
Query: 222 --FIIPRENP-------PQLDEH-FSRLMK--------EFVSLCLKKVPAERPSAKELLR 263
I NP PQ+ H FS++ + + +S L+ P+ R +A E L
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 264 HRF 266
H F
Sbjct: 322 HPF 324
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-32
Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 53/254 (20%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQK---EISVLSQC 68
R+ LIG GS+G V +A+DK + VAIK I ED I D ++ EI++L++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLI-DCKRILREIAILNRL 109
Query: 69 RSPYITEYY-----GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDL 120
++ + +L++++E +D ++ L E+ I +L +L
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVYLTELHIKTLLYNL 165
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM-- 178
L ++Y+H+ G +HRD+K AN L+ ++ VKV DFG L RT+ +
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFG----LARTVDYPENGNSQLPISPR 221
Query: 179 -----------------------------APEVIQNSEGYNEKADIWSLGITVIEMAKGE 209
APE+I E Y E D+WS+G E+
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281
Query: 210 PPLADLHPMR-VLF 222
H R LF
Sbjct: 282 KENVAYHADRGPLF 295
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 74/310 (23%), Positives = 120/310 (38%), Gaps = 65/310 (20%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ IG G+FG V++A L VA+K++ E S D D Q+E +++++ +P
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI--------------- 116
I + G + ++ EYMA G + + L P
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 117 -LRDLLHAI-------EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-- 166
+ L YL +HRD+ N L+ EN VK+ADFG L+R I
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG----LSRNIYSA 227
Query: 167 ---RRKTFVGTPF---WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMR 219
+ WM PE I + Y ++D+W+ G+ + E+ G P +
Sbjct: 228 DYYKADG--NDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284
Query: 220 VLFIIPR----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275
V++ + P LM+ C K+PA+RPS + R
Sbjct: 285 VIYYVRDGNILACPENCPLELYNLMRL----CWSKLPADRPSFCSIHRI----------- 329
Query: 276 LLERIRERPK 285
L+R+ ER +
Sbjct: 330 -LQRMCERAE 338
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 77/247 (31%), Positives = 108/247 (43%), Gaps = 44/247 (17%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRS 70
+ LIGRGS+G VY A+DK K+VAIK V + E + + I +EI++L++ +S
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 71 PYITEYY-----GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLH 122
YI Y L +L+I++E +DL ++ L E I IL +LL
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIAD----SDLKKLFKTPIFLTEEHIKTILYNLLL 140
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWM---- 178
++H G IHRD+K AN LL ++ VKV DFG L RTI+ K
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG----LARTINSEKDTNIVNDLEENEE 196
Query: 179 ----------------------APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH 216
APE+I E Y + DIWS G E+ +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 217 PMRV-LF 222
R LF
Sbjct: 257 TNRFPLF 263
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 68/282 (24%), Positives = 112/282 (39%), Gaps = 44/282 (15%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQCRS-P 71
+ +GRG+FG V +A ++K VA+K++ + E + E+ +L
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 72 YITEYYGSYLHQTK-LWIIMEYMAGGS---------VADLIQSGPPLDEMSIACILRDLL 121
+ G+ L +I+E+ G+ + P D L L+
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 122 H-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT 174
+E+L + IHRD+ A NILL+E VK+ DFG L R I + +V
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG----LARDIYKDPDYVRK 207
Query: 175 -----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMR-VLFIIPR 226
P WMAPE I + Y ++D+WS G+ + E+ G P + +
Sbjct: 208 GDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
Query: 227 ----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P + M + C P++RP+ EL+ H
Sbjct: 267 GTRMRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEH 304
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-31
Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 36/300 (12%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-- 69
R+ L++IG+GSFG V KA+D ++++ VA+K++ + +EI +L R
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV--RNEKRFHRQAAEEIRILEHLRKQ 153
Query: 70 ----SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHA 123
+ + ++ + + + E + ++ +LI+ + +L
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 124 IEYLHNEGKIHRDIKAANILLTENG--DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPE 181
++ LH IH D+K NILL + G +KV DFG S + + T++ + F+ APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY---TYIQSRFYRAPE 269
Query: 182 VIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-----------MRVLFIIPR---E 227
VI + Y D+WSLG + E+ G P L P + +L + + +
Sbjct: 270 VILGA-RYGMPIDMWSLGCILAELLTGYP----LLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYP 287
+ S + + R R + P
Sbjct: 325 ASKRAKNFVSS-KGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 69/279 (24%), Positives = 118/279 (42%), Gaps = 41/279 (14%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ-CRSP 71
+ +G G+FG V +A L K+ VA+K++ DE E + E+ ++S +
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVAD-------LIQSGPPLDEMSIACILRDLLH-- 122
I G+ H + +I EY G + + ++++ P + RDLLH
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 123 -----AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGT--- 174
+ +L ++ IHRD+ A N+LLT K+ DFG L R I ++
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG----LARDIMNDSNYIVKGNA 226
Query: 175 --PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPL-ADLHPMRVLFIIPR--- 226
P WMAPE I + Y ++D+WS GI + E+ G P L + ++
Sbjct: 227 RLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQ 285
Query: 227 -ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
P ++ +M+ C P RP+ +++
Sbjct: 286 MAQPAFAPKNIYSIMQA----CWALEPTHRPTFQQICSF 320
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 82/313 (26%), Positives = 128/313 (40%), Gaps = 71/313 (22%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRS 70
R+ +L+ IG G+ G V A+D L ++VAIK + +++ + +E+ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 71 PYITEYY------GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLL 121
I S ++I+ME M A+L IQ LD ++ +L +L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQM--ELDHERMSYLLYQML 137
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT---FVGTPFWM 178
I++LH+ G IHRD+K +NI++ + +K+ DFG L RT +V T ++
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAGTSFMMTPYVVTRYYR 193
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGE---------------------PPLADLH- 216
APEVI GY E DIWS+G + EM KG P +
Sbjct: 194 APEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252
Query: 217 ------------------PMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAE 254
LF P P EH + L L K+ ++
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLF--PDVLFPADSEHNKLKASQARDL-LSKMLVIDASK 309
Query: 255 RPSAKELLRHRFI 267
R S E L+H +I
Sbjct: 310 RISVDEALQHPYI 322
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 69/360 (19%), Positives = 127/360 (35%), Gaps = 82/360 (22%)
Query: 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK----------------------- 44
E + ++S + +G GSFG V + FD E K A+K
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVN 61
Query: 45 VIDL----------EESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94
+I L E + D ++ + + + + L +IMEY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 95 GGSVADL-------IQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL-TE 146
L I+SG + I+ + L A+ ++H+ G HRDIK N+L+ ++
Sbjct: 122 ----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177
Query: 147 NGDVKVADFGVSAQLTRTISRRKTFVG---TPFWMAPEVIQNSEGYNEKADIWSLGITVI 203
+ +K+ DFG + + + V + F+ APE++ + Y D+WS+G
Sbjct: 178 DNTLKLCDFG----SAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 204 EMAKGEP--------------------P----LADLHPMRVLFIIPRENPPQLDEHFSRL 239
E+ G+P P + ++P P +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEG 293
Query: 240 MK----EFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTP 295
+ + L+ P R + E + H F + R S ++ +P + P
Sbjct: 294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYE--SEVKNNSNFPHGVNQNIP 351
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 69/288 (23%), Positives = 110/288 (38%), Gaps = 50/288 (17%)
Query: 18 LELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ-CRSP 71
+++G G+FG V A ++K VA+K++ + E E + E+ +++Q
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVAD-LIQSGPPLDEMSIACI-------------- 116
I G+ +++I EY G + + L E I
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 117 -LRDLLH-------AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168
DLL +E+L + +HRD+ A N+L+T VK+ DFG L R I
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG----LARDIMSD 225
Query: 169 KTFVGT-----PF-WMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMR-V 220
+V P WMAPE + Y K+D+WS GI + E+ G P +
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284
Query: 221 LFIIPR----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+I + P E +M+ C +RPS L
Sbjct: 285 YKLIQNGFKMDQPFYATEEIYIIMQS----CWAFDSRKRPSFPNLTSF 328
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 70/339 (20%), Positives = 126/339 (37%), Gaps = 90/339 (26%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
+R+ ++ +G G+FG V + D + + VA+K++ + + E + EI VL +
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRYCEAARSEIQVLEHLNT 70
Query: 71 P------YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDL 120
+ + H + I+ E + G S D I+ LD I + +
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLD--HIRKMAYQI 127
Query: 121 LHAIEYLHNEGKIHRDIKAANILLTENG-------------------DVKVADFGVSAQL 161
++ +LH+ H D+K NIL ++ D+KV DFG +
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP---- 217
S T V T + APEVI G+++ D+WS+G +IE G + P
Sbjct: 188 DEHHS---TLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFT----VFPTHDS 239
Query: 218 -------MRVLFIIPRE----------------NPPQL--------------------DE 234
R+L +P+ + + +
Sbjct: 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQD 299
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273
+ + + L+ PA+R + +E L+H F +KS
Sbjct: 300 VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 58/307 (18%), Positives = 121/307 (39%), Gaps = 59/307 (19%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CRSP 71
+ + +GRG + +V++A + N+ V +K++ + + +I+ +EI +L P
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-KKKIK---REIKILENLRGGP 91
Query: 72 YITEYY---GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
I + +T + D Q L + I + ++L A++Y H
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNN----TDFKQLYQTLTDYDIRFYMYEILKALDYCH 147
Query: 129 NEGKIHRDIKAANILL-TENGDVKVADFGVSAQLTRTISRRKTF---VGTPFWMAPEVIQ 184
+ G +HRD+K N+++ E+ +++ D+G L + + V + ++ PE++
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWG----LAEFYHPGQEYNVRVASRYFKGPELLV 203
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPL---AD-----LHPMRVL--------------- 221
+ + Y+ D+WSLG + M + P D + +VL
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263
Query: 222 ------FIIPRENPPQLDEHFSRLMKEFVS-----LCLKKV----PAERPSAKELLRHRF 266
I+ R + + + + VS L K+ R +A+E + H +
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF-LDKLLRYDHQSRLTAREAMEHPY 322
Query: 267 IRNARKS 273
K
Sbjct: 323 FYTVVKD 329
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 75/346 (21%), Positives = 127/346 (36%), Gaps = 72/346 (20%)
Query: 21 IGRGSFGDVYKAFDKEL--NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+GRG++G VYKA K+ +KD A+K I E +EI++L + + P +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI---EGTGISMSACREIALLRELKHPNVISLQK 85
Query: 79 SYLHQT--KLWIIMEY--------MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
+L K+W++ +Y + + + L + +L +L I YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 129 NEGKIHRDIKAANILLT----ENGDVKVADFGVS---AQLTRTISRRKTFVGTPFWM-AP 180
+HRD+K ANIL+ E G VK+AD G + + ++ V T FW AP
Sbjct: 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT-FWYRAP 204
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEP-----------------------------P 211
E++ + Y + DIW++G E+ EP P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 212 -------LADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL------CLKKV----PAE 254
+ + L R N + K V L+K+ P +
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324
Query: 255 RPSAKELLRHRFIRNA--RKSPRLLERIRERPKYPIQEEPDTPING 298
R ++++ ++ + S PK E + G
Sbjct: 325 RITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKG 370
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 67/339 (19%), Positives = 123/339 (36%), Gaps = 96/339 (28%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS- 70
+ F + +G G+FG V + K A+KV+ + + E +L + ++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQND 91
Query: 71 ----PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLH 122
I +Y+G +++ + +I E + G S+ ++I G ++ I ++L
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE--DIKLYCIEILK 148
Query: 123 AIEYLHNEGKIHRDIKAANILLTENG-------------------------DVKVADFGV 157
A+ YL H D+K NILL + +K+ DFG
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP 217
+ + + + T + APEVI N G++ +D+WS G + E+ G L
Sbjct: 209 ATFKSDYHG---SIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSL----LFR 260
Query: 218 -----------MRVLFIIPRE----------------NPPQLDEHFS------------- 237
++ IP+ + +L +
Sbjct: 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320
Query: 238 ---------RLMKEFVSLCLKKVPAERPSAKELLRHRFI 267
L +F+ L+ P RPS ELL+H+F+
Sbjct: 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 84/346 (24%), Positives = 140/346 (40%), Gaps = 72/346 (20%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIK-VIDLEESEDEIEDIQKEISVLSQCRS 70
R+ +L+ IG G+ G V A+D L+++VAIK + +++ + +E+ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 71 PYITEYY------GSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLL 121
I + ++++ME M A+L IQ LD ++ +L +L
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQM--ELDHERMSYLLYQML 174
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT---FVGTPFWM 178
I++LH+ G IHRD+K +NI++ + +K+ DFG L RT +V T ++
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG----LARTAGTSFMMTPYVVTRYYR 230
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGE---------------------PPLADLH- 216
APEVI GY E DIWS+G + EM + + P +
Sbjct: 231 APEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 217 ------------------PMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV----PAE 254
LF P P EH + L L K+ PA+
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLF--PDSLFPADSEHNKLKASQARDL-LSKMLVIDPAK 346
Query: 255 RPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVR 300
R S + L+H +I N P +E + +E + I +
Sbjct: 347 RISVDDALQHPYI-NVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 391
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 64/349 (18%), Positives = 110/349 (31%), Gaps = 86/349 (24%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFD-KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
R+ + +G G+FG V + D VA+K+I E + EI+VL + +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARLEINVLKKIKE 75
Query: 71 P------YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLH 122
+ + I E + G + + ++ P + + L H
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 123 AIEYLHNEGKIHRDIKAANILLTENG-------------------DVKVADFGVSAQLTR 163
A+ +LH H D+K NIL + ++VADFG +
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE 194
Query: 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP------ 217
+ T V T + PEVI G+ + D+WS+G + E +G L
Sbjct: 195 HHT---TIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFT----LFQTHENRE 246
Query: 218 -----MRVLFIIPR---ENPPQLDEHFS-------------------------------- 237
++L IP + +
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306
Query: 238 -RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPK 285
+ + + L+ PA+R + E L H F R R +
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 76/381 (19%), Positives = 136/381 (35%), Gaps = 116/381 (30%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID--LEESED------EI-------- 55
++ ++ +G+G++G V+K+ D+ + VA+K I + S D EI
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 56 -EDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL---IQSGPPLDEM 111
E+I +++L+ R+ + Y ++ +YM DL I++ L+ +
Sbjct: 68 HENI---VNLLNVLRADNDRDVY----------LVFDYME----TDLHAVIRA-NILEPV 109
Query: 112 SIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171
++ L+ I+YLH+ G +HRD+K +NILL VKVADFG L+R+ +
Sbjct: 110 HKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFG----LSRSFVNIRRV 165
Query: 172 VGTPFWM-------------------------APEVIQNSEGYNEKADIWSLGITVIEMA 206
APE++ S Y + D+WSLG + E+
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 207 K---------------------GEPPLADLHP---------MRVLFIIPRENPPQLDEHF 236
P D+ + L + F
Sbjct: 226 CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIF 285
Query: 237 SRLMKEFVSL----------------CLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280
++ + + L+ P +R SA + L+H F+ E
Sbjct: 286 TKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNE--EPN 343
Query: 281 RERP-KYPIQEEPDTPINGVR 300
+ PI + I+ R
Sbjct: 344 CDHIITIPINDNVKHSIDDYR 364
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 78/292 (26%), Positives = 123/292 (42%), Gaps = 55/292 (18%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
E A + F LIG G FG VYK ++ VA+K ES IE+ + EI LS C
Sbjct: 35 EEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRT-PESSQGIEEFETEIETLSFC 92
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVAD----LIQSGPPLD---EMSIACILRDLL 121
R P++ G + ++ +I +YM G++ + + I +
Sbjct: 93 RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC------I 146
Query: 122 HA---IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS---AQLTRT-ISRRKTFV-G 173
A + YLH IHRD+K+ NILL EN K+ DFG+S +L +T +S T V G
Sbjct: 147 GAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS---TVVKG 203
Query: 174 TPFWMAPEVIQNSEGY------NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE 227
T ++ PE Y EK+D++S G+ + E+ + P ++ +
Sbjct: 204 TLGYIDPE-------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 228 NP------------PQLDEHFS-RLMKEFVSL---CLKKVPAERPSAKELLR 263
P L + +++F CL +RPS ++L
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 74/308 (24%), Positives = 126/308 (40%), Gaps = 46/308 (14%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIED-IQKEISVLSQCRS 70
R+ LIG+GSFG V KA+D+ + VAIK+I +++ + Q E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVRLLELMNK 109
Query: 71 P------YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ--SGPPLDEMSIACILRDLLH 122
YI ++ + L ++ E + ++ DL++ + + + +
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 123 AIEYLHNE--GKIHRDIKAANILLTENG--DVKVADFGVSAQLTRTISRRKTFVGTPFWM 178
A+ +L IH D+K NILL +K+ DFG S QL + I ++ + F+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY---QYIQSRFYR 225
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-----------MRVLFIIPR- 226
+PEV+ Y+ D+WSLG ++EM GEP L + VL I P
Sbjct: 226 SPEVLLGM-PYDLAIDMWSLGCILVEMHTGEP----LFSGANEVDQMNKIVEVLGIPPAH 280
Query: 227 --ENPPQLDEHFSRLMKEFVSLCL-------KKVPAERPSAKELLRHRFIRNARKSPRLL 277
+ P+ + F +L +L K P R L R++
Sbjct: 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESG 340
Query: 278 ERIRERPK 285
+ + K
Sbjct: 341 HTVADYLK 348
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 52/293 (17%)
Query: 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC 68
+ A FS+ ++GRG FG VYK + VA+K + E ++ Q E+ ++S
Sbjct: 26 QVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQTEVEMISMA 84
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVA----DLIQSGPPLD---EMSIAC-ILRDL 120
+ G + T+ ++ YMA GSVA + +S PPLD IA R L
Sbjct: 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGL 144
Query: 121 LHAIEYLHNEGK---IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV----- 172
YLH+ IHRD+KAANILL E + V DFG L + + + T V
Sbjct: 145 ----AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVR 196
Query: 173 GTPFWMAPEVIQNSEGY-NEKADIWSLGITVIEMAKGEPPLADLHPM-----------RV 220
GT +APE + G +EK D++ G+ ++E+ G+ +
Sbjct: 197 GTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 221 LFIIPRENP------PQLDEHFSRL-MKEFV---SLCLKKVPAERPSAKELLR 263
L +E L ++ +++ + LC + P ERP E++R
Sbjct: 255 LL---KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 76/284 (26%), Positives = 118/284 (41%), Gaps = 60/284 (21%)
Query: 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQ------KEISVLSQCRSPYI 73
+G G FG VYK + N VA+K + + +I + +EI V+++C+ +
Sbjct: 38 KMGEGGFGVVYKGYVN--NTTVAVKKLA---AMVDITTEELKQQFDQEIKVMAKCQHENL 92
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLI---QSGPPLD---EMSIAC-ILRDLLHAIEY 126
E G L ++ YM GS+ D + PPL IA + +
Sbjct: 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGI----NF 148
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT--------ISRRKTFVGTPFWM 178
LH IHRDIK+ANILL E K++DFG L R ++ R VGT +M
Sbjct: 149 LHENHHIHRDIKSANILLDEAFTAKISDFG----LARASEKFAQTVMTSR--IVGTTAYM 202
Query: 179 APEVIQNSEGY-NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDE--H 235
APE + G K+DI+S G+ ++E+ G P + + ++L I DE
Sbjct: 203 APEAL---RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE---EIEDEEKT 256
Query: 236 FSRLM---------KEFV------SLCLKKVPAERPSAKELLRH 264
+ S CL + +RP K++ +
Sbjct: 257 IEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 74/370 (20%), Positives = 126/370 (34%), Gaps = 122/370 (32%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-- 70
R+ + +G G F V+ ++D + K VA+KV+ E E EI +L R+
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIRLLKSVRNSD 94
Query: 71 ------PYITEYYGSYLHQ----TKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILR 118
+ + + T + ++ E + G + I L + I++
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 119 DLLHAIEYLHNEGK-IHRDIKAANILLT-------------------------------- 145
+L ++YLH + + IH DIK NILL+
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 146 -----------------ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
E VK+AD G + + T + + EV+ S G
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNA---CWVHKHFTEDIQTRQYRSLEVLIGS-G 269
Query: 189 YNEKADIWSLGITVIEMAKGEPP---------------LADLHPMRVLFIIPRE------ 227
YN ADIWS E+A G+ +A + + +L +PR+
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI--IELLGKVPRKLIVAGK 327
Query: 228 ------------------NPPQLDE------HFS----RLMKEFVSLCLKKVPAERPSAK 259
P L E +S +F+ L+ +P +R +A
Sbjct: 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387
Query: 260 ELLRHRFIRN 269
E LRH ++ +
Sbjct: 388 ECLRHPWLNS 397
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 32/228 (14%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----DEI--------EDI 58
G+++ + IG G FG +Y AF + A V+ +E E E+ +D
Sbjct: 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDC 95
Query: 59 QKEISVLSQCRSPYITEYYGSYLHQTKL----WIIMEYMAGGSVADLIQSGPPLDEMSIA 114
K+ Q I +YGS L + K +++ME + G + + + ++
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVL 154
Query: 115 CILRDLLHAIEYLHNEGKIHRDIKAANILL-TENGD-VKVADFGVSAQLTRTISR----- 167
+ +L +EY+H +H DIKAAN+LL +N D V +AD+G+S + +
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 168 --RKTFVGTPFWMAPEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
RK GT + + + +G ++D+ LG ++ G+ P
Sbjct: 215 NPRKGHNGTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CRS 70
G + IG GSFG +++ + N+ VAIK E + ++ E
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGC 65
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYL 127
I Y ++++ + G S+ DL+ + S+ + +L ++ +
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSI 122
Query: 128 HNEGKIHRDIKAANILL----TENGD-VKVADFGVSAQLTRTISR-------RKTFVGTP 175
H + ++RDIK N L+ ++N + + V DFG+ +++ +K GT
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 176 FWMAPEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
+M+ I G + + D+ +LG + +G P
Sbjct: 183 RYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 25/216 (11%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-S 70
G+R+ IG GSFGD+Y D ++VAIK+ E + + + E + +
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGG 64
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYL 127
I ++ME + G S+ DL + S+ +L ++ IEY+
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYI 121
Query: 128 HNEGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTISR-------RKTFVGTPFW 177
H++ IHRD+K N L+ V + DFG++ + + K GT +
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 178 MAPEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
+ I G + + D+ SLG ++ G P
Sbjct: 182 AS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 94.6 bits (234), Expect = 3e-21
Identities = 47/329 (14%), Positives = 91/329 (27%), Gaps = 84/329 (25%)
Query: 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-------ESEDEIEDIQKEIS 63
+ E IG G FG+V++ + VAIK+I +E + E+I EI
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 64 VL---------SQCRSPYITEYYGSYLHQ------------------------------T 84
+ R+ + Q
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI-HRDIKAANIL 143
+L+I++E+ GG + +++ + IL L ++ + HRD+ N+L
Sbjct: 136 QLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 144 LTENGDVKVAD-----------FGVSAQLTRTISRRKTFVGTPFWM----APEVIQNSEG 188
L + K+ G+ + R G + ++
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGD 254
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPM----------RVLFIIPRENPPQLDEHFSR 238
Y DI+ L + HP + +
Sbjct: 255 YQ--FDIYRLMKKENNNR-----WGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQ 307
Query: 239 LMKEFVSLCLKKVPAERPSAKELLRHRFI 267
+ ++ + SA +LL +
Sbjct: 308 IKRKIQE--FHRTMLNFSSATDLLCQHSL 334
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 7e-21
Identities = 41/237 (17%), Positives = 88/237 (37%), Gaps = 37/237 (15%)
Query: 7 LQEAAGSRFSSLELIGRGSFGDVYKAFD--------KELNKDVAIKV----------IDL 48
L + +G ++ R + G +Y+A + ++K+ +
Sbjct: 36 LTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNF 95
Query: 49 EESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL-WIIMEYMAGGSVADLIQ--SG 105
+ + + K L I G +HQ K ++++ + G S+ +
Sbjct: 96 FQRAAKPLQVNKWKK-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK 153
Query: 106 PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKV--ADFGVSAQLTR 163
L E S+ + LL A+E+LH +H ++ A NI + +V A +G + +
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 164 TIS-------RRKTFVGTPFWMAPEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
+ R G +++ + +G ++D+ SLG +++ G P
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 48/218 (22%), Positives = 88/218 (40%), Gaps = 27/218 (12%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CRS 70
G F + IG G+FG++ + N+ VAIK LE + + E Q
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILR---DLLHAIEYL 127
I + Y +++E + G S+ DL S+ +L L+ +EY+
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYV 121
Query: 128 HNEGKIHRDIKAANILL-----TENGDVKVADFGVSAQLTRTISR-------RKTFVGTP 175
H++ I+RD+K N L+ + + DF ++ + ++ K+ GT
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 176 FWMAPEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
+M+ I G + + D+ +LG + +G P
Sbjct: 182 RYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 71/329 (21%), Positives = 115/329 (34%), Gaps = 94/329 (28%)
Query: 21 IGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVL---------- 65
+GRG+FG V +A ++K VA+K++ + E + E+ +L
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 66 ------SQCRSPY--ITEY--YG---SYLHQTKLWIIMEYMAGGSVA-----------DL 101
++ P I E+ +G +YL + + G DL
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 102 IQSGPPLDEMSIACI---------------------------LRDLLH-------AIEYL 127
+ + + L L+ +E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-----RRKTFVGTPF-WMAPE 181
+ IHRD+ A NILL+E VK+ DFG L R I RK P WMAPE
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFG----LARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 182 VIQNSEGYNEKADIWSLGITVIE-MAKGEPPLADLHPMRVLFIIPR-----ENPPQLDEH 235
I + Y ++D+WS G+ + E + G P + + P
Sbjct: 266 TIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE 324
Query: 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ M + C P++RP+ EL+ H
Sbjct: 325 MYQTMLD----CWHGEPSQRPTFSELVEH 349
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 3e-19
Identities = 47/214 (21%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-S 70
G++F IG GSFG++Y + + N++VAIK+ E + + + E + +
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGG 62
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN 129
I + ++M+ + G S+ DL L ++ + +++ +E++H+
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 130 EGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTISRR-------KTFVGTPFWMA 179
+ +HRDIK N L+ V + DFG++ + T + + K GT + +
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 180 PEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
+ G + + D+ SLG ++ +G P
Sbjct: 182 ---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 46/236 (19%), Positives = 93/236 (39%), Gaps = 35/236 (14%)
Query: 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIE----- 56
+ + A + + IG+G FG +Y A + +KV + E
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQ 88
Query: 57 -----DIQKEISVLSQCRSPYITEYYGSYLHQTKL----WIIMEYMAGGSVADLIQS-GP 106
+ ++ + + + +Y+GS LH ++IM+ G + + ++
Sbjct: 89 RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK 147
Query: 107 PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL-TENGD-VKVADFGVSAQLTRT 164
++ + +L +EY+H +H DIKA+N+LL +N D V + D+G++ +
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 165 ISR-------RKTFVGTPFWMAPEVIQNSEGYNE--KADIWSLGITVIEMAKGEPP 211
++ GT + + I G + D+ LG +I+ G P
Sbjct: 208 GVHKAYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 2e-08
Identities = 75/524 (14%), Positives = 143/524 (27%), Gaps = 201/524 (38%)
Query: 25 SFGDVYKAFDKELNKDVAIK-VIDLEE---SEDEIEDI--------------------QK 60
+ D+ F+ + K V D+ + S++EI+ I Q+
Sbjct: 17 QYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQE 76
Query: 61 EI------SVL------------SQCRSP-YITEYYGSY---LH---------------- 82
E+ VL ++ R P +T Y L+
Sbjct: 77 EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP 136
Query: 83 ----QTKL-------WIIMEYMAG-G-SV--ADLIQSGPPLDEM---------------- 111
+ L ++++ + G G + D+ S +M
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196
Query: 112 SIACILRDLLHAIEYLHNEGKIHR--------DIKAA-NILLTENG---------DV--- 150
++ +L+ LL+ I+ H I+A LL +V
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNA 256
Query: 151 KVAD-FGVSAQL---TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGI--TVIE 204
K + F +S ++ TR F+ + +S + ++
Sbjct: 257 KAWNAFNLSCKILLTTRFKQV-TDFLSAATTTHISLDHHSMTLTPDE---VKSLLLKYLD 312
Query: 205 MAKGE-PPLA-DLHPMRVLFIIP---RENPPQLDEHFSRL----MKEFVSLCLKKV-PAE 254
+ P +P L II R+ D ++ + + + L + PAE
Sbjct: 313 CRPQDLPREVLTTNPR-RLSIIAESIRDGLATWD-NWKHVNCDKLTTIIESSLNVLEPAE 370
Query: 255 RPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASGTVKVVRD 314
R F R + + +P P I + + ++
Sbjct: 371 -------YRKMFDRLS---------V-----FP----PSAHI--------PTILLSLIWF 397
Query: 315 KRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREKKPEFS----YNQYT 370
+ V V V N +SL E K+ S Y +
Sbjct: 398 DVIKSDVMV------VVNKLHKYSLVEKQP---------------KESTISIPSIYLELK 436
Query: 371 PKRTAERSNHGFSASGSTLHESPDASPTRYARDSYFDDRQDDYY 414
K E + H ++ + P + D D Y+
Sbjct: 437 VKLENEYALH------RSIVDH-YNIPKTFDSDDLIPPYLDQYF 473
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 9e-05
Identities = 61/433 (14%), Positives = 127/433 (29%), Gaps = 106/433 (24%)
Query: 259 KELLRH---RFIRN--ARKSPRLLERIRERPKYP-IQEEPDTPINGVRAVGEASGTVKVV 312
K++L F+ N + + + I + + I D ++G + +
Sbjct: 19 KDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKD-AVSGTLRL------FWTL 71
Query: 313 RDKRSEETVQVSSQGQTVRNAGWNFSLSESHGTGTIRTAVKPPQVREKKPEFSYNQYTPK 372
K+ EE VQ + N + L I+T +++P Y +
Sbjct: 72 LSKQ-EEMVQKFVEEVLRINYKF---LMSP-----IKT-------EQRQPSMMTRMYIEQ 115
Query: 373 RTAERSNHGFSASGSTLHESPDASPTRY-ARDSYFDDRQDDYYEDDDTSASASGTVVIRS 431
R L+ +R + + E + V+I
Sbjct: 116 R-------------DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRP-----AKNVLIDG 157
Query: 432 PRGSRSSGLFRDRSAVSSSTYTSAEDASTSGTVVY---RGQHDDSDSARTPRSRLGIQER 488
GS G ++ V+ S + ++ + ++ +L Q
Sbjct: 158 VLGS---G----KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID 210
Query: 489 SSSASLEDSAVNLAEAKAAIQSGLRKGNARERLALGKMNNDGEYRR---------REQIT 539
+ S D + N+ +IQ+ LR RL K Y +
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELR------RLLKSKP-----YENCLLVLLNVQNAKAW 259
Query: 540 SSSD-------SSRDSR--DYLDAQRGFSRP----RQGSDEEESAKIASSSGALSVLLIP 586
++ + ++R + D+L A +E + +P
Sbjct: 260 NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP 319
Query: 587 SIKEAVADDSEGPVVRQVVSSLAYMERIKPGSCEVFVRRLLQQLASSKESSVKELQELSS 646
+E + + P + +S +A R + + + +L + ESS+ L+
Sbjct: 320 --REVL---TTNP---RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY 371
Query: 647 R-------IFTKG 652
R +F
Sbjct: 372 RKMFDRLSVFPPS 384
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 703 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.18 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.06 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.01 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.61 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.6 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.3 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.03 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.83 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.64 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.4 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.39 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.37 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.3 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.27 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.17 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.99 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.71 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.51 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.34 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.83 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.25 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-61 Score=519.13 Aligned_cols=257 Identities=30% Similarity=0.553 Sum_probs=230.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|++|+|||||+++++|.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999997654 44557889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
||+||+|.++|... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+........
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 183 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHH
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccccc
Confidence 99999999999643 4679999999999999999999999999999999999999999999999999987765444445
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
+.+||+.|||||++.+. .|+.++||||||||||||++|++||...+....+..|.....+.++..++..+++||.+||.
T Consensus 184 ~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~ 262 (350)
T 4b9d_A 184 ACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFK 262 (350)
T ss_dssp HHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcc
Confidence 67999999999999875 59999999999999999999999999988888888887777777888899999999999999
Q ss_pred cCCCCCCCHHHHHhchhhhcc
Q 005298 250 KVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 250 ~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+||.+|||++|+|+||||++.
T Consensus 263 ~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 263 RNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp SSGGGSCCHHHHHTSHHHHTT
T ss_pred CChhHCcCHHHHhcCHHhhcC
Confidence 999999999999999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-60 Score=514.43 Aligned_cols=257 Identities=39% Similarity=0.692 Sum_probs=232.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
..|++++.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+.+|++|+|||||+++++|.+++.+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4799999999999999999999999999999999765432 245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
|+||+|.+++.+ +++++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+........+.+
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~ 231 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 231 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccc
Confidence 999999999986 5799999999999999999999999999999999999999999999999999987766555667789
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--cchhhhHHHHHHHHHHhcc
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~--l~~~is~~L~dLI~~cL~~ 250 (703)
||+.|||||++.+. .|+.++||||||||||||++|.+||.+.+..+.+..|....++. ....+++.+++||.+||.+
T Consensus 232 GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~ 310 (346)
T 4fih_A 232 GTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 310 (346)
T ss_dssp SCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCS
T ss_pred cCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCC
Confidence 99999999999765 59999999999999999999999999988877777665544333 3467899999999999999
Q ss_pred CCCCCCCHHHHHhchhhhcccc
Q 005298 251 VPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
||.+|||++|+|+||||++...
T Consensus 311 dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 311 DPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp STTTSCCHHHHTTCGGGGGCCC
T ss_pred ChhHCcCHHHHhcCHhhcCCCC
Confidence 9999999999999999987643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=508.34 Aligned_cols=258 Identities=26% Similarity=0.479 Sum_probs=232.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|+++++||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|++|+|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999997543 1233578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc--cccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT--ISRR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~--~~~~ 168 (703)
|||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+... ....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~ 191 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence 99999999999998899999999999999999999999999999999999999999999999999999876432 2334
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
.++|||+.|||||++.+. .|+.++||||||||||+|++|.+||...+....+..|....+ .++..+++.+++||.+||
T Consensus 192 ~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~dli~~lL 269 (311)
T 4aw0_A 192 NSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-DFPEKFFPKARDLVEKLL 269 (311)
T ss_dssp CCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCTTCCHHHHHHHHHHS
T ss_pred cCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCcccCHHHHHHHHHHc
Confidence 578999999999999875 599999999999999999999999998887777777765443 566789999999999999
Q ss_pred ccCCCCCCCHHH------HHhchhhhcccc
Q 005298 249 KKVPAERPSAKE------LLRHRFIRNARK 272 (703)
Q Consensus 249 ~~dP~~RPTa~e------LL~Hpff~~~~~ 272 (703)
.+||.+|||++| |++||||+...+
T Consensus 270 ~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 270 VLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp CSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred cCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 999999999887 689999988754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=492.31 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=214.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
++|++++.||+|+||+||+|+++.+|+.||||++++... ......+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 589999999999999999999999999999999976542 233567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||| +|+|.+++...+++++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+..... ....+
T Consensus 93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~ 170 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKT 170 (275)
T ss_dssp ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-CccCC
Confidence 999 7899999998899999999999999999999999999999999999999999999999999999765433 33456
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|||||++.+..+++.++||||||||||+|++|++||...+.......+.... ..++..+++.+++||.+||.+
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 249 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV-YTLPKFLSPGAAGLIKRMLIV 249 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHSCS
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHccC
Confidence 8999999999999887656789999999999999999999999877766666665443 356678999999999999999
Q ss_pred CCCCCCCHHHHHhchhhhc
Q 005298 251 VPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpff~~ 269 (703)
||.+|||++|+++||||+.
T Consensus 250 dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 250 NPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp SGGGSCCHHHHHHCHHHHT
T ss_pred ChhHCcCHHHHHcCccccc
Confidence 9999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=517.34 Aligned_cols=257 Identities=39% Similarity=0.691 Sum_probs=232.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
..|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|++|+|||||+|+++|.+++.+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 579999999999999999999999999999999976543 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV 172 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~i 172 (703)
|+||+|.+++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+........+++
T Consensus 230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~ 308 (423)
T 4fie_A 230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 308 (423)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCE
T ss_pred CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccc
Confidence 999999999976 5699999999999999999999999999999999999999999999999999988766655667889
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--cchhhhHHHHHHHHHHhcc
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~--l~~~is~~L~dLI~~cL~~ 250 (703)
||+.|||||++.+. .|+.++||||||||||||++|.+||.+.+....+..|....++. ....+++.+++||.+||.+
T Consensus 309 GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~ 387 (423)
T 4fie_A 309 GTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 387 (423)
T ss_dssp ECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCS
T ss_pred cCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCC
Confidence 99999999999765 59999999999999999999999999988877777766544333 3357899999999999999
Q ss_pred CCCCCCCHHHHHhchhhhcccc
Q 005298 251 VPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
||.+|||+.|||+||||++...
T Consensus 388 dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 388 DPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp STTTSCCHHHHTTCGGGGGCCC
T ss_pred ChhHCcCHHHHhcCHHhcCCCC
Confidence 9999999999999999987543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-59 Score=500.14 Aligned_cols=257 Identities=28% Similarity=0.494 Sum_probs=222.4
Q ss_pred CCceEEEEEeecCceEEEEEEEc---CCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~---~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
.+|++++.||+|+||+||+|++. .+++.||||+++.... ......+.+|+.+|++|+|||||+++++|.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 47999999999999999999884 4688999999865431 1123467889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.........
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 183 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCC
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccc
Confidence 99999999999999998999999999999999999999999999999999999999999999999999998765555556
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
.+.+||+.|||||++.+. .|+.++||||||||||||++|.+||.+.+..+.+..|....+ .++..+++.+++||.+||
T Consensus 184 ~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L 261 (304)
T 3ubd_A 184 YSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-GMPQFLSPEAQSLLRMLF 261 (304)
T ss_dssp CSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCcCCHHHHHHHHHHc
Confidence 678999999999999875 599999999999999999999999999888777777765443 556789999999999999
Q ss_pred ccCCCCCCC-----HHHHHhchhhhccc
Q 005298 249 KKVPAERPS-----AKELLRHRFIRNAR 271 (703)
Q Consensus 249 ~~dP~~RPT-----a~eLL~Hpff~~~~ 271 (703)
.+||.+||| ++||++||||+...
T Consensus 262 ~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 262 KRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp CSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 999999998 58999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-58 Score=485.12 Aligned_cols=255 Identities=29% Similarity=0.498 Sum_probs=221.0
Q ss_pred hCCCc-eEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe----CC
Q 005298 11 AGSRF-SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QT 84 (703)
Q Consensus 11 ~~~~Y-~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~----~~ 84 (703)
..++| ++.+.||+|+||+||+|.+..++..||||++.... .....+.+.+|+.+|++|+|||||+++++|.+ ++
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 34566 77889999999999999999999999999996554 45556789999999999999999999999976 45
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeeeeccceEEecC-CCCeeEeccccchhh
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTE-NGDVKVADFGVSAQL 161 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~g--IVHRDIKPeNILLd~-~g~VKL~DFGlA~~~ 161 (703)
.+|||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++| ||||||||+||||+. +|++||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 68999999999999999999899999999999999999999999998 999999999999985 789999999999754
Q ss_pred hhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccce-eeccCCCC-CCCcchhhhHH
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV-LFIIPREN-PPQLDEHFSRL 239 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~-l~~I~~~~-~~~l~~~is~~ 239 (703)
.. ....+.+|||.|||||++.+ .|+.++||||||||||||+||.+||.+...... ...+.... ++.++..+++.
T Consensus 183 ~~--~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (290)
T 3fpq_A 183 RA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp CT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred CC--CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHH
Confidence 32 33456799999999999864 499999999999999999999999987654433 33344333 33456677889
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
+++||.+||.+||.+|||+.|+|+||||++
T Consensus 259 ~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 999999999999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=490.29 Aligned_cols=245 Identities=31% Similarity=0.437 Sum_probs=217.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
..|++.+.||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|++|+|||||+++++|.+++.+||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 468999999999999999999999999999999976532 24699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC-CeeEeccccchhhhhccc-----
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTIS----- 166 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g-~VKL~DFGlA~~~~~~~~----- 166 (703)
|+||+|.+++++.++|++..++.|+.||+.||.|||++|||||||||+||||+.+| ++||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 99999999999888999999999999999999999999999999999999999987 699999999986643221
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CcchhhhHHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEFV 244 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~--~l~~~is~~L~dLI 244 (703)
....++||+.|||||++.+. .|+.++||||||||||||++|.+||...+...++..|....++ .++..+++.+.+||
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li 290 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHH
T ss_pred cCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHH
Confidence 12346899999999999875 5999999999999999999999999988877777776655443 35678899999999
Q ss_pred HHHhccCCCCCCCHHHHHhc
Q 005298 245 SLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~H 264 (703)
.+||.+||.+|||+.||++|
T Consensus 291 ~~~L~~dP~~R~sa~el~~~ 310 (336)
T 4g3f_A 291 QEGLRKEPVHRASAMELRRK 310 (336)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-56 Score=488.34 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=223.0
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe------C
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH------Q 83 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~------~ 83 (703)
.+.+|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++|+|||||++++++.. .
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 4568999999999999999999999999999999997554 34456778899999999999999999999864 3
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
+.+|||||||+ |+|.+++...+++++..++.|++||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 67999999995 68999999989999999999999999999999999999999999999999999999999999976543
Q ss_pred c----ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC------------
Q 005298 164 T----ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------ 227 (703)
Q Consensus 164 ~----~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~------------ 227 (703)
. .....+++||+.|||||++.+..+|+.++||||||||||||++|.+||.+.+....+..|...
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 2 223456899999999999988777899999999999999999999999887765554443210
Q ss_pred ---------------CCCC---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 228 ---------------NPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 228 ---------------~~~~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+.. +...+++.+++||.+||.+||.+|||+.|+|+||||+...
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0101 1124678999999999999999999999999999998653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=472.34 Aligned_cols=254 Identities=29% Similarity=0.481 Sum_probs=207.6
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC---------
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--------- 84 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~--------- 84 (703)
+|++++.||+|+||+||+|+++.+|+.||||+++........+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 69999999999999999999999999999999987766666788999999999999999999999998654
Q ss_pred ---EEEEEEeccCCCCHHHHHHcCCCC---CHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccc
Q 005298 85 ---KLWIIMEYMAGGSVADLIQSGPPL---DEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 85 ---~lyLV~Eyv~gGsL~~~l~~~~~L---~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
.+|||||||+||+|.+++.....+ ++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccc
Confidence 379999999999999999876554 45678999999999999999999999999999999999999999999999
Q ss_pred hhhhhccc------------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccC
Q 005298 159 AQLTRTIS------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIP 225 (703)
Q Consensus 159 ~~~~~~~~------------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-~~~l~~I~ 225 (703)
+.+..... ...+.+||+.|||||++.+. .|+.++||||||||||||++ ||..... ...+..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~ 241 (299)
T 4g31_A 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVR 241 (299)
T ss_dssp --------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHH
T ss_pred eecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHh
Confidence 87643221 12346899999999999875 59999999999999999996 7764322 22233333
Q ss_pred CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 226 ~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
....++.....++.+.+||.+||.+||.+|||+.|||+||||++..
T Consensus 242 ~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 242 NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 3444444556677889999999999999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=461.76 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=223.9
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~-----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~ 84 (703)
....+|.+.+.||+|+||+||+|.+. .++..||||+++.. .....+.+.+|+.+|++|+|||||+++++|.+++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 34468999999999999999999875 36889999999754 4556678999999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCee
Q 005298 85 KLWIIMEYMAGGSVADLIQSG-------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~-------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VK 151 (703)
.+|||||||++|+|.+++... ..+++..+..|+.||+.||.|||+++||||||||+||||+.++++|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 999999999999999999753 3699999999999999999999999999999999999999999999
Q ss_pred Eeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC
Q 005298 152 VADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (703)
Q Consensus 152 L~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~ 228 (703)
|+|||+|+....... .....+||+.|||||++.+. .|+.++|||||||+||||+| |+.||...+..+....+....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986643322 12335799999999999875 59999999999999999998 999999988888887777777
Q ss_pred CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 229 ~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
.+..+..++..+.+||.+||.+||.+|||+.+|+ +|+++
T Consensus 248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~ 286 (299)
T 4asz_A 248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN 286 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence 7777888999999999999999999999999994 56654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=458.40 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=224.3
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~-----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~ 83 (703)
+..-.++++++.||+|+||+||+|... .+++.||||+++........+.|.+|+.+|++|+|||||+++++|.++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 344468899999999999999999863 467899999997655444567899999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC
Q 005298 84 TKLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~----------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~ 147 (703)
+.+|||||||++|+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+||||+.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 9999999999999999999643 358999999999999999999999999999999999999999
Q ss_pred CCeeEeccccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeecc
Q 005298 148 GDVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII 224 (703)
Q Consensus 148 g~VKL~DFGlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I 224 (703)
+++||+|||+++.+.... ......+||+.|||||++.+. .|+.++||||||||||||+| |..||.+.+..++...+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999998664332 223456899999999999875 59999999999999999998 89999999888888888
Q ss_pred CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 225 ~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.....++.+..++..+.+||.+||..||.+|||+.||+++
T Consensus 261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7777777888999999999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=494.39 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=222.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-----ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-----~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
.+|+++++||+|+||+||+|+++.+|+.||||++++.. ..........++.+++.++|||||+++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 48999999999999999999999999999999996432 2222333445567788889999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||||||+||+|..+|.+.+.|++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+... .
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~--~ 346 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--K 346 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--C
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC--C
Confidence 99999999999999999899999999999999999999999999999999999999999999999999999876432 3
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc---eeeccCCCCCCCcchhhhHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR---VLFIIPRENPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~---~l~~I~~~~~~~l~~~is~~L~dLI 244 (703)
..+.|||+.|||||++.....|+.++||||||||||||++|.+||...+... ....+. ..+..++..+++.+++||
T Consensus 347 ~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~-~~~~~~p~~~S~~a~dLI 425 (689)
T 3v5w_A 347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TMAVELPDSFSPELRSLL 425 (689)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH-HCCCCCCTTSCHHHHHHH
T ss_pred CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc-CCCCCCCccCCHHHHHHH
Confidence 4578999999999999765579999999999999999999999997654322 222222 234456778999999999
Q ss_pred HHHhccCCCCCCC-----HHHHHhchhhhcccc
Q 005298 245 SLCLKKVPAERPS-----AKELLRHRFIRNARK 272 (703)
Q Consensus 245 ~~cL~~dP~~RPT-----a~eLL~Hpff~~~~~ 272 (703)
.+||.+||.+|++ ++||++||||+...+
T Consensus 426 ~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 426 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp HHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred HHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 9999999999998 799999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-54 Score=459.05 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=216.1
Q ss_pred CCCceEEEEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~-----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
..+|.+.+.||+|+||+||+|.+. .+++.||||+++.. .....+.|.+|+.+|++|+|||||+++++|.+.+.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357899999999999999999865 36889999999754 455678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCee
Q 005298 87 WIIMEYMAGGSVADLIQSG---------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~---------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VK 151 (703)
|||||||++|+|.+++... .++++..+..|+.||+.||.|||+++||||||||+||||+.++++|
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEE
Confidence 9999999999999999753 4699999999999999999999999999999999999999999999
Q ss_pred Eeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC
Q 005298 152 VADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN 228 (703)
Q Consensus 152 L~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~ 228 (703)
|+|||+++.+..... .....+||+.|||||++.+. .|+.++||||||||||||+| |+.||...+..+.+..+....
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986543321 22346899999999999875 59999999999999999998 999999988888777777766
Q ss_pred CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 229 ~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.+..+..+++.+.+||.+||.+||.+|||+.||+++
T Consensus 278 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 278 ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 777788899999999999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=462.32 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=209.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEc---CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~---~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~l 86 (703)
...+|++.+.||+|+||+||+|+++ .+++.||||++..... ..++.+|+.+|+.+ +|||||+++++|.+.+++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 4568999999999999999999875 4688999999865433 35678999999998 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC-CCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~-g~VKL~DFGlA~~~~~~~ 165 (703)
|||||||+||+|.++++ .+++..++.|++||+.||.|||++|||||||||+||||+.+ +.+||+|||+|+......
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999999999994 59999999999999999999999999999999999999876 899999999996443211
Q ss_pred ----------------------------cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc
Q 005298 166 ----------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP 217 (703)
Q Consensus 166 ----------------------------~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~ 217 (703)
....+.+||+.|||||++.+...|+.++||||+|||||||++|++||...+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1123468999999999998876799999999999999999999999965432
Q ss_pred -cceeeccC----------------------CC-------------------------------CCCCcchhhhHHHHHH
Q 005298 218 -MRVLFIIP----------------------RE-------------------------------NPPQLDEHFSRLMKEF 243 (703)
Q Consensus 218 -~~~l~~I~----------------------~~-------------------------------~~~~l~~~is~~L~dL 243 (703)
...+..|. .. ........+++++++|
T Consensus 253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL 332 (361)
T 4f9c_A 253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL 332 (361)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence 11111110 00 0001123567899999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
|.+||.+||.+|||++|+|+||||++.
T Consensus 333 l~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 333 LDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=449.50 Aligned_cols=250 Identities=29% Similarity=0.513 Sum_probs=208.4
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
...+|++.+.||+|+||+||+|++.. .||||+++... .....+.+.+|+.+|++|+|||||++++++. ++.+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iV 109 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIV 109 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEE
Confidence 34688999999999999999998653 59999987554 4556788999999999999999999999875 4568999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc--c
Q 005298 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--S 166 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~--~ 166 (703)
||||+||+|.+++.. ..++++..+..|+.||+.||.|||+++||||||||+||||+.++++||+|||+|+...... .
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 999999999999975 4679999999999999999999999999999999999999999999999999997654322 2
Q ss_pred ccccccCCCCCCchhhhccc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-CCC----CCCCcchhhhHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-PRE----NPPQLDEHFSRL 239 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~--~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I-~~~----~~~~l~~~is~~ 239 (703)
.....+||+.|||||++.+. ..|+.++||||||||||||+||+.||.+.+....+..+ ... ..+.++..++..
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 269 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA 269 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence 23457999999999999643 24899999999999999999999999887655433322 222 123455678999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 240 MKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+.+||.+||.++|.+|||+.||+++
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-53 Score=482.87 Aligned_cols=255 Identities=23% Similarity=0.387 Sum_probs=228.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+|+++|.+.+.+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 58999999999999999999999999999999997654 44467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC--CCeeEeccccchhhhhcccccc
Q 005298 93 MAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN--GDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 93 v~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~--g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|+||+|.++|.. .+.|++..++.|+.||+.||.|||++||+||||||+||||+.+ |.+||+|||+++.+... ....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~~~~ 314 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVK 314 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-SEEE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-Ccee
Confidence 999999999964 4689999999999999999999999999999999999999854 89999999999876433 3345
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHHHHHH
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~dLI~~ 246 (703)
+.+||+.|||||++.+. .|+.++||||||||||+|++|.+||.+.+....+..|.... +......++..+++||.+
T Consensus 315 ~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ 393 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 393 (573)
T ss_dssp EECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHT
T ss_pred eeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence 67999999999999875 58999999999999999999999999988877777765543 233345789999999999
Q ss_pred HhccCCCCCCCHHHHHhchhhhcc
Q 005298 247 CLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
||.+||.+|||+.|+|+||||+..
T Consensus 394 ~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 394 LLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp TSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HccCChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=445.91 Aligned_cols=259 Identities=27% Similarity=0.478 Sum_probs=225.0
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyL 88 (703)
-.+|+++++||+|+||+||+|+++.+|+.||||++.... .......+..|+.++..+ +||||++++++|.+.+.+||
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 368999999999999999999999999999999987542 223356788999999988 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|||||+||+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++..........
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 181 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT 181 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999987654444445
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
.+.+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||...+.......|..... .++..++..+.+||.+||
T Consensus 182 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~~~~~~~li~~lL 259 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-VYPTWLHEDATGILKSFM 259 (353)
T ss_dssp ----CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHT
T ss_pred cccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHh
Confidence 568999999999999875 589999999999999999999999998887777666655433 455678899999999999
Q ss_pred ccCCCCCCCH------HHHHhchhhhcccc
Q 005298 249 KKVPAERPSA------KELLRHRFIRNARK 272 (703)
Q Consensus 249 ~~dP~~RPTa------~eLL~Hpff~~~~~ 272 (703)
.++|.+||++ .+|++||||+...+
T Consensus 260 ~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 260 TKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp CSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred hhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 9999999998 99999999988743
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=450.83 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=219.1
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCC-----CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC-CCeeeeEEEEEeC-C
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQ-T 84 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~t-----g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H-PnIV~L~~~~~~~-~ 84 (703)
..+|++.+.||+|+||+||+|.+..+ ++.||||++.........+.+.+|+.+|.++.| ||||+++++|... +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 46899999999999999999997654 468999999877666777889999999999976 8999999998764 5
Q ss_pred EEEEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC
Q 005298 85 KLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG 148 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~----------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g 148 (703)
.+|||||||++|+|.++|+.. ..+++..+..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 789999999999999999752 3589999999999999999999999999999999999999999
Q ss_pred CeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccc-eeecc
Q 005298 149 DVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMR-VLFII 224 (703)
Q Consensus 149 ~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~-~l~~I 224 (703)
++||+|||+|+.+..... .....+||+.|||||++.+. .|+.++||||||||||||+| |..||.+.+... ....+
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i 301 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 301 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999986643322 23456899999999999875 59999999999999999998 999998876444 33344
Q ss_pred CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 225 ~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.....+..+..+++.+.+||.+||..||.+|||+.||++|
T Consensus 302 ~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 302 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4555666778899999999999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=434.72 Aligned_cols=258 Identities=30% Similarity=0.519 Sum_probs=229.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||+||+|.++.+|+.||||++.... .......+.+|+.+|++++||||++++++|.+.+.+||||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 58999999999999999999999999999999986542 1223567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||++............
T Consensus 85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~ 164 (337)
T 1o6l_A 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998765444444557
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||...+.......+.... ..++..++..+++||.+||.+
T Consensus 165 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~ 242 (337)
T 1o6l_A 165 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKK 242 (337)
T ss_dssp CEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCS
T ss_pred cccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence 8999999999999765 58999999999999999999999998877666555554332 345667899999999999999
Q ss_pred CCCCCC-----CHHHHHhchhhhcccc
Q 005298 251 VPAERP-----SAKELLRHRFIRNARK 272 (703)
Q Consensus 251 dP~~RP-----Ta~eLL~Hpff~~~~~ 272 (703)
||.+|| ++.+|++||||....+
T Consensus 243 dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 243 DPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred CHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 999999 8999999999987643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=447.48 Aligned_cols=259 Identities=28% Similarity=0.500 Sum_probs=222.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV 89 (703)
.+|+++++||+|+||+||+|+++.+++.||||++++.. .......+..|+.++.++ +|||||+++++|.+.+.+|||
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 48999999999999999999999999999999997553 223345688899999887 899999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
||||+||+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++...........
T Consensus 132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~ 211 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 211 (396)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999976444444556
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--------ceeeccCCCCCCCcchhhhHHHH
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM--------RVLFIIPRENPPQLDEHFSRLMK 241 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~--------~~l~~I~~~~~~~l~~~is~~L~ 241 (703)
+.+||+.|+|||++.+. .|+.++|||||||+||||++|.+||...... ..+..........++..++..++
T Consensus 212 ~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 290 (396)
T 4dc2_A 212 TFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 290 (396)
T ss_dssp CCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred cccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHH
Confidence 78999999999999875 5899999999999999999999999643211 11111112233456677899999
Q ss_pred HHHHHHhccCCCCCCCH------HHHHhchhhhcccc
Q 005298 242 EFVSLCLKKVPAERPSA------KELLRHRFIRNARK 272 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa------~eLL~Hpff~~~~~ 272 (703)
+||.+||.+||.+||++ .+|++||||+...+
T Consensus 291 ~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 291 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp HHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred HHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 99999999999999985 89999999987643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=429.90 Aligned_cols=257 Identities=26% Similarity=0.471 Sum_probs=229.8
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
-++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++...+.+|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 358999999999999999999999999999999997554 4455678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||+++++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++...... .....
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~ 172 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDA 172 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGGGT
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-Ccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998765433 33456
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|+|||++.+....+.++|||||||+||+|++|.+||...+.......+..... .++..++..+.+||.+||..
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~ 251 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-RIPFYMSTDCENLLKRFLVL 251 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHCCS
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHCCC
Confidence 79999999999998876556899999999999999999999998876666555544332 44567889999999999999
Q ss_pred CCCCCCCHHHHHhchhhhcc
Q 005298 251 VPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpff~~~ 270 (703)
||.+|||+.|+++||||...
T Consensus 252 dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 252 NPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp STTTSCCHHHHTTCTTTTTT
T ss_pred ChhHCcCHHHHhcCHhhcCC
Confidence 99999999999999999764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=436.42 Aligned_cols=260 Identities=28% Similarity=0.516 Sum_probs=229.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~ly 87 (703)
...+|+++++||+|+||.||+|+++.+|+.||||+++.... ......+..|+.++..+ +||||++++++|.+.+.+|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 44699999999999999999999999999999999865421 22346678899999876 9999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||++.........
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998765433344
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....+||+.|+|||++.+. .|+.++|||||||++|+|++|..||...+.......+.... +.++..++..+++||.+|
T Consensus 175 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~l 252 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKL 252 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHH
T ss_pred ccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-CCCCcccCHHHHHHHHHH
Confidence 5578999999999999875 58999999999999999999999999887766666655443 345667899999999999
Q ss_pred hccCCCCCCCHH-HHHhchhhhcccc
Q 005298 248 LKKVPAERPSAK-ELLRHRFIRNARK 272 (703)
Q Consensus 248 L~~dP~~RPTa~-eLL~Hpff~~~~~ 272 (703)
|.++|.+||++. +|++||||+...+
T Consensus 253 L~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 253 FVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred hcCCHhHcCCChHHHHcCccccCCCH
Confidence 999999999998 9999999987643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=417.44 Aligned_cols=260 Identities=43% Similarity=0.774 Sum_probs=228.4
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++++.||+|+||+||+|.+..+++.||||++....... .+.+.+|+.++++++||||++++++|...+.+||||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 4468999999999999999999999999999999987554322 466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|||+|++|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++............
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 999999999999874 6999999999999999999999999999999999999999999999999998776555445556
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC--CCCCcchhhhHHHHHHHHHHh
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--NPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~--~~~~l~~~is~~L~dLI~~cL 248 (703)
.+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+... .....+..++..+.+||.+||
T Consensus 176 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 254 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254 (297)
T ss_dssp CCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHS
T ss_pred ccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHc
Confidence 7899999999999875 5899999999999999999999999887765544433222 223345678999999999999
Q ss_pred ccCCCCCCCHHHHHhchhhhccccC
Q 005298 249 KKVPAERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~~~~ 273 (703)
..||.+|||+.|+++||||+.....
T Consensus 255 ~~dp~~Rps~~ell~h~~~~~~~~~ 279 (297)
T 3fxz_A 255 EMDVEKRGSAKELLQHQFLKIAKPL 279 (297)
T ss_dssp CSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred cCChhHCcCHHHHhhChhhcccCcc
Confidence 9999999999999999999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=428.80 Aligned_cols=258 Identities=28% Similarity=0.493 Sum_probs=224.4
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyL 88 (703)
-.+|++++.||+|+||.||+|+++.+++.||||++.... .......+.+|+.++.++ +|||||+++++|.+.+.+||
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 358999999999999999999999999999999997553 345567788999999988 89999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||++..........
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~ 167 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCB
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999987644333445
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc---------cceeeccCCCCCCCcchhhhHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP---------MRVLFIIPRENPPQLDEHFSRL 239 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~---------~~~l~~I~~~~~~~l~~~is~~ 239 (703)
...+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||..... ......+.. ....++..++..
T Consensus 168 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p~~~s~~ 245 (345)
T 3a8x_A 168 STFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVK 245 (345)
T ss_dssp CCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-CCCCCCTTSCHH
T ss_pred cccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-CCCCCCCCCCHH
Confidence 567999999999999875 589999999999999999999999965321 111122222 233456678999
Q ss_pred HHHHHHHHhccCCCCCCCH------HHHHhchhhhccc
Q 005298 240 MKEFVSLCLKKVPAERPSA------KELLRHRFIRNAR 271 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RPTa------~eLL~Hpff~~~~ 271 (703)
+++||.+||.+||.+||++ .++++||||+...
T Consensus 246 ~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp HHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred HHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 9999999999999999995 8999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=432.87 Aligned_cols=259 Identities=26% Similarity=0.461 Sum_probs=228.6
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~ly 87 (703)
.-.+|+++++||+|+||+||+|.++.+++.||||++.... .....+.+..|+.++..+ +||||++++++|.+.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3469999999999999999999999999999999986542 122356788999999988 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||||||+||+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||++.........
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999998764433344
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....+||+.|+|||++.+. .|+.++|||||||+||||++|.+||...+.......|.... ..++..++..+.+||.+|
T Consensus 178 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~l 255 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGL 255 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHH
T ss_pred cccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHH
Confidence 5568999999999999765 58999999999999999999999999887766666665443 345668899999999999
Q ss_pred hccCCCCCCC-----HHHHHhchhhhccc
Q 005298 248 LKKVPAERPS-----AKELLRHRFIRNAR 271 (703)
Q Consensus 248 L~~dP~~RPT-----a~eLL~Hpff~~~~ 271 (703)
|.++|.+||+ +.+|++||||+...
T Consensus 256 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 256 MTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp TCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred hhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 9999999994 79999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=439.68 Aligned_cols=263 Identities=27% Similarity=0.435 Sum_probs=225.8
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
..+|+++++||+|+||+||+|.++.+++.||||++..... ......+.+|+.++..++||||++++++|.+.+.+|||
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 4689999999999999999999999999999999864321 11123478899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-c
Q 005298 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~ 167 (703)
||||.||+|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++........ .
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 232 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence 999999999999987 57899999999999999999999999999999999999999999999999999876543322 2
Q ss_pred cccccCCCCCCchhhhcc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC----CCCCcchhhhHH
Q 005298 168 RKTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----NPPQLDEHFSRL 239 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~----~~~~l~~~is~~ 239 (703)
....+||+.|+|||++.. ...|+.++|||||||+||||++|.+||...+..+.+..|... ..+.....++..
T Consensus 233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 312 (437)
T 4aw2_A 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSEN 312 (437)
T ss_dssp CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHH
T ss_pred cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHH
Confidence 334689999999999972 345899999999999999999999999988776666555431 222333458999
Q ss_pred HHHHHHHHhccCCCC--CCCHHHHHhchhhhccccCh
Q 005298 240 MKEFVSLCLKKVPAE--RPSAKELLRHRFIRNARKSP 274 (703)
Q Consensus 240 L~dLI~~cL~~dP~~--RPTa~eLL~Hpff~~~~~~~ 274 (703)
+++||.+||+.+|.+ |++++|+++||||+...+..
T Consensus 313 ~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 313 AKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp HHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred HHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 999999999988888 99999999999999876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=406.81 Aligned_cols=258 Identities=25% Similarity=0.401 Sum_probs=216.8
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++.+++.+|||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 58999999999999999999999999999999997654 33445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
|++++.+..+....+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 161 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSC
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCC
Confidence 99765555555557889999999999999999999999999999999999999999999999999997765444445567
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCC-CccceeeccCC------------------------
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPR------------------------ 226 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~-~~~~~l~~I~~------------------------ 226 (703)
+||+.|+|||++.+...++.++|||||||++|+|++|..||... +....+..+..
T Consensus 162 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T 3o0g_A 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred ccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccccc
Confidence 89999999999987666899999999999999999888885433 22221111100
Q ss_pred ----CCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 227 ----ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 227 ----~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.........++..+++||.+||.+||.+|||++|+|+||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 00111223578899999999999999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=425.77 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=228.5
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-----HHHHHHHHHHHHHhCCCCCeeeeEEEEEeC
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-----EIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~-----~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~ 83 (703)
.....+|++.+.||+|+||.||+|.++.+|+.||||++....... ..+.+.+|+.+|++++||||++++++|.+.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 345678999999999999999999999999999999997654221 246789999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC----CeeEeccccch
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG----DVKVADFGVSA 159 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g----~VKL~DFGlA~ 159 (703)
+.+|||||||+||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999999999888999999999999999999999999999999999999998776 79999999987
Q ss_pred hhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC---Ccchhh
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP---QLDEHF 236 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~---~l~~~i 236 (703)
.+... ......+||+.|+|||++.+. .|+.++||||||||+|+|++|.+||...+....+..+...... .....+
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (361)
T 2yab_A 168 EIEDG-VEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245 (361)
T ss_dssp ECCTT-CCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred EcCCC-CccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence 65432 233467899999999999764 5899999999999999999999999988776666665544322 223467
Q ss_pred hHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 237 s~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+..+++||.+||.+||.+|||+.|+|+||||...
T Consensus 246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 8899999999999999999999999999999854
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=420.36 Aligned_cols=254 Identities=28% Similarity=0.506 Sum_probs=226.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||+||+|.+..+|+.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 589999999999999999999999999999999865421 123567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||++..... ...+
T Consensus 86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~~~~ 162 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYT 162 (318)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---CBCC
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---cccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999876432 2345
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+.... ..++..++..+.+||.+||.+
T Consensus 163 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~ 240 (318)
T 1fot_A 163 LCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLLSRLITR 240 (318)
T ss_dssp CCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCS
T ss_pred ccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHHHHHhcc
Confidence 7899999999999765 58999999999999999999999998887766665554433 345567899999999999999
Q ss_pred CCCCCC-----CHHHHHhchhhhccc
Q 005298 251 VPAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 251 dP~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
||.+|| ++++|++||||+...
T Consensus 241 dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 241 DLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred CHHHcCCCcCCCHHHHhcCccccCCC
Confidence 999999 899999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=419.16 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=194.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC----EEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----KLWI 88 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~----~lyL 88 (703)
.+|.+.+.||+|+||+||+|.+ +|+.||||+++.... .......|+.++.+++|||||++++++..++ .+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4689999999999999999987 489999999865432 2223345677778899999999999998754 6899
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc--------CceeeeeccceEEecCCCCeeEeccccchh
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE--------GKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~--------gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
|||||++|+|.++++. .++++..+..|+.|++.||.|||++ +||||||||+||||+.++++||+|||+++.
T Consensus 79 V~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999999986 5699999999999999999999987 999999999999999999999999999876
Q ss_pred hhhccc----ccccccCCCCCCchhhhcccc-----CCccccchhhHHHHHHHHHhCCCCCCCCCccce-----------
Q 005298 161 LTRTIS----RRKTFVGTPFWMAPEVIQNSE-----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRV----------- 220 (703)
Q Consensus 161 ~~~~~~----~~~~~iGTp~Y~APEvl~~~~-----~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~----------- 220 (703)
...... .....+||+.|||||++.+.. .|+.++||||||||||||+||.+||........
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 543221 123468999999999997532 267799999999999999999887754322111
Q ss_pred ----eecc-CCCCCCCcch-----hhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 221 ----LFII-PRENPPQLDE-----HFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 221 ----l~~I-~~~~~~~l~~-----~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
...+ .....+.++. ..+..+.+|+.+||..||.+|||+.||++.
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0111 1122233332 345678999999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=417.99 Aligned_cols=261 Identities=24% Similarity=0.415 Sum_probs=221.9
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
....+|++++.||+|+||+||+|.+..+++.||||++.........+.+.+|+.++++++||||+++++++.+++..|||
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 34579999999999999999999999999999999997665555557789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc--cc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SR 167 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~--~~ 167 (703)
||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... ..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987553221 22
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee--ccCCCCCCCcchhhhHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--IIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~--~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
....+||+.|+|||++.+...++.++|||||||+||+|++|..||.......... .............++..+.+||.
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 243 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence 3457899999999999876655889999999999999999999997655432211 11222222334678899999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhcc
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+||..||.+|||+.|+++||||+..
T Consensus 244 ~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 244 KILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHccCChhhCcCHHHHhhChhhccc
Confidence 9999999999999999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=409.24 Aligned_cols=264 Identities=25% Similarity=0.434 Sum_probs=217.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|++++.||+|+||+||+|.+..+|+.||||++..... ......+.+|+.++++++||||+++++++...+..|+|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 689999999999999999999999999999999865543 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
|+++++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 162 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCC
Confidence 99999999999988899999999999999999999999999999999999999999999999999997665444444567
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---------------------C---
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------------E--- 227 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------------~--- 227 (703)
+||+.|+|||++.+...++.++|||||||++|+|++|.+||...........+.. .
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 4agu_A 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIP 242 (311)
T ss_dssp ---GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCC
T ss_pred cCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCC
Confidence 8999999999998766689999999999999999999999987765433222110 0
Q ss_pred CCCC------cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccChhH
Q 005298 228 NPPQ------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRL 276 (703)
Q Consensus 228 ~~~~------l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l 276 (703)
.+.. ....++..+.+||.+||..||.+|||+.|+|+||||++.+....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 297 (311)
T 4agu_A 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297 (311)
T ss_dssp CCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-----
T ss_pred CccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHHH
Confidence 0000 013567889999999999999999999999999999987654433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=422.93 Aligned_cols=255 Identities=28% Similarity=0.507 Sum_probs=227.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+|+.++||||+++++++.+.+.+||||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999865421 123567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||++||+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||++..... ....
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---~~~~ 197 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWT 197 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---CBCC
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC---Cccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999876533 2345
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...+.......+.... ..++..++..+.+||.+||.+
T Consensus 198 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~lL~~ 275 (350)
T 1rdq_E 198 LCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHHHHHSCS
T ss_pred ccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence 7899999999999875 58999999999999999999999999887766666665443 345667899999999999999
Q ss_pred CCCCCCC-----HHHHHhchhhhcccc
Q 005298 251 VPAERPS-----AKELLRHRFIRNARK 272 (703)
Q Consensus 251 dP~~RPT-----a~eLL~Hpff~~~~~ 272 (703)
||.+||+ +++|++||||....+
T Consensus 276 dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 276 DLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred CHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 9999998 999999999987643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=434.07 Aligned_cols=262 Identities=27% Similarity=0.467 Sum_probs=225.2
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
..+|+++++||+|+||+||+|+++.+++.||||++..... ......+.+|+.+++.++|||||+++++|.+.+.+|||
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV 147 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999864221 11123578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-ccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRR 168 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~~ 168 (703)
||||+||+|.+++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++..+.... ...
T Consensus 148 ~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 226 (410)
T 3v8s_A 148 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226 (410)
T ss_dssp ECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence 999999999999976 569999999999999999999999999999999999999999999999999997654332 233
Q ss_pred ccccCCCCCCchhhhcccc---CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSE---GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKE 242 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~---~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~d 242 (703)
.+.+||+.|+|||++.+.. .|+.++|||||||+||+|++|.+||...+.......|.... ..+....++..+++
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~ 306 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHH
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHH
Confidence 4679999999999997643 27889999999999999999999999887776666654321 12223468899999
Q ss_pred HHHHHhccCCCC--CCCHHHHHhchhhhccccCh
Q 005298 243 FVSLCLKKVPAE--RPSAKELLRHRFIRNARKSP 274 (703)
Q Consensus 243 LI~~cL~~dP~~--RPTa~eLL~Hpff~~~~~~~ 274 (703)
||.+||..+|.+ ||+++||++||||+...+..
T Consensus 307 li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 307 LICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW 340 (410)
T ss_dssp HHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred HHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence 999999999988 99999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=413.04 Aligned_cols=261 Identities=27% Similarity=0.441 Sum_probs=216.5
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
+....+|++++.||+|+||+||+|.+. +|+.||||++..... ......+.+|+.++++++||||+++++++.+++.+|
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 446679999999999999999999996 499999999865532 233567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
|||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 99999975 77777765 45699999999999999999999999999999999999999999999999999987654444
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----CCCC------------
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----ENPP------------ 230 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~----~~~~------------ 230 (703)
.....+||+.|+|||++.+...++.++|||||||++|+|++|.+||........+..+.. ..+.
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 445568999999999998766689999999999999999999999987655443322210 0000
Q ss_pred -------------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 231 -------------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 231 -------------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+...++..+.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 01234678899999999999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=428.85 Aligned_cols=258 Identities=29% Similarity=0.453 Sum_probs=220.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHH-HHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISV-LSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~I-Lk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
.+|+++++||+|+||+||+|+++.+++.||||++..... ......+..|..+ ++.++|||||+++++|.+.+.+|||
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 589999999999999999999999999999999975542 2334566777776 5778999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
||||+||+|.+++.+...+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||++...........
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~ 197 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS 197 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999976544444456
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
..+||+.|+|||++.+. .|+.++|||||||+||||++|.+||...+.......|... +..++..++..+++||.+||.
T Consensus 198 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~lL~ 275 (373)
T 2r5t_A 198 TFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PLQLKPNITNSARHLLEGLLQ 275 (373)
T ss_dssp SBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-CCCCCSSSCHHHHHHHHHHTC
T ss_pred cccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-ccCCCCCCCHHHHHHHHHHcc
Confidence 78999999999999875 5899999999999999999999999988776666555443 234556789999999999999
Q ss_pred cCCCCCCCH----HHHHhchhhhcccc
Q 005298 250 KVPAERPSA----KELLRHRFIRNARK 272 (703)
Q Consensus 250 ~dP~~RPTa----~eLL~Hpff~~~~~ 272 (703)
+||.+||++ .+|+.||||....+
T Consensus 276 ~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 276 KDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp SSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred cCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 999999986 79999999987643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=419.86 Aligned_cols=261 Identities=32% Similarity=0.571 Sum_probs=219.7
Q ss_pred hCCCceEEEEEeec--CceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 11 AGSRFSSLELIGRG--SFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 11 ~~~~Y~il~~LG~G--sfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
.+++|++++.||+| +||.||+|.+..+|+.||||++.... .......+.+|+.++++++|||||+++++|.+++.+|
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35689999999999 99999999999999999999997654 3455678889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 88 IIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
||||||++++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999999999775 679999999999999999999999999999999999999999999999999875442211
Q ss_pred -------cccccccCCCCCCchhhhccc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC--------
Q 005298 166 -------SRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP-------- 229 (703)
Q Consensus 166 -------~~~~~~iGTp~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~-------- 229 (703)
......+||+.|+|||++.+. ..|+.++||||||||||+|++|..||...+.......+.....
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 112234899999999999763 3589999999999999999999999987655443332221111
Q ss_pred -------------------------------------CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 230 -------------------------------------PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 230 -------------------------------------~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
......++..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 113345788899999999999999999999999999998764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=434.73 Aligned_cols=257 Identities=30% Similarity=0.527 Sum_probs=217.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.++++++||||++++++|...+.+||||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 57999999999999999999999999999999986532 3344567789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|||++++|.+++.....+++..++.|+.||+.||.|||+ +|||||||||+||||+.++.+||+|||++...........
T Consensus 228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 307 (446)
T 4ejn_A 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307 (446)
T ss_dssp CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----C
T ss_pred eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccc
Confidence 999999999999888899999999999999999999998 9999999999999999999999999999976544444456
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
..+||+.|+|||++.+. .|+.++||||||||||+|++|..||...+.......+.... ..++..+++.+.+||.+||.
T Consensus 308 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~ 385 (446)
T 4ejn_A 308 TFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLGPEAKSLLSGLLK 385 (446)
T ss_dssp CSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTC
T ss_pred cccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHcc
Confidence 68999999999999775 58999999999999999999999998877666555554333 24556789999999999999
Q ss_pred cCCCCCC-----CHHHHHhchhhhccc
Q 005298 250 KVPAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 250 ~dP~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
+||.+|| ++.|+++||||....
T Consensus 386 ~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 386 KDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp SSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred cCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 9999999 999999999998764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=415.10 Aligned_cols=259 Identities=27% Similarity=0.477 Sum_probs=216.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEc---CCCcEEEEEEeccCC---ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~---~tg~~VAIKvi~~~~---~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~ 84 (703)
...+|++++.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+|++++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 3468999999999999999999985 689999999997543 2233566789999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
.+|||||||+|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998765444
Q ss_pred ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHH
Q 005298 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 165 ~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI 244 (703)
.......+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+.... ..++..++..+.+||
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li 252 (327)
T 3a62_A 175 GTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLPPYLTQEARDLL 252 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHH
T ss_pred CccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHH
Confidence 4444567899999999999765 58999999999999999999999998877666555554332 245567889999999
Q ss_pred HHHhccCCCCCC-----CHHHHHhchhhhccc
Q 005298 245 SLCLKKVPAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 245 ~~cL~~dP~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
.+||.++|.+|| ++.++++||||+...
T Consensus 253 ~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 253 KKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp HHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred HHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 999999999999 899999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=420.64 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=225.9
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
..-++|++.+.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++...+.+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 345789999999999999999999999999999999864321 112357889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
|||||+ +|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~~ 163 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NF 163 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-BT
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-cc
Confidence 999999 7899999988889999999999999999999999999999999999999999999999999998765433 33
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....+||+.|+|||++.+..+++.++|||||||+||+|++|..||...........+... ...++..+++.+.+||.+|
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~ 242 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQSLIRRM 242 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS-CCCCCTTSCHHHHHHHHTT
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC-CCCCcccCCHHHHHHHHHH
Confidence 456789999999999987654578999999999999999999999887666555555433 3345667899999999999
Q ss_pred hccCCCCCCCHHHHHhchhhhcc
Q 005298 248 LKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
|..||.+|||+.|+++||||+..
T Consensus 243 L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 243 IVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp SCSSGGGSCCHHHHTTCHHHHTT
T ss_pred cCCChhHCcCHHHHHhChhhccC
Confidence 99999999999999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=419.32 Aligned_cols=256 Identities=24% Similarity=0.466 Sum_probs=225.6
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
..+|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.++++++|||||+++++|.+.+..||||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 458999999999999999999999999999999997654 3455678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC---CCeeEeccccchhhhhcccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~---g~VKL~DFGlA~~~~~~~~~ 167 (703)
|||.|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++...... ..
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~~ 186 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EA 186 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-CS
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-cc
Confidence 999999999999888899999999999999999999999999999999999999865 45999999998766432 23
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFV 244 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~dLI 244 (703)
....+||+.|+|||++.+. .|+.++||||||||+|+|++|.+||...+.......+.... +......++..+++||
T Consensus 187 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 265 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHH
T ss_pred cccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 3457899999999999765 58999999999999999999999998877665555443332 2233457899999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
.+||.+||.+|||+.++|+||||..
T Consensus 266 ~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 266 DSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=407.25 Aligned_cols=256 Identities=28% Similarity=0.471 Sum_probs=214.2
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-------------------------HHHHHHHHHHHHHH
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-------------------------DEIEDIQKEISVLS 66 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-------------------------~~~~~l~~Ei~ILk 66 (703)
..+|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999999999999999998654311 12356889999999
Q ss_pred hCCCCCeeeeEEEEEe--CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe
Q 005298 67 QCRSPYITEYYGSYLH--QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL 144 (703)
Q Consensus 67 ~L~HPnIV~L~~~~~~--~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL 144 (703)
+++||||+++++++.+ .+.+||||||+++++|.+++. ..++++..++.++.||+.||.|||++||+||||||+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 9999999999999987 678999999999999998764 4679999999999999999999999999999999999999
Q ss_pred cCCCCeeEeccccchhhhhcccccccccCCCCCCchhhhccccC--CccccchhhHHHHHHHHHhCCCCCCCCCccceee
Q 005298 145 TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG--YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF 222 (703)
Q Consensus 145 d~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~--~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~ 222 (703)
+.++.+||+|||++..+..........+||+.|+|||++.+... ++.++|||||||+||+|++|..||..........
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 250 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHH
Confidence 99999999999998766544333445689999999999876432 4778999999999999999999998776544433
Q ss_pred ccCCCC-CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 223 IIPREN-PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 223 ~I~~~~-~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
.+.... ..+....++..+.+||.+||.+||.+|||+.|+++||||.
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 332221 1122346789999999999999999999999999999996
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=415.32 Aligned_cols=261 Identities=27% Similarity=0.439 Sum_probs=212.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
...+|++++.||+|+||+||+|++..+++.||||++..... ......+.+|+.++++++||||+++++++..++.+|||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 34589999999999999999999999999999999976543 23346678999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec-----CCCCeeEeccccchhhhhc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT-----ENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd-----~~g~VKL~DFGlA~~~~~~ 164 (703)
|||++ ++|.+++.....+++..++.|+.||+.||.|||++||+||||||+||||+ ..+.+||+|||++..+...
T Consensus 112 ~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred EecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 99997 59999999988999999999999999999999999999999999999995 4456999999999876544
Q ss_pred ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-----------------
Q 005298 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----------------- 227 (703)
Q Consensus 165 ~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~----------------- 227 (703)
.......+||+.|+|||++.+...++.++|||||||++|+|++|.+||........+..+...
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence 444456789999999999987666899999999999999999999999876654433322100
Q ss_pred ---CCC---------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 228 ---NPP---------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 228 ---~~~---------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
..+ .+...++..+.+||.+||.+||.+|||+.|+|+||||+....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 000 011236788999999999999999999999999999987644
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=403.54 Aligned_cols=256 Identities=28% Similarity=0.497 Sum_probs=211.8
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|++++.||+|+||+||+|.+ .+++.||||++...... .....+.+|+.++++++||||+++++++...+.+|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5899999999999999999998 67999999998655422 224667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 92 yv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|+++ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++............
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence 9975 89998876 367999999999999999999999999999999999999999999999999998776544334445
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------------C-----
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------E----- 227 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~------------------~----- 227 (703)
.+||+.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+.. .
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence 68999999999997766689999999999999999999999987654332222110 0
Q ss_pred --CCC---CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 228 --NPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 228 --~~~---~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+. .+...++..+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 000 1123578899999999999999999999999999999753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=432.67 Aligned_cols=259 Identities=23% Similarity=0.420 Sum_probs=227.4
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
...+|++++.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.++++++|||||+++++|.+++..|||
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 45689999999999999999999999999999999976653 33457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec---CCCCeeEeccccchhhhhccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd---~~g~VKL~DFGlA~~~~~~~~ 166 (703)
||||.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++........
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 99999999999999889999999999999999999999999999999999999998 457899999999977655544
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEF 243 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~dL 243 (703)
.....+||+.|+|||++.+. .|+.++||||||||||+|++|.+||...+.......+.... +......+++.+++|
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 247 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred eeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 44567899999999999765 58999999999999999999999998887766655554332 223335789999999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
|.+||.+||.+|||+.|+|+||||...
T Consensus 248 i~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 248 INKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHcCCChhHCCCHHHHhcCccccCC
Confidence 999999999999999999999999753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=414.04 Aligned_cols=259 Identities=27% Similarity=0.457 Sum_probs=207.0
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||+|+||.||+|.+..+|+.||||++...........+.+|+.++++++||||+++++++..++.+|||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46899999999999999999999999999999999766544445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 92 YMAGGSVADLIQSG------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 92 yv~gGsL~~~l~~~------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
|++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 997 6999988643 359999999999999999999999999999999999999999999999999997765443
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-------------------
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------- 226 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~------------------- 226 (703)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+..
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T 2pmi_A 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242 (317)
T ss_dssp CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTC
T ss_pred ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhc
Confidence 4445568999999999998755689999999999999999999999987665433222110
Q ss_pred ------CCCC--------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 227 ------ENPP--------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 227 ------~~~~--------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
..+. .....++..+.+||.+||.+||.+|||+.|+|+||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 0000 01124678899999999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=412.33 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=224.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 4579999999999999999999999999999999987542 34567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC--CCCeeEeccccchhhhhcccc
Q 005298 91 EYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE--NGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~--~g~VKL~DFGlA~~~~~~~~~ 167 (703)
|||+|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+... ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~ 159 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DN 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-Cc
Confidence 999999999999765 47999999999999999999999999999999999999987 789999999998765432 22
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc---chhhhHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL---DEHFSRLMKEFV 244 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l---~~~is~~L~dLI 244 (703)
....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+.......+........ ...++..+.+||
T Consensus 160 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred cccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence 3456899999999999765 488999999999999999999999988877666555544333222 236789999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+||.+||.+|||+.|+|+||||+..
T Consensus 239 ~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 239 DRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHcCCChhHCcCHHHHhcChhhccC
Confidence 99999999999999999999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=402.90 Aligned_cols=265 Identities=63% Similarity=1.098 Sum_probs=236.6
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
+.......|++++.||+|+||.||+|.+..+++.||||++.........+.+.+|+.++++++||||+++++++.....+
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 16 LKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp CEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 34455678999999999999999999999999999999998766555678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
|+||||+++++|.+++.. .++++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 999999999999999875 6799999999999999999999999999999999999999999999999999876655444
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+....++.+...++..+.+||.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence 44567899999999999765 58899999999999999999999998887766666665556666777889999999999
Q ss_pred HhccCCCCCCCHHHHHhchhhhccccC
Q 005298 247 CLKKVPAERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~Hpff~~~~~~ 273 (703)
||..+|.+|||+.++++||||......
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~~~~~~~~ 280 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKFILRNAKK 280 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred HcCCChhhCcCHHHHhhChhhhcCCCc
Confidence 999999999999999999999766543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=411.71 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=224.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-----HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-----~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
...+|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+|++++||||++++++|...+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 445899999999999999999999999999999998755422 125678999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC----CeeEeccccchhh
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG----DVKVADFGVSAQL 161 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g----~VKL~DFGlA~~~ 161 (703)
+|+|||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999998888999999999999999999999999999999999999999877 7999999998765
Q ss_pred hhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC---CcchhhhH
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP---QLDEHFSR 238 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~---~l~~~is~ 238 (703)
... ......+||+.|+|||++.+. .++.++|||||||+||+|++|..||........+..+...... .....++.
T Consensus 169 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (326)
T 2y0a_A 169 DFG-NEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 246 (326)
T ss_dssp CTT-SCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCC-CccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCH
Confidence 432 233456899999999999764 5899999999999999999999999887665554444332221 22346788
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 239 LMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 239 ~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+.+||.+||.+||.+|||+.++|+||||+...
T Consensus 247 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 247 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 999999999999999999999999999997653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=428.33 Aligned_cols=261 Identities=28% Similarity=0.445 Sum_probs=223.1
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
..+|+++++||+|+||+||+|+++.+|+.||||++.+... ......+.+|+.++.+++||||++++++|.+.+.+|||
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 4689999999999999999999999999999999864321 12234578899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-c
Q 005298 90 MEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-R 167 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~ 167 (703)
||||+||+|.+++.+. ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++..+..... .
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~ 219 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence 9999999999999764 4899999999999999999999999999999999999999999999999999876543322 2
Q ss_pred cccccCCCCCCchhhhcc------ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC----CCCCcchhhh
Q 005298 168 RKTFVGTPFWMAPEVIQN------SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE----NPPQLDEHFS 237 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~------~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~----~~~~l~~~is 237 (703)
....+||+.|+|||++.. ...|+.++|||||||+||||++|.+||...+....+..|... ..+.....++
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 299 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCC
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCC
Confidence 335689999999999973 235889999999999999999999999988776666555431 2233446789
Q ss_pred HHHHHHHHHHhccCCCCC---CCHHHHHhchhhhccccC
Q 005298 238 RLMKEFVSLCLKKVPAER---PSAKELLRHRFIRNARKS 273 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~R---PTa~eLL~Hpff~~~~~~ 273 (703)
..+++||.+||. +|.+| |++++|++||||+...+.
T Consensus 300 ~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 300 EEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp HHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred HHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 999999999999 99998 599999999999987544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=415.44 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=217.8
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC----hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES----EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~----~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
..+|++.+.||+|+||.||+|.++.+|+.||||++..... ....+.+.+|+.++++++||||++++++|.+.+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3589999999999999999999999999999999864321 112467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC---eeEeccccchh
Q 005298 88 IIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD---VKVADFGVSAQ 160 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~---VKL~DFGlA~~ 160 (703)
||||||+|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 99999999999988753 346899999999999999999999999999999999999987654 99999999977
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC---cchhhh
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ---LDEHFS 237 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~---l~~~is 237 (703)
...........+||+.|+|||++.+. .|+.++||||||||||+|++|..||..... .....+....... ....++
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~~~~~~~~~~~~~s 260 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHIS 260 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHTCCCCCHHHHTTSC
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcCCCCCCccccccCC
Confidence 65543334567899999999999775 589999999999999999999999987532 2222332222211 124678
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..+++||.+||.+||.+|||+.++|+||||+..
T Consensus 261 ~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 999999999999999999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=392.54 Aligned_cols=259 Identities=24% Similarity=0.457 Sum_probs=226.6
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
...+|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4679999999999999999999999999999999987654 445567889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC---eeEeccccchhhhhccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTIS 166 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~---VKL~DFGlA~~~~~~~~ 166 (703)
|||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++...... .
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-~ 162 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-E 162 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-C
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-c
Confidence 999999999999988888999999999999999999999999999999999999986655 999999998665433 2
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC---CCCCcchhhhHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---NPPQLDEHFSRLMKEF 243 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~---~~~~l~~~is~~L~dL 243 (703)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+... .+......+++.+.+|
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred cccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHH
Confidence 23456899999999999775 5899999999999999999999999887765555444322 2223335778999999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
|.+||..+|.+|||+.|+|+||||.+..
T Consensus 242 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 242 IDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHcccChhhCCCHHHHhcCccccCCh
Confidence 9999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=423.13 Aligned_cols=260 Identities=26% Similarity=0.496 Sum_probs=224.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
...+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++|||||+++++|.+.+.+|+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3468999999999999999999999999999999986442 12235678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|||||.||+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++..+... ...
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~ 171 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQI 171 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-CCB
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-Cce
Confidence 9999999999999999889999999999999999999999999999999999999999999999999999765432 334
Q ss_pred ccccCCCCCCchhhhccc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccc---eeeccCCCCCCCcchhhhHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMR---VLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~--~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~---~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
...+||+.|+|||++... ..|+.++||||||||||+|++|..||....... ....+. .....++..++..+.+|
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~p~~~s~~~~~l 250 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-TTVVTYPSAWSQEMVSL 250 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-HCCCCCCTTSCHHHHHH
T ss_pred eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-hcccCCCCcCCHHHHHH
Confidence 567999999999999642 348899999999999999999999997543322 111221 22334566789999999
Q ss_pred HHHHhccCCCCCCC-HHHHHhchhhhcccc
Q 005298 244 VSLCLKKVPAERPS-AKELLRHRFIRNARK 272 (703)
Q Consensus 244 I~~cL~~dP~~RPT-a~eLL~Hpff~~~~~ 272 (703)
|.+||.++|.+||+ +++|+.||||....+
T Consensus 251 i~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp HHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred HHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 99999999999998 999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=403.84 Aligned_cols=254 Identities=28% Similarity=0.466 Sum_probs=213.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC--------
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-------- 84 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~-------- 84 (703)
.+|++++.||+|+||.||+|++..+|+.||||++.........+.+.+|+.+|++++|||||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 479999999999999999999999999999999987666666788999999999999999999999986643
Q ss_pred -------------------------------------------------EEEEEEeccCCCCHHHHHHcCCC---CCHHH
Q 005298 85 -------------------------------------------------KLWIIMEYMAGGSVADLIQSGPP---LDEMS 112 (703)
Q Consensus 85 -------------------------------------------------~lyLV~Eyv~gGsL~~~l~~~~~---L~e~~ 112 (703)
.+|+|||||++++|.+++..... .++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 38999999999999999987653 45667
Q ss_pred HHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc------------cccccccCCCCCCch
Q 005298 113 IACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI------------SRRKTFVGTPFWMAP 180 (703)
Q Consensus 113 i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~------------~~~~~~iGTp~Y~AP 180 (703)
++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+||+.|+||
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 245 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence 89999999999999999999999999999999999999999999987654331 122346799999999
Q ss_pred hhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHH
Q 005298 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKE 260 (703)
Q Consensus 181 Evl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~e 260 (703)
|++.+. .++.++|||||||++|+|++|..|+... ......+.....+......++.+.+||.+||.+||.+|||+.|
T Consensus 246 E~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 322 (332)
T 3qd2_B 246 EQIHGN-NYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322 (332)
T ss_dssp HHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHH
T ss_pred HHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHH
Confidence 999875 5899999999999999999998776322 1122222233333444567788999999999999999999999
Q ss_pred HHhchhhhc
Q 005298 261 LLRHRFIRN 269 (703)
Q Consensus 261 LL~Hpff~~ 269 (703)
+|+||||++
T Consensus 323 ~l~~~~f~~ 331 (332)
T 3qd2_B 323 IIENAIFEN 331 (332)
T ss_dssp HHHSTTCCC
T ss_pred Hhhchhhhc
Confidence 999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=455.28 Aligned_cols=259 Identities=26% Similarity=0.457 Sum_probs=231.2
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyL 88 (703)
-.+|+++++||+|+||+||+|.++.+++.||||++.... .....+.+..|+.+|..+ +||||++++++|.+.+.+||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 358999999999999999999999999999999986432 122346778899999988 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||||++||+|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++..........
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 499 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCB
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCccc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999997654444445
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
.+++||+.|+|||++.+. .|+.++||||||||||||++|.+||...+...++..|.... ..++..++..+.+||.+||
T Consensus 500 ~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL 577 (674)
T 3pfq_A 500 KTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLM 577 (674)
T ss_dssp CCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC-CCCCTTSCHHHHHHHHHHS
T ss_pred ccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHc
Confidence 678999999999999765 58999999999999999999999999988777777776544 3556789999999999999
Q ss_pred ccCCCCCCCH-----HHHHhchhhhcccc
Q 005298 249 KKVPAERPSA-----KELLRHRFIRNARK 272 (703)
Q Consensus 249 ~~dP~~RPTa-----~eLL~Hpff~~~~~ 272 (703)
.+||.+||++ ++|++||||+...+
T Consensus 578 ~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 578 TKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp CSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred cCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 9999999997 99999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=402.35 Aligned_cols=256 Identities=39% Similarity=0.706 Sum_probs=224.4
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
.|+..+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.++++++||||+++++++...+..||||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 48899999999999999999999999999999875542 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccC
Q 005298 94 AGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173 (703)
Q Consensus 94 ~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iG 173 (703)
++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............+|
T Consensus 125 ~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 203 (321)
T 2c30_A 125 QGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 203 (321)
T ss_dssp CSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCS
T ss_pred CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccC
Confidence 99999999865 57999999999999999999999999999999999999999999999999998766544444456789
Q ss_pred CCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--cchhhhHHHHHHHHHHhccC
Q 005298 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFVSLCLKKV 251 (703)
Q Consensus 174 Tp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~--l~~~is~~L~dLI~~cL~~d 251 (703)
|+.|+|||++.+. .++.++|||||||+||+|++|..||...........+....++. ....++..+.+||.+||..|
T Consensus 204 t~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 282 (321)
T 2c30_A 204 TPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRD 282 (321)
T ss_dssp CGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSS
T ss_pred CccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCC
Confidence 9999999999765 58999999999999999999999998877655554444333322 33567899999999999999
Q ss_pred CCCCCCHHHHHhchhhhcccc
Q 005298 252 PAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 252 P~~RPTa~eLL~Hpff~~~~~ 272 (703)
|.+|||+.++++||||.....
T Consensus 283 p~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 283 PQERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp TTTSCCHHHHHTSGGGGGCCC
T ss_pred hhhCcCHHHHhcChhhccCCC
Confidence 999999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=412.81 Aligned_cols=256 Identities=31% Similarity=0.394 Sum_probs=207.6
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||+|+||+||+|.+..+++.||||++...... .+.+.+|+.++++++||||+++++++.+.+.+|||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 46999999999999999999999999999999999754322 2567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC--eeEeccccchhhhhcccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD--VKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~--VKL~DFGlA~~~~~~~~~~~ 169 (703)
||++|+|.+++...+++++..++.|+.||+.||.|||++||+||||||+||||+.++. +||+|||++...... ....
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-~~~~ 175 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 175 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-CCCC
Confidence 9999999999988889999999999999999999999999999999999999987765 999999998744322 2234
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee----ccCCC-CCCCcchhhhHHHHHHH
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF----IIPRE-NPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~----~I~~~-~~~~l~~~is~~L~dLI 244 (703)
..+||+.|+|||++.+....+.++|||||||+||+|++|.+||.......... .+... ...+....++..+.+||
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 255 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHH
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHH
Confidence 56899999999999876544555999999999999999999998755432221 11111 11122235789999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+||.++|.+|||+.|+++||||...
T Consensus 256 ~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 256 SRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHccCChhHCcCHHHHHhCcchhcC
Confidence 99999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=425.74 Aligned_cols=261 Identities=27% Similarity=0.419 Sum_probs=201.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----C
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----T 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~-----~ 84 (703)
...+|++++.||+|+||+||+|++..+++.||||++.... .......+.+|+.+|++++|||||+++++|... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3468999999999999999999999999999999986543 344567889999999999999999999999543 5
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
.+||||||+ +++|.+++.....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||++......
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 799999998 5799999998889999999999999999999999999999999999999999999999999999765321
Q ss_pred c---------------------------cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh----------
Q 005298 165 I---------------------------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK---------- 207 (703)
Q Consensus 165 ~---------------------------~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt---------- 207 (703)
. ......+||++|+|||++.....|+.++||||||||||||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 1 123456899999999988666679999999999999999999
Q ss_pred -CCCCCCCCCccc--------------------eeec---------------------------cCCCCCC---Ccchhh
Q 005298 208 -GEPPLADLHPMR--------------------VLFI---------------------------IPRENPP---QLDEHF 236 (703)
Q Consensus 208 -G~~PF~~~~~~~--------------------~l~~---------------------------I~~~~~~---~l~~~i 236 (703)
|.++|.+..... .+.. +...... .....+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 667775543110 0000 0000000 111345
Q ss_pred hHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 237 s~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
+..+.+||.+||.+||.+|||++|+|+||||+....
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 788999999999999999999999999999987643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=418.85 Aligned_cols=262 Identities=26% Similarity=0.445 Sum_probs=210.4
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCC
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQT 84 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~ 84 (703)
+......+|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++++. ||||+++++++...+
T Consensus 3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 34556789999999999999999999999999999999985442 4455677889999999997 999999999998654
Q ss_pred --EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 85 --KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 85 --~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
.+|||||||+ ++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 7999999996 689999976 579999999999999999999999999999999999999999999999999987542
Q ss_pred h---------------------cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee
Q 005298 163 R---------------------TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (703)
Q Consensus 163 ~---------------------~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l 221 (703)
. .......++||++|+|||++.+...|+.++||||||||||+|++|.+||.+.+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 2 1112334689999999999987667999999999999999999999999887665544
Q ss_pred eccCCC--CC-------------------------------CCc-------------chhhhHHHHHHHHHHhccCCCCC
Q 005298 222 FIIPRE--NP-------------------------------PQL-------------DEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 222 ~~I~~~--~~-------------------------------~~l-------------~~~is~~L~dLI~~cL~~dP~~R 255 (703)
..|... .| ... ...+++.+.+||.+||..||.+|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 333210 00 000 11457889999999999999999
Q ss_pred CCHHHHHhchhhhcc
Q 005298 256 PSAKELLRHRFIRNA 270 (703)
Q Consensus 256 PTa~eLL~Hpff~~~ 270 (703)
||+.|+|+||||...
T Consensus 321 ~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 321 ISANDALKHPFVSIF 335 (388)
T ss_dssp CCHHHHTTSTTTTTT
T ss_pred CCHHHHhCCHHHHHh
Confidence 999999999999764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=393.89 Aligned_cols=259 Identities=27% Similarity=0.505 Sum_probs=200.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
.-.+|++.+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 44589999999999999999999999999999999864321 1224678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||||+++++|.+++... .++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 99999999999999865 67999999999999999999999999999999999999999999999999998766544333
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.... ...+..++..+.+||.+|
T Consensus 169 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~ 246 (278)
T 3cok_A 169 HYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD-YEMPSFLSIEAKDLIHQL 246 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSC-CCCCTTSCHHHHHHHHHH
T ss_pred ceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcc-cCCccccCHHHHHHHHHH
Confidence 4456899999999998765 58899999999999999999999998766555444443322 234567889999999999
Q ss_pred hccCCCCCCCHHHHHhchhhhccc
Q 005298 248 LKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
|..||.+|||+.++++||||....
T Consensus 247 l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 247 LRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp SCSSGGGSCCHHHHTTSTTTC---
T ss_pred cccCHhhCCCHHHHhcCccccCCC
Confidence 999999999999999999997653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=390.45 Aligned_cols=256 Identities=26% Similarity=0.462 Sum_probs=224.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 456899999999999999999999999999999998754332 2567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe---cCCCCeeEeccccchhhhhcccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL---TENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL---d~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... ..
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~ 164 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KM 164 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-SC
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-cc
Confidence 999999999999888889999999999999999999999999999999999999 77889999999998765433 23
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcc---hhhhHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD---EHFSRLMKEFV 244 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~---~~is~~L~dLI 244 (703)
....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+......... ..+++.+.+||
T Consensus 165 ~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLI 242 (277)
T ss_dssp BCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred hhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHH
Confidence 345689999999999865 3899999999999999999999999887766655555444332222 25789999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+||.++|.+|||+.++|+||||++.
T Consensus 243 ~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 243 RRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHccCChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=397.11 Aligned_cols=260 Identities=27% Similarity=0.475 Sum_probs=217.6
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
.+.....+|++.+.||+|+||.||+|.+..++..||||++.........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 16 ~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp ESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence 34455678999999999999999999999999999999997665444567889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec---CCCCeeEeccccch
Q 005298 87 WIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT---ENGDVKVADFGVSA 159 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd---~~g~VKL~DFGlA~ 159 (703)
|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999998853 47899999999999999999999999999999999999994 45789999999987
Q ss_pred hhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC--CCcchhhh
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP--PQLDEHFS 237 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~--~~l~~~is 237 (703)
.+... ......+||+.|+|||++.. .++.++|||||||+||+|++|..||...........+....+ ......++
T Consensus 176 ~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T 3is5_A 176 LFKSD-EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLT 252 (285)
T ss_dssp C-----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCC
T ss_pred ecCCc-ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCC
Confidence 65433 22345689999999999863 488999999999999999999999988765544433322221 11223468
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
+.+.+||.+||..||.+|||+.|+|+||||++
T Consensus 253 ~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 253 PQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 89999999999999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=410.70 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=209.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++++.||+|+||+||+|.+..+++.||||++...........+.+|+.++++++||||+++++++...+.+||||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999999999999999997654333333456799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 93 MAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 93 v~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 160 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence 96 5888888764 469999999999999999999999999999999999999999999999999987665444444556
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC---C-CC-----------------
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---N-PP----------------- 230 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~---~-~~----------------- 230 (703)
+||+.|+|||++.+...++.++|||||||++|+|++|.+||...+....+..+... . ..
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (324)
T 3mtl_A 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240 (324)
T ss_dssp --CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCC
T ss_pred cCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccc
Confidence 89999999999987666899999999999999999999999887654433222110 0 00
Q ss_pred --------CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 231 --------QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 231 --------~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.....++..+.+||.+||..||.+|||+.|+|+||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp CCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 01124678899999999999999999999999999998653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=390.82 Aligned_cols=261 Identities=24% Similarity=0.400 Sum_probs=224.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++++.||+|+||.||+|.+..+++.||||++.........+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 34689999999999999999999999999999999976665556788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc--ccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~ 168 (703)
||+++++|.+++.....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.... ...
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987553221 223
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee-ecc-CCCCCCCcchhhhHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FII-PRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l-~~I-~~~~~~~l~~~is~~L~dLI~~ 246 (703)
...+||+.|+|||++.+...++.++|||||||++|+|++|..||......... ..+ ...........++..+.+||.+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHH
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHH
Confidence 45689999999999987654578999999999999999999999876543211 111 1111222345788999999999
Q ss_pred HhccCCCCCCCHHHHHhchhhhccc
Q 005298 247 CLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
||..+|.+|||+.++++||||+...
T Consensus 245 ~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 245 ILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HCCCCchhCCCHHHHhcCccccChh
Confidence 9999999999999999999998653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=401.85 Aligned_cols=263 Identities=26% Similarity=0.414 Sum_probs=209.7
Q ss_pred cchhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC----hHHHHHHHHHHHHHHhC---CCCCeeeeEE
Q 005298 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES----EDEIEDIQKEISVLSQC---RSPYITEYYG 78 (703)
Q Consensus 6 ~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~----~~~~~~l~~Ei~ILk~L---~HPnIV~L~~ 78 (703)
++......+|++++.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+++++ +||||+++++
T Consensus 2 p~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp --------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred CCCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 3556678899999999999999999999999999999999864431 11124566777777766 4999999999
Q ss_pred EEEeCC-----EEEEEEeccCCCCHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCee
Q 005298 79 SYLHQT-----KLWIIMEYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (703)
Q Consensus 79 ~~~~~~-----~lyLV~Eyv~gGsL~~~l~~~~~--L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VK 151 (703)
++.... .+|+||||+. ++|.+++..... +++..++.|+.||+.||.|||++||+||||||+||||+.++.+|
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEE
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEE
Confidence 998765 5899999996 699999987654 99999999999999999999999999999999999999999999
Q ss_pred EeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC----
Q 005298 152 VADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---- 227 (703)
Q Consensus 152 L~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~---- 227 (703)
|+|||++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+....+..+...
T Consensus 161 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 161 LADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp ECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EeeCccccccCCC-cccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998765432 233457899999999999875 4899999999999999999999999877654433322110
Q ss_pred -------------------CCC---CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 228 -------------------NPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 228 -------------------~~~---~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+. .+...++..+.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 000 01135678899999999999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=413.60 Aligned_cols=253 Identities=30% Similarity=0.471 Sum_probs=216.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV 89 (703)
...+|++++.||+|+||.||+|.++.+|+.||||++..... ...+|+.++.++ +||||++++++|.+++.+|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 34589999999999999999999999999999999975542 235688888887 799999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC----CCeeEeccccchhhhhcc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN----GDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~----g~VKL~DFGlA~~~~~~~ 165 (703)
||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+... +.+||+|||++..+....
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 9999999999999988899999999999999999999999999999999999998543 359999999998765444
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCC---ccceeeccCCCC---CCCcchhhhHH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH---PMRVLFIIPREN---PPQLDEHFSRL 239 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~---~~~~l~~I~~~~---~~~l~~~is~~ 239 (703)
....+.+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||.... .......+.... +......++..
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 253 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred CceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHH
Confidence 445567999999999999764 48899999999999999999999997632 222333332222 22234578999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
+++||.+||.+||.+|||+.++++||||..
T Consensus 254 ~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 254 AKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 999999999999999999999999999965
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=407.17 Aligned_cols=267 Identities=27% Similarity=0.424 Sum_probs=220.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
.-.+|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.++++++||||+++++++...+.+|||
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3468999999999999999999999999999999986554 334456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|||+++++|..++.....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+........
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccC
Confidence 99999999999988888999999999999999999999999999999999999999999999999999977655444445
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---------------------CC
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------------EN 228 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------------~~ 228 (703)
..+||+.|+|||++.+...++.++|||||||++|+|++|.+||...........+.. ..
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence 678999999999998765689999999999999999999999987765433222110 00
Q ss_pred CC------C---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccChhHH
Q 005298 229 PP------Q---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLL 277 (703)
Q Consensus 229 ~~------~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~ 277 (703)
.+ . ....++..+.+||.+||..||.+|||+.|+|+||||+.......+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~ 320 (331)
T 4aaa_A 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFS 320 (331)
T ss_dssp CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHHHHH
T ss_pred CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhhhhh
Confidence 00 0 1125688999999999999999999999999999998764433333
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=393.22 Aligned_cols=257 Identities=32% Similarity=0.523 Sum_probs=221.4
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~--~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
.-.+|++.+.||+|+||.||+|.+..++..||||++...... .....+.+|+.++++++||||+++++++.+.+..|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 346899999999999999999999999999999998643311 124678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--~~ 164 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RR 164 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--cc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998654332 23
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
...+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... ..++..++..+.+||.+||
T Consensus 165 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l 242 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLL 242 (279)
T ss_dssp ---CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHC
T ss_pred cccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-CCCCCcCCHHHHHHHHHHh
Confidence 456899999999999765 58899999999999999999999998876655554443322 2445668899999999999
Q ss_pred ccCCCCCCCHHHHHhchhhhccc
Q 005298 249 KKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
..+|.+|||+.||++||||....
T Consensus 243 ~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 243 KHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp CSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ccChhhCCCHHHHhhCccccCCc
Confidence 99999999999999999998653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=389.37 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=218.6
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCC
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~ 84 (703)
+......+|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++.++ +||||+++++++.+.+
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 34445678999999999999999999999999999999987653 234456788999999999 9999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC-------------
Q 005298 85 KLWIIMEYMAGGSVADLIQSG----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN------------- 147 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~----~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~------------- 147 (703)
.+||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999999999764 679999999999999999999999999999999999999844
Q ss_pred ------CCeeEeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee
Q 005298 148 ------GDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL 221 (703)
Q Consensus 148 ------g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l 221 (703)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+|+..... .
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~ 237 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W 237 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---H
T ss_pred cccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---H
Confidence 47999999998765432 3457999999999998765677899999999999999999988755432 2
Q ss_pred eccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 222 FIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 222 ~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..+.....+.++..++..+.+||.+||..||.+|||+.++++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 2333344455667789999999999999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=395.10 Aligned_cols=270 Identities=43% Similarity=0.792 Sum_probs=226.0
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
....+|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+.+|+|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 35568999999999999999999999999999999986543 23357788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence 999999999998865 5679999999999999999999999999999999999999999999999999986554443344
Q ss_pred ccccCCCCCCchhhhc----cccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CcchhhhHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQ----NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKE 242 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~----~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~--~l~~~is~~L~d 242 (703)
...+||+.|+|||++. ....++.++|||||||++|+|++|..||...+.......+....++ ..+..++..+.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD 254 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence 5578999999999984 2345788999999999999999999999887765554444333322 335678899999
Q ss_pred HHHHHhccCCCCCCCHHHHHhchhhhccccChhHHHHh
Q 005298 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~e~i 280 (703)
||.+||..+|.+|||+.++++||||........+.+.+
T Consensus 255 li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~ 292 (302)
T 2j7t_A 255 FLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELV 292 (302)
T ss_dssp HHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHHHHHH
T ss_pred HHHHHcccChhhCCCHHHHhcChHHhhhccchhHHHHH
Confidence 99999999999999999999999999887665554443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=441.84 Aligned_cols=259 Identities=25% Similarity=0.437 Sum_probs=223.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
...+|+++++||+|+||+||+|+++.+|+.||||++..... ......+.+|+.+|++++||||++++++|.+.+.+||
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 34689999999999999999999999999999999865431 1224678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 89 IMEYMAGGSVADLIQSG----PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~----~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
|||||+||+|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||++..+...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 99999999999999763 46999999999999999999999999999999999999999999999999999876544
Q ss_pred ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----ceeeccCCCCCCCcchhhhHHH
Q 005298 165 ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM----RVLFIIPRENPPQLDEHFSRLM 240 (703)
Q Consensus 165 ~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~----~~l~~I~~~~~~~l~~~is~~L 240 (703)
.......+||+.|+|||++.+. .|+.++||||||||||||++|.+||...+.. .....+.. ....++..++..+
T Consensus 343 ~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-~~~~~p~~~s~~~ 420 (543)
T 3c4z_A 343 QTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAVTYPDKFSPAS 420 (543)
T ss_dssp CCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-CCCCCCTTSCHHH
T ss_pred CcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-cccCCCcccCHHH
Confidence 4444557999999999999874 5899999999999999999999999875432 22222222 2334567789999
Q ss_pred HHHHHHHhccCCCCCCC-----HHHHHhchhhhccc
Q 005298 241 KEFVSLCLKKVPAERPS-----AKELLRHRFIRNAR 271 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPT-----a~eLL~Hpff~~~~ 271 (703)
++||.+||.+||.+||+ +.+|++||||+...
T Consensus 421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 99999999999999996 58999999999764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=392.80 Aligned_cols=259 Identities=24% Similarity=0.464 Sum_probs=228.8
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
....+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.++++++||||+++++++...+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45569999999999999999999999999999999986543 3445678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998766544344
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....+||+.|+|||++.+. .++.++||||||+++|+|++|..||...........+.... ..++..++..+.+||.+|
T Consensus 172 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~ 249 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKM 249 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-CCCccccCHHHHHHHHHH
Confidence 4557899999999999764 58899999999999999999999998876555444443332 345567889999999999
Q ss_pred hccCCCCCCCHHHHHhchhhhcc
Q 005298 248 LKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
|..+|.+|||+.++++||||...
T Consensus 250 l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 250 LQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTS
T ss_pred cccChhhCcCHHHHhhChheecC
Confidence 99999999999999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=399.60 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=226.1
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-----HHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-----EIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~-----~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~ 84 (703)
....+|++.+.||+|+||.||+|.+..+|+.||||++....... ..+.+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34568999999999999999999999999999999987554211 3567899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC----CeeEeccccchh
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG----DVKVADFGVSAQ 160 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g----~VKL~DFGlA~~ 160 (703)
.+|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999999888999999999999999999999999999999999999999887 799999999876
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC---Ccchhhh
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP---QLDEHFS 237 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~---~l~~~is 237 (703)
.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...... .+...++
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 169 IEDG-VEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp CCTT-CCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred cCcc-ccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 5433 223456899999999999765 5899999999999999999999999887766555554433222 2234678
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
..+.+||.+||..||.+|||+.++++||||....
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 8999999999999999999999999999997653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=404.68 Aligned_cols=260 Identities=34% Similarity=0.604 Sum_probs=223.1
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
+....+|++++.||+|+||.||+|.+..++..||+|++...........+.+|+.++++++||||+++++++..++.+||
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 44457999999999999999999999999999999999877666667889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~-gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||||+++++|.+++.....+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++...... .
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 186 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M 186 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--C
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--c
Confidence 999999999999999888999999999999999999999986 9999999999999999999999999998765433 2
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeec------------------------
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI------------------------ 223 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~------------------------ 223 (703)
....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......
T Consensus 187 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp ----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred ccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 3456899999999999875 589999999999999999999999976543221110
Q ss_pred ------------------cCCCC-CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 224 ------------------IPREN-PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 224 ------------------I~~~~-~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
+.... +......++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 01111 1122234688999999999999999999999999999998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=403.33 Aligned_cols=261 Identities=28% Similarity=0.484 Sum_probs=218.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC----ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~----~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
...+|++.+.||+|+||.||+|.+..++..||||++.... .....+.+.+|+.++++++||||++++++|.+.+..
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 4568999999999999999999999999999999986442 234567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHc----------------------------------------CCCCCHHHHHHHHHHHHHHHHH
Q 005298 87 WIIMEYMAGGSVADLIQS----------------------------------------GPPLDEMSIACILRDLLHAIEY 126 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~----------------------------------------~~~L~e~~i~~i~~QLl~AL~y 126 (703)
|||||||+||+|.+++.. ...+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999999999999852 1124678899999999999999
Q ss_pred HHhcCceeeeeccceEEecCCC--CeeEeccccchhhhhccc----ccccccCCCCCCchhhhccc-cCCccccchhhHH
Q 005298 127 LHNEGKIHRDIKAANILLTENG--DVKVADFGVSAQLTRTIS----RRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLG 199 (703)
Q Consensus 127 LHs~gIVHRDIKPeNILLd~~g--~VKL~DFGlA~~~~~~~~----~~~~~iGTp~Y~APEvl~~~-~~~s~ksDVWSLG 199 (703)
||++||+||||||+||||+.++ .+||+|||++..+..... .....+||+.|+|||++.+. ..++.++||||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 9999999999999999998776 899999999876543221 12356899999999999652 4588999999999
Q ss_pred HHHHHHHhCCCCCCCCCccceeeccCCCCC---CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 200 ITVIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 200 vILyELLtG~~PF~~~~~~~~l~~I~~~~~---~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
|+||+|++|..||...........+..... ......+++.+.+||.+||..+|.+||++.++|+||||+...
T Consensus 264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 999999999999988776655544433222 122335789999999999999999999999999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=428.18 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=227.9
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... .+....+.+|+.+++.++||||+++++++...+.+||
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34689999999999999999999999999999999865421 1235678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|||||+|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||++...... ...
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~~~ 172 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFL 172 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-CCB
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-ccc
Confidence 9999999999999998889999999999999999999999999999999999999999999999999998765432 233
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
.+.+||+.|+|||++.+..+++.++|||||||+||+|++|..||...+.......+.... ...+..+++.+.+||.+||
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~~L 251 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-FYTPQYLNPSVISLLKHML 251 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-CCCCTTCCHHHHHHHHHHT
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-cCCCccCCHHHHHHHHHHc
Confidence 467899999999999876555789999999999999999999998877666555554433 2445678899999999999
Q ss_pred ccCCCCCCCHHHHHhchhhhcc
Q 005298 249 KKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..||.+|||+.+|++||||+..
T Consensus 252 ~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 252 QVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCCchhCcCHHHHHhCHHhhhc
Confidence 9999999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=393.09 Aligned_cols=268 Identities=52% Similarity=0.904 Sum_probs=223.3
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
+......+|++++.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.++++++||||+++++++...+.+
T Consensus 23 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 23 LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp -------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 345566799999999999999999999999999999999875432 35688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~-~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
|+||||+++++|.+++. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999996 46789999999999999999999999999999999999999999999999999987665444
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC--CcchhhhHHHHHH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP--QLDEHFSRLMKEF 243 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~--~l~~~is~~L~dL 243 (703)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+....++ ..+..++..+.+|
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 258 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF 258 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred cccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence 444567899999999999775 5899999999999999999999999887665444333322222 2355678999999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhccccChhHHH
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~e 278 (703)
|.+||..+|.+|||+.++++||||+.......+..
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~~~ 293 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRD 293 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGGHH
T ss_pred HHHHccCChhhCcCHHHHHhCHHHhcCCcchHHHH
Confidence 99999999999999999999999988765444433
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=416.20 Aligned_cols=261 Identities=31% Similarity=0.477 Sum_probs=213.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----C
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----T 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~-----~ 84 (703)
...+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4579999999999999999999999999999999996543 344567889999999999999999999999876 5
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
.+||||||++ ++|.+++.....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 7999999995 699999999888999999999999999999999999999999999999999999999999999765432
Q ss_pred cc----------------------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCC----------
Q 005298 165 IS----------------------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPL---------- 212 (703)
Q Consensus 165 ~~----------------------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF---------- 212 (703)
.. .....+||++|+|||++.....|+.++||||||||||||++|..||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~ 262 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence 11 2356789999999999866667999999999999999999855444
Q ss_pred -CCCCcc-----------------ceee---------------------------ccCCCCCCCc---chhhhHHHHHHH
Q 005298 213 -ADLHPM-----------------RVLF---------------------------IIPRENPPQL---DEHFSRLMKEFV 244 (703)
Q Consensus 213 -~~~~~~-----------------~~l~---------------------------~I~~~~~~~l---~~~is~~L~dLI 244 (703)
.+.+.. ..+. ......+..+ ...+++.+.+||
T Consensus 263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 342 (432)
T 3n9x_A 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL 342 (432)
T ss_dssp CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 332210 0000 0000011111 134788999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
.+||..||.+|||++|+|+||||.....
T Consensus 343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 343 ESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 9999999999999999999999988654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=408.78 Aligned_cols=258 Identities=30% Similarity=0.467 Sum_probs=221.5
Q ss_pred ccchhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-------HHHHHHHHHHHHHHhCCCCCeeeeE
Q 005298 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-------DEIEDIQKEISVLSQCRSPYITEYY 77 (703)
Q Consensus 5 ~~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-------~~~~~l~~Ei~ILk~L~HPnIV~L~ 77 (703)
..+......+|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+.++++++||||++++
T Consensus 16 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 95 (335)
T 3dls_A 16 AACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVL 95 (335)
T ss_dssp HHHTTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEE
T ss_pred ccCCcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 334445567999999999999999999999999999999998765321 1234577899999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCC-CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccc
Q 005298 78 GSYLHQTKLWIIMEYMAGG-SVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFG 156 (703)
Q Consensus 78 ~~~~~~~~lyLV~Eyv~gG-sL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFG 156 (703)
++|.+.+.+|+||||+.+| +|.+++.....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 96 DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999999998766 999999998899999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhh
Q 005298 157 VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF 236 (703)
Q Consensus 157 lA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~i 236 (703)
++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||....... ......+..+
T Consensus 176 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~ 247 (335)
T 3dls_A 176 SAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------EAAIHPPYLV 247 (335)
T ss_dssp TCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------TTCCCCSSCC
T ss_pred cceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------hhccCCCccc
Confidence 98765433 223456899999999999876655889999999999999999999997643211 1112233457
Q ss_pred hHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 237 s~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+..+.+||.+||.++|.+|||+.++++||||+..
T Consensus 248 ~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 8899999999999999999999999999999764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=396.62 Aligned_cols=264 Identities=45% Similarity=0.824 Sum_probs=199.1
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
....+|++.+.||+|+||.||+|.+..+++.||||++...........+.+|+.++++++||||+++++++...+..|+|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34579999999999999999999999999999999987655445567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 90 MEYMAGGSVADLIQS--------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~--------~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999999973 456999999999999999999999999999999999999999999999999998765
Q ss_pred hhcc-----cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC-------
Q 005298 162 TRTI-----SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP------- 229 (703)
Q Consensus 162 ~~~~-----~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~------- 229 (703)
.... ......+||+.|+|||++.....++.++|||||||++|+|++|..||................+
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 251 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence 3221 1123468999999999987644589999999999999999999999987765543332222211
Q ss_pred --CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccC
Q 005298 230 --PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 230 --~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~ 273 (703)
......++..+.+||.+||..||.+|||+.++++||||+.....
T Consensus 252 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp ---CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 12234678899999999999999999999999999999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=404.62 Aligned_cols=253 Identities=26% Similarity=0.459 Sum_probs=198.2
Q ss_pred CCceEE---EEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEE
Q 005298 13 SRFSSL---ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 13 ~~Y~il---~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyL 88 (703)
.+|++. +.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++++. ||||+++++++.++...||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 367775 7899999999999999999999999998643 2456788999999997 9999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC---CeeEeccccchhhhhcc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVADFGVSAQLTRTI 165 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g---~VKL~DFGlA~~~~~~~ 165 (703)
|||||++++|.+++.....+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|||++.......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 84 VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp EECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred EEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 999999999999999989999999999999999999999999999999999999998765 79999999987665444
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------cceeeccCCCCCCC---cchh
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-------MRVLFIIPRENPPQ---LDEH 235 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-------~~~l~~I~~~~~~~---l~~~ 235 (703)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+. ......+....... ....
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242 (325)
T ss_dssp --------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred CcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccC
Confidence 445567899999999999765 589999999999999999999999976543 22233333333222 1245
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
++..+++||.+||..||.+|||+.++++||||+..
T Consensus 243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp SCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 78999999999999999999999999999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=401.78 Aligned_cols=259 Identities=24% Similarity=0.463 Sum_probs=228.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
...+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.++++++||||+++++++.+.+.+||
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4468999999999999999999999999999999986543 34556788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999987665443444
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
...+||+.|+|||++.+. .++.++|||||||+||+|++|..||...........+.... ..++..++..+.+||.+||
T Consensus 199 ~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l 276 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKML 276 (335)
T ss_dssp CCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-CCCCTTSCHHHHHHHHHHT
T ss_pred cccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-CCCCccCCHHHHHHHHHHc
Confidence 567899999999999765 58899999999999999999999998776554444433322 2445678899999999999
Q ss_pred ccCCCCCCCHHHHHhchhhhccc
Q 005298 249 KKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
..||.+|||+.++++||||....
T Consensus 277 ~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 277 QTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp CSSGGGSCCGGGGGGSHHHHTSC
T ss_pred cCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999998653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=404.50 Aligned_cols=258 Identities=27% Similarity=0.450 Sum_probs=221.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----CE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----TK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~-----~~ 85 (703)
.+.+|++++.||+|+||.||+|.+..+++.||||++...........+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4579999999999999999999999999999999998666666678899999999999999999999999765 46
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
.|+||||+. ++|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 899999996 599999976 569999999999999999999999999999999999999999999999999987654332
Q ss_pred cc---cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------
Q 005298 166 SR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------- 226 (703)
Q Consensus 166 ~~---~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------- 226 (703)
.. ....+||+.|+|||++.+...++.++|||||||+||+|++|.+||...+....+..+..
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 21 23468999999999987766689999999999999999999999988766554433321
Q ss_pred -----------CCCCC---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 227 -----------ENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 227 -----------~~~~~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..... +...++..+.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00000 113467889999999999999999999999999999865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=405.89 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=206.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++++++||||++++++|...+.+||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 4457999999999999999999999999999999987543 2356789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC---CCCeeEeccccchhhhhcccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~---~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||||+. ++.+||+|||++...... ..
T Consensus 128 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~ 206 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VL 206 (349)
T ss_dssp CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-cc
Confidence 99999999999998888999999999999999999999999999999999999975 789999999998765432 22
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-eeeccCCCC---CCCcchhhhHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLFIIPREN---PPQLDEHFSRLMKEF 243 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~-~l~~I~~~~---~~~l~~~is~~L~dL 243 (703)
....+||+.|+|||++.+. .++.++|||||||+||+|++|..||....... ....+.... +......++..+.+|
T Consensus 207 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 285 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDL 285 (349)
T ss_dssp ------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred cccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHH
Confidence 3456899999999999875 58999999999999999999999998765443 222232222 223345788999999
Q ss_pred HHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 244 VSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
|.+||..||.+|||+.++|+||||...
T Consensus 286 i~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 286 VRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCC
Confidence 999999999999999999999999764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=388.26 Aligned_cols=258 Identities=27% Similarity=0.449 Sum_probs=216.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.++++++||||+++++++...+.+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 34689999999999999999999999999999999864321 1234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||||+++++|.+++.....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... ...
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~ 167 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFL 167 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC-cce
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998765432 223
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
...+||+.|+|||++.+....+.++||||||+++|+|++|..||...........+.... ..++..++..+.+||.+||
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l 246 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV-FYIPEYLNRSVATLLMHML 246 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHT
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-ccCchhcCHHHHHHHHHHc
Confidence 356899999999999876545789999999999999999999998776555444443322 2345667889999999999
Q ss_pred ccCCCCCCCHHHHHhchhhhcc
Q 005298 249 KKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..+|.+|||+.++++||||+..
T Consensus 247 ~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 247 QVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp CSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCChhhCCCHHHHHhChhhccC
Confidence 9999999999999999999764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=388.96 Aligned_cols=254 Identities=28% Similarity=0.488 Sum_probs=222.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++.+.||+|+||.||+|.+..++..||||++..... ......+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999864321 112467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 171 (284)
T 2vgo_A 94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RRRT 171 (284)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--CBCC
T ss_pred EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--cccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998654322 2345
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+|++.|+|||++.+. .++.++|||||||++|+|++|..||...........+.... ..++..++..+.+||.+||..
T Consensus 172 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~ 249 (284)
T 2vgo_A 172 MCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGSKDLISKLLRY 249 (284)
T ss_dssp CCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHSCS
T ss_pred ccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-cCCCCcCCHHHHHHHHHHhhc
Confidence 6899999999999875 58999999999999999999999998776555444443322 245567889999999999999
Q ss_pred CCCCCCCHHHHHhchhhhcc
Q 005298 251 VPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpff~~~ 270 (703)
+|.+||++.++++||||+..
T Consensus 250 ~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 250 HPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp SGGGSCCHHHHHTCHHHHHH
T ss_pred CHhhCCCHHHHhhCHHHHhh
Confidence 99999999999999999854
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=400.49 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=213.3
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----CCCeeeeEEEEEeC
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----SPYITEYYGSYLHQ 83 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-----HPnIV~L~~~~~~~ 83 (703)
.....+|++++.||+|+||+||+|.+..+++.||||++... ......+..|+.+++.+. |||||++++++...
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 34567999999999999999999999999999999998642 344567788999999996 99999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC---------------
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE--------------- 146 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~--------------- 146 (703)
+.+||||||+ +++|.+++.... .+++..++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence 9999999999 999999997654 5999999999999999999999999999999999999975
Q ss_pred ----------CCCeeEeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCC
Q 005298 147 ----------NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH 216 (703)
Q Consensus 147 ----------~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~ 216 (703)
++.+||+|||++..... .....+||+.|+|||++.+. .++.++|||||||+||+|++|.+||...+
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 78899999999875433 23456899999999999875 58999999999999999999999998765
Q ss_pred ccceeeccCCCCC---------------------------------------------CCcchhhhHHHHHHHHHHhccC
Q 005298 217 PMRVLFIIPRENP---------------------------------------------PQLDEHFSRLMKEFVSLCLKKV 251 (703)
Q Consensus 217 ~~~~l~~I~~~~~---------------------------------------------~~l~~~is~~L~dLI~~cL~~d 251 (703)
....+..+..... +.+....+..+.+||.+||.+|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 4433222211000 0001112367889999999999
Q ss_pred CCCCCCHHHHHhchhhh
Q 005298 252 PAERPSAKELLRHRFIR 268 (703)
Q Consensus 252 P~~RPTa~eLL~Hpff~ 268 (703)
|.+|||+.|+|+||||+
T Consensus 344 P~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGGSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999995
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=422.24 Aligned_cols=257 Identities=29% Similarity=0.548 Sum_probs=225.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
...+|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.++++++|||||+++++|.+.+.+|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34589999999999999999999999999999999865432 2345778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe---cCCCCeeEeccccchhhhhcc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL---TENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL---d~~g~VKL~DFGlA~~~~~~~ 165 (703)
|||||.+++|.+++.....+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+...
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 182 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS- 182 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-
Confidence 99999999999999988999999999999999999999999999999999999999 45689999999998765433
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC---CCcchhhhHHHHH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEHFSRLMKE 242 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~---~~l~~~is~~L~d 242 (703)
......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||...+....+..+..... .+....++..+++
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 260 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD 260 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence 22345689999999999975 489999999999999999999999998877666655544332 2233578999999
Q ss_pred HHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 243 FVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
||.+||.++|.+|||+.++|+||||+..
T Consensus 261 li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 261 LIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred HHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=386.51 Aligned_cols=255 Identities=28% Similarity=0.496 Sum_probs=219.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe----CCE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QTK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~----~~~ 85 (703)
.+..|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.++++++||||++++++|.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3457899999999999999999999999999999987554 45557789999999999999999999999876 456
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeeeeccceEEec-CCCCeeEeccccchhhh
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLT-ENGDVKVADFGVSAQLT 162 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~g--IVHRDIKPeNILLd-~~g~VKL~DFGlA~~~~ 162 (703)
+|+||||+++++|.+++.....+++..++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 8999999999999999998888999999999999999999999999 99999999999998 78899999999986543
Q ss_pred hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee-eccCCC-CCCCcchhhhHHH
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FIIPRE-NPPQLDEHFSRLM 240 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l-~~I~~~-~~~~l~~~is~~L 240 (703)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||......... ..+... .+..++...++.+
T Consensus 184 ~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (290)
T 1t4h_A 184 AS--FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp TT--SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred cc--ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHH
Confidence 32 2335689999999998864 4899999999999999999999999875543332 223222 2334455677899
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
.+||.+||..+|.+|||+.++++||||+.
T Consensus 260 ~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 99999999999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=421.47 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=208.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC------
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------ 83 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~------ 83 (703)
...+|++++.||+|+||+||+|++..+++.||||++.... .......+.+|+.+|+.++|||||+++++|...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3478999999999999999999999999999999997543 445567889999999999999999999999754
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
..+||||||+++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 467999999965 5666664 3599999999999999999999999999999999999999999999999999976543
Q ss_pred cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC----------------
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---------------- 227 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~---------------- 227 (703)
. ......+||+.|+|||++.+. .|+.++||||||||||+|++|++||.+.+....+..|...
T Consensus 217 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 217 S-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp C-CCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred C-cccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 2 233457999999999999875 5999999999999999999999999887654433322110
Q ss_pred ----------CCCCc---------------chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 228 ----------NPPQL---------------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 228 ----------~~~~l---------------~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
....+ ....+..+++||.+||.+||.+|||++|+|+||||...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 00000 01126779999999999999999999999999999854
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=422.24 Aligned_cols=259 Identities=29% Similarity=0.507 Sum_probs=223.8
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh------------HHHHHHHHHHHHHHhCCCCCeeeeE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE------------DEIEDIQKEISVLSQCRSPYITEYY 77 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~------------~~~~~l~~Ei~ILk~L~HPnIV~L~ 77 (703)
....+|++++.||+|+||+||+|.++.+++.||||++...... ...+.+.+|+.+|++++|||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3567899999999999999999999999999999998754321 2356788999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC---CeeEec
Q 005298 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVAD 154 (703)
Q Consensus 78 ~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g---~VKL~D 154 (703)
++|.+...+|||||||+||+|.+++.....+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999999998888999999999999999999999999999999999999999776 699999
Q ss_pred cccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc--
Q 005298 155 FGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-- 232 (703)
Q Consensus 155 FGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l-- 232 (703)
||++..+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||...+....+..+........
T Consensus 193 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 193 FGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp CTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred CCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 9998765433 23345789999999999864 489999999999999999999999998887766666654433221
Q ss_pred -chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 233 -DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 233 -~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
...++..+++||.+||.+||.+|||+.|+|+||||+...
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 246789999999999999999999999999999997653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=395.18 Aligned_cols=261 Identities=24% Similarity=0.433 Sum_probs=212.1
Q ss_pred hhhCCCceEE-EEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEE
Q 005298 9 EAAGSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 9 ~~~~~~Y~il-~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~l 86 (703)
.....+|++. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++.++ +||||+++++++.+.+.+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 3455689996 78999999999999999999999999997553 23356788999999985 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC---eeEeccccchhhhh
Q 005298 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD---VKVADFGVSAQLTR 163 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~---VKL~DFGlA~~~~~ 163 (703)
||||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999998765 99999999875532
Q ss_pred cc-------cccccccCCCCCCchhhhcc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-------------
Q 005298 164 TI-------SRRKTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR------------- 219 (703)
Q Consensus 164 ~~-------~~~~~~iGTp~Y~APEvl~~----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~------------- 219 (703)
.. ......+||+.|+|||++.. ...++.++|||||||++|+|++|..||.......
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 11 11234579999999999864 1247889999999999999999999998764322
Q ss_pred --eeeccCCCCCCC---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 220 --VLFIIPRENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 220 --~l~~I~~~~~~~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
....+....... ....++..+++||.+||..||.+|||+.|+|+||||+..
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 111121111111 113578899999999999999999999999999999865
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=402.55 Aligned_cols=257 Identities=43% Similarity=0.788 Sum_probs=222.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
..|++++.||+|+||+||+|.+..+++.||||++.... .....+.+.+|+.++++++||||++++++|..++..||||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 46999999999999999999999999999999987553 2334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 91 EYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 91 Eyv~gGsL~~~l~-~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
||+. |+|.+++. ...++++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ..
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----~~ 208 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----AN 208 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BC
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----CC
Confidence 9997 57777774 467899999999999999999999999999999999999999999999999999876532 24
Q ss_pred cccCCCCCCchhhhcc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC-CCCCcchhhhHHHHHHHHH
Q 005298 170 TFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~-~~~~l~~~is~~L~dLI~~ 246 (703)
..+||+.|+|||++.. ...++.++||||||||||+|++|.+||...+....+..+... .+......++..+.+||.+
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 5689999999999853 345889999999999999999999999887765554444333 2333456788999999999
Q ss_pred HhccCCCCCCCHHHHHhchhhhccccCh
Q 005298 247 CLKKVPAERPSAKELLRHRFIRNARKSP 274 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~Hpff~~~~~~~ 274 (703)
||..+|.+|||+.++++||||.......
T Consensus 289 ~l~~dP~~Rps~~~ll~h~~~~~~~~~~ 316 (348)
T 1u5q_A 289 CLQKIPQDRPTSEVLLKHRFVLRERPPT 316 (348)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred HcccChhhCcCHHHHhhChhhhccCCcc
Confidence 9999999999999999999998765443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=387.63 Aligned_cols=258 Identities=32% Similarity=0.526 Sum_probs=224.5
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe--CCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--~~~lyL 88 (703)
..+|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 458999999999999999999999999999999997654 34556789999999999999999999998865 578999
Q ss_pred EEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcC-----ceeeeeccceEEecCCCCeeEeccccch
Q 005298 89 IMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEG-----KIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~g-----IVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999999965 345999999999999999999999999 9999999999999999999999999987
Q ss_pred hhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHH
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL 239 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~ 239 (703)
.............||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.....+.++..++..
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHH
Confidence 664433333456899999999999775 5889999999999999999999999987766655555555555667788999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+.+||.+||..+|.+||++.+|++|+|+...
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 9999999999999999999999999999765
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=423.85 Aligned_cols=259 Identities=27% Similarity=0.512 Sum_probs=223.5
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
....+|++++.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+|++++|||||++++++.+...+|+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 34568999999999999999999999999999999985432 12234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec---CCCCeeEeccccchhhhhcc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd---~~g~VKL~DFGlA~~~~~~~ 165 (703)
|||||.+++|.+++.....+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||++..+...
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 999999999999998888999999999999999999999999999999999999995 4567999999998765433
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC---CCcchhhhHHHHH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEHFSRLMKE 242 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~---~~l~~~is~~L~d 242 (703)
......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||...+....+..+..... .+....++..+++
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 255 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence 23345689999999999975 489999999999999999999999998877666655543322 2233578899999
Q ss_pred HHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 243 FVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
||.+||.++|.+|||+.++|+||||+...
T Consensus 256 li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 256 LIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 99999999999999999999999998653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=411.51 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=222.3
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+|++++||||++++++|.+...+|||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 458999999999999999999999999999999987553 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC--CCCeeEeccccchhhhhccccc
Q 005298 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE--NGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 92 yv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~--~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++..+... ...
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~ 207 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIV 207 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SCE
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-cce
Confidence 99999999999765 47999999999999999999999999999999999999974 477999999998765432 222
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC---CCCCcchhhhHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE---NPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~---~~~~l~~~is~~L~dLI~ 245 (703)
...+||+.|+|||++.+. .++.++||||||||||+|++|..||...+....+..+... .+......++..+.+||.
T Consensus 208 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 286 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 286 (387)
T ss_dssp EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred eeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence 346899999999999764 5899999999999999999999999887765554444322 223334578899999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhcc
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+||.+||.+|||+.++|+||||+..
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 287 NLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp TTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHcCCChhHCcCHHHHhhCccccCC
Confidence 9999999999999999999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=385.91 Aligned_cols=258 Identities=27% Similarity=0.455 Sum_probs=220.5
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-----HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-----~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
..+|++.+.||+|+||.||+|.+..+++.||||++...... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 45799999999999999999999999999999998755321 1257789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC----CeeEeccccchhhh
Q 005298 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG----DVKVADFGVSAQLT 162 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g----~VKL~DFGlA~~~~ 162 (703)
|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998888899999999999999999999999999999999999998876 79999999987654
Q ss_pred hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC---CcchhhhHH
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP---QLDEHFSRL 239 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~---~l~~~is~~ 239 (703)
.. .......||+.|+|||++.+. .++.++||||||+++|+|++|..||...........+...... .....++..
T Consensus 164 ~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 164 AG-NEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp ---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred CC-CcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 32 223346799999999999765 5899999999999999999999999887665554444332221 223466888
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
+.+||.+||..+|.+|||+.++++||||+..+
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 99999999999999999999999999998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=403.13 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=213.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh----HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~----~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
...+|++++.||+|+||.||+|.+..+|+.||||++...... .....+.+|+.++++++||||++++++|...+.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 456899999999999999999999999999999998654321 1124678999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
|+||||+++ +|..++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999975 888888654 469999999999999999999999999999999999999999999999999998765544
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC------------------
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------------ 227 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~------------------ 227 (703)
......+||+.|+|||++.+...++.++|||||||+||+|++|.+||...+....+..+...
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 246 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence 44556789999999999977666899999999999999999999999876654333222100
Q ss_pred ----CCCC-----cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 228 ----NPPQ-----LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 228 ----~~~~-----l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..+. +...++..+.+||.+||..||.+|||+.|+|+||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 0000 114567899999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=390.76 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=215.9
Q ss_pred hhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 8 ~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
......+|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.++++++||||+++++++..++.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 3456679999999999999999999999999999999985543 34556789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
+|+||||++|++|.+++...+++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999987654332
Q ss_pred -cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC----cchhhhHHH
Q 005298 166 -SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ----LDEHFSRLM 240 (703)
Q Consensus 166 -~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~----l~~~is~~L 240 (703)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.............+. ....++..+
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244 (294)
T ss_dssp ---------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred ccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence 223346899999999999875 58999999999999999999999998876654433332222222 234678999
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
.++|.+||.++|.+||+..+.+.+.|.
T Consensus 245 ~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 245 SNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp HHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 999999999999999955555555554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=386.64 Aligned_cols=258 Identities=31% Similarity=0.514 Sum_probs=203.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHH-HHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI-EDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~-~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
...+|++++.||+|+||+||+|.+..+|+.||||++......... ..+.++..+++.++||||+++++++..++..|||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 456899999999999999999999999999999999766444333 3444555568889999999999999999999999
Q ss_pred EeccCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhc-CceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 90 MEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~----~~~~L~e~~i~~i~~QLl~AL~yLHs~-gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
|||++ ++|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 99997 58877664 467899999999999999999999998 9999999999999999999999999998765443
Q ss_pred ccccccccCCCCCCchhhh---ccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeec-cCCCCCCCcchhhhHH
Q 005298 165 ISRRKTFVGTPFWMAPEVI---QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFI-IPRENPPQLDEHFSRL 239 (703)
Q Consensus 165 ~~~~~~~iGTp~Y~APEvl---~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-~~~l~~-I~~~~~~~l~~~is~~ 239 (703)
. ......||+.|+|||++ .....++.++|||||||++|+|++|..||..... ...... +....+......++..
T Consensus 164 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (290)
T 3fme_A 164 V-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAE 242 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHH
T ss_pred c-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHH
Confidence 2 22345899999999997 2334588999999999999999999999976332 222222 2222333334578899
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+.+||.+||..+|.+|||+.++++||||+..
T Consensus 243 ~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 243 FVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 9999999999999999999999999999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=414.71 Aligned_cols=265 Identities=29% Similarity=0.494 Sum_probs=211.9
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-------ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-------SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH 82 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-------~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~ 82 (703)
....+|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+|++++|||||++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34579999999999999999999999999999999986542 1122345789999999999999999999975
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC---CeeEeccccch
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKVADFGVSA 159 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g---~VKL~DFGlA~ 159 (703)
.+.+|||||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+..+ .+||+|||++.
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 556899999999999999998888999999999999999999999999999999999999997644 59999999997
Q ss_pred hhhhcccccccccCCCCCCchhhhcc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee-eccCCCCCCC---cc
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FIIPRENPPQ---LD 233 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l-~~I~~~~~~~---l~ 233 (703)
..... ......+||+.|+|||++.+ ...|+.++|||||||+||+|++|.+||........+ ..+....... ..
T Consensus 291 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 291 ILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp SCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred ecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 66432 23345789999999999853 345788999999999999999999999865443222 2232222222 22
Q ss_pred hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccChhH
Q 005298 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRL 276 (703)
Q Consensus 234 ~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l 276 (703)
..++..+.+||.+||..||.+|||+.|+|+||||+.......+
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~ 412 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 412 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHHHH
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHHHH
Confidence 4578999999999999999999999999999999876443333
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=421.01 Aligned_cols=255 Identities=27% Similarity=0.506 Sum_probs=219.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|++++.||+|+||+||+|.+..++..||||++..... ......+.+|+.++++++|||||+++++|.+...+|||||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 479999999999999999999999999999999875431 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC---CCeeEeccccchhhhhccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~---g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||.+|+|.+++.....+++..++.|+.||+.||.|||++||+||||||+||||+.. +.+||+|||++..+... ...
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~~~ 195 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKM 195 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-BCB
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-ccc
Confidence 99999999999888899999999999999999999999999999999999999764 45999999998766433 233
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC---CcchhhhHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP---QLDEHFSRLMKEFVS 245 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~---~l~~~is~~L~dLI~ 245 (703)
...+||+.|+|||++.. .|+.++|||||||++|+|++|.+||........+..+...... +....++..+++||.
T Consensus 196 ~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 273 (494)
T 3lij_A 196 KERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273 (494)
T ss_dssp CCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHH
T ss_pred cccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHH
Confidence 45789999999999864 4899999999999999999999999988776666555443322 223467899999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhcc
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+||.++|.+|||+.++|+||||+..
T Consensus 274 ~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 274 QMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHCCCChhhCccHHHHhcCcccccC
Confidence 9999999999999999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=398.84 Aligned_cols=258 Identities=25% Similarity=0.483 Sum_probs=213.4
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCC--CCeeeeEEEEEeCCE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRS--PYITEYYGSYLHQTK 85 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~H--PnIV~L~~~~~~~~~ 85 (703)
...+.+|++++.||+|+||.||+|.+. +++.||||++.... .......+.+|+.+|+++.| |||+++++++..++.
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 345778999999999999999999985 58999999997654 34456788999999999986 999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
+|||||| .+++|.+++.....+++..+..|+.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 9999995 5889999999989999999999999999999999999999999999999997 6789999999997664332
Q ss_pred c--ccccccCCCCCCchhhhcc----------ccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceeec-cCCCCCCC
Q 005298 166 S--RRKTFVGTPFWMAPEVIQN----------SEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFI-IPRENPPQ 231 (703)
Q Consensus 166 ~--~~~~~iGTp~Y~APEvl~~----------~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~-~~l~~-I~~~~~~~ 231 (703)
. .....+||+.|+|||++.+ ...++.++|||||||+||+|++|..||...... ..+.. +.......
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 2 1235689999999999864 135888999999999999999999999764332 11111 22223334
Q ss_pred cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 232 l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
++...+..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 55566788999999999999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=392.21 Aligned_cols=260 Identities=47% Similarity=0.858 Sum_probs=215.9
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEe------C
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH------Q 83 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~------~ 83 (703)
..++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+++++ +||||+++++++.. .
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 56799999999999999999999999999999999875532 236788999999999 79999999999987 5
Q ss_pred CEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 84 TKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
+.+||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 6899999999999999999764 57999999999999999999999999999999999999999999999999998766
Q ss_pred hhcccccccccCCCCCCchhhhcc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCcchhh
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEHF 236 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~-~~~l~~~i 236 (703)
..........+||+.|+|||++.. ...++.++|||||||+||+|++|..||...+.......+.... +......+
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 259 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCS
T ss_pred CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcccc
Confidence 544334456789999999999862 2357889999999999999999999998877655544443332 22334567
Q ss_pred hHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 237 s~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
+..+.+||.+||..+|.+||++.++++||||+....
T Consensus 260 ~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 260 SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 899999999999999999999999999999987643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=385.35 Aligned_cols=259 Identities=30% Similarity=0.504 Sum_probs=223.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--------hHHHHHHHHHHHHHHhCC-CCCeeeeEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--------EDEIEDIQKEISVLSQCR-SPYITEYYGSYL 81 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--------~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~ 81 (703)
...+|++.+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 44699999999999999999999999999999999975531 223467789999999995 999999999999
Q ss_pred eCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 82 HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 82 ~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
..+..|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999998765
Q ss_pred hhcccccccccCCCCCCchhhhcc-----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcc
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQN-----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLD 233 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~-----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~ 233 (703)
... ......+||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+.... +....
T Consensus 175 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T 1phk_A 175 DPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253 (298)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred CCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence 432 23345689999999999862 3357889999999999999999999998776655444333222 22233
Q ss_pred hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 234 ~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..++..+.+||.+||..+|.+|||+.++++||||+..
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 5788999999999999999999999999999999865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=402.19 Aligned_cols=258 Identities=24% Similarity=0.430 Sum_probs=212.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe--------C
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLH--------Q 83 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--------~ 83 (703)
.+|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 589999999999999999999999999999999865542 2223567789999999999999999999987 4
Q ss_pred CEEEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 84 TKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
+.+||||||+++ +|...+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 578999999975 67666654 4679999999999999999999999999999999999999999999999999987653
Q ss_pred hc----ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---CCCCC----
Q 005298 163 RT----ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---ENPPQ---- 231 (703)
Q Consensus 163 ~~----~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---~~~~~---- 231 (703)
.. .......+||+.|+|||++.+...++.++|||||||++|+|++|.+||...........+.. ..++.
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 21 12234468999999999998766689999999999999999999999987655433222210 00100
Q ss_pred -------------------cch-----hhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 232 -------------------LDE-----HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 232 -------------------l~~-----~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
+.. ..++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 001 1267799999999999999999999999999998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=406.80 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=214.1
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC----
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT---- 84 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~---- 84 (703)
....+|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|++++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 35679999999999999999999999999999999985543 3445678899999999999999999999998763
Q ss_pred --EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 85 --KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 85 --~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
.+||||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 8899999987 679999999999999999999999999999999999999999999999999987653
Q ss_pred hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------- 226 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------- 226 (703)
. .....+||+.|+|||++.+...++.++||||||||+|+|++|++||.+.+....+..|..
T Consensus 180 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 180 S---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp S---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 2 234578999999999998755699999999999999999999999987765443332211
Q ss_pred --------------CCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 227 --------------ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 227 --------------~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.....+...+++.+.+||.+||..||.+|||+.++|+||||....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 001112245688999999999999999999999999999998654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=396.99 Aligned_cols=260 Identities=27% Similarity=0.455 Sum_probs=216.8
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC---
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--- 84 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~--- 84 (703)
....+|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 45679999999999999999999999999999999997653 3445678899999999999999999999988654
Q ss_pred -EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 85 -KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 85 -~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
..||||||++|++|.+++...+++++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 3599999999999999998888999999999999999999999999999999999999999999999999999876543
Q ss_pred cc---cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC---cchhhh
Q 005298 164 TI---SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ---LDEHFS 237 (703)
Q Consensus 164 ~~---~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~---l~~~is 237 (703)
.. ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+....+.. ....++
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp -------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred cccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 22 122346799999999999875 58999999999999999999999998877655544433332222 123578
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..+.+||.+||.+||.+||++.+++.|+|++..
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 899999999999999999999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=392.01 Aligned_cols=257 Identities=21% Similarity=0.356 Sum_probs=215.3
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC--EE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--KL 86 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~--~l 86 (703)
.....+|++.+.||+|+||+||+|.+..+++.||||++.........+.+.+|+.++++++||||+++++++.... .+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 3456799999999999999999999999999999999976544444677889999999999999999999998765 78
Q ss_pred EEEEeccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe----cCCCCeeEeccccch
Q 005298 87 WIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL----TENGDVKVADFGVSA 159 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~---~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL----d~~g~VKL~DFGlA~ 159 (703)
||||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||| +..+.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999999997643 39999999999999999999999999999999999999 777889999999987
Q ss_pred hhhhcccccccccCCCCCCchhhhcc-------ccCCccccchhhHHHHHHHHHhCCCCCCCCCccc----eeeccCC--
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQN-------SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR----VLFIIPR-- 226 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~-------~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~----~l~~I~~-- 226 (703)
..... ......+||+.|+|||++.. ...++.++||||||||||+|++|..||....... .+..+..
T Consensus 165 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 165 ELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp ECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred ecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 65443 22345689999999999863 2458899999999999999999999996543211 1111110
Q ss_pred ----------------------CCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchh
Q 005298 227 ----------------------ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRF 266 (703)
Q Consensus 227 ----------------------~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpf 266 (703)
.....+...++..+.+||.+||.+||.+|||++|+|+||-
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 0112345678889999999999999999999999999964
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=389.56 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=220.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 44689999999999999999999999999999999975432 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe---cCCCCeeEeccccchhhhhcccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL---TENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL---d~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...... .
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~ 163 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--I 163 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--T
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--c
Confidence 999999999999888889999999999999999999999999999999999999 67789999999998654322 2
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFV 244 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~dLI 244 (703)
....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.... +......++..+.+||
T Consensus 164 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 242 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFI 242 (304)
T ss_dssp THHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred cccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHH
Confidence 2346799999999999764 58999999999999999999999998876655444443322 2334467889999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+||..||.+|||+.++++||||...
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 243 CHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHcCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=408.67 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=204.7
Q ss_pred CCCceEE-EEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHH-HhCCCCCeeeeEEEEEe----CCE
Q 005298 12 GSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVL-SQCRSPYITEYYGSYLH----QTK 85 (703)
Q Consensus 12 ~~~Y~il-~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~IL-k~L~HPnIV~L~~~~~~----~~~ 85 (703)
..+|.++ ++||+|+||+||+|.+..+|+.||||++... ..+.+|+.++ +.++||||++++++|.. ...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 3478887 7999999999999999999999999998632 3567888887 45689999999999876 667
Q ss_pred EEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC---CCCeeEeccccchh
Q 005298 86 LWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSAQ 160 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~---~g~VKL~DFGlA~~ 160 (703)
+|||||||+||+|.+++.... .+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||++..
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999999998754 5999999999999999999999999999999999999997 78899999999876
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee----eccCCC---CCCCcc
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL----FIIPRE---NPPQLD 233 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l----~~I~~~---~~~~l~ 233 (703)
.... ......+||+.|+|||++.+. .|+.++||||||||||+|++|..||...+..... ..+... .+....
T Consensus 214 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 291 (400)
T 1nxk_A 214 TTSH-NSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291 (400)
T ss_dssp CC------------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTT
T ss_pred cCCC-CccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccc
Confidence 5432 233467899999999999764 5899999999999999999999999876543321 112111 122223
Q ss_pred hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 234 ~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..++..+.+||.+||.+||.+|||+.+|++||||...
T Consensus 292 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 5688999999999999999999999999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=401.56 Aligned_cols=256 Identities=27% Similarity=0.517 Sum_probs=221.4
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-------hHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ 83 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-------~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~ 83 (703)
..+|++.+.||.|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 3579999999999999999999999999999999865431 12245778999999999 799999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
+..||||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+..
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccCCCCCCchhhhccc-----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCc---chh
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNS-----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL---DEH 235 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~-----~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l---~~~ 235 (703)
. ......+||+.|+|||++.+. ..++.++|||||||+||+|++|..||........+..+........ ...
T Consensus 253 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 331 (365)
T 2y7j_A 253 G-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331 (365)
T ss_dssp T-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred C-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence 3 233457899999999998642 2478899999999999999999999988766555544433322211 235
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
++..+.+||.+||..||.+|||+.++|+||||+
T Consensus 332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 678899999999999999999999999999996
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=393.08 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=206.5
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHh-CCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQ-CRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~-L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||+||+|.+..+|+.||||++.... ..........|+..+.+ +.||||++++++|.+++.+||||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999986543 23333445555555554 49999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 91 Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ....
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~ 214 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGE 214 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-CCCc
Confidence 999 6788888765 457999999999999999999999999999999999999999999999999998765433 2234
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
..+||+.|+|||++.+ .++.++|||||||+||+|++|..||........+ .....++.+...++..+.+||.+||.
T Consensus 215 ~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~L~ 290 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL--RQGYLPPEFTAGLSSELRSVLVMMLE 290 (311)
T ss_dssp CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH--TTTCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred ccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH--hccCCCcccccCCCHHHHHHHHHHcC
Confidence 5679999999999875 4899999999999999999997776543322211 11112333455678999999999999
Q ss_pred cCCCCCCCHHHHHhchhhhc
Q 005298 250 KVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 250 ~dP~~RPTa~eLL~Hpff~~ 269 (703)
+||.+|||+.++|+||||++
T Consensus 291 ~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 291 PDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp SSTTTSCCHHHHHTSGGGSC
T ss_pred CChhhCcCHHHHHhCccccC
Confidence 99999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=407.82 Aligned_cols=255 Identities=25% Similarity=0.441 Sum_probs=211.1
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe-------
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH------- 82 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~------- 82 (703)
....+|++++.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.++|||||+++++|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45679999999999999999999999999999999986443 223479999999999999999999854
Q ss_pred -------------------------------CCEEEEEEeccCCCCHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHH
Q 005298 83 -------------------------------QTKLWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEYL 127 (703)
Q Consensus 83 -------------------------------~~~lyLV~Eyv~gGsL~~~l----~~~~~L~e~~i~~i~~QLl~AL~yL 127 (703)
...+||||||++ ++|.+.+ ..+..+++..++.|+.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334899999997 4766655 4467899999999999999999999
Q ss_pred HhcCceeeeeccceEEec-CCCCeeEeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHH
Q 005298 128 HNEGKIHRDIKAANILLT-ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMA 206 (703)
Q Consensus 128 Hs~gIVHRDIKPeNILLd-~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELL 206 (703)
|++||+||||||+||||+ .++.+||+|||++..+... ......+||+.|+|||++.+...++.++|||||||++|+|+
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 999999999999999998 5789999999999765433 23345689999999999987666899999999999999999
Q ss_pred hCCCCCCCCCccceeeccCCC-------------------CCC---------CcchhhhHHHHHHHHHHhccCCCCCCCH
Q 005298 207 KGEPPLADLHPMRVLFIIPRE-------------------NPP---------QLDEHFSRLMKEFVSLCLKKVPAERPSA 258 (703)
Q Consensus 207 tG~~PF~~~~~~~~l~~I~~~-------------------~~~---------~l~~~is~~L~dLI~~cL~~dP~~RPTa 258 (703)
+|.+||...+..+.+..+... ..+ .++..++..+.+||.+||..+|.+|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 999999887655443332110 000 1234578889999999999999999999
Q ss_pred HHHHhchhhhccc
Q 005298 259 KELLRHRFIRNAR 271 (703)
Q Consensus 259 ~eLL~Hpff~~~~ 271 (703)
.|+|+||||...+
T Consensus 317 ~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 317 YEAMAHPFFDHLR 329 (383)
T ss_dssp HHHHTSGGGHHHH
T ss_pred HHHhcCHHHHHHH
Confidence 9999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=406.54 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=215.8
Q ss_pred CCceE--EEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSS--LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~i--l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
..|.+ .+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+|++++|||||+++++|...+.+||||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 34555 678999999999999999999999999997653 344578899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe--cCCCCeeEeccccchhhhhcccc
Q 005298 91 EYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL--TENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL--d~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
|||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+... ..
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-~~ 244 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EK 244 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-CB
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-cc
Confidence 999999999988654 479999999999999999999999999999999999999 45678999999998765433 23
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFV 244 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~dLI 244 (703)
....+||+.|+|||++.+. .++.++||||||||||+|++|..||...+....+..+.... +......++..+++||
T Consensus 245 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred cccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 3456899999999999764 58999999999999999999999999887665555443322 2222356789999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
.+||.++|.+|||+.|+|+||||...+.
T Consensus 324 ~~~L~~dp~~Rps~~e~l~hp~~~~~~~ 351 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKHPWLSDHKL 351 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred HHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence 9999999999999999999999987643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=391.93 Aligned_cols=267 Identities=30% Similarity=0.503 Sum_probs=217.2
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-------hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQCRSPYITEYYGSYLH 82 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-------~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~ 82 (703)
....+|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 345689999999999999999999999999999999865431 1223467899999999999999999999876
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC---eeEeccccch
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD---VKVADFGVSA 159 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~---VKL~DFGlA~ 159 (703)
++ +|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 65 8999999999999999988889999999999999999999999999999999999999987654 9999999987
Q ss_pred hhhhcccccccccCCCCCCchhhhc--cccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee-eccCCCCCC---Ccc
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQ--NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-FIIPRENPP---QLD 233 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~--~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l-~~I~~~~~~---~l~ 233 (703)
..... ......+||+.|+|||++. ....++.++|||||||++|+|++|..||........+ ..+...... ...
T Consensus 166 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 166 ILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp ECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred ecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 65332 1223467999999999984 2345889999999999999999999999765543222 222222221 223
Q ss_pred hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccChhHHH
Q 005298 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278 (703)
Q Consensus 234 ~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~e 278 (703)
..++..+.+||.+||..||.+||++.++|+||||+.......+.+
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~~~~~~ 289 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHHHHHHH
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHHHHHHH
Confidence 457889999999999999999999999999999987654333333
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=399.00 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=206.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-----
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----- 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~----- 84 (703)
...+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4579999999999999999999999999999999987543 3455677889999999999999999999998765
Q ss_pred -EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 85 -KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 85 -~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
.+|||||||+ ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 7899999996 57888886 4589999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC------------
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ------------ 231 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~------------ 231 (703)
. ......+||+.|+|||++.+. .++.++||||||||||+|++|..||...+....+..+......+
T Consensus 180 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 180 S-FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred c-cccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 2 223456899999999999875 58999999999999999999999998876544333322111000
Q ss_pred -----------------------------cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 232 -----------------------------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 232 -----------------------------l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.....+..+++||.+||..||.+|||+.|+|+||||...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 011236789999999999999999999999999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=404.36 Aligned_cols=256 Identities=25% Similarity=0.486 Sum_probs=213.2
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCC--CCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR--SPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~--HPnIV~L~~~~~~~~~lyL 88 (703)
+.+|++++.||+|+||.||+|.+.. ++.||||++.... .....+.+.+|+.+|++|. |||||++++++..++.+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4569999999999999999999876 9999999997654 3455678999999999996 5999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc--
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-- 166 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-- 166 (703)
||| +.+++|.+++.....+++..+..|+.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+.....
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 999 55889999999888999999999999999999999999999999999999995 58999999999976643322
Q ss_pred ccccccCCCCCCchhhhccc----------cCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceeeccC-CCCCCCcch
Q 005298 167 RRKTFVGTPFWMAPEVIQNS----------EGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFIIP-RENPPQLDE 234 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~----------~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~-~~l~~I~-~~~~~~l~~ 234 (703)
.....+||+.|+|||++.+. ..|+.++||||||||||+|++|.+||...... ..+..+. ......++.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence 22456899999999998651 35888999999999999999999999765432 2222222 222233445
Q ss_pred hhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 235 ~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..+..+.+||.+||..||.+|||+.|+|+||||+..
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 567889999999999999999999999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=431.21 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=223.0
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
...+|+++++||+|+||.||+|.++.+|+.||||++..... ......+.+|+.+|++++|||||+++++|.+.+.+||
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 34689999999999999999999999999999999864321 1224567899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 89 IMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
|||||+||+|.+++...+ .+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++..+... .
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~-~ 340 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-Q 340 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-C
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC-c
Confidence 999999999999998754 4999999999999999999999999999999999999999999999999999765432 2
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc---eeeccCCCCCCCcchhhhHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR---VLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~---~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
.....+||+.|+|||++.+. .|+.++||||||||||+|++|.+||....... .+.......+..++..++..+++|
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dL 419 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSL 419 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred cccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence 23456899999999999875 58999999999999999999999998754321 111111223445567889999999
Q ss_pred HHHHhccCCCCCC-----CHHHHHhchhhhcccc
Q 005298 244 VSLCLKKVPAERP-----SAKELLRHRFIRNARK 272 (703)
Q Consensus 244 I~~cL~~dP~~RP-----Ta~eLL~Hpff~~~~~ 272 (703)
|.+||.+||.+|| ++.||++||||+...+
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 9999999999999 7999999999997643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=391.19 Aligned_cols=251 Identities=29% Similarity=0.521 Sum_probs=209.9
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
....+|++.+.||+|+||+||+|.+ +|+.||||++.... .....+.+.+|+.++++++||||+++++++...+.+||
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 3456999999999999999999987 48899999987654 34556788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhcC--ceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 89 IMEYMAGGSVADLIQSGPP---LDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~---L~e~~i~~i~~QLl~AL~yLHs~g--IVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
||||+++++|.+++..... +++..+..++.||+.||.|||++| |+||||||+||||+.++.+||+|||++.....
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999999987654 999999999999999999999999 99999999999999999999999999876554
Q ss_pred cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCcchhhhHHHHH
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLMKE 242 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~-~~~~~~l~~~is~~L~d 242 (703)
........+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+. ......++..+++.+.+
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 270 (309)
T 3p86_A 192 TFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270 (309)
T ss_dssp ----------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred cccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHH
Confidence 43344567899999999999875 58999999999999999999999999887665554442 23344566788999999
Q ss_pred HHHHHhccCCCCCCCHHHHHh
Q 005298 243 FVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~ 263 (703)
||.+||..+|.+|||+.+|++
T Consensus 271 li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 271 IIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999997
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=404.17 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=225.8
Q ss_pred hhhhCCCceEEEEEeecCceEEEEEE-----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe
Q 005298 8 QEAAGSRFSSLELIGRGSFGDVYKAF-----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH 82 (703)
Q Consensus 8 ~~~~~~~Y~il~~LG~GsfG~Vyka~-----d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~ 82 (703)
.+....+|++++.||+|+||.||+|. +..+++.||||++...........+.+|+.++++++|||||++++++..
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 34455789999999999999999999 4557889999999766666667789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC---CeeE
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG---DVKV 152 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~-------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g---~VKL 152 (703)
....|||||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999999753 3589999999999999999999999999999999999999655 5999
Q ss_pred eccccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCC
Q 005298 153 ADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENP 229 (703)
Q Consensus 153 ~DFGlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~ 229 (703)
+|||++..+.... ......+||+.|+|||++.+. .++.++|||||||+||+|++ |..||...........+.....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999997654332 223346789999999999775 58999999999999999998 9999998887777777766666
Q ss_pred CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 230 ~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
...+..++..+.+||.+||..+|.+|||+.+|+++.++.
T Consensus 305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 666778899999999999999999999999999997664
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=409.57 Aligned_cols=250 Identities=13% Similarity=0.158 Sum_probs=206.4
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHH---HHHHhCCCCCeeeeE-------EE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEI---SVLSQCRSPYITEYY-------GS 79 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei---~ILk~L~HPnIV~L~-------~~ 79 (703)
..+|++.+.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+ .+|++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 468999999999999999999999999999999987542 344567889999 455566899999998 77
Q ss_pred EEeCC-----------------EEEEEEeccCCCCHHHHHHcCCCCCH-------HHHHHHHHHHHHHHHHHHhcCceee
Q 005298 80 YLHQT-----------------KLWIIMEYMAGGSVADLIQSGPPLDE-------MSIACILRDLLHAIEYLHNEGKIHR 135 (703)
Q Consensus 80 ~~~~~-----------------~lyLV~Eyv~gGsL~~~l~~~~~L~e-------~~i~~i~~QLl~AL~yLHs~gIVHR 135 (703)
+.+.+ ..||||||+ +|+|.+++...+.+++ ..+..|+.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 66554 289999999 6899999986555555 7888899999999999999999999
Q ss_pred eeccceEEecCCCCeeEeccccchhhhhcccccccccCCCCCCchhhhccc----------cCCccccchhhHHHHHHHH
Q 005298 136 DIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS----------EGYNEKADIWSLGITVIEM 205 (703)
Q Consensus 136 DIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~----------~~~s~ksDVWSLGvILyEL 205 (703)
||||+||||+.++.+||+|||++..... .....+| +.|+|||++.+. ..++.++|||||||+||+|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 9999999999999999999999875432 2345678 999999999875 2589999999999999999
Q ss_pred HhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 206 AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 206 LtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
++|..||...+.......+... ...++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 307 ltg~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHSSCCC------CCSGGGGSS-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHCCCCCcccccccchhhhhhh-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 9999999877665555444332 145688999999999999999999999999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=402.90 Aligned_cols=258 Identities=29% Similarity=0.496 Sum_probs=217.4
Q ss_pred CCceEEEEEeecCceEEEEEEEc---CCCcEEEEEEeccCC---ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTK 85 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~---~tg~~VAIKvi~~~~---~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~ 85 (703)
.+|++++.||+|+||.||+|.+. .+++.||||+++... .....+.+.+|+.+|+++ .||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 58999999999999999999984 589999999986432 112235567899999999 69999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
+|||||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 213 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999987653322
Q ss_pred -cccccccCCCCCCchhhhccc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccceee----ccCCCCCCCcchhhhHH
Q 005298 166 -SRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF----IIPRENPPQLDEHFSRL 239 (703)
Q Consensus 166 -~~~~~~iGTp~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~----~I~~~~~~~l~~~is~~ 239 (703)
......+||+.|+|||++.+. ..++.++||||||||||+|++|..||.......... .+.. ..+.++..++..
T Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 292 (355)
T 1vzo_A 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSAL 292 (355)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-CCCCCCTTSCHH
T ss_pred CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc-cCCCCCcccCHH
Confidence 223456899999999999753 347889999999999999999999997554322211 1111 233456678899
Q ss_pred HHHHHHHHhccCCCCCC-----CHHHHHhchhhhccc
Q 005298 240 MKEFVSLCLKKVPAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
+.+||.+||.+||.+|| ++.++++||||....
T Consensus 293 ~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 99999999999999999 999999999998753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=387.03 Aligned_cols=252 Identities=21% Similarity=0.392 Sum_probs=212.7
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEe--CCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLH--QTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~--~~~lyL 88 (703)
..+|++++.||+|+||+||+|++..+++.||||++.... ...+.+|+.+++++. ||||+++++++.. ....++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 468999999999999999999999999999999986432 366889999999997 9999999999998 678999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC-CeeEeccccchhhhhcccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g-~VKL~DFGlA~~~~~~~~~ 167 (703)
||||+.+++|.++++. +++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++...... ..
T Consensus 111 v~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~ 186 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QE 186 (330)
T ss_dssp EEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-CC
T ss_pred EEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-Cc
Confidence 9999999999999854 89999999999999999999999999999999999999776 8999999998765433 23
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceeecc-------------C--------
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLFII-------------P-------- 225 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~-~~l~~I-------------~-------- 225 (703)
....+||+.|+|||++.+...++.++|||||||+||+|++|..||...... ..+..+ .
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence 345689999999999987567899999999999999999999999543221 110000 0
Q ss_pred ---------------CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 226 ---------------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 226 ---------------~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
..........++..+.+||.+||.+||.+|||+.|+|+||||+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0011122334789999999999999999999999999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=400.83 Aligned_cols=252 Identities=23% Similarity=0.443 Sum_probs=221.3
Q ss_pred CCCceEEEEEeecCceEEEEEEEc-------CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDK-------ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ 83 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~-------~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~ 83 (703)
..+|++.+.||+|+||.||+|.+. .++..||||++...........+.+|+.+++++ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 358999999999999999999875 345689999998766666678899999999999 899999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~----------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~ 147 (703)
+.+||||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||||+.+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC
Confidence 99999999999999999997643 48999999999999999999999999999999999999999
Q ss_pred CCeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeecc
Q 005298 148 GDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII 224 (703)
Q Consensus 148 g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I 224 (703)
+.+||+|||++..+..... ......||+.|+|||++.+. .|+.++|||||||+||||++ |..||...........+
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~ 318 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999876543221 22335678899999999775 58999999999999999999 99999988777666666
Q ss_pred CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 225 ~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.....+..+..++..+.+||.+||..+|.+||++.||+++
T Consensus 319 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 319 KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6665666777889999999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=393.89 Aligned_cols=262 Identities=26% Similarity=0.381 Sum_probs=218.9
Q ss_pred hhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC----
Q 005298 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ---- 83 (703)
Q Consensus 8 ~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~---- 83 (703)
......+|++.+.||+|+||.||+|.+..+|+.||||++...........+.+|+.++++++||||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 3456789999999999999999999999999999999997665666677888999999999999999999988764
Q ss_pred -CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 84 -TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 84 -~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
...|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 67999999996 699999876 579999999999999999999999999999999999999999999999999987653
Q ss_pred hccc----------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-------
Q 005298 163 RTIS----------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP------- 225 (703)
Q Consensus 163 ~~~~----------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~------- 225 (703)
.... .....+||+.|+|||++.....++.++|||||||+||+|++|.+||...+....+..+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 2211 12235899999999998765668999999999999999999999998765432221110
Q ss_pred ---------------------CCCCC---CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 226 ---------------------RENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 226 ---------------------~~~~~---~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
..... .....++..+.+||.+||..||.+|||+.++++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00000 01235788999999999999999999999999999998653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=391.30 Aligned_cols=253 Identities=28% Similarity=0.475 Sum_probs=223.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~-----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
...+|++++.||+|+||.||+|.+. .+++.||||++.........+.+.+|+.++++++||||+++++++...+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4469999999999999999999997 45689999999876666667889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccce
Q 005298 86 LWIIMEYMAGGSVADLIQSG------------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAAN 141 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~------------------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeN 141 (703)
+||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 204 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 204 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence 99999999999999999763 579999999999999999999999999999999999
Q ss_pred EEecCCCCeeEeccccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCcc
Q 005298 142 ILLTENGDVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPM 218 (703)
Q Consensus 142 ILLd~~g~VKL~DFGlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~ 218 (703)
|||+.++.+||+|||++..+.... .......||+.|+|||++.+. .++.++|||||||++|+|++ |..||......
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 283 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence 999999999999999987654332 122345789999999999875 48999999999999999999 99999988777
Q ss_pred ceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 219 RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 219 ~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.....+.......++..++..+.+||.+||..+|.+||++.+++++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 284 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 6666666666666777889999999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=386.46 Aligned_cols=262 Identities=26% Similarity=0.434 Sum_probs=218.1
Q ss_pred cccchhhhCCCceEEEEEeecCceEEEEEEE-cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCC------Ceeee
Q 005298 4 LAGLQEAAGSRFSSLELIGRGSFGDVYKAFD-KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP------YITEY 76 (703)
Q Consensus 4 i~~l~~~~~~~Y~il~~LG~GsfG~Vyka~d-~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HP------nIV~L 76 (703)
+....+....+|++++.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|+.+++.++|+ +|+++
T Consensus 5 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 5 ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp TCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred eeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 3445566778999999999999999999999 568999999998643 34567788999999988765 49999
Q ss_pred EEEEEeCCEEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC--------
Q 005298 77 YGSYLHQTKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-------- 146 (703)
Q Consensus 77 ~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~-------- 146 (703)
++++...+.+||||||+ +++|.+++.... ++++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 899999998765 6899999999999999999999999999999999999987
Q ss_pred -----------CCCeeEeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCC
Q 005298 147 -----------NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL 215 (703)
Q Consensus 147 -----------~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~ 215 (703)
++.+||+|||++..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CccccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 66899999999865432 23456899999999999875 5899999999999999999999999876
Q ss_pred CccceeeccCC---CCC----------------------------------------CCcchhhhHHHHHHHHHHhccCC
Q 005298 216 HPMRVLFIIPR---ENP----------------------------------------PQLDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 216 ~~~~~l~~I~~---~~~----------------------------------------~~l~~~is~~L~dLI~~cL~~dP 252 (703)
+.......+.. ..+ .......+..+.+||.+||..||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 54332211100 000 01123456789999999999999
Q ss_pred CCCCCHHHHHhchhhhcccc
Q 005298 253 AERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 253 ~~RPTa~eLL~Hpff~~~~~ 272 (703)
.+|||+.|+++||||+..++
T Consensus 318 ~~Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 318 AKRITLREALKHPFFDLLKK 337 (339)
T ss_dssp TTSCCHHHHTTSGGGGGGGC
T ss_pred ccccCHHHHhcCHHHHHHhc
Confidence 99999999999999987643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=385.18 Aligned_cols=260 Identities=26% Similarity=0.453 Sum_probs=211.8
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEE-------
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL------- 81 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~------- 81 (703)
....++|++++.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 34578999999999999999999999999999999998754 3455678899999999999999999999873
Q ss_pred -------eCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec-CCCCeeEe
Q 005298 82 -------HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT-ENGDVKVA 153 (703)
Q Consensus 82 -------~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd-~~g~VKL~ 153 (703)
....+|+||||++ |+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4478999999997 699999865 6799999999999999999999999999999999999997 46799999
Q ss_pred ccccchhhhhcc---cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC-
Q 005298 154 DFGVSAQLTRTI---SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP- 229 (703)
Q Consensus 154 DFGlA~~~~~~~---~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~- 229 (703)
|||++....... .......||+.|+|||++.....++.++|||||||++|+|++|..||...+.......+....+
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999987653221 2223457899999999987655689999999999999999999999988765443332221110
Q ss_pred -------------------------C---CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 230 -------------------------P---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 230 -------------------------~---~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
. .+...++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 0 11235788999999999999999999999999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=384.97 Aligned_cols=253 Identities=26% Similarity=0.445 Sum_probs=223.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~-----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
...+|++.+.||+|+||.||+|.+. .++..||||++.........+.+.+|+.++++++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 4569999999999999999999983 45689999999876666777889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCceeeeeccce
Q 005298 86 LWIIMEYMAGGSVADLIQSGPP------------------------LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAAN 141 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~------------------------L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeN 141 (703)
+|+||||+++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~N 180 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchhe
Confidence 9999999999999999986543 8999999999999999999999999999999999
Q ss_pred EEecCCCCeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCcc
Q 005298 142 ILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPM 218 (703)
Q Consensus 142 ILLd~~g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~ 218 (703)
|||+.++.+||+|||++........ ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999876543221 22345678899999999775 58999999999999999999 99999988777
Q ss_pred ceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 219 RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 219 ~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.....+........+..++..+.+||.+||..||.+||++.+|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 260 RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6666666555666677889999999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=383.89 Aligned_cols=264 Identities=27% Similarity=0.498 Sum_probs=225.9
Q ss_pred ccchhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC
Q 005298 5 AGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (703)
Q Consensus 5 ~~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~ 83 (703)
...+.....+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (287)
T 2wei_A 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (287)
T ss_dssp HHHTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhHHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC
Confidence 3455667789999999999999999999999999999999986543 223356788999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC---CCeeEeccccchh
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---GDVKVADFGVSAQ 160 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~---g~VKL~DFGlA~~ 160 (703)
+.+|+||||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++..
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999999999999877889999999999999999999999999999999999999764 4699999999876
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCC---CCcchhhh
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENP---PQLDEHFS 237 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~---~~l~~~is 237 (703)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+..... ......++
T Consensus 174 ~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 2wei_A 174 FQQN-TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (287)
T ss_dssp BCCC-SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred ecCC-CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence 5432 22334578999999999875 388999999999999999999999988776555444433221 12224678
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
..+.+||.+||..+|.+|||+.++++||||+...
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 9999999999999999999999999999998653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=391.39 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=220.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCc---EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~---~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
...+|++.+.||+|+||.||+|.+..++. .||||++.........+.+.+|+.++++++||||+++++++.+++.+|
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 34689999999999999999999986554 599999987666667788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 88 IIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
|||||+++++|.+++... ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999999999999754 6899999999999999999999999999999999999999999999999999876543322
Q ss_pred c---cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHH
Q 005298 167 R---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (703)
Q Consensus 167 ~---~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~d 242 (703)
. .....+|+.|+|||++.+. .++.++|||||||+||+|++ |..||...........+........+..++..+.+
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 285 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQ 285 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHH
Confidence 1 1223567889999999765 58999999999999999999 99999988877777766666666677789999999
Q ss_pred HHHHHhccCCCCCCCHHHHHh
Q 005298 243 FVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~ 263 (703)
||..||..+|.+|||+.+|++
T Consensus 286 li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 286 LMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999997
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=392.36 Aligned_cols=262 Identities=25% Similarity=0.470 Sum_probs=220.3
Q ss_pred hhhCCCceEE-EEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCE
Q 005298 9 EAAGSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTK 85 (703)
Q Consensus 9 ~~~~~~Y~il-~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~ 85 (703)
+....+|.+. +.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++++. ||||++++++|...+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 4455688888 899999999999999999999999999875432 233567889999999995 6999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC---CCCeeEeccccchh
Q 005298 86 LWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSAQ 160 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~---~g~VKL~DFGlA~~ 160 (703)
+|+|||||.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 9999999999999999855 367999999999999999999999999999999999999987 78999999999876
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---CCCCCcchhhh
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---ENPPQLDEHFS 237 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---~~~~~l~~~is 237 (703)
..... .....+||+.|+|||++.+. .++.++|||||||+||+|++|..||...+.......+.. ..+......++
T Consensus 184 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 184 IGHAC-ELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261 (327)
T ss_dssp C----------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred cCCcc-ccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence 54332 23456899999999999765 589999999999999999999999988766554433322 23334445788
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
..+.+||.+||..+|.+|||+.++|+||||+....
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 99999999999999999999999999999987543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=404.95 Aligned_cols=258 Identities=22% Similarity=0.411 Sum_probs=201.6
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC----
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ---- 83 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~---- 83 (703)
.....+|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 345679999999999999999999999999999999986543 344567888999999999999999999999764
Q ss_pred --CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 84 --TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 84 --~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
..+|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp GCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred cCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 5689999999 7899999876 67999999999999999999999999999999999999999999999999998765
Q ss_pred hhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---------------
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR--------------- 226 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~--------------- 226 (703)
... ....+||+.|+|||++.+...++.++||||||||||+|++|.+||.+.+....+..+..
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 183 ADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 432 34568999999999998756789999999999999999999999988765443322211
Q ss_pred ------------CCCCCc---chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 227 ------------ENPPQL---DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 227 ------------~~~~~l---~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.....+ ...+++.+.+||.+||..||.+|||+.++|+||||....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 000111 124578899999999999999999999999999998653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=384.37 Aligned_cols=254 Identities=27% Similarity=0.453 Sum_probs=214.0
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.++|++.+.||+|+||+||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 46899999999999999999999999999999998543 45567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc---
Q 005298 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR--- 167 (703)
Q Consensus 92 yv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~--- 167 (703)
|+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 9999999999987 578999999999999999999999999999999999999999999999999998765332211
Q ss_pred -----------cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC--CCCCCCcch
Q 005298 168 -----------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP--RENPPQLDE 234 (703)
Q Consensus 168 -----------~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~--~~~~~~l~~ 234 (703)
....+||+.|+|||++.+. .++.++|||||||+||+|++|..||............. .......+.
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCT
T ss_pred cccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCC
Confidence 1256899999999999875 58999999999999999999999997654322211110 001112345
Q ss_pred hhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 235 ~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
.+++.+.+||.+||..||.+|||+.++++ |+..
T Consensus 247 ~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~ 279 (310)
T 3s95_A 247 NCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279 (310)
T ss_dssp TCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 66778999999999999999999999987 4543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=378.85 Aligned_cols=262 Identities=31% Similarity=0.574 Sum_probs=211.5
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe---------
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--------- 82 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--------- 82 (703)
..+|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 45799999999999999999999999999999998643 3456788999999999999999999998865
Q ss_pred ----CCEEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecccc
Q 005298 83 ----QTKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (703)
Q Consensus 83 ----~~~lyLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGl 157 (703)
.+.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 45789999999999999999754 4688999999999999999999999999999999999999999999999999
Q ss_pred chhhhhc--------------ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCC-ccceee
Q 005298 158 SAQLTRT--------------ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLF 222 (703)
Q Consensus 158 A~~~~~~--------------~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~-~~~~l~ 222 (703)
+...... .......+||+.|+|||++.+...++.++|||||||++|+|++ ||.... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 8765321 1122346799999999999865568999999999999999998 554321 111111
Q ss_pred cc---CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccChhHHH
Q 005298 223 II---PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278 (703)
Q Consensus 223 ~I---~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~e 278 (703)
.+ ....++.+....+..+.+||.+||..||.+|||+.++++||||........+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~ 298 (303)
T 1zy4_A 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKE 298 (303)
T ss_dssp HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHHHHHH
T ss_pred hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHHHHHH
Confidence 11 222344556677888999999999999999999999999999986544443333
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=387.71 Aligned_cols=259 Identities=23% Similarity=0.414 Sum_probs=202.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCc---EEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~---~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
...+|++.+.||+|+||.||+|.+..++. .||||++.... .....+.+.+|+.++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45689999999999999999999887765 89999987553 334567899999999999999999999999887655
Q ss_pred ------EEEEeccCCCCHHHHHHcCC------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEec
Q 005298 87 ------WIIMEYMAGGSVADLIQSGP------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154 (703)
Q Consensus 87 ------yLV~Eyv~gGsL~~~l~~~~------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~D 154 (703)
|+||||+.+++|.+++.... .+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence 99999999999999996422 699999999999999999999999999999999999999999999999
Q ss_pred cccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCC
Q 005298 155 FGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQ 231 (703)
Q Consensus 155 FGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~ 231 (703)
||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++ |.+||...........+.......
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 259 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred ccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC
Confidence 999876543221 12234578899999999775 58999999999999999999 999999888777776666666666
Q ss_pred cchhhhHHHHHHHHHHhccCCCCCCC-------HHHHHhchhhhcc
Q 005298 232 LDEHFSRLMKEFVSLCLKKVPAERPS-------AKELLRHRFIRNA 270 (703)
Q Consensus 232 l~~~is~~L~dLI~~cL~~dP~~RPT-------a~eLL~Hpff~~~ 270 (703)
.+..++..+.+||.+||..||.+||| +++++.|+|+...
T Consensus 260 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 67788999999999999999999999 6777788888654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=394.52 Aligned_cols=254 Identities=24% Similarity=0.409 Sum_probs=217.0
Q ss_pred hhCCCceEEEEEeecCceEEEEEE-----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAF-----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ 83 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~-----d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~ 83 (703)
....+|++.+.||+|+||.||+|. +..+++.||||++.........+.+.+|+.++.++ +|||||++++++...
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 345799999999999999999999 55677999999998766666778899999999999 789999999999875
Q ss_pred C-EEEEEEeccCCCCHHHHHHcCCC-------------------------------------------------------
Q 005298 84 T-KLWIIMEYMAGGSVADLIQSGPP------------------------------------------------------- 107 (703)
Q Consensus 84 ~-~lyLV~Eyv~gGsL~~~l~~~~~------------------------------------------------------- 107 (703)
+ .+|+|||||.+|+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 5 48999999999999999976543
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc--cccccccCC
Q 005298 108 -----------LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRRKTFVGT 174 (703)
Q Consensus 108 -----------L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~~~~iGT 174 (703)
+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... .......||
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 8999999999999999999999999999999999999999999999999997653322 123346789
Q ss_pred CCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCcccee-eccCCCCCCCcchhhhHHHHHHHHHHhccCC
Q 005298 175 PFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVL-FIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252 (703)
Q Consensus 175 p~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l-~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP 252 (703)
+.|+|||++.+. .++.++||||||||||+|++ |..||......... ..+........+..+++.+.+||.+||..+|
T Consensus 259 ~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 337 (359)
T 3vhe_A 259 LKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 337 (359)
T ss_dssp GGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred ceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 999999999875 58999999999999999998 99999876643322 2333334445567788999999999999999
Q ss_pred CCCCCHHHHHhc
Q 005298 253 AERPSAKELLRH 264 (703)
Q Consensus 253 ~~RPTa~eLL~H 264 (703)
.+|||+.++++|
T Consensus 338 ~~Rps~~ell~~ 349 (359)
T 3vhe_A 338 SQRPTFSELVEH 349 (359)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCCCHHHHHHH
Confidence 999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=408.03 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=207.4
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC------CEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------TKLW 87 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~------~~ly 87 (703)
+|+++++||+|+||.||+|++..+|+.||||++.... ....+|+.+|++|+|||||+++++|... ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 7999999999999999999999999999999986442 2234799999999999999999988642 2478
Q ss_pred EEEeccCCCCHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC-CCeeEeccccchhhh
Q 005298 88 IIMEYMAGGSVADLIQ----SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLT 162 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~----~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~-g~VKL~DFGlA~~~~ 162 (703)
+||||+.+ +|..++. ....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||++..+.
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99999975 6666553 45789999999999999999999999999999999999999965 578999999997654
Q ss_pred hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------- 226 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------- 226 (703)
.. ......+||+.|+|||++.+...|+.++||||||||||||++|++||...+..+.+..+..
T Consensus 209 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 209 RG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp TT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred cC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 33 2234578999999999998765689999999999999999999999988765433322211
Q ss_pred ---CCCCC---------cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 227 ---ENPPQ---------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 227 ---~~~~~---------l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
...+. +...++..+.+||.+||.+||.+|||+.|+++||||...+
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 00000 2235678999999999999999999999999999997653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=380.21 Aligned_cols=256 Identities=32% Similarity=0.564 Sum_probs=212.2
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccC
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMA 94 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~ 94 (703)
|....+||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+.+|+||||++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 344459999999999999999999999999987553 3345778999999999999999999999999999999999999
Q ss_pred CCCHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC-CCCeeEeccccchhhhhccccccc
Q 005298 95 GGSVADLIQSG---PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-NGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 95 gGsL~~~l~~~---~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~-~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
+++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||||+. ++.+||+|||++............
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 182 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CC
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccc
Confidence 99999999764 35679999999999999999999999999999999999987 899999999998765443333445
Q ss_pred ccCCCCCCchhhhccc-cCCccccchhhHHHHHHHHHhCCCCCCCCCccce--eeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 171 FVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV--LFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~--l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
..||+.|+|||++.+. ..++.++|||||||++|+|++|..||........ .........+.++..++..+.+||.+|
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 262 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKC 262 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHT
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHH
Confidence 6899999999998754 2378899999999999999999999975433221 111111233455677899999999999
Q ss_pred hccCCCCCCCHHHHHhchhhhccc
Q 005298 248 LKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
|..+|.+||++.++|+||||+...
T Consensus 263 l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 263 FEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp TCSSTTTSCCHHHHHTSGGGCC--
T ss_pred ccCChhhCCCHHHHhcChhhhhcc
Confidence 999999999999999999998654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=404.90 Aligned_cols=254 Identities=29% Similarity=0.493 Sum_probs=211.7
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC------CCCCeeeeEEEEEeC
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC------RSPYITEYYGSYLHQ 83 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L------~HPnIV~L~~~~~~~ 83 (703)
....+|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+ +|+||+++++++...
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 3456899999999999999999999999999999998643 34456778888888877 578999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC--eeEeccccch
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD--VKVADFGVSA 159 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~--VKL~DFGlA~ 159 (703)
+.+||||||+. ++|.+++.... .+++..++.|+.||+.||.|||++|||||||||+||||+.++. +||+|||++.
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999995 69999987643 5999999999999999999999999999999999999999887 9999999986
Q ss_pred hhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC------------
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------ 227 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~------------ 227 (703)
.... ...+.+||+.|+|||++.+. .|+.++||||||||||+|++|.+||...+....+..+...
T Consensus 251 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 251 YEHQ---RVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp ETTC---CCCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred ecCC---cccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 5432 23457899999999999875 4899999999999999999999999876543322111100
Q ss_pred -----------C----------------------------CCC-------cchhhhHHHHHHHHHHhccCCCCCCCHHHH
Q 005298 228 -----------N----------------------------PPQ-------LDEHFSRLMKEFVSLCLKKVPAERPSAKEL 261 (703)
Q Consensus 228 -----------~----------------------------~~~-------l~~~is~~L~dLI~~cL~~dP~~RPTa~eL 261 (703)
. ++. +....++.+.+||.+||.+||.+|||+.|+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 0 000 111236789999999999999999999999
Q ss_pred Hhchhhhcc
Q 005298 262 LRHRFIRNA 270 (703)
Q Consensus 262 L~Hpff~~~ 270 (703)
|+||||+..
T Consensus 407 L~Hpw~~~~ 415 (429)
T 3kvw_A 407 LRHPWLRRR 415 (429)
T ss_dssp HTSTTTC--
T ss_pred hCChhhccC
Confidence 999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=396.29 Aligned_cols=255 Identities=26% Similarity=0.420 Sum_probs=210.5
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC--------CCCeeeeEE
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR--------SPYITEYYG 78 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~--------HPnIV~L~~ 78 (703)
+.+...++|++++.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++++. ||||+++++
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 3455668999999999999999999999999999999998643 445677889999999985 788999999
Q ss_pred EEE----eCCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhc-CceeeeeccceEEecCCC---
Q 005298 79 SYL----HQTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENG--- 148 (703)
Q Consensus 79 ~~~----~~~~lyLV~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~-gIVHRDIKPeNILLd~~g--- 148 (703)
+|. ....+||||||+ +++|.+++... ..+++..++.|+.||+.||.|||++ |||||||||+||||+.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 998 456899999999 55666655443 5799999999999999999999998 999999999999998775
Q ss_pred ----------------------------------------------CeeEeccccchhhhhcccccccccCCCCCCchhh
Q 005298 149 ----------------------------------------------DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182 (703)
Q Consensus 149 ----------------------------------------------~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEv 182 (703)
.+||+|||++...... ....+||+.|+|||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence 7999999998765432 345689999999999
Q ss_pred hccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee------cc-------------------------------C
Q 005298 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF------II-------------------------------P 225 (703)
Q Consensus 183 l~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~------~I-------------------------------~ 225 (703)
+.+. .++.++||||||||||+|++|..||...+...... .+ .
T Consensus 265 ~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 265 LIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hcCC-CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 9875 48999999999999999999999997654322110 00 0
Q ss_pred CCC----------CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 226 REN----------PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 226 ~~~----------~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
... ....+...+..+.+||.+||.+||.+|||+.|+|+||||+
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 000 0122356678899999999999999999999999999996
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=382.67 Aligned_cols=259 Identities=24% Similarity=0.432 Sum_probs=216.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC---ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEE--eCCE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQCRSPYITEYYGSYL--HQTK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~---~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~--~~~~ 85 (703)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++. ....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999999999999999986542 1234578899999999999999999999985 4568
Q ss_pred EEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 86 LWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
+||||||+.++ |.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999876 7777764 45799999999999999999999999999999999999999999999999999876532
Q ss_pred c--ccccccccCCCCCCchhhhcccc-CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHH
Q 005298 164 T--ISRRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240 (703)
Q Consensus 164 ~--~~~~~~~iGTp~Y~APEvl~~~~-~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L 240 (703)
. ........||+.|+|||++.+.. .++.++|||||||++|+|++|..||...+.......+.... ..++..++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~l 240 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDCGPPL 240 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-CCCCSSSCHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-CCCCCccCHHH
Confidence 1 12223467999999999987532 24678999999999999999999998876655554444332 24456788999
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+||.+||..||.+|||+.++++||||+...
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999999999999998653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=396.81 Aligned_cols=255 Identities=13% Similarity=0.121 Sum_probs=195.1
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhC--CCCCeeeeE-------EEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQC--RSPYITEYY-------GSYL 81 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L--~HPnIV~L~-------~~~~ 81 (703)
.+|++.+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999999987653 34456778885544444 699988766 4554
Q ss_pred eC-----------------CEEEEEEeccCCCCHHHHHHcC-CCCCHHHH------HHHHHHHHHHHHHHHhcCceeeee
Q 005298 82 HQ-----------------TKLWIIMEYMAGGSVADLIQSG-PPLDEMSI------ACILRDLLHAIEYLHNEGKIHRDI 137 (703)
Q Consensus 82 ~~-----------------~~lyLV~Eyv~gGsL~~~l~~~-~~L~e~~i------~~i~~QLl~AL~yLHs~gIVHRDI 137 (703)
.. ..+|||||||+ ++|.+++... ..+++..+ ..++.||+.||.|||++|||||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33 34899999998 8999999763 34454455 577799999999999999999999
Q ss_pred ccceEEecCCCCeeEeccccchhhhhcccccccccCCCCCCchhhhccc-cCCccccchhhHHHHHHHHHhCCCCCCCCC
Q 005298 138 KAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLADLH 216 (703)
Q Consensus 138 KPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLtG~~PF~~~~ 216 (703)
||+||||+.+|.+||+|||++....... ....||+.|+|||++.+. ..++.++|||||||+||+|++|..||....
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 9999999999999999999987654321 145677999999999751 358999999999999999999999998764
Q ss_pred ccc--eeec---cC---CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 217 PMR--VLFI---IP---RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 217 ~~~--~l~~---I~---~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
... .... .. ..........++..+.+||.+||.+||.+|||+.++|+||||+...
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 321 1111 10 0111122247889999999999999999999999999999998754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=396.99 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=213.8
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE--
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL-- 86 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l-- 86 (703)
....+|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||++++++|...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 35579999999999999999999999999999999997543 344567888999999999999999999999887654
Q ss_pred ----EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 87 ----WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 87 ----yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999996 68988874 459999999999999999999999999999999999999999999999999987653
Q ss_pred hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---------------- 226 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---------------- 226 (703)
.. ....+||+.|+|||++.+...++.++|||||||+||+|++|..||...+....+..+..
T Consensus 196 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 196 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred cC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 32 34568999999999998755689999999999999999999999987664433322211
Q ss_pred -----------CCCC---CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 227 -----------ENPP---QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 227 -----------~~~~---~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.... .+...+++.+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 0000 11234688999999999999999999999999999998653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=378.20 Aligned_cols=254 Identities=27% Similarity=0.397 Sum_probs=211.1
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~t---g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
+....+|++.+.||+|+||.||+|.+..+ +..||||++.........+.+.+|+.++++++||||+++++++ .++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCc
Confidence 34557999999999999999999998654 5679999987666666678899999999999999999999997 4567
Q ss_pred EEEEEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 86 LWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
.|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 899999999999999997644 7999999999999999999999999999999999999999999999999998765432
Q ss_pred cc-ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHH
Q 005298 165 IS-RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (703)
Q Consensus 165 ~~-~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~d 242 (703)
.. ......+|+.|+|||++... .++.++|||||||++|+|++ |.+||...........+.......++..++..+.+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 248 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 248 (281)
T ss_dssp ---------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 21 12234678899999999765 58999999999999999996 99999988777766666666666677789999999
Q ss_pred HHHHHhccCCCCCCCHHHHHhc
Q 005298 243 FVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~H 264 (703)
||.+||..+|.+|||+.+++++
T Consensus 249 li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 249 LMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=395.31 Aligned_cols=262 Identities=24% Similarity=0.405 Sum_probs=208.4
Q ss_pred hhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC----------ChHHHHHHHHHHHHHHhCCCCCeeeeE
Q 005298 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE----------SEDEIEDIQKEISVLSQCRSPYITEYY 77 (703)
Q Consensus 8 ~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~----------~~~~~~~l~~Ei~ILk~L~HPnIV~L~ 77 (703)
......+|++.+.||+|+||.||+|.+.. |..||||++.... .....+.+.+|+.++++++||||++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 34567899999999999999999999876 9999999985432 123357889999999999999999999
Q ss_pred EEEEe-----CCEEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCee
Q 005298 78 GSYLH-----QTKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVK 151 (703)
Q Consensus 78 ~~~~~-----~~~lyLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VK 151 (703)
+++.. ...+||||||+. |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+|
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence 99854 347899999997 5788777654 4799999999999999999999999999999999999999999999
Q ss_pred EeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-----
Q 005298 152 VADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----- 226 (703)
Q Consensus 152 L~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~----- 226 (703)
|+|||++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|..||...+....+..+..
T Consensus 175 l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 175 ICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp ECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999998754332 2234568999999999998756689999999999999999999999987654333222210
Q ss_pred ----------------------CCCC----CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 227 ----------------------ENPP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 227 ----------------------~~~~----~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
..+. .....+++.+.+||.+||..||.+|||+.|+|+||||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 0011 112345788999999999999999999999999999987644
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=392.97 Aligned_cols=258 Identities=28% Similarity=0.461 Sum_probs=218.4
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh----------------HHHHHHHHHHHHHHhCCCCCe
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE----------------DEIEDIQKEISVLSQCRSPYI 73 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~----------------~~~~~l~~Ei~ILk~L~HPnI 73 (703)
...++|++.+.||+|+||.||+|.+ +++.||||++...... ...+.+.+|+.++++++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3447999999999999999999999 7999999998643211 112778999999999999999
Q ss_pred eeeEEEEEeCCEEEEEEeccCCCCHHHH------HHc--CCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEe
Q 005298 74 TEYYGSYLHQTKLWIIMEYMAGGSVADL------IQS--GPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILL 144 (703)
Q Consensus 74 V~L~~~~~~~~~lyLV~Eyv~gGsL~~~------l~~--~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILL 144 (703)
+++++++.+.+.+|+||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999998 665 5789999999999999999999999 999999999999999
Q ss_pred cCCCCeeEeccccchhhhhcccccccccCCCCCCchhhhccccCCcc-ccchhhHHHHHHHHHhCCCCCCCCCc-cceee
Q 005298 145 TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE-KADIWSLGITVIEMAKGEPPLADLHP-MRVLF 222 (703)
Q Consensus 145 d~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~-ksDVWSLGvILyELLtG~~PF~~~~~-~~~l~ 222 (703)
+.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||..... .....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred cCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 99999999999998765432 3345689999999999987634655 99999999999999999999987665 33333
Q ss_pred ccCCCCCCCc------------------chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 223 IIPRENPPQL------------------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 223 ~I~~~~~~~l------------------~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.+........ ...++..+.+||.+||..||.+|||+.++++||||....
T Consensus 264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 3332221111 156789999999999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=373.35 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=218.9
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||+|+||.||+|.+.. ++.||||++...... .+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 4689999999999999999999874 778999999755422 3568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-cccc
Q 005298 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~~~ 169 (703)
|+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 9999999999965 4569999999999999999999999999999999999999999999999999987553322 2223
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
...||+.|+|||++.+. .++.++|||||||++|+|++ |.+||...........+........+..++..+.+||.+||
T Consensus 166 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 244 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 244 (269)
T ss_dssp STTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHT
T ss_pred CcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHc
Confidence 45678889999999765 58999999999999999999 99999988877776666666566667778999999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q 005298 249 KKVPAERPSAKELLRH 264 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~H 264 (703)
..+|.+|||+.++++|
T Consensus 245 ~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 245 RERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCCcccCcCHHHHHHH
Confidence 9999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=392.36 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=200.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE-----
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK----- 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~----- 85 (703)
.-.+|++.+.||+|+||.||+|.+..+|+.||||++..... ......+|+..+..++||||++++++|...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 34689999999999999999999999999999998854421 22346678888899999999999999976433
Q ss_pred --EEEEEeccCCCCHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHH--hcCceeeeeccceEEecC-CCCeeEeccc
Q 005298 86 --LWIIMEYMAGGSVADLI----QSGPPLDEMSIACILRDLLHAIEYLH--NEGKIHRDIKAANILLTE-NGDVKVADFG 156 (703)
Q Consensus 86 --lyLV~Eyv~gGsL~~~l----~~~~~L~e~~i~~i~~QLl~AL~yLH--s~gIVHRDIKPeNILLd~-~g~VKL~DFG 156 (703)
+||||||++++ |...+ .....+++..+..++.||+.||.||| ++||+||||||+||||+. ++.+||+|||
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 99 IYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred eeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 89999999764 44333 35678999999999999999999999 999999999999999997 8999999999
Q ss_pred cchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC---------
Q 005298 157 VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--------- 227 (703)
Q Consensus 157 lA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~--------- 227 (703)
++..+... ......+||+.|+|||++.+...++.++||||||||||+|++|.+||...+....+..+...
T Consensus 178 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 178 SAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp TCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 98766433 22345689999999999977666899999999999999999999999877654433332110
Q ss_pred ---------------C-------CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 228 ---------------N-------PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 228 ---------------~-------~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
. .+......+..+.+||.+||..||.+|||+.|+|+||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 0 0011123578899999999999999999999999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=385.63 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=223.0
Q ss_pred cccchhhhCCCceEEEEEeecCceEEEEEE-----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEE
Q 005298 4 LAGLQEAAGSRFSSLELIGRGSFGDVYKAF-----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78 (703)
Q Consensus 4 i~~l~~~~~~~Y~il~~LG~GsfG~Vyka~-----d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~ 78 (703)
+..+.+....+|++++.||+|+||.||+|. +..++..||||++...........+.+|+.++++++||||+++++
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (327)
T 2yfx_A 21 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 100 (327)
T ss_dssp GGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEE
Confidence 344556677899999999999999999999 556788999999976666666778999999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCCHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC---C
Q 005298 79 SYLHQTKLWIIMEYMAGGSVADLIQSG-------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN---G 148 (703)
Q Consensus 79 ~~~~~~~lyLV~Eyv~gGsL~~~l~~~-------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~---g 148 (703)
++...+..||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+ +
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcc
Confidence 999999999999999999999999865 348999999999999999999999999999999999999844 4
Q ss_pred CeeEeccccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccC
Q 005298 149 DVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIP 225 (703)
Q Consensus 149 ~VKL~DFGlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~ 225 (703)
.+||+|||++....... .......||+.|+|||++.+. .++.++|||||||+||+|++ |..||...........+.
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 69999999987654322 122345789999999999765 58999999999999999998 999998877666666665
Q ss_pred CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 226 ~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
.......+..++..+.+||.+||..+|.+||++.+|+++.|+.
T Consensus 260 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 5555566678899999999999999999999999999998764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=403.15 Aligned_cols=254 Identities=25% Similarity=0.424 Sum_probs=207.0
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC------
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT------ 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~------ 84 (703)
...+|+++++||+|+||.||+|.+..++. ||||++.... ....+|+.+++.++|||||+++++|...+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~-----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc-----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 34589999999999999999999988666 8888775432 12246999999999999999999996544
Q ss_pred EEEEEEeccCCCCHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec-CCCCeeEeccccchh
Q 005298 85 KLWIIMEYMAGGSVADLI---QSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT-ENGDVKVADFGVSAQ 160 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l---~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd-~~g~VKL~DFGlA~~ 160 (703)
.+|||||||+++.+..+. .....+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||++..
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 389999999765444332 3367899999999999999999999999999999999999999 789999999999876
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--------------
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------- 226 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~-------------- 226 (703)
+... ......+||+.|+|||++.+...|+.++||||||||||+|++|.+||.+.+....+..+..
T Consensus 192 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 192 LIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 5433 2334578999999999998766689999999999999999999999988765433322211
Q ss_pred ----------CCCCC----cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 227 ----------ENPPQ----LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 227 ----------~~~~~----l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
..+.. +...+++.+.+||.+||.+||.+|||+.++++||||+..+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 00001 1234678999999999999999999999999999998764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=388.42 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=213.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE----
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK---- 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~---- 85 (703)
...+|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.++++++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 4579999999999999999999999999999999986543 34446788899999999999999999999987654
Q ss_pred --EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 86 --LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 86 --lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
+|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 599999996 68888874 3599999999999999999999999999999999999999999999999999876532
Q ss_pred cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC------------------
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP------------------ 225 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~------------------ 225 (703)
. ....+||+.|+|||++.+...++.++|||||||+||+|++|..||...+....+..+.
T Consensus 179 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 179 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred C---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 2 3356899999999999875568999999999999999999999998765433222111
Q ss_pred ------------CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 226 ------------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 226 ------------~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
......+...++..+.+||.+||..||.+|||+.++|+||||....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0111223346789999999999999999999999999999998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=381.15 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=212.6
Q ss_pred hCCCceEEEEEeecCceEEEEEEEc-CCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhC---CCCCeeeeEEEEE----
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDK-ELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQC---RSPYITEYYGSYL---- 81 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~-~tg~~VAIKvi~~~~~~-~~~~~l~~Ei~ILk~L---~HPnIV~L~~~~~---- 81 (703)
...+|++++.||+|+||.||+|.+. .+|+.||||++...... .....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4579999999999999999999995 67899999998654321 1123456677777666 8999999999987
Q ss_pred -eCCEEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccc
Q 005298 82 -HQTKLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 82 -~~~~lyLV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
....+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5668999999997 69999997643 4999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------
Q 005298 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------ 226 (703)
Q Consensus 159 ~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~------------ 226 (703)
...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||........+..+..
T Consensus 168 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 168 RIYSFQ-MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCCGG-GGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred ccccCC-CCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 765432 233456899999999999775 589999999999999999999999987654433222110
Q ss_pred --------------CCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 227 --------------ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 227 --------------~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
.....+...++..+.+||.+||..||.+|||+.++++||||+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 0001123457889999999999999999999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=370.37 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=217.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++++.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 4568999999999999999999876 4778999999755422 356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-cc
Q 005298 91 EYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~ 168 (703)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 999999999999764 4599999999999999999999999999999999999999999999999999875543221 22
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....||+.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+..++..+.+||..|
T Consensus 163 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 241 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSC 241 (268)
T ss_dssp CSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHT
T ss_pred cCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHH
Confidence 234567789999999765 48999999999999999999 9999988877766666666555566677889999999999
Q ss_pred hccCCCCCCCHHHHHhc
Q 005298 248 LKKVPAERPSAKELLRH 264 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~H 264 (703)
|..+|.+|||+.+++++
T Consensus 242 l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 242 WHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCChhhCcCHHHHHHH
Confidence 99999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=384.87 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=210.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcE----EEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~----VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
...+|++++.||+|+||+||+|.+..+++. ||+|.+...........+.+|+.++++++||||++++++|.... .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 356899999999999999999999887765 47777654444445678899999999999999999999998765 7
Q ss_pred EEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
++|+||+.+|+|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 899999999999999976 4679999999999999999999999999999999999999999999999999998764432
Q ss_pred cc--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHH
Q 005298 166 SR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (703)
Q Consensus 166 ~~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~d 242 (703)
.. .....||+.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+..++..+.+
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250 (327)
T ss_dssp C-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHH
T ss_pred ccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 22 1234578899999999875 58999999999999999999 99999988776666666555555666778999999
Q ss_pred HHHHHhccCCCCCCCHHHHHhc
Q 005298 243 FVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~H 264 (703)
||.+||..+|.+||++.+++++
T Consensus 251 li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 251 IMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=373.29 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=216.4
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++++.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 3458999999999999999999887 5788999999755422 356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-ccc
Q 005298 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~~ 168 (703)
||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 99999999999976 5679999999999999999999999999999999999999999999999999987653322 122
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....||+.|+|||++.+. .++.++|||||||++|+|++ |..||...+.......+........+..++..+.+||.+|
T Consensus 179 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 257 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 257 (283)
T ss_dssp TSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred cCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHH
Confidence 334678889999999865 48999999999999999998 9999998887776666666655566677889999999999
Q ss_pred hccCCCCCCCHHHHHhc
Q 005298 248 LKKVPAERPSAKELLRH 264 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~H 264 (703)
|..+|.+|||+.++++|
T Consensus 258 l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 258 WHEKADERPTFKILLSN 274 (283)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhHCcCHHHHHHH
Confidence 99999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=392.49 Aligned_cols=253 Identities=24% Similarity=0.453 Sum_probs=223.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCC-------CcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEe
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKEL-------NKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH 82 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~t-------g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~ 82 (703)
...+|++.+.||+|+||.||+|.+..+ +..||||++...........+.+|+.+++++ +|||||++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 446899999999999999999997543 3589999998776677778899999999999 99999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE 146 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~~----------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~ 146 (703)
++.+||||||+++|+|.+++.... .+++..++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence 999999999999999999997643 4999999999999999999999999999999999999999
Q ss_pred CCCeeEeccccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeec
Q 005298 147 NGDVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI 223 (703)
Q Consensus 147 ~g~VKL~DFGlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~ 223 (703)
++.+||+|||++....... .......||+.|+|||++.+. .++.++|||||||+||+|++ |..||...........
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~ 305 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999987654322 122335678999999999875 58999999999999999999 9999998877776666
Q ss_pred cCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 224 I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+........+..++..+.+||.+||..+|.+|||+.+|+++
T Consensus 306 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 306 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 66665666677889999999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=380.23 Aligned_cols=259 Identities=35% Similarity=0.607 Sum_probs=197.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHH-HHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEIS-VLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~-ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
...+|++++.||+|+||.||+|.+..+|+.||||++...........+..|+. +++.++||||+++++++...+..|||
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 45799999999999999999999999999999999987655555556666666 77888999999999999999999999
Q ss_pred EeccCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhc-CceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 90 MEYMAGGSVADLIQS-----GPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~-----~~~L~e~~i~~i~~QLl~AL~yLHs~-gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
|||+.+ +|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++.....
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 999975 88888763 57899999999999999999999999 999999999999999999999999999876543
Q ss_pred cccccccccCCCCCCchhhhc---cccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeeccCCCCCCCc----chh
Q 005298 164 TISRRKTFVGTPFWMAPEVIQ---NSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFIIPRENPPQL----DEH 235 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~---~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-~~~l~~I~~~~~~~l----~~~ 235 (703)
.. ......||+.|+|||++. ....++.++|||||||+||+|++|..||..... ...+..+....++.+ ...
T Consensus 179 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3aln_A 179 SI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCC
T ss_pred cc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccccc
Confidence 32 223457999999999984 223588999999999999999999999986543 233333333333322 246
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
++..+.+||.+||..||.+|||+.+|++||||....
T Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 258 FSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 789999999999999999999999999999997653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=380.15 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=222.4
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ 83 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~-----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~ 83 (703)
.....+|++.+.||+|+||.||+|.+. .+++.||||++...........+.+|+.++++++||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344578999999999999999999877 467899999998666666677899999999999999999999999999
Q ss_pred CEEEEEEeccCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEe
Q 005298 84 TKLWIIMEYMAGGSVADLIQSG----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~----------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~ 153 (703)
+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 9999999999999999999652 467999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCC
Q 005298 154 DFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPP 230 (703)
Q Consensus 154 DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~ 230 (703)
|||++........ ......||+.|+|||++.+. .++.++|||||||+||+|++ |..||...........+......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 259 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcC
Confidence 9999876543321 22345678999999999765 58999999999999999999 89999887766666555555555
Q ss_pred CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 231 ~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
..+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 260 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 6667889999999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=380.36 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=212.4
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCC-cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCC------eeeeEEE
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELN-KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY------ITEYYGS 79 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg-~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPn------IV~L~~~ 79 (703)
+......+|++++.||+|+||+||+|.+..++ ..||||++... ....+.+.+|+.+++++.|++ |+.++++
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 34556689999999999999999999998877 79999998643 344577889999999987655 9999999
Q ss_pred EEeCCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe-------------
Q 005298 80 YLHQTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL------------- 144 (703)
Q Consensus 80 ~~~~~~lyLV~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL------------- 144 (703)
+...+.+||||||+ +++|.+++... .++++..++.++.||+.||.|||++||+||||||+||||
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 99999999999999 66777766554 479999999999999999999999999999999999999
Q ss_pred ------cCCCCeeEeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Q 005298 145 ------TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM 218 (703)
Q Consensus 145 ------d~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~ 218 (703)
+.++.+||+|||++..... .....+||+.|+|||++.+. .++.++|||||||+||+|++|..||......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5678999999999875432 23456899999999999865 5899999999999999999999999876543
Q ss_pred ceeeccCC---CCC----------------------------------------CCcchhhhHHHHHHHHHHhccCCCCC
Q 005298 219 RVLFIIPR---ENP----------------------------------------PQLDEHFSRLMKEFVSLCLKKVPAER 255 (703)
Q Consensus 219 ~~l~~I~~---~~~----------------------------------------~~l~~~is~~L~dLI~~cL~~dP~~R 255 (703)
..+..+.. ..+ .......+..+.+||.+||..||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 32211110 000 00112345689999999999999999
Q ss_pred CCHHHHHhchhhhccc
Q 005298 256 PSAKELLRHRFIRNAR 271 (703)
Q Consensus 256 PTa~eLL~Hpff~~~~ 271 (703)
||+.|+|+||||....
T Consensus 326 pt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 326 ITLAEALLHPFFAGLT 341 (355)
T ss_dssp CCHHHHTTSGGGGGCC
T ss_pred cCHHHHhcChhhcCCC
Confidence 9999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=395.01 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=220.4
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++.+.||+|+||.||+|.+..+++.||||++...........+.+|+.+|++++|||||++++++...+.+|||||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 35899999999999999999999999999999998766555566778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc--
Q 005298 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR-- 168 (703)
Q Consensus 92 yv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~-- 168 (703)
|+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 99999999999764 469999999999999999999999999999999999999999999999999987543321111
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....+++.|+|||++... .++.++|||||||+||||++ |..||...........+........+..++..+.+||.+|
T Consensus 273 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQC 351 (377)
T ss_dssp SCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 123457789999999765 48999999999999999998 9999998877666666655555666778899999999999
Q ss_pred hccCCCCCCCHHHHHhc
Q 005298 248 LKKVPAERPSAKELLRH 264 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~H 264 (703)
|..+|.+|||+.+|++.
T Consensus 352 l~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 352 WAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCCchhCcCHHHHHHH
Confidence 99999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=380.60 Aligned_cols=250 Identities=27% Similarity=0.436 Sum_probs=215.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEE--EEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDV--AIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~V--AIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV 89 (703)
++|++.+.||+|+||.||+|.+..++..+ |||.+...........+.+|+.+++++ +||||+++++++...+.+|||
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 58999999999999999999999888865 999987655555567789999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEe
Q 005298 90 MEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~----------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~ 153 (703)
|||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEc
Confidence 99999999999997654 79999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCc
Q 005298 154 DFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQL 232 (703)
Q Consensus 154 DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l 232 (703)
|||++...... .......+++.|+|||++.+. .++.++|||||||+||+|++ |..||...+.......+........
T Consensus 185 Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 262 (327)
T 1fvr_A 185 DFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 262 (327)
T ss_dssp CTTCEESSCEE-CCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCC
T ss_pred ccCcCcccccc-ccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCC
Confidence 99998643322 222345678999999999765 58899999999999999998 9999998877666666665555566
Q ss_pred chhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 233 ~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 263 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 263 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 67889999999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=386.14 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=213.7
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcE----EEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~----VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
..+|++++.||+|+||+||+|.+..+++. ||+|++...........+.+|+.++++++||||+++++++. ++..|
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 46899999999999999999999888876 77777654433333456778999999999999999999886 56689
Q ss_pred EEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 88 IIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
+||||+.+|+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999999999764 5799999999999999999999999999999999999999999999999999986643322
Q ss_pred --ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 167 --RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 167 --~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
......||+.|+|||++.+. .++.++|||||||+||+|++ |..||...........+........+..++..+.+|
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMV 249 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHH
T ss_pred cccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHH
Confidence 22345788899999999875 48999999999999999999 999999877666666666555556666788889999
Q ss_pred HHHHhccCCCCCCCHHHHHhc
Q 005298 244 VSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~H 264 (703)
|.+||..+|.+||++.+++++
T Consensus 250 i~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 250 MVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=382.80 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=212.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCC
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d-----~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~ 84 (703)
...+|++.+.||+|+||.||+|.+ ..++..||||++.........+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 446899999999999999999997 3467789999997655445567899999999999 8999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccce
Q 005298 85 KLWIIMEYMAGGSVADLIQSGP-----------------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAAN 141 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~-----------------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeN 141 (703)
.+||||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 202 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 202 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence 9999999999999999997643 37999999999999999999999999999999999
Q ss_pred EEecCCCCeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCcc
Q 005298 142 ILLTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPM 218 (703)
Q Consensus 142 ILLd~~g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~ 218 (703)
|||+.++.+||+|||++..+..... ......||+.|+|||++.+. .++.++|||||||+||+|++ |..||......
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 9999999999999999876543321 12345678999999999775 58999999999999999998 99999877644
Q ss_pred ceee-ccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 219 RVLF-IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 219 ~~l~-~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.... .+........+..++..+.+||.+||..+|.+|||+.+|+++
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 282 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 3332 223333445566788999999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=389.81 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=209.8
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CC-----CeeeeEEEEEe
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SP-----YITEYYGSYLH 82 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HP-----nIV~L~~~~~~ 82 (703)
.....+|++.+.||+|+||+||+|.+..+++.||||++... ......+..|+.+++.+. |+ +|+++++++..
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 44557999999999999999999999999999999998643 344567788999988885 44 49999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH--hcCceeeeeccceEEec--CCCCeeEeccc
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLH--NEGKIHRDIKAANILLT--ENGDVKVADFG 156 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLH--s~gIVHRDIKPeNILLd--~~g~VKL~DFG 156 (703)
.+.+||||||+. ++|.+++... ..+++..++.++.||+.||.||| ..|||||||||+||||+ .++.+||+|||
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999999995 5999999765 46999999999999999999999 57999999999999995 46789999999
Q ss_pred cchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC---------
Q 005298 157 VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE--------- 227 (703)
Q Consensus 157 lA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~--------- 227 (703)
++..... .....+||+.|+|||++.+. .++.++||||||||||+|++|.+||...+....+..+...
T Consensus 207 ~a~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 207 SSCQLGQ---RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp TCEETTC---CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred Cceeccc---ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9876543 23457899999999999875 4899999999999999999999999876544332221100
Q ss_pred ------------------------------CCCC------------------------cchhhhHHHHHHHHHHhccCCC
Q 005298 228 ------------------------------NPPQ------------------------LDEHFSRLMKEFVSLCLKKVPA 253 (703)
Q Consensus 228 ------------------------------~~~~------------------------l~~~is~~L~dLI~~cL~~dP~ 253 (703)
.++. ........+.+||.+||.+||.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 0000 0001124789999999999999
Q ss_pred CCCCHHHHHhchhhhcc
Q 005298 254 ERPSAKELLRHRFIRNA 270 (703)
Q Consensus 254 ~RPTa~eLL~Hpff~~~ 270 (703)
+|||+.|+|+||||+..
T Consensus 363 ~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TSCCHHHHTTSGGGCC-
T ss_pred hCCCHHHHhcCcccccC
Confidence 99999999999999764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=385.33 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=218.0
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH-----HHHHHHHHHHHHHhCC--CCCeeeeEEEEE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED-----EIEDIQKEISVLSQCR--SPYITEYYGSYL 81 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~-----~~~~l~~Ei~ILk~L~--HPnIV~L~~~~~ 81 (703)
.....+|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+|+.+++++. ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 445679999999999999999999999999999999986543211 2245678999999996 599999999999
Q ss_pred eCCEEEEEEeccCC-CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec-CCCCeeEeccccch
Q 005298 82 HQTKLWIIMEYMAG-GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT-ENGDVKVADFGVSA 159 (703)
Q Consensus 82 ~~~~lyLV~Eyv~g-GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd-~~g~VKL~DFGlA~ 159 (703)
..+.+|+||||+.+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999999976 89999998888999999999999999999999999999999999999999 67899999999987
Q ss_pred hhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHH
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRL 239 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~ 239 (703)
..... ......||+.|+|||++.+...++.++|||||||+||+|++|..||....... . ....++..++..
T Consensus 199 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~-~~~~~~~~~~~~ 269 (320)
T 3a99_A 199 LLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII------R-GQVFFRQRVSSE 269 (320)
T ss_dssp ECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------H-CCCCCSSCCCHH
T ss_pred ccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh------c-ccccccccCCHH
Confidence 65432 23356899999999999876655788999999999999999999997543211 0 112334567889
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 240 MKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
+.+||.+||..+|.+|||+.+|++||||+....
T Consensus 270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 999999999999999999999999999987643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=381.37 Aligned_cols=253 Identities=23% Similarity=0.443 Sum_probs=219.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEc-------CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEe
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDK-------ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH 82 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~-------~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~ 82 (703)
...+|++.+.||+|+||.||+|.+. .++..||||++...........+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4569999999999999999999986 457789999998766666778899999999999 89999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSGP----------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE 146 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~~----------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~ 146 (703)
.+.+||||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 999999999999999999998654 3899999999999999999999999999999999999999
Q ss_pred CCCeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeec
Q 005298 147 NGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI 223 (703)
Q Consensus 147 ~g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~ 223 (703)
++.+||+|||++........ ......+|+.|+|||++.+. .++.++|||||||+||+|++ |..||...........
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 271 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence 99999999999876543221 12334678899999999765 48999999999999999999 9999988776665555
Q ss_pred cCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 224 I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+........+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 272 LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55444555667789999999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=371.82 Aligned_cols=252 Identities=26% Similarity=0.462 Sum_probs=222.2
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
....+|++.+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 35578999999999999999999999999999999987543 3457789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-c
Q 005298 90 MEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-S 166 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~ 166 (703)
|||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 9999999999999863 459999999999999999999999999999999999999999999999999987654332 1
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
......||+.|+|||++.+. .++.++|||||||++|+|++ |.+||...+.......+........+..++..+.+||.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246 (288)
T ss_dssp EETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence 22335678899999999775 58999999999999999999 99999988776666666655556667788999999999
Q ss_pred HHhccCCCCCCCHHHHHhc
Q 005298 246 LCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~H 264 (703)
.||..+|.+|||+.++++.
T Consensus 247 ~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 247 ACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCChhhCcCHHHHHHH
Confidence 9999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=374.91 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=217.0
Q ss_pred hCCCceEEEEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCC
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d-----~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~ 84 (703)
...+|++.+.||+|+||.||+|.+ ..+++.||||++.........+.+.+|+.+++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 446999999999999999999985 4578899999998766666678899999999999 9999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC
Q 005298 85 KLWIIMEYMAGGSVADLIQSGP------------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE 146 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~------------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~ 146 (703)
..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 9999999999999999997644 4899999999999999999999999999999999999999
Q ss_pred CCCeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeec
Q 005298 147 NGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI 223 (703)
Q Consensus 147 ~g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~ 223 (703)
++.+||+|||++........ ......||+.|+|||++.+. .++.++|||||||+||+|++ |..||...........
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 99999999999876643322 12345678899999999775 58999999999999999998 9999987654433222
Q ss_pred -cCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 224 -IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 224 -I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+........+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 22223334456788999999999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=373.85 Aligned_cols=258 Identities=32% Similarity=0.566 Sum_probs=199.2
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHH-HHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEI-EDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~-~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
-.+|++++.||+|+||.||+|.+..+|+.||||++......... ..+.++..+++.++||||+++++++...+.+||||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 35899999999999999999999999999999999766544443 34445556788899999999999999999999999
Q ss_pred eccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhc-CceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 91 EYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~-gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||+ ++.+..++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..+.... ..
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~ 181 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-AK 181 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-cc
Confidence 999 6667666653 57899999999999999999999995 99999999999999999999999999987654332 22
Q ss_pred ccccCCCCCCchhhhcc----ccCCccccchhhHHHHHHHHHhCCCCCCCCC-ccceeeccCCCCCCCcc--hhhhHHHH
Q 005298 169 KTFVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLH-PMRVLFIIPRENPPQLD--EHFSRLMK 241 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~-~~~~l~~I~~~~~~~l~--~~is~~L~ 241 (703)
....||+.|+|||++.. ...++.++|||||||+||+|++|..||.... .......+....++.++ ..++..+.
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 261 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ 261 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHH
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHH
Confidence 34679999999999852 3357889999999999999999999998643 23333333333333222 35789999
Q ss_pred HHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 242 EFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
+||.+||..||.+||++.+|++||||+...
T Consensus 262 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 262 SFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 999999999999999999999999998653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=394.46 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=191.8
Q ss_pred CCceEE-EEEeecCceEEEEEEEc--CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe--CCEEE
Q 005298 13 SRFSSL-ELIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLW 87 (703)
Q Consensus 13 ~~Y~il-~~LG~GsfG~Vyka~d~--~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--~~~ly 87 (703)
..|++. ++||+|+||+||+|.++ .+++.||||++...... ..+.+|+.+|++|+|||||+++++|.. ...+|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 457774 57999999999999976 57899999998755432 457889999999999999999999965 67899
Q ss_pred EEEeccCCCCHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe----cCCCCeeEec
Q 005298 88 IIMEYMAGGSVADLIQS---------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL----TENGDVKVAD 154 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~---------~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL----d~~g~VKL~D 154 (703)
|||||+. ++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9999996 588887752 1259999999999999999999999999999999999999 6678999999
Q ss_pred cccchhhhhcc---cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------ceee
Q 005298 155 FGVSAQLTRTI---SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---------RVLF 222 (703)
Q Consensus 155 FGlA~~~~~~~---~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~---------~~l~ 222 (703)
||++..+.... ......+||+.|+|||++.+...++.++||||||||||+|++|.+||...... ..+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 99997664322 22345789999999999987666899999999999999999999999755431 0000
Q ss_pred ccCC--CCCC-C----------------------------------cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhch
Q 005298 223 IIPR--ENPP-Q----------------------------------LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHR 265 (703)
Q Consensus 223 ~I~~--~~~~-~----------------------------------l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hp 265 (703)
.+.. ..+. . .....+..+.+||.+||.+||.+|||+.|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000 0000 0 0001156789999999999999999999999999
Q ss_pred hhhcc
Q 005298 266 FIRNA 270 (703)
Q Consensus 266 ff~~~ 270 (703)
||...
T Consensus 336 ~f~~~ 340 (405)
T 3rgf_A 336 YFLED 340 (405)
T ss_dssp GGTSS
T ss_pred hhccC
Confidence 99764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=369.94 Aligned_cols=251 Identities=24% Similarity=0.420 Sum_probs=218.9
Q ss_pred CCCceEEE-EEeecCceEEEEEEEc--CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLE-LIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~-~LG~GsfG~Vyka~d~--~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
..+|.+++ .||+|+||.||+|.+. .++..||||++.........+.+.+|+.++++++||||+++++++ ..+.+|+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45788887 9999999999999864 468899999998766666778899999999999999999999999 5667999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-
Q 005298 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 166 (703)
||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999999999999964 45699999999999999999999999999999999999999999999999999876543221
Q ss_pred --ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 167 --RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 167 --~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
......||+.|+|||++.+. .++.++|||||||++|+|++ |..||...........+.....+.++..++..+.+|
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 245 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 245 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHH
Confidence 12234578999999999765 48999999999999999998 999998887766666666666666777899999999
Q ss_pred HHHHhccCCCCCCCHHHHHhc
Q 005298 244 VSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~H 264 (703)
|..||..+|.+||++.+++++
T Consensus 246 i~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 246 MSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=374.03 Aligned_cols=253 Identities=23% Similarity=0.425 Sum_probs=208.9
Q ss_pred hhCCCceEEEEEeecCceEEEEEE----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe--C
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--Q 83 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~----d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--~ 83 (703)
....+|++++.||+|+||+||+|. +..+++.||||++... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 345799999999999999999998 5678999999998754 35556789999999999999999999999865 3
Q ss_pred CEEEEEEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
..+||||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 56899999999999999997654 59999999999999999999999999999999999999999999999999997664
Q ss_pred hccc---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----------------ceeec
Q 005298 163 RTIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM----------------RVLFI 223 (703)
Q Consensus 163 ~~~~---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~----------------~~l~~ 223 (703)
.... ......|++.|+|||++.+. .++.++|||||||++|+|++|..||...... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 3321 12234678889999999875 5899999999999999999999998643211 11122
Q ss_pred cCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 224 I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+........+..++..+.+||.+||..+|.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 22333445567889999999999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=373.44 Aligned_cols=257 Identities=26% Similarity=0.496 Sum_probs=210.9
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCC--CCCeeeeEEEEEeCCEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCR--SPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~--HPnIV~L~~~~~~~~~ly 87 (703)
.+.+|++++.||+|+||.||+|.+.. ++.||||++.... .......+.+|+.+++++. ||||+++++++...+.+|
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 45689999999999999999999864 8999999997654 3455678999999999997 599999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 166 (703)
||||+ .+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. +.+||+|||++..+.....
T Consensus 105 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 105 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp EEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred EEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 99995 58899999998889999999999999999999999999999999999999964 8999999999876543322
Q ss_pred -ccccccCCCCCCchhhhccc----------cCCccccchhhHHHHHHHHHhCCCCCCCCCcc-ceee-ccCCCCCCCcc
Q 005298 167 -RRKTFVGTPFWMAPEVIQNS----------EGYNEKADIWSLGITVIEMAKGEPPLADLHPM-RVLF-IIPRENPPQLD 233 (703)
Q Consensus 167 -~~~~~iGTp~Y~APEvl~~~----------~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~-~~l~-~I~~~~~~~l~ 233 (703)
.....+||+.|+|||++.+. ..++.++|||||||+||+|++|..||...... .... .+.......++
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence 12345799999999998651 35788999999999999999999999765332 1111 12222233444
Q ss_pred hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 234 ~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
...+..+.+||.+||..+|.+||++.++++||||+..
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 5568899999999999999999999999999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=379.46 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=207.8
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-----HHHHHHHHHHHHHHhC----CCCCeeeeEEE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----DEIEDIQKEISVLSQC----RSPYITEYYGS 79 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-----~~~~~l~~Ei~ILk~L----~HPnIV~L~~~ 79 (703)
+....+|++.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 44567899999999999999999999999999999998655321 1233456799999998 89999999999
Q ss_pred EEeCCEEEEEEec-cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec-CCCCeeEecccc
Q 005298 80 YLHQTKLWIIMEY-MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT-ENGDVKVADFGV 157 (703)
Q Consensus 80 ~~~~~~lyLV~Ey-v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd-~~g~VKL~DFGl 157 (703)
+...+..|+|||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999999888899999999999999999999999999999999999999 789999999999
Q ss_pred chhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhh
Q 005298 158 SAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFS 237 (703)
Q Consensus 158 A~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is 237 (703)
+...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||...... .. ....++..++
T Consensus 187 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~-----~~~~~~~~~~ 257 (312)
T 2iwi_A 187 GALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--LE-----AELHFPAHVS 257 (312)
T ss_dssp CEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--HH-----TCCCCCTTSC
T ss_pred hhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH--hh-----hccCCcccCC
Confidence 8765432 2345689999999999987654566899999999999999999999754221 11 1123446678
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
..+.+||.+||..+|.+|||+.++++||||+...
T Consensus 258 ~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 8999999999999999999999999999998653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=363.40 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=217.4
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++.+.||+|+||.||+|.+. +++.||||++...... .+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 468999999999999999999987 5789999999755422 3578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-cccc
Q 005298 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~~~ 169 (703)
|+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99999999999764 569999999999999999999999999999999999999999999999999987653321 1223
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
...|++.|+|||++.+. .++.++||||||+++|+|++ |.+||...........+........+..++..+.+||.+||
T Consensus 164 ~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l 242 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 242 (267)
T ss_dssp STTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHc
Confidence 45678899999999765 58999999999999999999 99999887776666666555555566678899999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q 005298 249 KKVPAERPSAKELLRH 264 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~H 264 (703)
..+|.+||++.+++++
T Consensus 243 ~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 243 RERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=391.30 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=207.7
Q ss_pred CCCceEEEEEeecCceEEEEEEEc---CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDK---ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~---~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
..+|++.+.||+|+||.||+|.+. .++..||||+++........+.+.+|+.++++++||||+++++++...+.+||
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 358999999999999999999887 46788999999876666667889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 89 IMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 999999999999998654 7999999999999999999999999999999999999999999999999998766433221
Q ss_pred c---ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 168 R---KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 168 ~---~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
. ....+++.|+|||++.+. .++.++|||||||+||||++ |..||...........+........+..++..+.+|
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 282 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQL 282 (373)
T ss_dssp ----------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHH
T ss_pred ceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHH
Confidence 1 123457889999999775 58999999999999999997 999998887766665555444444556788999999
Q ss_pred HHHHhccCCCCCCCHHHHHh
Q 005298 244 VSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~ 263 (703)
|..||..+|.+||++.+|++
T Consensus 283 i~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 283 MLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=373.22 Aligned_cols=251 Identities=22% Similarity=0.389 Sum_probs=209.1
Q ss_pred CCCceEEEEEeecCceEEEEEE----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TK 85 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~----d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~ 85 (703)
..+|++++.||+|+||.||+|. +..+++.||||++...........+.+|+.++++++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3579999999999999999998 56789999999997665445567899999999999999999999999876 67
Q ss_pred EEEEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 86 LWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~-~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
+|+||||+++++|.+++. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 899999999999999994 4567999999999999999999999999999999999999999999999999998765433
Q ss_pred c---cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCC---------------ccceeeccCC
Q 005298 165 I---SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH---------------PMRVLFIIPR 226 (703)
Q Consensus 165 ~---~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~---------------~~~~l~~I~~ 226 (703)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .......+..
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred CcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence 2 223345788999999999775 48899999999999999999999864321 0111222233
Q ss_pred CCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 227 ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 227 ~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
......+..++..+.+||.+||..||.+|||+.++++
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 259 GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 3444566788999999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=366.95 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=214.9
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCc---EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE-EEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL-WII 89 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~---~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l-yLV 89 (703)
.|++.++||+|+||+||+|.+..++. .||||++.........+.+.+|+.++++++||||+++++++.+.+.. |+|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 66777999999999999999765544 89999998766666778899999999999999999999999876655 999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc---
Q 005298 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--- 165 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~--- 165 (703)
|||+.+++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 999999999999987 4678999999999999999999999999999999999999999999999999987554321
Q ss_pred -cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 166 -SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 166 -~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
.......||+.|+|||.+.+. .++.++|||||||++|+|++ |.+||...+.......+........+..++..+.+|
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 260 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQV 260 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHH
Confidence 222345789999999999765 58999999999999999999 555666666666655555555566677889999999
Q ss_pred HHHHhccCCCCCCCHHHHHhc
Q 005298 244 VSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~H 264 (703)
|.+||..+|.+|||+.++++.
T Consensus 261 i~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 261 MQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999973
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=380.59 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=186.7
Q ss_pred hhCCCceEEE-EEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe----CC
Q 005298 10 AAGSRFSSLE-LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QT 84 (703)
Q Consensus 10 ~~~~~Y~il~-~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~----~~ 84 (703)
....+|++++ +||+|+||+||+|.+..+|+.||||++... . ....+....++.+.||||+++++++.. ..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 3557999965 699999999999999999999999998643 1 122233344677899999999999987 55
Q ss_pred EEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC---CCCeeEeccccch
Q 005298 85 KLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSA 159 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~---~g~VKL~DFGlA~ 159 (703)
.+|||||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 6899999999999999998754 6999999999999999999999999999999999999986 4559999999987
Q ss_pred hhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee----eccC---CCCCCCc
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL----FIIP---RENPPQL 232 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l----~~I~---~~~~~~l 232 (703)
..... .....+||+.|+|||++.+. .++.++|||||||+||+|++|..||......... ..+. ...+...
T Consensus 180 ~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T 3fhr_A 180 ETTQN--ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256 (336)
T ss_dssp EC------------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred ecccc--ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence 55432 23456899999999998664 4889999999999999999999999765543321 1111 1122233
Q ss_pred chhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 233 ~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
...++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 35788999999999999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=370.47 Aligned_cols=251 Identities=24% Similarity=0.405 Sum_probs=215.3
Q ss_pred CCCceEEE-EEeecCceEEEEEEE--cCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 12 GSRFSSLE-LIGRGSFGDVYKAFD--KELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 12 ~~~Y~il~-~LG~GsfG~Vyka~d--~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
..+|++.+ .||+|+||.||+|.+ ..+++.||||++..... ....+.+.+|+.++++++||||+++++++ ..+..|
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35899998 999999999999954 56789999999875532 33467899999999999999999999998 667789
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999998765432211
Q ss_pred ---cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 168 ---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 168 ---~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
.....|++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+.....+..+..++..+.+|
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 252 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1224567899999999765 48899999999999999999 999999887766666666666666777889999999
Q ss_pred HHHHhccCCCCCCCHHHHHhc
Q 005298 244 VSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~H 264 (703)
|.+||..+|.+||++.++++.
T Consensus 253 i~~~l~~dp~~Rps~~~l~~~ 273 (291)
T 1xbb_A 253 MNLCWTYDVENRPGFAAVELR 273 (291)
T ss_dssp HHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999873
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=380.82 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=207.9
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV 89 (703)
.+.+|++.+.||+|+||+||+|.+..+|+.||||++..... .+.+.+|+.++++| +||||+++++++..++..|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 56799999999999999999999999999999999865432 24578899999999 999999999999999999999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC-----eeEeccccchhhhh
Q 005298 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD-----VKVADFGVSAQLTR 163 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~-----VKL~DFGlA~~~~~ 163 (703)
|||+ +++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+||||+.++. +||+|||++..+..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9999 9999999986 468999999999999999999999999999999999999998877 99999999976543
Q ss_pred cccc-------cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee---eccCCCC---C-
Q 005298 164 TISR-------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---FIIPREN---P- 229 (703)
Q Consensus 164 ~~~~-------~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l---~~I~~~~---~- 229 (703)
.... ....+||+.|+|||++.+. .++.++|||||||+||+|++|..||......... ..+.... +
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 3221 2457899999999999875 5899999999999999999999999876433221 1111110 1
Q ss_pred CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 230 ~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
..+...++ .+.+||..||..+|.+||++.+|++
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 01112345 8999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=375.29 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=215.6
Q ss_pred hCCCceEEEEEeecCceEEEEEEE-----cCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCC
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFD-----KELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d-----~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~ 84 (703)
...+|++.+.||+|+||.||+|.+ ..+++.||||++...........+.+|+.++.++ +||||+++++++...+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 456999999999999999999985 3567899999998766666677899999999999 7899999999988754
Q ss_pred -EEEEEEeccCCCCHHHHHHcCCC----------------CCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC
Q 005298 85 -KLWIIMEYMAGGSVADLIQSGPP----------------LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN 147 (703)
Q Consensus 85 -~lyLV~Eyv~gGsL~~~l~~~~~----------------L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~ 147 (703)
.+|+||||+++++|.+++..... +++..+..++.||+.||.|||++||+||||||+||||+.+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence 58999999999999999987554 8999999999999999999999999999999999999999
Q ss_pred CCeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccce-eec
Q 005298 148 GDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV-LFI 223 (703)
Q Consensus 148 g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~-l~~ 223 (703)
+.+||+|||++........ ......||+.|+|||++.+. .++.++|||||||++|+|++ |..||........ ...
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 263 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence 9999999999876543221 22345789999999999775 58999999999999999998 9999987654332 222
Q ss_pred cCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 224 I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+........+..+++.+.++|..||..+|.+|||+.++++|
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 264 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33333445556788999999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=372.88 Aligned_cols=248 Identities=24% Similarity=0.427 Sum_probs=208.6
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCC-------cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELN-------KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH 82 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg-------~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~ 82 (703)
....+|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 44579999999999999999999998877 479999986543 3345778999999999999999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC--------eeEe
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSGPP-LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD--------VKVA 153 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~~~-L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~--------VKL~ 153 (703)
++..||||||+++++|.+++..... +++..+..++.||+.||.|||++||+||||||+||||+.++. +||+
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 9999999999999999999987654 999999999999999999999999999999999999998887 9999
Q ss_pred ccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCCCc
Q 005298 154 DFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPPQL 232 (703)
Q Consensus 154 DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG-~~PF~~~~~~~~l~~I~~~~~~~l 232 (703)
|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++| .+||............. ....+
T Consensus 164 Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~--~~~~~ 237 (289)
T 4fvq_A 164 DPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE--DRHQL 237 (289)
T ss_dssp CCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--TTCCC
T ss_pred cCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh--ccCCC
Confidence 99998654322 2356899999999998755689999999999999999995 45555444332222211 12233
Q ss_pred chhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 233 ~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+..++..+.+||.+||..||.+|||+.++++|
T Consensus 238 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 238 PAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44557789999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=369.16 Aligned_cols=254 Identities=30% Similarity=0.534 Sum_probs=202.8
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
....+|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.++++++||||+++++++...+.+|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 34468999999999999999999999999999999987533 3455678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 88 IIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999999864 56799999999999999999999999999999999999999999999999999876654
Q ss_pred cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--ceeeccCCCC-CCCcchhhhHHH
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM--RVLFIIPREN-PPQLDEHFSRLM 240 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~--~~l~~I~~~~-~~~l~~~is~~L 240 (703)
.........|++.|+|||++.+. .++.++|||||||++|+|++|..||...... .....+.... ++.....++..+
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp ----------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 43334456899999999999765 5899999999999999999999999754321 2222222222 223335788999
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhc
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.+||.+||..||.+|||+.+++++
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=378.96 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=211.9
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEE----EEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDV----AIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~V----AIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
...+|++++.||+|+||.||+|.+..+++.| |+|.+...........+.+|+.++++++||||+++++++.... .
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 4579999999999999999999998888765 6666654444445678899999999999999999999998765 7
Q ss_pred EEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
++|+||+.+|+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 899999999999999976 4679999999999999999999999999999999999999999999999999997664332
Q ss_pred cc--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHH
Q 005298 166 SR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (703)
Q Consensus 166 ~~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~d 242 (703)
.. .....||+.|+|||++.+. .++.++|||||||+||+|++ |.+||...........+........+..++..+.+
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 250 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 250 (327)
T ss_dssp --------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHH
T ss_pred ccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHH
Confidence 21 2234578899999999875 58999999999999999999 99999988777766666666666667788999999
Q ss_pred HHHHHhccCCCCCCCHHHHHhc
Q 005298 243 FVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~H 264 (703)
||.+||..+|.+||++.++++.
T Consensus 251 li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 251 IMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=368.20 Aligned_cols=253 Identities=23% Similarity=0.388 Sum_probs=215.0
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcC---CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~---tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
....+|++.+.||+|+||.||+|.+.. ++..||||++.........+.+.+|+.++++++||||+++++++.. +..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 345699999999999999999998654 3457999999876666677889999999999999999999999865 456
Q ss_pred EEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 8999999999999999764 569999999999999999999999999999999999999999999999999987654322
Q ss_pred c-ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 166 S-RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 166 ~-~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
. ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+..+++.+.+|
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 246 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTL 246 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 1 12335678899999999765 58999999999999999998 999998777666555555445555667789999999
Q ss_pred HHHHhccCCCCCCCHHHHHhc
Q 005298 244 VSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~H 264 (703)
|.+||..+|.+||++.+++++
T Consensus 247 i~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 247 MTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCCchhCcCHHHHHHH
Confidence 999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=362.37 Aligned_cols=247 Identities=19% Similarity=0.369 Sum_probs=212.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC--CEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ--TKLW 87 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~--~~ly 87 (703)
...+|++.+.||+|+||.||+|.+. ++.||||++.... .....+.+.+|+.++++++||||+++++++.+. +.+|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 3468999999999999999999985 8999999997654 345567899999999999999999999999887 7889
Q ss_pred EEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcC--ceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 88 IIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~g--IVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
+||||+++++|.+++.... .+++..+..|+.||+.||.|||++| |+||||||+|||++.++.++|+|||+.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 9999999999999998765 5899999999999999999999999 9999999999999999999999998865422
Q ss_pred cccccccccCCCCCCchhhhccccC--CccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCcchhhhHHH
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNSEG--YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEHFSRLM 240 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~~~--~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~-~~~~~~l~~~is~~L 240 (703)
....+||+.|+|||++.+... ++.++|||||||++|+|++|..||...+.......+. ....+.++..++..+
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHH
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 234589999999999976431 2337999999999999999999998877655443332 334456667889999
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhc
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.+||.+||..+|.+|||+.++++.
T Consensus 241 ~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 241 SKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999963
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=364.45 Aligned_cols=248 Identities=27% Similarity=0.531 Sum_probs=202.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC---hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES---EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~---~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
...+|++.+.||+|+||.||+|.+. ++.||||++..... ....+.+.+|+.+++.++||||+++++++..++..|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 4579999999999999999999975 89999999865432 223567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcC---ceeeeeccceEEecC--------CCCeeEeccc
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG---KIHRDIKAANILLTE--------NGDVKVADFG 156 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~g---IVHRDIKPeNILLd~--------~g~VKL~DFG 156 (703)
+||||+++++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999999999864 68999999999999999999999999 899999999999986 6789999999
Q ss_pred cchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC-CCCCCCcchh
Q 005298 157 VSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP-RENPPQLDEH 235 (703)
Q Consensus 157 lA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~-~~~~~~l~~~ 235 (703)
++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+. .......+..
T Consensus 162 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3dtc_A 162 LAREWHRTT--KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238 (271)
T ss_dssp C---------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTT
T ss_pred ccccccccc--ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcc
Confidence 987654332 2346899999999999775 58999999999999999999999998876555443332 2233455677
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
++..+.+||.+||..+|.+|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 88999999999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=378.60 Aligned_cols=254 Identities=23% Similarity=0.376 Sum_probs=208.6
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----------CCCeeeeEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----------SPYITEYYGS 79 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-----------HPnIV~L~~~ 79 (703)
...+|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++++. ||||++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 346999999999999999999999999999999998643 334567889999999886 8999999999
Q ss_pred EEeCC----EEEEEEeccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhc-CceeeeeccceEEecC------
Q 005298 80 YLHQT----KLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNE-GKIHRDIKAANILLTE------ 146 (703)
Q Consensus 80 ~~~~~----~lyLV~Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~-gIVHRDIKPeNILLd~------ 146 (703)
+...+ .+++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+||||+.
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 98754 789999999 8999999976 35699999999999999999999998 9999999999999953
Q ss_pred CCCeeEeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccce------
Q 005298 147 NGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV------ 220 (703)
Q Consensus 147 ~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~------ 220 (703)
.+.+||+|||++...... ....+||+.|+|||++.+. .++.++||||||||||+|++|..||........
T Consensus 174 ~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC---CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 347999999998765432 3346899999999999875 489999999999999999999999975432110
Q ss_pred e-------------------------------eccCCC----------CCCCcchhhhHHHHHHHHHHhccCCCCCCCHH
Q 005298 221 L-------------------------------FIIPRE----------NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAK 259 (703)
Q Consensus 221 l-------------------------------~~I~~~----------~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~ 259 (703)
+ ..+... ....++..++..+.+||.+||..||.+|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 0 000000 01123456788999999999999999999999
Q ss_pred HHHhchhhhccc
Q 005298 260 ELLRHRFIRNAR 271 (703)
Q Consensus 260 eLL~Hpff~~~~ 271 (703)
|||+||||+...
T Consensus 330 ell~hp~f~~~~ 341 (373)
T 1q8y_A 330 GLVNHPWLKDTL 341 (373)
T ss_dssp HHHTCGGGTTCT
T ss_pred HHhhChhhhccc
Confidence 999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=372.07 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=209.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcC---CCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC--
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-- 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~---tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~-- 84 (703)
...+|++.+.||+|+||.||+|.+.. ++..||||++.... .....+.+.+|+.++++++||||+++++++...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 34689999999999999999998765 56689999987654 3455678999999999999999999999998755
Q ss_pred ---EEEEEEeccCCCCHHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecc
Q 005298 85 ---KLWIIMEYMAGGSVADLIQ------SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (703)
Q Consensus 85 ---~lyLV~Eyv~gGsL~~~l~------~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DF 155 (703)
..|+||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3599999999999999994 3457999999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCc
Q 005298 156 GVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQL 232 (703)
Q Consensus 156 GlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l 232 (703)
|++..+.... .......+++.|+|||++.+. .++.++|||||||++|+|++ |.+||...........+.....+..
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 270 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ 270 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred CcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCC
Confidence 9987654322 112235678899999999765 58999999999999999999 9999988877766666666666667
Q ss_pred chhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 233 ~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 271 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 271 PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77889999999999999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=376.84 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=214.1
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCC----cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELN----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg----~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
....+|++.+.||+|+||.||+|.+..++ ..||||++...........+.+|+.++++++||||+++++++...+.
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 34568999999999999999999987653 46999999866666667789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 86 LWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
+||||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999999764 67999999999999999999999999999999999999999999999999998766433
Q ss_pred ccc---cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHH
Q 005298 165 ISR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240 (703)
Q Consensus 165 ~~~---~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L 240 (703)
... .....+|+.|+|||++.+. .++.++|||||||+||+|++ |..||...........+........+..++..+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 279 (333)
T ss_dssp ----------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred cccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHH
Confidence 211 1123567889999999765 58999999999999999998 999998887766666665555555667789999
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhc
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.+||.+||..+|.+||++.+++++
T Consensus 280 ~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 280 YQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=367.45 Aligned_cols=251 Identities=19% Similarity=0.269 Sum_probs=210.7
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~ly 87 (703)
.....+|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++++ +|+||+++++++......|
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 4467899999999999999999999999999999999864432 24578899999999 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC-----eeEeccccchhh
Q 005298 88 IIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD-----VKVADFGVSAQL 161 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~-----VKL~DFGlA~~~ 161 (703)
+||||+ +++|.+++... .++++..+..++.||+.||.|||++||+||||||+||||+.++. +||+|||++...
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999999 99999999864 46999999999999999999999999999999999999987765 999999998765
Q ss_pred hhccc-------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc---eeeccCC----C
Q 005298 162 TRTIS-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR---VLFIIPR----E 227 (703)
Q Consensus 162 ~~~~~-------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~---~l~~I~~----~ 227 (703)
..... .....+||+.|+|||++.+. .++.++|||||||+||+|++|..||....... ....+.. .
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 43322 12456899999999999775 48999999999999999999999998754322 1111111 1
Q ss_pred CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 228 ~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
..+.+...++..+.+||.+||..+|.+||++.+|++.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1112223678899999999999999999999999873
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=372.23 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=206.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
.-++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.++++++||||+++++++..++.+|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3468999999999999999999999999999999987543 33445788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-cc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~ 167 (703)
||||+++++|.+++....++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987654332 22
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCcchhhhHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~--~~~l~~~is~~L~dLI~ 245 (703)
....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.... +......++..+.+||.
T Consensus 192 ~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 270 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIA 270 (309)
T ss_dssp -----CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHH
T ss_pred ccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHH
Confidence 2346799999999999765 58899999999999999999999998765443222222222 12334567889999999
Q ss_pred HHhccCCCCCC-CHHHHHh
Q 005298 246 LCLKKVPAERP-SAKELLR 263 (703)
Q Consensus 246 ~cL~~dP~~RP-Ta~eLL~ 263 (703)
+||..+|.+|| +++++++
T Consensus 271 ~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 271 RGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHTCSSGGGSCSSHHHHHH
T ss_pred HhccCCHHHHHHhHHHHHH
Confidence 99999999999 8888876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=367.14 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=213.9
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEE-eCCEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL-HQTKLW 87 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~t---g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~-~~~~ly 87 (703)
..+|++.+.||+|+||.||+|.+..+ +..||||.+.........+.+.+|+.++++++||||+++++++. .++..|
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 34899999999999999999997543 34689999987666677788999999999999999999999865 466889
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-
Q 005298 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~- 165 (703)
+||||+++++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 99999999999999976 4568999999999999999999999999999999999999999999999999987654322
Q ss_pred ---cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHH
Q 005298 166 ---SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (703)
Q Consensus 166 ---~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~ 241 (703)
.......||+.|+|||++.+. .++.++|||||||++|+|++ |.+||...+.......+........+..++..+.
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 262 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 262 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred hccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 112335678899999999775 58999999999999999999 6777877766666555555555566677899999
Q ss_pred HHHHHHhccCCCCCCCHHHHHhc
Q 005298 242 EFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+||.+||..+|.+|||+.++++.
T Consensus 263 ~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 263 EVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999973
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=377.67 Aligned_cols=255 Identities=28% Similarity=0.421 Sum_probs=209.3
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
.....+|++.+.||+|+||.||+|.+. +++.||||++...........+.+|+.++++++||||+++++++...+..|+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 345679999999999999999999854 5899999998765433333468899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhc---CceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 89 IMEYMAGGSVADLIQSGP----PLDEMSIACILRDLLHAIEYLHNE---GKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~----~L~e~~i~~i~~QLl~AL~yLHs~---gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
||||+.+++|.+++.... ++++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 999999999999998643 499999999999999999999999 9999999999999999999999999998765
Q ss_pred hhccc-ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCC-----cc------------ceeec
Q 005298 162 TRTIS-RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLH-----PM------------RVLFI 223 (703)
Q Consensus 162 ~~~~~-~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~-----~~------------~~l~~ 223 (703)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .. .....
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred CcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence 43222 22345699999999999775 48999999999999999999999995210 00 00001
Q ss_pred -cCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhch
Q 005298 224 -IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHR 265 (703)
Q Consensus 224 -I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hp 265 (703)
.............+..+.+||.+||..+|.+|||+.+|++|-
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 111122334566778999999999999999999999999873
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=365.31 Aligned_cols=251 Identities=27% Similarity=0.473 Sum_probs=211.1
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh---HH---HHHHHHHHHHHHhCCCCCeeeeEEEEEe
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE---DE---IEDIQKEISVLSQCRSPYITEYYGSYLH 82 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~---~~---~~~l~~Ei~ILk~L~HPnIV~L~~~~~~ 82 (703)
.....+|++.+.||+|+||.||+|.+..+++.||||++...... .. .+.+.+|+.++++++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 34567999999999999999999999999999999998654422 11 1678899999999999999999999876
Q ss_pred CCEEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcC--ceeeeeccceEEecCCCC-----eeEec
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGD-----VKVAD 154 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~g--IVHRDIKPeNILLd~~g~-----VKL~D 154 (703)
.. ++||||+++++|.+++... ..+++..+..++.||+.||.|||++| |+||||||+||||+.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 66 7999999999999888654 57999999999999999999999999 999999999999988776 99999
Q ss_pred cccchhhhhcccccccccCCCCCCchhhhcc-ccCCccccchhhHHHHHHHHHhCCCCCCCCCccce--eec-cCCCCCC
Q 005298 155 FGVSAQLTRTISRRKTFVGTPFWMAPEVIQN-SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV--LFI-IPRENPP 230 (703)
Q Consensus 155 FGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~-~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~--l~~-I~~~~~~ 230 (703)
||++..... .....+||+.|+|||++.. ...++.++|||||||++|+|++|..||........ ... ......+
T Consensus 173 fg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 173 FGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp CTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred CCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 999875433 2335689999999999843 23478899999999999999999999987654332 111 1233445
Q ss_pred CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 231 ~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.++..+++.+.+||.+||..||.+|||+.++++.
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 5667889999999999999999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=390.77 Aligned_cols=256 Identities=21% Similarity=0.364 Sum_probs=212.8
Q ss_pred hhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC--E
Q 005298 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT--K 85 (703)
Q Consensus 8 ~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~--~ 85 (703)
+.....+|++.+.||+|+||+||+|.+..+|+.||||++.........+.+.+|+.++++++||||+++++++...+ .
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 34556799999999999999999999999999999999976544444577889999999999999999999998765 7
Q ss_pred EEEEEeccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe----cCCCCeeEeccccc
Q 005298 86 LWIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL----TENGDVKVADFGVS 158 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~---~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL----d~~g~VKL~DFGlA 158 (703)
.|||||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999997643 39999999999999999999999999999999999999 67778999999998
Q ss_pred hhhhhcccccccccCCCCCCchhhhccc-------cCCccccchhhHHHHHHHHHhCCCCCCCCCcc----ceeeccCCC
Q 005298 159 AQLTRTISRRKTFVGTPFWMAPEVIQNS-------EGYNEKADIWSLGITVIEMAKGEPPLADLHPM----RVLFIIPRE 227 (703)
Q Consensus 159 ~~~~~~~~~~~~~iGTp~Y~APEvl~~~-------~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~----~~l~~I~~~ 227 (703)
...... ......+||+.|+|||++... ..++.++|||||||++|+|++|..||...... ..+..+...
T Consensus 164 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 164 RELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp EECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred eEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 765433 233456899999999998641 34788999999999999999999999643221 111111111
Q ss_pred C------------------------CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 228 N------------------------PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 228 ~------------------------~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
. ...+...++..+.+||.+||.+||.+||++.+++++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 1 123446788899999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=375.74 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=212.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+.+|+||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 4579999999999999999999965 68999999986553 344678899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-
Q 005298 91 EYMAGGSVADLIQSGP----PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI- 165 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~----~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~- 165 (703)
||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999996543 58999999999999999999999999999999999999999999999999987543221
Q ss_pred -cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeec----------------cCCCC
Q 005298 166 -SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFI----------------IPREN 228 (703)
Q Consensus 166 -~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~----------------I~~~~ 228 (703)
.......||+.|+|||++.+. .++.++|||||||+||+|++|..||....+...... +....
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred cccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence 112345799999999999775 589999999999999999999999976554332211 11112
Q ss_pred CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 229 ~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
...+...++..+.+||.+||..||.+|||+.+++++
T Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 234456788899999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=374.45 Aligned_cols=253 Identities=22% Similarity=0.394 Sum_probs=215.4
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCc-----EEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCC
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNK-----DVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~-----~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~ 84 (703)
...+|++.+.||+|+||.||+|.+..++. .||||++.........+.+.+|+.+++++ +||||+++++++...+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45689999999999999999999987664 79999998766666778899999999999 8999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCe
Q 005298 85 KLWIIMEYMAGGSVADLIQS--------------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDV 150 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~--------------~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~V 150 (703)
.+||||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEE
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeE
Confidence 99999999999999999964 3468999999999999999999999999999999999999999999
Q ss_pred eEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeecc-CC
Q 005298 151 KVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFII-PR 226 (703)
Q Consensus 151 KL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I-~~ 226 (703)
||+|||++........ ......||+.|+|||++.+. .++.++|||||||++|+|++ |..||...........+ ..
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhc
Confidence 9999999876543221 12335678899999999775 58999999999999999998 99999876544333222 22
Q ss_pred CCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 227 ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 227 ~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
......+..++..+.+||..||..+|.+|||+.+|+++
T Consensus 283 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 283 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 22334455678899999999999999999999999974
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=371.43 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=207.2
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe----CCE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QTK 85 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~----~~~ 85 (703)
....+|++++.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 3456899999999999999999999999999999998654 34556788999999999999999999999873 447
Q ss_pred EEEEEeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhh
Q 005298 86 LWIIMEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~ 161 (703)
.|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 8999999999999999975 577999999999999999999999999999999999999999999999999987654
Q ss_pred hhccc---------ccccccCCCCCCchhhhcccc--CCccccchhhHHHHHHHHHhCCCCCCCCCc--cceeeccCCCC
Q 005298 162 TRTIS---------RRKTFVGTPFWMAPEVIQNSE--GYNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPREN 228 (703)
Q Consensus 162 ~~~~~---------~~~~~iGTp~Y~APEvl~~~~--~~s~ksDVWSLGvILyELLtG~~PF~~~~~--~~~l~~I~~~~ 228 (703)
..... ......||+.|+|||++.... .++.++|||||||++|+|++|..||..... ......+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 32111 112346899999999986532 268899999999999999999999954211 11111111122
Q ss_pred CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 229 ~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
..+....++..+.+||.+||..||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 223345678999999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=362.86 Aligned_cols=251 Identities=25% Similarity=0.478 Sum_probs=200.9
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHh--CCCCCeeeeEEEEEe--
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ--CRSPYITEYYGSYLH-- 82 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~--L~HPnIV~L~~~~~~-- 82 (703)
++.....+|++++.||+|+||+||+|.+ +++.||||++.... ...+..|.+++.. ++||||+++++++..
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 3455678999999999999999999987 58999999986432 3445566777666 899999999998765
Q ss_pred --CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCceeeeeccceEEecCCCCeeE
Q 005298 83 --QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH--------NEGKIHRDIKAANILLTENGDVKV 152 (703)
Q Consensus 83 --~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLH--------s~gIVHRDIKPeNILLd~~g~VKL 152 (703)
...+|+||||+++|+|.++++. ..+++..+..++.||+.||.||| ++||+||||||+||||+.++.+||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999964 67999999999999999999999 999999999999999999999999
Q ss_pred eccccchhhhhcccc----cccccCCCCCCchhhhcccc-----CCccccchhhHHHHHHHHHhC----------CCCCC
Q 005298 153 ADFGVSAQLTRTISR----RKTFVGTPFWMAPEVIQNSE-----GYNEKADIWSLGITVIEMAKG----------EPPLA 213 (703)
Q Consensus 153 ~DFGlA~~~~~~~~~----~~~~iGTp~Y~APEvl~~~~-----~~s~ksDVWSLGvILyELLtG----------~~PF~ 213 (703)
+|||++......... ....+||+.|+|||++.+.. .++.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999998655432221 23458999999999997652 245789999999999999999 88886
Q ss_pred CCCcccee----ec-c-CCCCCCCc-----chhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 214 DLHPMRVL----FI-I-PRENPPQL-----DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 214 ~~~~~~~l----~~-I-~~~~~~~l-----~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
........ .. + .....+.+ ...++..+.+||.+||..||.+|||+.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 54332211 11 1 11112222 24577889999999999999999999999873
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=365.31 Aligned_cols=251 Identities=26% Similarity=0.482 Sum_probs=212.7
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe----
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH---- 82 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~---- 82 (703)
+......+|++++.||+|+||.||+|.+..+++.||||++.... ..+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence 44556779999999999999999999999999999999987543 346789999999999999999999865
Q ss_pred ------------CCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC
Q 005298 83 ------------QTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG 148 (703)
Q Consensus 83 ------------~~~lyLV~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g 148 (703)
...+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC
Confidence 45689999999999999999653 6799999999999999999999999999999999999999999
Q ss_pred CeeEeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC
Q 005298 149 DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN 228 (703)
Q Consensus 149 ~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~ 228 (703)
.+||+|||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ....+..
T Consensus 160 ~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~~~~~-- 233 (284)
T 2a19_B 160 QVKIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETSK--FFTDLRD-- 233 (284)
T ss_dssp EEEECCCTTCEESSCC-SCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--HHHHHHT--
T ss_pred CEEECcchhheecccc-ccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHHH--HHHHhhc--
Confidence 9999999998765433 223456799999999999765 589999999999999999999998853221 1111111
Q ss_pred CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 229 ~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
..++..++..+.+||.+||..||.+|||+.+++++.+...
T Consensus 234 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 -GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1233567888999999999999999999999999977643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=373.03 Aligned_cols=250 Identities=26% Similarity=0.457 Sum_probs=212.1
Q ss_pred CCceEEEEEeecCceEEEEEE----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEE--eCCEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYL--HQTKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~----d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~--~~~~l 86 (703)
.+|++++.||+|+||.||+|. +..+++.||||++... .....+.+.+|+.++++++||||+++++++. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 599999999999999999998 5678999999998755 3455677999999999999999999999987 45679
Q ss_pred EEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
||||||+++++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence 999999999999999976 4569999999999999999999999999999999999999999999999999987654322
Q ss_pred c---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------------ceeeccCCC
Q 005298 166 S---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---------------RVLFIIPRE 227 (703)
Q Consensus 166 ~---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~---------------~~l~~I~~~ 227 (703)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...... .....+...
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred ccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence 1 22345688999999999775 4899999999999999999999998643221 111222233
Q ss_pred CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 228 ~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.....+..++..+.+||.+||..+|.+|||+.+++++
T Consensus 261 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3445567789999999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=373.18 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=202.5
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC----EEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----KLW 87 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~----~ly 87 (703)
..+|++++.||+|+||+||+|.+. ++.||||++.... ........|+.++++++|||||++++++.... .+|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 358999999999999999999876 8999999986543 23345667999999999999999999998744 479
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc----------CceeeeeccceEEecCCCCeeEecccc
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE----------GKIHRDIKAANILLTENGDVKVADFGV 157 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~----------gIVHRDIKPeNILLd~~g~VKL~DFGl 157 (703)
||||||++|+|.+++.. ..+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+
T Consensus 99 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 99999999999999977 4599999999999999999999999 999999999999999999999999999
Q ss_pred chhhhhccc--ccccccCCCCCCchhhhccc----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceee---------
Q 005298 158 SAQLTRTIS--RRKTFVGTPFWMAPEVIQNS----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--------- 222 (703)
Q Consensus 158 A~~~~~~~~--~~~~~iGTp~Y~APEvl~~~----~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~--------- 222 (703)
+..+..... .....+||+.|+|||++.+. ..++.++|||||||+||+|++|..||..........
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 976543322 22346899999999999763 236678999999999999999999997643321110
Q ss_pred -------cc-CCCCCCCcc-----hhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 223 -------II-PRENPPQLD-----EHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 223 -------~I-~~~~~~~l~-----~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.+ .....+.+. ...+..+.+||.+||..||.+|||+.+|++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01 111122222 2345679999999999999999999999973
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=364.41 Aligned_cols=254 Identities=28% Similarity=0.516 Sum_probs=200.9
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
..+...++|++.+.||+|+||.||+|.+.. .||||++.... .....+.+.+|+.++++++||||+++++++ ....
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 345667899999999999999999998653 59999997655 455567899999999999999999999954 5667
Q ss_pred EEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 86 LWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 8999999999999999954 467999999999999999999999999999999999999999999999999998755421
Q ss_pred --ccccccccCCCCCCchhhhcc--ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-CC----CCCCCcchh
Q 005298 165 --ISRRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-PR----ENPPQLDEH 235 (703)
Q Consensus 165 --~~~~~~~iGTp~Y~APEvl~~--~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I-~~----~~~~~l~~~ 235 (703)
........||+.|+|||++.. ...++.++|||||||++|+|++|..||...........+ .. .....+...
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 122234679999999999862 235788999999999999999999999876554332221 11 112234457
Q ss_pred hhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 236 FSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 236 is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
++..+.+||.+||..+|.+|||+.++++.
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 88999999999999999999999999873
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=360.78 Aligned_cols=249 Identities=24% Similarity=0.446 Sum_probs=213.8
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
....+|++++.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.++++++||||+++++++. .+..|+|
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 34578999999999999999999976 477899999865432 2467889999999999999999999876 4568999
Q ss_pred EeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-c
Q 005298 90 MEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-S 166 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~ 166 (703)
|||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999999999997543 79999999999999999999999999999999999999999999999999987654322 1
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
......+++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+..++..+.+||.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 244 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHH
Confidence 22334678899999999764 48899999999999999999 99999887766666555555555566788999999999
Q ss_pred HHhccCCCCCCCHHHHHh
Q 005298 246 LCLKKVPAERPSAKELLR 263 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~ 263 (703)
+||..+|.+|||+.++++
T Consensus 245 ~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 245 LCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHhccChhhCCCHHHHHH
Confidence 999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=378.56 Aligned_cols=256 Identities=22% Similarity=0.286 Sum_probs=202.7
Q ss_pred cchhhhCCCceEEEEEeecCceEEEEEEEcC---CCcEEEEEEeccCCChHH----------HHHHHHHHHHHHhCCCCC
Q 005298 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKE---LNKDVAIKVIDLEESEDE----------IEDIQKEISVLSQCRSPY 72 (703)
Q Consensus 6 ~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~---tg~~VAIKvi~~~~~~~~----------~~~l~~Ei~ILk~L~HPn 72 (703)
.+.+....+|++.+.||+|+||.||+|.+.. ++..||||++........ ...+.+|+.+++.++|||
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 30 VLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp EEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred eeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 3445566899999999999999999999987 788999999876543211 123567889999999999
Q ss_pred eeeeEEEEEe----CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC
Q 005298 73 ITEYYGSYLH----QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG 148 (703)
Q Consensus 73 IV~L~~~~~~----~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g 148 (703)
|+++++++.. ...+||||||+ +++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+||||+.++
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC
Confidence 9999999988 78899999999 999999998877999999999999999999999999999999999999999877
Q ss_pred --CeeEeccccchhhhhccc-------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-
Q 005298 149 --DVKVADFGVSAQLTRTIS-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM- 218 (703)
Q Consensus 149 --~VKL~DFGlA~~~~~~~~-------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~- 218 (703)
.+||+|||++..+..... .....+||+.|+|||++.+. .++.++|||||||+||+|++|..||......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 999999999976543221 11346899999999999875 5899999999999999999999999643211
Q ss_pred ceeecc----CCCCCCCc-----chhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 219 RVLFII----PRENPPQL-----DEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 219 ~~l~~I----~~~~~~~l-----~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
...... ....+..+ ...++..+.+||..||..+|.+||++.+|++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 111111 11111111 1157789999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=388.74 Aligned_cols=243 Identities=28% Similarity=0.450 Sum_probs=212.7
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-EEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-KLWIIM 90 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~-~lyLV~ 90 (703)
..+|++++.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|++++|||||++++++.... .+||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 458999999999999999999886 7899999997543 3467889999999999999999999987765 799999
Q ss_pred eccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 91 EYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|||++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 343 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---Q 343 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---c
Confidence 9999999999997644 3799999999999999999999999999999999999999999999999998754322 2
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....+++.|+|||++.+. .++.++|||||||+||||++ |..||...........+........+..+++.+.+||.+|
T Consensus 344 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 422 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNC 422 (450)
T ss_dssp ---CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHH
Confidence 234678999999999775 58999999999999999998 9999998877776666666666667788999999999999
Q ss_pred hccCCCCCCCHHHHHh
Q 005298 248 LKKVPAERPSAKELLR 263 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~ 263 (703)
|..+|.+|||+.+|++
T Consensus 423 l~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 423 WHLDAATRPTFLQLRE 438 (450)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCChhHCcCHHHHHH
Confidence 9999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=361.47 Aligned_cols=243 Identities=28% Similarity=0.449 Sum_probs=206.3
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-CEEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-TKLWIIM 90 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~-~~lyLV~ 90 (703)
..+|++++.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.++++++||||+++++++... +.+|+||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 468999999999999999999875 8899999986443 356788999999999999999999987654 4789999
Q ss_pred eccCCCCHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 91 EYMAGGSVADLIQSGPP--LDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~--L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||+++++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~ 171 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---Q 171 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc---c
Confidence 99999999999976543 899999999999999999999999999999999999999999999999998755432 2
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...........+........+..+++.+.++|.+|
T Consensus 172 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 250 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNC 250 (278)
T ss_dssp ----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 234788999999999765 58999999999999999998 9999988877666666666656667778899999999999
Q ss_pred hccCCCCCCCHHHHHh
Q 005298 248 LKKVPAERPSAKELLR 263 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~ 263 (703)
|..+|.+||++.++++
T Consensus 251 l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 251 WHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred hcCChhhCCCHHHHHH
Confidence 9999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=370.49 Aligned_cols=251 Identities=22% Similarity=0.395 Sum_probs=210.4
Q ss_pred hCCCc-eEEEEEeecCceEEEEEE----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe--C
Q 005298 11 AGSRF-SSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--Q 83 (703)
Q Consensus 11 ~~~~Y-~il~~LG~GsfG~Vyka~----d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--~ 83 (703)
...+| ++++.||+|+||+||++. +..+++.||||++...........+.+|+.++++++||||+++++++.+ .
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 34466 999999999999998875 4457899999999877666677889999999999999999999999988 4
Q ss_pred CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 84 TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
..+||||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 6899999999999999999764 599999999999999999999999999999999999999999999999999876543
Q ss_pred ccc---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---------------ceeeccC
Q 005298 164 TIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPM---------------RVLFIIP 225 (703)
Q Consensus 164 ~~~---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~---------------~~l~~I~ 225 (703)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...... .....+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 221 12345688999999999875 4889999999999999999999999653211 1112222
Q ss_pred CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 226 ~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.......+..++..+.+||.+||..+|.+|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 33444556778999999999999999999999999996
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=388.18 Aligned_cols=264 Identities=25% Similarity=0.360 Sum_probs=203.1
Q ss_pred cccccchhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEE
Q 005298 2 ADLAGLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSY 80 (703)
Q Consensus 2 ~~i~~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~ 80 (703)
.++..+.......|.+.++||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+|+++ +|||||++++++
T Consensus 4 ~~~p~~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~ 78 (434)
T 2rio_A 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSE 78 (434)
T ss_dssp ----CCSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccccchhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEE
Confidence 4566777778888989999999999999875 44579999999986432 35678899999876 899999999999
Q ss_pred EeCCEEEEEEeccCCCCHHHHHHcCCCCC-------HHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC------
Q 005298 81 LHQTKLWIIMEYMAGGSVADLIQSGPPLD-------EMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN------ 147 (703)
Q Consensus 81 ~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~-------e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~------ 147 (703)
.+++.+|||||||+ |+|.+++....... +..+..++.||+.||.|||++|||||||||+||||+.+
T Consensus 79 ~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~ 157 (434)
T 2rio_A 79 TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD 157 (434)
T ss_dssp ECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSC
T ss_pred ecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccc
Confidence 99999999999995 69999998754332 33457899999999999999999999999999999754
Q ss_pred -------CCeeEeccccchhhhhccc----ccccccCCCCCCchhhhcc------ccCCccccchhhHHHHHHHHHh-CC
Q 005298 148 -------GDVKVADFGVSAQLTRTIS----RRKTFVGTPFWMAPEVIQN------SEGYNEKADIWSLGITVIEMAK-GE 209 (703)
Q Consensus 148 -------g~VKL~DFGlA~~~~~~~~----~~~~~iGTp~Y~APEvl~~------~~~~s~ksDVWSLGvILyELLt-G~ 209 (703)
+.+||+|||++........ .....+||+.|+|||++.+ ...++.++||||||||||+|++ |.
T Consensus 158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~ 237 (434)
T 2rio_A 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237 (434)
T ss_dssp CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence 4799999999876643321 1234689999999999965 2458899999999999999998 99
Q ss_pred CCCCCCCccce--eeccCCC--CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 210 PPLADLHPMRV--LFIIPRE--NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 210 ~PF~~~~~~~~--l~~I~~~--~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.||........ ....... ........++..+.+||.+||..||.+|||+.+|++||||+...
T Consensus 238 ~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~~ 303 (434)
T 2rio_A 238 HPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS 303 (434)
T ss_dssp CTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCHH
T ss_pred CCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCcH
Confidence 99976543221 1111110 11122356788999999999999999999999999999997653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=372.85 Aligned_cols=244 Identities=19% Similarity=0.225 Sum_probs=199.5
Q ss_pred hCCCceEEEEEeecCceEEEEEE-----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCCeeeeEEEEEe
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAF-----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGSYLH 82 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~-----d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~---HPnIV~L~~~~~~ 82 (703)
...+|++.+.||+|+||+||+|. +..+++.||||++.... ...+..|+.+++++. |+||+++++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 45689999999999999999994 67789999999986543 345777888888887 8999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC-----------
Q 005298 83 QTKLWIIMEYMAGGSVADLIQS-----GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE----------- 146 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~-----~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~----------- 146 (703)
.+..|||||||++|+|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999999973 567999999999999999999999999999999999999998
Q ss_pred CCCeeEeccccchhhhh--cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc
Q 005298 147 NGDVKVADFGVSAQLTR--TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII 224 (703)
Q Consensus 147 ~g~VKL~DFGlA~~~~~--~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I 224 (703)
++.+||+|||++..+.. ........+||+.|+|||++.+. .|+.++||||||||||+|++|..||......... +
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~ 295 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--P 295 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--E
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHHHhCCCccccCCCCcee--e
Confidence 89999999999965432 22234457899999999999875 4899999999999999999999999654332221 1
Q ss_pred CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 225 ~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
..... .+ ..+..+.+|+..||..+|.+|++..+.+.+
T Consensus 296 ~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 296 EGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp CSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred chhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 11111 11 246778999999999999999654444443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=360.57 Aligned_cols=252 Identities=20% Similarity=0.306 Sum_probs=201.3
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEE-EeCCE
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY-LHQTK 85 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~-~~~~~ 85 (703)
+....+.+|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++++.|++++..+..+ ...+.
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 344567899999999999999999999999999999998754432 24578899999999987766666655 66788
Q ss_pred EEEEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe---cCCCCeeEeccccchhh
Q 005298 86 LWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL---TENGDVKVADFGVSAQL 161 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL---d~~g~VKL~DFGlA~~~ 161 (703)
.||||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999999 9999999974 5679999999999999999999999999999999999999 78899999999998765
Q ss_pred hhccc-------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC---C----C
Q 005298 162 TRTIS-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP---R----E 227 (703)
Q Consensus 162 ~~~~~-------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~---~----~ 227 (703)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+. . .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 43221 12356899999999999875 48999999999999999999999998755432221111 0 0
Q ss_pred CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 228 NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 228 ~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
....+...++..+.+||..||..+|.+|||+.+|++
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 011122456889999999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=395.64 Aligned_cols=249 Identities=26% Similarity=0.468 Sum_probs=219.2
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.+|++++|||||+++++|.....+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3579999999999999999999999999999999875432 25678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-ccc
Q 005298 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SRR 168 (703)
Q Consensus 92 yv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~~ 168 (703)
||.+|+|.+++... ..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||++....... ...
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 99999999999753 469999999999999999999999999999999999999999999999999987654322 122
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....+++.|+|||++... .++.++|||||||+||||++ |..||...+.......+........+..++..+.+||.+|
T Consensus 377 ~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 455 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 455 (495)
T ss_dssp TTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 234567889999999765 48999999999999999999 9999998877666666665555566778899999999999
Q ss_pred hccCCCCCCCHHHHHh
Q 005298 248 LKKVPAERPSAKELLR 263 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~ 263 (703)
|..+|.+|||+.+|++
T Consensus 456 l~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 456 WQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCcChhHCcCHHHHHH
Confidence 9999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=359.72 Aligned_cols=250 Identities=21% Similarity=0.316 Sum_probs=206.2
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEE-EeCCEEE
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSY-LHQTKLW 87 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~-~~~~~ly 87 (703)
...+.+|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+.|++++..+..+ ...+..|
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 34678999999999999999999999999999999998655432 4578999999999988766666554 6678899
Q ss_pred EEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec---CCCCeeEeccccchhhhh
Q 005298 88 IIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT---ENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~-~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd---~~g~VKL~DFGlA~~~~~ 163 (703)
+||||+ +++|.+++. ....+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 999999997 356799999999999999999999999999999999999994 788999999999876543
Q ss_pred ccc-------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccce---eeccCC----CCC
Q 005298 164 TIS-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRV---LFIIPR----ENP 229 (703)
Q Consensus 164 ~~~-------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~---l~~I~~----~~~ 229 (703)
... ......||+.|+|||++.+. .++.++|||||||+||+|++|..||........ +..+.. ...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 322 12456899999999999875 489999999999999999999999987543221 111111 011
Q ss_pred CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 230 PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 230 ~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
..+...++..+.+||.+||..+|.+|||+.+|++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1122457889999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=367.05 Aligned_cols=249 Identities=23% Similarity=0.393 Sum_probs=188.4
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEE--------
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYL-------- 81 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~-------- 81 (703)
...+|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++++. ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 345899999999999999999999999999999998544 3445677899999999996 999999999994
Q ss_pred eCCEEEEEEeccCCCCHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeeeeccceEEecCCCCeeEeccc
Q 005298 82 HQTKLWIIMEYMAGGSVADLIQS---GPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLTENGDVKVADFG 156 (703)
Q Consensus 82 ~~~~lyLV~Eyv~gGsL~~~l~~---~~~L~e~~i~~i~~QLl~AL~yLHs~g--IVHRDIKPeNILLd~~g~VKL~DFG 156 (703)
....+|+||||+. |+|.+++.. .+++++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 3446899999995 789888864 567999999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhccc------------ccccccCCCCCCchhhhc--cccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee
Q 005298 157 VSAQLTRTIS------------RRKTFVGTPFWMAPEVIQ--NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF 222 (703)
Q Consensus 157 lA~~~~~~~~------------~~~~~iGTp~Y~APEvl~--~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~ 222 (703)
++........ .....+||+.|+|||++. ....++.++|||||||+||+|++|..||..........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 263 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence 9876543211 112457999999999983 22357889999999999999999999998765443332
Q ss_pred ccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 223 IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 223 ~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
... .......++..+.+||.+||..+|.+|||+.+++++
T Consensus 264 ~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 264 GKY---SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp --C---CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred Ccc---cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 221 122234556778999999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=381.55 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=206.2
Q ss_pred CceEEEEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe-CCEEEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKLWII 89 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~t---g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~-~~~lyLV 89 (703)
.|++.+.||+|+||+||+|.+..+ +..||||.++..........+.+|+.++++++||||+++++++.. ++..|+|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 688999999999999999987643 346899998766556677889999999999999999999998754 5688999
Q ss_pred EeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc--
Q 005298 90 MEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-- 166 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-- 166 (703)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 249 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence 9999999999999864 4689999999999999999999999999999999999999999999999999876533211
Q ss_pred --ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 167 --RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 167 --~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
......+|+.|+|||++.+. .++.++|||||||+||+|++ |.+||...+.......+........+..++..+.+|
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~l 328 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 328 (373)
T ss_dssp --------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11234678899999999765 58999999999999999999 788898777666655555555555667789999999
Q ss_pred HHHHhccCCCCCCCHHHHHhc
Q 005298 244 VSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~H 264 (703)
|.+||..+|.+|||+.+++++
T Consensus 329 i~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 329 MLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=377.10 Aligned_cols=253 Identities=18% Similarity=0.269 Sum_probs=201.2
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCC-----CcEEEEEEeccCCChH--HH--------HHHHHHHHHHHhCCCCCe
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESED--EI--------EDIQKEISVLSQCRSPYI 73 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~t-----g~~VAIKvi~~~~~~~--~~--------~~l~~Ei~ILk~L~HPnI 73 (703)
+....+|++.+.||+|+||.||+|.+..+ ++.||||++....... +. ..+..|+..++.++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 34566999999999999999999998764 5889999986553111 11 123456667788899999
Q ss_pred eeeEEEEEeC----CEEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec--C
Q 005298 74 TEYYGSYLHQ----TKLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT--E 146 (703)
Q Consensus 74 V~L~~~~~~~----~~lyLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd--~ 146 (703)
+++++++... ...||||||| |++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+ .
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 9999998875 5689999999 99999999775 6899999999999999999999999999999999999999 7
Q ss_pred CCCeeEeccccchhhhhcccc-------cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc
Q 005298 147 NGDVKVADFGVSAQLTRTISR-------RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR 219 (703)
Q Consensus 147 ~g~VKL~DFGlA~~~~~~~~~-------~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~ 219 (703)
++.+||+|||++..+...... ....+||+.|+|||++.+. .++.++|||||||+||+|++|..||.......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 899999999999765433211 1345699999999999875 48999999999999999999999998543221
Q ss_pred eeec-cCCCCCCCc---------chhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 220 VLFI-IPRENPPQL---------DEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 220 ~l~~-I~~~~~~~l---------~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.... ........+ ...++..+.+||..||..+|.+||++.+|++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111 000000001 1345788999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=388.50 Aligned_cols=248 Identities=24% Similarity=0.408 Sum_probs=214.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||+|+||+||+|.+.. +..||||+++.... ..+.+.+|+.+|++++|||||++++++. .+.+||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34589999999999999999999864 78899999975432 3577899999999999999999999986 66789999
Q ss_pred eccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-cc
Q 005298 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~ 167 (703)
|||.+|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||++....... ..
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 999999999999753 378999999999999999999999999999999999999999999999999997654321 11
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
.....+++.|+|||++... .++.++|||||||+||||++ |..||...........+........+..++..+.+||.+
T Consensus 342 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 420 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 420 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred cCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 2234567889999999765 58999999999999999999 999999887776666665555555667889999999999
Q ss_pred HhccCCCCCCCHHHHHh
Q 005298 247 CLKKVPAERPSAKELLR 263 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~ 263 (703)
||..+|.+|||+.+|+.
T Consensus 421 cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 421 CWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhHCcCHHHHHH
Confidence 99999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=356.85 Aligned_cols=232 Identities=26% Similarity=0.441 Sum_probs=192.4
Q ss_pred hCCCceEE-EEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHH-HhCCCCCeeeeEEEEEe----CC
Q 005298 11 AGSRFSSL-ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVL-SQCRSPYITEYYGSYLH----QT 84 (703)
Q Consensus 11 ~~~~Y~il-~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~IL-k~L~HPnIV~L~~~~~~----~~ 84 (703)
...+|.++ ++||+|+||.||+|.+..+++.||||++... ..+.+|+.++ +.++||||+++++++.. ..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 44578888 8899999999999999999999999998632 4567888887 66799999999999987 77
Q ss_pred EEEEEEeccCCCCHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC---CCCeeEeccccch
Q 005298 85 KLWIIMEYMAGGSVADLIQSGP--PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSA 159 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~--~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~---~g~VKL~DFGlA~ 159 (703)
.+||||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 8999999999999999998754 6999999999999999999999999999999999999998 7889999999874
Q ss_pred hhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---CCCCCcc---
Q 005298 160 QLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---ENPPQLD--- 233 (703)
Q Consensus 160 ~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---~~~~~l~--- 233 (703)
... + ..++.++|||||||+||+|++|..||...........+.. .....++
T Consensus 169 ~~~----------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 169 ETT----------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp ECT----------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred ccc----------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 321 1 2477899999999999999999999977654333221111 1111122
Q ss_pred -hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 234 -EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 234 -~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
..++..+.+||.+||..||.+|||+.++++||||....
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 46789999999999999999999999999999998653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=360.64 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=197.5
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHh--CCCCCeeeeEEEEEeC---
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ--CRSPYITEYYGSYLHQ--- 83 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~--L~HPnIV~L~~~~~~~--- 83 (703)
.....+|++++.||+|+||.||+|.+. ++.||||++.... ......|.+++.. ++||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 344568999999999999999999886 8999999985432 2334455566555 4999999999999987
Q ss_pred -CEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc--------CceeeeeccceEEecCCCCeeEec
Q 005298 84 -TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE--------GKIHRDIKAANILLTENGDVKVAD 154 (703)
Q Consensus 84 -~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~--------gIVHRDIKPeNILLd~~g~VKL~D 154 (703)
..+|+||||+++|+|.++++. ..+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 789999999999999999976 4799999999999999999999999 999999999999999999999999
Q ss_pred cccchhhhhcccc----cccccCCCCCCchhhhccccCCcc------ccchhhHHHHHHHHHhC----------CCCCCC
Q 005298 155 FGVSAQLTRTISR----RKTFVGTPFWMAPEVIQNSEGYNE------KADIWSLGITVIEMAKG----------EPPLAD 214 (703)
Q Consensus 155 FGlA~~~~~~~~~----~~~~iGTp~Y~APEvl~~~~~~s~------ksDVWSLGvILyELLtG----------~~PF~~ 214 (703)
||++..+...... ....+||+.|+|||++.+.. +.. ++|||||||+||||++| ..||..
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 9998655432221 22468999999999997653 344 38999999999999999 667755
Q ss_pred CCcccee-----ecc-CCCCCCCcc-----hhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 215 LHPMRVL-----FII-PRENPPQLD-----EHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 215 ~~~~~~l-----~~I-~~~~~~~l~-----~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
....... ..+ .....+.++ ..++..+.+||.+||..||.+|||+.+|++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 4322111 001 111122222 3678889999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=355.70 Aligned_cols=244 Identities=30% Similarity=0.487 Sum_probs=204.7
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC---ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEecc
Q 005298 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~---~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
..+.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.++++++||||+++++++...+..|+||||+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 348999999999999986 58899999986532 2345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc--cc
Q 005298 94 AGGSVADLIQS---GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS--RR 168 (703)
Q Consensus 94 ~gGsL~~~l~~---~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~--~~ 168 (703)
++++|.+++.. ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 99999999963 45799999999999999999999999999999999999999999999999999875533211 12
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC--------------CCCCCCcch
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP--------------RENPPQLDE 234 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~--------------~~~~~~l~~ 234 (703)
...+||+.|+|||++.+ .++.++|||||||++|+|++|.+||...........+. .......+.
T Consensus 193 ~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS 270 (307)
T ss_dssp SSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCH
T ss_pred cccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccch
Confidence 34579999999999875 37899999999999999999999998765433222110 111223456
Q ss_pred hhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 235 ~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
..+..+.++|.+||..+|.+|||+.+++++
T Consensus 271 ~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 271 TSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 678889999999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=362.56 Aligned_cols=243 Identities=30% Similarity=0.557 Sum_probs=201.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||+|+||.||+|.+. ++.||||++... ...+.+.+|+.++++++||||+++++++. +..||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~ 78 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVM 78 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEE
Confidence 3468999999999999999999875 789999998633 34577899999999999999999999876 4479999
Q ss_pred eccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---cCceeeeeccceEEecCCCC-eeEeccccchhhhh
Q 005298 91 EYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHN---EGKIHRDIKAANILLTENGD-VKVADFGVSAQLTR 163 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~---~L~e~~i~~i~~QLl~AL~yLHs---~gIVHRDIKPeNILLd~~g~-VKL~DFGlA~~~~~ 163 (703)
||+++++|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999999998755 47899999999999999999999 89999999999999998886 79999999875533
Q ss_pred cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc--eeeccCCCCCCCcchhhhHHHH
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR--VLFIIPRENPPQLDEHFSRLMK 241 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~--~l~~I~~~~~~~l~~~is~~L~ 241 (703)
. .....||+.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+.....+.....++..+.
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 159 H---MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234 (307)
T ss_dssp ---------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHH
T ss_pred c---cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHH
Confidence 2 2345799999999999765 58999999999999999999999997654322 2223333445566678899999
Q ss_pred HHHHHHhccCCCCCCCHHHHHhc
Q 005298 242 EFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+||.+||..+|.+|||+.+++++
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=371.63 Aligned_cols=248 Identities=17% Similarity=0.310 Sum_probs=204.2
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCC--------CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeee-----
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKEL--------NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE----- 75 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~t--------g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~----- 75 (703)
...+.+|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.++++++||||++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhh
Confidence 34468999999999999999999999874 889999998744 35788999999999999887
Q ss_pred ----------eEEEEEe-CCEEEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceE
Q 005298 76 ----------YYGSYLH-QTKLWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANI 142 (703)
Q Consensus 76 ----------L~~~~~~-~~~lyLV~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNI 142 (703)
+++++.. ++.+||||||+ +++|.+++... ..+++..+..|+.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6777776 78899999999 99999999876 7899999999999999999999999999999999999
Q ss_pred EecCCC--CeeEeccccchhhhhccc-------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCC
Q 005298 143 LLTENG--DVKVADFGVSAQLTRTIS-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLA 213 (703)
Q Consensus 143 LLd~~g--~VKL~DFGlA~~~~~~~~-------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~ 213 (703)
||+.++ .+||+|||++..+..... ......||+.|+|||++.+. .++.++|||||||+||+|++|..||.
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999988 899999999976543321 11345899999999999875 58999999999999999999999998
Q ss_pred CCCc-cc-eeeccC--CCCCCCc------chhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 214 DLHP-MR-VLFIIP--RENPPQL------DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 214 ~~~~-~~-~l~~I~--~~~~~~l------~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.... .. ....+. ...+..+ ...++..+.+||.+||..||.+||++.+|++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 6542 11 111110 0111111 13568999999999999999999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=358.11 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=203.1
Q ss_pred CCCceEEEEEeecCceEEEEEEEcC-CCc--EEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKE-LNK--DVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~-tg~--~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~l 86 (703)
..+|++++.||+|+||+||+|.+.. +++ .||||++.... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4689999999999999999998643 333 69999986543 2345678899999999999999999999998765 8
Q ss_pred EEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 87 WIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 9999999999999999763 579999999999999999999999999999999999999999999999999987654322
Q ss_pred c---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCC-CCCCcchhhhHHH
Q 005298 166 S---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLM 240 (703)
Q Consensus 166 ~---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~-~~~~l~~~is~~L 240 (703)
. ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...+.......+... .....+..++..+
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 254 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 254 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred cchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHH
Confidence 1 12235678899999999765 48899999999999999999 99999888766655554332 2334556789999
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhc
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.++|.+||..+|.+|||+.+++++
T Consensus 255 ~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 255 YNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999973
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=361.57 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=192.5
Q ss_pred cchhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHH--HHhCCCCCeeeeEEEEEe-
Q 005298 6 GLQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISV--LSQCRSPYITEYYGSYLH- 82 (703)
Q Consensus 6 ~l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~I--Lk~L~HPnIV~L~~~~~~- 82 (703)
......-.+|++++.||+|+||.||+|.+ +++.||||++.... ...+..|..+ +..++||||+++++.+..
T Consensus 6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp ---CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 33344557999999999999999999976 58999999986543 2333334444 556899999999986643
Q ss_pred ----CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc---------CceeeeeccceEEecCCCC
Q 005298 83 ----QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE---------GKIHRDIKAANILLTENGD 149 (703)
Q Consensus 83 ----~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~---------gIVHRDIKPeNILLd~~g~ 149 (703)
...+|||||||++|+|.+++... .+++..+..++.||+.||.|||++ ||+||||||+||||+.++.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 33679999999999999999764 459999999999999999999999 9999999999999999999
Q ss_pred eeEeccccchhhhhc--------ccccccccCCCCCCchhhhccc------cCCccccchhhHHHHHHHHHhCCCCCCCC
Q 005298 150 VKVADFGVSAQLTRT--------ISRRKTFVGTPFWMAPEVIQNS------EGYNEKADIWSLGITVIEMAKGEPPLADL 215 (703)
Q Consensus 150 VKL~DFGlA~~~~~~--------~~~~~~~iGTp~Y~APEvl~~~------~~~s~ksDVWSLGvILyELLtG~~PF~~~ 215 (703)
+||+|||++..+... .......+||+.|+|||++.+. ..++.++|||||||+||||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999998765321 1122345799999999999762 24667899999999999999997776443
Q ss_pred Cccceeecc-------------------CCCCCCCcc------hhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 216 HPMRVLFII-------------------PRENPPQLD------EHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 216 ~~~~~l~~I-------------------~~~~~~~l~------~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
......... .....+.++ ..+++.+.+||.+||..||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 221111000 011111222 246678999999999999999999999976
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=396.62 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=212.2
Q ss_pred CCceEEE-EEeecCceEEEEEEEcC--CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLE-LIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~-~LG~GsfG~Vyka~d~~--tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
.+|.+.+ .||+|+||.||+|.+.. ++..||||+++........+.+.+|+.+|++++|||||++++++.. +.+|||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3566666 89999999999998763 5678999999765544556789999999999999999999999876 569999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc-
Q 005298 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR- 167 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~- 167 (703)
||||.+|+|.+++.. ...+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||++..+......
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 999999999999965 456999999999999999999999999999999999999999999999999999765432211
Q ss_pred --cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHH
Q 005298 168 --RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 168 --~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI 244 (703)
.....+++.|+|||++.+. .++.++||||||||||||++ |..||...+..+....+........+..++..+.+||
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 572 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALM 572 (613)
T ss_dssp --------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 1223467899999999765 58999999999999999998 9999999888777777777666677788999999999
Q ss_pred HHHhccCCCCCCCHHHHHh
Q 005298 245 SLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~ 263 (703)
..||..+|.+||++.+|++
T Consensus 573 ~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 573 SDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHTTCSSTTTSCCHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHH
Confidence 9999999999999999865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=383.32 Aligned_cols=261 Identities=23% Similarity=0.382 Sum_probs=202.4
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
..+|++.++||+|+||+||. ....+++.||||++..... ..+.+|+.+|+++ +|||||++++++.+...+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34799999999999999764 3445799999999864432 2356799999999 7999999999999999999999
Q ss_pred eccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC---CC--CeeEeccccchhhhhc
Q 005298 91 EYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NG--DVKVADFGVSAQLTRT 164 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~---~g--~VKL~DFGlA~~~~~~ 164 (703)
|||. |+|.+++.... .+.+..+..++.||+.||.|||++|||||||||+||||+. ++ .+||+|||++..+...
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9995 69999997653 4666678899999999999999999999999999999953 23 5789999999766432
Q ss_pred c---cccccccCCCCCCchhhhcc--ccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCC--CCCcchhh
Q 005298 165 I---SRRKTFVGTPFWMAPEVIQN--SEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPREN--PPQLDEHF 236 (703)
Q Consensus 165 ~---~~~~~~iGTp~Y~APEvl~~--~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~--~~~l~~~i 236 (703)
. ......+||+.|+|||++.+ ...++.++||||||||||+|++ |.+||...........+.... ........
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence 2 22345689999999999974 2346779999999999999999 999996654333222222111 11223456
Q ss_pred hHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccccChhHHH
Q 005298 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278 (703)
Q Consensus 237 s~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~~~~l~e 278 (703)
+..+.+||.+||..||.+|||+.++++||||+...+...+..
T Consensus 257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~~~~~~~ 298 (432)
T 3p23_A 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQ 298 (432)
T ss_dssp HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHHHHHHHH
T ss_pred cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHHHHHHHH
Confidence 778999999999999999999999999999987654333333
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=383.48 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=210.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|++++||||+++++++.. +.+||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34589999999999999999999875 567999998754422 4678999999999999999999999866 6789999
Q ss_pred eccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-cc
Q 005298 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~ 167 (703)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 99999999999964 3569999999999999999999999999999999999999999999999999987654321 11
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
.....+++.|+|||++... .++.++|||||||+||||++ |..||...........+........+..++..+.+||.+
T Consensus 338 ~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 416 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 416 (452)
T ss_dssp -----CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 2234578899999999765 58999999999999999999 999999887777766666665566677889999999999
Q ss_pred HhccCCCCCCCHHHHHh
Q 005298 247 CLKKVPAERPSAKELLR 263 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~ 263 (703)
||..+|.+|||+.+|++
T Consensus 417 cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 417 CWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=396.31 Aligned_cols=244 Identities=24% Similarity=0.417 Sum_probs=210.2
Q ss_pred EEEeecCceEEEEEEE--cCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFD--KELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d--~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
+.||+|+||.||+|.+ ..+++.||||+++... .....+.+.+|+.+|++++|||||++++++. .+.+|||||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 4899999999999955 4567899999987543 2334578999999999999999999999986 4568999999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc---cccccc
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---RRKTFV 172 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~---~~~~~i 172 (703)
|+|.+++.....+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||++..+..... ......
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 533 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence 99999999888999999999999999999999999999999999999999999999999999976643321 122345
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccC
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~d 251 (703)
||+.|+|||++.+. .++.++|||||||+||||++ |..||...+.......+........+..++..+.+||..||..+
T Consensus 534 ~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~d 612 (635)
T 4fl3_A 534 WPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 612 (635)
T ss_dssp -CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 78899999999765 58999999999999999998 99999998887777777776667777889999999999999999
Q ss_pred CCCCCCHHHHHhc
Q 005298 252 PAERPSAKELLRH 264 (703)
Q Consensus 252 P~~RPTa~eLL~H 264 (703)
|.+||++.+|++.
T Consensus 613 P~~RPs~~~l~~~ 625 (635)
T 4fl3_A 613 VENRPGFAAVELR 625 (635)
T ss_dssp TTTSCCHHHHHHH
T ss_pred HhHCcCHHHHHHH
Confidence 9999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=361.48 Aligned_cols=251 Identities=24% Similarity=0.428 Sum_probs=208.5
Q ss_pred hCCCceEEEEEeecCceEEEEEE----EcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC--
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAF----DKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT-- 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~----d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~-- 84 (703)
...+|++++.||+|+||.||+|. +..+++.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 34579999999999999999998 4668999999998754 3445678999999999999999999999987654
Q ss_pred EEEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 85 KLWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 789999999999999999765 4699999999999999999999999999999999999999999999999999876543
Q ss_pred ccc---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc----------c------ceeecc
Q 005298 164 TIS---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP----------M------RVLFII 224 (703)
Q Consensus 164 ~~~---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~----------~------~~l~~I 224 (703)
... ......+++.|+|||++.+. .++.++|||||||+||+|++|..||..... . .....+
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 321 12234678889999999775 488999999999999999999999863210 0 011122
Q ss_pred CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 225 ~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
........+..++..+.+||.+||..+|.+|||+.+|++
T Consensus 277 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222334456678899999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=355.84 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=204.2
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHh--CCCCCeeeeEEEEEeCC--
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ--CRSPYITEYYGSYLHQT-- 84 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~--L~HPnIV~L~~~~~~~~-- 84 (703)
.....+|++.+.||+|+||.||+|.+ +|+.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 44557899999999999999999988 4899999998643 23567788888887 79999999999998876
Q ss_pred --EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCceeeeeccceEEecCCCCeeEec
Q 005298 85 --KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH--------NEGKIHRDIKAANILLTENGDVKVAD 154 (703)
Q Consensus 85 --~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLH--------s~gIVHRDIKPeNILLd~~g~VKL~D 154 (703)
.+|+||||+++|+|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred cceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 89999999999999999976 56999999999999999999999 89999999999999999999999999
Q ss_pred cccchhhhhccc----ccccccCCCCCCchhhhccccC-----CccccchhhHHHHHHHHHhC----------CCCCCCC
Q 005298 155 FGVSAQLTRTIS----RRKTFVGTPFWMAPEVIQNSEG-----YNEKADIWSLGITVIEMAKG----------EPPLADL 215 (703)
Q Consensus 155 FGlA~~~~~~~~----~~~~~iGTp~Y~APEvl~~~~~-----~s~ksDVWSLGvILyELLtG----------~~PF~~~ 215 (703)
||++........ .....+||+.|+|||++.+... ++.++|||||||+||+|++| ..||...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~ 270 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270 (342)
T ss_dssp CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence 999876543321 2244689999999999976421 33689999999999999999 7888765
Q ss_pred Cccc-----eeeccC-CCCCCCcc-----hhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 216 HPMR-----VLFIIP-RENPPQLD-----EHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 216 ~~~~-----~l~~I~-~~~~~~l~-----~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.... ....+. ....+.++ ..++..+.+||.+||..+|.+|||+.+|++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 3321 111111 11222222 3566789999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=387.90 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=214.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|++|+|||||++++++.. +.+||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 34589999999999999999999875 567999999754422 4678999999999999999999999866 6789999
Q ss_pred eccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-cc
Q 005298 91 EYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~ 167 (703)
|||.+|+|.+++.. ...+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||++..+.... ..
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 99999999999964 3569999999999999999999999999999999999999999999999999997654321 11
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
.....+++.|+|||++... .++.++||||||||||||++ |..||......+....+........+..++..+.+||.+
T Consensus 421 ~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 499 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 499 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 2234578899999999875 58999999999999999999 999999887777666666655556667889999999999
Q ss_pred HhccCCCCCCCHHHHHh
Q 005298 247 CLKKVPAERPSAKELLR 263 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~ 263 (703)
||..+|.+|||+.+|++
T Consensus 500 cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 500 CWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcCCChhHCcCHHHHHH
Confidence 99999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=363.05 Aligned_cols=251 Identities=24% Similarity=0.433 Sum_probs=206.7
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
....+|++.+.||+|+||.||+|.+.. .||||++..... ....+.+.+|+.++++++||||+++++++...+.+|+
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 445799999999999999999998864 499999875432 2233557789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc---
Q 005298 89 IMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT--- 164 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~--- 164 (703)
||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 999999999999998754 799999999999999999999999999999999999998 679999999997654321
Q ss_pred --ccccccccCCCCCCchhhhcc--------ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC-cc
Q 005298 165 --ISRRKTFVGTPFWMAPEVIQN--------SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ-LD 233 (703)
Q Consensus 165 --~~~~~~~iGTp~Y~APEvl~~--------~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~-l~ 233 (703)
........||+.|+|||++.. ...++.++|||||||++|+|++|..||...........+.....+. ..
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 265 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ 265 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCC
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCc
Confidence 122234569999999999874 2347889999999999999999999998877655554444333322 23
Q ss_pred hhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 234 ~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
..++..+.+||.+||..+|.+|||+.++++.
T Consensus 266 ~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 266 IGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 4678889999999999999999999999973
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=373.61 Aligned_cols=249 Identities=14% Similarity=0.178 Sum_probs=198.5
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh--HHHHHHHHHHHHHHhCCC-CCe----------------
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE--DEIEDIQKEISVLSQCRS-PYI---------------- 73 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~--~~~~~l~~Ei~ILk~L~H-PnI---------------- 73 (703)
.+|++.++||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.+++.+.| .|+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3588999999999999999999999999999998744432 225778999999999987 221
Q ss_pred -----eeeEEEEEe-----CCEEEEEEeccCCCCHHHHHHc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCceeee
Q 005298 74 -----TEYYGSYLH-----QTKLWIIMEYMAGGSVADLIQS-------GPPLDEMSIACILRDLLHAIEYLHNEGKIHRD 136 (703)
Q Consensus 74 -----V~L~~~~~~-----~~~lyLV~Eyv~gGsL~~~l~~-------~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRD 136 (703)
..++.++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 111111121 22467788877 6899998841 34578889999999999999999999999999
Q ss_pred eccceEEecCCCCeeEeccccchhhhhcccccccccCCCCCCchhhhc---------cccCCccccchhhHHHHHHHHHh
Q 005298 137 IKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ---------NSEGYNEKADIWSLGITVIEMAK 207 (703)
Q Consensus 137 IKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~---------~~~~~s~ksDVWSLGvILyELLt 207 (703)
|||+||||+.++.+||+|||++...... ....+| +.|+|||++. ....++.++||||||||||+|++
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 9999999999999999999998765433 345688 9999999993 22347889999999999999999
Q ss_pred CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 208 GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 208 G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
|+.||...+.......+.... ..++..+.+||.+||.++|.+||++.++++||||+...
T Consensus 313 g~~Pf~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 313 ADLPNTDDAALGGSEWIFRSC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp SSCCCCTTGGGSCSGGGGSSC-----CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCCCCCCcchhhhHHHHHhhc-----ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence 999998876655554443322 24678899999999999999999999999999998753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=381.58 Aligned_cols=249 Identities=21% Similarity=0.336 Sum_probs=207.1
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC-CCeeeeEEEEEeCCEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H-PnIV~L~~~~~~~~~lyL 88 (703)
..+.+|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.|.| ++|+.+..++...+..||
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 4578999999999999999999999999999999998655432 347889999999987 666677777778889999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEe---cCCCCeeEeccccchhhhhc
Q 005298 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILL---TENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILL---d~~g~VKL~DFGlA~~~~~~ 164 (703)
||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||++..+...
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999 9999999975 5689999999999999999999999999999999999999 57899999999999765433
Q ss_pred cc-------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee---eccCC----CCCC
Q 005298 165 IS-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---FIIPR----ENPP 230 (703)
Q Consensus 165 ~~-------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l---~~I~~----~~~~ 230 (703)
.. .....+||+.|+|||++.+. .++.++||||||||||+|++|..||......... ..+.. ....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 22 12256899999999999875 4899999999999999999999999876542211 11111 1111
Q ss_pred CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 231 QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 231 ~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.+...++..+.+||..||..+|.+||++.+|++
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 223466889999999999999999999999876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=391.08 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=215.6
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~t---g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
..+|++.+.||+|+||.||+|.+..+ +..||||++.........+.+.+|+.++++++||||+++++++. ++.+||
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 45899999999999999999998653 56799999876666666788999999999999999999999984 566899
Q ss_pred EEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-
Q 005298 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 166 (703)
||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 547 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence 99999999999999764 4799999999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
......||+.|+|||++.+. .++.++|||||||+||||++ |.+||...........+.......++..++..+.+||.
T Consensus 548 ~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 626 (656)
T 2j0j_A 548 KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 626 (656)
T ss_dssp ------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred eccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHH
Confidence 12234678899999999765 58999999999999999997 99999988777766666665666677788999999999
Q ss_pred HHhccCCCCCCCHHHHHhc
Q 005298 246 LCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~H 264 (703)
+||..||.+|||+.+|++.
T Consensus 627 ~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 627 KCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHH
Confidence 9999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=371.18 Aligned_cols=241 Identities=21% Similarity=0.286 Sum_probs=195.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-------hHHHHHHHHHHHHHHhCC---------CCCeeee
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-------EDEIEDIQKEISVLSQCR---------SPYITEY 76 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-------~~~~~~l~~Ei~ILk~L~---------HPnIV~L 76 (703)
.+|++++.||+|+||+||+|++ +|+.||||++..... ....+.+.+|+.+++.++ |||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 5899999999999999999998 689999999976532 223467889999998885 7888877
Q ss_pred EEEEE------------------------------eCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 005298 77 YGSYL------------------------------HQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY 126 (703)
Q Consensus 77 ~~~~~------------------------------~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~y 126 (703)
++++. ..+.+|||||||++|+|.+.+.+ ..+++..++.|+.||+.||.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence 77653 26789999999999977666644 678999999999999999999
Q ss_pred HH-hcCceeeeeccceEEecCCC--------------------CeeEeccccchhhhhcccccccccCCCCCCchhhhcc
Q 005298 127 LH-NEGKIHRDIKAANILLTENG--------------------DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185 (703)
Q Consensus 127 LH-s~gIVHRDIKPeNILLd~~g--------------------~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~ 185 (703)
|| ++|||||||||+||||+.++ .+||+|||++..... ...+||+.|+|||++.+
T Consensus 177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSGGGCC
T ss_pred HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccChhhhcC
Confidence 99 99999999999999999887 899999999976543 24589999999999986
Q ss_pred ccCCccccchhhHHHH-HHHHHhCCCCCCCCCc----c-ceeeccC--CCCCCCcchhhhHHHHHHHHHHhccCCCCCCC
Q 005298 186 SEGYNEKADIWSLGIT-VIEMAKGEPPLADLHP----M-RVLFIIP--RENPPQLDEHFSRLMKEFVSLCLKKVPAERPS 257 (703)
Q Consensus 186 ~~~~s~ksDVWSLGvI-LyELLtG~~PF~~~~~----~-~~l~~I~--~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPT 257 (703)
. .+.++|||||+++ .+++++|..||..... . .....+. ..........+++.+++||.+||.++ |
T Consensus 252 ~--~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s 324 (336)
T 2vuw_A 252 D--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S 324 (336)
T ss_dssp C--SSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred C--CccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence 4 3889999998777 7779999999954210 0 1111111 11222334578999999999999976 9
Q ss_pred HHHHH-hchhhh
Q 005298 258 AKELL-RHRFIR 268 (703)
Q Consensus 258 a~eLL-~Hpff~ 268 (703)
+.|+| +||||+
T Consensus 325 a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 325 ATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHCGGGC
T ss_pred HHHHHhcCCCcC
Confidence 99999 999994
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=342.71 Aligned_cols=224 Identities=18% Similarity=0.236 Sum_probs=192.1
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.++.+++||||+++++++...+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 456799999999999999999999999999999999976543 455678899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
|||||++|++|.++++.+ .....+..|+.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999999653 4566788999999999999999999999999999999999999998543
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee---ccCCCCCC---CcchhhhHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF---IIPRENPP---QLDEHFSRLMK 241 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~---~I~~~~~~---~l~~~is~~L~ 241 (703)
|++ .++.++|||||||+||+|++|..||...+....+. ......+. .+...++..+.
T Consensus 175 ---------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 ---------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp ---------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred ---------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 333 26789999999999999999999998877654332 22222222 12356889999
Q ss_pred HHHHHHhccCCCCCCCHHHHHhc
Q 005298 242 EFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+||.+||.+||.+| |+.++++.
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHcccCCccC-CHHHHHHH
Confidence 99999999999999 99999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=397.37 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=212.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe------CC
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH------QT 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~------~~ 84 (703)
..++|++.+.||+|+||.||+|.+..+|+.||||++.........+.+.+|+.++++++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 447999999999999999999999999999999998766666667889999999999999999999998765 67
Q ss_pred EEEEEEeccCCCCHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC---eeEeccccc
Q 005298 85 KLWIIMEYMAGGSVADLIQSGP---PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD---VKVADFGVS 158 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~---~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~---VKL~DFGlA 158 (703)
..|||||||+|++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999999999999998644 6999999999999999999999999999999999999997765 999999998
Q ss_pred hhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc--------------eeecc
Q 005298 159 AQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR--------------VLFII 224 (703)
Q Consensus 159 ~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~--------------~l~~I 224 (703)
...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||....... .....
T Consensus 172 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 172 KELDQG-ELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CBTTSC-CCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccc-cccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 766433 233457899999999999765 58999999999999999999999996531110 00000
Q ss_pred C---------CCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 225 P---------RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 225 ~---------~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
. ...+..+...++..+.+||.+||.+||.+|||+.++++||||...
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 0 011223456788999999999999999999999999999999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=389.04 Aligned_cols=245 Identities=21% Similarity=0.326 Sum_probs=207.3
Q ss_pred hhhCCCceEEEEEeecCceEEEEEEEcC-CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE--
Q 005298 9 EAAGSRFSSLELIGRGSFGDVYKAFDKE-LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK-- 85 (703)
Q Consensus 9 ~~~~~~Y~il~~LG~GsfG~Vyka~d~~-tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~-- 85 (703)
+...++|++++.||+|+||.||+|.+.. +|+.||||++...........+.+|+.++++++|||||+++++|...+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 3456899999999999999999999986 7999999998766556667788999999999999999999999987665
Q ss_pred ---EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 86 ---LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 86 ---lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
.|||||||+|++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+||||+.+ .+||+|||++....
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 7999999999999998765 79999999999999999999999999999999999999875 89999999987654
Q ss_pred hcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHH
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~d 242 (703)
.. ...+||+.|+|||++.+. ++.++||||||||||+|++|.+||...... .+. .......++..+.+
T Consensus 233 ~~----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----~~~---~~~~~~~~~~~l~~ 299 (681)
T 2pzi_A 233 SF----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----GLP---EDDPVLKTYDSYGR 299 (681)
T ss_dssp CC----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----SCC---TTCHHHHHCHHHHH
T ss_pred cC----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----ccc---ccccccccCHHHHH
Confidence 32 456899999999999753 588999999999999999999998753211 111 11122345688999
Q ss_pred HHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 243 FVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 243 LI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
||.+||.+||.+||+..+.+.|+|+.-
T Consensus 300 li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 300 LLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 999999999999999999999998864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=336.94 Aligned_cols=230 Identities=16% Similarity=0.188 Sum_probs=163.3
Q ss_pred EEeecCceEEEEEEEcCCCcEEEEEEeccCC---------ChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEE
Q 005298 20 LIGRGSFGDVYKAFDKELNKDVAIKVIDLEE---------SEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 20 ~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~---------~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV 89 (703)
.++.|++|.+..++....|+.|+||++.+.. .+...+.+.+|+++|+++ .|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4567788888888877889999999996542 123356789999999999 699999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
||||+|++|.++|..++++++. .|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+..........
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~ 397 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT 397 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence 9999999999999999999875 4789999999999999999999999999999999999999999987765555566
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
+.+||+.|||||++.+. +...+|+|++|+++|+|+++..+|... +.. .+.. ...+..++..++.
T Consensus 398 t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~~~~~-----l~~----~~~~-----~~~~~~l~~~l~~ 461 (569)
T 4azs_A 398 NLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSNWLYA-----VWQ----EPVE-----RWNFVLLLALFEK 461 (569)
T ss_dssp HHHHHHHHHHHHHC-------------------CCCCTTHHHHHHH-----HHT----SCGG-----GCSHHHHHHHHHT
T ss_pred CceechhhccHHHhCCC--CCCcccccccccchhhhccccchhHHH-----hhc----CCCC-----CCcHHHHHHHHhC
Confidence 78999999999999763 677899999999999987765554210 000 0000 0113556677788
Q ss_pred cCCCCCCCHHHHHhchhhh
Q 005298 250 KVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 250 ~dP~~RPTa~eLL~Hpff~ 268 (703)
.+|..|+.......++|..
T Consensus 462 ~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 462 KAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp GGGSCCGGGSSCCHHHHHH
T ss_pred CCCCCCCChhhhccchhHH
Confidence 8888888777777777764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-28 Score=274.80 Aligned_cols=185 Identities=22% Similarity=0.286 Sum_probs=146.4
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--h-----HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--E-----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~-----~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
..+.||+|+||+||+|. ..+..+++|++..... . ...+.+.+|+.+|++++||||+++..++...+..|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 35689999999999993 4578899998643321 1 1245689999999999999999666666677788999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc--
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR-- 167 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~-- 167 (703)
||||+|++|.+++.. +..|+.||+.||.|||++||+||||||+|||++. ++||+|||+++........
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 999999999999875 6789999999999999999999999999999998 9999999999876443221
Q ss_pred -----cccccCCCCCCchhhhccc-cCCccccchhhHHHHHHHHHhCCCCCC
Q 005298 168 -----RKTFVGTPFWMAPEVIQNS-EGYNEKADIWSLGITVIEMAKGEPPLA 213 (703)
Q Consensus 168 -----~~~~iGTp~Y~APEvl~~~-~~~s~ksDVWSLGvILyELLtG~~PF~ 213 (703)
...++||+.|||||++... ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2357899999999999751 247788999999999998888777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=227.86 Aligned_cols=160 Identities=18% Similarity=0.239 Sum_probs=126.7
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-----------------HHHHHHHHHHHHHHhCCCCCee
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----------------DEIEDIQKEISVLSQCRSPYIT 74 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-----------------~~~~~l~~Ei~ILk~L~HPnIV 74 (703)
+..|++.+.||.|+||.||+|.+ .+|+.||||+++..... .....+.+|+.+|++++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 44667779999999999999999 78999999998643211 13567889999999999 4 6
Q ss_pred eeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEec
Q 005298 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVAD 154 (703)
Q Consensus 75 ~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~D 154 (703)
++++++.. +..|+|||||+|++|.+ +.. .....++.||+.||.|||++||+||||||+||||+ +|.+||+|
T Consensus 165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 165 AVPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp SSCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred CcCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 66665543 55699999999999998 421 23557999999999999999999999999999999 99999999
Q ss_pred cccchhhhhcccccccccCCCCCCchhhhccc---------cCCccccchhh
Q 005298 155 FGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS---------EGYNEKADIWS 197 (703)
Q Consensus 155 FGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~---------~~~s~ksDVWS 197 (703)
||++. .+..|+|||++... ..|+..+|+|.
T Consensus 236 FG~a~-------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 236 FPQSV-------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CTTCE-------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCCCe-------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99874 34568999987531 12555667665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.5e-21 Score=197.11 Aligned_cols=140 Identities=22% Similarity=0.311 Sum_probs=111.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcE--EEEEEeccCCCh-----------------------HHHHHHHHHHHHHHh
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKD--VAIKVIDLEESE-----------------------DEIEDIQKEISVLSQ 67 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~--VAIKvi~~~~~~-----------------------~~~~~l~~Ei~ILk~ 67 (703)
.-|++.+.||.|+||.||+|.+..+|+. ||||+++..... .....+.+|+.+|.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3578999999999999999999778999 999997543211 112367899999999
Q ss_pred CCCCCe--eeeEEEEEeCCEEEEEEeccCC-C----CHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hcCceeeeecc
Q 005298 68 CRSPYI--TEYYGSYLHQTKLWIIMEYMAG-G----SVADLIQSGPPLDEMSIACILRDLLHAIEYLH-NEGKIHRDIKA 139 (703)
Q Consensus 68 L~HPnI--V~L~~~~~~~~~lyLV~Eyv~g-G----sL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLH-s~gIVHRDIKP 139 (703)
|.|++| +.++.+ +..||||||+.+ | +|.++... +++..+..++.||+.+|.||| ++|||||||||
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 988764 334432 346899999942 3 78877543 345678899999999999999 99999999999
Q ss_pred ceEEecCCCCeeEeccccchhh
Q 005298 140 ANILLTENGDVKVADFGVSAQL 161 (703)
Q Consensus 140 eNILLd~~g~VKL~DFGlA~~~ 161 (703)
+|||++. .++|+|||++...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999988 8999999998643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.8e-17 Score=181.46 Aligned_cols=139 Identities=20% Similarity=0.176 Sum_probs=102.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC----------------h-HHH----HHHHHHHHHHHhCCCC
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES----------------E-DEI----EDIQKEISVLSQCRSP 71 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~----------------~-~~~----~~l~~Ei~ILk~L~HP 71 (703)
.-|++...||.|+||.||+|.+. +|+.||||+++.... . ... ....+|...|.+|.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 45999999999999999999986 599999998753210 0 000 1123577777777655
Q ss_pred CeeeeEEEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCC--
Q 005298 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGD-- 149 (703)
Q Consensus 72 nIV~L~~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~-- 149 (703)
+|....-+.... .+|||||++|++|..+.. ......++.||+.+|.|||.+|||||||||.||||+.+|.
T Consensus 174 gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 174 GFPVPEPIAQSR--HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp TCSCCCEEEEET--TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCCCeeeeccC--ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 443222222222 279999999999876532 2345678899999999999999999999999999998763
Q ss_pred --------eeEeccccchh
Q 005298 150 --------VKVADFGVSAQ 160 (703)
Q Consensus 150 --------VKL~DFGlA~~ 160 (703)
+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 88999996543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=9.5e-13 Score=133.61 Aligned_cols=138 Identities=18% Similarity=0.187 Sum_probs=111.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..|++...++.|+++.||++... +..|++|+...... .....+.+|+.+++.|. +..+.++++++...+..|+|||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 46999999999999999999754 68999999864211 11245888999999884 6778899999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN------------------------------------------ 129 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs------------------------------------------ 129 (703)
|++|.+|.+.+. +......++.++..+|..||.
T Consensus 91 ~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 91 EADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred ecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999999987631 122345788899999999998
Q ss_pred -----------------cCceeeeeccceEEecCCCCeeEeccccc
Q 005298 130 -----------------EGKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 130 -----------------~gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
..++|+|++|.|||++.++.+.|+||+.+
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 44899999999999987656679999975
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=6.6e-12 Score=125.70 Aligned_cols=136 Identities=15% Similarity=0.086 Sum_probs=101.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCC--eeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY--ITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPn--IV~L~~~~~~~~~lyL 88 (703)
....|.+..+.+.|.++.||++.. .+|..|+||+..... ...+..|+.+++.+.+.+ +.++++++..++..|+
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 345677765555677799999964 457889999975431 245778999998886544 5668888888888999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG------------------------------------- 131 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~g------------------------------------- 131 (703)
||||++|.+|. .. ... ...++.++...|..||...
T Consensus 93 v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 93 LLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99999998884 21 122 2356677777777777643
Q ss_pred ---------------------ceeeeeccceEEecCCCCeeEeccccch
Q 005298 132 ---------------------KIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 132 ---------------------IVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.18 E-value=3.8e-11 Score=128.01 Aligned_cols=143 Identities=16% Similarity=0.255 Sum_probs=108.1
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEec--cCCChHHHHHHHHHHHHHHhCC--CCCeeeeEEEEEeC---CEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID--LEESEDEIEDIQKEISVLSQCR--SPYITEYYGSYLHQ---TKL 86 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~--~~~~~~~~~~l~~Ei~ILk~L~--HPnIV~L~~~~~~~---~~l 86 (703)
....++.|+.|.++.||++... +..+++|+.. ..........+.+|+.+++.|. +..+++++.++.+. +..
T Consensus 39 ~~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 39 GPLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CCCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred CCceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 3446788999999999998765 4678899875 3322222356888999999987 45678888888776 458
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 005298 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN------------------------------------- 129 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs------------------------------------- 129 (703)
|+||||++|..|.+.. ...++......++.++...|..||.
T Consensus 117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999999998875421 2347788889999999999999997
Q ss_pred ---------------------cCceeeeeccceEEecCCCC--eeEeccccchh
Q 005298 130 ---------------------EGKIHRDIKAANILLTENGD--VKVADFGVSAQ 160 (703)
Q Consensus 130 ---------------------~gIVHRDIKPeNILLd~~g~--VKL~DFGlA~~ 160 (703)
..+||+|++|.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997753 68999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.06 E-value=1.6e-10 Score=120.41 Aligned_cols=181 Identities=19% Similarity=0.224 Sum_probs=122.4
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCC--eeeeEEEEEeCC---EEEEEEe
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPY--ITEYYGSYLHQT---KLWIIME 91 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPn--IV~L~~~~~~~~---~lyLV~E 91 (703)
++.++.|.+..||++. ..+++|+... ......+.+|+.+|+.+. +.. +.+++......+ ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4669999999999873 5699998642 234567899999998873 332 344444433333 3489999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN------------------------------------------ 129 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs------------------------------------------ 129 (703)
|++|.+|..... ..++..+...++.|+...|..||.
T Consensus 97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 999998876433 346778888888888888888886
Q ss_pred ----------------cCceeeeeccceEEecC--CCCeeEeccccchhhhhcccccccccCCCCC---Cchhhhc----
Q 005298 130 ----------------EGKIHRDIKAANILLTE--NGDVKVADFGVSAQLTRTISRRKTFVGTPFW---MAPEVIQ---- 184 (703)
Q Consensus 130 ----------------~gIVHRDIKPeNILLd~--~g~VKL~DFGlA~~~~~~~~~~~~~iGTp~Y---~APEvl~---- 184 (703)
..++|+|++|.||+++. .+.+.|+||+.+...... . .......+ ..|+.+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~---Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-N---DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-H---HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-H---HHHHHHhhccccCHHHHHHHHH
Confidence 13699999999999998 456889999987532111 0 01111111 2333211
Q ss_pred ccc---------CCccccchhhHHHHHHHHHhCCCCC
Q 005298 185 NSE---------GYNEKADIWSLGITVIEMAKGEPPL 212 (703)
Q Consensus 185 ~~~---------~~s~ksDVWSLGvILyELLtG~~PF 212 (703)
... ......+.|+++.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000 0112358999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=4.1e-07 Score=95.37 Aligned_cols=133 Identities=19% Similarity=0.182 Sum_probs=94.9
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCC---CeeeeEEEEE-eCCEEEEEEec
Q 005298 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP---YITEYYGSYL-HQTKLWIIMEY 92 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HP---nIV~L~~~~~-~~~~lyLV~Ey 92 (703)
-++.++.|....||+. +..+++|+.. .......+..|+.+|+.|.+. .|.+++.+.. ..+..|+||||
T Consensus 23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV-----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp CEEEEEECSSEEEEEE-----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeeecCCCcceeEEEE-----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 4567899999999998 5778999853 234457889999999998652 3556666654 34567899999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE------------------------------------------ 130 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~------------------------------------------ 130 (703)
++|.+|....- ..++......++.++...|..||..
T Consensus 95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99988876321 2244555555555555555555532
Q ss_pred ------------------CceeeeeccceEEecC---CCC-eeEeccccch
Q 005298 131 ------------------GKIHRDIKAANILLTE---NGD-VKVADFGVSA 159 (703)
Q Consensus 131 ------------------gIVHRDIKPeNILLd~---~g~-VKL~DFGlA~ 159 (703)
.++|+|++|.|||++. ++. +.|+||+.+.
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 3599999999999987 355 4899999764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=5.2e-07 Score=91.48 Aligned_cols=136 Identities=15% Similarity=0.163 Sum_probs=97.8
Q ss_pred ceEEEEEeecCc-eEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEEEEec
Q 005298 15 FSSLELIGRGSF-GDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 15 Y~il~~LG~Gsf-G~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
|+... +..|.. ..||+......+..+++|+-.. .....+.+|..+|+.|. +--+.+++.++.+.+..|+|||+
T Consensus 27 ~~~~~-~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~ 101 (272)
T 4gkh_A 27 YRWAR-DNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA 101 (272)
T ss_dssp CEEEE-EECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred CeEEE-ccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence 44433 344544 4799988877788899998642 23456888999998874 22367888888899999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE------------------------------------------ 130 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~------------------------------------------ 130 (703)
++|.++.+..... ......+..++...|.-||..
T Consensus 102 l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 102 IPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp CCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred eCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 9999888765431 122334555566666666631
Q ss_pred ----------------CceeeeeccceEEecCCCCeeEeccccch
Q 005298 131 ----------------GKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 131 ----------------gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 16899999999999987777899999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.1e-06 Score=94.82 Aligned_cols=78 Identities=22% Similarity=0.264 Sum_probs=50.8
Q ss_pred EEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC---h---HHHHHHHHHHHHHHhCCC--CC-eeeeEEEEEeCCEEE
Q 005298 17 SLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES---E---DEIEDIQKEISVLSQCRS--PY-ITEYYGSYLHQTKLW 87 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~---~---~~~~~l~~Ei~ILk~L~H--Pn-IV~L~~~~~~~~~ly 87 (703)
.++.||.|.++.||++.....++.|+||....... . .....+..|+.+|+.+.. |. +.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999997766678999998643211 0 112456778888887742 33 4455543 445568
Q ss_pred EEEeccCCC
Q 005298 88 IIMEYMAGG 96 (703)
Q Consensus 88 LV~Eyv~gG 96 (703)
+||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.23 E-value=1.1e-05 Score=83.99 Aligned_cols=136 Identities=22% Similarity=0.273 Sum_probs=79.1
Q ss_pred eEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----CCCeeeeE-E--EEEeCCEEE
Q 005298 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----SPYITEYY-G--SYLHQTKLW 87 (703)
Q Consensus 16 ~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-----HPnIV~L~-~--~~~~~~~ly 87 (703)
.-++.|+.|..+.||++... +..+++|+.... . ..+..|+.+++.|. .|.++... + +....+..|
T Consensus 35 ~~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~--~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 35 EKIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP--E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp CEEEECC----CEEEEEEET--TEEEEEEEECSC--H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred EEeeeccccccCcEEEEEeC--CCCEEEEecCCC--H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 34567777888999998764 345999998642 2 23344555555442 34444311 1 223467889
Q ss_pred EEEeccCCCCHH---------------HHHHc--CC--C---------CCHHH---------------------------
Q 005298 88 IIMEYMAGGSVA---------------DLIQS--GP--P---------LDEMS--------------------------- 112 (703)
Q Consensus 88 LV~Eyv~gGsL~---------------~~l~~--~~--~---------L~e~~--------------------------- 112 (703)
+||||++|..+. .+... .. + ..+..
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 11111 10 1 01110
Q ss_pred ----HHHHHHHHHHHHHHHHh-------------cCceeeeeccceEEecCCCCeeEeccccc
Q 005298 113 ----IACILRDLLHAIEYLHN-------------EGKIHRDIKAANILLTENGDVKVADFGVS 158 (703)
Q Consensus 113 ----i~~i~~QLl~AL~yLHs-------------~gIVHRDIKPeNILLd~~g~VKL~DFGlA 158 (703)
+..+..++..++.+|+. ..++|+|++|.|||++.++.+.|+||+.+
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 11122234445666652 47999999999999987888999999965
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=8.4e-06 Score=86.24 Aligned_cols=85 Identities=8% Similarity=0.083 Sum_probs=56.4
Q ss_pred ceEEEEE-eecCceEEEEEEEc--C----CCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCC---CCeeeeEEEEEe
Q 005298 15 FSSLELI-GRGSFGDVYKAFDK--E----LNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRS---PYITEYYGSYLH 82 (703)
Q Consensus 15 Y~il~~L-G~GsfG~Vyka~d~--~----tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~H---PnIV~L~~~~~~ 82 (703)
...++.| +.|....+|++... . .+..+++|+...... ......+..|+.+++.|.. ..+.+++.++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456788 88999999988653 1 156899998643210 0001356778888887742 346777777665
Q ss_pred C---CEEEEEEeccCCCCHH
Q 005298 83 Q---TKLWIIMEYMAGGSVA 99 (703)
Q Consensus 83 ~---~~lyLV~Eyv~gGsL~ 99 (703)
. +..|+||||++|..|.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3568999999986653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.83 E-value=4.7e-05 Score=82.96 Aligned_cols=76 Identities=18% Similarity=0.152 Sum_probs=45.9
Q ss_pred eEEEEEeecCceEEEEEEEcCCCcEEEEEEecc-----CCC-h--HHHHHHHHHHHHHH-hCCCCCeeeeEEEEEeCCEE
Q 005298 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL-----EES-E--DEIEDIQKEISVLS-QCRSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 16 ~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~-----~~~-~--~~~~~l~~Ei~ILk-~L~HPnIV~L~~~~~~~~~l 86 (703)
.-++.||.|..+.||++.. .+..|+||.... ... . .....+..|+..+. ......+.+++.+. ....
T Consensus 37 ~~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~ 112 (420)
T 2pyw_A 37 LVIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMA 112 (420)
T ss_dssp CEEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTT
T ss_pred eEEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCcc
Confidence 3567899999999999954 467899994321 100 0 01122333333222 22234566666654 5667
Q ss_pred EEEEecc-CC
Q 005298 87 WIIMEYM-AG 95 (703)
Q Consensus 87 yLV~Eyv-~g 95 (703)
++||||+ +|
T Consensus 113 ~lv~e~l~~g 122 (420)
T 2pyw_A 113 LIGMRYLEPP 122 (420)
T ss_dssp EEEECCCCTT
T ss_pred EEEEeecCCc
Confidence 9999999 77
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00022 Score=75.51 Aligned_cols=78 Identities=15% Similarity=0.150 Sum_probs=61.6
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCCeeeeEEEEEeCCEEEEEEe
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~---HPnIV~L~~~~~~~~~lyLV~E 91 (703)
-.-++.|+.|.+..+|+... .+..|++|+.... ....+..|+..|+.|. ...+++++.+....+..|+|||
T Consensus 38 i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 34567899999999999875 3678899987532 2466888998888873 3568888888888889999999
Q ss_pred ccCCCCH
Q 005298 92 YMAGGSV 98 (703)
Q Consensus 92 yv~gGsL 98 (703)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.64 E-value=8.9e-05 Score=76.85 Aligned_cols=131 Identities=13% Similarity=0.122 Sum_probs=74.6
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCe-eeeEEEEEeCCEEEEEEecc-CC
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIMEYM-AG 95 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnI-V~L~~~~~~~~~lyLV~Eyv-~g 95 (703)
++.|+.|....+|++ ..|++|+..... ........|+.+++.+..-++ .+++.+ +.+.-++|+||+ +|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~--~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT--EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc--cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence 788999999999999 568999875321 111123567777776642222 455543 344458899999 76
Q ss_pred CCHHHH---------------H---Hc-CCCCC-----HHHHHHHHHH--------------HHHHHHHHH----h----
Q 005298 96 GSVADL---------------I---QS-GPPLD-----EMSIACILRD--------------LLHAIEYLH----N---- 129 (703)
Q Consensus 96 GsL~~~---------------l---~~-~~~L~-----e~~i~~i~~Q--------------Ll~AL~yLH----s---- 129 (703)
.+|... + +. ...++ ...+..+..+ +...+..|. .
T Consensus 93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 554320 0 01 11111 1122222111 111122221 1
Q ss_pred cCceeeeeccceEEecCCCCeeEeccccch
Q 005298 130 EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 130 ~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
..++|+|+.|.||+ ..++.+.|+||..+.
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 13799999999999 556778999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0011 Score=68.24 Aligned_cols=86 Identities=12% Similarity=0.060 Sum_probs=60.0
Q ss_pred chhhhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC---CCeeeeEEEEEeC
Q 005298 7 LQEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS---PYITEYYGSYLHQ 83 (703)
Q Consensus 7 l~~~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H---PnIV~L~~~~~~~ 83 (703)
+.+..+.+..-++.+|.|..+.||++... +|+.|++|+...... .....+..|+..|+.|.- --+++++.+ +.
T Consensus 9 ~~~l~G~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~ 84 (288)
T 3f7w_A 9 VTELTGREVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD 84 (288)
T ss_dssp HHHHHCCCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET
T ss_pred HHHhcCCCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC
Confidence 34556778999999999999999999765 589999998643321 112457789999888742 123444443 23
Q ss_pred CEEEEEEeccCCCCH
Q 005298 84 TKLWIIMEYMAGGSV 98 (703)
Q Consensus 84 ~~lyLV~Eyv~gGsL 98 (703)
-++||||++++..
T Consensus 85 --~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 85 --RTLAMEWVDERPP 97 (288)
T ss_dssp --TEEEEECCCCCCC
T ss_pred --ceEEEEeecccCC
Confidence 3789999987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.39 E-value=0.001 Score=67.32 Aligned_cols=136 Identities=16% Similarity=0.163 Sum_probs=93.2
Q ss_pred CCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccccC
Q 005298 96 GSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173 (703)
Q Consensus 96 GsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~iG 173 (703)
-+|.++++. +.+++|++++.+++|.+.+|.-+-. ..-..+=+.|..|+|..+|.|.+.+ ..+. ..
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~ 99 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG 99 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence 379999864 6799999999999999999877622 2222444567999999999987763 2110 12
Q ss_pred CCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc---
Q 005298 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK--- 250 (703)
Q Consensus 174 Tp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~--- 250 (703)
...+.+||... ...+.+.=|||||+++|.-+--.. ++..+..+++.|.+||..|..-
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL------------------~e~eE~eLS~~LE~LL~~Mt~~~~d 159 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGL------------------KENEERELSPPLEQLIDHMANTVEA 159 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHTTTC------------------CTTEEECCCHHHHHHHHHHTTCCC-
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCC------------------CcccchhhCHHHHHHHHHHHhcccc
Confidence 33466888764 235678899999999999874322 2344456789999999999755
Q ss_pred ----------------------CCCCCCCHHHHHhc
Q 005298 251 ----------------------VPAERPSAKELLRH 264 (703)
Q Consensus 251 ----------------------dP~~RPTa~eLL~H 264 (703)
.+..|++.++|++.
T Consensus 160 ~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~ 195 (229)
T 2yle_A 160 DGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL 195 (229)
T ss_dssp -------------------CCSCCCCCCSHHHHHHH
T ss_pred cccccccccccccccccccccccccCcCCHHHHHHH
Confidence 24678899999864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00034 Score=73.31 Aligned_cols=137 Identities=16% Similarity=0.190 Sum_probs=71.4
Q ss_pred EEEEEeecCceE-EEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC--CCeeeeEEEEEeCCEEEEEEecc
Q 005298 17 SLELIGRGSFGD-VYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PYITEYYGSYLHQTKLWIIMEYM 93 (703)
Q Consensus 17 il~~LG~GsfG~-Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H--PnIV~L~~~~~~~~~lyLV~Eyv 93 (703)
-++.|+.|+... +|+... .++..+++|....... ..+..|+.+++.|.. -.+.+++.+....+ ++|||++
T Consensus 22 ~~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 22 NRTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp EECC--------CCEEEEC-TTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eeeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 345676665554 566643 2256777886543211 234556676666532 23455665533333 7899999
Q ss_pred CCCCHHHHHHcC--------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHH
Q 005298 94 AGGSVADLIQSG--------------------------PPLDEMSIA-------CIL-------------RDLLHAIEYL 127 (703)
Q Consensus 94 ~gGsL~~~l~~~--------------------------~~L~e~~i~-------~i~-------------~QLl~AL~yL 127 (703)
.+..+.+++... ..+...... .+. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 777765443211 112221111 000 0111222333
Q ss_pred H------hcCceeeeeccceEEecCC----CCeeEeccccchh
Q 005298 128 H------NEGKIHRDIKAANILLTEN----GDVKVADFGVSAQ 160 (703)
Q Consensus 128 H------s~gIVHRDIKPeNILLd~~----g~VKL~DFGlA~~ 160 (703)
. ...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1 2369999999999999874 6789999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0031 Score=65.33 Aligned_cols=139 Identities=13% Similarity=0.179 Sum_probs=78.1
Q ss_pred eEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----CCCeeeeE-E--EEEeCCEEE
Q 005298 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----SPYITEYY-G--SYLHQTKLW 87 (703)
Q Consensus 16 ~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-----HPnIV~L~-~--~~~~~~~ly 87 (703)
.-++.|+.|....||++... +..+++|+...... ...+..|+.++..|. .|.++... + +....+..+
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEEEECC---EEEEEEEES--SCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eEeeccCCCcccceEEEEeC--CccEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 44677888988999998754 33688999865211 234556777766653 34333211 1 122356789
Q ss_pred EEEeccCCCCHHH---------------HHHcCC----C----CCHHHHHHH---------------HHHHHHHHHHHHh
Q 005298 88 IIMEYMAGGSVAD---------------LIQSGP----P----LDEMSIACI---------------LRDLLHAIEYLHN 129 (703)
Q Consensus 88 LV~Eyv~gGsL~~---------------~l~~~~----~----L~e~~i~~i---------------~~QLl~AL~yLHs 129 (703)
+|++|++|..+.. +..... + ......... -..+...+.+++.
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999998865311 111100 1 111111110 0113445555553
Q ss_pred -------cCceeeeeccceEEecCCCCeeEeccccch
Q 005298 130 -------EGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 130 -------~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
.++||+|++|.|||++.++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 368999999999999877656899998653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00077 Score=70.07 Aligned_cols=76 Identities=16% Similarity=0.122 Sum_probs=47.4
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC--CCeeeeEEE-----EEeCCEEEEEE
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PYITEYYGS-----YLHQTKLWIIM 90 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H--PnIV~L~~~-----~~~~~~lyLV~ 90 (703)
+..|+ |....||++... .|+.+++|+...... ....+..|+.++..|.. -.+++++.. ...++..++||
T Consensus 31 ~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp CEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred EEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 35677 888899987543 366899999863321 12456667777776632 113333332 22356778999
Q ss_pred eccCCCC
Q 005298 91 EYMAGGS 97 (703)
Q Consensus 91 Eyv~gGs 97 (703)
+|++|..
T Consensus 107 ~~i~G~~ 113 (328)
T 1zyl_A 107 PSVGGRQ 113 (328)
T ss_dssp ECCCCEE
T ss_pred EecCCCC
Confidence 9998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00055 Score=75.32 Aligned_cols=75 Identities=15% Similarity=0.154 Sum_probs=50.4
Q ss_pred eEEEEEeecCceEEEEEEEcC-------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCe-eeeEEEEEeCCEEE
Q 005298 16 SSLELIGRGSFGDVYKAFDKE-------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLW 87 (703)
Q Consensus 16 ~il~~LG~GsfG~Vyka~d~~-------tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnI-V~L~~~~~~~~~ly 87 (703)
.-++.|+.|....||++.... .+..|++|+...... ...+..|..+++.|...+| +++++.+. + .
T Consensus 76 ~~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g 148 (429)
T 1nw1_A 76 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--G 148 (429)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred eEEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--C
Confidence 346788889999999998653 357899999743222 1344578888888743333 56666543 2 3
Q ss_pred EEEeccCCCC
Q 005298 88 IIMEYMAGGS 97 (703)
Q Consensus 88 LV~Eyv~gGs 97 (703)
+|+||++|.+
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 8999998644
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00062 Score=73.99 Aligned_cols=136 Identities=13% Similarity=0.192 Sum_probs=82.0
Q ss_pred EEEEeecCceEEEEEEEcC-------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEEE
Q 005298 18 LELIGRGSFGDVYKAFDKE-------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~-------tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyLV 89 (703)
++.|..|-...+|++.... .+..|++|+.... ......+.+|..+++.|. +.-..++++++.+ .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 4567778888999998642 3578999985321 112345668999888774 2223566665543 299
Q ss_pred EeccCCCCHHH--------------HHH---c-C----CCC--CHHHHHHHHHHHHH-------------------HHHH
Q 005298 90 MEYMAGGSVAD--------------LIQ---S-G----PPL--DEMSIACILRDLLH-------------------AIEY 126 (703)
Q Consensus 90 ~Eyv~gGsL~~--------------~l~---~-~----~~L--~e~~i~~i~~QLl~-------------------AL~y 126 (703)
|||++|.+|.. .+. . . ... -+.++..|+.++-. .+..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99998865431 111 1 1 112 24566666655432 2333
Q ss_pred HH----hc----CceeeeeccceEEecCC----CCeeEeccccch
Q 005298 127 LH----NE----GKIHRDIKAANILLTEN----GDVKVADFGVSA 159 (703)
Q Consensus 127 LH----s~----gIVHRDIKPeNILLd~~----g~VKL~DFGlA~ 159 (703)
|. .. .++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 33 22 48999999999999876 689999998763
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00076 Score=71.84 Aligned_cols=76 Identities=16% Similarity=0.214 Sum_probs=45.1
Q ss_pred EEEEEeecCceEEEEEEEcC--------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCC-eeeeEEEEEeCCEEE
Q 005298 17 SLELIGRGSFGDVYKAFDKE--------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQTKLW 87 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~--------tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPn-IV~L~~~~~~~~~ly 87 (703)
-++.|+.|....||++.... .+..|++|+..... ........|..+++.|...+ +.++++.+ .+ +
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~ 110 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--G 110 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--cceecHHHHHHHHHHHHhcCCCCceEEec--CC--c
Confidence 45678888889999997653 13689999864321 11112457888887774323 44666543 33 7
Q ss_pred EEEeccCCCCH
Q 005298 88 IIMEYMAGGSV 98 (703)
Q Consensus 88 LV~Eyv~gGsL 98 (703)
+||||++|.+|
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.014 Score=61.77 Aligned_cols=74 Identities=12% Similarity=0.027 Sum_probs=45.5
Q ss_pred eEEEEEeecC--ceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC---CCCeeeeEEE------EEeCC
Q 005298 16 SSLELIGRGS--FGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR---SPYITEYYGS------YLHQT 84 (703)
Q Consensus 16 ~il~~LG~Gs--fG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~---HPnIV~L~~~------~~~~~ 84 (703)
..++.|..|. ...||++.... | .+++|+...... ..|+.+++.|. -|+|++++.. ....+
T Consensus 24 ~~~~~l~~G~g~~N~vy~v~~~~-g-~~vLK~~~~~~~-------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g 94 (339)
T 3i1a_A 24 HTAQFIQGGADTNAFAYQADSES-K-SYFIKLKYGYHD-------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKH 94 (339)
T ss_dssp SEEEEETTTSCSSCEEEEEECSS-C-EEEEEEEECSSC-------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSS
T ss_pred ceeEEeeccCccccceEEEEeCC-C-CEEEEEecCccc-------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECC
Confidence 3456664443 67899997543 4 899998765432 34555554442 2324444422 23457
Q ss_pred EEEEEEeccCCCCH
Q 005298 85 KLWIIMEYMAGGSV 98 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL 98 (703)
..++||+|++|..+
T Consensus 95 ~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 95 FKIIAYPFIHAPNG 108 (339)
T ss_dssp EEEEEEECCCCCBT
T ss_pred EEEEEEeccCCCcC
Confidence 88999999998765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.012 Score=65.54 Aligned_cols=77 Identities=17% Similarity=0.209 Sum_probs=49.7
Q ss_pred eEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCe-eeeEEEEEeCCEEEEEEeccC
Q 005298 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI-TEYYGSYLHQTKLWIIMEYMA 94 (703)
Q Consensus 16 ~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnI-V~L~~~~~~~~~lyLV~Eyv~ 94 (703)
.-++.|+.|-...+|++.....+..|++|+..... .. .-....|..+++.|...+| .++++++ .+ .+||||++
T Consensus 111 ~~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~ 184 (458)
T 2qg7_A 111 LEFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMD 184 (458)
T ss_dssp EEEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCC
T ss_pred eEEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeC
Confidence 35678888999999999876545889999874321 11 1112578888888865444 5677665 23 25999998
Q ss_pred CCCH
Q 005298 95 GGSV 98 (703)
Q Consensus 95 gGsL 98 (703)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.83 E-value=0.071 Score=58.67 Aligned_cols=76 Identities=11% Similarity=0.128 Sum_probs=48.4
Q ss_pred EEEEEeecCceEEEEEEEcCC-------CcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEE
Q 005298 17 SLELIGRGSFGDVYKAFDKEL-------NKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 17 il~~LG~GsfG~Vyka~d~~t-------g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyL 88 (703)
-++.|..|-...+|++..... +..|++|+..... .. .-...+|..+++.|. +.-..++++.+ .+ ++
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~ 147 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GR 147 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CE
Confidence 456777788899999987531 5789999864321 11 112356888887774 22234555432 33 78
Q ss_pred EEeccCCCCH
Q 005298 89 IMEYMAGGSV 98 (703)
Q Consensus 89 V~Eyv~gGsL 98 (703)
|+||++|.+|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.25 E-value=0.091 Score=56.81 Aligned_cols=28 Identities=36% Similarity=0.515 Sum_probs=23.7
Q ss_pred ceeeeeccceEEe------cCCCCeeEeccccch
Q 005298 132 KIHRDIKAANILL------TENGDVKVADFGVSA 159 (703)
Q Consensus 132 IVHRDIKPeNILL------d~~g~VKL~DFGlA~ 159 (703)
++|+|+.+.|||+ +.++.++++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 345679999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 703 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-89 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-89 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-87 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-85 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-83 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-82 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-80 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-80 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-78 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-78 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-77 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-76 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-76 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-74 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-73 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-72 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-72 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-71 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-70 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-70 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-70 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-69 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-69 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-69 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-68 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-68 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-68 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-67 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-67 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-67 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-67 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-66 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-66 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-65 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-65 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-64 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-63 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-63 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-63 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-63 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-62 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-61 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-61 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-61 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-60 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-59 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-59 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-58 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-58 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-56 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-55 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-53 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-39 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-25 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 278 bits (713), Expect = 3e-89
Identities = 118/268 (44%), Positives = 169/268 (63%), Gaps = 8/268 (2%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ + +G G+FG VYKA +KE + A KVID + SE+E+ED EI +L+ C P I
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNI 71
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ ++ ++ LWI++E+ AGG+V ++ + PL E I + + L A+ YLH+
Sbjct: 72 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 131
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ----NSEG 188
IHRD+KA NIL T +GD+K+ADFGVSA+ TRTI RR +F+GTP+WMAPEV+
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSL 246
Y+ KAD+WSLGIT+IEMA+ EPP +L+PMRVL I + PP L +S K+F+
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 251
Query: 247 CLKKVPAERPSAKELLRHRFIRNARKSP 274
CL+K R + +LL+H F+ P
Sbjct: 252 CLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 278 bits (712), Expect = 7e-89
Identities = 113/290 (38%), Positives = 167/290 (57%), Gaps = 10/290 (3%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRS 70
FS L IG GSFG VY A D ++ VAIK + +S ++ +DI KE+ L + R
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P +Y G YL + W++MEY G + L PL E+ IA + L + YLH+
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ--NSEG 188
IHRD+KA NILL+E G VK+ DFG + ++ +FVGTP+WMAPEVI +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFVGTPYWMAPEVILAMDEGQ 190
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQL-DEHFSRLMKEFVSLC 247
Y+ K D+WSLGIT IE+A+ +PPL +++ M L+ I + P L H+S + FV C
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPIN 297
L+K+P +RP+++ LL+HRF+ R +++ I +R K ++E +
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI-QRTKDAVRELDNLQYR 299
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (701), Expect = 2e-87
Identities = 115/271 (42%), Positives = 170/271 (62%), Gaps = 5/271 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+++ E IG+G+ G VY A D ++VAI+ ++L++ + E I EI V+ + ++P I
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-ELIINEILVMRENKNPNI 79
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
Y SYL +LW++MEY+AGGS+ D++ DE IA + R+ L A+E+LH+ I
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQVI 138
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRDIK+ NILL +G VK+ DFG AQ+T S+R T VGTP+WMAPEV+ + Y K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKV 197
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLKKV 251
DIWSLGI IEM +GEPP + +P+R L++I P+L E S + ++F++ CL
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 252 PAERPSAKELLRHRFIRNARKSPRLLERIRE 282
+R SAKELL+H+F++ A+ L I
Sbjct: 258 VEKRGSAKELLQHQFLKIAKPLSSLTPLIAA 288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 267 bits (683), Expect = 4e-85
Identities = 65/259 (25%), Positives = 123/259 (47%), Gaps = 4/259 (1%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ ++ +G G++G+V A ++ + VA+K++D++ + D E+I+KEI + +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
++YG ++ +EY +GG + D I+ + E L+ + YLH G
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRR--KTFVGTPFWMAPEVIQNSEGYNE 191
HRDIK N+LL E ++K++DFG++ R GT ++APE+++ E + E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLD--EHFSRLMKEFVSLCLK 249
D+WS GI + M GE P + +E L+ + + L
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 245
Query: 250 KVPAERPSAKELLRHRFIR 268
+ P+ R + ++ + R+
Sbjct: 246 ENPSARITIPDIKKDRWYN 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (672), Expect = 2e-83
Identities = 82/265 (30%), Positives = 129/265 (48%), Gaps = 13/265 (4%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYI 73
+ L IG GS+G K K K + K +D +E E + + E+++L + + P I
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 74 TEYYGSYLHQT--KLWIIMEYMAGGSVADLIQSG----PPLDEMSIACILRDLLHAIEYL 127
YY + +T L+I+MEY GG +A +I G LDE + ++ L A++
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 128 HNEGK-----IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
H +HRD+K AN+ L +VK+ DFG++ L S K FVGTP++M+PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKE 242
+ YNEK+DIWSLG + E+ PP + I ++ +S + E
Sbjct: 186 MNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNE 244
Query: 243 FVSLCLKKVPAERPSAKELLRHRFI 267
++ L RPS +E+L + I
Sbjct: 245 IITRMLNLKDYHRPSVEEILENPLI 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (662), Expect = 5e-82
Identities = 81/258 (31%), Positives = 133/258 (51%), Gaps = 6/258 (2%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE--IEDIQKEISVLSQCRS 70
F +G+G FG+VY A +K+ +A+KV+ + E +++E+ + S R
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P I YG + T++++I+EY G+V +Q DE A + +L +A+ Y H++
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRDIK N+LL G++K+ADFG S + RR T GT ++ PE+I+ ++
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEG-RMHD 182
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
EK D+WSLG+ E G+PP I R + + ++ +S LK
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT-FPDFVTEGARDLISRLLKH 241
Query: 251 VPAERPSAKELLRHRFIR 268
P++RP +E+L H +I
Sbjct: 242 NPSQRPMLREVLEHPWIT 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (650), Expect = 3e-80
Identities = 73/266 (27%), Positives = 131/266 (49%), Gaps = 15/266 (5%)
Query: 14 RFSSLEL-IGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSP 71
RF ++ IGRGSF VYK D E +VA + + ++ E + ++E +L + P
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 72 YITEYYGSYLHQTK----LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
I +Y S+ K + ++ E M G++ ++ + + R +L +++L
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 128 HNEGK--IHRDIKAANILLT-ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
H IHRD+K NI +T G VK+ D G++ + + K +GTP +MAPE+ +
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEMYE 186
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--IIPRENPPQLDEHFSRLMKE 242
Y+E D+++ G+ ++EMA E P ++ ++ + P D+ +KE
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIR 268
+ C+++ ER S K+LL H F +
Sbjct: 245 IIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 256 bits (655), Expect = 3e-80
Identities = 92/305 (30%), Positives = 148/305 (48%), Gaps = 47/305 (15%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
F + +G G+ G V+K K +A K+I LE I +E+ VL +C SPYI
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+YG++ ++ I ME+M GGS+ +++ + E + + ++ + YL + KI
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 134 -HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
HRD+K +NIL+ G++K+ DFGVS QL + +FVGT +M+PE +Q Y+ +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQG-THYSVQ 183
Query: 193 ADIWSLGITVIEMAKGEPPLAD-------------------------------------- 214
+DIWS+G++++EMA G P+
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 215 ----LHPMRVLFIIPRENPPQLDEH-FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269
+ +L I E PP+L FS ++FV+ CL K PAER K+L+ H FI+
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
Query: 270 ARKSP 274
+
Sbjct: 304 SDAEE 308
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 249 bits (638), Expect = 2e-78
Identities = 81/272 (29%), Positives = 132/272 (48%), Gaps = 18/272 (6%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDL--------EESEDEIEDIQKEISVL 65
+ E++GRG V + K K+ A+K+ID+ EE ++ E KE+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 66 SQCRS-PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAI 124
+ P I + +Y T +++ + M G + D + L E I+R LL I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 125 EYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQ 184
LH +HRD+K NILL ++ ++K+ DFG S QL + + GTP ++APE+I+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIE 182
Query: 185 NSE-----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHF 236
S GY ++ D+WS G+ + + G PP M +L +I N + +
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242
Query: 237 SRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268
S +K+ VS L P +R +A+E L H F +
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 249 bits (638), Expect = 6e-78
Identities = 76/279 (27%), Positives = 139/279 (49%), Gaps = 9/279 (3%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ +++G G+F +V A DK K VAIK I + E + ++ EI+VL + + P I
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
Y L++IM+ ++GG + D I E + ++ +L A++YLH+ G +
Sbjct: 70 VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 134 HRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
HRD+K N+L E+ + ++DFG+S S T GTP ++APEV+ + Y+
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQ-KPYS 187
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLC 247
+ D WS+G+ + G PP D + ++ I + + S K+F+
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPRLLER-IRERPK 285
++K P +R + ++ L+H +I + + + + E+ K
Sbjct: 248 MEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIK 286
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (630), Expect = 4e-77
Identities = 70/263 (26%), Positives = 135/263 (51%), Gaps = 15/263 (5%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSP 71
+ + + IG GSFG VYK + + DVA+K++++ + +++ + E+ VL + R
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNE 130
I + G Y +L I+ ++ G S+ + + + + I R ++YLH +
Sbjct: 65 NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTR--TISRRKTFVGTPFWMAPEVI--QNS 186
IHRD+K+ NI L E+ VK+ DFG++ +R + + G+ WMAPEVI Q+
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-----PRENPPQLDEHFSRLMK 241
Y+ ++D+++ GI + E+ G+ P ++++ + + + ++ + + MK
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 242 EFVSLCLKKVPAERPSAKELLRH 264
++ CLKK ERP ++L
Sbjct: 244 RLMAECLKKKRDERPLFPQILAS 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (624), Expect = 3e-76
Identities = 64/260 (24%), Positives = 127/260 (48%), Gaps = 6/260 (2%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSP 71
F +++G GSF V A + +++ AIK+++ E+++ + +E V+S+ P
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
+ + Y ++ KL+ + Y G + I+ DE +++ A+EYLH +G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTR--TISRRKTFVGTPFWMAPEVIQNSEGY 189
IHRD+K NILL E+ +++ DFG + L+ +R +FVGT +++PE++ +
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSA 187
Query: 190 NEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249
+ +D+W+LG + ++ G PP + + I + E F ++ V L
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-IKLEYDFPEKFFPKARDLVEKLLV 246
Query: 250 KVPAERPSAKELLRHRFIRN 269
+R +E+ + ++
Sbjct: 247 LDATKRLGCEEMEGYGPLKA 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 245 bits (627), Expect = 9e-76
Identities = 68/329 (20%), Positives = 134/329 (40%), Gaps = 15/329 (4%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ E +G G+FG V++ ++ + A K + E + E ++KEI +S R P +
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTL 85
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ ++ ++ +I E+M+GG + + + + E +R + + ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 133 IHRDIKAANILLT--ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
+H D+K NI+ T + ++K+ DFG++A L K GT + APEV + +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEG-KPVG 203
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLC 247
D+WS+G+ + G P + L + + S K+F+
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEASG 307
L P R + + L H ++ P +I I++ T + G
Sbjct: 264 LLADPNTRMTIHQALEHPWLTPGNA-PGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLG 322
Query: 308 TVKVVRDKRSEETVQVSSQGQTVRNAGWN 336
+ R + Q ++R+A W+
Sbjct: 323 RISNYSSLR-----KHRPQEYSIRDAFWD 346
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 241 bits (616), Expect = 3e-74
Identities = 64/291 (21%), Positives = 131/291 (45%), Gaps = 15/291 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
+ LE +G G+FG V++ +K + K I+ D+ ++ EIS+++Q P +
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK-YTVKNEISIMNQLHHPKL 88
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ ++ + ++ +I+E+++GG + D I + + E + +R ++++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 133 IHRDIKAANILL--TENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
+H DIK NI+ + VK+ DFG++ +L K T + APE++ E
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDR-EPVG 206
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLC 247
D+W++G+ + G P A + L + R + S K+F+
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPR------LLERIRERPKYPIQEEP 292
L+K P +R + + L H +++ + +IR++ K + P
Sbjct: 267 LQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWP 317
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (609), Expect = 2e-73
Identities = 70/305 (22%), Positives = 137/305 (44%), Gaps = 12/305 (3%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
++ E +GRG FG V++ + K K + ++ ++ + ++KEIS+L+ R I
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHRNI 63
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGK 132
+ S+ +L +I E+++G + + I + L+E I + + A+++LH+
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 133 IHRDIKAANILLT--ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
H DI+ NI+ + +K+ +FG + QL + P + APEV Q+ + +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQH-DVVS 181
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSLC 247
D+WSLG V + G P +++ I + + S +FV
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 248 LKKVPAERPSAKELLRHRFIRNA--RKSPRLLERIRERPKYPIQEEPDTPINGVRAVGEA 305
L K R +A E L+H +++ R S +++ ++ R Y + D + A
Sbjct: 242 LVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISC 301
Query: 306 SGTVK 310
G ++
Sbjct: 302 GGAIR 306
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 1e-72
Identities = 73/260 (28%), Positives = 133/260 (51%), Gaps = 6/260 (2%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLS-QCRS 70
F +++G+GSFG V+ A K+ N+ AIK + + +D++E E VLS
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P++T + ++ + L+ +MEY+ GG + IQS D +++ +++LH++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYN 190
G ++RD+K NILL ++G +K+ADFG+ + ++ TF GTP ++APE++ + YN
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYN 181
Query: 191 EKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250
D WS G+ + EM G+ P + I R + P + K+ + +
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 251 VPAERPSAK-ELLRHRFIRN 269
P +R + ++ +H R
Sbjct: 241 EPEKRLGVRGDIRQHPLFRE 260
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 4e-72
Identities = 75/291 (25%), Positives = 138/291 (47%), Gaps = 15/291 (5%)
Query: 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE-----IEDIQKEI 62
QE + + E +G G F V K +K A K I ++ EDI++E+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 63 SVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLH 122
S+L + + P + + Y ++T + +I+E +AGG + D + L E L+ +L+
Sbjct: 65 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGD----VKVADFGVSAQLTRTISRRKTFVGTPFWM 178
+ YLH+ H D+K NI+L + +K+ DFG++ ++ + K GTP ++
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFV 183
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEH 235
APE++ N E +AD+WS+G+ + G P L + N + +
Sbjct: 184 APEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 236 FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKY 286
S L K+F+ L K P +R + ++ L+H +I+ + + + L P++
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP-KDTQQALSSAWSHPQF 292
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 3e-71
Identities = 72/273 (26%), Positives = 124/273 (45%), Gaps = 25/273 (9%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
L+ IG+G FGDV + VA+K I ++ + E SV++Q R
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSN 61
Query: 73 ITEYYGSYLHQ-TKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHN 129
+ + G + + L+I+ EYMA GS+ D ++S L + D+ A+EYL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 130 EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRD+ A N+L++E+ KV+DFG++ + + S + T W APE ++ + +
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS---STQDTGKLPVKWTAPEALRE-KKF 177
Query: 190 NEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
+ K+D+WS GI + E+ + G P + V+ + + + + E + C
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237
Query: 249 KKVPAERPSAKELLRHRFIRNARKSPRLLERIR 281
A RPS +L LE I+
Sbjct: 238 HLDAAMRPSFLQLREQ------------LEHIK 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 1e-70
Identities = 64/262 (24%), Positives = 115/262 (43%), Gaps = 12/262 (4%)
Query: 21 IGRGSFGDVYKAFDKELNK--DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYG 78
+G G+FG V + + K DVAIKV+ + + E++ +E ++ Q +PYI G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 79 SYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
L ++ME GG + + + ++A +L + ++YL + +HRD+
Sbjct: 77 -VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135
Query: 138 KAANILLTENGDVKVADFGVSAQLTR---TISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
A N+LL K++DFG+S L + R W APE I ++ ++D
Sbjct: 136 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSD 194
Query: 195 IWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPA 253
+WS G+T+ E + G+ P + V+ I + + + +S C
Sbjct: 195 VWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWE 254
Query: 254 ERPSAKEL---LRHRFIRNARK 272
+RP + +R + A K
Sbjct: 255 DRPDFLTVEQRMRACYYSLASK 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 2e-70
Identities = 67/286 (23%), Positives = 114/286 (39%), Gaps = 31/286 (10%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDL----EESEDEIEDIQKEISVLSQCRSPYI 73
L+ +G G F VYKA DK N+ VAIK I L E + +EI +L + P I
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 74 TEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
++ H++ + ++ ++M + + L I + L +EYLH +
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKA 193
HRD+K N+LL ENG +K+ADFG++ V T ++ APE++ + Y
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 194 DIWSLGITVIEMAKGEPPLADLHPMRVLFII---------------------------PR 226
D+W++G + E+ P L + L I P
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 227 ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272
+ + + + P R +A + L+ ++ N
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 3e-70
Identities = 61/256 (23%), Positives = 112/256 (43%), Gaps = 12/256 (4%)
Query: 21 IGRGSFGDVYKAF--DKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPYITEYY 77
+G G+FG V K + K++ K VA+K++ E +++ E +V+ Q +PYI
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDI 137
G ++ME G + +Q + + +I ++ + ++YL +HRD+
Sbjct: 75 G-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 138 KAANILLTENGDVKVADFGVSAQLT---RTISRRKTFVGTPFWMAPEVIQNSEGYNEKAD 194
A N+LL K++DFG+S L + W APE I ++ K+D
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSD 192
Query: 195 IWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPA 253
+WS G+ + E + G+ P + V ++ + R M + ++LC
Sbjct: 193 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVE 252
Query: 254 ERPSAKEL---LRHRF 266
RP + LR+ +
Sbjct: 253 NRPGFAAVELRLRNYY 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 1e-69
Identities = 82/288 (28%), Positives = 140/288 (48%), Gaps = 11/288 (3%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPY 72
F L+L+G+G+FG V +K + A+K++ E ++DE+ E VL R P+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
+T ++ +L +MEY GG + + E +++ A+EYLH+
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
++RDIK N++L ++G +K+ DFG+ + + KTF GTP ++APEV+++ Y
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRA 185
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
D W LG+ + EM G P + R+ +I + S K ++ LKK P
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-LMEEIRFPRTLSPEAKSLLAGLLKKDP 244
Query: 253 AERPS-----AKELLRHRFIRNARKSPRLLERIRERPKYP-IQEEPDT 294
+R AKE++ HRF + ++++ P P + E DT
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSINWQ-DVVQKKLLPPFKPQVTSEVDT 291
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 228 bits (581), Expect = 6e-69
Identities = 71/292 (24%), Positives = 134/292 (45%), Gaps = 15/292 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVID-----LEESEDEIEDIQKEISVLSQC 68
FS +IGRG FG+VY + K A+K +D +++ E + + +S++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLH 128
P+I ++ KL I++ M GG + + E + +++ +E++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
N ++RD+K ANILL E+G V+++D G++ ++ + VGT +MAPEV+Q
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVA 182
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHP--MRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
Y+ AD +SLG + ++ +G P + + +L + FS ++ +
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 242
Query: 247 CLKKVPAERPS-----AKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPD 293
L++ R A+E+ F R+ + + P P + E +
Sbjct: 243 LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ-MVFLQKYPPPLIPPRGEVN 293
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 226 bits (577), Expect = 6e-69
Identities = 80/289 (27%), Positives = 138/289 (47%), Gaps = 15/289 (5%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE--ESEDEIEDIQKEISVLSQCRSPY 72
F L +G GSFG V+ + + A+KV+ E ++E E +LS P+
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I +G++ ++++IM+Y+ GG + L++ ++ A+EYLH++
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
I+RD+K NILL +NG +K+ DFG + + T GTP ++APEV+ + YN+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAPEVVST-KPYNKS 181
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVP 252
D WS GI + EM G P D + M+ I + F+ +K+ +S + +
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-LNAELRFPPFFNEDVKDLLSRLITRDL 240
Query: 253 AER-----PSAKELLRHRFIRNARKSPRLLERIRERPKYP--IQEEPDT 294
++R +++ H + + +LL R E P P Q + DT
Sbjct: 241 SQRLGNLQNGTEDVKNHPWFKEVVWE-KLLSRNIETPYEPPIQQGQGDT 288
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 1e-68
Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 7/253 (2%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYIT 74
+ L+ +G G FG V + DVAIK+I ++ + +E V+ +
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED--EFIEEAKVMMNLSHEKLV 62
Query: 75 EYYGSYLHQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
+ YG Q ++II EYMA G + + ++ + + +D+ A+EYL ++ +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQNSEGYNEK 192
HRD+ A N L+ + G VKV+DFG+S + W PEV+ ++ K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSK 181
Query: 193 ADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251
+DIW+ G+ + E+ + G+ P I + S + + C +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 241
Query: 252 PAERPSAKELLRH 264
ERP+ K LL +
Sbjct: 242 ADERPTFKILLSN 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 224 bits (571), Expect = 2e-68
Identities = 75/302 (24%), Positives = 127/302 (42%), Gaps = 45/302 (14%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKEL-----NKDVAIKVIDLEESEDEIEDIQKEISVLSQ 67
+ + IG G+FG V++A L VA+K++ E S D D Q+E +++++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 68 CRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS----------------------- 104
+P I + G + ++ EYMA G + + ++S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 105 -GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-- 161
PPL CI R + + YL +HRD+ N L+ EN VK+ADFG+S +
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRV 220
WM PE I Y ++D+W+ G+ + E+ + G P + V
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 221 LFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERI 280
++ + N E+ + + LC K+PA+RPS + R+L+R+
Sbjct: 252 IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH------------RILQRM 299
Query: 281 RE 282
E
Sbjct: 300 CE 301
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 5e-68
Identities = 71/273 (26%), Positives = 123/273 (45%), Gaps = 19/273 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
S + ++ IG G FG V+ + VAIK I +E D +E V+ + P
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEE--DFIEEAEVMMKLSHPK 61
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPL-DEMSIACILRDLLHAIEYLHNEG 131
+ + YG L Q + ++ E+M G ++D +++ L ++ + D+ + YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTR-TISRRKTFVGTPFWMAPEVIQNSEGYN 190
IHRD+ A N L+ EN +KV+DFG++ + + W +PEV S Y+
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYS 180
Query: 191 EKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249
K+D+WS G+ + E+ ++G+ P + V+ I S + + ++ C K
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240
Query: 250 KVPAERPSAKELLRHRFIRNARKSPRLLERIRE 282
+ P +RP+ LLR L I E
Sbjct: 241 ERPEDRPAFSRLLRQ------------LAEIAE 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 223 bits (568), Expect = 6e-68
Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 13/274 (4%)
Query: 8 QEAAGSRFSSLELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISV 64
+E S ++IG G FG+V K K VAIK + +E + D E S+
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 65 LSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL-IQSGPPLDEMSIACILRDLLHA 123
+ Q P + G T + II E+M GS+ Q+ + + +LR +
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQL-----TRTISRRKTFVGTPFWM 178
++YL + +HRD+ A NIL+ N KV+DFG+S L T + W
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200
Query: 179 APEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFS 237
APE IQ + +D+WS GI + E+ + GE P D+ V+ I ++
Sbjct: 201 APEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259
Query: 238 RLMKEFVSLCLKKVPAERPSAKELLRH--RFIRN 269
+ + + C +K RP +++ + IRN
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 2e-67
Identities = 70/275 (25%), Positives = 114/275 (41%), Gaps = 18/275 (6%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIE-----DIQKEISVLSQ 67
S++ L+G G FG VY N VAIK ++ + D E + E+ +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 68 CRSPY--ITEYYGSYLHQTKLWIIMEYMAGGS-VADLIQSGPPLDEMSIACILRDLLHAI 124
S + + + +I+E + D I L E +L A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 125 EYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI 183
+ HN G +HRDIK NIL+ N G++K+ DFG A L T F GT + PE I
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWI 181
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243
+ + A +WSLGI + +M G+ P + + S +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------IRGQVFFRQRVSSECQHL 234
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLE 278
+ CL P++RP+ +E+ H ++++ E
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 220 bits (562), Expect = 2e-67
Identities = 72/267 (26%), Positives = 129/267 (48%), Gaps = 13/267 (4%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVI--DLEESEDEIEDIQKEISVLSQCRSP 71
R+ E++G G +V+ A D L++DVA+KV+ DL ++E + P
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 72 YITEYYGSYLHQTK----LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
I Y + +T +I+MEY+ G ++ D++ + P+ ++ D A+ +
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQL---TRTISRRKTFVGTPFWMAPEVIQ 184
H G IHRD+K ANI+++ VKV DFG++ + ++++ +GT +++PE +
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMK 241
+ + ++D++SLG + E+ GEPP P+ V + RE+ P E S +
Sbjct: 188 G-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIR 268
V L K P R +R +R
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 3e-67
Identities = 76/296 (25%), Positives = 135/296 (45%), Gaps = 32/296 (10%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CRSPYITEYY 77
+++G G G V + F+K + A+K++ + ++E+ + + + P+I
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWRASQCPHIVRIV 71
Query: 78 GSY----LHQTKLWIIMEYMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEG 131
Y + L I+ME + GG + IQ E + I++ + AI+YLH+
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 132 KIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEG 188
HRD+K N+L T N +K+ DFG + + T + T TP+++APEV+ E
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVL-GPEK 189
Query: 189 YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------ENPPQLDEHFSRLMK 241
Y++ D+WSLG+ + + G PP H + + + E P S +K
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK 249
Query: 242 EFVSLCLKKVPAERPSAKELLRHRFIRNARKSP-------RLLERIRERPKYPIQE 290
+ LK P +R + E + H +I + K P R+L+ +ER + +E
Sbjct: 250 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 305
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 4e-67
Identities = 79/322 (24%), Positives = 130/322 (40%), Gaps = 40/322 (12%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
G R+++L IG G++G V A+D VAIK I E + + +EI +L + R
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 72 YITEYYGSYLHQT----KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYL 127
I T K ++ ++ G + L+++ L I L +L ++Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT---RTISRRKTFVGTPFWMAPEVIQ 184
H+ +HRD+K +N+LL D+K+ DFG++ +V T ++ APE++
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 185 NSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------------------- 224
NS+GY + DIWS+G + EM P H + L I
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 225 -------PRENPPQLDEHFSRLMKEFVSL---CLKKVPAERPSAKELLRHRFIRNARKSP 274
P +N + F + + L L P +R ++ L H ++
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305
Query: 275 RLLERIRERPKYPIQEEPDTPI 296
E I E P E D P
Sbjct: 306 D--EPIAEAPFKFDMELDDLPK 325
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 1e-66
Identities = 72/279 (25%), Positives = 112/279 (40%), Gaps = 20/279 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD---VAIKVIDLEESEDEIEDIQKEISVLSQCR 69
R IG G FGDV++ VAIK S+ E +E + Q
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLH 128
P+I + G + + +WIIME G + +Q LD S+ L A+ YL
Sbjct: 67 HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 129 NEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQNSE 187
++ +HRDI A N+L++ N VK+ DFG+S + + + + WMAPE I N
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-NFR 184
Query: 188 GYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246
+ +D+W G+ + E+ G P + V+ I + + + ++
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK 244
Query: 247 CLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPK 285
C P+ RP EL L I E K
Sbjct: 245 CWAYDPSRRPRFTELKAQ------------LSTILEEEK 271
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 218 bits (555), Expect = 3e-66
Identities = 71/284 (25%), Positives = 122/284 (42%), Gaps = 30/284 (10%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
++ LE IG G++G VYKA + + A+K I LE E E +EIS+L + +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I + Y + +L ++ E++ L L+ ++ L LL+ I Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
+HRD+K N+L+ G++K+ADFG++ + + + T ++ AP+V+ S+ Y+
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 193 ADIWSLGITVIEMAKGEPPLADLHPMRVLFII---------------------------- 224
DIWS+G EM G P + L I
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268
+ + +S LK P +R +AK+ L H + +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 4e-66
Identities = 61/255 (23%), Positives = 113/255 (44%), Gaps = 9/255 (3%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+E +G G FG+V+ + + VA+K + + + E +++ Q +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQR 69
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNE 130
+ Y + Q ++II EYM GS+ D + SG L + + + + ++
Sbjct: 70 LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT-FVGTPFWMAPEVIQNSEGY 189
IHRD++AANIL+++ K+ADFG++ + + W APE I +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTF 187
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
K+D+WS GI + E+ G P + V+ + R ++ + + + LC
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 249 KKVPAERPSAKELLR 263
K+ P +RP+ L
Sbjct: 248 KERPEDRPTFDYLRS 262
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 6e-66
Identities = 60/285 (21%), Positives = 110/285 (38%), Gaps = 34/285 (11%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ 67
+++G G+FG V A ++K VA+K++ + E E + E+ +++Q
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 68 CRS-PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS---------------------- 104
S I G+ +++I EY G + + ++S
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 105 -GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT- 162
L + C + +E+L + +HRD+ A N+L+T VK+ DFG++ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 163 -RTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRV 220
R WMAPE + Y K+D+WS GI + E+ + G P +
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 221 LF-IIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ +I + + + + C +RPS L
Sbjct: 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 1e-65
Identities = 65/263 (24%), Positives = 115/263 (43%), Gaps = 11/263 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+G+G FG+V+ + VAIK + E +E V+ + R
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFLQEAQVMKKLRHEK 73
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLI--QSGPPLDEMSIACILRDLLHAIEYLHNE 130
+ + Y + + ++I+ EYM+ GS+ D + ++G L + + + + Y+
Sbjct: 74 LVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRT-ISRRKTFVGTPFWMAPEVIQNSEGY 189
+HRD++AANIL+ EN KVADFG++ + + R+ W APE +
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRF 191
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
K+D+WS GI + E+ KG P + VL + R + + + C
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCW 251
Query: 249 KKVPAERPSAKELLR--HRFIRN 269
+K P ERP+ + L + +
Sbjct: 252 RKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-65
Identities = 70/279 (25%), Positives = 116/279 (41%), Gaps = 12/279 (4%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQC 68
S + ++IG G FG+VYK K + VAIK + +E + D E ++ Q
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADL-IQSGPPLDEMSIACILRDLLHAIEYL 127
I G + II EYM G++ + + + +LR + ++YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF---VGTPFWMAPEVIQ 184
N +HRD+ A NIL+ N KV+DFG+S L T W APE I
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 185 NSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243
+ +D+WS GI + E+ GE P +L V+ I + +
Sbjct: 187 Y-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 244 VSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRE 282
+ C ++ A RP +++ + ++P L+ + +
Sbjct: 246 MMQCWQQERARRPKFADIV--SILDKLIRAPDSLKTLAD 282
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 5e-65
Identities = 73/299 (24%), Positives = 128/299 (42%), Gaps = 34/299 (11%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-R 69
+ ++IG G+FG V KA K+ L D AIK + S+D+ D E+ VL +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 70 SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----------------SGPPLDEMSI 113
P I G+ H+ L++ +EY G++ D ++ + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 114 ACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVG 173
D+ ++YL + IHRD+ A NIL+ EN K+ADFG+ ++ ++
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL-SRGQEVYVKKTMGRL 188
Query: 174 TPFWMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQL 232
WMA E + N Y +D+WS G+ + E+ + G P + + +P+ +
Sbjct: 189 PVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEE 291
+ + + + C ++ P ERPS ++L L R+ E K +
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS------------LNRMLEERKTYVNTT 294
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (545), Expect = 1e-64
Identities = 67/274 (24%), Positives = 132/274 (48%), Gaps = 9/274 (3%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+ + +G G +G+VY+ K+ + VA+K + E E+E+ KE +V+ + + P
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 74
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ--SGPPLDEMSIACILRDLLHAIEYLHNE 130
+ + G + +II E+M G++ D ++ + + + + + + A+EYL +
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFV-GTPFWMAPEVIQNSEGY 189
IHRD+ A N L+ EN VKVADFG+S +T W APE + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKF 193
Query: 190 NEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
+ K+D+W+ G+ + E+A G P + +V ++ ++ + E + E + C
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253
Query: 249 KKVPAERPSAKELLR--HRFIRNARKSPRLLERI 280
+ P++RPS E+ + + + S + + +
Sbjct: 254 QWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 287
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (539), Expect = 1e-63
Identities = 73/289 (25%), Positives = 122/289 (42%), Gaps = 30/289 (10%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
F +E IG G++G VYKA +K + VA+K I L+ E+E +EIS+L + P
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADL-IQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
I + + KL+++ E++ + + + I L LL + + H+
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
+HRD+K N+L+ G +K+ADFG++ + V T ++ APE++ + Y+
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFII--------------------------- 224
DIWSLG EM + LF I
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 225 -PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272
R++ ++ + +S L P +R SAK L H F ++ K
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-63
Identities = 58/256 (22%), Positives = 109/256 (42%), Gaps = 11/256 (4%)
Query: 19 ELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITE 75
E+IGRG FG VY + + A+K ++ E+ E ++ P +
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 76 YYGSYLH-QTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKI 133
G L + +++ YM G + + I+ + + +++L ++ +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 134 HRDIKAANILLTENGDVKVADFGVSAQL----TRTISRRKTFVGTPFWMAPEVIQNSEGY 189
HRD+ A N +L E VKVADFG++ + ++ + WMA E +Q + +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKF 211
Query: 190 NEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248
K+D+WS G+ + E+ +G PP D++ + + + E+ + E + C
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 271
Query: 249 KKVPAERPSAKELLRH 264
RPS EL+
Sbjct: 272 HPKAEMRPSFSELVSR 287
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-63
Identities = 64/301 (21%), Positives = 120/301 (39%), Gaps = 44/301 (14%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSP 71
S++ L IG+G+FG+V+KA ++ + VA+K + +E E E +EI +L +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 72 YITEYYGSYLHQT--------KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHA 123
+ + ++++ ++ L I +++ LL+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 124 IEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT----ISRRKTFVGTPFWMA 179
+ Y+H +HRD+KAAN+L+T +G +K+ADFG++ + +R V T ++
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------PRENPPQL 232
PE++ Y D+W G + EM P + L +I E P +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 233 DEH------------------------FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIR 268
D + + + L PA+R + + L H F
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309
Query: 269 N 269
+
Sbjct: 310 S 310
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 3e-63
Identities = 59/260 (22%), Positives = 110/260 (42%), Gaps = 13/260 (5%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKD---VAIKVI--DLEESEDEIEDIQKEISVLSQC 68
LE +G GSFG V + + VA+K + D+ + ++D +E++ +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 69 RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYL 127
+ YG L + ++ E GS+ D ++ +++ + + YL
Sbjct: 69 DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 128 HNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR---TISRRKTFVGTPFWMAPEVIQ 184
++ IHRD+ A N+LL VK+ DFG+ L + ++ W APE ++
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 185 NSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENP-PQLDEHFSRLMKE 242
++ +D W G+T+ EM G+ P L+ ++L I +E E + +
Sbjct: 188 T-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYN 246
Query: 243 FVSLCLKKVPAERPSAKELL 262
+ C P +RP+ L
Sbjct: 247 VMVQCWAHKPEDRPTFVALR 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 4e-63
Identities = 59/290 (20%), Positives = 110/290 (37%), Gaps = 20/290 (6%)
Query: 15 FSSLELIGRGSFGDVYKAFDKELNKD----VAIKVIDLEESEDEIEDIQKEISVLSQCRS 70
F ++++G G+FG VYK + VAIK + S ++I E V++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 71 PYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
P++ G L T I G + + + + + + + YL +
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 131 GKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT--FVGTPFWMAPEVIQNSEG 188
+HRD+ A N+L+ VK+ DFG++ L WMA E I +
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RI 189
Query: 189 YNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247
Y ++D+WS G+TV E+ G P + + I+ + + + + C
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 248 LKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEPDTPIN 297
RP +EL+ ++ P+ + + D ++
Sbjct: 250 WMIDADSRPKFRELIIE------------FSKMARDPQRYLVIQGDERMH 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 6e-63
Identities = 64/270 (23%), Positives = 118/270 (43%), Gaps = 19/270 (7%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ 67
+ + +G+GSFG VY+ K + KD VAIK ++ S E + E SV+ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 68 CRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQ----------SGPPLDEMSIACIL 117
++ G +IME M G + ++ P + +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 118 RDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT--FVGTP 175
++ + YL+ +HRD+ A N ++ E+ VK+ DFG++ + T RK +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 176 FWMAPEVIQNSEGYNEKADIWSLGITVIEMA-KGEPPLADLHPMRVLFIIPRENPPQLDE 234
WM+PE +++ + +D+WS G+ + E+A E P L +VL + +
Sbjct: 200 RWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 258
Query: 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ ++ E + +C + P RPS E++
Sbjct: 259 NCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (527), Expect = 5e-62
Identities = 52/279 (18%), Positives = 100/279 (35%), Gaps = 25/279 (8%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
G+R+ IG GSFGD+Y D ++VAIK+ ++ ++ E + +
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL---HIESKIYKMMQGG 62
Query: 72 -YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
I ++ME + ++ + ++ IEY+H++
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 122
Query: 131 GKIHRDIKAANILLTENGD---VKVADFGVSAQLTRTIS-------RRKTFVGTPFWMAP 180
IHRD+K N L+ V + DFG++ + + K GT + +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 181 EVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-------PPQLD 233
+ + D+ SLG ++ G P L R + L
Sbjct: 183 NTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 234 EHFSRLMKEFVSLCLKKVPAERPSA---KELLRHRFIRN 269
+ + +++ C ++P ++L R+ F R
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (529), Expect = 1e-61
Identities = 79/289 (27%), Positives = 137/289 (47%), Gaps = 14/289 (4%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSP 71
+F ++ +G GSFG V KE A+K++D ++ +IE E +L P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
++ + S+ + L+++MEY+AGG + ++ E ++ EYLH+
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 132 KIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNE 191
I+RD+K N+L+ + G ++V DFG + R R T GTP +APE+I + +GYN+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEIILS-KGYNK 217
Query: 192 KADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251
D W+LG+ + EMA G PP P+++ I + HFS +K+ + L+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-GKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 252 PAER-----PSAKELLRHRFIRNARKSPRLLERIRERPKYP-IQEEPDT 294
+R ++ H++ + +R E P P + DT
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFATTDWI-AIYQRKVEAPFIPKFKGPGDT 324
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-61
Identities = 66/288 (22%), Positives = 124/288 (43%), Gaps = 30/288 (10%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
++ LE IG G++G V+KA ++E ++ VA+K + L+ + E +EI +L + +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 73 ITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK 132
I + KL ++ E+ LD + L LL + + H+
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 133 IHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEK 192
+HRD+K N+L+ NG++K+A+FG++ + V T ++ P+V+ ++ Y+
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 193 ADIWSLGITVIEMAKGEPPLADLHP--------MRVLFIIPRENPPQLDE---------- 234
D+WS G E+A PL + R+L E P + +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 235 -----------HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271
+ ++ + LK P +R SA+E L+H + +
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 204 bits (519), Expect = 6e-61
Identities = 51/301 (16%), Positives = 98/301 (32%), Gaps = 34/301 (11%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSP 71
G + IG GSFG +++ + N+ VAIK ++ D + +L+ C
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGI 63
Query: 72 YITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG 131
Y+G ++++ + L G ++A + +L ++ +H +
Sbjct: 64 PNVYYFGQ--EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 132 KIHRDIKAANILLTE-----NGDVKVADFGVSAQLTRTIS-------RRKTFVGTPFWMA 179
++RDIK N L+ + V DFG+ ++ +K GT +M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 180 PEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-------PRENPPQL 232
+ + D+ +LG + +G P L +L
Sbjct: 182 INTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYPIQEEP 292
F +++ P L L ++ ER E
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQ------------GLFSKVLERLNTTEDENF 288
Query: 293 D 293
D
Sbjct: 289 D 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-60
Identities = 65/279 (23%), Positives = 128/279 (45%), Gaps = 28/279 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-------VAIKVIDLEESEDEIEDIQKEISVL 65
R + +G G+FG V A L+KD VA+K++ + +E ++ D+ E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 66 SQC-RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPP----------------L 108
+ I G+ L++I+EY + G++ + +Q+ P L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 109 DEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168
+ + +EYL ++ IHRD+ A N+L+TE+ +K+ADFG++ + +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 169 KTFV--GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIP 225
KT WMAPE + + Y ++D+WS G+ + E+ G P + + ++
Sbjct: 193 KTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ + + + + C VP++RP+ K+L+
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 4e-60
Identities = 71/296 (23%), Positives = 130/296 (43%), Gaps = 39/296 (13%)
Query: 14 RFSSLELIGRGSFGDVYKAFD-KELNKDVAIKVIDLEESEDEIE-DIQKEISVLSQCRS- 70
++ + IG G++G V+KA D K + VA+K + ++ E+ + +E++VL +
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 71 --PYITEYYGSYL-----HQTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLH 122
P + + +TKL ++ E++ L + P + +I ++ LL
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 123 AIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEV 182
+++LH+ +HRD+K NIL+T +G +K+ADFG A++ + V T ++ APEV
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG-LARIYSFQMALTSVVVTLWYRAPEV 186
Query: 183 IQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------ 224
+ S Y D+WS+G EM + +P + L I
Sbjct: 187 LLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 225 --------PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272
+ + L K+ + CL PA+R SA L H + ++ +
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-59
Identities = 67/279 (24%), Positives = 113/279 (40%), Gaps = 29/279 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ 67
+R S + +G G+FG V +A L K VA+K++ E E + E+ VLS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 68 C-RSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQS------------------GPPL 108
I G+ +I EY G + + ++ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 109 DEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168
D + + + +L ++ IHRD+ A NILLT K+ DFG++ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 169 KT--FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEM-AKGEPPLADLHPMRVLFIIP 225
WMAPE I N Y ++D+WS GI + E+ + G P + + +
Sbjct: 203 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 226 REN-PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263
+E EH M + + C P +RP+ K++++
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-59
Identities = 84/310 (27%), Positives = 143/310 (46%), Gaps = 19/310 (6%)
Query: 2 ADLAGLQEAAG-SRFSSLELIGRGSFGDVYKAFD---KELNKDVAIKVID---LEESEDE 54
A+L G E G F L+++G G++G V+ + K A+KV+ + +
Sbjct: 12 ANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 71
Query: 55 IEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSI 113
E + E VL R SP++ + ++ +TKL +I++Y+ GG + + E +
Sbjct: 72 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV 131
Query: 114 ACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT-RTISRRKTFV 172
+ +++ A+E+LH G I+RDIK NILL NG V + DFG+S + R F
Sbjct: 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 191
Query: 173 GTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---EN 228
GT +MAP++++ + G+++ D WSLG+ + E+ G P I R ++
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251
Query: 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPS-----AKELLRHRFIRNARKSPRLLERIRER 283
P + S L K+ + L K P +R A E+ H F + L +
Sbjct: 252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD-DLAAKKVPA 310
Query: 284 PKYPIQEEPD 293
P P+ +
Sbjct: 311 PFKPVIRDEL 320
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 1e-58
Identities = 65/310 (20%), Positives = 118/310 (38%), Gaps = 44/310 (14%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYI 73
++ ++IG GSFG VY+A + + VAIK + ++ +E+ ++ + I
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 75
Query: 74 TEYYGSYLHQTK------LWIIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAI 124
+ + L ++++Y+ ++ L + + + L ++
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 125 EYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVI 183
Y+H+ G HRDIK N+LL + +K+ DFG + QL R +++ + ++ APE+I
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 194
Query: 184 QNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------- 224
+ Y D+WS G + E+ G+P + L I
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 225 PRENPPQLDEH---------FSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275
PQ+ H S L+ P R + E H F R
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 314
Query: 276 LLERIRERPK 285
L R+ P
Sbjct: 315 KLPNGRDTPA 324
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-58
Identities = 71/316 (22%), Positives = 127/316 (40%), Gaps = 46/316 (14%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSP 71
+ + L+ +G G++G V A D VAIK + +SE + +E+ +L R
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 72 YITEYYGSYLHQ------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
+ + T +++M +M G + L++ L E I ++ +L +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLR 135
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
Y+H G IHRD+K N+ + E+ ++K+ DFG++ Q S +V T ++ APEVI N
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVILN 192
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII--------------------- 224
Y + DIWS+G + EM G+ + L I
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 225 ---------PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275
+++ + + S L + L +R +A E L H + + +
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT-- 310
Query: 276 LLERIRERPKYPIQEE 291
E + KY +
Sbjct: 311 --EDEPQVQKYDDSFD 324
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 193 bits (492), Expect = 1e-56
Identities = 55/300 (18%), Positives = 115/300 (38%), Gaps = 49/300 (16%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPY 72
+ + +GRG + +V++A + N+ V +K++ + + I++EI +L R P
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGPN 91
Query: 73 ITEYYGSYLHQTK--LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNE 130
I ++ E++ L Q L + I + ++L A++Y H+
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM 148
Query: 131 GKIHRDIKAANILLT-ENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGY 189
G +HRD+K N+++ E+ +++ D+G+ A+ V + ++ PE++ + + Y
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 190 NEKADIWSLGITVIEMAKGEPPL------------------------------------- 212
+ D+WSLG + M + P
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
Query: 213 ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272
D+ R + S +F+ L+ R +A+E + H + K
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 8e-56
Identities = 61/279 (21%), Positives = 115/279 (41%), Gaps = 28/279 (10%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKD-----VAIKVIDLEESEDEIEDIQKEISVLSQ 67
R + +GRG+FG V +A ++K VA+K++ + E + E+ +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 68 CRSPYITEYYGSYLHQT--KLWIIMEYMAGGSVADLIQS----------------GPPLD 109
+ L +I+E+ G+++ ++S L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 110 EMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR--TISR 167
+ C + +E+L + IHRD+ A NILL+E VK+ DFG++ + + R
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLF-IIP 225
+ WMAPE I + Y ++D+WS G+ + E+ P + +
Sbjct: 193 KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 226 RENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264
+ ++ + M + + C P++RP+ EL+ H
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (487), Expect = 1e-55
Identities = 60/320 (18%), Positives = 126/320 (39%), Gaps = 45/320 (14%)
Query: 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRS 70
R+ +L +G G++G V AFD + VA+K + +S + +E+ +L +
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 71 PYITEYYGSYLHQTKLW-----IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIE 125
+ + L ++ ++ G + ++++ L + + ++ +L ++
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLK 135
Query: 126 YLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQN 185
Y+H+ IHRD+K +N+ + E+ ++K+ DFG++ +V T ++ APE++ N
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLN 192
Query: 186 SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII--------------------- 224
YN+ DIWS+G + E+ G + L +I
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 225 ---------PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK--- 272
P+ N + + L + + L +R +A + L H +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312
Query: 273 --SPRLLERIRERPKYPIQE 290
++ E I E
Sbjct: 313 EPVADPYDQSFESRDLLIDE 332
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 9e-55
Identities = 61/308 (19%), Positives = 119/308 (38%), Gaps = 59/308 (19%)
Query: 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYY 77
E IG+G FG+V++ + ++VA+K+ E + EI R I +
Sbjct: 8 QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFR--EAEIYQTVMLRHENILGFI 63
Query: 78 GSY----LHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGK- 132
+ T+LW++ +Y GS+ D + + + + + +LH E
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 133 -------IHRDIKAANILLTENGDVKVADFGVSAQL----TRTISRRKTFVGTPFWMAPE 181
HRD+K+ NIL+ +NG +AD G++ + VGT +MAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 182 VIQNSEG-----YNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHF 236
V+ +S ++ADI+++G+ E+A+ ++ + + P ++E
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 237 ---------------------SRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARKSPR 275
R+M + + C A R +A + +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT----------- 291
Query: 276 LLERIRER 283
L ++ ++
Sbjct: 292 -LSQLSQQ 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-53
Identities = 72/332 (21%), Positives = 137/332 (41%), Gaps = 60/332 (18%)
Query: 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLE-ESEDEIEDIQKEISVLSQCRSPY 72
R+ +L+ IG G+ G V A+D L+++VAIK + +++ + +E+ ++
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 73 ITEYYGSYLHQ------TKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEY 126
I + Q ++++ME M + LD ++ +L +L I++
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKH 134
Query: 127 LHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNS 186
LH+ G IHRD+K +NI++ + +K+ DFG+ A+ T +V T ++ APEVI
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILG- 192
Query: 187 EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM------ 240
GY E DIWS+G + EM + + + + + E +L
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 241 -----------------------------------KEFVSLCLKKVPAERPSAKELLRHR 265
++ +S L PA+R S + L+H
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 266 FIRNARK-------SPRLLERIRERPKYPIQE 290
+I P++ ++ + ++ I+E
Sbjct: 313 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEE 344
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (370), Expect = 2e-39
Identities = 59/345 (17%), Positives = 122/345 (35%), Gaps = 78/345 (22%)
Query: 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY 72
+R+ + +G G F V+ A D N VA+K++ ++ E + EI +L +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDAD 70
Query: 73 ITE-------------YYGSYLHQTKLWIIMEYMAGGSVADLI---QSGPPLDEMSIACI 116
T+ + ++ + ++M + G + + + + I
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 117 LRDLLHAIEYLHNEGKI-HRDIKAANILLTENG------DVKVADFGVSAQLTRTISRRK 169
+ LL ++Y+H I H DIK N+L+ +K+AD G +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYT 187
Query: 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPP---------LADLHPMRV 220
+ T + +PEV+ + + ADIWS + E+ G+ D +
Sbjct: 188 NSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 221 LFIIPRENPP--------------------------------------QLDEHFSRLMKE 242
+ + E P + + ++ + +
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 243 FVSLCLKKVPAERPSAKELLRHRFIRNARKSPRLLERIRERPKYP 287
F+S L+ P +R A L+ H ++++ + R+ +R Y
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEI--RVPDRELYG 349
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (255), Expect = 1e-25
Identities = 30/205 (14%), Positives = 71/205 (34%), Gaps = 38/205 (18%)
Query: 19 ELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDE-----------------IEDIQKE 61
+L+G G V+ + ++ + +K + + + I + E
Sbjct: 6 KLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 62 ISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLL 121
L + + + + Y + ++ME + + + + +L +L
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELY-------RVRVENPDEVLDMIL 113
Query: 122 HAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTFVGTPFWMAPE 181
+ ++ G +H D+ N+L++E G + + DF S ++ R
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWRE------ILERDVR 166
Query: 182 VIQN--SEGYNEKADIWSLGITVIE 204
I S Y + DI S +++
Sbjct: 167 NIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 703 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.46 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.0 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.94 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.93 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.74 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.56 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-59 Score=482.89 Aligned_cols=258 Identities=24% Similarity=0.424 Sum_probs=222.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++++.||+|+||+||+|+++.+|+.||||+++.....+..+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999999999999999998765555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc--ccccc
Q 005298 93 MAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRRKT 170 (703)
Q Consensus 93 v~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~~~ 170 (703)
|+||+|.+++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|..+.... .....
T Consensus 85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 164 (271)
T d1nvra_ 85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164 (271)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccc
Confidence 9999999999888899999999999999999999999999999999999999999999999999998664322 22345
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc--CCCCCCCcchhhhHHHHHHHHHHh
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII--PRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I--~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
.+||+.|||||++.+..+++.++||||||||||+|++|++||............ ...........+++.+.+||.+||
T Consensus 165 ~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 244 (271)
T d1nvra_ 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244 (271)
T ss_dssp CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHS
T ss_pred eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHc
Confidence 789999999999987765678899999999999999999999765543322221 222233334678999999999999
Q ss_pred ccCCCCCCCHHHHHhchhhhcc
Q 005298 249 KKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+||.+|||++|+|+||||++.
T Consensus 245 ~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 245 VENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp CSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCChhHCcCHHHHhcCHhhCcC
Confidence 9999999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-58 Score=481.42 Aligned_cols=260 Identities=43% Similarity=0.778 Sum_probs=230.7
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 45899999999999999999999999999999998765432 24678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
||+||+|.+++.. ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++..+..........
T Consensus 98 y~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred ecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 9999999999876 579999999999999999999999999999999999999999999999999998775554455667
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC--CCCcchhhhHHHHHHHHHHhc
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN--PPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~--~~~l~~~is~~L~dLI~~cL~ 249 (703)
+||+.|||||++.+. .|+.++|||||||+||+|++|.+||.+.+....+..+.... ....+..++..+++||.+||.
T Consensus 177 ~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 255 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255 (293)
T ss_dssp CSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred ccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence 899999999999875 58999999999999999999999999887766555543322 234567889999999999999
Q ss_pred cCCCCCCCHHHHHhchhhhccccCh
Q 005298 250 KVPAERPSAKELLRHRFIRNARKSP 274 (703)
Q Consensus 250 ~dP~~RPTa~eLL~Hpff~~~~~~~ 274 (703)
+||.+|||+.|+|+||||+.....+
T Consensus 256 ~dP~~R~s~~eil~Hp~~~~~~~~~ 280 (293)
T d1yhwa1 256 MDVEKRGSAKELLQHQFLKIAKPLS 280 (293)
T ss_dssp SSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred CChhHCcCHHHHhcCHhhCCCCCCC
Confidence 9999999999999999998654433
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-58 Score=474.66 Aligned_cols=253 Identities=32% Similarity=0.533 Sum_probs=227.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||+||+|+++.+++.||||++..... ......+.+|+.++++++|||||++++++.+++.+||||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 479999999999999999999999999999999864331 223567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|||++|+|.+++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||++...... ....
T Consensus 86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~~~~ 163 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTT 163 (263)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--CCEE
T ss_pred eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--cccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999765432 3345
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|||||++.+. .|+.++|||||||+||+|++|.+||...+....+..+.... ..++..+++.+++||.+||.+
T Consensus 164 ~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 241 (263)
T d2j4za1 164 LCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLISRLLKH 241 (263)
T ss_dssp TTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHHHHHTCS
T ss_pred cCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHHccC
Confidence 7899999999999875 58999999999999999999999999887777766665544 356678899999999999999
Q ss_pred CCCCCCCHHHHHhchhhhc
Q 005298 251 VPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 251 dP~~RPTa~eLL~Hpff~~ 269 (703)
||.+|||++|+|+||||..
T Consensus 242 dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 242 NPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp SGGGSCCHHHHHTCHHHHH
T ss_pred CHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=472.80 Aligned_cols=254 Identities=32% Similarity=0.534 Sum_probs=217.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe--CCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH--QTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~--~~~lyLV 89 (703)
.+|++++.||+|+||+||+|+++.+|+.||||++.... .+...+.+.+|+.+|++++|||||++++++.+ .+.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999999999999999997664 45567789999999999999999999999865 4568999
Q ss_pred EeccCCCCHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhcC-----ceeeeeccceEEecCCCCeeEeccccchh
Q 005298 90 MEYMAGGSVADLIQS----GPPLDEMSIACILRDLLHAIEYLHNEG-----KIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~----~~~L~e~~i~~i~~QLl~AL~yLHs~g-----IVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
||||+||+|.+++.. +..+++..++.|+.||+.||.|||++| ||||||||+||||+.+|.+||+|||++..
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999853 568999999999999999999999976 99999999999999999999999999987
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHH
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L 240 (703)
+..........+||+.|||||++.+. .|+.++||||||||||||++|.+||...+..+....+.....+.++..+++.+
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l 242 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242 (269)
T ss_dssp C-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence 76554455668999999999999765 58999999999999999999999999888877777777666667778899999
Q ss_pred HHHHHHHhccCCCCCCCHHHHHhchhh
Q 005298 241 KEFVSLCLKKVPAERPSAKELLRHRFI 267 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~Hpff 267 (703)
++||.+||.+||.+|||+.|||+|||+
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=475.43 Aligned_cols=258 Identities=45% Similarity=0.788 Sum_probs=230.1
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
...|++++.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+.+|++|+|||||+++++|.+++.+|||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 347999999999999999999999999999999997653 3345778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 92 yv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||+||+|.+++.+ ..++++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++...........+
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 9999999999754 567999999999999999999999999999999999999999999999999999776555445557
Q ss_pred ccCCCCCCchhhhcc----ccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC--cchhhhHHHHHHH
Q 005298 171 FVGTPFWMAPEVIQN----SEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ--LDEHFSRLMKEFV 244 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~----~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~--l~~~is~~L~dLI 244 (703)
.+||+.|||||++.. ...|+.++|||||||+||+|++|.+||.+.+..+.+..+....++. .+..+++.+++||
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li 249 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence 899999999999852 3458899999999999999999999999988887777666554433 3568899999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+||.+||.+|||+.|||+||||+..
T Consensus 250 ~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 250 KKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-57 Score=478.78 Aligned_cols=258 Identities=34% Similarity=0.613 Sum_probs=222.4
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++++.||+|+||+||+|+++.+|+.||||+++..........+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45689999999999999999999999999999999987655566678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +|||||||||+||||+.+|++||+|||+|..+... ...
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~~ 161 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN 161 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--TC-
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--ccc
Confidence 999999999999988899999999999999999999997 59999999999999999999999999999876543 334
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee----------------------------
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---------------------------- 221 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l---------------------------- 221 (703)
+++||+.|||||++.+. .|+.++||||||||||||++|+.||...+.....
T Consensus 162 ~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp --CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred cccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 67999999999999875 5999999999999999999999999765432110
Q ss_pred --------------eccCCCCCCCcc-hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 222 --------------FIIPRENPPQLD-EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 222 --------------~~I~~~~~~~l~-~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
..+....++.++ ..++.++++||.+||..||.+|||++|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 000111112222 34678999999999999999999999999999998653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-57 Score=481.45 Aligned_cols=257 Identities=30% Similarity=0.526 Sum_probs=232.8
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||.||+|+++.+|+.||||++++.. .......+.+|+.+|++++|||||+++++|.+.+.+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 47999999999999999999999999999999997543 1233577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|||+||+|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...........
T Consensus 85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~ 164 (337)
T d1o6la_ 85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164 (337)
T ss_dssp ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCC
T ss_pred eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876555555567
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|||||++.+. .|+.++||||||||||||++|.+||...+.......+.... ..++..+++.+++||.+||.+
T Consensus 165 ~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~~ 242 (337)
T d1o6la_ 165 FCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKK 242 (337)
T ss_dssp CEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCS
T ss_pred ceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-CCCCccCCHHHHHHHHhhccC
Confidence 8999999999999875 58999999999999999999999999988777666665544 456778999999999999999
Q ss_pred CCCCCC-----CHHHHHhchhhhccc
Q 005298 251 VPAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 251 dP~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
||.+|+ +++||++||||....
T Consensus 243 dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 243 DPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred CchhhcccccccHHHHHcCcccccCC
Confidence 999999 499999999998764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-57 Score=475.44 Aligned_cols=258 Identities=29% Similarity=0.468 Sum_probs=211.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
....|++.+.||+|+||+||+|+++.+|+.||||++...........+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45679999999999999999999999999999999987655555567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec---CCCCeeEeccccchhhhhcccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT---ENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd---~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
|||+||+|.+++...+.+++..+..|+.||+.||.|||++|||||||||+|||+. .++.+||+|||++...... ..
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~~ 165 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SV 165 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-Ce
Confidence 9999999999999989999999999999999999999999999999999999995 4689999999999765433 33
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFV 244 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~dLI 244 (703)
..+.+||+.|||||++.+. .|+.++|||||||+||+|++|.+||.+.+.......+.... +......+++.+++||
T Consensus 166 ~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 244 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244 (307)
T ss_dssp -------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred eeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHH
Confidence 4467899999999999875 58999999999999999999999999887766665555433 2334467899999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.+||.+||.+|||++|+|+||||+..
T Consensus 245 ~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 245 RHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-56 Score=472.81 Aligned_cols=259 Identities=41% Similarity=0.750 Sum_probs=229.0
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
+...|++++.||+|+||+||+|++..+|+.||||++..... ....+.+.+|+.+|++|+|||||+++++|.+++.+||
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 34469999999999999999999999999999999976542 3445778999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccc
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
|||||.+|+|..++..+.++++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++..... .
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~ 168 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A 168 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----B
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----C
Confidence 999999999998888888999999999999999999999999999999999999999999999999999876533 3
Q ss_pred ccccCCCCCCchhhhccc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC-CCCcchhhhHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN-PPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~--~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~-~~~l~~~is~~L~dLI~ 245 (703)
...+||+.|||||++.+. ..|+.++|||||||+||||++|..||.+.+....+..+.... +...+..+++.+++||.
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~ 248 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 457899999999998642 348899999999999999999999999887766665554443 33445678999999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhccccC
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRNARKS 273 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~~~~~ 273 (703)
+||.+||.+|||++|+|+||||......
T Consensus 249 ~~L~~dP~~Rpt~~ell~Hp~~~~~~~~ 276 (309)
T d1u5ra_ 249 SCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (309)
T ss_dssp HHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence 9999999999999999999999865443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-57 Score=473.17 Aligned_cols=258 Identities=26% Similarity=0.483 Sum_probs=227.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999986543 1223567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc--ccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--SRR 168 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~--~~~ 168 (703)
|||+||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.... ...
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 999999999999988999999999999999999999999999999999999999999999999999998664322 233
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
...+||+.|||||++.+. .|+.++|||||||+||+|++|.+||...+.......|....+ .++..+++.+++||.+||
T Consensus 168 ~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L 245 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFFPKARDLVEKLL 245 (288)
T ss_dssp --CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-CCCTTCCHHHHHHHHTTS
T ss_pred ccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC-CCCccCCHHHHHHHHHHc
Confidence 457899999999999875 589999999999999999999999998887777777665543 456788999999999999
Q ss_pred ccCCCCCCCHHH------HHhchhhhcccc
Q 005298 249 KKVPAERPSAKE------LLRHRFIRNARK 272 (703)
Q Consensus 249 ~~dP~~RPTa~e------LL~Hpff~~~~~ 272 (703)
.+||.+|||++| |++||||+...+
T Consensus 246 ~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 246 VLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp CSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred cCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 999999999987 688999987643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-56 Score=461.17 Aligned_cols=254 Identities=29% Similarity=0.505 Sum_probs=220.1
Q ss_pred hCCCc-eEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe----CC
Q 005298 11 AGSRF-SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH----QT 84 (703)
Q Consensus 11 ~~~~Y-~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~----~~ 84 (703)
..++| ++.+.||+|+||+||+|++..+++.||||++.... .....+.+.+|+++|++++|||||+++++|.+ +.
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 44566 77889999999999999999999999999987654 45567789999999999999999999999875 45
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcC--ceeeeeccceEEec-CCCCeeEeccccchhh
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEG--KIHRDIKAANILLT-ENGDVKVADFGVSAQL 161 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~g--IVHRDIKPeNILLd-~~g~VKL~DFGlA~~~ 161 (703)
.+|||||||++|+|.+++.+...+++..++.|+.||+.||.|||+++ ||||||||+||||+ .++.+||+|||+++..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 68999999999999999998889999999999999999999999998 99999999999997 4789999999999754
Q ss_pred hhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-eeeccCCCC-CCCcchhhhHH
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLFIIPREN-PPQLDEHFSRL 239 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~-~l~~I~~~~-~~~l~~~is~~ 239 (703)
.. ......+||+.|||||++.+ .|+.++||||||||||+|++|++||....... ....+.... +..++..+++.
T Consensus 166 ~~--~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (270)
T d1t4ha_ 166 RA--SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241 (270)
T ss_dssp CT--TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred cC--CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence 32 23346799999999999864 48999999999999999999999998765443 333444333 33455677899
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHhchhhh
Q 005298 240 MKEFVSLCLKKVPAERPSAKELLRHRFIR 268 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RPTa~eLL~Hpff~ 268 (703)
+++||.+||.+||++|||++|||+||||+
T Consensus 242 ~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999999999999999999995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-56 Score=462.73 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=228.6
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-----HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----DEIEDIQKEISVLSQCRSPYITEYYGSYLHQT 84 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-----~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~ 84 (703)
....+|++++.||+|+||+||+|+++.+|+.||||++.+.... ...+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4556899999999999999999999999999999998654321 23578899999999999999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC----CeeEeccccchh
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG----DVKVADFGVSAQ 160 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g----~VKL~DFGlA~~ 160 (703)
.+|||||||+||+|.+++...+.+++..++.|+.||+.||.|||++|||||||||+|||++.++ .+||+|||++..
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999999998888999999999999999999999999999999999999998776 599999999876
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC---Ccchhhh
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP---QLDEHFS 237 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~---~l~~~is 237 (703)
.... ....+.+||+.|+|||++.+. .|+.++|||||||+||+|++|..||.+.+..+.+..+...... .....++
T Consensus 167 ~~~~-~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 167 IDFG-NEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp CTTS-CBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred cCCC-ccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 6433 334467899999999999874 5899999999999999999999999988877776666554432 2335678
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 238 RLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 238 ~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
..+++||.+||.+||.+|||++|+|+||||+...
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999999998643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-56 Score=471.96 Aligned_cols=257 Identities=28% Similarity=0.532 Sum_probs=228.8
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHH-hCCCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLS-QCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk-~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
.+|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+..|+.++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 47999999999999999999999999999999996432 1223455666777665 68999999999999999999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
||||++|+|.+++.....+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||++...........
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~ 161 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN 161 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccccc
Confidence 99999999999999989999999999999999999999999999999999999999999999999999987655555556
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhc
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLK 249 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~ 249 (703)
..+||+.|+|||++.+. .|+.++|||||||+||+|++|+.||.+.+...+...+.... +.++..+++.+++||.+||.
T Consensus 162 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 162 TFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFV 239 (320)
T ss_dssp CCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSC
T ss_pred ccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-CCCCccCCHHHHHHHHHhcc
Confidence 67999999999999875 58999999999999999999999999888777777666544 35667889999999999999
Q ss_pred cCCCCCCCHH-HHHhchhhhccc
Q 005298 250 KVPAERPSAK-ELLRHRFIRNAR 271 (703)
Q Consensus 250 ~dP~~RPTa~-eLL~Hpff~~~~ 271 (703)
+||.+|||+. +|++||||+...
T Consensus 240 ~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 240 REPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp SSGGGSBTTBSCGGGSGGGTTCC
T ss_pred cCCCCCcCHHHHHHhCchhccCC
Confidence 9999999995 899999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-55 Score=464.27 Aligned_cols=254 Identities=28% Similarity=0.507 Sum_probs=228.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46999999999999999999999999999999986432 1223577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
|||+||+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||++..... ...+
T Consensus 84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---~~~~ 160 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYT 160 (316)
T ss_dssp CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---CBCC
T ss_pred eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc---cccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999976543 2346
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|||||++.+. .|+.++|||||||+||+|++|..||...+.......+..... .++..+++.++++|.+||.+
T Consensus 161 ~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~ 238 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-RFPPFFNEDVKDLLSRLITR 238 (316)
T ss_dssp CCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCS
T ss_pred ccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhh
Confidence 7999999999999775 589999999999999999999999998887777666655433 45667899999999999999
Q ss_pred CCCCCC-----CHHHHHhchhhhccc
Q 005298 251 VPAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 251 dP~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
||.+|+ |+++|++||||+...
T Consensus 239 dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 239 DLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred CHHhccccchhhHHHHHcCcccccCC
Confidence 999996 899999999998874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.3e-55 Score=470.82 Aligned_cols=255 Identities=23% Similarity=0.387 Sum_probs=226.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEec
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEY 92 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Ey 92 (703)
.+|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|++|+|||||+++++|.+++.+||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 48999999999999999999999999999999997553 44567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC--CCCeeEeccccchhhhhcccccc
Q 005298 93 MAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE--NGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 93 v~gGsL~~~l~-~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~--~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|+||+|.+++. ..+++++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||++..+... ....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~~ 183 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVK 183 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-SCEE
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-cccc
Confidence 99999999985 4567999999999999999999999999999999999999964 578999999999766433 2334
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHHHHHH
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~dLI~~ 246 (703)
+.+||+.|||||++.+. .|+.++||||||||||+|++|.+||.+.+..+.+..|.... +......+++.+++||.+
T Consensus 184 ~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 262 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262 (350)
T ss_dssp EECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHH
T ss_pred eecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence 67999999999999875 58999999999999999999999999887777666654433 233445789999999999
Q ss_pred HhccCCCCCCCHHHHHhchhhhcc
Q 005298 247 CLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
||.+||.+|||++|+|+||||+..
T Consensus 263 ~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 263 LLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp HCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred HccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-55 Score=469.58 Aligned_cols=254 Identities=28% Similarity=0.515 Sum_probs=228.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
.+|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++++|||||+++++|.+...+|+||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999999999999999986432 1223567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 91 EYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||+.||+|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.. ...+
T Consensus 121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---~~~~ 197 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWT 197 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---CBCC
T ss_pred ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---cccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999986643 2346
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhcc
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKK 250 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~ 250 (703)
.+||+.|||||++.+. .|+.++||||||||||+|++|.+||.+.+....+..|....+ .++..+++.+.+||.+||.+
T Consensus 198 ~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCTTCCHHHHHHHHHHSCS
T ss_pred ccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CCCccCCHHHHHHHHHHhhh
Confidence 7899999999999875 589999999999999999999999998887777666655443 45668899999999999999
Q ss_pred CCCCCC-----CHHHHHhchhhhccc
Q 005298 251 VPAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 251 dP~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
||.+|+ |+++|++||||+...
T Consensus 276 dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 276 DLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred CHHhccccccccHHHHHcCccccCCC
Confidence 999995 999999999998764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7e-55 Score=470.44 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=223.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-----ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-----SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-----~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
.+|+++++||+|+||+||+|+++.+|+.||||++.... ..........|+.+++.++|||||+++++|.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 47999999999999999999999999999999986432 1122233345577888889999999999999999999
Q ss_pred EEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 88 IIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
||||||+||+|.+++.+...+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+... .
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~--~ 161 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--K 161 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS--C
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC--c
Confidence 99999999999999998899999999999999999999999999999999999999999999999999999866433 3
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee--eccCCCCCCCcchhhhHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL--FIIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l--~~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
....+||+.|||||++.....|+.++||||||||||+|++|+.||...+..... .......+..++..+++.+++||.
T Consensus 162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 241 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHH
T ss_pred ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHH
Confidence 345789999999999976667999999999999999999999999876543322 222333455666789999999999
Q ss_pred HHhccCCCCCCC-----HHHHHhchhhhcccc
Q 005298 246 LCLKKVPAERPS-----AKELLRHRFIRNARK 272 (703)
Q Consensus 246 ~cL~~dP~~RPT-----a~eLL~Hpff~~~~~ 272 (703)
+||.+||.+||| ++||++||||+...+
T Consensus 242 ~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp HHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred HHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 999999999999 799999999988753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.5e-55 Score=469.42 Aligned_cols=255 Identities=23% Similarity=0.402 Sum_probs=226.0
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||+|+||+||+|++..+|+.||||++.... ......+.+|+.+|++|+|||||+++++|.+++.+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357999999999999999999999999999999987654 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEec--CCCCeeEeccccchhhhhccccc
Q 005298 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLT--ENGDVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 92 yv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd--~~g~VKL~DFGlA~~~~~~~~~~ 168 (703)
||+||+|.+++... .++++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|..+... ...
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~~~ 185 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIV 185 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SCE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-Cce
Confidence 99999999987654 4799999999999999999999999999999999999998 5689999999999876543 233
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcchhhhHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~~is~~L~dLI~ 245 (703)
.+.+||+.|||||++.+. .|+.++|||||||+||+|++|.+||.+.+....+..+.... +......+++.+++||.
T Consensus 186 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 264 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264 (352)
T ss_dssp EEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred eeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence 457899999999999775 59999999999999999999999999888777666654433 33344678999999999
Q ss_pred HHhccCCCCCCCHHHHHhchhhhc
Q 005298 246 LCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
+||.+||.+|||+.|+|+||||+.
T Consensus 265 ~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 265 NLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp TTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HHccCChhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=459.20 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=217.4
Q ss_pred eEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChH----HHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 16 SSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESED----EIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 16 ~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~----~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
+.+++||+|+||+||+|+++.+|+.||||+++...... ....+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 46889999999999999999999999999986543221 23468899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
||.++++..++..+..+++..++.|++||+.||.|||++|||||||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence 99999888888878889999999999999999999999999999999999999999999999999998776655555667
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC----------------------CCC
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------------------ENP 229 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~----------------------~~~ 229 (703)
+||+.|+|||++.....|+.++||||||||||||++|.+||...+..+.+..|.. ...
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence 9999999999998766789999999999999999999999987765544332210 000
Q ss_pred CC-----cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 230 PQ-----LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 230 ~~-----l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
+. ....+++.+.+||.+||.+||++|||+.|+|+||||++.
T Consensus 241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 01 112467899999999999999999999999999999854
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.7e-54 Score=448.19 Aligned_cols=257 Identities=31% Similarity=0.514 Sum_probs=226.9
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC--------hHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES--------EDEIEDIQKEISVLSQCR-SPYITEYYGSYLH 82 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~--------~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~ 82 (703)
..+|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|++|+ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4689999999999999999999999999999999876542 123456889999999997 9999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
++.+|||||||+||+|.++++..+++++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999998765
Q ss_pred hcccccccccCCCCCCchhhhccc-----cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCC---CCCcch
Q 005298 163 RTISRRKTFVGTPFWMAPEVIQNS-----EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPREN---PPQLDE 234 (703)
Q Consensus 163 ~~~~~~~~~iGTp~Y~APEvl~~~-----~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~---~~~l~~ 234 (703)
... .....+||+.|+|||++.+. ..++.++||||+|||||+|++|++||...+.......+.... +.....
T Consensus 162 ~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (277)
T d1phka_ 162 PGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240 (277)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred CCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 432 33457899999999998632 346889999999999999999999999888766655554332 333445
Q ss_pred hhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 235 HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 235 ~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
.+++.+++||.+||.++|.+|||++|||+||||+.
T Consensus 241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 89999999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-54 Score=456.49 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=225.0
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 3568999999999999999999999999999999997653 23456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC--CCeeEeccccchhhhhcccc
Q 005298 91 EYMAGGSVADLIQSGP-PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN--GDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~~-~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~--g~VKL~DFGlA~~~~~~~~~ 167 (703)
|||+||+|.+++...+ ++++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||++...... ..
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~ 159 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DN 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-Cc
Confidence 9999999999998654 79999999999999999999999999999999999999854 47999999998766433 23
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCC---cchhhhHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQ---LDEHFSRLMKEFV 244 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~---l~~~is~~L~dLI 244 (703)
..+.+||+.|+|||.+.+. .|+.++||||||||||+|++|.+||...+....+..|....... ....+++.+++||
T Consensus 160 ~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence 3457899999999999775 58999999999999999999999999988777777665544322 2236789999999
Q ss_pred HHHhccCCCCCCCHHHHHhchhhhc
Q 005298 245 SLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
.+||.+||.+|||+.|+|+||||+.
T Consensus 239 ~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 239 DRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred HHHccCChhHCcCHHHHhcCHhhcc
Confidence 9999999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-54 Score=449.07 Aligned_cols=259 Identities=27% Similarity=0.404 Sum_probs=217.3
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-HHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-DEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|++++.||+|+||+||+|++..+|+.||||++...... ...+.+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4899999999999999999999999999999999655422 235678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccccccc
Q 005298 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKT 170 (703)
Q Consensus 92 yv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~ 170 (703)
||.++.+..+... ...+++..++.|+.||+.||.|||++|||||||||+|||++.++++||+|||++............
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~ 161 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence 9976544444333 457999999999999999999999999999999999999999999999999999877665555666
Q ss_pred ccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------------C---C-
Q 005298 171 FVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------E---N- 228 (703)
Q Consensus 171 ~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~------------------~---~- 228 (703)
.+||+.|+|||++....+++.++|||||||++|+|++|+.||...+....+..+.. . .
T Consensus 162 ~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T d1gz8a_ 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241 (298)
T ss_dssp CBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSC
T ss_pred ecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccc
Confidence 79999999999988877778999999999999999999999987665443322110 0 0
Q ss_pred ---CCC---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 229 ---PPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 229 ---~~~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
... ....++..+++||.+||.+||.+|||+.|||+||||++..
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 000 1124578899999999999999999999999999998753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-53 Score=440.99 Aligned_cols=256 Identities=28% Similarity=0.475 Sum_probs=216.6
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|++++.||+|+||+||+|+++ +|+.||||+++.... ....+.+.+|+.+|++++|||||+++++|...+..|++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 48999999999999999999986 789999999976542 2235788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
|+.++.+..+....+.+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++.............
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence 99988888888888999999999999999999999999999999999999999999999999999998776554455567
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccC------------------C-------
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIP------------------R------- 226 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~------------------~------- 226 (703)
+|++.|+|||.+.+...++.++|||||||+||||++|++||.+.+..+.+..+. .
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence 899999999999877778999999999999999999999998765433322210 0
Q ss_pred CCC---CCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 227 ENP---PQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 227 ~~~---~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
..+ ......+++.+.+||.+||.+||++|||+.|+|+||||++
T Consensus 241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 000 1123456789999999999999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-54 Score=444.16 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=217.1
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCCh-----HHHHHHHHHHHHHHhCC--CCCeeeeEEEEEeC
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESE-----DEIEDIQKEISVLSQCR--SPYITEYYGSYLHQ 83 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~-----~~~~~l~~Ei~ILk~L~--HPnIV~L~~~~~~~ 83 (703)
..++|++.++||+|+||+||+|++..+|+.||||++...... ....++.+|+.+|++++ |||||+++++|.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 357899999999999999999999999999999998654311 11234668999999987 89999999999999
Q ss_pred CEEEEEEeccCC-CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCC-CCeeEeccccchhh
Q 005298 84 TKLWIIMEYMAG-GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTEN-GDVKVADFGVSAQL 161 (703)
Q Consensus 84 ~~lyLV~Eyv~g-GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~-g~VKL~DFGlA~~~ 161 (703)
+.+|+||||+.+ ++|.+++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+ +.+||+|||++...
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999976 6889999888899999999999999999999999999999999999999854 79999999998764
Q ss_pred hhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCCCcchhhhHHHH
Q 005298 162 TRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (703)
Q Consensus 162 ~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~ 241 (703)
.. ....+.+||+.|||||++.+..+++.++|||||||+||+|++|..||...+. +.. ....++..++++++
T Consensus 162 ~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~-~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 162 KD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR-GQVFFRQRVSSECQ 232 (273)
T ss_dssp CS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-CCCCCSSCCCHHHH
T ss_pred cc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhh-cccCCCCCCCHHHH
Confidence 33 2345678999999999998776667889999999999999999999976432 111 12234557889999
Q ss_pred HHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 242 EFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
+||.+||.+||.+|||++|+|+||||++..
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-53 Score=449.86 Aligned_cols=251 Identities=27% Similarity=0.447 Sum_probs=211.9
Q ss_pred CCCceEEE-EEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHh-CCCCCeeeeEEEEEe----CCE
Q 005298 12 GSRFSSLE-LIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQ-CRSPYITEYYGSYLH----QTK 85 (703)
Q Consensus 12 ~~~Y~il~-~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~-L~HPnIV~L~~~~~~----~~~ 85 (703)
-.+|+++. +||+|+||+||+|++..+++.||||+++.. ..+.+|+.++.+ ++|||||+++++|.+ +..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 35899985 699999999999999999999999998642 457789998655 589999999999976 467
Q ss_pred EEEEEeccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC---CCCeeEeccccchh
Q 005298 86 LWIIMEYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSAQ 160 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~---~g~VKL~DFGlA~~ 160 (703)
+|||||||+||+|.+++... .+|++..++.|+.||+.||.|||++||+||||||+|||++. .+.+||+|||+++.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 99999999999999999864 47999999999999999999999999999999999999985 46799999999976
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceee----ccCCCC---CCCcc
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF----IIPREN---PPQLD 233 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~----~I~~~~---~~~l~ 233 (703)
.... ......+||+.|||||++.+. .|+.++||||||||||+|+||.+||.+.+...... .+.... +....
T Consensus 164 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 241 (335)
T d2ozaa1 164 TTSH-NSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241 (335)
T ss_dssp CCCC-CCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHH
T ss_pred ccCC-CccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCccc
Confidence 6443 334567899999999999775 59999999999999999999999998765543322 222221 22333
Q ss_pred hhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 234 EHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 234 ~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
..+++.+++||.+||.+||.+|||+.|+|+||||...
T Consensus 242 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 5789999999999999999999999999999999753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-52 Score=440.34 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=213.5
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCc---EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNK---DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~---~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
..+|++.++||+|+||+||+|.++.+++ .||||++.........+.+.+|+.+|++|+|||||++++++..++.+||
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3589999999999999999999987665 6899998776677777889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc
Q 005298 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR 167 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~ 167 (703)
|||||++|+|.+++.. .+.+++..+..|+.||+.||.|||+++||||||||+||||+.++++||+|||+++.+......
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 9999999999998876 457999999999999999999999999999999999999999999999999999766432221
Q ss_pred -----cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHH
Q 005298 168 -----RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMK 241 (703)
Q Consensus 168 -----~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~ 241 (703)
.....||+.|||||++.+. .|+.++|||||||+||||+| |.+||.+....+....+.....++.+..++..+.
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 263 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263 (299)
T ss_dssp -----------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHH
Confidence 1124689999999999875 58999999999999999998 8999999888877777777666677788999999
Q ss_pred HHHHHHhccCCCCCCCHHHHHhc
Q 005298 242 EFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+||.+||..+|.+|||+.||+++
T Consensus 264 ~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 264 QLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=434.45 Aligned_cols=254 Identities=24% Similarity=0.427 Sum_probs=222.6
Q ss_pred CCceEEEE-EeecCceEEEEEEEcC--CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLEL-IGRGSFGDVYKAFDKE--LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~-LG~GsfG~Vyka~d~~--tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
.+|.+.+. ||+|+||+||+|.++. ++..||||+++........+.+.+|+.+|++++|||||++++++.. +.+|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 47888885 9999999999998764 4558999999877666677889999999999999999999999865 568999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc---
Q 005298 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--- 165 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~--- 165 (703)
||||++|+|.+++.. +..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||++..+....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 999999999999764 4679999999999999999999999999999999999999999999999999997664322
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHH
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFV 244 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI 244 (703)
......+||+.|||||++.+. .++.++|||||||+||||+| |..||.+.+..+....+.....+..+..+++.+.+||
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 245 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALM 245 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 122345789999999999875 58999999999999999998 9999998887777777777777778889999999999
Q ss_pred HHHhccCCCCCCCHHHH---Hhchhhh
Q 005298 245 SLCLKKVPAERPSAKEL---LRHRFIR 268 (703)
Q Consensus 245 ~~cL~~dP~~RPTa~eL---L~Hpff~ 268 (703)
.+||..+|++|||+.+| |+|+|+.
T Consensus 246 ~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 246 SDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999888 5677764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=433.37 Aligned_cols=248 Identities=24% Similarity=0.420 Sum_probs=213.2
Q ss_pred EEEeecCceEEEEEEEc--CCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEeccCC
Q 005298 19 ELIGRGSFGDVYKAFDK--ELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIMEYMAG 95 (703)
Q Consensus 19 ~~LG~GsfG~Vyka~d~--~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~Eyv~g 95 (703)
+.||+|+||+||+|.+. .+++.||||+++... .....+.+.+|+.+|++++|||||+++++|.. +..|||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999864 456889999986543 23345789999999999999999999999865 457899999999
Q ss_pred CCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc---cccccc
Q 005298 96 GSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS---RRKTFV 172 (703)
Q Consensus 96 GsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~---~~~~~i 172 (703)
|+|.+++.....+++..+..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+++.+..... ......
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 99999999989999999999999999999999999999999999999999999999999999976543222 122357
Q ss_pred CCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHhccC
Q 005298 173 GTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKV 251 (703)
Q Consensus 173 GTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~d 251 (703)
||+.|||||++.+. .|+.++|||||||+||||++ |.+||.+.+..+....+.....+..+..++..+.+||.+||..|
T Consensus 172 gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~d 250 (277)
T d1xbba_ 172 WPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 250 (277)
T ss_dssp CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCC
Confidence 99999999999875 58999999999999999997 89999998887777777777777788899999999999999999
Q ss_pred CCCCCCHHHHH---hchhhh
Q 005298 252 PAERPSAKELL---RHRFIR 268 (703)
Q Consensus 252 P~~RPTa~eLL---~Hpff~ 268 (703)
|.+|||+.+|+ +|+|+.
T Consensus 251 p~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 251 VENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp TTTSCCHHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHhhCHHhh
Confidence 99999999984 566553
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.6e-52 Score=430.59 Aligned_cols=256 Identities=28% Similarity=0.490 Sum_probs=213.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC----
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT---- 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~---- 84 (703)
...+|++.+.||+|+||+||+|++..+|+.||||+++... .......+.+|+.+|++++|||||++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 4578999999999999999999999999999999997654 3445678999999999999999999999998754
Q ss_pred EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 85 KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
.+|||||||+|++|.+++...+++++..++.|+.||+.||.|||++|||||||||+||||+.++.++|+|||++......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 48999999999999999998899999999999999999999999999999999999999999999999999987654322
Q ss_pred c---cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCCCCC---CcchhhhH
Q 005298 165 I---SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRENPP---QLDEHFSR 238 (703)
Q Consensus 165 ~---~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~~~~---~l~~~is~ 238 (703)
. ......+||+.|||||++.+. .|+.++||||||||||+|+||.+||...+..+....+....+. .....+|+
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp --------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred cccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 1 233456899999999999875 5899999999999999999999999988776666555443332 23457889
Q ss_pred HHHHHHHHHhccCCCCCC-CHHHHHhchhhh
Q 005298 239 LMKEFVSLCLKKVPAERP-SAKELLRHRFIR 268 (703)
Q Consensus 239 ~L~dLI~~cL~~dP~~RP-Ta~eLL~Hpff~ 268 (703)
.+.+||.+||.+||.+|| |++++ .|+|++
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 999999999999999999 55555 566664
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-52 Score=436.09 Aligned_cols=254 Identities=25% Similarity=0.428 Sum_probs=218.9
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++.+.||+|+||+||+|++..+++.||||+++.... ..+.+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 4589999999999999999999999999999999875433 24678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-cc
Q 005298 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (703)
Q Consensus 92 yv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~ 168 (703)
||++|+|.+++... ..+++..+..|+.||+.||.|||++|||||||||+||||+.++++||+|||+++....... ..
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 99999999999653 5789999999999999999999999999999999999999999999999999986643322 22
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCC-CCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPL-ADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF-~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....|++.|||||++.+. .|+.++|||||||+||||++|..|| ...+.......+.....+..+..+++.+.+||.+|
T Consensus 174 ~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 252 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252 (287)
T ss_dssp TTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHH
Confidence 234689999999999875 5899999999999999999976655 44444444455555566677788999999999999
Q ss_pred hccCCCCCCCHHHHHhchhhhcc
Q 005298 248 LKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
|..||.+|||+.+|++ +|...
T Consensus 253 l~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 253 WQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp TCSSGGGSCCHHHHHH--HHHHT
T ss_pred cCCCHhHCcCHHHHHH--HHHHH
Confidence 9999999999999976 45443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=432.52 Aligned_cols=258 Identities=27% Similarity=0.436 Sum_probs=211.2
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCC-CcEEEEEEeccCCCh-HHHHHHHHHHHHHHhC---CCCCeeeeEEEEEe----
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKEL-NKDVAIKVIDLEESE-DEIEDIQKEISVLSQC---RSPYITEYYGSYLH---- 82 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~t-g~~VAIKvi~~~~~~-~~~~~l~~Ei~ILk~L---~HPnIV~L~~~~~~---- 82 (703)
..+|++++.||+|+||+||+|++..+ ++.||||+++..... .....+.+|+.+|+.| +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46999999999999999999999765 678999998654322 1223456777777665 89999999999864
Q ss_pred -CCEEEEEEeccCCCCHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchh
Q 005298 83 -QTKLWIIMEYMAGGSVADLIQ-SGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 83 -~~~lyLV~Eyv~gGsL~~~l~-~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
...+|++||||.++.+..... ....+++..++.++.||+.||.|||++|||||||||+|||++..+.+||+|||++..
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 357899999998887765554 346799999999999999999999999999999999999999999999999999875
Q ss_pred hhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC--------------
Q 005298 161 LTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------------- 226 (703)
Q Consensus 161 ~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~-------------- 226 (703)
.... ......+||+.|||||++.+. .|+.++||||||||||||++|++||...+..+.+..+..
T Consensus 166 ~~~~-~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 166 YSFQ-MALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCGG-GGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hccc-ccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 5433 334567999999999999875 599999999999999999999999987765443322210
Q ss_pred ------------CCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 227 ------------ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 227 ------------~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.....+...+++.+++||.+||.+||.+|||+.|+|+||||++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 001122345788999999999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-52 Score=426.17 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=209.2
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||+|+||+||+|.+. +++.||||+++..... .+.+.+|+.++++++|||||+++++|..++.+|||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 468999999999999999999987 4778999998754432 3578999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-ccc
Q 005298 92 YMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~~ 169 (703)
||++|+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+||||+.++++||+|||+++....... ...
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999999998654 5689999999999999999999999999999999999999999999999999976644322 223
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
...||+.|||||++.+. .|+.++|||||||+||||+| |.+||...+....+..+.....+..+..+++.+.+||.+||
T Consensus 161 ~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 239 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239 (263)
T ss_dssp ----CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred ceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHc
Confidence 46799999999999875 58999999999999999999 57777776666666666666666677788999999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q 005298 249 KKVPAERPSAKELLRH 264 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~H 264 (703)
..||.+|||++||++|
T Consensus 240 ~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 240 KERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCCHhHCcCHHHHHHH
Confidence 9999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=423.36 Aligned_cols=258 Identities=25% Similarity=0.402 Sum_probs=223.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
.+|++++.||+|+||+||+|++..+|+.||||+++... .......+.+|+.+|+.++|||||+++++|.+...+++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 48999999999999999999999999999999997654 34457889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccccc
Q 005298 92 YMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRKTF 171 (703)
Q Consensus 92 yv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~~~ 171 (703)
++.+++|..++...+.+++..++.++.|++.||+|||++|||||||||+||||+.++++||+|||++.............
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~ 161 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceee
Confidence 99999999999999999999999999999999999999999999999999999999999999999998776554455556
Q ss_pred cCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cceeecc--------------------------
Q 005298 172 VGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHP-MRVLFII-------------------------- 224 (703)
Q Consensus 172 iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~-~~~l~~I-------------------------- 224 (703)
.+++.|+|||++.....++.++|||||||++|||++|..||..... .+....+
T Consensus 162 ~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T d1unla_ 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred ccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccc
Confidence 7899999999998776689999999999999999999999744322 1111110
Q ss_pred --CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 225 --PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 225 --~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
...........+++.+.+||.+||++||.+|||++|+|+||||++.
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 0011122334678899999999999999999999999999999764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-52 Score=439.11 Aligned_cols=251 Identities=23% Similarity=0.379 Sum_probs=214.0
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCc-----EEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNK-----DVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKL 86 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~-----~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~l 86 (703)
.+|++.++||+|+||+||+|++..+++ .||||++...........+.+|+.+|.++ +|||||+++++|.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 589999999999999999999876543 69999987655555567889999999998 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEE
Q 005298 87 WIIMEYMAGGSVADLIQSG-----------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANIL 143 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~-----------------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNIL 143 (703)
|||||||++|+|.++++.. ..+++..++.|+.||+.||.|||+++||||||||+|||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 9999999999999999754 35899999999999999999999999999999999999
Q ss_pred ecCCCCeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccce
Q 005298 144 LTENGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRV 220 (703)
Q Consensus 144 Ld~~g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~ 220 (703)
++.++++||+|||+|+....... ...+.+||+.|||||++.+. .|+.++|||||||+||||+| |.+||.+.+....
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999976544322 22346789999999999875 58999999999999999997 8999988766554
Q ss_pred eecc-CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 221 LFII-PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 221 l~~I-~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+..+ .....+..+..+++.+++||.+||..+|.+|||++||++|
T Consensus 276 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 276 FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4433 3444556677899999999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=427.58 Aligned_cols=254 Identities=24% Similarity=0.433 Sum_probs=218.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIM 90 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~ 90 (703)
...+|++++.||+|+||+||+|.++ +++.||||+++..... .+.+.+|+.+|++++|||||++++++. ++.+||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~ 86 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEE
Confidence 3468999999999999999999986 5789999999754322 357899999999999999999999875 45679999
Q ss_pred eccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc-cc
Q 005298 91 EYMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI-SR 167 (703)
Q Consensus 91 Eyv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~-~~ 167 (703)
|||++|+|.+++... .++++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+.... ..
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999999987543 369999999999999999999999999999999999999999999999999998764332 22
Q ss_pred cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHH
Q 005298 168 RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSL 246 (703)
Q Consensus 168 ~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG-~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~ 246 (703)
.....||+.|||||++.+. .|+.++|||||||+||||+|| .+||...+.......+.....+..+..+++.+.+||.+
T Consensus 167 ~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 245 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHH
Confidence 3346799999999999875 589999999999999999995 55666666666666676666667778899999999999
Q ss_pred HhccCCCCCCCHHHHHh--chhhhc
Q 005298 247 CLKKVPAERPSAKELLR--HRFIRN 269 (703)
Q Consensus 247 cL~~dP~~RPTa~eLL~--Hpff~~ 269 (703)
||..+|++|||+.+|++ |+||..
T Consensus 246 cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 246 CWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999999998 788863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=437.34 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=213.9
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC-----
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----- 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~----- 84 (703)
...+|++++.||+|+||+||+|++..+|+.||||+++... .....+.+.+|+.+|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 5689999999999999999999999999999999997543 4455678899999999999999999999998755
Q ss_pred -EEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh
Q 005298 85 -KLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR 163 (703)
Q Consensus 85 -~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~ 163 (703)
.+||||||| +.+|..+++. .+|++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 6788888765 6799999999999999999999999999999999999999999999999999876533
Q ss_pred cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-------------------
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------- 224 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I------------------- 224 (703)
.....+||+.|+|||++.+...++.++|||||||+||+|++|.+||...+....+..+
T Consensus 174 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 174 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 3346789999999999987667899999999999999999999999876543322111
Q ss_pred -----------CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 225 -----------PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 225 -----------~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
...........+++.+.+||.+||..||.+|||+.|||+||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 01111122346788999999999999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-52 Score=430.43 Aligned_cols=250 Identities=28% Similarity=0.517 Sum_probs=207.7
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV 89 (703)
..++|++.+.||+|+||+||+|+.. ..||||+++... .....+.+.+|+.+|++++|||||++++++. ...+|||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv 81 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV 81 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence 4578999999999999999999754 359999987554 4556788999999999999999999999864 4568999
Q ss_pred EeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc--c
Q 005298 90 MEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI--S 166 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~--~ 166 (703)
||||++|+|.+++.. ..++++..+..|+.||+.||.|||+++||||||||+||||+.++++||+|||++....... .
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 999999999999965 4679999999999999999999999999999999999999999999999999997654322 2
Q ss_pred ccccccCCCCCCchhhhccc--cCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-CCCC-C---CCcchhhhHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNS--EGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII-PREN-P---PQLDEHFSRL 239 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~--~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I-~~~~-~---~~l~~~is~~ 239 (703)
.....+||+.|||||++.+. ..|+.++|||||||+||||+||+.||.+.+....+..+ .... + ...+..+++.
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 241 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence 23456899999999999643 24789999999999999999999999887655433222 2221 1 2345678899
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 240 MKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 240 L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+.+||.+||..+|.+|||+.||+++
T Consensus 242 l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=431.85 Aligned_cols=258 Identities=23% Similarity=0.398 Sum_probs=212.0
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-hHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe--------
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-EDEIEDIQKEISVLSQCRSPYITEYYGSYLH-------- 82 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~-------- 82 (703)
-++|++++.||+|+||+||+|++..+|+.||||++..... ......+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3799999999999999999999999999999999865542 2335678899999999999999999998865
Q ss_pred CCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhh
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLT 162 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~ 162 (703)
++.+|+|||||.++.+..+......+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||++..+.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 34689999999888887777777889999999999999999999999999999999999999999999999999986553
Q ss_pred hc----ccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC------------
Q 005298 163 RT----ISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------ 226 (703)
Q Consensus 163 ~~----~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~------------ 226 (703)
.. .......+||+.|+|||++.+...|+.++|||||||+||||++|++||...+.......+..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 22 12234468999999999998776799999999999999999999999987654433222110
Q ss_pred --------------CCCCCcch-----hhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhc
Q 005298 227 --------------ENPPQLDE-----HFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRN 269 (703)
Q Consensus 227 --------------~~~~~l~~-----~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~ 269 (703)
.....+.. ..++.+.+||.+||.+||++|||++|+|+||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 00011111 23567889999999999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-51 Score=422.08 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=213.3
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCC----cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELN----KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg----~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
....+|++.++||+|+||+||+|.++.++ ..||||++...........+.+|+.+|++++|||||++++++.+.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 44578999999999999999999987654 47999999877666667789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhc
Q 005298 86 LWIIMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRT 164 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~ 164 (703)
+|+|||||.+++|.+++... ..+++..+..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+++.+...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999999988654 67999999999999999999999999999999999999999999999999999766433
Q ss_pred ccc---cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCCCcchhhhHHH
Q 005298 165 ISR---RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPPQLDEHFSRLM 240 (703)
Q Consensus 165 ~~~---~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG-~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L 240 (703)
... .....||+.|||||++.+. .|+.++|||||||+||||++| .+||...+.......+.....++.+..++..+
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242 (283)
T ss_dssp ----------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred CccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHH
Confidence 221 2235689999999999775 589999999999999999985 55556566666666666666667778899999
Q ss_pred HHHHHHHhccCCCCCCCHHHHHh
Q 005298 241 KEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
.+||.+||..+|.+|||+.+|++
T Consensus 243 ~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 243 YQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=435.49 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=213.9
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC----EE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----KL 86 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~----~l 86 (703)
.+.+|++++.||+|+||+||+|++..+|+.||||+++........+.+.+|+.+|++|+|||||++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 46789999999999999999999999999999999987666667788999999999999999999999997653 23
Q ss_pred EEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 87 WIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 87 yLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
+++++|+.+|+|.+++.. ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++........
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 444555669999999976 4799999999999999999999999999999999999999999999999999876543322
Q ss_pred ---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeecc-------------------
Q 005298 167 ---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFII------------------- 224 (703)
Q Consensus 167 ---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I------------------- 224 (703)
.....+||+.|+|||++.....++.++||||+||++|+|++|.+||...+.......+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 2345689999999999877667899999999999999999999999876542222111
Q ss_pred --------CCCCCCC---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 225 --------PRENPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 225 --------~~~~~~~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
....... +...++..+++||.+||.+||.+|||+.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 1111111 123567789999999999999999999999999999855
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=421.06 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=212.8
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCC---CcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKEL---NKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~t---g~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyL 88 (703)
..+|++.+.||+|+||+||+|++..+ +..||||.++........+.+.+|+.+|++++|||||++++++. ++.+||
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 46899999999999999999998754 45789999876666777788999999999999999999999985 567899
Q ss_pred EEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-
Q 005298 89 IMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS- 166 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~- 166 (703)
|||||++|+|.+++.. ...+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||++..+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 9999999999998754 55799999999999999999999999999999999999999999999999999976643322
Q ss_pred ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHH
Q 005298 167 RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVS 245 (703)
Q Consensus 167 ~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~ 245 (703)
......||+.|+|||++.+. .|+.++|||||||+||||++ |.+||...+..+....+.....++++..+++.+.+||.
T Consensus 165 ~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 243 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243 (273)
T ss_dssp ------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 22345789999999999875 58999999999999999997 89999998888888777777777788899999999999
Q ss_pred HHhccCCCCCCCHHHHHhc
Q 005298 246 LCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 246 ~cL~~dP~~RPTa~eLL~H 264 (703)
+||..||.+|||+.||++|
T Consensus 244 ~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 244 KCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=437.69 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=209.6
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC------CEEE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ------TKLW 87 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~------~~ly 87 (703)
+|+.+++||+|+||+||+|++..+|+.||||++..... .+.+|+.+|++|+|||||+++++|... .++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 79999999999999999999999999999999975532 234799999999999999999998643 3589
Q ss_pred EEEeccCCCCHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC-CeeEeccccchhhhh
Q 005298 88 IIMEYMAGGSVADL---IQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTR 163 (703)
Q Consensus 88 LV~Eyv~gGsL~~~---l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g-~VKL~DFGlA~~~~~ 163 (703)
||||||+++.+..+ ......+++..++.|+.||+.||+|||++|||||||||+||||+.++ .+||+|||++..+..
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 99999976643333 34567899999999999999999999999999999999999999775 899999999876643
Q ss_pred cccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-----------------
Q 005298 164 TISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR----------------- 226 (703)
Q Consensus 164 ~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~----------------- 226 (703)
. ....+.+||+.|+|||++.+...|+.++|||||||++|||++|++||...+..+.+..+..
T Consensus 176 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 176 G-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp T-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred C-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 3 3344678999999999988766799999999999999999999999987665443322210
Q ss_pred -------CCCC----CcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhccc
Q 005298 227 -------ENPP----QLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNAR 271 (703)
Q Consensus 227 -------~~~~----~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~ 271 (703)
.... .....+++.+.+||.+||.+||.+|||+.|+|+||||+..+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000 11235688999999999999999999999999999998653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-50 Score=426.54 Aligned_cols=252 Identities=21% Similarity=0.385 Sum_probs=212.2
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeC--CEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQ--TKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~--~~lyLV 89 (703)
.+|++++.||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|+++. ||||++++++|... ..+|+|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 47999999999999999999999999999999987543 356889999999995 99999999999854 569999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC-CeeEeccccchhhhhccccc
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG-DVKVADFGVSAQLTRTISRR 168 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g-~VKL~DFGlA~~~~~~~~~~ 168 (703)
||||.+++|..+. ..+++..++.++.||+.||.|||++|||||||||+||||+.++ .+||+|||+|...... ...
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~~~ 186 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEY 186 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-CCC
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-Ccc
Confidence 9999999998764 5699999999999999999999999999999999999998765 6999999998765433 334
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccc-eee-------------------------
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMR-VLF------------------------- 222 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~-~l~------------------------- 222 (703)
...+||+.|+|||.+.+...++.++|||||||++|+|++|..||....... ...
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 567899999999999887778999999999999999999999997654211 000
Q ss_pred --ccC-C--------CCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcccc
Q 005298 223 --IIP-R--------ENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNARK 272 (703)
Q Consensus 223 --~I~-~--------~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~~~ 272 (703)
.+. . .........+++++.+||.+||.+||.+|||++|+|+||||+...+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 000 0 0111223457889999999999999999999999999999987653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=419.53 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=222.4
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++++.||+|+||+||+|+++ +++.||||+++..... .+.+.+|+.++++++|||||+++++|.+++.+|+|||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 368999999999999999999985 6889999999765432 3568999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-ccc
Q 005298 92 YMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~~ 169 (703)
|+++|+|..++.. ...+++..+..|+.||++||.|||++||+||||||+||||+.++.+||+|||++..+..... ...
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 9999999999754 46799999999999999999999999999999999999999999999999999976543322 222
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
...||+.|+|||++.+. .|+.++|||||||++|||+| |+.||...+..+....+........+..+++.+.+||.+||
T Consensus 160 ~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl 238 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238 (258)
T ss_dssp CSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred ccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHc
Confidence 36799999999999875 48999999999999999998 89999999888888777777777778889999999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q 005298 249 KKVPAERPSAKELLRH 264 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~H 264 (703)
..+|.+|||+++|++|
T Consensus 239 ~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 239 HEKADERPTFKILLSN 254 (258)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred cCCHhHCcCHHHHHHH
Confidence 9999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-51 Score=431.90 Aligned_cols=259 Identities=29% Similarity=0.512 Sum_probs=222.4
Q ss_pred CCceEEEEEeecCceEEEEEEE---cCCCcEEEEEEeccCC---ChHHHHHHHHHHHHHHhCCC-CCeeeeEEEEEeCCE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFD---KELNKDVAIKVIDLEE---SEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQTK 85 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d---~~tg~~VAIKvi~~~~---~~~~~~~l~~Ei~ILk~L~H-PnIV~L~~~~~~~~~ 85 (703)
.+|++++.||+|+||+||+|++ +.+|+.||||+++... .....+.+.+|+.+|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 4799999999999999999987 4578999999986542 12234668899999999977 899999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhh-c
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTR-T 164 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~-~ 164 (703)
+|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||++..+.. .
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~ 183 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence 999999999999999999989999999999999999999999999999999999999999999999999999976532 2
Q ss_pred ccccccccCCCCCCchhhhcccc-CCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC---CCCCCcchhhhHHH
Q 005298 165 ISRRKTFVGTPFWMAPEVIQNSE-GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR---ENPPQLDEHFSRLM 240 (703)
Q Consensus 165 ~~~~~~~iGTp~Y~APEvl~~~~-~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~---~~~~~l~~~is~~L 240 (703)
.....+..|++.|++||.+.+.. +++.++|||||||+||+|++|..||...+.......+.. ...+.++..++..+
T Consensus 184 ~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 263 (322)
T d1vzoa_ 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 263 (322)
T ss_dssp GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHH
Confidence 33345678999999999997643 467899999999999999999999987766554433322 23445667899999
Q ss_pred HHHHHHHhccCCCCCC-----CHHHHHhchhhhccc
Q 005298 241 KEFVSLCLKKVPAERP-----SAKELLRHRFIRNAR 271 (703)
Q Consensus 241 ~dLI~~cL~~dP~~RP-----Ta~eLL~Hpff~~~~ 271 (703)
.+||.+||.+||.+|| |++|+++||||+...
T Consensus 264 ~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 9999999999999999 589999999998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-50 Score=419.25 Aligned_cols=252 Identities=28% Similarity=0.465 Sum_probs=223.6
Q ss_pred hCCCceEEEEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~-----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
+.++|++++.||+|+||+||+|.++ .+++.||||+++.....+..+.+.+|+.+|++++||||++++++|...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3468999999999999999999875 35689999999877677777889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccce
Q 005298 86 LWIIMEYMAGGSVADLIQSG------------------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAAN 141 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~------------------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeN 141 (703)
.++||||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 99999999999999999643 248899999999999999999999999999999999
Q ss_pred EEecCCCCeeEeccccchhhhhcccc--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCC-CCCCCCCcc
Q 005298 142 ILLTENGDVKVADFGVSAQLTRTISR--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGE-PPLADLHPM 218 (703)
Q Consensus 142 ILLd~~g~VKL~DFGlA~~~~~~~~~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~-~PF~~~~~~ 218 (703)
|||+.++++||+|||++..+...... ..+.+||+.|+|||++.+. .|+.++||||||||||||++|. +||...+..
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 99999999999999999766433222 2346799999999999875 5999999999999999999985 789888888
Q ss_pred ceeeccCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 219 RVLFIIPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 219 ~~l~~I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
+....+.....+..+..+++.+.+||.+||..+|.+|||+.||++
T Consensus 250 e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 250 EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888777777788899999999999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-50 Score=421.51 Aligned_cols=251 Identities=23% Similarity=0.374 Sum_probs=212.7
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCc----EEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNK----DVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~----~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
..+|+++++||+|+||+||+|.+..+|+ .||||.+.........+.+.+|+.+|++++|||||+++++|.++ ..+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 3579999999999999999999988776 58888876554445567899999999999999999999999865 567
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
+++||+.+++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.++++||+|||++..+.....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 88899999999987765 46899999999999999999999999999999999999999999999999999987654332
Q ss_pred c--cccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHH
Q 005298 167 R--RKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEF 243 (703)
Q Consensus 167 ~--~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dL 243 (703)
. .....||+.|||||++.+. .|+.++|||||||+||||+| |.+||...+.......+.....+..+..++..+.+|
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~l 245 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 245 (317)
T ss_dssp --------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHH
T ss_pred cccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 2 2234689999999999875 59999999999999999998 899998887777666666666667778899999999
Q ss_pred HHHHhccCCCCCCCHHHHHhc
Q 005298 244 VSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 244 I~~cL~~dP~~RPTa~eLL~H 264 (703)
|.+||..+|.+|||+.||+.|
T Consensus 246 i~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 246 MVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCChhhCcCHHHHHHH
Confidence 999999999999999999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=427.96 Aligned_cols=255 Identities=22% Similarity=0.391 Sum_probs=212.1
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeC-----CE
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQ-----TK 85 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~-----~~ 85 (703)
..+|++++.||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|++|+|||||+++++|... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999999999999999997654 344567788999999999999999999999743 34
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
.++|++|+.||+|.+++.. .++++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 4666777789999999965 5799999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCCC------------------
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPRE------------------ 227 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~~------------------ 227 (703)
...+.+||+.|+|||++.+...++.++|||||||+||+|++|.+||...+.......+...
T Consensus 174 -~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 174 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp -GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred -ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 2345789999999999888777899999999999999999999999876543332222110
Q ss_pred ---------CCCC---cchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 228 ---------NPPQ---LDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 228 ---------~~~~---l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
.... ....+++.+++||.+||.+||.+|||+.|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0000 113467889999999999999999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=418.56 Aligned_cols=250 Identities=27% Similarity=0.422 Sum_probs=216.4
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcE--EEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCCEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKD--VAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~--VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~~lyLV 89 (703)
.+|++.++||+|+||+||+|+++.+|.. ||||.+.........+.+.+|+.+|.++ +|||||+++++|.+++.+|||
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6899999999999999999999988874 6777776554555567899999999999 799999999999999999999
Q ss_pred EeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEe
Q 005298 90 MEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVA 153 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~----------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~ 153 (703)
||||++|+|.++++.. ..+++..+..++.||+.||.|||+++||||||||+|||++.++.+||+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~ 169 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence 9999999999999754 579999999999999999999999999999999999999999999999
Q ss_pred ccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCC-CCCCCCCccceeeccCCCCCCCc
Q 005298 154 DFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGE-PPLADLHPMRVLFIIPRENPPQL 232 (703)
Q Consensus 154 DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~-~PF~~~~~~~~l~~I~~~~~~~l 232 (703)
|||++...... .......||+.|+|||.+.+. .|+.++||||||||||||++|. +||...+..+....+.....+..
T Consensus 170 DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~ 247 (309)
T d1fvra_ 170 DFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247 (309)
T ss_dssp CTTCEESSCEE-CCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCC
T ss_pred ccccccccccc-ccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 99998755433 222356799999999999875 4899999999999999999965 67888888777777777777777
Q ss_pred chhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 233 ~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+..+++.+.+||.+||..||++|||+.+|+++
T Consensus 248 ~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 88899999999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=415.77 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=211.8
Q ss_pred CCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEEEEEe
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLWIIME 91 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~lyLV~E 91 (703)
..+|++.+.||+|+||+||+|++..+ ..||||+++..... .+.+.+|+.+|++++|||||++++++. ++.+|+|||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEE
Confidence 45899999999999999999999765 57999998755432 367899999999999999999999985 456799999
Q ss_pred ccCCCCHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc-cc
Q 005298 92 YMAGGSVADLIQS--GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS-RR 168 (703)
Q Consensus 92 yv~gGsL~~~l~~--~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~-~~ 168 (703)
||++|+|..++.. ...+++..+..|+.||+.||.|||++||+||||||+||||+.++++||+|||++........ ..
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 9999999998854 45799999999999999999999999999999999999999999999999999976543322 22
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG-~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....||+.|+|||++... .++.++|||||||+||||++| .+||......+.+..+......+.+..++..+++||.+|
T Consensus 172 ~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~c 250 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250 (285)
T ss_dssp ----CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHH
Confidence 346799999999999875 589999999999999999995 555566666666676766666677889999999999999
Q ss_pred hccCCCCCCCHHHHHh--chhhhc
Q 005298 248 LKKVPAERPSAKELLR--HRFIRN 269 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~--Hpff~~ 269 (703)
|..||++||++++|+. ++||..
T Consensus 251 l~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 251 WRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cccCHhHCcCHHHHHHHHhhhhcC
Confidence 9999999999999987 677754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=414.96 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=205.2
Q ss_pred CCCceEEEEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeC-C
Q 005298 12 GSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQ-T 84 (703)
Q Consensus 12 ~~~Y~il~~LG~GsfG~Vyka~d~~-----tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~-~ 84 (703)
..+|++.+.||+|+||+||+|.+.. +++.||||+++..........+.+|+.++.++ +|||||.+++++... .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 4689999999999999999999754 45789999998666666677788888888776 689999999988764 5
Q ss_pred EEEEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCC
Q 005298 85 KLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENG 148 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~----------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g 148 (703)
.+|+|||||++|+|.+++... ..+++..+..|+.||+.||.|||++|||||||||+||||+.++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence 689999999999999999643 3589999999999999999999999999999999999999999
Q ss_pred CeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhC-CCCCCCCCcccee-ecc
Q 005298 149 DVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVL-FII 224 (703)
Q Consensus 149 ~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG-~~PF~~~~~~~~l-~~I 224 (703)
++||+|||+++....... .....+||+.|||||++.+. .|+.++|||||||+||||++| .+||........+ ..+
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~ 250 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999976543322 23356899999999999875 589999999999999999986 5678766544333 334
Q ss_pred CCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 225 PRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 225 ~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
.....+..+..+++.+.+||.+||..||.+|||+.||++|
T Consensus 251 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4445566777889999999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=422.39 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=201.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCC-ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe------CCE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEE-SEDEIEDIQKEISVLSQCRSPYITEYYGSYLH------QTK 85 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~-~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~------~~~ 85 (703)
.+|++++.||+|+||+||+|++..+|+.||||++.... .......+.+|+.+|++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999999999999999997554 34556788999999999999999999999964 468
Q ss_pred EEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcc
Q 005298 86 LWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~ 165 (703)
+|+|||||.++.|..+ ...+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~- 172 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS- 172 (355)
T ss_dssp EEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc-
Confidence 9999999976555444 356999999999999999999999999999999999999999999999999998765443
Q ss_pred cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-------------------
Q 005298 166 SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR------------------- 226 (703)
Q Consensus 166 ~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~------------------- 226 (703)
......+||+.|+|||++.+. .++.++||||+||++|+|++|++||...+.......+..
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp --------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred cccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 333457899999999999875 689999999999999999999999976654332211100
Q ss_pred ---C-------------------CCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHhchhhhcc
Q 005298 227 ---E-------------------NPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLRHRFIRNA 270 (703)
Q Consensus 227 ---~-------------------~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~Hpff~~~ 270 (703)
. ........++..+.+||.+||.+||++||||+|||+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0 0001123467889999999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=411.99 Aligned_cols=252 Identities=24% Similarity=0.458 Sum_probs=218.3
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCC-------cEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEe
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELN-------KDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLH 82 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg-------~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~ 82 (703)
...+|++.+.||+|+||.||+|++..++ ..||||++...........+.+|+.++.++ +|||||+++++|.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3469999999999999999999876554 479999998777777778889999999888 79999999999999
Q ss_pred CCEEEEEEeccCCCCHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC
Q 005298 83 QTKLWIIMEYMAGGSVADLIQSG----------------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE 146 (703)
Q Consensus 83 ~~~lyLV~Eyv~gGsL~~~l~~~----------------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~ 146 (703)
++.+|+|||||++|+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+|||++.
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence 99999999999999999999754 35899999999999999999999999999999999999999
Q ss_pred CCCeeEeccccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeec
Q 005298 147 NGDVKVADFGVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI 223 (703)
Q Consensus 147 ~g~VKL~DFGlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~ 223 (703)
++.+||+|||++........ .....+||+.|+|||++.+. .|+.++||||||||||||++ |.+||...+.......
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~ 249 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence 99999999999886654322 22346799999999999875 59999999999999999998 7999988887777667
Q ss_pred cCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 224 IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 224 I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
+.....+..+..+++.+.+||.+||.++|.+|||+.||++
T Consensus 250 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 250 LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 7666677778889999999999999999999999999997
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=404.99 Aligned_cols=243 Identities=28% Similarity=0.457 Sum_probs=208.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe-CCEEEEEEe
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKLWIIME 91 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~-~~~lyLV~E 91 (703)
.+|++++.||+|+||.||+|.++ |..||||+++... ..+.+.+|+.++++++|||||++++++.+ .+.+|||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 47999999999999999999985 7899999996543 34678999999999999999999998865 466899999
Q ss_pred ccCCCCHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccccc
Q 005298 92 YMAGGSVADLIQSG--PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISRRK 169 (703)
Q Consensus 92 yv~gGsL~~~l~~~--~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~~~ 169 (703)
|+++|+|.+++... ..+++..++.|+.||+.||.|||+++||||||||+|||++.+|++||+|||++...... ..
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---~~ 158 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QD 158 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC---Cc
Confidence 99999999999653 35899999999999999999999999999999999999999999999999998765432 23
Q ss_pred cccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCCCCCCcchhhhHHHHHHHHHHh
Q 005298 170 TFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRENPPQLDEHFSRLMKEFVSLCL 248 (703)
Q Consensus 170 ~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~cL 248 (703)
...+|+.|+|||++.+. .++.++|||||||++|||+| |.+||...+..+....+.....+.++..+++.+.+||.+||
T Consensus 159 ~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl 237 (262)
T d1byga_ 159 TGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237 (262)
T ss_dssp ---CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 46789999999999875 58999999999999999998 79999888877878888777777888889999999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q 005298 249 KKVPAERPSAKELLRH 264 (703)
Q Consensus 249 ~~dP~~RPTa~eLL~H 264 (703)
..||.+|||+.+|+++
T Consensus 238 ~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 238 HLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred ccCHhHCcCHHHHHHH
Confidence 9999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=408.63 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=223.5
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcC-----CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKE-----LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTK 85 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~-----tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ 85 (703)
...+|++.+.||+|+||+||+|.+.. ++..||||+++..........+.+|+.++++++|||||++++++..++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 34799999999999999999998753 3678999999876666677789999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecc
Q 005298 86 LWIIMEYMAGGSVADLIQSG----------PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADF 155 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~~l~~~----------~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DF 155 (703)
.++|||||.+|+|.+++... ..+++..+..|+.||+.||.|||+++||||||||+||||+.++++||+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeec
Confidence 99999999999999998532 35789999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhccc--ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhC-CCCCCCCCccceeeccCCCCCCCc
Q 005298 156 GVSAQLTRTIS--RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKG-EPPLADLHPMRVLFIIPRENPPQL 232 (703)
Q Consensus 156 GlA~~~~~~~~--~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG-~~PF~~~~~~~~l~~I~~~~~~~l 232 (703)
|++..+..... .....+||+.|+|||.+.+. .++.++|||||||+||||+|| .+||...+....+..+.....+..
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~ 256 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK 256 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 99976644322 22345789999999999875 588999999999999999998 588988888777777777777777
Q ss_pred chhhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 233 DEHFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 233 ~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
+..++..+.+||.+||..+|.+|||+.+|+++
T Consensus 257 p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 257 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 78899999999999999999999999999983
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=404.25 Aligned_cols=249 Identities=23% Similarity=0.383 Sum_probs=203.8
Q ss_pred CCceEEEEEeecCceEEEEEEEcC-CC--cEEEEEEeccCC--ChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCCEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKE-LN--KDVAIKVIDLEE--SEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~-tg--~~VAIKvi~~~~--~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~~ly 87 (703)
.+|++++.||+|+||+||+|+... ++ ..||||+++... .....+.+.+|+.+|++++|||||++++++.+ ..+|
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 579999999999999999998653 33 478999986543 33456789999999999999999999999965 4678
Q ss_pred EEEeccCCCCHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhccc
Q 005298 88 IIMEYMAGGSVADLIQS-GPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTIS 166 (703)
Q Consensus 88 LV~Eyv~gGsL~~~l~~-~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~ 166 (703)
+|||||++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 99999999999987754 45799999999999999999999999999999999999999999999999999987643322
Q ss_pred ---ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeeccCCC-CCCCcchhhhHHHH
Q 005298 167 ---RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFIIPRE-NPPQLDEHFSRLMK 241 (703)
Q Consensus 167 ---~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~I~~~-~~~~l~~~is~~L~ 241 (703)
......|++.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+... ..++.+..++..+.
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~ 245 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHH
T ss_pred cceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHH
Confidence 12235688899999999875 59999999999999999998 89999998887776666443 34456678899999
Q ss_pred HHHHHHhccCCCCCCCHHHHHh
Q 005298 242 EFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 242 dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
+||.+||..||++|||+.+|++
T Consensus 246 ~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 246 NVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999974
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=404.15 Aligned_cols=252 Identities=26% Similarity=0.391 Sum_probs=217.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEc-----CCCcEEEEEEeccCCChHHHHHHHHHHHHHHhC-CCCCeeeeEEEEEeCC
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDK-----ELNKDVAIKVIDLEESEDEIEDIQKEISVLSQC-RSPYITEYYGSYLHQT 84 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~-----~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L-~HPnIV~L~~~~~~~~ 84 (703)
...+|++.++||+|+||.||+|.+. .+++.||||+++..........+.+|+.+++++ +|||||++++++.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3468999999999999999999863 467899999998777677777899999999999 6999999999999999
Q ss_pred EEEEEEeccCCCCHHHHHHcCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC
Q 005298 85 KLWIIMEYMAGGSVADLIQSGP------------------PLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE 146 (703)
Q Consensus 85 ~lyLV~Eyv~gGsL~~~l~~~~------------------~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~ 146 (703)
.+|||||||++|+|.+++.... .+++..+..|+.||+.||.|||+++||||||||+|||++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 9999999999999999997533 5899999999999999999999999999999999999999
Q ss_pred CCCeeEeccccchhhhhcc--cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccceeec
Q 005298 147 NGDVKVADFGVSAQLTRTI--SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAK-GEPPLADLHPMRVLFI 223 (703)
Q Consensus 147 ~g~VKL~DFGlA~~~~~~~--~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLt-G~~PF~~~~~~~~l~~ 223 (703)
++++||+|||++....... ......+||+.|+|||++.+. .++.++|||||||+||||+| |.+||...+....+..
T Consensus 181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999998664322 222346899999999999875 58999999999999999998 6777766665544433
Q ss_pred -cCCCCCCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 224 -IPRENPPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 224 -I~~~~~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
+.....+..+..++..+.+||.+||..||.+|||+.||++
T Consensus 260 ~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 260 MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3344555666788999999999999999999999999996
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=399.44 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=208.1
Q ss_pred EEEEeecCceEEEEEEEcCCC---cEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEe-CCEEEEEEecc
Q 005298 18 LELIGRGSFGDVYKAFDKELN---KDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLH-QTKLWIIMEYM 93 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg---~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~-~~~lyLV~Eyv 93 (703)
.++||+|+||+||+|.+..++ ..||||.++........+.+.+|+++|++|+|||||++++++.. ++.+|+|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 578999999999999986643 46999999876677778899999999999999999999999876 56899999999
Q ss_pred CCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEeccccchhhhhcccc----c
Q 005298 94 AGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGVSAQLTRTISR----R 168 (703)
Q Consensus 94 ~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~~~~~~~~----~ 168 (703)
++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++......... .
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~ 191 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceec
Confidence 999999998754 46788899999999999999999999999999999999999999999999999765433211 2
Q ss_pred ccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCC-CccceeeccCCCCCCCcchhhhHHHHHHHHHH
Q 005298 169 KTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADL-HPMRVLFIIPRENPPQLDEHFSRLMKEFVSLC 247 (703)
Q Consensus 169 ~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~-~~~~~l~~I~~~~~~~l~~~is~~L~dLI~~c 247 (703)
....||+.|+|||.+... .++.++|||||||+||||++|..||... +..+....+..+..+..+..+++.+.+||.+|
T Consensus 192 ~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~c 270 (311)
T d1r0pa_ 192 TGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 270 (311)
T ss_dssp TCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHH
Confidence 235789999999999875 5899999999999999999977776543 44445555555566667778899999999999
Q ss_pred hccCCCCCCCHHHHHhc
Q 005298 248 LKKVPAERPSAKELLRH 264 (703)
Q Consensus 248 L~~dP~~RPTa~eLL~H 264 (703)
|..||++||++.||++|
T Consensus 271 l~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 271 WHPKAEMRPSFSELVSR 287 (311)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHH
Confidence 99999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-47 Score=393.56 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=202.2
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCC-eeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPY-ITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPn-IV~L~~~~~~~~~lyLV 89 (703)
++++|++++.||+|+||.||+|++..+|+.||||++...... ..+..|+.+++++.|+| |+.++.++..++..|+|
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 467899999999999999999999999999999998754322 35788999999998766 55556667788899999
Q ss_pred EeccCCCCHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC---CCCeeEeccccchhhhhcc
Q 005298 90 MEYMAGGSVADLI-QSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE---NGDVKVADFGVSAQLTRTI 165 (703)
Q Consensus 90 ~Eyv~gGsL~~~l-~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~---~g~VKL~DFGlA~~~~~~~ 165 (703)
|||+. ++|...+ .....+++..+..++.||+.||.|||++|||||||||+|||++. +..+||+|||++..+....
T Consensus 82 me~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99994 5555555 45678999999999999999999999999999999999999864 4579999999998664322
Q ss_pred c-------ccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCccceeeccCC-------CCCCC
Q 005298 166 S-------RRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLFIIPR-------ENPPQ 231 (703)
Q Consensus 166 ~-------~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~~I~~-------~~~~~ 231 (703)
. .....+||+.|||||++.+. .++.++|||||||++|||++|..||...........+.. ...+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 1 23456899999999999875 589999999999999999999999987655443332211 11112
Q ss_pred cchhhhHHHHHHHHHHhccCCCCCCCHHHH---Hhchhhhc
Q 005298 232 LDEHFSRLMKEFVSLCLKKVPAERPSAKEL---LRHRFIRN 269 (703)
Q Consensus 232 l~~~is~~L~dLI~~cL~~dP~~RPTa~eL---L~Hpff~~ 269 (703)
+...+|+.+.+||..||.++|.+||++.+| |+|+|.+.
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 334678999999999999999999998754 66666543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-45 Score=384.52 Aligned_cols=249 Identities=19% Similarity=0.264 Sum_probs=207.2
Q ss_pred hhCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC-CCeeeeEEEEEeCCEEEE
Q 005298 10 AAGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-PYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 10 ~~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H-PnIV~L~~~~~~~~~lyL 88 (703)
..+++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.|.| +||+.+++++..+...|+
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 357899999999999999999999999999999999865432 2456789999999976 899999999999999999
Q ss_pred EEeccCCCCHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecC-----CCCeeEeccccchhhh
Q 005298 89 IMEYMAGGSVADLIQSG-PPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTE-----NGDVKVADFGVSAQLT 162 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~-~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~-----~g~VKL~DFGlA~~~~ 162 (703)
||||+ +++|.+++... ..+++..+..++.|++.||.|||++|||||||||+||||+. .+.+||+|||+++.+.
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999988764 47999999999999999999999999999999999999974 5789999999997654
Q ss_pred hcc-------cccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee---eccCC----CC
Q 005298 163 RTI-------SRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL---FIIPR----EN 228 (703)
Q Consensus 163 ~~~-------~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l---~~I~~----~~ 228 (703)
... ......+||+.|||||++.+. .++.++|||||||++|||++|..||......... ..+.. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 321 123356899999999999875 5999999999999999999999999765433221 11110 11
Q ss_pred CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHHh
Q 005298 229 PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELLR 263 (703)
Q Consensus 229 ~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL~ 263 (703)
+..+...+|+++.+|+..|+..+|.+||+++.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11233467889999999999999999999887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=385.00 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=193.9
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCCCCeeeeEEEEEeCC----EEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRSPYITEYYGSYLHQT----KLWI 88 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~HPnIV~L~~~~~~~~----~lyL 88 (703)
..|.+.+.||+|+||+||+|+. +|+.||||+++... ........|+..+.+++|||||++++++.+.+ .+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 5789999999999999999986 58999999986442 11222334566667889999999999998754 6899
Q ss_pred EEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------cCceeeeeccceEEecCCCCeeEeccccchh
Q 005298 89 IMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN--------EGKIHRDIKAANILLTENGDVKVADFGVSAQ 160 (703)
Q Consensus 89 V~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs--------~gIVHRDIKPeNILLd~~g~VKL~DFGlA~~ 160 (703)
|||||++|+|.+++++ .++++..+..++.|++.||.|||. +|||||||||+||||+.++++||+|||++..
T Consensus 79 v~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999999987 469999999999999999999996 5999999999999999999999999999876
Q ss_pred hhhccc----ccccccCCCCCCchhhhcccc-----CCccccchhhHHHHHHHHHhCCCCCCCCCccceee---------
Q 005298 161 LTRTIS----RRKTFVGTPFWMAPEVIQNSE-----GYNEKADIWSLGITVIEMAKGEPPLADLHPMRVLF--------- 222 (703)
Q Consensus 161 ~~~~~~----~~~~~iGTp~Y~APEvl~~~~-----~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l~--------- 222 (703)
...... .....+||+.|||||++.+.. .++.++|||||||+||||+||.+||..........
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 643221 223468999999999987532 25678999999999999999998875432211110
Q ss_pred ------c-cCCCCCCCcch-----hhhHHHHHHHHHHhccCCCCCCCHHHHHhc
Q 005298 223 ------I-IPRENPPQLDE-----HFSRLMKEFVSLCLKKVPAERPSAKELLRH 264 (703)
Q Consensus 223 ------~-I~~~~~~~l~~-----~is~~L~dLI~~cL~~dP~~RPTa~eLL~H 264 (703)
. ......+.++. .....+.+|+.+||..||++|||+.||+++
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0 00111122222 344668999999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.4e-43 Score=371.35 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=197.7
Q ss_pred CCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----------CCCeeeeEEEEE
Q 005298 13 SRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----------SPYITEYYGSYL 81 (703)
Q Consensus 13 ~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-----------HPnIV~L~~~~~ 81 (703)
++|+++++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.+++.++ |+|||++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 57999999999999999999999999999999997542 33466788999988875 578999999886
Q ss_pred e--CCEEEEEEeccCCCCHHHH-H--HcCCCCCHHHHHHHHHHHHHHHHHHHh-cCceeeeeccceEEecCCCC------
Q 005298 82 H--QTKLWIIMEYMAGGSVADL-I--QSGPPLDEMSIACILRDLLHAIEYLHN-EGKIHRDIKAANILLTENGD------ 149 (703)
Q Consensus 82 ~--~~~lyLV~Eyv~gGsL~~~-l--~~~~~L~e~~i~~i~~QLl~AL~yLHs-~gIVHRDIKPeNILLd~~g~------ 149 (703)
. ....+++++++..+..... . .....+++..++.++.||+.||.|||+ +||+||||||+||||+.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 5 3566777776654433222 2 335689999999999999999999998 89999999999999987653
Q ss_pred eeEeccccchhhhhcccccccccCCCCCCchhhhccccCCccccchhhHHHHHHHHHhCCCCCCCCCcccee--------
Q 005298 150 VKVADFGVSAQLTRTISRRKTFVGTPFWMAPEVIQNSEGYNEKADIWSLGITVIEMAKGEPPLADLHPMRVL-------- 221 (703)
Q Consensus 150 VKL~DFGlA~~~~~~~~~~~~~iGTp~Y~APEvl~~~~~~s~ksDVWSLGvILyELLtG~~PF~~~~~~~~l-------- 221 (703)
+||+|||.+..... .....+||+.|+|||++... .|+.++|||||||++++|++|+.||.........
T Consensus 171 ~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeeccccccccc---ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 99999999865432 23457899999999999875 5899999999999999999999999654321100
Q ss_pred -----------------------------eccCCCC----------CCCcchhhhHHHHHHHHHHhccCCCCCCCHHHHH
Q 005298 222 -----------------------------FIIPREN----------PPQLDEHFSRLMKEFVSLCLKKVPAERPSAKELL 262 (703)
Q Consensus 222 -----------------------------~~I~~~~----------~~~l~~~is~~L~dLI~~cL~~dP~~RPTa~eLL 262 (703)
..+.... ........++.+.+||.+||.+||.+|||++|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0000000 1123356678899999999999999999999999
Q ss_pred hchhhhcc
Q 005298 263 RHRFIRNA 270 (703)
Q Consensus 263 ~Hpff~~~ 270 (703)
+||||++.
T Consensus 327 ~Hp~f~~~ 334 (362)
T d1q8ya_ 327 NHPWLKDT 334 (362)
T ss_dssp TCGGGTTC
T ss_pred cCcccCCC
Confidence 99999855
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=1.6e-24 Score=210.48 Aligned_cols=170 Identities=16% Similarity=0.203 Sum_probs=122.7
Q ss_pred ceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCC-----------------hHHHHHHHHHHHHHHhCCCCCeeeeE
Q 005298 15 FSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEES-----------------EDEIEDIQKEISVLSQCRSPYITEYY 77 (703)
Q Consensus 15 Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~-----------------~~~~~~l~~Ei~ILk~L~HPnIV~L~ 77 (703)
+.+.+.||+|+||+||+|.+. +|+.||||+++.... .........|..++.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999986 699999998753211 01123455788999999999999988
Q ss_pred EEEEeCCEEEEEEeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhcCceeeeeccceEEecCCCCeeEecccc
Q 005298 78 GSYLHQTKLWIIMEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHNEGKIHRDIKAANILLTENGDVKVADFGV 157 (703)
Q Consensus 78 ~~~~~~~~lyLV~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs~gIVHRDIKPeNILLd~~g~VKL~DFGl 157 (703)
++. . .+++|||+++..+.. +++..+..++.||+.+|.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 653 2 279999998765543 4556678899999999999999999999999999999865 489999999
Q ss_pred chhhhhcccccccccC-CCCCCchhhhccccCCccccchhhHHHHH
Q 005298 158 SAQLTRTISRRKTFVG-TPFWMAPEVIQNSEGYNEKADIWSLGITV 202 (703)
Q Consensus 158 A~~~~~~~~~~~~~iG-Tp~Y~APEvl~~~~~~s~ksDVWSLGvIL 202 (703)
+.....+.... +.. .... -.+.+. +.|+.++|+||+.--+
T Consensus 149 a~~~~~~~~~~--~l~rd~~~-~~~~f~--r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 149 SVEVGEEGWRE--ILERDVRN-IITYFS--RTYRTEKDINSAIDRI 189 (191)
T ss_dssp CEETTSTTHHH--HHHHHHHH-HHHHHH--HHHCCCCCHHHHHHHH
T ss_pred cccCCCCCcHH--HHHHHHHH-HHHHHc--CCCCCcccHHHHHHHH
Confidence 86554321110 000 0000 012232 3478899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.46 E-value=1.8e-07 Score=91.99 Aligned_cols=141 Identities=17% Similarity=0.154 Sum_probs=94.8
Q ss_pred hCCCceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEEEE
Q 005298 11 AGSRFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLWII 89 (703)
Q Consensus 11 ~~~~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~lyLV 89 (703)
.-.+|++++..+.++.+.||++. ..+..++||+...... .....+.+|..++..|. +--+.+++.+...++..|+|
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 44688888887777778999885 3466788888753321 11234677888877664 33356777888888999999
Q ss_pred EeccCCCCHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 005298 90 MEYMAGGSVADLIQSGPPLDEMSIACILRDLLHAIEYLHN---------------------------------------- 129 (703)
Q Consensus 90 ~Eyv~gGsL~~~l~~~~~L~e~~i~~i~~QLl~AL~yLHs---------------------------------------- 129 (703)
|++++|.++.+..... .....++.++...|..||+
T Consensus 89 ~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9999998886654211 1112223333333344442
Q ss_pred -------------c------CceeeeeccceEEecCCCCeeEeccccch
Q 005298 130 -------------E------GKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 130 -------------~------gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
. .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 27899999999999877666799999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.00 E-value=3.9e-06 Score=81.73 Aligned_cols=75 Identities=12% Similarity=0.110 Sum_probs=52.2
Q ss_pred EEeecC-ceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC--CCeeeeEEEEEeCCEEEEEEeccCCC
Q 005298 20 LIGRGS-FGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS--PYITEYYGSYLHQTKLWIIMEYMAGG 96 (703)
Q Consensus 20 ~LG~Gs-fG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H--PnIV~L~~~~~~~~~lyLV~Eyv~gG 96 (703)
.+..|. .+.||+.... .+..+++|...... ...+..|+.+|+.|.. -.+.+++.+..+++..|+||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 344444 4689988754 46678999865443 2346778887776642 33667788888888999999999886
Q ss_pred CHH
Q 005298 97 SVA 99 (703)
Q Consensus 97 sL~ 99 (703)
++.
T Consensus 92 ~~~ 94 (255)
T d1nd4a_ 92 DLL 94 (255)
T ss_dssp ETT
T ss_pred ccc
Confidence 653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.94 E-value=6.8e-06 Score=86.81 Aligned_cols=78 Identities=19% Similarity=0.198 Sum_probs=49.9
Q ss_pred EEEEeecCceEEEEEEEcCCCcEEEEEEeccC------CChHHHHHHHHHHHHHHhCC-C--CCeeeeEEEEEeCCEEEE
Q 005298 18 LELIGRGSFGDVYKAFDKELNKDVAIKVIDLE------ESEDEIEDIQKEISVLSQCR-S--PYITEYYGSYLHQTKLWI 88 (703)
Q Consensus 18 l~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~------~~~~~~~~l~~Ei~ILk~L~-H--PnIV~L~~~~~~~~~lyL 88 (703)
.+.||.|....||++.+...++.|+||.-... ...-...+...|+.+|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56799999999999998888889999974321 01112345567888887662 2 345555543 4556689
Q ss_pred EEeccCCCC
Q 005298 89 IMEYMAGGS 97 (703)
Q Consensus 89 V~Eyv~gGs 97 (703)
||||+.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.93 E-value=0.0011 Score=67.29 Aligned_cols=68 Identities=16% Similarity=0.137 Sum_probs=43.8
Q ss_pred ceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCCC-----CCeeeeE--EEEEeCCEEEEEEeccCCC
Q 005298 26 FGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCRS-----PYITEYY--GSYLHQTKLWIIMEYMAGG 96 (703)
Q Consensus 26 fG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~H-----PnIV~L~--~~~~~~~~lyLV~Eyv~gG 96 (703)
--.||++... +|..|++|+.+.... ..+++..|..++..|.. +..+..- ..+..++..+.+++|+.|.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 4589999764 588999999865432 13557778888777642 2222211 1334567789999999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.74 E-value=0.0019 Score=67.22 Aligned_cols=76 Identities=16% Similarity=0.155 Sum_probs=51.2
Q ss_pred eEEEEEeecCceEEEEEEEcC-------CCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-CCCeeeeEEEEEeCCEEE
Q 005298 16 SSLELIGRGSFGDVYKAFDKE-------LNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-SPYITEYYGSYLHQTKLW 87 (703)
Q Consensus 16 ~il~~LG~GsfG~Vyka~d~~-------tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-HPnIV~L~~~~~~~~~ly 87 (703)
-.++.|+.|-.-.+|++.... ....|.+++.-... .. ....+|..+++.+. +.-..++++++. + .
T Consensus 45 l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~-idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g 117 (395)
T d1nw1a_ 45 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TE-SHLVAESVIFTLLSERHLGPKLYGIFS--G--G 117 (395)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CH-HHHHHHHHHHHHHHHTTSSSCEEEEET--T--E
T ss_pred eEEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hh-hHHHHHHHHHHHHHhCCCCCeEEEEcC--C--c
Confidence 345788889999999998653 24568888865222 22 34567888888875 333457777653 3 6
Q ss_pred EEEeccCCCCH
Q 005298 88 IIMEYMAGGSV 98 (703)
Q Consensus 88 LV~Eyv~gGsL 98 (703)
+|+||++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 88999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.56 E-value=0.0046 Score=61.63 Aligned_cols=141 Identities=11% Similarity=0.139 Sum_probs=73.0
Q ss_pred CceEEEEEeecCceEEEEEEEcCCCcEEEEEEeccCCChHHHHHHHHHHHHHHhCC-----CCCeeeeEE---EEEeCCE
Q 005298 14 RFSSLELIGRGSFGDVYKAFDKELNKDVAIKVIDLEESEDEIEDIQKEISVLSQCR-----SPYITEYYG---SYLHQTK 85 (703)
Q Consensus 14 ~Y~il~~LG~GsfG~Vyka~d~~tg~~VAIKvi~~~~~~~~~~~l~~Ei~ILk~L~-----HPnIV~L~~---~~~~~~~ 85 (703)
+..-++.|..|---+.|++.... ..|++|++...... ..+..|+.++..|. .|..+...+ +......
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~--g~yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~ 93 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 93 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESS--CCEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred CceEeecCCCCcccCeEEEEECC--CcEEEEEcCCCCCH---HHHHHHHHHHHhhhhccccccccceecCCCcceeeecc
Confidence 33445556677778899987653 35899998643222 34455666666553 233222211 2223456
Q ss_pred EEEEEeccCCCCHHH-----H------HH------cCC------CCCHH------------------HHHHHHHHHHHHH
Q 005298 86 LWIIMEYMAGGSVAD-----L------IQ------SGP------PLDEM------------------SIACILRDLLHAI 124 (703)
Q Consensus 86 lyLV~Eyv~gGsL~~-----~------l~------~~~------~L~e~------------------~i~~i~~QLl~AL 124 (703)
.+.++.++.|..... . +. ... ..... .....+..+...+
T Consensus 94 ~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 173 (316)
T d2ppqa1 94 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 173 (316)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred cceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhh
Confidence 677777766532211 0 00 000 00000 1111222222222
Q ss_pred HHHH----hcCceeeeeccceEEecCCCCeeEeccccch
Q 005298 125 EYLH----NEGKIHRDIKAANILLTENGDVKVADFGVSA 159 (703)
Q Consensus 125 ~yLH----s~gIVHRDIKPeNILLd~~g~VKL~DFGlA~ 159 (703)
.-.+ ..|+||+|+.+.||+++.+...-|+||+.|+
T Consensus 174 ~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 174 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 2222 1379999999999999988777899999763
|